Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
PLCXD1	FLJ11323	ENSG00000182378	"Phosphatidylinositol specific phospholipase C X domain containing 1"	Q9NUJ7	X	276322-303356	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.3"	"Cell line enhanced"	"Detected in many"		"HEL: 53.0"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 42.3;cerebellum: 24.6;cerebral cortex: 19.1;pons and medulla: 29.2"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA007721	Approved		Approved	Cytosol				Cytosol		"HPA007721: AB_1079630"	"unprognostic (2.73e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.57e-2)"	"prognostic unfavourable (8.10e-4)"	"unprognostic (3.80e-2)"	"prognostic favourable (2.50e-4)"	"unprognostic (1.47e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.80e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.11e-3)"	"prognostic unfavourable (7.82e-14)"	"unprognostic (6.01e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.78e-1)"	7.4	1.5	6.5	5.3	42.3	18.8	8.7	24.6	19.1	8.9	3.7	2.1	2.1	5.3	9.1	2.1	11.4	3.5	5.3	2.8	7.1	4.2	3.1	5.4	3.5	10.0	4.8	3.6	19.3	4.3	2.3	5.5	12.5	29.2	3.5	3.5	2.1	7.0	2.4	4.5	11.6	5.9	2.1	22.2	10.5	17.3	3.6	6.7	2.1	5.1	2.1	5.4	4.7	7.9	5.8	2.9	6.3	11.9	1.8	4.1	2.7	8.7	33.4	8.1	12.1	1.7	1.3	6.4	7.9	0.9	4.2	4.1	13.5	9.5	11.2	5.5	3.4	2.7	2.0	5.2	2.2	6.7	14.9	53.0	10.8	18.0	5.2	5.4	20.9	6.9	0.7	15.6	1.6	3.2	13.8	6.1	3.0	2.7	16.3	8.0	17.2	6.5	9.3	4.4	16.4	1.3	4.1	8.7	4.6	8.0	4.8	7.3	9.1	7.5	2.3	5.6	9.0	6.1	8.6	2.1	5.5	26.0	3.7	14.4	6.0	4.3	3.8	6.3	2.8	8.1	3.9	2.3	2.2	3.4	2.9	5.8	2.8	2.7	4.9	1.8	11.9	2.7	4.1	2.7	6.5	42.3	24.6	19.1	7.1	4.2	4.8	3.6	29.2	6.7
GTPBP6	"FLJ20977, PGPL"	ENSG00000178605	"GTP binding protein 6 (putative)"		X	304529-318819	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB034924, HPA035467, HPA055418"	Approved		Uncertain	Mitochondria				Mitochondria		"CAB034924: AB_2115410, HPA035467: AB_10671104, HPA055418: "	"unprognostic (5.00e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.30e-3)"	"prognostic unfavourable (8.87e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.10e-2)"	"prognostic favourable (1.71e-4)"	"unprognostic (3.38e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.99e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.05e-2)"	6.3	4.9	22.2	5.6	40.5	8.1	33.6	30.5	29.9	18.9	5.2	0.6	0.6	7.0	17.0	0.6	4.7	6.3	3.1	19.7	22.7	5.9	21.1	4.0	4.1	6.0	39.5	15.0	18.2	11.9	2.1	16.6	16.6	26.4	4.1	1.6	0.6	11.2	4.7	22.8	5.7	7.6	1.9	25.5	6.4	7.5	2.4	34.2	0.6	4.1	0.6	1.9	3.7	25.4	7.3	11.1	8.1	6.3	5.3	9.2	3.8	15.2	25.3	5.6	11.7	6.5	7.1	20.9	9.5	7.1	12.1	11.1	38.6	12.8	19.1	13.5	5.3	9.5	5.9	9.2	2.0	15.9	17.2	15.8	12.4	26.4	17.6	10.6	15.5	8.8	12.3	8.0	5.9	9.7	11.6	9.0	4.9	30.1	18.8	14.0	13.7	18.0	8.4	9.9	30.6	7.0	17.8	15.8	13.5	10.4	11.8	17.5	10.5	9.3	12.8	17.7	12.2	26.1	14.6	12.3	11.0	29.5	9.2	14.0	8.1	8.1	6.3	6.7	7.8	6.3	7.6	7.3	6.9	8.7	6.1	6.0	8.5	7.7	0.9	5.3	5.8	11.1	9.2	3.8	22.2	40.5	30.5	29.9	22.7	5.9	39.5	15.0	26.4	34.2
PPP2R3B	"PPP2R3L, PPP2R3LY, PR48, PR70"	ENSG00000167393	"Protein phosphatase 2 regulatory subunit B''beta"	Q9Y5P8	X	333963-386955	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 43.5"	"Cell line enhanced"	"Detected in many"		"PC-3: 15.2;U-698: 23.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.3"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA026606			Supported	Nucleoplasm				Nucleoplasm		"HPA026606: "	"unprognostic (1.25e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.79e-2)"	"prognostic favourable (2.92e-5)"	"unprognostic (4.65e-2)"	"unprognostic (2.29e-8)"	"unprognostic (1.15e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.17e-1)"	"prognostic favourable (1.90e-5)"	1.8	1.3	8.8	1.1	11.7	3.8	4.8	9.1	8.7	7.6	1.2	0.0	0.0	1.4	6.6	0.7	2.4	2.3	1.4	17.7	12.2	2.9	4.1	1.1	1.5	1.7	15.4	6.2	6.9	2.9	1.5	11.0	8.9	13.0	2.4	0.7	0.0	1.6	1.2	43.5	3.9	1.3	1.6	8.3	1.8	1.8	4.1	15.0	0.0	1.0	0.0	0.9	2.9	2.6	0.1	0.6	2.3	0.1	0.0	1.3	0.1	0.5	5.2	0.7	2.2	0.1	0.2	7.0	5.8	1.5	5.2	6.2	5.2	0.0	0.0	3.2	4.4	0.0	0.2	0.0	1.3	3.7	4.2	1.2	1.8	0.2	0.0	1.9	2.2	0.1	0.1	0.0	3.2	0.1	1.0	0.3	1.2	2.6	8.8	7.7	2.3	15.2	4.0	3.4	0.3	1.4	1.5	0.0	9.0	0.0	0.9	4.1	0.0	2.3	0.3	3.1	2.9	0.0	1.9	0.0	0.0	23.8	0.1	2.6	3.9	0.0	0.0	2.3	0.1	0.1	1.3	0.1	0.1	0.0	0.6	0.1	0.3	0.3	0.1	0.0	0.1	0.5	0.0	0.1	8.8	11.7	9.1	8.7	12.2	2.9	15.4	6.2	13.0	15.0
SHOX	"GCFX, PHOG, SHOXY, SS"	ENSG00000185960	"Short stature homeobox"	O15266	X	624344-659411	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.3;breast: 13.9"	"Group enriched"	"Detected in some"	4	"BJ: 19.1;BJ hTERT+: 8.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"pons and medulla: 6.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA035141, HPA060931"			Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA035141: , HPA060931: "	"unprognostic (7.51e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-1)"	"unprognostic (6.82e-2)"			"unprognostic (2.45e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.67e-6)"	"unprognostic (1.99e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.38e-1)"	3.8	1.0	0.3	0.7	0.3	3.0	13.9	1.8	0.8	0.3	0.4	0.2	0.2	1.4	0.3	0.6	0.3	0.4	0.4	0.4	0.7	0.3	0.3	0.3	0.3	0.6	0.3	1.4	0.3	0.9	0.0	0.3	4.8	6.3	0.8	0.3	0.2	1.4	0.2	2.8	1.4	1.0	0.2	0.4	1.6	0.4	0.4	0.2	0.2	0.5	0.2	0.2	0.3	0.3	2.2	1.9	5.5	1.8	2.5	1.5	0.8	0.1	0.2	0.1	0.2	0.2	0.1	3.2	19.1	8.8	2.9	3.1	0.3	0.3	0.3	0.1	0.4	0.3	0.2	0.0	0.9	0.2	0.1	0.1	1.3	0.1	0.1	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.2	0.8	0.1	0.2	0.1	0.2	0.1	0.3	0.1	0.3	0.2	0.0	0.2	0.2	0.0	0.1	0.1	0.1	0.5	0.0	0.1	0.3	0.2	0.1	0.1	0.9	0.1	0.2	0.1	0.2	0.1	5.5	1.8	1.8	1.4	1.1	1.5	1.6	1.1	1.2	0.5	2.2	1.5	1.5	5.2	2.5	1.5	1.9	1.0	0.8	0.3	0.3	1.8	0.4	0.7	0.3	0.3	1.4	6.3	0.2
CRLF2	"CRL2, TSLPR"	ENSG00000205755	"Cytokine receptor like factor 2"	Q9HC73	X	1187549-1212750	"Cancer-related genes, Predicted membrane proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"endometrium 1: 7.8"	"Cell line enhanced"	"Detected in some"		"HMC-1: 18.1;RPMI-8226: 4.6;U-698: 3.9"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	43	"plasmacytoid DC: 4.3"	"Lineage enriched"	"Detected in single"	43	"dendritic cells: 4.3"														"Intracellular and membrane"						"unprognostic (7.84e-2)"	"unprognostic (7.99e-4)"	"unprognostic (6.02e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.15e-3)"	"unprognostic (2.31e-6)"	"unprognostic (1.72e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.88e-5)"	"unprognostic (7.09e-3)"	"unprognostic (4.81e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.62e-1)"	0.8	0.0	0.2	4.1	0.2	4.1	0.6	0.2	0.2	3.0	0.7	0.2	0.2	0.2	7.8	0.2	0.9	0.2	3.7	0.2	0.2	0.1	0.9	0.2	1.9	0.2	0.2	0.2	0.2	0.2	0.0	0.2	1.0	0.2	0.6	0.9	0.2	0.8	0.2	0.2	0.7	1.5	0.3	0.2	0.6	1.0	0.2	0.2	0.2	0.2	0.2	1.4	1.3	0.6	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.5	0.0	0.6	1.0	0.2	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.5	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.7	1.0	3.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
CSF2RA	"alphaGMR, CD116, CSF2R"	ENSG00000198223	"Colony stimulating factor 2 receptor alpha subunit"	P15509	X	1268800-1310381	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 60.2;placenta: 79.5"	"Group enriched"	"Detected in some"	7	"BEWO: 59.0;HMC-1: 17.7;SK-MEL-30: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 30.0;eosinophil: 36.0;intermediate monocyte: 17.7;myeloid DC: 31.9;neutrophil: 60.2;plasmacytoid DC: 30.5"	"Group enriched"	"Detected in many"	28	"dendritic cells: 31.9;granulocytes: 60.2;monocytes: 30.0"									CAB016148	Uncertain				"Secreted to blood"		9400000			"CAB016148: AB_626868"	"unprognostic (4.19e-2)"	"prognostic favourable (2.38e-5)"	"unprognostic (5.47e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.88e-2)"	"prognostic favourable (2.81e-4)"	"unprognostic (8.24e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.48e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.91e-3)"	"prognostic unfavourable (5.53e-4)"	"unprognostic (3.60e-1)"	"unprognostic (9.44e-2)"	8.7	2.3	11.8	11.1	11.1	8.9	17.7	3.4	9.6	3.1	2.2	0.6	0.6	2.2	4.4	0.6	2.1	2.2	5.7	3.7	15.0	4.7	2.4	1.7	11.2	8.3	18.8	6.5	3.5	1.0	0.2	2.1	79.5	13.2	1.5	3.3	0.6	3.1	1.0	0.6	1.8	3.3	2.9	25.5	12.6	1.7	0.6	16.3	0.6	2.5	0.6	10.4	4.2	1.5	0.3	31.9	60.2	30.0	1.4	0.2	10.1	0.1	3.4	0.2	0.0	0.0	0.0	59.0	0.0	0.1	0.1	0.0	1.2	0.3	0.0	3.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.4	0.0	0.0	1.3	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	5.4	0.5	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	1.0	0.0	41.3	2.7	4.9	0.0	0.0	1.7	0.3	0.0	0.1	0.1	0.1	0.0	5.3	0.0	2.4	30.0	36.0	0.0	17.7	0.2	0.3	0.0	0.0	31.9	0.1	0.0	0.0	60.2	1.4	8.4	30.5	0.1	10.1	11.8	11.1	3.4	9.6	15.0	4.7	18.8	6.5	13.2	16.3
IL3RA	CD123	ENSG00000185291	"Interleukin 3 receptor subunit alpha"	P26951	X	1336616-1382689	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 163.1;breast: 50.7;vagina: 65.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 47.8;NB-4: 9.2;RPMI-8226: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"basophil: 163.1;plasmacytoid DC: 49.1"	"Group enriched"	"Detected in many"	33	"dendritic cells: 49.1;granulocytes: 163.1"									"HPA003539, CAB018374"	Uncertain									"CAB018374: AB_2233620, HPA003539: AB_1078438"	"prognostic favourable (9.78e-4)"	"prognostic favourable (4.27e-4)"	"unprognostic (8.13e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.73e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.50e-3)"	"unprognostic (9.41e-2)"	"unprognostic (2.85e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.46e-1)"	14.9	1.2	7.8	7.7	7.8	12.1	50.7	5.0	10.1	9.7	4.6	1.5	1.5	2.4	13.8	1.5	2.8	4.2	5.6	9.2	11.1	2.4	5.4	1.5	15.9	12.3	8.5	3.9	7.6	2.6	0.6	3.7	9.3	10.9	4.4	3.1	1.5	5.6	1.5	5.7	6.8	5.4	6.1	7.6	5.3	4.2	1.5	7.9	1.5	7.0	1.5	6.4	6.8	65.4	0.7	49.1	163.1	3.2	1.1	0.0	0.7	0.1	3.9	1.5	0.5	0.0	0.0	0.5	0.5	0.1	0.0	0.0	0.3	0.6	0.5	2.7	0.0	3.8	0.0	0.0	0.0	47.8	1.6	0.2	0.7	0.1	0.0	0.3	6.6	0.0	0.0	0.0	0.0	3.1	0.1	2.5	0.0	0.6	0.2	9.2	1.2	0.2	0.5	1.7	19.5	0.0	0.5	0.2	0.1	0.2	0.1	1.1	0.5	7.3	0.1	0.2	0.6	0.2	0.1	5.2	1.4	0.4	4.3	1.1	0.0	163.1	0.4	6.7	0.0	2.4	0.0	0.2	0.0	0.0	1.1	0.7	0.0	0.0	0.3	1.1	3.2	49.1	0.0	0.7	7.8	7.8	5.0	10.1	11.1	2.4	8.5	3.9	10.9	7.9
SLC25A6	"ANT3, ANT3Y, MGC17525"	ENSG00000169100	"Solute carrier family 25 member 6"	P12236	X	1386152-1392724	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 85.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA046835, HPA071684"	Approved		Supported	Mitochondria			7200000	Mitochondria		"HPA046835: , HPA071684: "	"unprognostic (1.13e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.57e-3)"	18.5	19.7	12.1	12.2	14.0	23.7	14.4	8.2	12.2	9.8	16.5			28.9	14.3	4.8	16.4	10.4	7.0	9.4	10.3	8.2	18.4	5.4	11.1	14.4	9.4		25.6	38.7	10.1	14.0	8.6		12.4	8.8		45.0	12.5	6.1	14.9	23.3	7.7	5.8	15.4	19.2	2.4			16.3		9.5	14.2	11.2	62.2	85.7	3.7	69.0	30.1	43.6	71.2	22.0	48.3	34.3	35.0	23.8	46.4	37.1	33.8	32.4	24.9	24.8	63.8	27.0	81.9	27.3	22.2	14.3	23.0	40.3	7.9	20.5	73.1	44.8	33.1	72.8	55.8	32.2	54.7	76.5	74.3	19.5	28.7	37.0	31.2	19.3	24.4	46.9	59.6	61.7	43.5	65.0	30.1	28.4	63.5	30.4	55.4	56.0	88.0	22.8	69.4	96.1	38.5	66.4	42.2	25.5	14.3	49.7	33.6	50.1	8.0	55.3	3.8	31.1	13.8	2.4	58.1	3.7	29.4	69.0	43.6	62.2	40.4	34.8	85.7	47.5	38.1	37.2	3.0	30.1	67.9	41.0	38.7	71.2										
ASMTL		ENSG00000169093	"Acetylserotonin O-methyltransferase like"	O95671	X	1403139-1453762	"Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 51.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA003630, HPA021865"	Supported		Enhanced	Cytosol				Cytosol		"HPA003630: AB_1078230, HPA021865: AB_1845099"	"unprognostic (3.89e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.87e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.05e-2)"	"unprognostic (8.17e-2)"	"unprognostic (5.23e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.91e-3)"	"unprognostic (7.24e-2)"	"unprognostic (3.26e-3)"	"unprognostic (9.70e-2)"	"unprognostic (8.38e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.20e-1)"	10.4	11.7	28.5	8.9	42.3	9.1	33.6	24.5	38.9	46.4	10.6	3.3	3.3	6.9	52.0	9.2	8.6	11.4	8.2	50.0	29.4	11.4	35.2	15.3	7.0	11.8	25.5	55.3	47.6	13.2	9.9	31.4	27.5	36.7	12.5	4.6	3.3	16.2	16.0	10.0	11.0	8.9	7.5	31.9	11.5	9.0	4.6	25.0	3.3	12.8	3.3	7.2	9.1	31.5	19.8	23.3	34.5	16.4	27.8	16.9	12.3	5.2	9.1	10.9	8.3	6.6	10.3	15.3	6.2	8.2	7.1	9.2	8.4	6.3	9.2	3.5	8.2	1.9	2.8	3.0	4.5	13.7	9.2	8.0	6.1	9.9	15.0	3.7	51.6	13.6	5.2	5.4	5.3	8.4	4.0	7.5	5.6	19.6	16.0	14.7	13.2	5.7	13.1	10.4	22.5	5.0	2.9	0.4	5.1	8.4	10.8	7.7	2.5	5.0	10.9	6.0	6.6	11.3	2.3	9.7	2.9	23.5	7.6	5.4	1.7	20.1	14.2	34.5	16.9	16.4	14.8	13.8	15.3	15.6	12.1	19.8	13.5	10.6	20.4	27.8	11.5	23.3	16.5	12.3	28.5	42.3	24.5	38.9	29.4	11.4	25.5	55.3	36.7	25.0
P2RY8	P2Y8	ENSG00000182162	"P2Y receptor family member 8"	Q86VZ1	X	1462572-1537107	"Cancer-related genes, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 26.7;lymphoid tissue: 19.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 33.2;RPMI-8226: 20.4;THP-1: 20.4;U-266/70: 27.9;U-698: 54.3;U-937: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA003631	Enhanced									"HPA003631: AB_1079543"	"unprognostic (4.32e-2)"	"unprognostic (3.22e-5)"	"unprognostic (6.31e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.17e-1)"	"prognostic favourable (7.80e-5)"	"prognostic favourable (1.73e-4)"	"unprognostic (5.27e-3)"	"unprognostic (5.76e-3)"	"unprognostic (5.52e-3)"	"prognostic favourable (6.54e-4)"	"unprognostic (4.29e-2)"	"unprognostic (8.45e-3)"	"unprognostic (2.90e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.80e-1)"	2.9	4.8	0.5	8.9	2.2	13.9	8.2	0.9	1.8	4.7	1.6	0.5	0.5	1.3	7.1	0.5	0.8	0.8	1.6	11.8	0.9	0.2	13.5	0.8	2.1	19.0	3.6	1.7	5.8	1.1	1.0	6.9	3.4	2.7	1.6	1.3	0.5	1.6	0.5	1.1	0.4	7.8	0.5	3.9	16.6	2.0	0.5	2.0	0.5	8.1	0.5	16.7	2.7	2.8	18.5	5.8	17.8	7.3	15.6	26.7	18.3	0.1	0.1	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	33.2	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.3	0.3	1.6	0.0	14.5	3.5	0.0	0.0	0.0	0.0	0.0	0.3	14.0	0.0	0.0	16.4	16.4	0.2	0.3	14.8	0.1	20.4	0.0	0.2	0.0	0.2	0.1	0.3	0.1	0.1	20.4	0.0	0.3	0.3	0.1	0.0	27.9	5.2	54.3	0.0	16.9	0.0	17.8	7.3	12.4	26.7	5.5	24.6	15.4	20.2	25.1	5.8	18.5	16.1	16.5	4.7	15.6	2.2	1.5	15.9	18.3	0.5	2.2	0.9	1.8	0.9	0.2	3.6	1.7	2.7	2.0
AKAP17A	"721P, CCDC133, CXYorf3, DXYS155E, MGC39904, SFRS17A, XE7, XE7Y"	ENSG00000197976	"A-kinase anchoring protein 17A"	Q02040	X	1591593-1602514	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 7.0"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043247, HPA051020"	Supported		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA043247: AB_10964776, HPA051020: "	"unprognostic (4.55e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (3.40e-4)"	"unprognostic (5.38e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.73e-3)"	"unprognostic (6.25e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.91e-3)"	"prognostic favourable (2.42e-4)"	"unprognostic (1.55e-3)"	"prognostic unfavourable (3.52e-7)"	"unprognostic (1.86e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.03e-2)"	"prognostic favourable (1.11e-5)"	7.4	10.3	28.1	14.5	42.3	18.0	24.5	27.5	25.2	32.8	7.2	2.5	2.5	14.2	40.9	9.7	9.2	9.1	7.4	12.5	27.1	3.4	20.3	16.4	12.2	15.4	37.6	27.1	38.0	15.6	5.2	31.0	42.7	33.7	12.6	4.3	2.5	17.0	7.8	6.9	12.3	11.6	3.2	27.8	21.4	14.2	7.0	37.2	2.5	16.1	2.5	8.9	6.8	47.6	1.8	1.8	7.0	1.0	1.3	1.6	0.4	9.5	12.3	9.8	11.1	4.8	6.2	24.1	10.4	4.2	8.4	7.1	13.6	8.8	14.4	6.7	5.1	8.4	6.0	5.2	5.0	11.8	20.5	17.9	11.8	12.6	10.4	6.9	30.1	5.5	9.6	6.2	6.9	5.7	11.2	9.1	4.9	6.3	15.3	30.0	14.7	10.7	11.6	11.7	12.0	5.6	6.6	11.0	16.1	8.1	13.2	12.5	8.6	12.7	11.0	13.1	6.0	11.3	8.9	39.6	6.6	20.0	5.3	11.3	3.4	7.0	1.0	1.9	0.8	0.5	0.9	1.8	1.0	1.6	0.6	1.2	0.8	0.8	4.1	1.3	0.8	1.8	0.5	0.4	28.1	42.3	27.5	25.2	27.1	3.4	37.6	27.1	33.7	37.2
ASMT	"ASMTY, HIOMT, HIOMTY"	ENSG00000196433	"Acetylserotonin O-methyltransferase"	P46597	X	1615001-1643081	"Enzymes, Predicted intracellular proteins"	"Melatonin biosynthesis"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 8.8;epididymis: 7.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;NTERA-2: 1.4;U-266/70: 2.1;U-266/84: 3.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"pons and medulla: 8.8"	"Group enriched"	"Detected in some"	4	"memory B-cell: 2.2;memory CD8 T-cell: 2.0;naive B-cell: 3.8;NK-cell: 1.0"	"Group enriched"	"Detected in many"	4	"B-cells: 3.8;NK-cells: 1.0;T-cells: 2.0"																				"unprognostic (1.84e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-1)"	"unprognostic (8.55e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.43e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.79e-3)"	0.6	2.3	0.6	1.2	0.7	2.4	0.8	1.2	0.6	1.3	0.8	0.6	0.6	0.3	1.4	7.0	0.6	0.9	0.7	0.6	0.8	0.7	0.6	0.6	0.8	0.8	1.8	0.6	0.7	1.3	0.7	3.8	0.6	8.8	1.0	0.2	0.6	1.2	1.0	0.8	1.6	0.7	0.9	4.1	1.4	0.6	0.6	0.6	0.6	1.1	0.6	0.6	0.6	0.9	3.8	0.0	0.5	0.0	1.0	2.0	0.1	0.1	0.0	0.1	0.1	0.3	0.0	2.9	0.2	0.0	0.6	0.0	0.0	0.1	0.4	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.1	1.4	0.0	0.8	0.1	0.2	0.8	0.1	0.1	0.0	0.0	0.4	0.1	0.1	0.4	0.0	0.0	0.0	1.2	0.0	2.1	3.7	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.5	2.0	0.0	3.8	0.2	0.1	0.5	1.0	0.0	0.0	0.0	0.1	0.6	0.7	1.2	0.6	0.8	0.7	1.8	0.6	8.8	0.6
DHRSX	"DHRS5X, DHRS5Y, DHRSXY, DHRSY, SDR46C1, SDR7C6"	ENSG00000169084	"Dehydrogenase/reductase X-linked"	Q8N5I4	X	2219516-2502805	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003035	Approved		Approved	"Actin filaments,Cytosol"	"Secreted to blood"			"Actin filaments, Cytosol"		"HPA003035: AB_1080631"	"unprognostic (7.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.95e-2)"	"unprognostic (4.65e-3)"	"unprognostic (8.87e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.59e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.69e-2)"	7.3	9.5	21.5	3.1	26.7	2.9	55.7	21.5	25.3	32.1	7.3	1.2	1.2	4.6	25.1	6.4	3.2	7.5	6.7	37.8	23.7	3.4	34.6	18.9	5.8	3.2	21.8	16.9	25.0	15.2	5.5	24.2	32.7	28.3	7.7	6.5	1.2	10.8	5.7	6.3	4.9	6.5	5.3	26.5	5.9	8.6	3.4	23.6	1.2	8.1	1.2	2.7	6.1	27.4	12.2	18.3	30.0	21.1	8.7	9.1	10.0	4.5	20.8	14.0	6.5	17.6	11.0	10.6	10.4	17.6	8.0	10.8	15.5	9.9	7.2	13.4	12.3	2.2	9.7	8.4	5.6	13.3	15.0	7.0	10.9	11.6	20.2	3.8	5.6	13.6	10.4	6.9	6.9	6.3	7.6	3.6	12.8	5.2	13.9	5.3	3.4	5.8	5.4	7.4	2.0	8.6	11.1	13.4	13.4	9.9	11.8	7.7	5.1	6.0	8.5	8.7	2.1	4.9	6.1	4.2	0.0	18.8	5.8	5.0	3.9	6.5	21.1	17.1	8.4	15.7	8.9	12.2	7.6	7.0	18.3	10.6	7.2	6.0	30.0	8.7	9.5	14.8	9.1	10.0	21.5	26.7	21.5	25.3	23.7	3.4	21.8	16.9	28.3	23.6
ZBED1	"ALTE, DREF, hDREF, KIAA0785, TRAMP"	ENSG00000214717	"Zinc finger BED-type containing 1"	O96006	X	2486414-2500967	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 63.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA077591			Approved	"Nucleoplasm,Nuclear membrane,Centrosome"				Nucleoplasm	"Nuclear membrane, Centrosome"	"HPA077591: "	"unprognostic (7.66e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (3.13e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.27e-1)"	8.5	10.5	24.8	6.0	30.7	3.1	63.7	24.8	29.0	36.8	8.1	1.7	1.7	10.6	28.9	2.8	6.1	6.4	7.1	43.4	27.3	7.2	39.6	13.6	5.9	6.0	25.1	19.6	28.7	10.4	6.8	27.8	37.5	32.5	6.8	6.4	1.7	7.7	6.3	29.5	9.5	11.2	5.1	30.4	7.9	6.6	3.4	27.1	1.7	5.4	1.7	4.8	5.8	31.4	12.7	13.7	13.0	12.4	5.4	11.5	10.2	5.1	12.9	9.4	10.3	6.0	6.4	42.5	7.3	8.1	4.3	5.0	16.4	4.6	10.2	8.5	9.7	2.4	8.9	7.6	3.2	12.0	11.9	7.6	11.0	13.9	7.9	4.6	15.9	9.4	6.0	4.5	3.4	10.2	9.6	3.4	8.4	3.6	7.7	3.7	23.1	7.6	6.2	9.3	4.8	7.2	10.1	11.2	11.0	6.2	16.8	11.6	4.6	10.0	13.9	9.3	4.9	5.1	7.9	4.1	0.0	16.9	3.8	6.7	5.2	1.8	11.6	9.7	11.5	12.4	10.3	9.4	6.8	6.5	13.7	12.7	6.6	5.4	13.0	5.4	9.3	10.1	6.6	10.2	24.8	30.7	24.8	29.0	27.3	7.2	25.1	19.6	32.5	27.1
CD99	MIC2	ENSG00000002586	"CD99 molecule (Xg blood group)"	P14209	X	2691133-2741309	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 359.1;breast: 433.0;heart muscle: 347.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 124.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB000020, HPA035304"	Supported		Approved	"Golgi apparatus"			34000000	"Golgi apparatus"		"CAB000020: AB_2076419, HPA035304: AB_10672861"	"unprognostic (3.71e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.97e-3)"	"unprognostic (7.01e-3)"	"unprognostic (2.14e-2)"	"unprognostic (6.98e-3)"	"unprognostic (3.89e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (5.87e-7)"	"unprognostic (2.11e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.61e-2)"	45.7	14.1	85.8	14.4	100.5	11.1	433.0	45.7	60.9	243.9	31.8	4.5	4.5	19.9	258.4	18.3	26.1	22.2	35.2	347.0	103.4	14.7	66.4	24.6	24.5	16.6	161.0	56.6	187.4	28.9	3.3	67.0	138.7	185.5	30.5	20.6	4.5	18.1	37.7	18.9	28.0	23.8	31.1	359.1	18.5	21.7	23.3	101.3	4.5	15.2	4.5	16.1	24.7	208.8	32.7	62.6	4.3	47.1	32.1	107.1	103.6	23.8	27.4	30.6	41.4	124.2	94.2	18.4	64.0	100.3	40.2	58.6	39.5	16.8	1.6	12.5	88.7	9.3	12.2	16.1	33.4	32.4	30.8	4.6	19.1	34.3	39.4	7.3	36.5	58.5	19.9	22.0	15.5	73.3	5.7	0.0	37.9	18.7	63.6	24.9	10.0	29.9	10.8	25.6	45.2	23.2	16.4	0.1	13.5	15.4	13.8	38.4	12.2	22.8	67.6	49.6	8.4	47.3	21.5	0.1	0.0	10.4	33.2	18.3	30.9	1.8	47.1	1.5	107.1	11.6	60.4	32.7	72.6	94.6	44.6	20.2	26.8	57.1	4.3	32.1	2.6	62.6	74.3	103.6	85.8	100.5	45.7	60.9	103.4	14.7	161.0	56.6	185.5	101.3
XG	PBDX	ENSG00000124343	"Xg blood group"	P55808	X	2752048-2816500	"Blood group antigen proteins, Predicted membrane proteins"		"Blood group antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 22.8;placenta: 18.4;skin 1: 25.8"	"Group enriched"	"Detected in some"	6	"ASC diff: 33.7;ASC TERT1: 25.0;fHDF/TERT166: 15.7;hTCEpi: 23.4;T-47d: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	16	"memory B-cell: 2.1;naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	21	"B-cells: 2.1"					"Low region specificity"	"Detected in all"														"prognostic unfavourable (4.25e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.86e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-2)"	"unprognostic (8.62e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.10e-6)"	"unprognostic (3.96e-3)"	"unprognostic (7.98e-2)"	"unprognostic (5.83e-3)"	"unprognostic (6.77e-3)"	8.9	0.0	0.3	0.3	0.6	0.8	9.1	0.5	0.6	22.8	0.3	0.3	0.3	0.0	2.6	0.3	7.1	0.6	3.0	1.2	1.4	0.0	1.3	0.3	0.3	0.3	0.6	0.3	1.1	0.3	0.0	0.3	18.4	1.9	0.5	0.0	0.3	4.1	0.4	1.4	25.8	0.3	0.3	4.2	0.3	0.1	0.3	0.3	0.3	0.9	0.3	2.4	1.2	7.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.7	25.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.7	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	23.4	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	1.7	12.6	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.5	0.6	1.4	0.0	0.6	0.3	1.9	0.3
GYG2	GN-2	ENSG00000056998	"Glycogenin 2"	O15488	X	2828788-2882820	"Enzymes, Predicted intracellular proteins"	"Glycogen biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 76.7;brain: 21.2;breast: 30.4"	"Cell line enhanced"	"Detected in many"		"AF22: 17.7;BEWO: 12.8;CACO-2: 13.1;Hep G2: 14.2;NTERA-2: 17.4;SK-MEL-30: 37.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 42.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA005495, HPA064686"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoli, Cytosol"	Nucleoplasm	"HPA005495: AB_1079035, HPA064686: "	"unprognostic (4.45e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.41e-3)"	"unprognostic (8.50e-2)"	"unprognostic (2.07e-3)"	"unprognostic (5.16e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.43e-3)"	"unprognostic (6.74e-2)"	"prognostic favourable (3.01e-5)"	"unprognostic (9.76e-2)"	"unprognostic (6.10e-5)"	"unprognostic (1.78e-1)"	"unprognostic (5.05e-3)"	"unprognostic (5.41e-2)"	"unprognostic (6.60e-2)"	76.7	1.4	4.6	1.3	4.6	0.5	30.4	2.1	3.7	2.1	3.5	8.2	0.7	1.2	4.2	0.9	1.0	3.6	1.7	1.7	3.9	2.9	1.4	9.9	0.7	0.7	5.5	2.9	1.9	3.2	0.4	0.5	1.6	12.9	2.7	2.0	4.2	2.8	4.4	0.5	1.2	1.3	2.8	21.2	0.5	2.2	0.8	5.1	0.0	1.3	0.5	0.6	2.9	1.4	1.0	0.6	0.6	0.4	1.2	0.7	0.0	0.0	5.4	17.7	0.0	10.6	0.0	12.8	0.5	3.1	3.1	3.9	13.1	0.3	0.0	1.4	2.2	0.0	10.0	0.2	3.0	0.1	2.8	0.0	0.2	14.2	3.1	0.0	4.3	3.8	0.1	0.3	0.0	0.0	0.1	0.0	3.2	0.8	0.0	0.4	17.4	0.1	2.9	5.9	0.0	0.0	0.0	0.0	0.3	0.0	0.1	37.7	1.7	10.7	0.0	0.0	3.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.2	0.7	0.5	0.4	0.3	0.1	1.0	0.3	0.2	0.6	1.2	0.4	0.6	0.4	0.0	4.6	4.6	2.1	3.7	3.9	2.9	5.5	2.9	12.9	5.1
ARSD		ENSG00000006756	"Arylsulfatase D"	P51689	X	2903970-2929351	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 15.7;EFO-21: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			"HPA004694, HPA063835"	Approved		Approved	"Vesicles,Lipid droplets"				"Vesicles, Lipid droplets"		"HPA004694: AB_1078221, HPA063835: "	"unprognostic (3.92e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.33e-1)"	"prognostic favourable (5.21e-4)"	"unprognostic (5.90e-3)"	"unprognostic (6.32e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.09e-3)"	"unprognostic (7.18e-2)"	"unprognostic (3.93e-1)"	"prognostic favourable (1.97e-5)"	"unprognostic (1.37e-1)"	"unprognostic (3.93e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.11e-3)"	8.1	5.6	3.7	10.1	3.5	2.3	14.2	3.2	5.0	14.7	15.4	5.8	27.4	11.9	8.9	19.2	9.3	16.6	16.8	8.7	5.7	3.6	34.1	23.8	13.1	11.3	3.1	3.3	13.0	48.1	8.5	3.9	16.2	8.7	11.5	8.5	7.8	15.8	30.9	1.6	5.9	22.3	12.0	4.5	5.7	19.5	5.2	3.3	1.8	12.9	5.6	7.1	12.4	6.9	2.1	6.3	5.7	8.5	3.0	2.6	3.2	4.5	8.1	2.2	10.5	9.5	5.5	0.1	2.6	4.8	1.2	0.8	0.5	15.7	0.0	16.9	5.3	0.0	0.4	1.3	1.1	0.1	0.0	0.0	0.0	2.6	5.2	0.0	6.3	8.6	4.3	2.3	2.5	7.8	0.0	0.0	5.2	11.0	0.0	1.1	1.8	3.4	1.9	0.0	0.1	8.4	0.1	0.0	5.9	3.6	4.3	2.7	11.6	8.7	7.1	0.0	0.3	0.8	1.2	0.1	0.0	0.0	7.7	5.5	5.9	2.1	8.5	5.7	2.6	7.1	1.0	2.1	1.3	2.0	6.3	1.4	0.3	1.5	1.5	3.0	2.7	4.4	0.4	3.2	3.7	3.5	3.2	5.0	5.7	3.6	3.1	3.3	8.7	3.3
ARSE	"CDPX, CDPX1"	ENSG00000157399	"Arylsulfatase E (chondrodysplasia punctata 1)"	P51690	X	2934632-2968310	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"liver: 43.0;pancreas: 99.4"	"Cell line enhanced"	"Detected in many"		"A549: 32.0;CACO-2: 19.8;Hep G2: 29.7;NTERA-2: 14.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	17	"myeloid DC: 1.6"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 1.6"					"Low region specificity"	"Detected in all"			"HPA060518, HPA070651"	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA060518: , HPA070651: "	"unprognostic (2.07e-1)"	"unprognostic (6.60e-3)"	"prognostic favourable (8.95e-4)"	"unprognostic (8.74e-3)"	"unprognostic (1.14e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.94e-2)"	"unprognostic (4.76e-2)"	0.2	0.1	0.9	2.4	1.1	0.0	0.4	0.3	0.7	0.8	7.9	0.7	1.3	6.5	1.1	2.3	0.3	1.3	8.4	0.4	0.9	0.8	16.6	43.0	0.8	0.2	0.6	1.0	2.5	99.4	0.0	0.4	0.7	0.7	0.4	6.4	0.6	0.2	0.9	0.2	0.1	7.8	0.5	0.6	0.2	1.2	0.7	0.6	0.2	0.2	0.3	0.2	0.2	0.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.9	32.0	3.0	0.0	0.9	1.7	0.5	1.3	2.8	1.4	1.7	19.8	0.0	0.0	6.0	0.0	0.0	0.0	0.2	0.8	0.0	2.1	0.0	0.0	29.7	0.8	0.0	0.0	3.2	0.0	1.1	0.0	1.3	0.0	0.0	4.0	0.0	0.0	0.0	14.9	0.0	0.9	0.4	0.1	3.5	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	1.8	0.0	0.0	0.0	2.6	0.0	0.0	0.0	3.3	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.3	0.7	0.9	0.8	0.6	1.0	0.7	0.6
ARSH		ENSG00000205667	"Arylsulfatase family member H"	Q5FYA8	X	3006613-3033571	"Predicted membrane proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"breast: 3.1;epididymis: 3.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.2;RT4: 1.4;SK-BR-3: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (3.43e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.01e-2)"	"unprognostic (8.90e-2)"		"unprognostic (6.79e-2)"		"unprognostic (2.56e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.56e-4)"	"unprognostic (3.48e-2)"	"unprognostic (2.39e-1)"		"unprognostic (1.63e-1)"		"unprognostic (2.65e-2)"	"unprognostic (6.75e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.2	0.0			0.0	0.0	3.7	1.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.5	0.0	0.0	0.0		0.2	0.0		0.9	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.1			0.0		0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ARSF		ENSG00000062096	"Arylsulfatase F"	P54793	X	3041471-3112726	"Predicted membrane proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.3;kidney: 11.5;skin 1: 8.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;U-266/70: 1.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.9"					"Cell type enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"											HPA000549			Uncertain	Cytosol	"Secreted in other tissues"			Cytosol		"HPA000549: AB_1845055"	"unprognostic (2.19e-2)"	"unprognostic (8.88e-2)"		"unprognostic (2.87e-1)"	"unprognostic (5.41e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.72e-2)"	"unprognostic (4.70e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.48e-1)"	0.0	4.6	2.7	0.0	5.3	0.0	0.1	0.0	1.9	0.4	0.0			0.0	0.0	2.5	3.1	0.0	0.0	0.0	1.3	0.5	11.5	1.7	0.0	0.0	1.5		0.0	0.2	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	8.3	0.0	0.0	0.2	0.0	0.0	0.0			0.0		0.5	0.6	1.5	0.3	0.2	1.9	0.3	0.8	0.3	0.0	0.2	0.4	0.5	0.7	0.0	0.2	2.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.2	0.3	0.0	0.0	0.2	0.0	0.2	0.3	0.2	0.0	0.0	0.4	0.3	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.1	0.5	0.1	0.1	1.1	0.1	0.1	0.8	0.3	0.3	1.9	0.3	0.4	0.2	0.3	0.3	0.1	0.3	0.2	0.0	0.3	0.3	0.3	1.2	0.8	0.1	0.2	0.1	0.0										
MXRA5	DKFZp564I1922	ENSG00000101825	"Matrix remodeling associated 5"	Q9NR99	X	3308565-3346641	"Cancer-related genes, Disease related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 49.4;pancreas: 46.6"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 12.5;BJ hTERT+: 47.9;fHDF/TERT166: 22.4;HaCaT: 19.9;HSkMC: 9.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA000508	Uncertain				"Secreted - unknown location"		1700000			"HPA000508: AB_2147995"	"unprognostic (7.51e-2)"	"unprognostic (6.45e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavourable (1.81e-4)"	"unprognostic (7.05e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (8.94e-4)"	6.5	12.1	0.5	10.4	1.2	0.0	7.5	0.4	0.8	49.4	4.4	0.6	18.8	2.1	11.4	6.0	8.7	4.2	5.8	9.2	0.6	0.5	8.0	4.5	5.9	0.9	0.6	0.7	7.9	46.6	0.5	1.4	7.9	0.8	11.0	5.9	10.2	11.5	29.5	1.1	16.6	7.8	8.8	0.5	7.7	5.1	4.0	0.3	5.7	15.0	11.7	6.2	12.7	9.6	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	12.5	0.0	7.4	47.9	0.0	0.0	0.0	0.2	0.0	0.6	22.4	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	2.3	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.4	0.8	0.6	0.5	0.6	0.7	0.8	0.3
PRKX	PKX1	ENSG00000183943	"Protein kinase, X-linked"	P51817	X	3604370-3713608	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 38.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA015324	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA015324: AB_1855715"	"unprognostic (1.07e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.15e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.70e-2)"	4.3	1.3	12.3	7.5	15.8	5.4	11.2	4.4	12.3	6.9	5.2	5.4	11.5	4.1	7.3	8.4	13.6	16.5	3.9	4.0	14.0	7.4	14.2	2.0	8.4	9.5	27.9	5.6	4.8	4.1	3.2	2.3	6.6	22.7	3.7	5.2	3.1	6.5	5.3	1.6	9.9	6.0	3.0	17.6	10.0	3.1	6.1	22.7	6.1	28.8	3.2	8.0	3.7	11.2	2.5	2.8	12.2	4.1	3.3	3.8	1.7	4.5	4.2	11.6	8.6	2.2	3.0	10.6	2.7	1.0	1.3	1.8	6.2	3.1	0.4	2.7	2.1	3.1	10.8	8.1	2.3	5.0	7.5	5.0	3.2	0.1	2.3	6.4	38.9	2.0	8.7	1.4	5.4	13.1	5.8	6.5	4.4	3.9	7.3	5.8	7.7	4.8	13.7	11.1	8.5	10.7	3.8	7.8	5.0	2.8	1.8	2.7	1.4	5.1	7.1	1.2	2.0	1.9	1.8	0.1	0.3	5.8	0.7	5.8	3.0	12.2	3.1	1.8	3.5	3.3	3.8	2.5	3.7	3.3	2.3	2.4	3.1	3.3	0.8	3.3	4.1	2.8	2.5	1.7	12.3	15.8	4.4	12.3	14.0	7.4	27.9	5.6	22.7	22.7
NLGN4X	"HLNX, KIAA1260, NLGN, NLGN4"	ENSG00000146938	"Neuroligin 4, X-linked"	Q8N0W4	X	5840637-6228863	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Asperger syndrome, Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 56.3"	"Group enriched"	"Detected in some"	4	"AF22: 30.9;NTERA-2: 24.4"	"Cancer enhanced"	"Detected in many"		"glioma: 8.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	6	"B-cells: 1.5"									HPA001651	Approved									"HPA001651: AB_1079470"	"unprognostic (2.21e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.32e-2)"	"unprognostic (5.10e-3)"	"unprognostic (7.16e-4)"	"unprognostic (6.70e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.10e-2)"	4.9	2.3	8.3	2.8	10.7	0.3	3.4	12.2	19.2	8.2	3.6	3.7	0.4	2.1	3.7	1.0	1.3	3.4	4.0	5.4	7.9	9.9	0.8	2.2	1.9	1.7	5.6	6.4	16.8	0.9	12.3	2.6	5.4	5.7	2.0	3.2	2.1	1.5	3.3	0.7	1.2	2.9	5.6	4.3	3.2	1.9	3.9	3.9	56.3	1.0	0.0	1.1	3.6	1.8	1.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	30.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	3.9	0.0	24.4	0.0	0.0	0.0	0.0	2.2	6.2	1.5	1.9	0.0	0.0	0.0	3.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	8.3	10.7	12.2	14.7	7.9	9.9	5.6	6.4	5.7	3.9
VCX3A	"VCX-8r, VCX-A, VCX3"	ENSG00000169059	"Variable charge, X-linked 3A"	Q9NNX9	X	6533618-6535118	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	195	"testis: 28.8"	"Cell line enhanced"	"Detected in some"		"HMC-1: 7.3;PC-3: 3.7;U-138 MG: 11.0;U-2197: 2.7;U-266/70: 6.9"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044996, HPA049357"	Supported									"HPA044996: , HPA049357: "					"unprognostic (1.11e-1)"			"unprognostic (1.39e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.43e-1)"					"unprognostic (3.29e-2)"		"unprognostic (1.64e-2)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.1		0.0	0.0		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	28.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	3.7	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	1.6	0.0	0.0	11.0	0.0	2.7	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PUDP	"DXF68S1E, FAM16AX, GS1, HDHD1, HDHD1A"	ENSG00000130021	"Pseudouridine 5'-phosphatase"	Q08623	X	7048920-7148190	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"							HPA072672	Approved						14000			"HPA072672: "	"unprognostic (1.84e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.92e-1)"	"unprognostic (3.47e-1)"	"unprognostic (5.63e-3)"	"unprognostic (1.00e-3)"	"unprognostic (3.22e-2)"	"unprognostic (4.86e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavourable (7.27e-4)"	"unprognostic (2.24e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.92e-2)"	"prognostic favourable (4.80e-4)"	"unprognostic (3.42e-2)"	10.8	9.3	10.2	10.3	12.5	2.6	7.5	7.8	10.5	9.1	15.0	9.7	9.1	15.2	8.6	6.3	9.9	17.0	7.1	17.1	8.1	10.6	19.8	10.1	10.3	13.1	12.5	7.1	9.6	8.9	7.3	11.2	42.4	10.0	7.4	10.5	8.3	9.8	6.9	31.8	5.0	15.1	9.8	10.6	11.2	15.8	7.7	11.4	13.3	10.4	8.9	13.1	10.2	8.9	7.0	11.1	2.1	14.9	5.1	9.6	7.5	19.9	18.8	29.8	12.4	15.2	15.0	5.1	7.1	6.9	7.9	8.1	26.7	12.3	9.2	14.8	7.1	6.1	13.5	16.0	12.3	8.2	26.0	9.7	7.1	14.6	7.2	8.5	11.0	7.8	6.2	21.5	10.0	23.6	18.6	8.4	12.5	9.3	9.5	12.6	15.7	9.3	7.1	11.5	24.9	11.4	7.5	7.1	7.5	5.7	10.6	10.6	11.8	8.0	9.1	4.9	3.0	20.4	6.0	26.8	0.1	15.0	7.0	4.9	9.5	2.1	14.4	1.6	6.4	14.9	6.4	7.0	6.8	6.0	11.1	5.2	5.2	5.8	1.5	5.1	14.0	3.6	9.6	7.5	10.2	12.5	7.8	10.5	8.1	10.6	12.5	7.1	10.0	11.4
STS	"ARSC, ARSC1"	ENSG00000101846	"Steroid sulfatase"	P08842	X	7219456-7354810	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Pregnancy, Steroid metabolism"	Hydrolase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"placenta: 258.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 19.9;RPMI-8226: 25.4;U-266/70: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 4.7"	"Low lineage specificity"	"Detected in many"											HPA002904	Enhanced									"HPA002904: AB_1080116"	"unprognostic (1.09e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.23e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavourable (3.47e-4)"	"unprognostic (4.05e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.34e-1)"	10.3	2.2	3.0	2.2	3.9	0.0	4.1	2.3	9.0	3.4	3.5	2.3	2.2	0.8	2.4	2.2	2.2	2.6	4.1	3.6	3.9	4.0	2.5	4.7	5.0	2.2	3.8	2.4	2.4	2.2	1.6	2.2	258.8	2.4	2.9	3.0	2.3	2.2	3.3	4.0	2.3	2.4	3.8	2.4	2.2	6.7	2.2	2.3	2.2	2.4	2.2	2.2	4.9	2.7	0.9	1.9	1.9	4.7	1.0	0.7	1.0	4.0	1.2	2.7	0.9	19.9	10.3	14.7	8.3	3.0	2.2	2.1	7.2	3.8	7.6	1.6	6.0	1.0	1.6	1.3	2.2	0.6	3.2	0.4	4.6	2.0	1.1	1.1	4.3	3.4	0.2	1.4	0.8	3.4	0.4	7.9	5.9	0.9	0.6	1.0	1.0	1.8	1.0	1.6	25.4	5.6	5.9	2.0	1.7	1.6	3.0	0.9	1.2	0.4	5.9	8.9	0.5	11.4	1.3	42.2	0.0	17.7	2.1	0.9	2.3	0.0	3.2	0.6	0.5	4.7	0.2	0.6	0.2	0.3	1.9	0.9	0.1	0.5	1.9	1.0	2.5	0.3	0.7	1.0	3.0	3.9	2.3	9.0	3.9	4.0	3.8	2.4	2.4	2.3
VCX	"VCX-10r, VCX-B1, VCX1, VCX10R"	ENSG00000182583	"Variable charge, X-linked"	Q9H320	X	7842262-7844143	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	51	"testis: 22.7"	"Cell line enhanced"	"Detected in some"		"NB-4: 3.7;RPMI-8226: 3.0;THP-1: 3.4;U-138 MG: 3.3;U-266/70: 6.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044996, HPA049357"	Supported									"HPA044996: , HPA049357: "					"unprognostic (1.65e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.73e-1)"			"unprognostic (7.89e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.20e-1)"		"unprognostic (7.18e-3)"	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.4	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.7	2.2	0.0	0.8	0.0	3.7	1.8	0.4	0.5	0.0	3.0	0.0	1.5	0.1	0.2	0.0	0.0	0.0	1.5	3.4	0.0	3.3	0.8	2.2	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0
PNPLA4	"DXS1283E, GS2, iPLA2eta"	ENSG00000006757	"Patatin like phospholipase domain containing 4"	P41247	X	7898247-7927739	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA003656	Approved				"Intracellular and membrane"					"HPA003656: AB_1079033"	"unprognostic (2.97e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.17e-3)"	"unprognostic (3.08e-2)"	"prognostic unfavourable (5.29e-4)"	"prognostic unfavourable (5.37e-4)"	"unprognostic (3.15e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.42e-2)"	"unprognostic (6.30e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.27e-1)"	"prognostic favourable (2.23e-12)"	"unprognostic (5.23e-2)"	"unprognostic (6.71e-3)"	"unprognostic (6.30e-2)"	"unprognostic (2.12e-1)"	11.3	18.1	12.6	6.0	18.8	4.7	13.9	5.0	11.5	8.9	8.9	8.5	13.3	11.2	9.2	11.4	13.2	15.0	6.2	24.0	10.9	11.9	26.5	39.8	5.8	6.3	12.0	8.7	14.0	21.0	13.3	17.0	4.7	12.2	8.0	7.5	13.1	18.9	10.7	40.9	10.8	10.5	7.4	11.2	5.4	11.5	7.8	10.6	7.2	23.6	21.1	8.9	6.6	9.5	13.2	18.3	7.6	10.4	9.0	10.3	8.4	18.6	7.6	1.2	19.3	0.4	0.2	5.2	5.8	0.6	10.1	6.2	7.7	6.9	5.9	0.0	1.9	11.0	0.0	19.5	17.3	0.2	13.7	4.2	14.8	16.1	12.8	7.3	6.2	13.2	20.0	5.1	12.1	7.0	16.4	0.2	0.1	4.9	0.1	7.2	20.4	16.3	0.1	0.1	6.5	13.3	8.5	11.1	5.6	17.6	7.3	9.9	11.3	5.5	4.0	0.1	5.1	15.5	0.1	8.9	0.1	11.1	0.1	0.1	1.6	5.2	9.8	7.6	5.4	10.4	6.2	12.3	7.8	5.9	18.3	13.2	10.3	9.8	0.7	9.0	9.7	13.5	4.8	8.4	12.6	18.8	5.0	11.5	10.9	11.9	12.0	8.7	12.2	10.6
VCX2	VCX-2r	ENSG00000177504	"Variable charge, X-linked 2"	Q9H322	X	8169944-8171267	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	106	"testis: 21.5"	"Group enriched"	"Detected in some"	5	"T-47d: 1.8;U-266/70: 2.4"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 0.8;testis cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044642, HPA044996, HPA049357"	Enhanced									"HPA044642: , HPA044996: , HPA049357: "															"unprognostic (1.34e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	21.5			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
VCX3B	VCX-C	ENSG00000205642	"Variable charge, X-linked 3B"	Q9H321	X	8464830-8466510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	61	"testis: 21.7"	"Cell line enriched"	"Detected in some"	19	"U-138 MG: 20.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044996, HPA049357"	Supported									"HPA044996: , HPA049357: "		"unprognostic (1.60e-1)"		"unprognostic (1.25e-1)"	"unprognostic (1.67e-1)"			"unprognostic (7.51e-2)"		"unprognostic (2.07e-1)"		"unprognostic (4.19e-3)"	"unprognostic (4.41e-2)"		"unprognostic (3.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.58e-2)"	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1		0.0	0.1	0.0	0.0	0.0		0.1	0.0		0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	21.7			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	20.4	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ANOS1	"ADMLX, KAL, KAL1, KALIG-1, WFDC19"	ENSG00000011201	"Anosmin 1"	P23352	X	8528874-8732186	"Disease related genes, Predicted secreted proteins"	"Cell adhesion, Chemotaxis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.5;lung: 37.1;parathyroid gland: 27.7"	"Group enriched"	"Detected in some"	5	"NTERA-2: 26.9;U-2 OS: 13.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in brain"						"unprognostic (2.93e-1)"	"unprognostic (5.33e-2)"	"unprognostic (9.54e-2)"	"unprognostic (4.16e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.53e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.09e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.38e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.56e-2)"	5.4	4.0	13.8	1.3	14.0	0.6	3.6	1.3	18.0	4.5	1.0	7.3	1.3	0.7	0.9	3.2	1.6	1.4	1.9	4.6	11.1	7.9	1.1	1.1	37.1	1.8	5.7	6.0	0.9	0.8	27.7	1.0	1.4	19.3	4.1	1.3	6.0	2.8	4.5	10.9	3.0	0.9	1.1	25.5	1.1	1.1	5.0	8.5	1.3	8.5	1.0	1.2	1.6	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.6	0.5	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.5	3.0	0.1	4.0	0.4	4.4	0.0	0.0	0.0	1.1	0.1	2.2	0.2	0.1	0.0	0.0	0.0	0.3	0.3	0.2	0.0	26.9	0.0	0.0	0.0	0.0	1.5	0.5	1.5	0.0	1.3	0.4	0.0	0.0	0.7	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	14.0	1.3	7.6	11.1	7.9	5.7	6.0	19.3	8.5
FAM9A	TEX39A	ENSG00000183304	"Family with sequence similarity 9 member A"	Q8IZU1	X	8790795-8801383	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 9.2"	"Cell line enriched"	"Detected in single"	19	"U-266/84: 13.6"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"eosinophil: 1.3"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.3"									HPA056076	Uncertain									"HPA056076: "															"unprognostic (3.43e-2)"			0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0			0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.8	0.0	0.0	0.4		0.1	0.2	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.3	9.2			0.0		0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0										
FAM9B	TEX39B	ENSG00000177138	"Family with sequence similarity 9 member B"	Q8IZU0	X	9024232-9164639	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 3.4;liver: 3.7;testis: 11.4"	"Group enriched"	"Detected in some"	49	"U-266/70: 20.7;U-266/84: 22.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 3.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.4"									HPA035135	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm		"HPA035135: AB_10669999"		"unprognostic (3.95e-1)"			"unprognostic (4.49e-1)"		"unprognostic (3.76e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.48e-1)"		"unprognostic (1.40e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.08e-10)"	"unprognostic (4.08e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.54e-2)"		0.1	0.1	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.2			0.1	2.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.1	0.0		0.6	0.2	0.0	0.0	0.0		0.4	0.0		0.0	0.2	0.2	0.5	0.5	0.1	0.0	1.1	0.2	11.4			0.1		0.0	0.2	0.6	0.8	0.7	3.4	0.7	0.7	0.4	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	20.7	22.2	0.1	0.0	0.1	0.0	1.0	0.7	0.4	0.3	0.3	0.3	0.5	0.4	0.3	0.2	0.8	0.4	0.4	3.4	0.7	0.4	0.7	0.3	0.4										
TBL1X	"EBI, TBL1"	ENSG00000101849	"Transducin beta like 1 X-linked"	O60907	X	9463295-9741037	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator	Deafness	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 17.3"									"CAB005363, HPA067703"	Approved		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"CAB005363: AB_2240272, HPA067703: "	"prognostic unfavourable (8.50e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-1)"	"prognostic favourable (1.32e-4)"	"unprognostic (2.66e-1)"	"prognostic favourable (4.58e-4)"	"unprognostic (6.71e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.53e-1)"	6.5	7.1	10.1	6.0	12.3	4.5	8.1	3.3	8.1	21.4	7.9	13.2	18.0	2.1	33.0	26.4	8.3	12.4	6.7	5.2	8.6	9.0	12.5	11.0	5.2	9.5	7.6	6.0	13.8	11.3	21.0	24.3	14.5	7.5	24.7	4.1	9.8	5.5	33.0	4.9	5.8	4.2	22.4	9.0	5.7	7.0	9.9	8.5	14.7	9.4	3.4	7.1	15.3	24.5	3.2	3.1	17.3	4.2	0.3	3.1	1.7	0.0	13.5	8.6	23.0	8.0	8.4	8.5	5.2	11.6	10.0	10.5	10.1	9.3	14.4	0.3	10.3	3.1	18.8	4.1	14.7	5.9	9.3	9.0	16.5	11.9	11.4	3.2	32.5	7.5	4.7	10.4	5.5	9.2	15.8	25.1	5.7	11.4	7.8	12.2	17.1	14.6	17.6	6.8	17.6	13.6	7.7	11.1	5.0	12.5	3.1	7.5	6.1	7.1	13.3	3.5	8.7	0.3	2.0	15.3	11.9	11.4	12.9	7.9	3.3	4.4	4.2	4.9	2.1	2.6	1.7	2.0	1.6	1.9	3.1	3.2	3.1	2.8	17.3	0.3	1.7	0.3	2.5	1.7	10.1	12.3	3.3	8.1	8.6	9.0	7.6	6.0	7.5	8.5
GPR143	OA1	ENSG00000101850	"G protein-coupled receptor 143"	P51810	X	9725346-9786297	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Albinism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"retina: 51.5"	"Cell line enriched"	"Detected in some"	7	"SK-MEL-30: 57.3"	"Cancer enriched"	"Detected in all"	9	"melanoma: 84.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"basophil: 5.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 5.0"	"Not detected"	"Not detected"							HPA003648	Enhanced									"HPA003648: "	"unprognostic (4.60e-2)"	"prognostic favourable (8.73e-4)"	"unprognostic (7.43e-3)"	"unprognostic (5.41e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.78e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.18e-2)"	"unprognostic (8.40e-2)"	"prognostic favourable (2.45e-5)"	"unprognostic (2.75e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.59e-2)"	0.8	1.3	4.2	0.0	7.6	0.0	2.1	1.5	4.5	2.0	1.6	3.0	3.6	0.6	3.9	7.0	2.8	3.7	1.1	0.4	3.4	3.7	6.6	2.0	1.2	0.4	5.7	3.1	4.5	2.1	3.0	2.0	7.9	6.3	3.4	1.8	51.5	4.1	6.3	0.2	11.5	0.5	1.2	4.3	0.2	0.9	1.0	2.2	1.0	4.2	1.0	1.8	1.8	1.1	0.5	0.1	5.0	0.3	0.1	0.3	0.0	0.6	0.1	1.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.1	0.2	0.9	0.0	1.3	0.0	0.6	0.0	0.0	2.5	0.0	0.0	0.0	4.3	0.0	0.0	4.1	0.0	0.0	0.0	0.0	8.3	1.1	0.3	0.0	0.1	0.0	57.3	0.7	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.3	0.2	0.3	0.1	0.1	0.4	0.1	0.1	0.1	0.5	0.1	0.2	0.8	0.1	0.1	0.0	0.0	0.0	4.2	7.6	1.5	4.5	3.4	3.7	5.7	3.1	6.3	2.2
SHROOM2	APXL	ENSG00000146950	"Shroom family member 2"	Q13796	X	9786456-9949443	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 12.4;RT4: 12.9;WM-115: 15.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							"HPA051646, HPA061435"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cell Junctions"	Cytosol	"HPA051646: , HPA061435: "	"unprognostic (8.65e-3)"	"unprognostic (1.36e-3)"	"unprognostic (4.68e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.99e-3)"	"unprognostic (8.05e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.73e-2)"	"prognostic favourable (1.35e-7)"	"unprognostic (1.56e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.67e-3)"	1.3	3.6	6.8	1.3	7.7	0.5	2.5	2.8	17.0	4.7	3.2	3.7	4.6	1.8	3.3	5.8	7.2	3.6	6.3	1.5	7.4	5.5	5.3	7.6	8.1	1.0	5.7	9.1	13.8	7.2	5.5	6.1	14.3	5.8	10.6	3.0	3.6	6.0	5.8	0.7	7.9	1.4	2.1	7.9	1.7	2.6	5.8	2.5	1.8	3.1	3.4	3.4	6.4	4.3	0.0	0.9	1.1	0.0	0.0	0.2	0.0	4.0	0.5	7.6	1.0	0.4	1.2	4.3	0.4	1.3	1.6	2.7	5.0	0.0	0.0	1.4	1.0	3.3	3.9	10.8	1.9	0.0	2.9	0.0	0.0	0.8	2.5	0.0	5.2	0.2	7.5	12.4	0.5	9.3	0.0	0.0	2.6	4.3	0.0	0.0	6.6	0.0	0.0	8.3	0.0	7.0	12.9	1.1	0.6	0.3	0.1	12.0	4.4	0.2	4.3	12.1	1.5	0.0	0.4	0.0	0.0	0.0	7.9	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.9	0.0	0.0	6.8	7.7	2.8	17.0	7.4	5.5	5.7	9.1	5.8	2.5
CLDN34		ENSG00000234469	"Claudin 34"	H7C241	X	9967358-9968352	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	8	"testis: 5.4"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 1.2;RT4: 4.3;U-138 MG: 1.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (1.54e-2)"	"unprognostic (6.73e-5)"		"unprognostic (1.25e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.43e-2)"		"unprognostic (1.53e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.31e-3)"	"unprognostic (5.39e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.89e-2)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1			0.0	0.1	0.5	0.4	0.1	0.0	0.0	0.1	0.0	0.4	0.4	0.3	0.0	0.0		0.6	0.5	0.0	0.1	0.2		0.5	0.0		0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	5.4			0.0		0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.5	4.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
WWC3	"BM042, KIAA1280"	ENSG00000047644	"WWC family member 3"	Q9ULE0	X	10015562-10144478	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 56.9"	"Cell line enhanced"	"Detected in many"		"T-47d: 53.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA039814	Uncertain		Approved	"Actin filaments,Cytosol"				Cytosol	"Actin filaments"	"HPA039814: AB_10674987"	"unprognostic (2.53e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavourable (1.31e-4)"	"unprognostic (9.84e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.21e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.58e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.06e-5)"	"unprognostic (9.90e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.50e-2)"	10.2	13.2	8.9	9.8	12.6	5.3	10.3	13.7	10.1	10.0	13.1	18.2	56.9	4.5	11.6	22.0	12.4	8.9	10.8	15.4	10.0	7.2	7.2	3.9	21.0	12.5	13.1	6.4	18.7	9.4	9.9	6.7	25.7	10.6	11.3	5.6	12.6	9.0	44.4	7.6	12.3	10.8	13.2	9.4	11.8	11.2	6.9	11.8	6.2	12.2	8.1	10.2	10.2	18.1	6.6	0.7	12.3	1.0	2.7	6.9	2.1	6.7	7.7	9.4	3.1	3.9	5.6	8.9	3.8	6.7	2.3	2.6	1.0	7.1	0.7	0.0	5.1	3.5	2.1	4.0	1.9	5.0	0.7	1.5	5.0	0.7	8.5	0.0	2.4	3.6	8.4	5.8	6.2	10.9	0.1	9.2	5.6	13.9	1.6	0.4	8.8	2.7	4.9	0.4	2.9	2.2	3.5	1.0	2.6	4.7	6.1	4.1	53.9	0.5	14.5	6.8	0.1	10.0	4.2	7.5	5.0	2.5	4.1	2.5	10.0	4.1	1.0	0.2	6.9	0.8	6.0	2.4	3.4	5.1	0.5	6.6	3.2	3.8	12.3	2.7	0.8	0.7	1.6	2.1	8.9	12.6	13.7	10.1	10.0	7.2	13.1	6.4	10.6	11.8
CLCN4	"ClC-4, CLC4"	ENSG00000073464	"Chloride voltage-gated channel 4"	P51793	X	10156945-10237660	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.1;epididymis: 22.8;skeletal muscle: 34.6"	"Cell line enhanced"	"Detected in many"		"HEL: 16.7;SCLC-21H: 17.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 2.3;memory B-cell: 1.7;naive B-cell: 6.8;neutrophil: 4.4"	"Group enriched"	"Detected in many"	9	"B-cells: 6.8;granulocytes: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031313, HPA063637"	Enhanced		Approved	Vesicles				Vesicles		"HPA031313: AB_10601358, HPA063637: "	"unprognostic (1.01e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.07e-2)"	"prognostic unfavourable (2.13e-5)"	"unprognostic (2.96e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.99e-2)"	"prognostic favourable (9.55e-4)"	"unprognostic (9.70e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-1)"	3.1	3.4	9.7	2.0	21.3	2.1	1.6	18.6	29.1	2.0	1.4	15.7	0.0	1.2	1.3	22.8	2.3	3.0	2.8	11.4	13.0	10.5	3.4	3.5	3.4	2.9	23.5	10.4	2.2	2.4	8.9	3.9	1.7	18.2	2.1	1.1	6.0	2.3	1.7	34.6	1.2	1.2	1.4	15.2	3.2	2.1	2.2	17.9	0.0	6.8	2.0	2.2	2.3	0.8	6.8	0.6	4.4	0.5	0.0	0.0	0.6	4.9	3.1	2.3	0.0	1.1	2.0	0.1	0.1	0.0	0.0	0.0	6.0	3.4	3.7	9.0	1.0	1.1	1.4	3.4	0.1	0.0	3.5	16.7	1.7	2.5	5.5	0.0	0.0	10.0	2.7	4.3	1.1	6.4	1.2	0.0	2.3	0.5	0.0	0.1	2.9	10.8	0.0	3.8	0.0	1.5	0.5	17.3	6.5	7.1	0.7	0.0	1.8	2.1	6.3	2.7	4.6	11.8	0.4	0.4	8.3	1.3	8.6	0.0	3.4	2.3	0.5	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.6	6.8	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.6	9.7	21.3	18.6	26.7	13.0	10.5	23.5	10.4	18.2	17.9
MID1	"FXY, OS, RNF59, TRIM18"	ENSG00000101871	"Midline 1"	O15344	X	10445310-10833654	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 56.8;AF22: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002878, HPA003715"	Approved		Approved	"Centriolar satellite"				"Centriolar satellite"		"HPA002878: , HPA003715: AB_1079384"	"unprognostic (1.99e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (3.06e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.25e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.12e-3)"	"unprognostic (5.88e-2)"	13.4	3.6	6.5	10.4	8.4	0.3	8.6	16.3	7.1	17.5	21.5	3.8	11.7	7.7	17.9	11.3	12.2	7.7	13.1	13.2	6.2	4.2	7.9	4.9	10.4	4.2	4.5	3.7	12.0	4.8	2.7	6.6	7.8	4.9	14.6	12.8	15.9	7.1	19.1	2.8	3.9	8.7	30.6	2.6	1.3	5.3	6.5	4.1	0.8	6.2	7.1	5.8	17.1	20.5	1.0	0.7	3.3	0.0	0.0	0.1	0.1	12.2	56.8	43.0	6.6	2.5	3.6	5.3	7.7	6.4	7.9	8.1	10.4	3.7	4.1	2.5	7.0	8.4	3.5	5.3	5.9	0.2	5.1	0.9	8.1	0.2	1.1	0.0	0.2	4.1	2.8	5.2	5.5	7.6	0.6	0.7	3.1	1.9	1.6	0.1	13.7	4.1	1.2	11.0	0.0	5.8	11.3	3.0	1.1	3.3	9.7	3.6	6.7	0.0	4.8	2.6	0.3	13.3	6.7	0.6	0.3	0.1	5.6	0.0	12.8	0.1	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.1	6.5	8.4	16.3	5.2	6.2	4.2	4.5	3.7	4.9	4.1
HCCS	"CCHL, MLS"	ENSG00000004961	"Holocytochrome c synthase"	P53701	X	11111301-11123078	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002946	Approved		Enhanced	Mitochondria	"Intracellular and membrane"			Mitochondria		"HPA002946: AB_1079041"	"prognostic unfavourable (8.69e-5)"	"unprognostic (6.89e-3)"	"unprognostic (8.46e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.44e-2)"	"prognostic unfavourable (1.35e-5)"	"unprognostic (9.18e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (6.17e-8)"	"unprognostic (2.66e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.93e-2)"	10.6	14.2	8.8	9.0	12.7	11.8	9.6	11.0	17.7	6.7	15.5	7.4	8.0	17.2	8.5	5.5	15.8	6.9	9.8	36.9	8.4	8.3	15.9	19.0	9.5	10.1	8.2	11.1	10.0	11.4	11.5	10.0	12.8	10.6	7.8	15.2	9.3	12.8	8.0	41.6	13.8	14.4	10.4	6.3	12.3	12.2	10.5	6.0	10.3	10.8	16.4	11.8	11.4	17.3	18.1	28.4	13.3	29.7	8.4	11.1	8.7	23.2	26.8	12.5	12.0	11.8	11.4	13.3	23.5	17.9	29.7	25.5	31.1	17.0	14.5	12.1	18.8	21.6	25.9	22.4	29.0	13.5	20.3	14.5	34.4	15.5	20.9	15.8	17.7	11.1	17.5	28.2	19.3	21.0	26.8	16.8	19.9	31.5	11.4	12.8	22.7	29.0	11.2	25.2	28.4	20.0	18.3	9.1	10.7	23.4	25.5	15.0	19.7	11.4	20.6	19.3	10.4	49.2	20.0	12.4	12.6	19.2	15.5	12.7	18.4	10.1	22.5	13.3	9.9	29.7	9.5	18.1	9.7	8.9	28.4	15.5	8.5	11.1	6.2	8.4	24.8	25.9	10.4	8.7	8.8	12.7	11.0	17.7	8.4	8.3	8.2	11.1	10.6	6.0
ARHGAP6	rhoGAPX-1	ENSG00000047648	"Rho GTPase activating protein 6"	O43182	X	11137543-11665701	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 57.3;seminal vesicle: 58.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.8;ASC TERT1: 19.2;HEL: 18.9;HMC-1: 13.3;HSkMC: 18.9;K-562: 13.7;RT4: 10.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 12.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001798, HPA036779, HPA064390"	Enhanced		Supported	Cytosol	"Intracellular and membrane"		920000	Cytosol		"HPA001798: , HPA036779: AB_10672229, HPA064390: "	"unprognostic (2.36e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.31e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.46e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.59e-1)"	"prognostic favourable (1.55e-8)"	"unprognostic (1.60e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.28e-2)"	"unprognostic (7.99e-4)"	9.4	1.2	16.7	2.6	10.0	0.7	6.3	0.6	2.9	9.5	11.7	4.1	57.3	2.0	10.2	9.0	4.1	7.6	5.4	3.6	5.6	4.3	6.0	1.1	8.7	1.2	2.3	3.6	15.1	1.9	1.1	6.6	6.2	2.7	24.8	3.7	3.2	2.5	58.8	8.0	2.3	4.2	12.1	3.1	5.0	4.1	2.2	3.3	0.0	25.9	3.1	1.4	14.3	8.0	1.3	0.2	1.0	0.9	0.0	0.1	2.7	0.0	0.0	1.3	0.0	14.8	19.2	0.3	0.1	0.3	0.7	0.5	0.1	0.0	0.0	0.0	2.6	0.0	0.5	0.0	0.7	0.0	0.2	18.9	0.0	0.0	5.4	0.0	13.3	18.9	0.0	1.3	0.0	0.3	13.7	6.4	0.8	0.0	0.0	0.0	0.3	0.2	0.0	6.3	8.0	4.5	10.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	3.8	0.1	0.3	0.0	0.0	0.1	0.0	2.0	1.0	0.3	0.5	0.0	0.9	0.0	1.3	0.0	0.1	0.2	0.4	0.0	0.0	1.0	0.0	0.7	0.2	0.0	2.7	16.7	10.0	0.6	2.9	5.6	4.3	2.3	3.6	2.7	3.3
AMELX	"AIH1, AMG"	ENSG00000125363	"Amelogenin, X-linked"	Q99217	X	11293413-11300761	"Disease related genes, Predicted secreted proteins"	Biomineralization		"Amelogenesis imperfecta, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"ductus deferens: 3.5;epididymis: 3.0;seminal vesicle: 9.4"	"Cell line enhanced"	"Detected in single"		"K-562: 1.3"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 1.9"	"Region enhanced"	"Detected in single"		"amygdala: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"								"unprognostic (1.76e-1)"									"unprognostic (1.00e-1)"		"unprognostic (2.00e-1)"				0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.1	0.3	3.5	0.0	0.0	3.0	0.0	0.1	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	9.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.6	0.5	0.5	0.0	0.7	0.0	0.0
MSL3	MSL3L1	ENSG00000005302	"MSL complex subunit 3"	Q8N5Y2	X	11758159-11775753	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA034535, HPA034536"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA034535: AB_10603878, HPA034536: AB_10670973"	"unprognostic (2.58e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.56e-2)"	"unprognostic (5.36e-2)"	"prognostic favourable (3.28e-4)"	"prognostic unfavourable (4.93e-4)"	"unprognostic (8.36e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.13e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavourable (3.14e-9)"	"unprognostic (1.20e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.35e-1)"	"prognostic favourable (2.17e-4)"	11.4	8.1	11.7	23.4	13.3	19.0	10.7	11.9	18.8	7.8	9.3	10.0	6.4	8.6	9.6	7.5	11.9	9.4	10.9	7.7	11.1	11.2	9.9	9.2	14.4	32.5	11.8	10.5	8.6	7.5	7.0	7.9	12.3	15.7	9.7	10.5	4.6	9.9	8.9	24.0	13.7	16.2	10.1	11.3	34.1	9.5	10.5	10.0	49.1	10.1	9.4	30.2	13.9	15.5	25.7	27.1	39.0	33.4	24.5	37.1	30.9	11.3	12.4	16.4	14.4	13.6	18.9	7.0	14.6	13.2	16.0	19.3	7.6	11.6	16.4	15.1	13.9	9.5	19.5	11.9	19.5	10.5	13.7	8.7	14.1	3.9	12.4	13.2	16.9	11.6	15.4	19.3	8.4	27.3	15.8	10.3	16.0	11.6	10.6	15.0	13.4	20.4	7.7	16.7	19.8	11.2	14.2	10.8	13.0	15.8	6.8	9.5	11.5	8.7	26.1	15.5	10.9	25.2	13.4	8.2	9.8	18.9	11.3	7.5	12.8	26.7	31.1	22.4	24.2	27.5	23.0	25.7	28.6	27.8	24.0	25.3	37.1	34.5	39.0	24.5	33.4	27.1	33.6	30.9	11.7	13.3	11.9	18.8	11.1	11.2	11.8	10.5	15.7	10.0
FRMPD4	"KIAA0316, PDZD10, PDZK10"	ENSG00000169933	"FERM and PDZ domain containing 4"	Q14CM0	X	12138466-12724523	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 16.4;parathyroid gland: 28.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 4.2;LHCN-M2: 5.9;U-2197: 9.3;U-266/70: 8.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.05e-1)"	"unprognostic (3.70e-2)"			"unprognostic (3.50e-2)"	"unprognostic (2.68e-3)"		"unprognostic (8.84e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.25e-1)"	0.6	0.6	5.5	0.6	10.9	0.5	0.6	3.8	16.4	0.7	1.1	1.0	0.0	0.6	0.7	1.0	0.7	0.6	0.6	2.1	8.1	3.5	0.6	0.6	0.6	0.5	2.7	6.9	0.6	0.5	28.3	0.6	0.5	2.9	1.1	0.8	1.9	0.5	0.6	1.1	0.6	0.6	0.6	0.8	0.5	0.6	1.0	1.5	0.0	0.6	0.0	0.6	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.3	0.7	0.0	1.1	2.1	3.4	4.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.3	2.2	3.4	0.0	0.2	0.0	0.1	0.0	0.0	1.5	0.0	1.3	2.3	0.0	0.0	0.7	5.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	9.3	1.0	8.6	3.9	0.0	2.4	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	10.9	3.8	14.6	8.1	3.5	2.7	6.9	2.9	1.5
PRPS2		ENSG00000101911	"Phosphoribosyl pyrophosphate synthetase 2"	P11908	X	12791355-12824222	"Enzymes, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 138.1;testis: 109.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067599, CAB070417"	Enhanced		Uncertain	Vesicles				Vesicles		"CAB070417: AB_11152035, HPA067599: "	"unprognostic (7.50e-2)"	"prognostic favourable (1.90e-4)"	"unprognostic (2.09e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.63e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.98e-2)"	"unprognostic (2.64e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.04e-1)"	5.4	20.8	4.0	10.2	8.7	6.1	6.1	3.7	11.5	18.7	13.3	5.7	44.4	4.1	17.0	21.7	9.6	9.6	13.2	3.3	4.0	3.5	10.8	9.0	5.4	10.7	2.7	7.7	75.3	19.9	20.1	2.4	3.2	2.9	14.9	10.2	4.4	11.1	138.1	1.5	10.3	6.3	12.2	3.9	7.6	14.3	109.7	3.1	26.2	7.8	5.5	10.9	15.1	10.2	21.9	17.7	10.5	12.5	15.0	22.7	16.7	31.0	20.6	7.2	13.0	8.9	10.5	4.0	15.5	8.5	17.2	16.7	14.6	25.0	9.1	7.0	7.4	23.6	13.8	16.9	20.3	24.5	29.8	11.2	17.0	13.5	8.2	22.1	11.5	10.1	11.4	12.7	17.0	7.0	8.3	12.7	14.5	21.4	33.7	10.2	15.3	27.8	18.0	30.8	23.3	10.3	25.8	13.9	9.4	18.7	0.7	11.7	18.6	10.0	6.5	13.5	9.8	49.5	16.5	30.0	11.0	21.7	14.2	11.2	21.2	10.5	12.5	5.6	11.7	12.4	13.6	18.0	17.0	11.1	17.7	21.9	22.7	15.3	5.5	15.0	7.7	12.6	14.0	16.7	4.0	8.7	3.7	11.5	4.0	3.5	2.7	7.7	2.9	3.1
TLR7		ENSG00000196664	"Toll like receptor 7"	Q9NYK1	X	12867083-12890380	"FDA approved drug targets, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.5"	"Group enriched"	"Detected in some"	5	"Daudi: 15.6;U-266/70: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059613	Supported									"HPA059613: "	"unprognostic (1.22e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.36e-3)"	"unprognostic (9.29e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.06e-2)"	"unprognostic (8.27e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.75e-1)"	"unprognostic (6.91e-2)"	"unprognostic (3.55e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.53e-3)"	"unprognostic (1.34e-1)"	2.9	3.1	7.6	7.2	11.3	1.0	7.6	1.7	7.9	2.5	3.3	10.6	0.0	3.2	1.8	2.9	1.8	1.7	5.3	4.1	8.4	5.1	2.2	1.5	7.7	6.9	17.4	2.6	1.6	1.9	1.5	2.2	11.0	12.9	2.2	4.0	1.5	2.7	2.0	1.4	1.4	4.9	3.5	26.5	6.7	3.0	1.5	17.2	7.7	1.7	0.5	9.4	5.2	1.6	6.9	15.7	3.2	8.9	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	16.1	0.0	3.0	0.0	0.3	0.0	0.2	7.2	3.2	0.0	8.9	0.0	6.9	0.0	0.0	3.7	5.8	0.0	0.0	0.4	0.0	6.8	15.7	0.0	2.2	7.6	11.3	1.7	7.9	8.4	5.1	17.4	2.6	12.9	17.2
TLR8	CD288	ENSG00000101916	"Toll like receptor 8"	Q9NR97	X	12906620-12923169	"CD markers, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.8;lymphoid tissue: 45.6"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.2;PC-3: 2.7;THP-1: 1.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	94	"classical monocyte: 10.0;intermediate monocyte: 9.6;myeloid DC: 5.3;neutrophil: 17.8;non-classical monocyte: 9.2"	"Group enriched"	"Detected in many"	100	"dendritic cells: 5.3;granulocytes: 17.8;monocytes: 10.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA001608	Enhanced									"HPA001608: AB_1080295"	"unprognostic (1.32e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.96e-3)"	"unprognostic (4.43e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.66e-2)"	8.5	1.4	0.9	16.0	1.5	4.7	1.2	0.7	1.1	1.0	1.5	0.4	0.0	0.6	1.0	3.2	1.0	2.0	2.4	3.0	2.0	1.0	2.0	4.0	13.7	33.0	1.7	0.1	1.1	1.0	0.2	1.0	4.0	1.9	1.4	1.7	0.9	1.2	0.0	1.4	0.8	2.0	3.5	3.3	45.6	1.3	1.2	1.6	3.5	1.0	1.1	2.4	4.2	2.4	0.1	5.3	17.8	10.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.1	0.2	0.0	0.4	0.2	0.0	0.0	0.3	0.0	0.0	10.0	0.0	0.0	9.6	0.0	0.1	0.0	0.0	5.3	0.0	0.0	0.0	17.8	0.0	9.2	0.0	0.0	2.0	0.9	1.5	0.7	1.1	2.0	1.0	1.7	0.1	1.9	1.6
TMSB4X	"TB4X, TMSB4"	ENSG00000205542	"Thymosin beta 4, X-linked"	P62328	X	12975108-12977227	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"blood: 1074.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			CAB033806	Approved		Approved	Nucleoplasm,Vesicles,Cytosol			400000000	"Nucleoplasm, Vesicles, Cytosol"		"CAB033806: AB_2256019"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.16e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.27e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (6.20e-4)"	"unprognostic (5.98e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.98e-1)"	122.3	97.5	79.8	105.4	76.4	169.0	87.1	33.2	74.8	92.3	93.3	62.0	59.7	38.5	83.7	67.2	62.7	53.0	92.5	54.9	90.8	67.8	69.6	50.8	134.4	205.2	111.4	84.0	61.9	51.0	4.4	23.4	53.4	74.3	46.6	86.6	31.2	42.3	100.4	28.9	39.6	71.5	75.1	195.6	205.7	98.9	26.4	63.8	96.8	34.4	48.6	154.5	112.2	62.1	296.5	495.3	775.0	554.0	272.7	521.9	1074.5	141.5	118.6	233.1	367.2	285.8	313.3	0.5	75.1	196.5	58.3	100.5	24.4	119.2	33.9	72.6	227.8	62.4	34.5	50.3	78.5	198.2	1.9	42.2	70.3	0.3	66.6	164.9	350.9	145.8	72.2	69.0	60.4	350.3	5.3	0.5	206.3	50.4	196.0	357.9	83.8	81.8	151.1	82.5	138.5	347.1	41.5	24.8	10.5	108.8	5.1	13.8	136.7	167.5	281.7	85.2	42.2	482.6	74.5	110.6	80.3	65.8	130.3	68.4	61.3	544.9	512.5	775.0	364.8	524.7	309.6	296.5	407.3	391.0	495.3	275.6	345.8	349.0	576.0	272.7	554.0	204.1	521.9	1074.5	79.8	76.4	33.2	74.8	90.8	67.8	111.4	84.0	74.3	63.8
FAM9C	TEX39C	ENSG00000187268	"Family with sequence similarity 9 member C"	Q8IZT9	X	13035618-13044682	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 29.8;testis: 12.0"	"Cell line enriched"	"Detected in some"	55	"AN3-CA: 63.6"	"Cancer enriched"	"Detected in single"	22	"testis cancer: 4.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	10	"eosinophil: 3.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 3.0"																				"unprognostic (2.28e-1)"				"unprognostic (7.35e-2)"			"unprognostic (1.90e-1)"		"unprognostic (1.66e-1)"	"unprognostic (3.35e-2)"		"unprognostic (2.06e-4)"	"unprognostic (3.96e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.89e-1)"		0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.2	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.0	1.3	0.0	2.0	0.0	0.1	0.0	0.1	29.8	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.0	0.1	0.0	0.3	0.0	0.1	0.1	0.3	63.6	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.5	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.5	0.0	0.6	0.0	0.2	0.5	0.0	0.0	0.3	0.3	0.1	0.5	0.0	0.2	0.4	0.2	0.3	0.2	0.2	1.1	0.2	0.1	0.3	0.4	0.2	0.1	0.3	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
ATXN3L	MJDL	ENSG00000123594	"Ataxin 3 like"	Q9H3M9	X	13318236-13320399	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	30	"testis: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA024123, HPA027539"	Uncertain									"HPA024123: AB_1845133, HPA027539: AB_10602435"																		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EGFL6	MAEG	ENSG00000198759	"EGF like domain multiple 6"	Q8IUX8	X	13569605-13633575	"Predicted secreted proteins"	"Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"placenta: 137.5"	"Group enriched"	"Detected in some"	5	"BJ hTERT+: 9.4;NTERA-2: 3.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA001838	Enhanced				"Secreted to extracellular matrix"					"HPA001838: "	"unprognostic (1.66e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.15e-3)"	"unprognostic (3.76e-3)"	"unprognostic (1.77e-2)"	"prognostic favourable (9.73e-4)"	"unprognostic (4.13e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.19e-3)"	"prognostic favourable (4.95e-4)"	"unprognostic (2.39e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.14e-9)"	"unprognostic (7.10e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.82e-3)"	16.1	0.1	0.3	0.2	0.2	0.1	2.3	0.0	0.2	0.4	4.1	0.0	0.1	0.2	0.5	0.4	3.3	0.6	1.5	0.6	0.1	0.7	0.2	0.1	18.6	0.2	0.1	0.1	0.2	0.3	0.1	1.7	137.5	0.9	0.6	0.2	27.1	0.2	0.1	0.1	0.4	0.2	2.0	0.6	0.2	0.4	0.2	0.0	0.0	0.2	0.2	0.4	4.1	1.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.1	0.7	0.1	0.1	0.9	0.0
TCEANC	MGC17403	ENSG00000176896	"Transcription elongation factor A N-terminal and central domain containing"	Q8N8B7	X	13653189-13681964	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000337, HPA001013"	Uncertain		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA000337: , HPA001013: AB_1079371"	"unprognostic (1.44e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.74e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.29e-3)"	"unprognostic (4.03e-2)"	"unprognostic (4.29e-6)"	"unprognostic (3.82e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.63e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.11e-4)"	2.2	2.4	2.1	1.1	2.1	6.3	3.9	3.3	1.8	2.1	1.6			1.3	2.3	5.0	1.1	2.8	1.2	2.0	1.9	2.3	2.1	2.8	2.5	3.6	2.1		4.1	2.7	1.6	2.3	1.5		2.1	2.1		2.3	1.7	2.6	2.0	2.5	2.1	2.4	4.4	1.9	1.0			3.1		2.8	1.9	1.6	5.6	3.7	9.9	2.7	2.4	6.1	3.1	0.7	2.1	2.4	4.1	5.1	6.0	0.9	0.7	1.9	2.0	0.9	0.7	1.7	2.5	2.3	1.6	1.2	2.0	1.1	0.5	2.6	3.0	1.3	1.2	1.1	2.8	2.0	2.5	5.1	2.0	1.1	8.4	0.6	2.5	4.3	2.8	1.8	3.2	2.0	3.2	0.6	2.6	2.2	5.1	1.1	1.3	2.5	2.3	2.1	2.3	3.0	2.4	1.9	1.1	1.7	0.9	1.6	0.3	3.4	2.0	1.7	2.4	1.2	0.9	9.9	2.7	6.8	4.7	2.2	5.1	5.6	5.1	6.1	2.2	5.2	6.1	5.6	3.4	2.4	2.4	3.7	5.8	3.1										
RAB9A	RAB9	ENSG00000123595	"RAB9A, member RAS oncogene family"	P51151	X	13689125-13710506	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003094, CAB016411"	Supported		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB016411: AB_630176, HPA003094: AB_1079736"	"unprognostic (3.40e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.56e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.77e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.88e-2)"	"prognostic favourable (3.35e-5)"	"unprognostic (3.93e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.68e-2)"	17.1	36.0	17.7	20.3	17.1	30.6	48.4	16.2	24.1	14.8	17.6	20.2	19.7	9.3	18.8	14.3	19.7	11.9	14.5	23.1	16.9	14.3	19.6	15.6	17.3	21.0	24.7	13.8	18.9	23.6	19.1	11.3	17.8	18.1	13.5	16.2	8.0	22.8	17.6	12.0	21.2	12.3	15.3	25.5	15.1	14.2	6.4	23.4	9.8	16.8	13.2	19.3	16.1	19.7	13.1	19.1	17.7	25.7	19.8	27.3	13.9	12.4	6.7	8.6	20.3	28.9	23.2	7.7	7.0	24.6	10.7	15.7	7.2	14.0	11.3	17.4	10.9	12.8	12.8	14.9	10.6	25.0	19.9	3.6	14.8	8.2	17.4	6.3	9.8	24.9	26.4	13.5	14.5	9.9	6.9	16.8	11.5	8.6	5.9	10.3	9.2	12.7	8.2	9.1	33.8	29.5	11.6	7.1	5.0	14.8	21.1	24.1	11.7	6.7	7.7	8.2	4.2	28.9	4.2	13.3	23.1	4.5	8.2	5.4	8.0	17.7	25.7	11.1	27.3	16.6	21.1	13.1	15.0	22.4	17.6	10.0	11.3	19.4	15.3	19.8	14.5	19.1	11.7	13.9	17.7	17.1	16.2	24.1	16.9	14.3	24.7	13.8	18.1	23.4
TRAPPC2	"hYP38334, MIP-2A, SEDL, SEDT, TRS20, ZNF547L"	ENSG00000196459	"Trafficking protein particle complex 2"	"P0DI81, P0DI82"	X	13712244-13734635	"Disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Transcription, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB004665, HPA063308"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"				"Endoplasmic reticulum, Vesicles"	Nucleoplasm	"CAB004665: AB_425678, HPA063308: "	"unprognostic (1.97e-1)"	"prognostic favourable (8.09e-4)"	"unprognostic (2.13e-1)"	"unprognostic (4.18e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.76e-2)"	"prognostic favourable (6.35e-4)"	"unprognostic (3.50e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.36e-1)"	"prognostic favourable (7.89e-5)"	6.5	6.4	15.6	9.5	13.7	9.5	9.4	24.1	16.1	10.5	9.4	10.1	8.8	8.2	16.4	8.7	8.5	9.4	7.6	6.4	14.4	14.2	10.1	10.1	7.8	16.1	10.4	13.0	11.7	11.2	8.9	19.5	7.2	11.5	8.9	9.1	10.2	8.1	8.3	4.9	10.3	8.8	16.0	11.5	11.1	10.7	4.3	11.1	4.3	8.8	4.2	16.4	8.1	9.4	11.2	10.7	13.7	6.6	18.5	16.1	9.0	6.7	5.2	8.0	20.6	6.2	4.8	3.3	6.3	5.4	5.0	5.4	4.4	8.3	11.4	10.2	5.2	8.9	10.7	9.0	6.9	11.5	15.9	8.5	12.3	3.5	4.7	11.6	16.4	6.2	5.1	10.7	14.7	4.4	10.7	19.6	5.1	11.1	11.4	15.4	7.7	9.4	11.3	10.7	11.1	7.9	5.0	8.6	11.4	11.6	9.3	8.0	11.6	7.7	5.8	5.1	4.6	9.1	4.0	10.2	9.9	14.3	4.7	8.3	5.2	13.7	4.9	8.6	16.1	6.6	16.0	11.2	12.8	15.8	4.3	11.1	10.8	15.5	10.0	18.5	5.4	10.7	15.3	9.0	15.6	13.7	24.1	16.1	14.4	14.2	10.4	13.0	11.5	11.1
OFD1	"71-7A, CXorf5, JBTS10, RP23"	ENSG00000046651	"OFD1, centriole and centriolar satellite protein"	O75665	X	13734745-13769353	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Joubert syndrome, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 31.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031102, HPA031103, HPA031104"	Approved		Supported	Microtubules				Microtubules		"HPA031102: AB_10670836, HPA031103: AB_10602188, HPA031104: AB_10669655"	"unprognostic (3.10e-3)"	"prognostic favourable (9.62e-4)"	"unprognostic (2.83e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.42e-3)"	"unprognostic (2.20e-3)"	"unprognostic (3.03e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavourable (1.63e-4)"	"unprognostic (3.32e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.04e-2)"	"prognostic favourable (2.76e-7)"	7.8	8.0	10.1	20.1	12.3	16.6	18.0	18.7	10.9	19.3	15.0	13.3	16.6	12.5	18.9	15.6	13.5	13.0	15.2	8.3	12.5	9.0	14.9	8.7	11.9	21.2	13.6	8.5	16.1	15.1	27.8	27.2	10.3	12.6	14.9	10.3	9.2	18.4	15.8	7.1	14.2	22.0	9.7	14.6	18.4	14.6	11.7	16.1	16.5	17.7	9.3	19.7	15.0	13.6	8.0	31.5	2.9	1.4	6.7	7.4	2.1	10.0	4.6	6.7	11.9	5.6	8.8	5.0	3.2	7.3	3.7	4.8	8.1	11.4	14.7	8.3	3.7	9.9	4.8	8.7	6.1	7.2	12.2	6.8	13.6	6.8	4.2	9.0	12.5	7.0	6.0	8.5	8.4	4.1	10.2	13.3	4.2	7.9	6.2	10.8	7.0	6.6	15.6	7.8	29.1	5.8	8.6	6.9	11.0	14.9	12.1	7.4	11.4	8.2	3.7	6.7	3.5	7.9	4.0	9.9	9.3	17.2	5.5	4.0	5.4	2.0	0.8	2.9	6.1	1.0	7.1	6.6	5.4	7.4	1.8	8.0	4.5	6.6	2.4	6.7	1.4	31.5	4.1	2.1	10.1	12.3	18.7	10.9	12.5	9.0	13.6	8.5	12.6	16.1
GPM6B	"M6B, MGC17150, MGC54284"	ENSG00000046653	"Glycoprotein M6B"	Q13491	X	13771031-13938638	"Predicted membrane proteins"	"Differentiation, Neurogenesis, Osteogenesis, Protein transport, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 219.5"	"Cell line enhanced"	"Detected in some"		"AF22: 41.9;AN3-CA: 41.6;ASC TERT1: 21.3;HSkMC: 31.4;SK-MEL-30: 41.3"	"Group enriched"	"Detected in many"	14	"glioma: 192.5;melanoma: 41.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	222	"plasmacytoid DC: 33.4"	"Lineage enriched"	"Detected in single"	240	"dendritic cells: 33.4"	"Low region specificity"	"Detected in all"							HPA002913	Approved									"HPA002913: AB_2263553"	"unprognostic (1.56e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.70e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.75e-3)"	"unprognostic (2.12e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.27e-2)"	"prognostic favourable (2.67e-4)"	"unprognostic (1.79e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.38e-3)"	"unprognostic (8.34e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-1)"	4.6	5.5	68.4	3.9	55.1	2.0	12.4	24.1	219.5	10.2	5.7	68.7	1.1	3.6	4.3	6.7	6.4	4.2	3.9	5.9	62.6	33.1	4.5	2.0	6.7	2.6	68.9	47.3	3.1	2.9	1.9	2.6	2.1	44.1	9.9	4.9	3.2	7.4	16.9	2.1	7.1	4.3	3.8	109.4	7.2	3.3	3.0	64.8	0.0	3.5	0.0	2.3	3.3	2.7	0.1	33.4	0.1	0.0	0.1	0.1	0.2	0.1	0.1	41.9	41.6	11.9	21.3	0.1	0.2	1.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	2.1	0.2	0.0	0.1	6.8	0.1	2.8	0.1	0.4	0.1	0.2	31.4	0.2	0.0	0.5	0.0	0.1	1.9	0.4	0.1	0.8	0.1	13.1	0.7	0.5	3.8	6.3	0.0	0.1	2.1	1.2	0.2	1.2	41.3	0.2	0.9	0.0	0.2	0.3	0.1	0.5	0.1	0.0	0.0	0.3	0.0	3.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	33.4	0.0	0.2	68.4	55.1	24.1	43.1	62.6	33.1	68.9	47.3	44.1	64.8
GEMIN8	"FAM51A1, FLJ20514"	ENSG00000046647	"Gem nuclear organelle associated protein 8"	Q9NWZ8	X	14008279-14029893	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028613	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA028613: AB_10602905"	"unprognostic (7.10e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavourable (7.78e-5)"	"unprognostic (3.87e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.07e-2)"	"unprognostic (7.75e-2)"	"prognostic favourable (7.73e-5)"	13.4	13.5	14.5	12.9	17.0	12.0	19.9	12.3	20.0	16.5	13.9	24.0	27.3	9.0	21.5	16.9	13.2	22.8	16.4	15.5	14.8	14.0	16.7	12.9	14.5	16.0	16.6	14.7	28.9	22.2	18.7	27.4	10.3	21.0	13.1	11.9	16.8	24.7	30.2	7.6	15.7	10.0	17.1	23.3	12.5	13.6	8.2	12.7	14.6	21.3	7.9	13.2	12.7	13.0	11.3	15.4	0.8	6.9	9.9	15.2	7.5	6.3	6.3	7.5	1.8	12.2	18.7	3.7	5.9	6.6	5.2	3.6	3.3	11.0	14.8	14.2	4.8	8.5	4.6	10.4	5.0	7.9	9.5	3.8	4.7	7.4	7.1	9.0	8.0	15.0	17.2	9.0	15.7	11.2	6.6	13.1	7.8	8.5	9.0	14.1	8.1	3.7	13.8	5.2	26.3	8.7	6.2	7.4	20.5	6.3	11.9	7.0	16.3	9.0	8.5	3.8	2.2	11.1	2.4	8.9	4.4	9.3	8.8	5.5	2.2	0.6	6.7	0.2	9.4	6.4	11.6	11.3	15.2	8.9	12.2	9.8	13.1	9.8	0.8	9.9	6.9	15.4	8.4	7.5	14.5	17.0	12.3	20.0	14.8	14.0	16.6	14.7	21.0	12.7
GLRA2	GLR	ENSG00000101958	"Glycine receptor alpha 2"	P23416	X	14529298-14731812	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	14	"brain: 21.0;intestine: 11.1"	"Cell line enriched"	"Detected in single"	33	"AN3-CA: 19.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB070422	Approved									"CAB070422: AB_11153055"	"unprognostic (2.52e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.74e-2)"			"unprognostic (1.81e-2)"	"unprognostic (3.39e-1)"	"unprognostic (5.82e-2)"	"unprognostic (7.95e-3)"		"unprognostic (1.13e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.69e-2)"			0.4	0.5	14.5	0.7	13.2	0.7	0.5	21.0	10.8	0.4	4.1	0.1	0.0	0.7	0.5	0.5	0.4	0.8	0.7	0.4	3.6	13.9	0.5	0.5	0.4	0.5	1.6	8.4	0.9	0.5	0.4	0.5	0.8	10.1	0.4	11.1	1.1	0.8	0.5	0.5	0.8	0.9	0.7	6.5	0.5	0.5	0.9	0.8	0.0	0.5	0.0	0.4	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	19.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	13.2	21.0	10.4	3.6	13.9	1.6	8.4	10.1	0.8
FANCB	"FAAP95, FAB, FLJ34064"	ENSG00000181544	"Fanconi anemia complementation group B"	Q8NB91	X	14835961-14873069	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Fanconi anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA003124	Uncertain									"HPA003124: AB_1078813"	"unprognostic (3.49e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.16e-2)"	"unprognostic (8.42e-3)"	"unprognostic (7.99e-2)"	"unprognostic (2.42e-2)"	"unprognostic (4.05e-5)"	"unprognostic (6.93e-3)"	"unprognostic (1.77e-3)"	"unprognostic (7.70e-3)"	"unprognostic (2.76e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-11)"	"unprognostic (4.46e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.96e-2)"	1.6	0.9	2.7	3.2	8.2	10.9	2.0	3.5	4.6	2.4	1.5	4.7	0.0	1.1	1.7	1.0	3.3	1.5	0.9	1.2	3.9	1.2	1.1	0.9	1.5	6.2	7.7	1.3	2.1	1.2	1.2	0.7	3.2	5.5	1.2	2.1	0.3	1.7	0.7	0.9	1.7	2.0	1.7	4.3	2.9	1.4	1.4	7.9	7.5	1.2	1.4	4.5	1.8	2.2	3.0	1.0	1.8	1.2	1.6	1.9	1.1	6.2	4.2	4.2	3.4	0.3	0.7	1.4	9.6	2.6	7.7	9.1	3.2	4.3	9.1	1.7	3.4	6.0	9.5	3.4	12.0	4.4	4.5	3.7	6.3	1.5	0.1	4.8	2.9	0.1	0.3	7.4	1.7	3.5	5.7	6.6	4.3	3.0	4.5	2.7	5.2	6.3	4.3	9.6	4.0	0.7	2.3	2.8	3.0	5.1	1.9	3.0	3.3	1.7	1.7	5.9	3.4	12.8	5.5	1.6	3.4	6.2	2.6	3.5	11.9	1.5	1.2	0.9	1.3	0.8	0.9	3.0	0.8	1.7	0.9	2.8	0.9	0.8	1.8	1.6	0.5	1.0	1.9	1.1	2.7	8.2	3.5	4.6	3.9	1.2	7.7	1.3	5.5	7.9
MOSPD2	MGC26706	ENSG00000130150	"Motile sperm domain containing 2"	Q8NHP6	X	14873441-14922327	"Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 30.2"	"Group enriched"	"Detected in all"	4	"granulocytes: 30.2;monocytes: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003334	Uncertain		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA003334: AB_2146004"	"unprognostic (2.74e-1)"	"unprognostic (4.39e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.57e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavourable (8.91e-4)"	"unprognostic (1.51e-1)"	"unprognostic (7.24e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.96e-2)"	11.2	7.1	11.9	10.4	20.8	12.4	8.5	8.0	18.0	11.3	6.2	24.6	8.5	7.4	9.1	9.9	11.9	6.5	10.9	5.9	16.7	11.1	8.6	8.3	12.2	11.1	33.0	13.8	10.4	7.8	6.6	11.5	14.1	33.9	7.1	8.1	4.9	18.5	6.4	3.7	21.4	7.3	8.0	40.4	12.0	7.3	5.6	27.0	7.8	13.1	6.2	9.2	7.8	10.6	2.3	2.7	30.2	8.4	4.3	2.3	2.7	5.6	7.5	5.7	3.1	19.2	12.2	6.1	12.9	12.1	9.2	11.1	3.8	6.9	7.1	3.6	21.5	9.1	7.1	5.4	12.2	5.4	6.4	2.4	7.2	3.5	11.9	4.7	7.1	11.0	7.8	8.2	11.0	8.1	3.2	10.3	8.7	2.4	4.7	3.9	3.9	6.9	4.4	7.6	6.0	7.5	3.8	1.8	4.3	9.8	4.6	20.8	4.0	6.9	8.2	8.8	3.7	29.5	4.9	6.2	5.7	4.8	11.4	3.9	11.9	7.8	8.3	3.9	2.0	7.9	2.1	1.2	1.8	1.2	2.7	2.3	2.0	2.3	30.2	4.3	8.4	1.1	1.9	2.7	11.9	20.8	8.0	18.0	16.7	11.1	33.0	13.8	33.9	27.0
ASB9	"DKFZP564L0862, FLJ20636, MGC4954"	ENSG00000102048	"Ankyrin repeat and SOCS box containing 9"	Q96DX5	X	15235288-15270467	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 21.0"	"Cell line enhanced"	"Detected in many"		"A549: 14.9;EFO-21: 11.8;PC-3: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 4.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA003014, HPA003060, CAB004997"	Enhanced									"CAB004997: AB_426132, HPA003014: AB_1078226, HPA003060: AB_1078225"	"unprognostic (8.26e-3)"	"unprognostic (1.70e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.23e-2)"	"unprognostic (9.30e-2)"	"prognostic unfavourable (4.36e-4)"	"unprognostic (2.88e-1)"	"unprognostic (2.27e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.57e-1)"	1.6	0.9	0.6	1.6	0.4	1.1	2.1	0.5	0.8	2.4	0.9	0.4	1.3	0.7	4.1	6.4	2.1	1.3	4.0	1.5	0.6	0.3	11.6	11.6	3.6	1.6	1.7	0.3	1.1	6.8	0.1	0.6	1.9	0.9	1.6	1.4	1.3	3.0	2.5	1.9	1.0	1.3	1.3	0.5	8.9	2.4	21.0	0.3	4.0	1.3	2.0	3.2	1.0	0.9	0.5	4.3	1.2	1.8	0.5	3.6	1.0	0.8	14.9	0.1	1.4	0.1	0.7	0.4	0.3	1.6	1.7	0.6	3.3	0.1	0.2	11.8	0.5	4.3	0.0	0.7	1.1	3.0	0.3	3.5	7.4	6.8	0.0	0.0	0.0	3.9	0.1	0.1	0.0	5.5	0.0	3.4	1.0	1.2	2.9	0.1	7.0	31.0	0.0	6.6	3.2	4.6	2.5	1.8	1.5	0.5	0.8	5.1	0.0	0.4	4.7	0.0	1.1	0.7	2.2	0.2	2.9	0.1	0.4	0.0	8.2	1.2	1.8	0.1	0.2	0.0	2.0	0.2	0.6	0.2	4.3	0.5	3.6	1.0	0.7	0.5	0.1	0.2	0.1	1.0	0.6	0.4	0.5	0.8	0.6	0.3	1.7	0.3	0.9	0.3
ASB11	DKFZp779E2460	ENSG00000165192	"Ankyrin repeat and SOCS box containing 11"	Q8WXH4	X	15281697-15315656	"Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"heart muscle: 51.8;skeletal muscle: 50.7;tongue: 29.8"	"Cell line enhanced"	"Detected in single"		"SK-MEL-30: 1.6"	"Cancer enriched"	"Detected in single"	20	"melanoma: 2.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"amygdala: 2.2;basal ganglia: 7.7;cerebral cortex: 5.7;hippocampal formation: 2.9;olfactory region: 5.0"	"Low region specificity"	"Detected in single"														"unprognostic (5.89e-3)"				"unprognostic (1.04e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.54e-2)"		"unprognostic (2.04e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"		"unprognostic (6.21e-2)"		2.2	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	1.2	1.3	0.1	0.0	51.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	5.0	2.2	0.0	50.7	0.5	0.1	0.0	0.1	0.1	2.8	0.1	0.0	0.0	0.3	29.8	2.3	0.1	0.1	0.6	0.6	0.8	0.3	1.4	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.2	0.4	0.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.2	0.4	0.4	0.3	0.1	0.3	0.1	0.2	0.3	0.2	0.2	0.1	0.6	0.3	0.3	0.8	1.4	0.1	0.6	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
PIGA	GPI3	ENSG00000165195	"Phosphatidylinositol glycan anchor biosynthesis class A"	P37287	X	15319451-15335580	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001174	Approved									"HPA001174: "	"unprognostic (1.15e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.99e-3)"	"unprognostic (2.24e-2)"	"unprognostic (7.37e-3)"	"unprognostic (3.93e-3)"	"prognostic unfavourable (7.64e-4)"	"unprognostic (1.85e-3)"	"unprognostic (5.97e-3)"	"unprognostic (2.24e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.18e-2)"	6.9	6.1	6.8	5.0	8.6	16.1	7.0	7.6	10.0	6.0	6.8	9.6	5.8	3.5	6.2	7.5	9.9	5.6	7.8	6.2	8.0	5.4	7.5	11.0	14.4	5.9	9.6	6.4	7.0	9.9	8.5	5.2	10.8	16.7	5.9	7.5	7.0	11.5	9.1	4.2	10.9	4.8	5.2	10.2	5.7	7.2	5.3	9.4	4.7	8.6	8.5	8.7	11.6	6.6	2.9	3.9	16.7	7.6	1.5	4.4	2.4	12.4	7.7	8.0	4.1	2.4	2.4	6.6	3.2	5.2	7.2	6.9	8.4	5.5	5.8	2.7	2.6	4.9	13.3	10.8	11.8	5.2	9.1	5.0	9.5	4.9	4.1	7.1	2.6	3.4	7.3	9.3	14.8	4.5	5.4	6.3	4.3	7.8	7.9	2.6	4.2	8.6	2.8	11.5	9.2	5.1	8.4	5.6	8.6	6.5	5.9	12.6	6.0	6.2	3.8	5.4	2.2	11.9	6.5	4.8	6.1	9.0	8.3	5.0	6.8	16.7	3.6	3.9	2.7	6.0	3.8	2.9	4.4	2.7	3.9	2.2	4.0	3.1	5.2	1.5	7.6	2.5	3.8	2.4	6.8	8.6	7.6	10.0	8.0	5.4	9.6	6.4	16.7	9.4
VEGFD	"FIGF, VEGF-D"	ENSG00000165197	"Vascular endothelial growth factor D"	O43915	X	15345591-15384376	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 39.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 7.1;ASC TERT1: 5.9;EFO-21: 2.6;HSkMC: 5.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA027342	Uncertain				"Secreted to blood"	592125	340000			"HPA027342: AB_1848597"	"unprognostic (5.90e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.06e-3)"	"unprognostic (5.57e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.59e-5)"	"unprognostic (3.08e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.75e-2)"	9.5	7.4	0.6	1.8	1.0	0.1	19.5	1.1	0.7	10.5	7.6	0.2	4.1	1.1	10.1	12.9	15.4	2.7	3.5	27.8	0.6	1.1	1.0	1.3	39.0	0.7	0.8	0.2	7.3	2.6	0.2	4.4	0.2	0.8	22.2	1.9	0.2	1.5	1.8	12.0	0.5	4.3	9.8	0.6	2.3	3.4	14.9	0.1	0.0	2.0	17.5	1.2	12.3	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.1	1.8	7.1	5.9	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	2.6	0.0	0.5	0.5	0.0	0.0	0.0	0.1	0.0	1.5	0.6	0.4	0.0	0.8	5.9	0.7	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.5	0.5	0.4	0.3	0.1	0.6	0.0	0.7	0.3	0.0	0.1	0.3	0.3	0.4	1.1	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	1.1	0.7	0.6	1.1	0.8	0.2	0.8	0.1
PIR		ENSG00000087842	Pirin	O00625	X	15384799-15493564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 117.9;SK-MEL-30: 44.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000697	Approved		Supported	Cytosol				Cytosol		"HPA000697: AB_1079621"	"unprognostic (3.46e-3)"	"prognostic favourable (2.78e-4)"	"unprognostic (4.26e-2)"	"unprognostic (5.62e-3)"	"unprognostic (4.16e-3)"	"unprognostic (2.09e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"prognostic favourable (4.94e-4)"	"unprognostic (3.78e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (6.11e-7)"	"unprognostic (1.99e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-1)"	20.9	16.1	14.1	5.9	16.8	5.7	26.5	8.5	13.5	8.1	7.5	14.0	21.8	7.7	11.2	18.8	20.7	16.2	13.4	14.0	11.7	12.1	13.9	23.7	18.6	8.6	20.8	9.8	13.0	2.6	5.4	9.1	12.1	15.6	12.1	8.3	25.0	7.5	18.0	9.8	13.7	6.9	24.6	26.0	15.5	13.8	7.2	14.4	1.3	12.1	19.9	9.1	26.5	11.7	0.0	0.5	1.0	0.5	0.0	2.2	0.3	2.3	13.0	7.8	11.5	4.6	5.2	2.5	0.7	4.5	1.9	4.3	3.6	20.4	0.0	25.9	2.0	16.6	9.1	3.6	0.7	0.0	2.0	1.4	14.7	10.5	6.0	0.7	5.2	1.5	12.6	7.3	2.5	117.9	1.0	3.3	1.6	4.9	0.5	0.6	8.4	8.2	0.0	1.5	6.4	3.8	23.0	3.0	8.3	6.3	3.5	44.3	7.3	4.5	7.3	1.0	1.9	4.9	1.4	1.5	6.4	0.0	5.0	2.6	10.3	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.3	14.1	16.8	8.5	13.5	11.7	12.1	20.8	9.8	15.6	14.4
BMX	"ETK, PSCTK3"	ENSG00000102010	"BMX non-receptor tyrosine kinase"	P51813	X	15464246-15556529	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell adhesion, Stress response"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 57.1"	"Cell line enriched"	"Detected in single"	121	"HUVEC TERT2: 88.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	17	"neutrophil: 10.5"	"Lineage enriched"	"Detected in single"	105	"granulocytes: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001048, CAB032495"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"CAB032495: AB_2290760, HPA001048: AB_1078289"	"unprognostic (7.80e-2)"	"unprognostic (4.92e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.81e-2)"	8.2	0.3	0.1	1.0	0.7	3.6	5.4	0.1	0.3	2.2	5.5	0.1	4.6	2.4	2.6	57.1	1.5	2.5	2.6	10.5	0.5	0.0	0.2	0.9	3.7	6.5	0.4	0.0	1.4	0.9	0.2	0.6	2.6	0.7	2.2	1.4	0.5	1.5	0.6	4.2	1.6	5.5	2.2	0.4	2.4	1.5	1.9	0.1	0.2	2.2	1.1	0.8	2.8	2.4	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.3	0.5	0.0	0.4	0.0	0.7	0.1
ACE2		ENSG00000130234	"Angiotensin I converting enzyme 2"	Q9BYF1	X	15561033-15602148	"Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	"Carboxypeptidase, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 122.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;HaCaT: 4.1;Hep G2: 2.4;NB-4: 2.2;RPMI-8226: 2.0;RT4: 2.4;SH-SY5Y: 2.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA000288, CAB026174"	Enhanced				"Secreted to blood"		85000			"CAB026174: , HPA000288: AB_1078160"	"unprognostic (1.40e-1)"	"unprognostic (7.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.26e-2)"	"prognostic favourable (4.21e-4)"	"unprognostic (2.34e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (2.12e-5)"	"unprognostic (1.94e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.10e-2)"	4.5	0.4	0.2	0.8	0.2	0.0	2.3	0.2	0.2	0.4	49.1	0.2	2.3	46.0	0.4	2.7	1.2	0.6	16.4	10.5	0.2	0.1	23.2	1.2	0.8	0.6	0.2	0.2	1.3	1.6	0.0	0.2	1.0	0.2	0.5	1.3	0.2	1.1	1.2	0.7	0.2	122.0	0.3	0.2	0.2	0.5	17.9	0.2	0.2	4.5	0.5	0.2	0.4	0.9	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.4	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.6	0.0	4.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.2	0.0	0.0	2.0	0.4	2.4	0.6	2.8	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
CLTRN	"NX17, TMEM27"	ENSG00000147003	"Collectrin, amino acid transport regulator"	Q9HBJ8	X	15627318-15665031	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"kidney: 204.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 10.7;hTERT-HME1: 6.1;RPTEC TERT1: 9.8"	"Cancer enriched"	"Detected in many"	35	"renal cancer: 106.2"	"Region enriched"	"Detected in single"	9	"pons and medulla: 5.0"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048543	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"				"Endoplasmic reticulum, Vesicles"		"HPA048543: "	"unprognostic (1.27e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.90e-2)"	"prognostic favourable (5.65e-4)"	"unprognostic (1.05e-2)"	"unprognostic (3.03e-1)"	"prognostic favourable (6.78e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.33e-2)"	0.1	0.2	0.3	0.1	0.4	0.0	0.3	0.1	0.2	0.2	0.2	0.5	0.1	0.1	0.2	1.6	0.2	0.4	0.6	0.2	0.5	0.4	204.4	11.5	0.6	0.1	0.3	0.1	0.8	1.2	4.0	0.2	0.7	5.0	0.3	0.0	11.3	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.1	2.4	0.3	0.1	0.2	0.7	0.1	0.1	0.4	0.2	0.9	0.6	0.0	0.5	0.0	3.0	0.4	3.0	2.2	1.5	0.6	0.8	1.2	1.0	0.1	0.0	0.1	0.1	0.2	0.5	0.3	2.1	0.1	10.7	0.9	2.5	0.0	0.4	1.4	0.3	0.0	1.0	1.6	0.0	0.0	0.2	2.4	0.4	6.1	0.0	0.7	0.6	0.3	3.5	0.2	0.4	3.6	3.1	0.3	0.5	1.3	9.8	0.2	1.4	1.3	0.8	0.2	2.0	1.0	0.3	0.1	0.2	0.5	0.4	0.0	0.6	0.3	0.4	0.9	0.1	0.1	0.0	0.5	0.0	0.6	0.2	1.3	0.4	0.8	0.5	0.6	0.9	3.0	0.9	0.0	0.0	0.0	0.0	0.8	0.4	0.3	0.4	0.1	0.2	0.5	0.4	0.3	0.1	5.0	0.1
CA5B		ENSG00000169239	"Carbonic anhydrase 5B"	Q9Y2D0	X	15688830-15788409	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 15.4;fHDF/TERT166: 17.5;hTERT-HME1: 23.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA012618	Uncertain		Supported	Mitochondria				Mitochondria		"HPA012618: AB_1846000"	"unprognostic (1.62e-2)"	"unprognostic (2.10e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.59e-5)"	"unprognostic (2.50e-1)"	"unprognostic (6.89e-4)"	"unprognostic (4.11e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favourable (6.66e-6)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.08e-1)"	9.3	4.6	10.6	4.9	11.1	4.1	10.2	3.1	7.8	28.7	3.6	11.5	1.4	2.2	9.8	3.7	8.1	9.5	9.1	6.5	9.9	8.2	10.3	7.8	7.3	8.8	12.2	6.7	15.2	4.4	16.8	4.4	3.9	13.1	6.2	4.7	29.5	8.3	6.2	2.0	7.5	4.1	9.4	7.1	5.3	5.4	23.0	8.1	2.3	8.9	10.9	11.6	6.3	9.4	4.3	3.5	2.7	3.6	7.9	13.3	7.0	2.7	1.6	1.9	3.1	5.8	15.4	1.1	2.9	3.7	2.1	3.1	0.8	1.8	0.8	3.0	17.5	3.0	6.8	3.3	3.8	0.7	3.2	1.5	2.1	0.7	5.7	1.9	3.3	3.6	3.5	2.8	23.0	3.1	0.7	2.0	10.1	1.5	1.5	1.5	0.7	12.2	0.9	1.4	1.4	3.3	2.0	1.7	3.6	4.0	1.4	2.6	2.0	1.9	4.2	2.5	1.7	13.6	1.6	1.5	1.5	0.8	2.8	3.8	4.7	2.7	3.0	0.3	13.1	3.6	11.4	3.6	13.3	12.3	3.5	4.3	9.8	8.3	1.7	7.9	2.3	0.5	10.0	7.0	10.6	11.1	3.1	7.8	9.9	8.2	12.2	6.7	13.1	8.1
ZRSR2	"U2AF1-RS2, U2AF1L2, URP, ZC3H22"	ENSG00000169249	"Zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2"	Q15696	X	15790472-15823260	"Cancer-related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"																		"prognostic favourable (7.96e-4)"	"unprognostic (1.54e-2)"	"unprognostic (7.31e-2)"	"prognostic favourable (8.50e-5)"	"unprognostic (8.08e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.14e-3)"	"unprognostic (5.72e-3)"	"unprognostic (8.46e-2)"	"unprognostic (3.47e-3)"	"unprognostic (6.90e-2)"	"unprognostic (2.85e-2)"	"prognostic unfavourable (4.87e-5)"	"unprognostic (8.14e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.65e-2)"	"prognostic favourable (2.97e-4)"	11.4	9.7	16.7	13.4	21.7	32.5	14.2	22.5	22.1	20.7	13.6	7.6	11.2	9.1	17.1	17.7	10.9	11.8	8.8	12.8	16.1	14.4	11.5	8.2	13.9	21.7	18.1	11.6	16.7	9.2	15.7	31.1	9.8	16.0	11.8	10.9	9.4	10.6	10.6	31.7	12.3	12.4	14.5	20.1	21.1	9.5	4.8	17.5	7.9	12.8	5.6	16.5	21.8	16.7	23.8	17.8	22.0	18.8	10.2	20.3	7.6	9.7	6.5	11.2	10.5	15.9	13.7	4.4	8.0	7.5	7.8	8.0	7.7	8.0	11.1	13.8	7.4	9.6	10.7	13.9	8.1	8.2	14.2	7.3	15.3	7.1	10.9	16.7	17.2	6.8	12.8	14.3	23.4	13.5	11.4	11.0	9.4	11.9	8.8	17.6	14.2	9.1	10.3	15.6	11.3	9.3	7.7	7.8	8.5	18.8	16.8	11.7	13.2	9.6	9.5	7.8	5.6	20.5	7.5	9.3	7.9	10.6	6.0	12.0	10.0	22.0	18.8	16.6	13.5	16.6	13.1	21.6	17.1	18.0	10.9	23.8	20.3	14.8	21.0	10.2	15.6	17.8	16.0	7.6	16.7	21.7	22.5	22.1	16.1	14.4	18.1	11.6	16.0	17.5
AP1S2	"MRX59, MRXS5, PGS, SIGMA1B"	ENSG00000182287	"Adaptor related protein complex 1 sigma 2 subunit"	P56377	X	15825806-15854931	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 218.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 66.0;SK-MEL-30: 87.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 49.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 55.2;monocytes: 74.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049894, HPA060945"	Enhanced		Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA049894: , HPA060945: "	"prognostic favourable (9.86e-4)"	"unprognostic (4.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.47e-3)"	"unprognostic (3.85e-1)"	"unprognostic (2.03e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.43e-2)"	"prognostic favourable (5.53e-6)"	"unprognostic (1.85e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.08e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.13e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.47e-2)"	10.1	8.2	21.2	11.7	17.9	12.6	9.7	13.0	17.6	12.0	17.3	9.8	12.6	4.8	25.7	218.0	9.8	5.6	7.0	34.2	12.7	19.9	5.2	5.8	8.9	11.6	16.1	11.8	4.5	4.1	8.2	11.7	13.1	39.7	5.5	8.0	13.3	5.1	13.2	41.4	5.0	8.7	24.9	18.5	14.1	9.9	8.6	11.4	9.8	10.7	8.6	9.6	8.5	5.9	8.2	55.2	12.5	74.9	5.5	8.4	44.8	3.3	2.8	31.9	15.7	6.0	4.1	1.1	10.0	4.7	7.8	10.0	2.0	3.5	5.7	44.7	14.6	3.9	8.8	2.7	13.0	8.1	14.1	3.4	5.0	3.1	5.3	12.7	3.8	2.4	2.8	7.4	7.6	15.6	3.1	66.0	14.0	1.8	3.3	6.7	42.5	10.5	7.2	23.3	11.5	8.7	0.8	3.9	15.5	4.5	1.3	87.3	14.9	13.0	8.2	13.3	5.1	18.5	9.3	7.6	17.3	12.1	7.1	5.7	32.3	8.2	74.9	8.0	5.6	67.8	5.4	8.2	5.7	4.5	55.2	7.5	4.1	4.0	12.5	5.5	34.7	17.9	8.4	44.8	21.2	17.9	13.0	17.6	12.7	19.9	16.1	11.8	39.7	11.4
GRPR	"BB2, BB2R"	ENSG00000126010	"Gastrin releasing peptide receptor"	P30550	X	16123556-16153021	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 24.5"	"Group enriched"	"Detected in some"	10	"PC-3: 17.6;T-47d: 22.0;U-138 MG: 30.1"	"Cancer enhanced"	"Detected in some"		"breast cancer: 6.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.9;non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA069604			Supported	"Plasma membrane"				"Plasma membrane"		"HPA069604: "	"unprognostic (3.32e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.68e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.86e-2)"	0.5	0.4	3.4	4.7	2.3	0.2	3.5	0.3	3.5	3.7	1.4	0.0	2.5	0.2	1.0	2.8	7.5	0.3	0.2	0.5	3.5	0.4	0.3	0.3	0.4	0.2	0.3	1.9	0.3	24.5	0.4	0.3	0.2	1.1	0.7	0.6	2.0	0.4	0.4	0.4	0.3	0.5	1.2	0.4	0.3	2.1	0.4	0.0	0.0	0.4	0.0	0.2	0.4	0.4	0.6	0.2	0.4	1.9	0.0	0.1	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.0	0.5	0.0	2.3	0.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.2	17.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	22.0	0.0	0.1	30.1	0.3	0.0	0.9	0.1	0.1	0.1	0.0	0.0	0.4	0.0	1.1	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.4	0.0	1.6	0.1	0.0	0.4	3.4	2.3	0.3	3.5	3.5	0.4	0.3	1.9	1.1	0.0
MAGEB17		ENSG00000182798	"MAGE family member B17"	A8MXT2	X	16167481-16171464	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pancreas: 4.4;testis: 5.4"	"Cell line enhanced"	"Detected in some"		"U-138 MG: 3.2;U-2 OS: 7.1;U-266/70: 17.4"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA003756	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm		"HPA003756: AB_2250114"	"unprognostic (1.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.04e-4)"	"unprognostic (2.75e-1)"	"unprognostic (5.11e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.44e-2)"	0.1	0.0	0.1	0.4	0.0	0.0	0.6	0.1	0.0	0.6	0.4			0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	4.4	0.0	0.0	0.0		0.4	0.2		0.0	0.0	0.5	0.0	0.1	0.4	0.0	0.0	1.2	5.4			0.0		0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.7	0.0	0.0	3.2	7.1	0.0	0.2	17.4	0.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0										
CTPS2		ENSG00000047230	"CTP synthase 2"	Q9NRF8	X	16588003-16712936	"Enzymes, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017437	Uncertain		Approved	Nucleoplasm,Cytosol			14000	"Nucleoplasm, Cytosol"		"HPA017437: AB_1847326"	"unprognostic (1.40e-1)"	"unprognostic (6.69e-2)"	"unprognostic (3.37e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavourable (2.37e-5)"	"unprognostic (6.57e-3)"	"unprognostic (8.52e-2)"	"unprognostic (4.31e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.89e-2)"	"unprognostic (7.22e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.93e-2)"	"unprognostic (5.04e-2)"	"prognostic favourable (4.56e-4)"	10.0	12.0	7.8	11.5	11.9	7.8	13.5	14.3	9.9	17.5	13.3	14.8	10.8	15.6	22.0	10.2	9.6	12.1	11.9	7.2	8.6	7.1	8.1	13.4	8.3	7.9	9.1	6.1	17.9	14.9	22.9	8.5	8.3	9.3	12.8	12.6	14.1	11.8	9.7	5.5	9.2	12.8	14.0	12.3	7.1	11.3	4.4	10.8	11.5	11.8	8.4	10.6	11.8	11.2	1.6	3.3	1.1	6.1	3.8	2.4	1.4	7.5	6.9	11.3	9.4	5.8	4.4	0.1	4.2	3.5	6.8	6.2	7.0	7.9	0.2	13.3	4.3	6.1	15.9	7.6	8.1	0.0	10.5	4.3	9.7	10.1	3.0	3.0	0.1	4.8	2.6	6.3	5.4	9.0	6.1	0.3	6.1	10.0	0.1	2.4	19.4	8.1	0.1	6.5	2.3	7.2	8.5	7.1	13.0	13.2	1.0	7.6	18.3	8.8	5.8	3.5	1.9	9.3	3.6	0.2	0.1	25.1	2.8	2.7	3.9	0.4	1.5	1.1	1.3	0.8	2.4	1.6	2.2	1.4	3.3	1.4	1.7	1.7	0.1	3.8	6.1	2.2	2.0	1.4	7.8	11.9	14.3	9.9	8.6	7.1	9.1	6.1	9.3	10.8
S100G	"CABP1, CABP9K, CALB3"	ENSG00000169906	"S100 calcium binding protein G"	P29377	X	16650158-16654670	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"intestine: 74.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.0;PC-3: 2.2;RPMI-8226: 6.8;SH-SY5Y: 1.2"	"Group enriched"	"Detected in some"	5	"breast cancer: 4.7;renal cancer: 0.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.5"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.2"	"Low region specificity"	"Detected in all"			"CAB017688, HPA055873"	Enhanced									"CAB017688: AB_1119899, HPA055873: "	"unprognostic (2.68e-2)"									"unprognostic (2.78e-1)"				"unprognostic (9.88e-3)"				0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.2	18.0	0.0	0.0	74.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	9.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.2	0.0	0.0	6.8	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.4	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SYAP1	"FLJ14495, PRO3113"	ENSG00000169895	"Synapse associated protein 1"	Q96A49	X	16719632-16765336	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000175, HPA000882, HPA048047"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA000175: AB_1080142, HPA000882: , HPA048047: "	"unprognostic (4.66e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.06e-1)"	"prognostic favourable (3.18e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.14e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.28e-3)"	17.6	31.3	13.1	12.9	12.3	26.2	16.5	10.2	14.0	17.1	23.8	12.2	16.1	20.6	17.0	13.7	18.5	14.4	20.7	25.7	13.5	13.7	28.7	51.4	17.6	11.4	15.8	11.0	19.9	14.3	22.8	15.9	18.9	18.4	16.2	16.1	10.7	15.9	21.3	22.5	12.6	33.0	12.3	17.3	13.7	16.9	10.1	11.2	15.3	16.2	13.3	15.1	17.9	13.5	12.6	11.1	17.8	15.0	13.8	15.2	9.1	16.0	13.6	9.8	18.3	13.4	15.2	4.5	12.8	9.2	10.8	10.8	12.7	13.4	12.6	18.9	12.5	9.6	11.9	16.8	14.4	8.2	23.9	5.0	14.6	12.1	9.6	8.5	7.8	10.4	8.0	18.6	15.8	14.8	10.8	7.1	14.5	18.9	4.6	9.2	11.4	15.0	5.0	12.4	12.6	15.9	10.6	10.1	12.4	23.9	17.1	12.7	22.6	7.7	11.6	13.9	7.3	28.1	10.4	7.8	6.6	14.6	13.6	4.3	11.3	9.2	10.5	12.7	15.2	11.3	12.3	12.6	13.0	13.9	11.1	10.8	13.1	13.6	17.8	13.8	15.0	9.2	14.4	9.1	13.1	12.3	10.2	14.0	13.5	13.7	15.8	11.0	18.4	11.2
TXLNG	"CXorf15, FIAT, FLJ11209, LSR5, MGC126621, MGC126625, TXLNGX"	ENSG00000086712	"Taxilin gamma"	Q9NUQ3	X	16786427-16844519	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000297, HPA000841"	Approved		Approved	Cytosol				Cytosol		"HPA000297: AB_1078590, HPA000841: AB_1078589"	"unprognostic (2.48e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.78e-2)"	"unprognostic (4.15e-2)"	"prognostic unfavourable (6.33e-6)"	"unprognostic (2.61e-2)"	"unprognostic (5.27e-3)"	"unprognostic (6.96e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.00e-3)"	16.2	20.1	14.4	13.5	17.5	14.9	14.0	24.9	19.9	13.2	11.1	5.6	13.0	9.9	12.0	8.4	8.4	12.0	9.1	6.9	12.4	10.1	9.4	9.6	9.2	13.8	11.8	10.1	21.1	10.3	13.9	20.1	6.9	12.8	8.6	7.5	5.4	8.4	17.2	17.3	7.4	8.6	10.3	11.2	8.8	8.9	7.1	17.4	6.0	12.8	5.5	13.5	13.6	23.8	6.5	3.4	1.6	3.0	4.3	7.4	3.4	11.9	7.4	7.2	12.7	13.2	7.2	3.8	4.8	4.6	5.5	5.4	10.4	7.1	25.2	12.2	2.6	7.8	24.6	15.7	9.9	7.6	30.0	9.0	10.3	6.6	5.5	13.3	6.4	4.3	7.7	12.8	23.1	6.9	17.2	7.5	4.2	7.1	12.2	7.4	21.5	8.8	8.5	9.8	20.8	4.4	6.0	11.7	8.5	11.1	10.6	8.8	12.9	5.5	3.4	3.5	4.6	12.1	8.2	7.9	12.0	25.5	4.4	8.8	3.5	1.0	3.0	1.6	5.3	2.2	6.7	6.1	5.7	6.0	3.3	6.5	6.9	7.4	1.1	4.3	2.5	3.4	5.8	3.4	14.4	17.5	24.9	19.9	12.4	10.1	11.8	10.1	12.8	17.4
RBBP7	RbAp46	ENSG00000102054	"RB binding protein 7, chromatin remodeling factor"	Q16576	X	16839283-16870414	"Predicted intracellular proteins"	"DNA replication, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037084, HPA060710, HPA060724"	Supported		Enhanced	Nucleoplasm			25000	Nucleoplasm		"CAB037084: AB_477448, HPA060710: , HPA060724: "	"unprognostic (5.18e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.09e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavourable (5.55e-4)"	"unprognostic (3.64e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.00e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"prognostic favourable (2.43e-4)"	"unprognostic (5.65e-2)"	16.0	81.2	16.6	21.1	26.7	20.3	15.5	13.3	16.2	34.6	22.8	15.3	103.2	13.1	32.3	77.3	20.9	24.5	19.7	36.2	15.1	13.1	17.3	18.5	14.3	19.7	13.7	15.5	41.6	19.0	47.8	16.0	28.7	12.2	26.2	18.1	16.5	19.0	87.6	78.2	16.4	17.9	25.9	15.9	16.0	23.5	31.6	13.6	30.8	18.1	18.2	24.5	24.3	18.5	36.6	29.4	23.7	41.2	32.8	37.7	27.3	53.2	39.7	30.2	39.8	19.0	22.5	19.2	26.5	26.7	39.1	44.4	23.2	35.3	59.0	40.8	25.7	28.3	53.8	39.5	52.0	33.3	73.9	24.9	48.3	27.6	16.1	37.6	30.2	17.4	14.6	45.1	33.1	39.2	24.9	31.5	30.9	35.8	42.0	34.8	33.9	36.9	36.9	55.6	69.6	28.4	35.9	28.1	20.9	50.1	24.1	23.5	80.0	22.8	18.1	18.9	19.4	49.8	29.4	22.0	31.5	77.4	24.3	25.4	22.9	16.6	18.3	23.7	36.4	31.3	34.8	36.6	30.4	37.7	25.4	31.0	32.2	35.9	7.4	32.8	41.2	29.4	27.9	27.3	16.6	26.7	13.3	16.2	15.1	13.1	13.7	15.5	12.2	13.6
REPS2	POB1	ENSG00000169891	"RALBP1 associated Eps domain containing 2"	Q8NFH8	X	16946691-17153280	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 23.6;Karpas-707: 9.6;RH-30: 6.9;RPMI-8226: 7.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"basophil: 4.6;eosinophil: 4.2;neutrophil: 14.2"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000565, HPA026073"	Uncertain				"Intracellular and membrane"					"HPA000565: AB_1079800, HPA026073: AB_1856176"	"unprognostic (6.58e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.35e-2)"	"unprognostic (7.83e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.70e-3)"	"prognostic favourable (5.36e-4)"	"unprognostic (4.85e-2)"	"unprognostic (2.87e-2)"	"unprognostic (5.53e-2)"	"prognostic unfavourable (3.24e-4)"	"unprognostic (1.83e-1)"	"prognostic favourable (4.08e-4)"	"unprognostic (5.89e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.43e-2)"	"prognostic favourable (4.56e-4)"	2.5	12.3	10.6	1.4	24.1	2.9	3.7	13.2	24.7	17.7	4.6	11.6	8.1	2.4	4.7	14.0	1.6	2.4	2.3	1.8	10.2	10.0	11.6	8.0	5.0	0.6	11.3	16.0	4.7	10.9	10.1	5.8	2.9	9.8	9.1	5.1	4.7	5.1	9.0	1.1	1.1	2.2	4.6	9.6	1.3	6.7	2.3	9.4	0.0	2.3	0.0	0.8	2.5	1.3	0.2	0.4	14.2	0.3	0.0	0.0	0.1	1.1	0.5	0.0	0.1	0.6	0.4	0.1	0.0	0.0	0.1	0.2	0.1	4.2	0.0	0.5	0.0	0.2	0.9	2.3	0.4	23.6	0.5	0.0	0.6	0.0	0.6	0.0	0.1	4.5	0.8	0.0	3.9	1.3	0.0	9.6	0.2	1.1	0.0	0.3	0.1	0.7	0.0	6.9	7.2	0.3	2.3	3.4	0.2	1.7	1.7	1.3	3.2	0.2	0.2	0.0	0.2	0.1	0.3	0.4	0.0	0.3	0.0	0.3	0.2	4.6	0.3	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	14.2	0.0	0.2	0.3	0.0	0.1	10.6	24.1	13.2	24.7	10.2	10.0	11.3	16.0	9.8	9.4
NHS		ENSG00000188158	"NHS actin remodeling regulator"	Q6T4R5	X	17375420-17735994	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 10.9;RPTEC TERT1: 16.3;RT4: 10.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.1;neutrophil: 2.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031497, HPA076257"	Uncertain		Supported	"Cell Junctions"				"Cell Junctions"		"HPA031497: AB_10610144, HPA076257: "	"unprognostic (1.39e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.17e-1)"	"prognostic favourable (1.68e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.27e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.83e-3)"	5.1	6.7	3.6	6.0	3.6	0.6	14.2	5.9	6.3	10.2	5.9	1.3	10.0	1.9	10.7	7.1	3.7	5.3	10.4	3.5	2.2	3.1	11.8	0.7	3.7	2.6	1.5	1.1	7.8	0.9	0.7	5.1	5.5	4.7	7.0	3.5	9.4	3.2	8.8	1.1	4.2	2.5	11.2	5.3	2.1	3.6	12.4	1.3	0.8	4.5	2.2	1.3	8.1	16.0	0.1	0.6	2.0	1.1	0.0	0.2	0.3	6.4	2.6	4.6	0.0	0.1	0.2	7.5	2.9	2.0	1.3	0.7	0.2	1.3	0.4	10.9	2.0	5.7	2.9	3.6	1.9	0.1	0.9	0.0	4.3	0.0	0.0	0.0	0.0	0.6	2.6	0.0	5.9	0.0	0.0	0.0	0.6	3.1	0.0	0.0	5.7	1.7	0.0	0.0	0.2	16.3	10.0	1.1	2.4	8.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	6.9	0.1	7.1	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.3	3.6	3.6	5.9	6.3	2.2	3.1	1.5	1.1	4.7	1.3
SCML1		ENSG00000047634	"Scm polycomb group protein like 1"	Q9UN30	X	17737449-17754988	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 17.1"	"Low lineage specificity"	"Detected in many"											"HPA035270, HPA035271, HPA061397"	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"HPA035270: AB_10672860, HPA035271: AB_10602795, HPA061397: "	"unprognostic (6.36e-2)"	"unprognostic (5.86e-3)"	"unprognostic (3.83e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.18e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.49e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.07e-3)"	12.6	12.1	5.9	6.7	6.2	3.1	9.6	5.5	7.7	9.6	10.7	6.7	13.5	8.8	10.4	8.3	6.8	7.2	6.2	7.2	6.4	4.6	7.8	30.4	11.9	8.2	5.1	4.1	19.6	7.4	4.1	8.8	10.9	9.5	8.5	8.3	12.7	7.1	15.0	19.5	6.2	8.5	11.1	8.0	7.9	6.0	35.4	4.3	6.3	5.2	7.3	6.1	11.5	7.6	3.5	2.2	0.8	3.2	8.0	17.1	2.1	10.0	2.7	8.6	3.0	8.2	10.9	1.0	9.7	9.5	10.8	13.9	5.7	4.6	0.0	4.3	6.8	5.8	11.2	7.0	16.1	0.0	22.2	0.7	7.8	11.0	11.0	0.0	5.4	7.2	6.4	14.3	10.6	0.1	1.6	0.0	9.9	3.2	0.0	0.0	1.4	10.8	0.0	4.5	4.5	4.3	2.4	1.8	2.2	4.5	0.0	3.7	1.5	0.2	5.1	10.5	4.3	39.0	6.4	6.0	5.5	0.0	8.5	0.9	2.9	0.0	1.1	0.7	0.2	2.9	0.2	1.3	2.9	0.3	2.2	3.5	17.1	8.0	0.8	8.0	3.2	0.5	0.4	2.1	5.9	6.2	5.5	7.7	6.4	4.6	5.1	4.1	9.5	4.3
RAI2		ENSG00000131831	"Retinoic acid induced 2"	Q9Y5P3	X	17800049-17861337	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	10	"ASC diff: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"naive CD4 T-cell: 1.5;naive CD8 T-cell: 5.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051054	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA051054: "	"unprognostic (3.45e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.49e-1)"	"prognostic favourable (2.77e-4)"	"unprognostic (1.31e-2)"	"prognostic favourable (3.39e-14)"	"unprognostic (1.57e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.80e-2)"	23.6	9.7	2.5	10.1	4.0	0.0	28.5	4.0	4.9	41.0	13.7	1.7	15.0	3.5	29.6	17.8	12.2	27.9	21.2	16.1	2.4	2.7	9.4	1.9	14.5	12.9	2.4	1.8	32.7	7.7	4.6	11.1	7.1	2.9	28.3	4.5	10.7	6.6	18.7	7.2	8.3	8.8	20.4	2.7	2.4	12.0	16.2	2.1	2.0	15.1	6.3	5.9	24.2	53.6	0.0	0.0	0.0	0.0	0.4	5.1	0.4	0.0	0.0	0.1	0.0	48.4	4.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.9	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.8	0.2	0.0	0.0	0.0	2.6	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.5	5.1	0.0	0.4	0.0	0.0	0.0	0.4	2.5	4.0	4.0	4.9	2.4	2.7	2.4	1.8	2.9	2.1
BEND2	"CXorf20, MGC33653"	ENSG00000177324	"BEN domain containing 2"	Q8NDZ0	X	18162931-18220883	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 23.2"	"Cell line enhanced"	"Detected in single"		"HeLa: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basophil: 4.1;neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 4.1"									"HPA009420, HPA013142"	Enhanced									"HPA009420: AB_2064489, HPA013142: AB_2668784"														"unprognostic (2.23e-2)"	"unprognostic (1.17e-1)"			0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	4.1	0.4	0.4	0.4	5.1	0.4	0.2	0.4	0.8	0.0	0.1	0.4	0.5	0.0	0.0	0.2	0.5	0.2	0.1	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.4	1.5	0.2	0.1	0.5	0.5	0.0	0.0	0.1	0.2	0.0	0.5	0.8	0.3	0.5	0.1	0.5	0.4	0.3	0.2	0.3	0.7	0.0	0.4	0.4	0.0	0.2	0.3	0.4	0.2	0.1	0.8	0.4	0.2	0.4	0.1	0.8	0.2	0.8	0.2	0.7	0.4	4.1	0.4	0.1	0.3	0.1	0.1	0.2	0.2	0.2	0.1	0.4	0.3	0.4	1.8	0.4	0.1	0.3	0.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SCML2		ENSG00000102098	"Scm polycomb group protein like 2"	Q9UQR0	X	18239314-18354727	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 20.0;REH: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 7.0"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 7.0"					"Low region specificity"	"Detected in all"			"HPA001662, HPA064713"	Enhanced		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA001662: AB_1079879, HPA064713: "	"unprognostic (5.15e-2)"	"unprognostic (2.57e-2)"	"unprognostic (7.93e-2)"	"unprognostic (7.26e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.95e-5)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.15e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.35e-4)"	"unprognostic (3.30e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.31e-3)"	2.4	7.7	3.1	2.1	4.1	8.6	3.1	3.4	3.8	3.7	3.7	3.7	2.0	2.1	4.9	2.5	2.3	2.9	2.8	2.0	2.3	2.0	1.5	2.6	1.3	2.0	3.6	0.5	9.5	3.9	3.2	8.0	7.1	2.3	2.9	2.3	3.6	10.0	2.2	2.0	3.4	2.0	6.5	2.2	2.3	1.7	19.0	4.2	12.5	4.3	2.3	2.1	2.7	4.2	0.8	7.0	0.2	0.2	0.9	0.7	0.2	0.9	3.3	11.8	3.0	0.9	1.5	3.5	2.0	1.4	4.0	4.5	4.8	0.7	0.0	0.4	0.9	0.0	16.5	0.2	4.9	0.0	13.5	0.0	3.0	2.1	0.5	10.3	2.7	0.6	0.6	2.9	3.4	0.2	7.7	0.0	2.8	1.5	16.5	5.5	20.0	4.2	17.8	5.9	2.4	0.0	0.2	7.2	8.4	3.5	3.3	0.0	4.2	4.6	0.3	3.6	2.6	8.0	1.8	0.0	9.4	16.5	1.2	7.1	2.7	0.0	0.2	0.2	0.7	0.2	0.7	0.2	0.3	0.2	0.9	0.8	0.2	0.1	0.2	0.9	0.1	7.0	0.0	0.2	3.1	4.1	3.4	3.8	2.3	2.0	3.6	0.5	2.3	4.2
CDKL5	"CFAP247, EIEE2, STK9"	ENSG00000008086	"Cyclin dependent kinase like 5"	O76039	X	18425583-18653629	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.0"	"Cell line enhanced"	"Detected in many"		"A549: 12.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 7.7;eosinophil: 2.1;neutrophil: 4.7"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002847, CAB011577"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB011577: AB_727019, HPA002847: AB_1080107"	"unprognostic (7.01e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.25e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.63e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.66e-1)"	"prognostic favourable (5.54e-4)"	"unprognostic (7.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.99e-1)"	3.3	3.2	8.0	1.8	24.7	3.2	4.3	3.9	28.0	5.4	2.7	7.7	1.8	1.5	4.5	2.8	5.2	2.8	3.1	5.0	8.0	3.7	6.3	2.2	6.9	1.4	3.5	13.2	6.7	4.5	6.2	5.0	5.4	5.9	6.7	2.2	2.0	3.9	4.4	3.0	3.5	1.9	4.0	5.7	2.3	4.9	14.0	5.7	1.6	5.1	0.8	2.1	5.6	4.6	0.7	1.0	7.7	1.0	0.5	0.6	0.2	1.7	12.3	3.5	3.1	3.3	4.5	2.5	2.0	3.8	2.8	3.2	4.0	2.3	1.9	0.4	1.3	0.5	4.0	3.0	5.9	0.5	2.6	0.0	7.1	3.1	1.6	0.1	0.8	2.6	3.1	6.8	7.1	1.3	0.1	1.9	4.2	1.7	0.8	0.8	7.1	3.0	0.7	3.8	0.1	2.4	8.9	0.7	4.4	4.5	1.1	2.2	1.6	0.7	7.3	4.3	1.9	7.9	1.5	0.3	0.1	0.3	2.4	0.5	4.2	7.7	1.0	2.1	0.6	0.6	0.3	0.2	0.4	0.3	0.3	0.7	0.6	0.6	4.7	0.5	0.6	1.0	0.2	0.2	8.0	24.7	3.9	28.0	8.0	3.7	3.5	13.2	5.9	5.7
RS1	"RS, XLRS1"	ENSG00000102104	"Retinoschisin 1"	O15537	X	18639910-18672109	"Disease related genes, Predicted secreted proteins"	"Cell adhesion, Sensory transduction, Vision"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"retina: 54.9"	"Cell line enhanced"	"Detected in single"		"HeLa: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059546	Enhanced				"Secreted in other tissues"					"HPA059546: "	"unprognostic (8.31e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.80e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.14e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.04e-4)"	0.1	0.0	1.0	0.1	2.3	0.0	0.1	0.6	3.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.0	0.4	0.4	0.1	5.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	54.9	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.5	0.1	0.2	0.1	0.1	0.5	0.1	0.5	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.2	0.1	0.1	0.1	0.0	1.0	2.3	0.6	2.4	1.0	0.4	0.1	0.1	0.1	0.1
PPEF1	"PPEF, PPP7CA"	ENSG00000086717	"Protein phosphatase with EF-hand domain 1"	O14829	X	18675909-18827921	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.6;testis: 20.2"	"Cell line enhanced"	"Detected in some"		"A549: 3.5;HeLa: 5.1;SH-SY5Y: 2.9;SK-MEL-30: 1.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034577			Uncertain	"Plasma membrane,Cytokinetic bridge"				"Plasma membrane"	"Cytokinetic bridge"	"HPA034577: AB_10602817"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.06e-2)"	"unprognostic (9.85e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.96e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.10e-11)"	"unprognostic (5.41e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.19e-2)"	0.1	0.5	3.1	0.2	6.4	1.4	3.9	0.2	10.6	0.2	0.2	0.1	0.0	0.1	0.3	0.9	0.2	0.2	0.3	0.3	1.9	1.0	0.3	0.1	0.4	0.3	1.7	6.9	0.2	0.2	0.1	0.7	1.0	0.2	0.5	0.1	0.0	0.3	0.6	0.1	0.7	0.1	0.2	10.5	0.3	0.1	20.2	0.0	0.1	0.4	0.0	0.3	0.4	0.1	0.2	1.3	0.0	0.9	0.0	0.0	0.2	0.0	3.5	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	1.2	0.0	5.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.2	0.3	2.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.1	6.4	0.2	10.6	1.9	1.0	1.7	6.9	0.2	0.0
PHKA2	"PHK, PYK"	ENSG00000044446	"Phosphorylase kinase regulatory subunit alpha 2"	P46019	X	18892300-18984598	"Disease related genes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	Calmodulin-binding	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002912	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA002912: AB_10961321"	"unprognostic (3.90e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavourable (1.25e-5)"	"unprognostic (2.07e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.82e-1)"	"prognostic favourable (7.68e-4)"	"unprognostic (7.51e-2)"	"prognostic unfavourable (1.55e-5)"	"unprognostic (2.05e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.16e-2)"	"prognostic favourable (2.96e-5)"	9.5	8.6	4.0	9.8	8.3	10.8	7.9	10.9	5.9	8.7	7.7	7.8	4.5	10.1	8.5	5.4	5.8	8.3	10.9	8.6	4.2	3.7	6.2	29.4	5.4	14.1	7.1	3.6	14.5	13.1	8.8	16.9	11.6	6.9	8.3	5.2	9.5	7.4	12.4	6.0	6.9	10.1	4.9	6.6	8.5	6.9	12.4	5.4	29.6	9.2	3.4	9.1	7.2	10.4	3.0	3.2	9.9	5.6	4.2	3.4	2.6	8.5	8.0	4.7	7.7	6.4	6.0	13.1	3.7	3.1	5.5	6.0	8.4	5.5	9.9	2.8	4.8	7.9	8.4	9.6	5.9	5.0	8.8	11.9	12.4	10.1	4.5	11.1	15.4	9.9	6.4	6.6	9.7	5.6	3.9	6.2	3.8	8.7	11.7	18.6	5.7	8.8	9.3	9.7	11.0	3.6	3.8	4.1	6.3	11.4	11.7	5.1	14.5	6.4	10.0	7.5	4.4	8.0	5.7	6.0	5.0	7.6	4.3	6.1	4.0	5.1	4.6	9.9	3.2	5.6	3.4	2.5	2.6	2.3	3.2	3.0	3.2	3.0	8.2	4.2	3.6	1.7	3.2	2.6	4.0	8.3	10.9	5.9	4.2	3.7	7.1	3.6	6.9	5.4
ADGRG2	"EDDM6, GPR64, HE6, TM7LN2"	ENSG00000173698	"Adhesion G protein-coupled receptor G2"	Q8IZP9	X	18989309-19122637	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"epididymis: 202.4"	"Cell line enhanced"	"Detected in some"		"A549: 6.1;BEWO: 7.7;HeLa: 6.4;NTERA-2: 6.7;SH-SY5Y: 7.0;U-2197: 15.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA001478, HPA050029"	Enhanced		Approved	"Plasma membrane,Cytosol"			7900000	"Plasma membrane, Cytosol"		"HPA001478: AB_1078923, HPA050029: AB_2680996"	"unprognostic (3.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.43e-3)"	"unprognostic (2.63e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.54e-7)"	"unprognostic (6.37e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.35e-1)"	4.4	0.3	0.4	0.9	0.2	0.2	2.8	0.1	0.2	0.8	1.0	0.1	6.6	0.2	0.5	202.4	0.9	6.9	1.4	1.8	0.6	0.6	0.7	0.9	1.7	3.1	0.2	0.2	0.9	0.9	24.8	1.9	0.6	0.3	3.2	0.2	1.6	9.6	0.8	0.6	0.3	1.4	0.6	0.2	1.2	3.5	4.7	0.2	2.7	1.8	0.6	1.9	1.1	1.5	0.1	0.2	0.9	0.6	0.0	0.2	0.0	0.2	6.1	0.0	0.0	0.1	0.9	7.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	6.4	0.2	0.9	0.0	0.0	0.1	0.1	0.0	1.2	0.0	0.0	0.2	0.0	1.0	0.0	2.3	6.7	2.0	0.0	0.1	4.4	0.0	1.2	2.3	7.0	1.5	0.1	0.0	0.1	0.1	0.1	0.2	0.4	15.3	2.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.9	0.1	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.0	0.7	0.0	0.6	0.1	0.0	0.0	0.4	0.2	0.1	0.2	0.6	0.6	0.2	0.2	0.3	0.2
PDHA1	PDHA	ENSG00000131828	"Pyruvate dehydrogenase E1 alpha 1 subunit"	P08559	X	19343893-19361705	"Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 107.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047487, HPA047864, HPA063053"	Approved		Supported	Mitochondria	"Intracellular and membrane"		15000	Mitochondria		"HPA047487: , HPA047864: , HPA063053: "	"unprognostic (5.71e-3)"	"unprognostic (2.46e-3)"	"unprognostic (5.71e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.90e-2)"	"unprognostic (8.68e-2)"	"prognostic favourable (1.13e-7)"	"unprognostic (3.72e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.06e-2)"	22.5	16.1	14.7	11.7	24.3	20.4	14.7	18.6	25.0	12.3	28.6	13.0	27.7	22.7	13.0	21.6	17.2	12.4	11.8	89.3	15.5	12.2	36.6	26.6	10.5	8.9	14.8	19.9	12.2	28.7	25.0	11.6	14.9	19.0	10.8	28.2	12.7	41.8	18.3	107.3	12.7	21.1	21.2	12.7	11.5	24.9	6.3	12.0	11.3	15.0	44.9	14.9	13.1	12.4	39.4	45.1	34.8	46.1	35.5	36.6	31.9	25.7	32.1	23.3	24.5	22.6	17.3	28.6	17.8	15.9	37.0	28.6	45.7	16.6	44.1	13.2	21.4	33.7	71.4	30.9	39.0	14.6	39.8	21.9	55.3	40.2	24.0	34.9	17.9	22.3	28.8	34.1	33.8	22.4	19.2	18.7	25.8	34.1	29.1	35.9	23.7	56.2	30.1	39.0	54.0	63.6	26.4	12.9	13.7	28.4	36.0	32.2	38.0	24.5	13.9	19.1	17.2	52.0	22.5	15.9	16.4	29.2	18.0	24.5	16.5	34.8	35.0	24.2	30.3	46.1	36.6	39.4	29.4	32.8	45.1	29.3	29.0	30.6	6.1	35.5	39.1	29.8	31.1	31.9	14.7	24.3	18.6	25.0	15.5	12.2	14.8	19.9	19.0	12.0
MAP3K15	"ASK3, bA723P2.3, FLJ16518"	ENSG00000180815	"Mitogen-activated protein kinase kinase kinase 15"	Q6ZN16	X	19360056-19515261	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 17.3;brain: 13.2"	"Cell line enhanced"	"Detected in some"		"A549: 3.4;HAP1: 8.6;HEK 293: 7.2;HEL: 2.9;REH: 4.4"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in some"	6	"pons and medulla: 13.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA004006			Approved	Vesicles				Vesicles		"HPA004006: AB_1079358"	"unprognostic (2.87e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.21e-2)"	"unprognostic (6.56e-8)"	"unprognostic (3.47e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.98e-2)"	"unprognostic (8.20e-2)"	0.1	17.3	0.5	0.4	0.3	0.5	0.1	2.3	0.1	0.1	0.1	5.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.5	3.6	0.1	0.5	0.0	0.1	0.0	1.3	4.1	0.4	5.7	0.0	13.2	0.1	0.0	4.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	2.6	0.1	2.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	8.6	0.0	0.0	1.4	7.2	2.9	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	2.2	2.2	0.9	4.4	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.3	2.3	0.1	0.4	0.5	0.1	0.0	13.2	0.0
SH3KBP1	CIN85	ENSG00000147010	"SH3 domain containing kinase binding protein 1"	Q96B97	X	19533975-19887601	"Predicted intracellular proteins"	"Apoptosis, Endocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003351, HPA003355, CAB021892"	Enhanced		Supported	Cytosol				Cytosol		"CAB021892: , HPA003351: AB_1079956, HPA003355: AB_1079954"	"unprognostic (1.17e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.48e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.88e-2)"	"unprognostic (6.47e-2)"	"unprognostic (9.91e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.76e-3)"	"unprognostic (5.96e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (2.10e-6)"	"unprognostic (4.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.92e-2)"	25.0	6.6	17.2	31.0	23.7	32.2	25.3	3.3	18.1	10.6	19.3	23.6	2.6	7.1	6.3	6.6	4.6	6.6	11.3	14.4	17.2	20.1	7.9	8.2	16.6	32.9	30.2	11.4	5.7	3.6	13.1	10.2	17.0	22.6	5.1	19.1	6.8	12.5	4.1	6.1	14.7	12.2	7.9	28.8	22.0	9.6	3.0	27.0	19.5	11.5	5.5	34.9	10.7	17.1	13.6	35.8	51.3	24.5	17.8	51.2	39.4	12.4	13.1	2.1	4.7	10.6	20.5	11.0	11.3	16.5	5.8	9.3	8.9	25.8	23.3	11.9	16.3	1.4	4.8	4.5	9.4	7.6	3.3	5.0	3.4	7.1	6.9	31.6	40.0	12.0	4.5	12.0	35.7	8.7	1.8	28.2	14.7	5.6	18.8	32.1	3.6	17.5	11.7	20.4	2.1	6.7	2.5	1.5	1.5	10.5	1.4	16.0	1.3	37.2	27.6	10.2	8.8	12.9	12.4	41.3	27.3	20.7	21.7	26.3	45.0	10.4	24.5	39.6	46.1	18.7	36.0	13.6	45.1	47.7	31.9	12.2	37.6	37.3	51.3	17.8	21.5	35.8	51.2	39.4	17.2	23.7	3.3	18.1	17.2	20.1	30.2	11.4	22.6	27.0
BCLAF3	CXorf23	ENSG00000173681	"BCLAF1 and THRAP3 family member 3"	A2AJT9	X	19912860-19970298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027215	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA027215: AB_1847358"	"unprognostic (2.46e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.72e-2)"	"prognostic favourable (5.42e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.30e-2)"	"prognostic favourable (5.56e-4)"	4.3	2.4	3.7	2.8	3.4	2.5	4.6	8.1	3.4	3.4	4.5			2.6	5.0	8.1	2.8	3.6	3.6	2.7	4.0	3.2	3.8	2.0	3.8	3.2	3.7		5.1	3.2	7.1	3.3	2.5		4.6	5.4		3.1	4.9	3.9	5.3	4.1	3.4	4.2	4.1	3.1	1.8			4.2		3.3	4.2	3.9	2.8	2.3	4.8	1.4	1.4	1.6	0.3	5.7	4.6	6.4	10.7	5.7	8.1	3.5	5.3	4.5	3.5	4.9	4.1	6.2	5.9	3.2	6.3	4.2	5.6	4.0	6.7	3.8	4.6	3.8	4.8	4.0	8.1	5.2	6.6	7.2	6.2	3.9	5.3	4.0	2.7	14.1	4.0	4.4	3.6	3.4	5.6	5.9	1.6	6.4	7.9	9.2	5.8	3.9	6.0	6.7	5.7	5.3	6.8	4.7	7.3	5.9	2.9	14.1	3.9	4.5	3.4	4.9	5.1	2.9	5.0	4.1	0.9	1.8	1.5	1.2	1.6	1.2	1.2	1.5	0.7	2.8	1.2	1.4	4.8	1.4	1.4	2.3	0.5	0.3										
MAP7D2	FLJ14503	ENSG00000184368	"MAP7 domain containing 2"	Q96T17	X	20006713-20116917	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.8;epididymis: 38.7"	"Cell line enhanced"	"Detected in some"		"A549: 8.6;CACO-2: 12.4;HEK 293: 17.0;HeLa: 14.7;Hep G2: 7.3;SCLC-21H: 19.6;SiHa: 8.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"basophil: 5.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051508, HPA059537"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA051508: , HPA059537: "	"unprognostic (1.51e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.45e-5)"	"unprognostic (5.65e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.95e-2)"	"unprognostic (7.77e-3)"	"unprognostic (3.58e-4)"	"unprognostic (2.21e-2)"	"prognostic unfavourable (7.27e-5)"	"unprognostic (9.12e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.19e-1)"	0.7	3.6	11.1	0.9	18.5	1.3	1.0	12.9	30.8	0.7	1.3	0.8	0.7	1.3	1.2	38.7	0.9	3.0	1.1	0.9	16.5	10.3	4.1	0.7	0.9	0.8	10.4	15.0	0.8	1.7	0.7	3.0	8.1	24.2	1.5	1.5	0.8	0.8	2.8	1.0	1.5	1.8	1.0	7.1	0.7	8.9	9.7	2.1	0.0	0.6	0.0	0.9	0.7	0.5	0.0	0.8	5.5	0.1	0.0	0.3	0.0	0.0	8.6	0.8	0.0	0.0	0.2	0.0	0.9	0.0	0.1	0.1	12.4	0.3	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.6	17.0	0.0	14.7	7.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.4	0.0	0.2	0.0	0.0	1.0	0.0	19.6	3.3	8.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.9	0.0	0.9	5.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	11.1	18.5	12.9	21.7	16.5	10.3	10.4	15.0	24.2	2.1
EIF1AX	"eIF-1A, eIF-4C, EIF1A, EIF4C"	ENSG00000173674	"Eukaryotic translation initiation factor 1A, X-linked"	P47813	X	20124518-20141844	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA002561	Uncertain	Supported	Approved	Cytosol				Cytosol		"HPA002561: AB_1078724"	"unprognostic (1.91e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.26e-3)"	"unprognostic (7.13e-3)"	"unprognostic (2.22e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.82e-2)"	"unprognostic (4.73e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.23e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.52e-1)"	30.9	23.2	22.0	23.7	28.8	28.3	53.4	35.4	57.3	26.1	23.6	14.5	23.9	22.7	33.8	18.7	32.6	24.7	18.4	29.2	21.4	19.5	31.0	32.0	22.1	20.9	23.5	23.5	37.0	33.0	28.7	19.8	24.7	29.0	19.5	16.9	12.0	25.2	25.0	61.5	22.5	18.9	32.5	34.1	16.5	22.7	18.0	23.7	14.8	25.7	24.6	17.2	29.3	33.9	31.1	30.2	12.6	19.9	27.2	30.9	23.8	45.8	25.9	20.0	26.6	19.5	26.6	16.3	41.0	15.1	22.4	17.7	37.2	22.0	42.9	27.5	27.1	19.7	35.2	35.6	35.1	17.5	58.1	19.0	32.6	31.7	13.6	50.5	26.8	12.4	21.8	34.6	54.4	31.2	49.1	24.1	22.0	22.4	31.1	31.7	51.9	43.1	25.6	45.9	45.9	17.6	25.6	23.2	26.0	43.5	34.0	26.9	27.6	21.5	17.8	27.3	17.0	88.9	30.6	16.5	31.2	50.9	18.6	23.2	20.6	12.6	19.1	11.5	23.1	19.9	30.2	31.1	26.5	27.1	18.3	27.7	30.9	25.8	4.7	27.2	19.2	30.2	20.3	23.8	22.0	28.8	35.4	57.3	21.4	19.5	23.5	23.5	29.0	23.7
RPS6KA3	"CLS, HU-3, MRX19, RSK, RSK2"	ENSG00000177189	"Ribosomal protein S6 kinase A3"	P51812	X	20149911-20267519	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 67.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003221, CAB003853, CAB013520"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"CAB003853: AB_562343, CAB013520: AB_2533378, HPA003221: AB_1853553"	"unprognostic (1.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-1)"	19.7	12.5	9.9	23.0	12.5	8.2	16.5	15.2	12.1	11.4	23.2	4.4	22.1	13.7	12.4	10.1	13.6	12.7	15.7	21.3	9.7	8.8	14.1	25.8	21.6	34.0	9.9	10.0	12.7	14.0	36.6	9.8	11.0	10.2	14.5	18.8	7.7	14.3	11.3	45.2	11.7	23.7	16.1	11.7	25.8	11.8	4.8	9.7	29.4	13.5	15.0	18.2	20.3	19.0	4.2	8.6	12.5	6.9	8.3	11.3	2.7	12.6	22.2	8.4	4.3	8.2	14.5	2.5	11.0	16.8	8.2	11.3	25.1	16.4	8.3	3.8	11.5	9.0	9.6	9.3	15.3	7.0	7.6	9.8	14.0	67.5	8.4	19.0	10.2	9.2	7.5	12.9	16.3	29.8	6.4	23.9	8.6	6.0	12.3	5.8	6.0	13.4	6.6	17.8	9.6	7.1	10.6	3.9	3.8	14.8	4.5	16.0	0.0	5.7	16.6	9.0	6.3	28.5	6.2	19.1	11.6	9.3	17.0	9.5	21.2	12.5	4.7	9.5	6.3	6.9	11.3	2.9	7.3	6.9	7.0	4.2	5.0	6.0	7.5	8.3	6.9	8.6	3.5	2.7	9.9	12.5	15.2	12.1	9.7	8.8	9.9	10.0	10.2	9.7
CNKSR2	"CNK2, KIAA0902, KSR2"	ENSG00000149970	"Connector enhancer of kinase suppressor of Ras 2"	Q8WXI2	X	21372801-21654695	"Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 38.4"	"Cell line enhanced"	"Detected in some"		"A549: 6.7;AF22: 4.7;NTERA-2: 10.8;PC-3: 5.5;RH-30: 10.1;U-251 MG: 6.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.9;naive CD4 T-cell: 3.0"	"Group enriched"	"Detected in many"	5	"B-cells: 2.9;T-cells: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001502			Approved	"Golgi apparatus,Plasma membrane"				"Golgi apparatus, Plasma membrane"		"HPA001502: AB_1078542"	"unprognostic (1.33e-2)"	"unprognostic (1.00e-3)"	"unprognostic (5.35e-2)"	"unprognostic (4.90e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.40e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.47e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.13e-2)"	2.0	5.2	23.5	1.4	29.6	1.3	2.1	31.3	38.4	1.4	1.2	1.7	0.0	1.1	1.4	1.8	1.1	2.3	1.2	1.7	26.4	4.4	1.0	2.0	2.8	2.4	3.1	20.8	1.9	4.9	1.0	1.0	1.1	1.8	2.2	1.1	3.5	1.7	1.2	7.4	1.1	1.2	1.2	1.7	1.8	1.3	1.8	5.0	0.6	1.2	0.0	2.6	1.3	0.7	2.9	0.1	0.6	0.0	0.0	3.0	0.3	0.0	6.7	4.7	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	1.4	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.1	10.8	5.5	0.0	10.1	0.0	0.0	0.0	4.6	1.8	0.0	0.1	0.2	0.0	0.6	0.0	0.1	2.1	0.0	6.7	3.5	0.0	3.5	0.9	0.0	2.6	0.1	0.0	0.6	0.1	0.0	0.4	1.1	0.6	0.0	0.0	2.9	3.0	1.0	0.0	0.0	0.0	0.1	0.8	0.3	23.5	29.6	31.3	24.4	26.4	4.4	3.1	20.8	1.8	5.0
KLHL34	"FLJ34960, RP11-450P7.3"	ENSG00000185915	"Kelch like family member 34"	Q8N239	X	21654690-21658330	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"skeletal muscle: 31.1"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.1;PC-3: 1.1;SCLC-21H: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.0"	"Lineage enriched"	"Detected in single"	4	"T-cells: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA060287	Uncertain									"HPA060287: "	"unprognostic (2.00e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.68e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.74e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.29e-1)"	0.3	0.1	0.7	0.1	0.9	0.0	0.0	1.7	0.8	0.0	0.3	0.1	0.0	1.1	0.0	0.0	0.3	0.0	0.0	1.8	0.5	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	3.1	0.6	0.0	31.1	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	2.8	0.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	3.0	0.5	0.0	0.5	0.5	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.4	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.1	0.0	1.1	1.1	0.1	0.8	0.2	0.0	0.2	1.0	0.5	0.0	0.1	0.0	0.1	0.1	0.8	0.2	0.1	0.1	0.5	0.1	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.0	0.3	3.0	0.9	0.0	0.0	0.0	0.0	0.6	0.5	0.7	0.9	1.7	0.8	0.5	0.3	0.2	0.0	0.2	0.0
SMPX	"DFN6, DFNX4"	ENSG00000091482	"Small muscle protein, X-linked"	Q9UHP9	X	21705972-21758163	"Disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	23	"heart muscle: 108.8;skeletal muscle: 155.8;tongue: 74.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.6;Hep G2: 6.7;HSkMC: 7.3;Karpas-707: 5.0;U-266/70: 7.4;U-266/84: 2.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA077360			Approved	"Plasma membrane"			45000	"Plasma membrane"		"HPA077360: "	"unprognostic (7.29e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (3.04e-5)"	"unprognostic (1.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (5.27e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.58e-2)"		"unprognostic (2.67e-2)"	"unprognostic (2.82e-1)"		"unprognostic (8.38e-2)"	1.4	0.0	0.1	0.6	0.1	0.0	0.2	0.6	0.9	0.1	4.0	0.0	0.0	0.1	0.1	4.7	4.0	0.1	0.1	108.8	0.1	0.2	0.0	0.2	0.0	0.1	0.7	0.3	0.2	0.1	0.0	0.0	0.0	0.0	1.6	0.5	0.0	3.6	0.1	155.8	0.0	0.9	1.8	0.1	0.0	1.5	0.1	0.0	0.0	1.0	74.5	4.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.7	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	5.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	7.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.9	0.1	0.2	0.7	0.3	0.0	0.0
MBTPS2	"KFSD, S2P"	ENSG00000012174	"Membrane bound transcription factor peptidase, site 2"	O43462	X	21839636-21885424	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Ichthyosis, Osteogenesis imperfecta, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005494, CAB009486"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria, Cytosol"		"CAB009486: AB_2140370, HPA005494: AB_1079329"	"unprognostic (7.97e-3)"	"unprognostic (9.12e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.05e-2)"	12.0	17.4	9.3	7.2	13.9	2.5	12.7	20.8	18.5	11.8	9.3	13.4	6.9	7.6	14.7	9.1	9.3	10.9	10.1	11.6	9.9	10.7	13.9	26.0	8.6	6.6	10.6	13.0	18.7	12.2	17.9	15.6	22.3	17.4	15.7	9.1	12.4	14.1	13.1	14.5	8.2	8.1	14.6	14.6	7.5	9.1	6.9	7.0	7.1	13.1	7.4	6.7	11.4	9.1	3.9	6.9	1.5	4.8	4.6	5.9	3.3	9.1	19.0	9.1	9.2	11.5	14.3	4.4	13.5	13.8	12.9	11.3	7.5	12.6	7.9	7.1	14.4	8.6	12.5	7.8	16.0	5.9	10.0	3.9	12.1	6.2	15.8	8.4	3.9	13.5	8.4	19.5	14.4	9.9	10.9	8.9	14.7	5.7	3.4	4.4	8.5	14.1	4.3	16.9	8.8	9.0	4.6	2.2	18.7	19.1	12.1	16.7	16.3	7.2	11.7	16.3	3.8	23.7	10.1	10.9	13.8	3.8	18.1	3.5	15.6	0.1	4.3	1.5	4.5	4.8	4.2	3.9	3.5	4.1	6.9	3.8	4.7	5.6	0.5	4.6	4.8	4.8	5.9	3.3	9.3	13.9	20.8	18.5	9.9	10.7	10.6	13.0	17.4	7.0
YY2	ZNF631	ENSG00000230797	"YY2 transcription factor"	O15391	X	21855987-21858727	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 9.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA001119, HPA030335"	Enhanced		Approved	"Nuclear bodies"				"Nuclear bodies"		"HPA001119: AB_1858930, HPA030335: "	"unprognostic (1.90e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.75e-2)"	"unprognostic (8.39e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.78e-4)"	"unprognostic (4.04e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-1)"	1.6	1.8	0.7	1.4	0.9	0.3	1.4	1.8	0.8	1.6	1.2			0.3	2.8	1.9	1.3	1.6	1.2	1.2	0.5	0.6	1.0	2.5	1.4	0.7	0.8		3.3	1.4	1.5	2.5	2.2		1.8	0.9		1.3	1.6	1.2	1.8	0.8	2.0	1.1	0.9	0.9	9.5			1.6		0.6	1.1	1.5	1.5	1.2	0.0	0.6	1.4	2.7	0.5	3.6	3.3	2.3	7.3	2.8	1.2	0.3	4.0	2.3	4.6	5.3	2.6	6.0	4.1	2.3	5.2	2.0	4.9	5.4	8.1	2.9	4.7	1.1	8.8	2.1	5.0	4.4	2.2	2.4	4.1	3.5	5.7	2.9	4.2	4.9	8.1	2.5	2.4	4.6	4.3	4.3	2.3	3.8	6.3	2.5	1.6	1.3	3.2	2.3	2.0	6.5	3.5	1.4	3.1	8.5	1.7	14.7	4.7	3.3	3.9	2.6	5.6	2.2	6.7	0.0	0.6	0.0	0.8	0.1	0.6	1.5	1.3	0.8	0.6	1.1	2.7	0.6	0.0	1.4	0.4	1.2	1.2	0.5										
SMS	"MRSR, SPMSY, SpS, SRS"	ENSG00000102172	"Spermine synthase"	P52788	X	21940573-21994835	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Polyamine biosynthesis"	Transferase	"FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029849, HPA029852"	Approved		Approved	"Nuclear bodies,Cytosol"			26000	"Nuclear bodies"	Cytosol	"HPA029849: AB_10602072, HPA029852: AB_10611521"	"unprognostic (2.51e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (7.49e-4)"	"prognostic unfavourable (7.79e-8)"	"unprognostic (1.02e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.18e-3)"	"unprognostic (3.95e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (7.85e-5)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.50e-2)"	21.7	48.1	29.7	18.7	25.0	18.6	28.4	36.6	35.4	20.8	23.1	8.1	26.0	23.5	20.8	31.3	19.2	13.3	20.9	26.3	22.3	25.0	55.1	19.5	17.6	18.5	25.6	28.5	42.4	16.7	13.6	19.2	63.6	24.2	61.3	24.4	15.7	20.7	20.6	18.0	9.7	25.1	36.8	17.4	18.9	18.8	18.4	11.0	19.6	27.6	11.7	20.8	28.2	16.5	13.2	19.4	37.0	25.7	11.7	20.3	12.3	90.6	23.2	39.6	15.0	10.5	17.8	12.3	24.9	14.9	38.3	36.7	28.8	29.7	32.9	8.6	25.4	19.9	38.7	45.4	75.8	15.2	18.1	17.0	28.0	20.4	19.3	32.9	15.0	11.7	13.9	39.3	73.9	36.6	36.2	4.6	52.1	19.3	24.3	33.0	67.1	34.5	24.3	27.2	25.0	51.0	12.9	18.9	15.3	19.9	25.6	65.5	23.1	13.7	32.3	27.8	28.0	57.6	40.4	3.5	7.0	19.6	54.2	14.7	38.5	2.9	21.4	37.0	7.6	22.1	9.4	13.2	12.0	13.2	19.4	8.3	7.9	9.3	21.1	11.7	25.7	4.0	20.3	12.3	29.7	25.0	36.6	35.4	22.3	25.0	25.6	28.5	24.2	11.0
PHEX	"HPDR, HPDR1, HYP, HYP1, PEX, XLH"	ENSG00000102174	"Phosphate regulating endopeptidase homolog X-linked"	P78562	X	22032441-22251310	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	Biomineralization	"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 8.3;lung: 6.7"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 5.6;HUVEC TERT2: 4.3;PC-3: 4.7;TIME: 4.8;U-87 MG: 10.3;WM-115: 4.3"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 5.9"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	37	"plasmacytoid DC: 8.3"	"Lineage enriched"	"Detected in single"	37	"dendritic cells: 8.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"														"unprognostic (2.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.84e-8)"	"unprognostic (1.18e-1)"	"unprognostic (1.58e-1)"	"prognostic favourable (2.51e-4)"	"unprognostic (7.68e-2)"	0.3	0.0	1.8	1.9	1.1	0.0	1.7	0.9	1.1	0.8	0.9	0.8	0.3	1.2	5.0	0.3	0.4	0.1	2.0	0.3	1.5	1.8	0.3	0.3	6.7	3.4	2.0	0.3	3.9	0.3	0.0	0.3	0.3	5.0	1.3	0.0	0.3	2.8	0.9	0.3	0.1	1.4	3.9	3.8	3.4	0.0	0.3	0.3	1.3	4.8	0.3	4.3	0.5	0.6	0.1	8.3	0.0	0.0	0.0	0.2	0.0	0.3	0.8	0.2	0.1	0.1	0.4	0.0	0.0	0.1	0.1	0.3	1.3	0.1	0.1	1.3	0.1	0.1	0.0	5.6	0.3	0.0	0.1	0.1	0.5	0.0	0.1	0.1	0.2	2.2	1.1	1.1	3.3	4.3	0.0	0.4	0.5	0.0	0.0	0.2	0.0	4.7	0.0	1.0	0.0	0.6	0.2	0.1	0.2	0.4	2.4	0.8	2.8	0.0	4.8	1.0	0.1	0.6	0.8	0.0	0.0	0.0	10.3	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	8.3	0.0	0.0	1.8	1.1	0.9	1.1	1.5	1.8	2.0	0.3	5.0	0.3
CBLL2	"CT138, FLJ25735, HAKAIL, ZNF645"	ENSG00000175809	"Cbl proto-oncogene like 2"	Q8N7E2	X	22272943-22274461	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	52	"testis: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5			0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0										
DDX53	"CAGE, CT26"	ENSG00000184735	"DEAD-box helicase 53"	Q86TM3	X	22999961-23003589	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"testis: 11.5"	"Cell line enhanced"	"Detected in some"		"K-562: 6.2;RPMI-8226: 3.2;U-2197: 2.1;U-266/84: 14.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA003186			Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA003186: AB_1078637"														"unprognostic (5.76e-1)"	"unprognostic (1.12e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.1	0.0	0.4	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PTCHD1	FLJ30296	ENSG00000165186	"Patched domain containing 1"	Q96NR3	X	23334016-23404372	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Autism, Autism spectrum disorder"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 27.8"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.3;RT4: 3.1;WM-115: 10.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	4	"cerebellum: 27.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046110	Uncertain									"HPA046110: "	"unprognostic (1.50e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.14e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.50e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.68e-4)"	"unprognostic (5.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	1.6	2.3	6.6	0.9	5.5	0.7	6.0	27.8	8.9	6.2	8.4	1.0	3.5	1.4	5.1	2.1	4.5	0.9	0.8	0.8	5.3	2.7	0.8	0.6	1.2	0.6	3.1	5.8	0.8	0.8	0.5	1.7	0.5	6.5	4.4	2.9	0.0	1.8	11.7	1.1	0.8	1.8	10.2	2.6	1.4	3.4	1.1	3.8	0.0	1.0	0.0	0.6	5.4	2.9	0.7	0.4	1.2	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.3	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	1.2	0.4	0.0	1.4	0.0	0.0	3.1	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	10.4	1.2	0.3	0.4	0.3	0.2	0.2	0.3	0.3	0.2	0.1	0.7	0.3	0.3	1.0	0.3	0.2	0.4	0.1	0.0	6.6	5.5	27.8	6.5	5.3	2.7	3.1	5.8	6.5	3.8
PRDX4	AOE37-2	ENSG00000123131	"Peroxiredoxin 4"	Q13162	X	23664262-23686399	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"liver: 127.6;pancreas: 320.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008659, CAB027389, CAB047362"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"		11000000	"Endoplasmic reticulum, Cytosol"		"CAB008659: AB_1620984, CAB027389: , CAB047362: "	"unprognostic (3.82e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.08e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (1.33e-6)"	"unprognostic (7.44e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.10e-2)"	11.6	14.8	3.8	7.0	6.4	3.9	11.2	3.3	5.4	13.2	10.7	6.5	17.4	8.9	11.5	10.5	13.1	9.6	12.9	17.6	3.8	4.0	11.8	127.6	8.9	16.9	7.2	4.0	14.6	320.8	6.1	15.8	21.9	7.4	9.3	11.4	8.0	25.4	14.1	7.8	7.2	10.6	8.8	8.1	12.6	12.8	25.2	6.1	4.7	12.0	10.0	15.0	10.8	8.7	27.9	31.4	2.0	39.3	24.1	22.7	21.3	24.2	33.5	14.2	27.4	77.4	39.6	20.0	32.7	35.7	29.7	43.4	35.1	30.6	20.9	15.4	42.4	29.4	40.8	20.3	28.5	12.7	78.5	14.8	29.6	44.3	32.3	19.0	14.1	41.9	26.3	28.9	29.0	37.2	28.5	77.1	27.4	36.1	9.7	29.8	49.0	49.2	13.5	35.5	117.8	26.5	8.5	20.8	17.7	30.1	35.8	24.1	37.8	24.3	24.5	21.2	14.0	54.7	24.5	25.3	30.6	22.3	38.0	24.7	30.2	1.7	20.6	2.0	17.8	32.2	21.8	27.9	22.7	18.6	31.4	16.2	16.4	16.7	1.5	24.1	39.3	22.0	22.1	21.3	3.8	6.4	3.3	5.4	3.8	4.0	7.2	4.0	7.4	6.1
ACOT9	"ACATE2, CGI-16, MT-ACT48"	ENSG00000123130	"Acyl-CoA thioesterase 9"	Q9Y305	X	23702253-23766475	"Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA035533	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA035533: AB_10696506"	"unprognostic (5.69e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavourable (3.23e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.75e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.15e-3)"	"unprognostic (6.53e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	19.1	15.9	6.3	14.1	7.7	10.5	29.2	6.5	13.6	15.4	16.3	5.4	17.6	11.5	21.2	16.1	12.0	14.5	15.5	35.7	5.7	7.7	12.8	15.5	23.6	36.0	7.3	8.6	13.4	16.6	9.1	7.8	13.3	12.7	12.8	12.7	13.9	16.3	23.0	28.8	10.4	12.5	35.7	13.8	15.8	15.0	7.1	4.5	3.8	15.1	11.4	9.7	15.9	14.4	5.5	16.4	11.1	26.5	6.0	10.0	8.4	26.4	18.1	7.9	17.4	13.0	14.8	4.0	21.0	18.3	20.9	20.3	16.0	24.0	1.3	13.5	23.4	16.2	9.9	26.8	29.1	6.2	15.1	9.0	19.0	11.6	17.5	3.5	11.4	13.1	18.3	24.4	27.8	30.4	5.7	9.1	22.5	9.2	4.8	8.5	11.5	22.1	5.1	30.1	11.2	24.7	9.9	1.5	7.6	22.8	9.6	13.5	10.8	4.6	28.2	17.4	11.6	25.2	11.4	2.2	5.2	0.1	12.9	3.5	14.7	9.1	16.1	11.1	5.6	22.2	7.6	5.5	7.0	6.3	16.4	4.6	2.3	5.3	8.4	6.0	26.5	2.8	10.0	8.4	6.3	7.7	6.5	13.6	5.7	7.7	7.3	8.6	12.7	4.5
SAT1	"SAT, SSAT"	ENSG00000130066	"Spermidine/spermine N1-acetyltransferase 1"	P21673	X	23783173-23786226	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 71.3;hTERT-HME1: 109.8;RPTEC TERT1: 91.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 206.1"	"Group enriched"	"Detected in all"	9	"granulocytes: 206.1;monocytes: 136.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB047343, HPA055312, CAB069914"	Supported									"CAB047343: , CAB069914: AB_830224, HPA055312: "	"unprognostic (4.19e-2)"	"unprognostic (3.92e-2)"	"unprognostic (6.41e-2)"	"prognostic favourable (2.87e-4)"	"unprognostic (8.58e-2)"	"unprognostic (7.90e-3)"	"unprognostic (8.52e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.38e-3)"	"unprognostic (2.23e-1)"	"unprognostic (7.58e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.97e-3)"	"unprognostic (1.65e-1)"	93.5	40.5	34.2	73.0	60.5	177.2	57.2	14.2	38.9	49.2	56.5	24.6	143.2	82.2	43.9	51.9	56.9	36.8	80.6	81.5	53.7	27.7	79.2	116.1	163.6	67.3	31.9	22.2	26.5	32.3	19.3	74.4	185.7	100.2	51.0	49.9	39.3	110.6	173.3	14.4	25.4	65.5	23.5	100.8	108.6	64.5	25.6	27.1	23.0	102.7	41.1	60.6	52.4	29.6	7.3	19.0	206.1	136.4	1.8	13.2	34.6	7.8	15.9	4.0	6.3	34.5	14.1	11.0	11.5	19.4	2.8	6.7	7.5	23.2	13.1	21.2	2.7	11.9	2.1	71.3	10.5	4.3	9.7	6.3	6.9	63.5	44.4	6.1	6.1	29.2	54.5	22.3	109.8	23.6	2.6	11.6	8.3	7.4	4.4	27.6	2.7	7.3	3.8	2.6	15.6	91.3	16.2	1.1	1.1	11.8	26.9	22.7	4.1	1.3	8.8	23.5	1.1	14.0	5.6	4.9	1.1	2.9	14.0	3.6	4.4	25.8	42.0	26.9	4.1	110.5	2.6	7.3	4.9	3.3	19.0	4.7	2.9	3.3	206.1	1.8	136.4	9.4	13.2	34.6	34.2	60.5	14.2	38.9	53.7	27.7	31.9	22.2	100.2	27.1
APOO	"FAM121B, MGC4825, Mic23, MIC26, My025"	ENSG00000184831	"Apolipoprotein O"	Q9BUR5	X	23833353-23907934	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003187	Supported		Approved	Mitochondria,Cytosol	"Secreted to blood"			Mitochondria	Cytosol	"HPA003187: AB_1079375"	"unprognostic (2.53e-2)"	"prognostic favourable (3.77e-4)"	"unprognostic (4.86e-2)"	"unprognostic (6.38e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.18e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-1)"	"prognostic favourable (2.56e-6)"	"unprognostic (2.53e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.88e-3)"	5.6	13.1	25.5	5.4	21.2	4.4	9.0	18.5	30.9	9.1	10.9	8.5	5.5	9.2	7.2	13.5	7.2	13.6	6.1	38.4	26.0	23.8	29.5	12.2	5.5	6.6	24.9	17.5	7.1	9.0	20.1	15.8	7.1	21.5	9.3	12.5	11.7	14.6	10.4	26.0	4.3	7.6	7.8	18.1	5.4	10.3	10.5	6.8	7.7	13.3	10.4	7.2	6.3	5.8	9.8	14.2	8.5	13.3	7.8	15.0	6.6	14.6	13.4	22.6	15.7	3.8	8.6	3.6	7.4	9.1	15.7	16.5	7.9	7.0	12.7	9.3	6.7	12.1	28.3	14.6	17.5	13.4	20.2	6.4	13.3	12.5	9.0	16.2	7.2	9.6	8.8	17.3	12.9	10.9	9.1	14.4	14.5	13.8	16.2	17.4	20.5	21.7	12.6	11.2	30.5	30.7	7.6	15.3	11.1	16.0	15.3	15.7	26.4	7.2	2.7	10.2	6.1	36.2	11.2	11.2	19.7	11.5	16.4	8.0	14.8	8.5	4.2	1.5	11.5	13.3	15.0	9.8	12.7	11.3	12.0	8.3	10.3	10.1	2.5	7.8	12.6	14.2	11.5	6.6	25.5	21.2	18.5	30.9	26.0	23.8	24.9	17.5	21.5	6.8
CXorf58	FLJ25444	ENSG00000165182	"Chromosome X open reading frame 58"	Q96LI9	X	23907801-23939507	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"testis: 8.4"	"Cell line enhanced"	"Detected in some"		"PC-3: 2.4;U-266/70: 2.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"monocytes: 1.0;T-cells: 1.8"									"HPA031542, HPA031543, HPA031544"	Uncertain									"HPA031542: , HPA031543: AB_10603789, HPA031544: "	"unprognostic (9.74e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.19e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.39e-2)"	"unprognostic (5.06e-3)"	0.1	0.4	0.2	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0			0.0	0.1	0.2	0.0	0.9	0.0	0.2	0.2	0.3	0.6	0.2	0.1	0.0	0.2		0.0	0.4	0.2	0.3	0.0		0.0	0.0		0.3	0.0	0.7	0.0	0.1	0.0	0.3	0.0	0.0	8.4			0.6		0.0	0.2	0.0	0.1	0.2	0.1	1.0	0.0	1.8	0.1	0.8	0.3	0.0	0.0	0.2	0.0	0.4	0.1	0.4	0.1	0.1	0.0	1.0	1.2	0.3	0.0	0.7	0.1	0.9	0.0	0.5	0.7	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.8	0.7	0.6	0.0	0.4	0.2	0.1	0.2	0.1	1.0	0.0	2.4	0.5	0.0	0.1	1.3	0.0	1.2	0.2	0.6	0.1	0.5	1.4	0.1	0.4	0.1	0.0	0.2	0.4	2.3	1.1	0.3	0.2	0.1	0.4	0.0	0.0	0.1	0.3	1.0	1.4	0.1	1.3	1.0	0.0	0.1	1.0	0.7	0.0	0.0	0.2	0.2	1.8	0.1										
KLHL15	KIAA1677	ENSG00000174010	"Kelch like family member 15"	Q96M94	X	23983720-24027186	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 25.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065730	Uncertain		Approved	Aggresome,Cytosol				Cytosol	Aggresome	"HPA065730: "	"unprognostic (5.89e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.13e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.37e-3)"	"unprognostic (7.42e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.40e-2)"	2.9	6.1	1.7	1.3	2.3	25.1	1.3	2.8	1.8	1.9	2.0			1.0	2.3	4.0	4.3	3.8	1.9	2.1	1.6	1.9	2.2	6.4	1.6	1.4	1.3		4.6	2.9	4.3	2.6	1.2		2.8	1.2		1.3	1.8	2.6	1.0	1.5	2.2	1.6	1.5	3.4	9.0			2.3		1.2	1.3	1.1	1.4	2.1	2.8	2.6	1.6	2.8	1.3	4.2	4.1	4.6	6.8	6.9	4.9	4.8	6.9	6.0	3.2	3.9	3.7	3.8	11.2	2.5	4.4	3.2	7.3	3.7	7.8	4.3	15.0	7.1	11.1	2.0	4.3	9.2	5.0	5.1	1.9	5.4	5.4	2.3	4.5	15.8	5.9	1.5	8.3	9.0	8.7	5.1	6.6	8.4	6.9	2.9	3.8	12.2	5.7	9.6	2.3	7.9	3.2	8.3	2.9	4.9	3.0	9.7	4.4	8.8	8.8	12.9	3.9	6.0	3.8	1.5	1.1	2.8	2.0	2.6	2.8	1.0	1.8	2.3	2.1	1.4	2.4	2.4	1.5	1.6	2.6	1.7	1.8	1.3										
EIF2S3	"EIF2, EIF2G, EIF2gamma"	ENSG00000130741	"Eukaryotic translation initiation factor 2 subunit gamma"	P41091	X	24054716-24077971	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease mutation, Epilepsy, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											CAB012471	Approved									"CAB012471: AB_873547"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.46e-3)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.66e-3)"	"unprognostic (6.94e-3)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (5.44e-6)"	"unprognostic (4.88e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-1)"	37.3	27.0	20.6	24.6	26.0	23.7	30.3	24.9	26.1	39.9	29.8	18.2	15.0	23.7	35.2	17.0	33.7	31.8	20.1	21.5	22.2	13.0	30.6	33.6	23.4	37.8	27.1	17.6	60.6	56.0	21.0	22.2	23.2	24.8	28.4	25.5	22.1	26.8	16.5	31.4	26.5	28.7	38.5	27.0	31.2	30.4	15.9	25.1	40.5	40.3	19.4	41.0	47.8	31.5	44.0	31.7	14.1	37.7	25.2	55.7	34.0	47.0	46.1	22.7	36.0	23.8	49.5	15.5	26.2	25.6	23.4	26.9	51.8	35.5	81.4	27.8	20.8	32.6	70.2	55.0	28.9	26.5	41.8	32.5	88.3	31.1	25.5	53.7	43.3	43.5	35.0	27.0	55.8	33.5	50.2	35.4	25.0	22.9	32.5	48.2	53.2	30.2	31.9	42.1	51.9	29.4	43.4	12.3	26.1	43.7	43.4	44.1	58.0	38.7	25.2	19.5	13.4	34.5	23.3	30.4	56.6	46.7	24.0	36.4	22.6	14.1	37.6	7.0	24.1	37.7	41.0	44.0	42.9	32.3	31.7	35.2	55.7	45.3	13.7	25.2	31.3	24.1	32.1	34.0	20.6	26.0	24.9	26.1	22.2	13.0	27.1	17.6	24.8	25.1
ZFX	ZNF926	ENSG00000005889	"Zinc finger protein, X-linked"	P17010	X	24149173-24216255	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA001748, HPA003877, HPA071863"	Supported		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA001748: AB_1080650, HPA003877: AB_1080648, HPA071863: "	"unprognostic (2.60e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.99e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.22e-3)"	"unprognostic (2.39e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.95e-2)"	20.3	8.8	10.8	8.2	11.7	25.9	23.5	22.1	12.6	18.5	12.2	7.2	8.4	6.6	18.5	11.0	10.6	15.8	7.2	17.8	10.1	6.6	16.6	11.3	9.7	12.7	13.1	9.6	20.2	11.8	20.2	17.9	23.2	10.4	16.4	6.5	7.0	9.4	13.1	24.1	8.9	11.8	15.7	11.3	12.4	10.1	5.4	14.7	16.4	13.9	8.9	10.6	12.5	25.3	11.9	9.6	16.6	10.3	9.9	10.7	7.0	8.0	10.9	11.3	13.1	15.3	10.7	5.9	7.6	7.2	8.8	9.2	6.7	6.0	9.3	10.3	11.7	10.3	12.9	14.1	11.8	9.0	16.0	8.2	33.8	3.9	6.4	10.8	14.5	9.3	4.5	17.1	22.3	11.0	9.7	10.1	6.3	4.4	7.7	8.0	6.5	8.4	10.6	9.0	8.0	5.2	13.0	6.0	9.0	23.0	9.2	7.4	5.8	5.7	10.8	7.8	4.6	10.8	5.3	5.7	7.5	9.3	6.1	4.6	9.0	11.2	8.7	13.5	10.6	10.3	10.7	8.4	9.9	10.6	9.6	11.9	9.9	9.4	16.6	9.9	9.4	6.9	5.7	7.0	10.8	11.7	22.1	12.6	10.1	6.6	13.1	9.6	10.4	14.7
PDK3		ENSG00000067992	"Pyruvate dehydrogenase kinase 3"	Q15120	X	24465221-24539837	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046583, HPA072492"	Approved		Supported	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"HPA046583: , HPA072492: "	"unprognostic (5.41e-3)"	"unprognostic (5.43e-3)"	"unprognostic (5.35e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-3)"	"unprognostic (5.38e-2)"	"prognostic unfavourable (2.76e-4)"	"unprognostic (1.51e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.28e-2)"	"unprognostic (9.43e-3)"	9.6	5.6	5.7	9.8	17.3	16.3	12.8	3.3	23.6	8.0	14.7	5.5	5.6	13.6	7.3	15.7	9.5	13.2	7.0	16.9	12.5	6.8	13.7	11.1	11.2	13.4	6.2	13.7	11.0	7.3	12.8	14.1	7.7	14.9	8.3	10.1	9.9	19.3	5.2	3.9	14.2	15.6	8.6	6.1	17.9	12.7	23.1	4.8	12.5	6.2	4.1	14.9	10.3	9.2	4.5	7.2	36.4	10.9	7.1	11.0	6.7	9.0	4.6	3.9	6.5	0.1	0.0	4.1	2.7	2.4	3.7	6.5	0.4	11.0	9.1	1.8	0.7	2.0	11.3	6.9	9.9	7.8	5.4	4.9	5.3	2.6	1.3	4.1	4.8	0.7	3.0	0.9	0.9	5.5	0.9	13.9	0.5	16.9	7.8	5.4	7.0	5.4	4.0	7.0	13.4	3.2	17.6	2.5	3.2	14.7	6.0	4.5	8.2	1.6	0.1	2.6	3.8	4.8	3.2	8.9	6.8	11.0	7.1	6.4	5.3	9.4	8.9	21.3	7.6	10.9	11.0	4.5	6.2	6.2	7.2	4.1	4.9	5.7	36.4	7.1	10.4	2.3	5.1	6.7	5.7	17.3	3.3	23.6	12.5	6.8	6.2	13.7	14.9	4.8
PCYT1B	"CCT-beta, CTB"	ENSG00000102230	"Phosphate cytidylyltransferase 1, choline, beta"	Q9Y5K3	X	24558087-24672677	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.9;testis: 15.6"	"Cell line enhanced"	"Detected in some"		"AF22: 8.2;CACO-2: 17.6;HEL: 21.6;Hep G2: 9.0;NTERA-2: 9.3;SCLC-21H: 6.4"	"Cancer enhanced"	"Detected in some"		"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.7;neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006367	Uncertain									"HPA006367: AB_1079585"	"unprognostic (4.49e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.88e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.65e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.63e-6)"	"unprognostic (2.62e-4)"	"unprognostic (4.56e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.96e-4)"	0.8	1.1	12.0	1.1	11.4	2.0	1.0	3.1	23.9	1.6	1.1	13.7	2.3	1.3	3.2	1.7	2.8	5.7	1.7	4.2	10.0	6.0	1.0	0.6	2.1	0.6	7.8	10.5	4.0	3.1	0.7	1.4	3.6	10.7	2.3	1.3	2.1	1.0	6.4	0.7	0.7	1.1	6.1	10.3	1.0	0.9	15.6	8.7	0.0	0.6	0.0	0.7	0.9	0.4	0.4	0.5	2.7	0.5	0.6	0.2	1.4	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	17.6	0.0	0.0	4.6	0.0	0.9	3.8	0.0	0.0	0.0	0.1	21.6	0.0	9.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.5	9.3	0.0	0.0	1.1	0.0	0.0	0.0	6.4	5.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.3	0.0	0.5	0.2	0.0	0.0	4.2	0.6	0.2	2.7	0.3	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.4	0.2	0.2	2.2	0.6	0.5	0.5	0.2	1.4	12.0	11.4	3.1	11.3	10.0	6.0	7.8	10.5	10.7	8.7
POLA1	"NSX, p180, POLA"	ENSG00000101868	"DNA polymerase alpha 1, catalytic subunit"	P09884	X	24693919-24996986	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"DNA replication, Host-virus interaction"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002947, CAB012274"	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB012274: , HPA002947: AB_1079652"	"unprognostic (6.92e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.27e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (4.80e-5)"	"unprognostic (1.87e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.48e-2)"	"unprognostic (8.41e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.08e-1)"	10.5	5.5	8.0	15.0	10.2	14.3	10.9	12.0	9.6	10.1	9.7	11.8	5.8	5.7	11.2	7.7	10.2	8.9	5.5	9.3	7.8	6.6	6.1	4.9	7.2	12.7	10.3	4.5	12.9	7.3	8.5	8.5	10.7	8.7	7.3	11.0	7.5	7.9	9.3	22.4	9.3	7.5	9.7	13.1	9.0	7.9	5.7	10.0	30.1	7.0	8.5	14.7	9.9	10.6	4.6	2.5	1.2	4.6	2.7	3.8	1.7	14.0	10.5	13.9	11.2	2.6	3.1	3.1	10.5	5.8	11.3	13.0	8.7	7.4	18.0	3.6	4.5	11.6	26.4	8.5	15.3	9.3	11.2	13.4	20.5	6.5	1.1	17.5	7.2	2.0	1.8	14.1	4.1	5.8	12.3	9.2	7.8	9.8	19.0	5.9	13.5	8.8	17.1	36.5	13.6	4.1	9.3	12.6	7.8	12.4	5.9	5.6	11.6	5.8	4.6	10.0	6.9	19.1	10.0	5.5	7.9	14.5	5.8	8.3	11.1	0.0	2.0	1.2	3.0	4.6	2.9	4.6	3.4	3.8	2.5	3.2	2.4	2.4	0.6	2.7	1.3	1.6	3.6	1.7	8.0	10.2	12.0	9.6	7.8	6.6	10.3	4.5	8.7	10.0
ARX	"CT121, EIEE1, ISSX, MRX29, MRX32, MRX33, MRX36, MRX38, MRX43, MRX54, MRX76, MRX87, MRXS1, PRTS"	ENSG00000004848	"Aristaless related homeobox"	Q96QS3	X	25003694-25016420	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation, Epilepsy, Lissencephaly, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 25.2;ovary: 58.7;skeletal muscle: 16.9"	"Cell line enhanced"	"Detected in some"		"HAP1: 2.9;PC-3: 6.0;THP-1: 2.5;U-266/70: 12.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 9.5;basal ganglia: 6.7;cerebral cortex: 25.2;hippocampal formation: 10.4;olfactory region: 17.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (8.28e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (3.54e-7)"	"unprognostic (9.85e-2)"	"unprognostic (7.96e-3)"		"unprognostic (1.18e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-6)"	"unprognostic (6.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.91e-1)"	0.5	0.5	9.5	0.5	6.7	0.5	0.7	0.3	25.2	0.5	1.1	1.9	0.0	2.9	0.5	1.8	0.5	1.1	0.5	0.5	10.4	2.6	0.6	0.5	0.8	0.5	0.9	17.1	58.7	2.7	4.4	0.5	0.5	0.0	0.7	1.1	0.0	0.5	0.5	16.9	0.5	1.0	0.5	0.3	0.6	4.9	13.6	3.1	0.0	0.5	0.5	0.8	0.5	0.5	0.0	0.1	0.6	0.4	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	2.9	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	6.0	0.6	0.0	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.1	0.5	2.5	0.0	0.0	0.2	0.0	0.0	12.8	0.4	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	9.5	6.7	0.3	25.2	10.4	2.6	0.9	17.1	0.0	3.1
MAGEB18	MGC33889	ENSG00000176774	"MAGE family member B18"	Q96M61	X	26138343-26140735	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	12	"testis: 4.2"	"Cell line enriched"	"Detected in single"	29	"Karpas-707: 9.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA046141	Enhanced									"HPA046141: AB_2679554"															"unprognostic (1.66e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2			0.0		0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0										
MAGEB6B	MAGEB6P1	ENSG00000232030	"MAGE family member B6B"		X	26160601-26161824	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	34	"testis: 3.3"	"Cell line enhanced"	"Detected in some"		"K-562: 2.3;U-2197: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	3.3			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MAGEB6	"CT3.4, FLJ40242, MAGE-B6, MAGEB6A"	ENSG00000176746	"MAGE family member B6"	Q8N7X4	X	26192440-26195646	"Cancer-related genes, Predicted intracellular proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	87	"testis: 8.6"	"Cell line enriched"	"Detected in single"	10	"K-562: 9.8"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA041853, HPA076711"	Enhanced									"HPA041853: AB_10796785, HPA076711: "									"unprognostic (2.05e-1)"						"unprognostic (1.31e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MAGEB5	"CT3.3, MAGE-B5"	ENSG00000188408	"MAGE family member B5"	Q9BZ81	X	26216169-26218270	"Cancer-related genes, Predicted intracellular proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	10	"testis: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA052627	Uncertain									"HPA052627: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PPP4R3C	"FLFL3P, FLJ32867, PPP4R3CP, SMEK3P, smk1"	ENSG00000224960	"Protein phosphatase 4 regulatory subunit 3C"	Q6ZMV5	X	27460211-27463341	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"testis: 6.6"	"Cell line enriched"	"Detected in single"	148	"U-2197: 21.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.6;testis cancer: 0.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"																												"unprognostic (8.74e-2)"			0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.7		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	6.6			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DCAF8L2	WDR42C	ENSG00000189186	"DDB1 and CUL4 associated factor 8 like 2"	P0C7V8	X	27590382-27748821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	50	"testis: 35.0"	"Cell line enriched"	"Detected in some"	6	"U-2 OS: 14.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																														"unprognostic (2.88e-1)"	"unprognostic (1.13e-1)"					"unprognostic (5.60e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.5	2.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEB10	FLJ32965	ENSG00000177689	"MAGE family member B10"	Q96LZ2	X	27807990-27823014	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 1.9;testis: 7.1"	"Cell line enhanced"	"Detected in some"		"U-2 OS: 4.1"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"							"Not detected"	"Not detected"			HPA000611	Uncertain									"HPA000611: AB_2138307"															"unprognostic (2.77e-1)"			0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0		0.1	0.0	0.0	0.0	0.0		0.0	0.0		0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	7.1			0.0		0.0	0.1	0.0	0.7	0.5	1.9	0.4	0.6	0.5	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.2	0.5	0.5	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.1	0.9	0.9	0.0	0.0	0.3	0.9	0.2	0.0	0.1	0.1	0.4	1.1	0.8	0.0	0.4	0.3	0.3	0.1	0.1	0.5	0.4	0.7	0.0	0.1	0.2	1.3	0.0	1.1	0.0	0.1	0.2	0.0	0.4	4.1	0.4	0.0	0.3	0.1	0.2	0.3	0.4	0.4	1.9	0.4	0.5	0.4	0.3	0.2	0.3	0.3	0.5	0.1	0.7	0.4	0.3	1.7	0.6	0.3	0.5	0.1	0.0										
DCAF8L1	WDR42B	ENSG00000226372	"DDB1 and CUL4 associated factor 8 like 1"	A6NGE4	X	27977993-27981449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	21	"testis: 8.4"	"Cell line enriched"	"Detected in single"	23	"Karpas-707: 20.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043787	Enhanced									"HPA043787: AB_10961430"															"unprognostic (1.40e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IL1RAPL1	"IL1R8, IL1RAPL, MRX10, MRX21, MRX34, OPHN4, TIGIRR-2"	ENSG00000169306	"Interleukin 1 receptor accessory protein like 1"	Q9NZN1	X	28587399-29956723	"Disease related genes, Plasma proteins, Predicted membrane proteins"		Receptor	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 26.7"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 1.5;SK-MEL-30: 2.0;U-2 OS: 1.9;WM-115: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"																		"unprognostic (2.51e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.25e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.95e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.74e-4)"	"unprognostic (2.29e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.58e-3)"	1.5	1.0	12.9	1.0	21.8	0.9	1.5	6.9	17.2	1.2	1.5	15.0	0.0	1.1	1.2	1.5	1.7	1.0	1.5	2.7	10.9	3.3	1.1	1.8	1.1	1.1	21.7	10.1	2.3	1.2	1.0	1.5	1.6	12.3	2.1	1.5	0.0	1.2	2.1	2.2	0.9	1.7	1.2	9.9	0.9	1.4	1.6	26.7	0.0	1.7	0.0	1.0	2.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.6	0.4	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	1.0	0.1	0.0	0.3	0.0	1.1	0.1	0.0	1.5	0.0	0.0	0.1	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	7.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	21.8	6.9	17.2	10.9	3.3	21.7	10.1	12.3	26.7
MAGEB2	"CT3.2, DAM6, MAGE-XP-2, MGC26438"	ENSG00000099399	"MAGE family member B2"	O15479	X	30215560-30220089	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"testis: 35.8"	"Cell line enhanced"	"Detected in some"		"HL-60: 25.5;K-562: 18.3;Karpas-707: 22.3;U-2 OS: 26.5;U-266/70: 43.8;U-266/84: 45.7"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 33.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.4"	"Low lineage specificity"	"Detected in single"											"HPA065224, HPA074544, HPA075519"	Enhanced		Approved	Cytosol				Cytosol		"HPA065224: , HPA074544: AB_2732258, HPA075519: AB_2732294"					"unprognostic (4.52e-1)"	"unprognostic (2.55e-2)"		"unprognostic (6.39e-2)"	"unprognostic (5.02e-1)"					"unprognostic (6.57e-2)"	"unprognostic (1.79e-2)"		"unprognostic (1.00e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.5	0.0	0.0	0.0	0.0	0.0	0.0	18.3	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	26.5	0.0	0.0	43.8	45.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
MAGEB3	CT3.5	ENSG00000198798	"MAGE family member B3"	O15480	X	30230436-30237492	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"epididymis: 20.5;testis: 7.8"	"Cell line enriched"	"Detected in single"	13	"U-266/70: 6.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			HPA072203	Approved									"HPA072203: "															"unprognostic (3.34e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8			0.0		0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	6.9	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0										
MAGEB4	"CT3.6, MGC33144"	ENSG00000120289	"MAGE family member B4"	O15481	X	30242052-30244193	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	27	"epididymis: 26.3;testis: 18.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA030456	Enhanced									"HPA030456: AB_10602707"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEB1	"CT3.1, DAM10, MAGE-Xp, MAGEL1, MGC9322"	ENSG00000214107	"MAGE family member B1"	P43366	X	30243730-30252038	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	34	"testis: 23.9"	"Group enriched"	"Detected in some"	68	"K-562: 13.4;U-266/70: 30.6;U-266/84: 21.3"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 7.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA001193, HPA002820"	Enhanced									"HPA001193: AB_1079296, HPA002820: AB_1079295"															"unprognostic (1.26e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	30.6	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NR0B1	"AHC, AHCH, DAX1, DSS"	ENSG00000169297	"Nuclear receptor subfamily 0 group B member 1"	P51843	X	30304206-30309598	"Cancer-related genes, Disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Receptor, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"adrenal gland: 23.9;testis: 36.0"	"Group enriched"	"Detected in some"	4	"A549: 34.3;RT4: 10.8"	"Cancer enhanced"	"Detected in many"		"lung cancer: 4.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA061948, HPA067207"			Supported	"Nuclear speckles,Vesicles,Centriolar satellite"				"Nuclear speckles"	"Vesicles, Centriolar satellite"	"HPA061948: , HPA067207: "		"unprognostic (1.50e-2)"			"unprognostic (9.68e-2)"			"unprognostic (9.47e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.81e-1)"	"unprognostic (7.45e-3)"		"unprognostic (4.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.33e-3)"			0.4	23.9	1.0	0.0	0.8	0.0	0.2	0.4	1.1	1.3	0.1	1.7	0.0	0.0	0.4	0.9	0.1	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.1	0.0	0.5	0.6	3.5	2.1	0.0	1.6	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.6	0.1	0.7	36.0	0.7	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.9	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	5.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.4	1.1	0.9	0.9	0.5	0.6	0.6	0.7
CXorf21	FLJ11577	ENSG00000120280	"Chromosome X open reading frame 21"	Q9HAI6	X	30558824-30577844	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.9;bone marrow: 16.0;lymphoid tissue: 16.7"	"Cell line enriched"	"Detected in some"	7	"THP-1: 57.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA001185	Uncertain		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA001185: AB_1078591"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.25e-3)"	"unprognostic (9.07e-3)"	"unprognostic (5.94e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.66e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.23e-2)"	6.5	2.1	4.6	9.8	4.0	16.0	2.0	0.8	4.4	1.4	3.0	2.3	0.2	4.3	1.2	2.4	1.4	1.5	3.6	1.5	5.0	2.1	1.9	2.8	6.1	12.9	6.3	0.0	1.0	2.0	0.7	1.5	2.7	5.1	1.5	3.1	1.1	3.3	0.5	0.8	1.1	5.3	1.8	9.9	16.7	3.1	0.8	5.2	9.1	1.4	1.2	9.3	4.8	1.4	11.1	21.9	14.9	18.9	3.2	1.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	4.7	2.6	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	7.4	0.0	0.0	7.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.8	0.0	0.0	0.0	0.0	0.0	5.4	0.5	2.6	0.0	8.3	0.0	3.4	10.3	11.4	0.8	9.6	0.1	11.1	1.0	0.5	12.0	10.8	1.0	0.7	14.9	3.2	18.9	21.9	1.6	3.5	4.6	4.0	0.8	4.4	5.0	2.1	6.3	0.0	5.1	5.2
GK	"GK1, GKD"	ENSG00000198814	"Glycerol kinase"	P32189	X	30653359-30731456	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.4;intestine: 37.9;kidney: 35.4;liver: 40.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 51.4"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 51.4"									HPA060687	Supported									"HPA060687: "	"unprognostic (8.78e-3)"	"unprognostic (8.41e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.15e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.56e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.58e-2)"	"prognostic favourable (3.24e-9)"	"unprognostic (1.59e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.57e-3)"	"unprognostic (4.11e-3)"	2.8	4.9	2.4	17.0	7.6	1.6	1.8	2.5	4.7	3.0	7.5	2.7	1.5	28.4	2.5	4.0	4.9	2.7	7.9	4.9	4.6	2.6	35.4	40.7	11.7	8.1	3.8	2.5	2.0	1.9	3.2	5.3	2.3	4.1	1.9	3.4	2.9	6.6	0.6	1.4	3.1	37.9	1.9	6.0	6.4	2.0	2.0	2.2	5.4	2.2	3.8	4.5	4.3	1.7	1.7	4.0	51.4	6.6	1.2	3.2	1.6	2.5	2.0	2.7	4.7	1.7	6.4	1.1	6.2	22.1	4.6	5.2	3.3	2.4	7.4	1.0	2.4	0.1	5.0	2.0	6.1	4.7	5.6	4.3	4.2	26.8	10.6	8.0	9.4	3.9	3.1	14.5	13.8	3.6	2.3	10.5	1.2	3.7	6.2	8.6	4.5	2.4	8.6	4.2	7.6	3.4	8.7	2.9	3.6	5.5	5.6	12.3	6.4	5.8	1.4	3.3	1.4	0.1	2.8	5.5	5.9	7.2	5.8	5.3	3.3	1.3	6.6	2.2	0.5	2.0	0.4	0.8	0.9	0.6	4.0	1.7	0.5	0.6	51.4	1.2	2.4	1.2	3.2	1.6	2.4	7.6	2.5	4.7	4.6	2.6	3.8	2.5	4.1	2.2
TAB3	MAP3K7IP3	ENSG00000157625	"TGF-beta activated kinase 1 and MAP3K7 binding protein 3"	Q8N5C8	X	30827442-30975084	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 3.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034980, HPA034981"	Approved		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"HPA034980: AB_10602708, HPA034981: "	"unprognostic (4.39e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.35e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.51e-1)"	"prognostic favourable (8.45e-4)"	"unprognostic (5.91e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.75e-1)"	6.1	8.0	5.9	6.6	6.9	10.1	6.5	9.1	9.2	7.6	6.5	4.2	17.9	5.2	40.3	7.4	13.2	9.2	10.6	6.9	6.1	5.3	16.9	23.3	8.0	8.1	6.7	6.6	11.3	17.3	25.0	9.4	39.3	9.1	12.9	6.7	9.3	11.5	15.0	8.8	8.1	7.4	9.6	5.2	7.1	8.4	26.7	3.6	8.3	7.7	14.5	15.6	6.6	7.9	1.0	0.6	0.8	1.1	3.9	1.0	0.4	22.8	5.5	5.7	5.8	4.4	6.7	6.0	7.0	8.9	4.8	5.4	6.2	19.6	10.4	4.3	8.2	11.9	8.7	18.1	7.0	17.7	8.4	9.7	6.4	15.1	3.9	10.1	7.5	4.8	10.9	8.2	21.0	7.9	11.0	8.5	6.2	11.0	8.0	5.1	6.8	9.3	5.2	10.0	7.7	8.0	6.7	4.7	6.7	7.9	12.0	15.3	10.3	4.1	7.6	5.3	7.8	26.6	6.5	11.1	8.4	10.3	8.3	4.8	7.4	0.2	0.5	0.8	0.7	1.1	0.9	0.8	1.0	0.4	0.6	1.0	1.0	1.0	0.8	3.9	0.8	0.3	0.6	0.4	5.9	6.9	9.1	9.2	6.1	5.3	6.7	6.6	9.1	3.6
FTHL17	CT38	ENSG00000132446	"Ferritin heavy chain like 17"	Q9BXU8	X	31071241-31072053	"Predicted intracellular proteins"	"Iron storage"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	17	"testis: 12.7"	"Group enriched"	"Detected in some"	14	"hTERT-HME1: 1.4;T-47d: 1.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																				"unprognostic (5.67e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DMD	"BMD, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272, MRX85"	ENSG00000198947	Dystrophin	P11532	X	31097677-33339441	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cancer-related genes, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 16.1;Hep G2: 14.7;RH-30: 20.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 2.6;naive B-cell: 4.9;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	18	"B-cells: 4.9;dendritic cells: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000119, HPA002725, HPA023885"	Enhanced									"CAB000119: , HPA002725: AB_1078714, HPA023885: AB_1847931"	"unprognostic (3.91e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-4)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.84e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.82e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.51e-2)"	19.8	11.8	12.5	11.6	11.1	0.7	11.8	15.6	11.6	18.9	25.6	6.8	30.3	4.5	22.2	10.0	13.1	12.5	22.3	27.5	10.0	7.6	4.4	36.2	5.9	3.7	8.5	9.8	11.7	34.5	4.9	4.1	10.3	7.8	14.5	6.8	10.7	19.7	31.6	57.7	8.5	7.4	48.2	6.1	1.9	11.9	4.6	7.4	0.0	6.2	34.5	4.7	32.6	7.9	4.9	1.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	16.1	0.0	0.1	0.1	4.8	3.2	0.3	1.7	1.9	8.0	0.0	0.2	0.0	8.8	5.4	6.4	8.2	2.7	4.7	5.1	0.2	7.3	14.7	9.3	0.0	1.5	2.1	6.0	3.0	11.3	4.3	0.6	0.1	4.6	0.3	2.5	0.0	8.1	7.4	0.1	20.3	0.0	0.1	1.3	0.3	4.5	0.0	1.2	2.3	1.1	0.0	0.5	0.1	0.0	0.2	3.3	0.1	6.6	0.3	0.4	0.0	8.8	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.1	0.0	0.7	4.9	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	12.5	11.1	15.6	11.6	10.0	7.6	8.5	9.8	7.8	7.4
FAM47A	MGC27003	ENSG00000185448	"Family with sequence similarity 47 member A"	Q5JRC9	X	34129756-34132314	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	127	"testis: 12.7"	"Group enriched"	"Detected in some"	7	"REH: 1.4;U-266/84: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA000610	Uncertain									"HPA000610: AB_1078805"															"unprognostic (1.68e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM47	"BCMP1, DKFZp564E153, DKFZP761J17121, TM4SF10, VAB-9"	ENSG00000147027	"Transmembrane protein 47"	Q9BQJ4	X	34627064-34657288	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 27.0;fHDF/TERT166: 82.8;RPTEC TERT1: 20.4;U-2197: 18.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046658	Approved		Approved	"Nuclear membrane"				"Nuclear membrane"		"HPA046658: "	"unprognostic (1.50e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.74e-3)"	"unprognostic (7.29e-2)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (1.67e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.36e-1)"	"prognostic favourable (4.05e-6)"	"unprognostic (2.69e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.94e-2)"	19.7	11.3	22.3	4.3	28.3	0.0	19.0	8.1	18.5	26.7	13.7	15.0	7.6	4.5	24.8	18.7	19.2	19.5	15.4	18.4	24.1	17.2	15.0	12.8	11.7	2.9	10.5	9.5	15.3	5.9	2.0	4.5	0.6	14.0	18.4	8.1	19.0	17.1	26.0	11.8	3.6	6.3	29.9	6.9	3.7	8.5	7.0	15.7	0.3	10.9	4.8	2.1	21.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	12.3	5.1	10.9	8.3	0.0	27.0	0.0	5.3	4.6	0.0	0.0	0.0	2.2	82.8	0.0	3.5	0.9	7.9	0.0	2.3	0.0	3.4	0.0	6.3	0.0	0.0	7.5	0.0	2.1	2.4	5.9	0.0	0.0	10.0	0.2	0.0	0.0	1.4	0.0	0.0	6.2	0.0	20.4	7.8	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	10.9	1.1	18.1	1.1	0.0	0.0	0.0	4.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	28.3	8.1	12.4	24.1	17.2	10.5	9.5	14.0	15.7
FAM47B	FLJ35782	ENSG00000189132	"Family with sequence similarity 47 member B"	Q8NA70	X	34942796-34944915	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	44	"testis: 18.8"	"Cell line enhanced"	"Detected in single"		"U-138 MG: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046829, HPA050996"	Uncertain									"HPA046829: , HPA050996: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEB16		ENSG00000189023	"MAGE family member B16"	A2A368	X	35798342-35803735	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	44	"testis: 9.0"	"Cell line enriched"	"Detected in some"	5	"U-266/70: 36.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA055743, HPA076456"	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA055743: , HPA076456: "															"unprognostic (2.12e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CFAP47	"CHDC2, CXorf22, CXorf30, CXorf59, FLJ36601, MGC34831, RP13-11B7.1"	ENSG00000165164	"Cilia and flagella associated protein 47"	Q6ZTR5	X	35919734-36385319	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.4;fallopian tube: 12.8;pituitary gland: 24.5"	"Group enriched"	"Detected in some"	7	"Karpas-707: 4.1;U-266/70: 7.7"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044633, HPA054859"	Uncertain									"HPA044633: AB_10960684, HPA054859: "	"unprognostic (1.88e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.50e-5)"	"unprognostic (2.69e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.48e-2)"	"unprognostic (5.19e-3)"	0.3	0.3	2.0	0.2	5.9	0.2	0.3	0.3	1.2	0.9	0.3	6.2	1.2	0.2	0.7	7.0	0.3	12.8	0.2	0.3	3.7	1.3	0.4	0.5	3.7	0.2	1.2	1.5	5.3	0.3	2.3	24.5	0.3	12.4	0.3	0.2	2.0	0.3	0.3	0.3	0.3	0.3	0.2	1.1	0.3	0.3	2.1	2.7	0.0	1.0	0.0	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	4.1	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	5.9	0.3	1.2	3.7	1.3	1.2	1.5	12.4	2.7
FAM47C		ENSG00000198173	"Family with sequence similarity 47 member C"	Q5HY64	X	37008397-37011666	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	22	"testis: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																				"unprognostic (8.69e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.3	0.3	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.9			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PRRG1	PRGP1	ENSG00000130962	"Proline rich and Gla domain 1"	O14668	X	37349275-37457295	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.4"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 38.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078129			Approved	"Nucleoplasm,Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"	Nucleoplasm	"HPA078129: "	"unprognostic (8.82e-2)"	"prognostic unfavourable (4.65e-4)"	"unprognostic (8.34e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.24e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavourable (1.22e-4)"	"unprognostic (8.21e-2)"	"prognostic favourable (2.05e-7)"	"unprognostic (1.43e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.48e-1)"	11.6	5.5	12.0	3.1	22.0	0.7	5.8	2.6	18.7	6.7	5.7	35.9	4.6	4.1	6.2	2.5	5.9	4.0	12.4	8.5	17.9	10.7	14.9	10.7	6.3	2.5	31.0	9.9	6.2	2.6	1.2	2.3	10.6	21.3	5.1	6.0	3.0	3.9	11.6	19.3	3.1	4.3	7.5	43.4	4.0	3.4	2.4	23.7	0.0	11.6	2.9	1.6	5.9	4.5	0.6	0.2	2.6	1.7	0.2	0.4	0.1	14.7	3.4	2.7	2.7	9.2	7.5	1.2	6.2	8.4	2.3	4.0	8.1	9.5	0.0	10.9	4.9	4.8	7.4	4.7	3.9	0.0	2.4	2.6	3.5	2.7	11.3	0.0	3.4	11.6	4.0	4.4	3.7	11.7	1.2	0.0	7.8	1.1	0.0	0.0	3.3	7.0	0.0	6.1	0.0	38.6	0.7	0.0	0.0	4.6	7.3	2.8	0.0	1.6	8.3	3.5	2.1	6.8	1.9	0.0	0.0	0.0	3.5	0.0	3.3	2.6	1.7	0.1	0.2	0.5	0.2	0.6	0.1	0.3	0.1	0.4	0.2	0.4	0.8	0.2	0.2	0.2	0.2	0.1	12.0	22.0	2.6	13.9	17.9	10.7	31.0	9.9	21.3	23.7
AF241726.2		ENSG00000250349			X	37349330-38687674	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in many"	4	"brain: 17.4;skeletal muscle: 16.5"	"Cell line enhanced"	"Detected in some"		"A-431: 1.3;CACO-2: 2.0;HDLM-2: 1.7;HEK 293: 2.0;MOLT-4: 1.2;SCLC-21H: 1.5;U-266/70: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA003140	Uncertain									"HPA003140: AB_1078454"																		2.7	1.9	3.3	1.7	10.2	1.8	1.9	2.1	6.1	1.7	1.9	17.4	1.3	1.7	1.7	1.7	1.8	1.7	1.7	2.1	3.7	1.9	2.2	2.0	2.1	1.7	14.9	4.1	1.9	1.8	1.7	1.7	3.7	9.9	1.8	1.7	0.6	1.8	1.7	16.5	1.8	1.8	1.7	12.2	1.9	1.7	1.7	11.1	0.0	2.0	0.5	1.7	1.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.7	2.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.4	0.0	0.0	0.4	0.3	0.0	0.4	0.0	1.2	0.1	0.0	0.0	0.5	0.4	0.0	0.5	0.0	1.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.3	10.2	2.1	6.1	3.7	1.9	14.9	4.1	9.9	11.1
LANCL3	FLJ42925	ENSG00000147036	"LanC like 3"	Q6ZV70	X	37571569-37684463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 7.1;lung: 6.8"	"Cell line enhanced"	"Detected in some"		"HEL: 16.8;HMC-1: 5.5;K-562: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 7.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005470, HPA076575"	Approved		Approved	Mitochondria				Mitochondria		"HPA005470: AB_2134886, HPA076575: "	"unprognostic (6.76e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.26e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.90e-5)"	"unprognostic (4.01e-3)"	"unprognostic (7.93e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.08e-2)"	1.2	0.8	0.7	0.3	2.3	0.9	0.4	2.5	2.4	1.2	3.8	0.7	0.2	0.6	0.5	0.3	4.6	0.2	0.9	0.7	1.1	2.8	0.4	0.2	6.8	0.4	1.3	1.3	1.3	0.2	0.1	1.7	0.2	2.2	0.6	2.8	2.5	1.1	0.9	1.0	2.6	1.1	1.9	1.8	0.2	2.2	1.8	0.9	0.2	1.2	1.7	1.2	1.8	2.9	0.3	0.2	7.1	0.2	1.1	1.8	0.7	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	1.1	2.4	0.3	0.0	0.0	0.3	16.8	1.7	0.0	0.0	0.0	5.5	0.0	0.4	0.0	0.1	0.3	3.8	0.0	1.2	0.0	0.2	0.3	0.4	1.7	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.2	0.0	0.0	1.5	0.7	0.0	0.0	2.8	0.0	0.4	7.1	0.2	0.9	1.0	0.2	0.8	0.2	0.4	1.8	0.1	0.3	0.1	1.0	1.1	1.1	0.2	0.2	0.6	0.7	0.7	2.3	2.5	2.4	1.1	2.8	1.3	1.3	2.2	0.9
XK	"Kx, NA, NAC, X1k, XKR1"	ENSG00000047597	"X-linked Kx blood group"	P51811	X	37685756-37732130	"Blood group antigen proteins, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"	"Blood group antigen"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.6"	"Cell line enhanced"	"Detected in many"		"HEL: 24.7;HL-60: 12.7;K-562: 15.9;NB-4: 11.7;RPMI-8226: 11.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	40	"basophil: 9.4;eosinophil: 6.8"	"Lineage enriched"	"Detected in single"	94	"granulocytes: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019036	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria				Mitochondria	"Nucleoplasm, Vesicles"	"HPA019036: AB_1846286"	"unprognostic (2.37e-2)"	"unprognostic (7.13e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.00e-2)"	"unprognostic (7.97e-2)"	"unprognostic (4.56e-1)"	"unprognostic (3.59e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (5.90e-2)"	"unprognostic (4.44e-8)"	"unprognostic (1.74e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.43e-1)"	0.6	2.9	4.9	3.0	5.1	14.0	1.1	10.2	8.3	1.8	16.5	1.2	0.0	12.9	1.2	0.8	2.7	4.8	2.0	8.1	4.7	6.6	1.4	2.1	1.5	0.7	3.0	5.9	1.2	7.9	2.2	3.8	1.4	4.4	2.1	13.8	1.0	8.6	1.5	5.9	1.2	23.6	3.2	1.6	1.2	13.3	3.5	0.2	0.1	1.4	5.9	0.8	2.9	2.5	0.0	0.0	9.4	0.0	0.0	0.0	0.7	9.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	8.2	0.1	0.0	1.5	8.8	0.0	0.0	0.0	2.4	24.7	1.4	0.0	0.0	12.7	2.0	0.0	0.4	0.0	0.0	0.0	15.9	6.3	0.0	0.9	0.1	11.7	3.1	3.2	0.0	0.0	11.2	0.0	0.6	2.3	0.0	0.4	0.8	0.0	1.2	3.1	0.0	0.0	0.4	0.0	1.3	5.4	8.9	0.0	0.1	6.8	0.0	9.4	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	4.9	5.1	10.2	8.3	4.7	6.6	3.0	5.9	4.4	0.2
CYBB	"CGD, GP91-PHOX, NOX2"	ENSG00000165168	"Cytochrome b-245 beta chain"	P04839	X	37780011-37813461	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"	"Chronic granulomatous disease, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.3;lung: 49.4;lymphoid tissue: 74.5"	"Group enriched"	"Detected in some"	5	"Daudi: 16.1;NB-4: 19.4;REH: 16.5;RPMI-8226: 63.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 50.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA051227	Enhanced						640000			"HPA051227: "	"unprognostic (5.83e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.32e-2)"	"unprognostic (5.73e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.72e-2)"	16.4	11.0	9.7	44.2	13.2	42.6	8.1	2.5	6.7	3.7	6.0	10.4	0.2	5.2	3.4	6.3	3.2	6.0	7.5	10.1	6.8	6.5	6.2	11.8	49.4	74.5	12.6	2.9	5.3	4.5	1.4	4.9	16.1	10.3	4.8	8.9	4.5	6.0	2.7	2.5	2.2	16.1	15.3	20.3	49.9	4.9	2.3	10.3	5.4	3.4	3.5	20.2	13.9	3.1	8.1	17.5	20.0	50.3	0.1	0.1	22.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	16.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	1.1	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	19.4	0.0	0.1	16.5	0.0	63.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.0	0.0	2.7	0.0	0.3	45.5	20.0	0.0	50.3	0.1	8.1	0.0	0.0	12.1	7.2	0.0	0.0	3.7	0.1	42.7	17.5	0.1	22.0	9.7	13.2	2.5	6.7	6.8	6.5	12.6	2.9	10.3	10.3
DYNLT3	"TCTE1L, TCTEX1L"	ENSG00000165169	"Dynein light chain Tctex-type 3"	P51808	X	37836757-37847637	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003938	Approved									"HPA003938: AB_1847920"	"unprognostic (1.27e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.00e-1)"	"unprognostic (7.62e-2)"	"prognostic unfavourable (4.77e-4)"	"unprognostic (1.13e-1)"	"unprognostic (5.15e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.69e-2)"	15.8	36.2	20.5	9.7	24.7	14.4	14.5	16.8	37.8	20.7	12.3	6.6	10.9	7.0	19.5	15.5	37.1	10.2	21.9	17.5	29.1	35.3	29.2	25.1	14.1	7.6	29.9	23.6	14.9	8.0	22.1	28.5	22.5	60.3	16.3	13.2	11.2	11.5	17.1	7.0	6.7	8.2	21.6	17.2	10.0	13.2	14.3	10.7	5.7	15.5	18.5	12.0	19.9	16.9	11.1	4.6	10.8	8.7	9.9	23.9	8.9	16.2	4.8	0.5	0.0	21.0	24.4	2.6	11.2	12.2	6.2	10.4	8.9	8.8	5.9	5.5	22.5	6.5	7.0	9.5	12.5	9.7	8.1	4.7	23.3	4.7	10.5	0.0	3.4	10.6	13.6	15.3	6.8	19.3	2.3	8.5	28.8	5.3	0.1	7.1	2.9	24.3	8.1	0.0	9.4	11.4	12.0	11.0	4.6	20.4	4.2	32.4	5.1	4.8	10.3	13.2	7.1	15.2	12.5	5.7	5.1	6.7	31.7	7.5	16.2	10.8	6.0	4.3	11.6	8.7	23.9	11.1	16.3	15.2	4.0	8.0	14.3	13.7	4.9	9.9	5.2	4.6	8.9	8.9	20.5	24.7	16.8	37.8	29.1	35.3	29.9	23.6	60.3	10.7
HYPM	"CXorf27, HIP17"	ENSG00000187516	"Huntingtin interacting protein M"	O75409	X	37990817-37991317	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	110	"testis: 28.3"	"Cell line enriched"	"Detected in single"	4	"NTERA-2: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA003356	Enhanced									"HPA003356: AB_1078593"															"unprognostic (2.99e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
SYTL5		ENSG00000147041	"Synaptotagmin like 5"	Q8TDW5	X	38006582-38128819	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 17.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.8;MCF7: 6.3;SK-MEL-30: 16.4;U-2 OS: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	19	"non-classical monocyte: 1.8"	"Lineage enriched"	"Detected in single"	19	"monocytes: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA026074	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol				Nucleoplasm	"Microtubules, Cytosol"	"HPA026074: AB_1857697"	"unprognostic (3.60e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.96e-2)"	0.5	6.0	10.5	3.4	11.0	0.0	2.9	0.5	2.5	7.0	7.3	0.5	0.5	2.3	2.6	1.0	12.2	0.2	2.9	0.9	9.2	8.9	1.0	6.1	2.4	0.5	2.4	0.5	0.5	6.4	0.0	1.1	17.0	0.5	2.0	3.5	1.5	7.1	1.7	0.5	0.0	14.3	3.9	1.3	0.8	13.8	0.7	0.5	0.7	0.9	1.2	5.9	1.3	0.5	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	6.8	1.6	0.0	0.0	0.6	0.7	0.0	0.0	0.1	0.0	0.7	0.0	3.4	0.0	0.0	0.0	0.0	0.1	0.5	0.7	0.0	0.1	0.1	0.2	0.3	6.3	0.0	0.0	2.9	0.0	0.0	2.3	0.0	0.0	0.4	3.6	0.1	0.3	1.4	16.4	0.0	0.0	0.0	0.2	5.5	0.0	3.6	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	10.5	11.0	0.5	2.5	9.2	8.9	2.4	0.5	0.5	0.5
SRPX	ETX1	ENSG00000101955	"Sushi repeat containing protein, X-linked"	P78539	X	38149336-38220924	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 82.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 278.5;ASC TERT1: 62.2;HSkMC: 93.6;HUVEC TERT2: 57.7"	"Group enriched"	"Detected in all"	6	"glioma: 64.2;melanoma: 70.1;pancreatic cancer: 14.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	56	"plasmacytoid DC: 10.5"	"Lineage enriched"	"Detected in single"	56	"dendritic cells: 10.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"		310000				"unprognostic (2.35e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-3)"	"prognostic unfavourable (1.18e-4)"	"unprognostic (6.48e-2)"	"unprognostic (3.83e-3)"	"unprognostic (3.50e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavourable (7.80e-13)"	"unprognostic (6.94e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavourable (3.36e-4)"	56.2	11.9	2.2	8.5	5.0	0.0	82.4	6.6	4.8	14.1	23.1	7.7	10.1	3.1	17.7	35.5	15.1	37.1	23.3	28.9	5.3	2.9	4.1	6.6	14.2	27.7	9.6	1.9	11.6	7.8	1.4	1.5	34.1	13.4	22.1	10.2	4.7	9.5	6.6	9.9	8.7	14.4	27.8	18.9	0.6	13.3	14.9	7.3	0.9	17.8	5.3	5.1	29.6	54.6	0.0	10.5	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.8	0.0	278.5	62.2	0.0	2.5	4.8	0.8	1.4	0.0	0.2	0.0	0.0	5.2	0.1	0.1	2.2	0.7	0.0	0.9	0.0	0.0	0.0	12.5	0.2	0.0	93.6	0.1	8.3	4.2	57.7	0.0	0.0	9.3	0.1	0.0	0.0	0.7	1.8	0.0	3.1	0.4	0.0	0.1	0.1	0.1	0.1	0.0	11.6	0.0	0.0	24.8	6.0	3.1	7.8	7.2	0.0	0.0	0.0	17.5	0.2	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.5	0.0	0.1	2.2	5.0	6.6	3.2	5.3	2.9	9.6	1.9	13.4	7.3
RPGR	"COD1, CORDX1, CRD, RP15, RP3"	ENSG00000156313	"Retinitis pigmentosa GTPase regulator"	Q92834	X	38269163-38327564	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation, Sensory transduction, Vision"	"Guanine-nucleotide releasing factor"	"Cancer-related genes, Ciliopathy, Cone-rod dystrophy, Deafness, Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 55.4"	"Cell line enhanced"	"Detected in many"		"HL-60: 22.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 15.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 15.3"									"HPA001593, HPA073455"	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA001593: AB_1079835, HPA073455: "	"unprognostic (3.22e-2)"	"unprognostic (1.16e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.94e-2)"	"unprognostic (3.46e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.03e-6)"	"unprognostic (1.93e-1)"	"unprognostic (7.59e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.61e-3)"	16.4	5.9	6.1	7.1	9.0	17.4	13.8	7.2	7.0	8.3	8.4	7.1	2.5	5.1	8.8	9.4	5.4	20.8	9.4	6.3	7.2	9.4	4.9	4.9	10.7	7.8	8.9	4.2	7.9	7.2	3.8	55.4	6.3	14.6	5.9	6.4	6.3	3.7	4.8	13.3	4.3	6.2	8.3	9.9	5.1	4.9	11.6	5.7	5.8	8.3	3.6	5.4	7.7	10.9	1.9	2.6	15.3	2.6	1.6	3.1	1.7	3.3	4.4	2.5	2.3	2.9	4.1	1.9	4.2	4.9	3.1	3.6	1.9	1.7	4.9	1.4	2.7	3.2	3.0	1.3	4.3	5.2	5.5	1.8	2.1	3.9	2.6	22.5	4.3	5.9	1.8	6.2	7.0	14.1	2.3	0.0	4.2	1.3	6.6	12.6	6.5	5.6	4.9	8.6	4.6	2.7	2.2	1.9	3.7	4.6	1.9	5.0	1.2	3.9	16.4	3.4	6.0	8.0	5.0	1.4	2.7	4.3	8.0	4.4	4.6	1.4	2.6	5.7	1.4	2.3	3.1	1.9	1.7	1.8	2.6	1.8	2.5	2.0	15.3	1.6	1.8	1.8	1.9	1.7	6.1	9.0	7.2	7.0	7.2	9.4	8.9	4.2	14.6	5.7
OTC		ENSG00000036473	"Ornithine carbamoyltransferase"	P00480	X	38352545-38421450	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"intestine: 59.1;liver: 90.3"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.8;RPMI-8226: 1.0;SH-SY5Y: 1.1;SiHa: 1.8"	"Cancer enriched"	"Detected in some"	20	"liver cancer: 59.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA000243, HPA000570"	Enhanced		Supported	Mitochondria			1800000	Mitochondria		"HPA000243: AB_1079535, HPA000570: AB_1079534"			"unprognostic (6.93e-2)"		"unprognostic (2.48e-1)"		"unprognostic (1.89e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.19e-2)"			"unprognostic (7.70e-3)"	"unprognostic (5.61e-2)"			0.4	0.1	0.1	0.4	0.2	0.0	0.2	0.1	0.1	0.8	16.5	0.0	0.2	26.9	1.1	0.2	0.2	0.3	5.3	0.2	0.1	0.2	0.1	90.3	0.7	2.3	0.2	0.0	0.2	0.8	0.0	0.1	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.1	0.1	59.1	0.8	0.3	0.1	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.6	1.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.0
TSPAN7	"A15, CD231, DXS1692E, MRX58, MXS1, TALLA-1, TM4SF2"	ENSG00000156298	"Tetraspanin 7"	P41732	X	38561370-38688920	"CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 131.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 13.3;Hep G2: 10.6;MOLT-4: 55.3;SCLC-21H: 31.0;U-266/70: 20.5"	"Cancer enhanced"	"Detected in all"		"glioma: 71.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 2.9"	"Low lineage specificity"	"Detected in single"											"HPA003140, CAB062566, CAB068245"	Enhanced									"CAB062566: , CAB068245: , HPA003140: AB_1078454"	"unprognostic (1.12e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (3.40e-4)"	"unprognostic (5.06e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.88e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.01e-2)"	"prognostic favourable (1.70e-4)"	"unprognostic (1.54e-1)"	"prognostic favourable (5.48e-7)"	"unprognostic (5.65e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-3)"	15.2	28.7	39.6	3.5	83.0	0.8	7.3	83.8	131.1	12.4	18.5	11.5	2.3	7.9	11.6	9.2	7.9	10.5	5.8	17.1	34.5	30.7	15.8	12.0	16.2	8.8	19.4	37.7	5.2	4.4	4.1	11.4	6.6	23.8	5.6	17.3	8.1	3.3	7.4	17.9	4.9	7.8	14.5	11.9	21.3	4.6	1.7	9.5	0.0	11.8	5.4	8.2	8.2	4.2	0.9	0.5	0.3	0.2	0.3	2.9	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.9	0.3	0.0	13.3	2.5	0.0	0.0	10.6	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	55.3	0.0	2.9	0.0	2.7	1.1	0.0	1.4	0.2	31.0	3.2	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.7	0.0	0.2	20.5	5.8	0.0	1.3	0.1	0.4	0.2	0.1	0.0	0.6	0.2	0.7	0.4	1.1	2.9	0.1	0.9	2.1	1.8	0.3	0.3	0.0	0.5	0.0	0.1	39.6	83.0	83.8	86.3	34.5	30.7	19.4	37.7	23.8	9.5
MID1IP1	"FLJ10386, G12-like, MIG12, STRAIT11499, THRSPL"	ENSG00000165175	"MID1 interacting protein 1"	Q9NPA3	X	38801432-38806537	"Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 69.2;skeletal muscle: 86.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 3.7;eosinophil: 14.0;neutrophil: 8.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038816	Uncertain									"HPA038816: AB_10670908"	"unprognostic (5.35e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.08e-2)"	"prognostic unfavourable (2.20e-4)"	"unprognostic (2.62e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.31e-3)"	"prognostic favourable (1.15e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.18e-2)"	"prognostic favourable (8.06e-4)"	20.3	9.3	26.9	9.4	59.5	58.4	8.9	5.4	33.3	5.0	9.3	33.7	7.2	11.6	5.5	5.9	7.7	8.7	5.6	6.7	29.1	21.0	8.9	13.9	21.9	7.2	69.2	12.3	13.1	30.6	3.6	3.6	6.5	42.3	8.7	4.3	5.1	7.7	10.3	86.1	6.2	8.7	7.0	31.6	5.8	19.7	9.7	62.9	3.0	4.0	7.1	4.7	9.4	10.5	0.7	1.3	14.0	1.8	0.8	1.5	0.8	18.1	16.8	4.5	3.5	21.4	10.1	4.9	10.3	7.1	2.2	4.2	5.5	13.9	17.7	9.1	3.2	17.1	14.7	12.0	1.4	12.1	5.8	15.1	14.6	4.4	16.3	7.0	11.6	14.8	9.7	8.6	7.5	2.2	13.9	19.3	3.1	15.0	12.2	19.1	15.6	29.9	33.7	5.6	34.8	5.7	9.0	10.9	13.1	5.4	10.6	26.5	8.8	21.5	3.1	6.4	7.2	8.0	7.5	49.5	19.0	16.2	19.5	11.5	7.0	3.7	1.8	14.0	1.0	1.3	1.1	0.5	1.5	1.0	1.3	0.7	1.4	1.3	8.2	0.8	1.8	1.3	0.5	0.8	26.9	59.5	5.4	33.3	29.1	21.0	69.2	12.3	42.3	62.9
BCOR	"FLJ20285, KIAA1575"	ENSG00000183337	"BCL6 corepressor"	Q6W2J9	X	40049815-40177329	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA056308, HPA073591"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA056308: , HPA073591: "	"unprognostic (2.75e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.45e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.80e-3)"	"prognostic unfavourable (1.30e-5)"	"unprognostic (3.82e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.91e-3)"	"unprognostic (6.83e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.55e-1)"	9.1	12.8	8.7	8.7	10.5	20.6	13.3	11.5	12.0	10.0	12.6	22.7	11.9	7.8	11.1	13.9	13.6	10.4	8.6	13.0	7.1	5.4	11.2	13.3	11.4	15.2	12.9	8.4	19.8	13.6	19.7	11.9	12.5	10.7	13.2	8.2	13.7	11.1	16.5	28.8	13.6	10.3	12.9	8.6	11.4	11.5	9.8	15.8	18.4	16.0	11.4	13.5	13.8	25.5	6.5	7.3	7.6	7.1	8.2	6.8	11.8	12.9	8.6	17.5	21.4	2.0	1.5	3.0	4.4	7.0	5.6	4.6	3.6	5.2	11.8	5.2	8.2	12.1	28.5	3.7	5.0	20.6	25.9	13.1	13.2	14.1	3.4	10.6	7.6	2.6	5.5	6.2	3.6	7.6	33.7	28.5	6.9	8.3	24.0	22.2	17.2	13.4	11.7	18.1	13.3	10.3	8.2	12.5	22.7	9.2	8.2	6.9	8.8	23.4	6.2	6.1	7.7	8.9	4.9	16.9	13.1	12.3	5.3	9.7	9.3	7.6	5.0	4.5	6.8	6.1	4.3	6.5	4.7	3.9	7.3	5.5	4.7	4.8	1.1	8.2	7.1	3.1	5.5	11.8	8.7	10.5	11.5	12.0	7.1	5.4	12.9	8.4	10.7	15.8
ATP6AP2	"APT6M8-9, ATP6IP2, ATP6M8-9, M8-9, PRR, RENR"	ENSG00000182220	"ATPase H+ transporting accessory protein 2"	O75787	X	40579372-40606848	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Disease mutation, Epilepsy, Mental retardation, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 176.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003156	Approved									"HPA003156: AB_1078245"	"unprognostic (1.45e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.09e-1)"	"prognostic favourable (2.01e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.86e-2)"	25.0	23.8	33.8	17.4	39.3	30.6	31.7	31.5	76.0	35.0	24.0	22.1	13.0	10.0	30.8	25.5	21.4	22.7	23.9	19.3	35.5	36.7	48.7	30.0	30.2	37.9	32.1	34.7	22.3	16.3	176.7	16.1	30.2	37.8	26.4	25.0	21.0	16.8	31.8	8.7	24.0	16.8	35.7	27.8	22.6	15.8	11.9	17.2	16.2	56.1	12.6	19.1	25.7	20.0	16.1	53.2	60.8	78.0	20.0	29.6	85.8	14.7	19.3	14.1	19.0	93.6	59.6	8.8	33.2	51.5	24.5	28.7	11.1	24.2	8.5	16.5	48.4	15.2	21.7	25.8	33.5	16.6	17.1	10.6	18.8	10.7	34.4	18.8	19.8	51.6	34.6	30.1	24.2	32.6	10.7	23.0	37.0	18.5	8.1	16.4	13.0	21.8	7.7	24.8	28.5	31.6	16.5	10.2	9.5	32.3	20.1	20.2	26.1	17.3	32.0	30.9	16.9	36.8	11.1	7.1	12.3	8.4	25.5	15.9	24.0	34.4	78.0	60.8	25.9	55.1	27.0	16.1	26.4	26.6	53.2	15.7	29.6	27.0	39.5	20.0	54.1	19.3	24.7	85.8	33.8	39.3	31.5	76.0	35.5	36.7	32.1	34.7	37.8	17.2
MPC1L	SLC54A3	ENSG00000238205	"Mitochondrial pyruvate carrier 1 like"	P0DKB6	X	40623566-40624136	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"testis: 26.1"	"Cell line enhanced"	"Detected in some"		"BJ: 1.1;BJ hTERT+: 1.0;PC-3: 1.8;U-2197: 1.4"	"Cancer enriched"	"Detected in single"	9	"testis cancer: 3.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"																										"unprognostic (8.47e-4)"		"unprognostic (1.00e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.3	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CXorf38	MGC39350	ENSG00000185753	"Chromosome X open reading frame 38"	Q8TB03	X	40626921-40647554	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050120	Approved		Approved	Cytosol				Cytosol		"HPA050120: "	"unprognostic (5.40e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavourable (7.30e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.73e-2)"	"prognostic favourable (1.44e-8)"	12.5	12.5	6.5	14.2	9.6	11.7	11.7	8.2	7.2	11.6	14.3	9.7	13.9	10.1	12.5	13.9	9.4	13.0	8.8	11.2	7.7	6.1	11.1	11.2	14.4	25.3	8.5	7.2	12.4	9.6	16.5	9.4	12.5	8.8	8.5	9.7	7.8	11.0	19.3	7.1	9.1	14.6	8.9	10.9	18.3	8.2	4.8	9.0	17.3	16.5	7.5	16.4	12.2	9.9	9.0	13.7	21.3	21.9	6.7	9.8	9.4	9.4	5.0	5.1	3.9	5.6	9.7	3.0	6.5	9.0	8.1	8.5	6.6	13.4	16.5	6.2	9.7	6.4	6.2	10.9	7.6	23.0	10.1	10.5	5.6	3.5	9.7	18.7	16.8	8.2	7.2	11.5	10.7	9.8	4.6	11.8	14.8	9.3	12.3	11.9	4.7	11.5	10.3	11.0	11.7	9.4	15.0	6.1	8.1	12.9	6.1	7.1	10.4	7.8	11.3	10.1	6.3	7.7	5.3	13.5	5.0	7.1	13.1	8.8	6.8	9.5	16.1	21.3	9.6	15.0	9.6	6.8	8.8	7.0	13.7	9.0	7.9	7.4	20.4	6.7	21.9	5.9	9.8	9.4	6.5	9.6	8.2	7.2	7.7	6.1	8.5	7.2	8.8	9.0
MED14	"CRSP150, CRSP2, CSRP, CXorf4, EXLM1, RGR1, TRAP170"	ENSG00000180182	"Mediator complex subunit 14"	O60244	X	40648306-40735858	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064182			Approved	Nucleoplasm				Nucleoplasm		"HPA064182: "	"unprognostic (5.21e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.16e-1)"	"unprognostic (7.95e-3)"	"unprognostic (4.38e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.89e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.64e-1)"	11.0	11.4	12.0	18.5	14.7	19.6	10.5	19.2	16.8	12.9	17.7	20.5	11.4	18.1	14.4	21.9	15.0	10.0	11.1	14.6	13.8	12.5	13.0	15.5	12.4	16.2	12.4	11.5	14.9	12.9	21.5	15.9	13.5	15.1	12.0	15.6	14.7	10.6	12.2	53.8	16.7	19.8	16.2	12.8	13.5	12.8	5.7	11.7	31.7	16.2	18.4	20.9	17.5	12.8	4.0	5.7	6.0	7.3	7.7	5.2	2.4	24.2	12.0	19.4	17.1	8.7	11.3	3.9	9.6	12.1	13.9	17.8	11.0	12.1	14.1	6.6	12.2	18.5	32.9	15.3	20.9	12.8	24.8	14.2	14.7	10.0	9.3	14.9	14.7	8.1	9.4	20.3	17.8	16.7	9.6	13.8	14.5	12.5	13.6	13.3	21.4	14.1	6.9	20.8	14.0	13.3	11.3	12.5	11.1	22.8	10.4	10.6	15.3	8.9	15.1	14.3	15.0	17.9	11.7	12.9	13.1	14.0	13.8	10.2	10.3	4.3	3.6	6.0	4.5	7.3	5.2	3.9	4.3	4.4	5.7	4.0	4.9	3.8	1.9	7.7	3.9	3.1	3.9	2.4	12.0	14.7	19.2	16.8	13.8	12.5	12.4	11.5	15.1	11.7
USP9X	"DFFRX, FAF, MRX99"	ENSG00000124486	"Ubiquitin specific peptidase 9, X-linked"	Q93008	X	41085635-41236579	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, Chromosome partition, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011618, HPA047417, CAB070164"	Approved		Uncertain	Vesicles				Vesicles		"CAB011618: AB_470860, CAB070164: AB_10011071, HPA047417: "	"unprognostic (5.42e-3)"	"unprognostic (6.42e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.99e-2)"	"unprognostic (4.76e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.33e-1)"	18.0	21.8	17.7	14.0	15.9	15.5	16.8	16.6	16.7	18.4	20.6	11.4	25.4	13.2	19.6	19.0	17.3	17.0	17.1	20.9	14.2	14.2	18.5	34.2	16.7	23.1	15.2	15.4	15.7	16.5	45.8	17.0	41.1	12.9	13.4	14.4	13.9	14.2	25.2	42.8	14.8	22.0	17.3	14.0	16.7	16.9	16.9	14.0	21.1	20.3	17.6	16.5	20.3	19.9	6.4	5.5	13.0	5.0	4.9	7.8	3.1	19.0	22.6	20.1	20.5	16.9	17.7	4.6	11.0	14.8	12.5	14.6	10.4	8.9	12.8	6.2	25.0	12.9	34.5	20.0	21.1	16.1	24.8	14.9	21.9	9.3	14.3	12.9	10.9	15.3	9.0	30.0	28.5	19.3	18.0	10.5	19.3	14.0	9.2	5.1	21.2	12.5	10.1	27.5	8.3	11.9	15.8	11.4	10.7	46.2	12.8	12.6	12.4	7.2	20.6	19.2	14.8	18.1	11.8	9.6	11.2	16.4	13.7	5.8	9.5	3.3	4.7	6.0	5.6	4.2	7.8	6.4	6.6	6.2	5.5	4.7	6.7	6.0	13.0	4.9	5.0	4.2	5.6	3.1	17.7	15.9	16.6	16.7	14.2	14.2	15.2	15.4	12.9	14.0
DDX3X	"DBX, DDX14, DDX3, HLP2"	ENSG00000215301	"DEAD-box helicase 3, X-linked"	O00571	X	41333284-41364472	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Chromosome partition, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059585"	Supported	Supported	Approved	Nucleoplasm,Cytosol			110000	Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059585: "	"unprognostic (2.42e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.66e-1)"	"unprognostic (8.12e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.95e-1)"	"unprognostic (4.77e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.93e-2)"	80.9	49.3	26.1	40.0	34.5	49.3	46.5	31.1	36.2	52.4	43.3	35.1	21.3	29.5	56.4	25.9	53.5	56.3	42.6	47.6	30.8	24.5	55.6	77.9	45.3	40.4	41.4	29.0	60.1	30.9	68.7	60.2	79.9	37.9	30.0	29.2	30.8	37.4	26.5	63.4	42.2	54.0	57.2	53.9	46.1	43.0	27.0	39.0	49.2	45.6	44.0	42.6	55.8	50.2	13.1	20.5	32.0	21.6	17.3	21.5	17.9	45.4	50.5	47.2	25.9	55.6	47.2	28.8	33.1	46.6	34.0	27.4	51.9	30.6	0.5	23.7	37.1	30.7	57.7	46.6	56.7	26.9	45.0	28.9	50.3	31.2	28.9	54.1	52.0	34.1	33.1	57.3	55.4	53.3	53.0	28.6	31.6	34.4	34.1	16.9	45.4	20.4	40.0	50.3	37.0	32.0	61.2	32.3	48.9	75.0	38.5	39.7	34.6	36.8	48.1	35.1	37.6	37.5	39.3	33.4	39.6	44.9	35.4	32.8	33.2	22.5	20.2	17.5	14.8	21.1	21.5	13.1	14.5	16.3	20.5	9.0	16.3	15.1	32.0	17.3	21.6	6.9	14.3	17.9	26.1	34.5	31.1	36.2	30.8	24.5	41.4	29.0	37.9	39.0
NYX	"CLRP, CSNB1, CSNB1A, CSNB4"	ENSG00000188937	Nyctalopin	Q9GZU5	X	41447434-41475710	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Congenital stationary night blindness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"retina: 13.9"	"Group enriched"	"Detected in some"	7	"HDLM-2: 7.2;NTERA-2: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"									"unprognostic (3.27e-2)"	"unprognostic (6.72e-2)"				"unprognostic (4.21e-2)"	"unprognostic (4.10e-4)"			"unprognostic (1.83e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.80e-1)"			0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	13.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.7	0.0	0.0	0.1	0.0	0.3	0.0
CASK	"CAGH39, FGS4, LIN2, TNRC8"	ENSG00000147044	"Calcium/calmodulin dependent serine protein kinase"	O14936	X	41514934-41923645	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 26.3"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001949, HPA023857"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB001949: , HPA023857: AB_1846035"	"unprognostic (6.30e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavourable (6.11e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.85e-2)"	9.1	15.9	13.9	18.8	12.7	9.8	13.2	14.2	15.7	11.1	22.1	20.0	7.1	27.1	12.2	13.7	17.2	9.9	16.0	7.0	12.1	12.8	14.6	10.8	10.3	13.6	16.3	8.5	13.9	14.2	11.1	9.8	13.4	11.9	10.7	23.8	10.4	15.9	7.7	5.8	12.8	32.9	12.1	10.1	9.6	16.2	2.9	14.3	30.9	9.3	8.1	14.0	11.8	13.1	0.6	0.3	26.3	0.8	2.4	2.3	0.3	10.8	13.9	13.3	7.9	9.0	7.4	4.3	9.5	7.9	5.6	5.1	29.9	17.7	0.1	4.9	11.8	21.8	14.7	9.7	9.4	9.6	8.2	0.0	12.5	10.6	9.3	1.7	1.4	8.4	26.7	10.6	13.6	4.5	0.8	8.5	12.1	12.7	3.1	0.7	12.2	9.1	5.1	32.8	5.2	12.6	23.7	12.2	6.5	17.9	7.1	5.4	7.7	0.3	5.3	10.5	10.6	8.9	5.2	3.3	2.0	3.6	10.3	1.2	6.7	26.3	0.8	4.8	0.5	0.7	0.5	0.4	0.6	0.8	0.2	0.6	0.7	0.7	1.1	2.4	0.4	0.3	2.3	0.3	13.9	12.7	14.2	14.2	12.1	12.8	16.3	8.5	11.9	14.3
GPR34		ENSG00000171659	"G protein-coupled receptor 34"	Q9UPC5	X	41688973-41697277	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 60.8"	"Cell line enhanced"	"Detected in some"		"HMC-1: 5.1;U-937: 1.4"	"Cancer enhanced"	"Detected in all"		"glioma: 26.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"basophil: 60.8;eosinophil: 25.3"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 60.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010668, CAB025490"	Uncertain		Uncertain	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB025490: , HPA010668: AB_1849294"	"unprognostic (1.26e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.81e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-3)"	"unprognostic (3.18e-2)"	25.1	12.4	15.1	9.7	16.6	0.4	15.0	2.1	11.7	10.5	9.1	13.5	1.0	4.4	4.9	6.6	5.8	5.5	12.2	5.9	16.0	9.5	11.7	5.3	11.4	26.8	22.4	7.5	5.4	4.4	2.8	3.3	29.3	15.4	5.7	9.3	4.9	7.1	6.4	2.1	2.4	11.4	11.5	34.0	22.3	5.1	5.0	21.4	1.9	3.4	1.5	11.1	12.5	3.7	0.3	0.4	60.8	2.8	3.0	0.1	0.5	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	1.0	0.4	0.0	0.2	0.0	0.1	5.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.8	0.3	0.5	0.1	1.1	0.0	0.3	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.1	0.8	0.1	0.0	0.0	0.1	0.6	1.4	0.0	60.8	2.2	25.3	0.0	2.8	0.0	0.3	0.1	0.0	0.4	0.1	0.0	0.0	0.2	3.0	1.5	0.0	0.1	0.5	15.1	16.6	2.1	11.7	16.0	9.5	22.4	7.5	15.4	21.4
GPR82		ENSG00000171657	"G protein-coupled receptor 82"	Q96P67	X	41724155-41730135	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 23.2;lymphoid tissue: 12.0"	"Cell line enriched"	"Detected in single"	16	"HMC-1: 9.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"eosinophil: 23.2;NK-cell: 6.6"	"Group enriched"	"Detected in many"	9	"granulocytes: 23.2;NK-cells: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA035914	Approved									"HPA035914: AB_10670671"	"unprognostic (5.62e-3)"	"unprognostic (1.81e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.28e-2)"	"unprognostic (4.62e-4)"	"unprognostic (1.41e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.00e-3)"	"unprognostic (1.18e-1)"	1.2	2.2	1.6	3.9	5.9	0.2	1.1	0.6	1.5	0.9	2.7	0.3	0.0	3.0	0.8	1.1	1.1	1.1	1.1	0.7	2.5	1.1	4.7	5.0	10.0	9.0	2.5	0.1	0.7	1.5	0.1	1.1	0.3	3.2	1.1	2.1	0.8	0.8	0.7	0.4	0.7	5.2	0.6	7.3	3.6	1.6	0.4	2.3	1.6	0.8	0.6	12.0	2.4	0.9	0.1	0.2	23.2	1.6	6.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.3	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.2	23.2	0.0	1.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	6.6	1.4	0.0	0.0	0.1	1.6	5.9	0.6	1.5	2.5	1.1	2.5	0.1	3.2	2.3
PPP1R2C	"I-4, PPP1R2P9"	ENSG00000102055	"PPP1R2C family member C"	O14990	X	42777368-42778247	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 37.8"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	38	"testis cancer: 1.8"					"Group enriched"	"Detected in some"	7	"memory B-cell: 1.2;T-reg: 2.4"	"Group enriched"	"Detected in many"	18	"B-cells: 1.2;T-cells: 2.4"																																		"unprognostic (1.74e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1										
MAOA		ENSG00000189221	"Monoamine oxidase A"	P21397	X	43654907-43746824	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	Oxidoreductase	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 39.5;HHSteC: 74.2;HSkMC: 18.6;hTCEpi: 20.9;RT4: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.0;MAIT T-cell: 1.3"	"Group enriched"	"Detected in many"	10	"monocytes: 1.0;T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009437, HPA054807, HPA059299"	Enhanced		Enhanced	Mitochondria,Cytosol				Mitochondria	Cytosol	"CAB009437: AB_2137260, HPA054807: , HPA059299: "	"unprognostic (9.54e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.89e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.98e-3)"	72.3	11.0	8.2	10.2	7.8	0.3	35.2	3.3	6.1	12.4	85.7	2.8	10.7	53.6	12.5	6.2	36.6	12.0	14.7	37.8	6.7	8.3	77.8	45.9	34.4	5.2	11.1	6.1	14.2	24.4	9.6	1.5	79.8	8.7	26.2	39.9	6.2	49.1	12.9	12.5	11.2	90.1	23.6	3.4	2.1	19.3	5.5	4.7	0.0	68.6	9.7	3.9	35.3	35.1	0.0	0.0	0.1	1.0	0.0	1.3	0.1	0.0	0.8	0.1	2.3	39.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.0	1.4	5.3	0.0	0.0	0.5	1.6	0.1	4.2	74.2	0.0	4.0	18.6	20.9	0.0	10.9	4.7	0.0	0.1	1.3	0.6	0.0	0.1	0.3	1.2	0.0	0.0	0.1	5.3	30.6	0.7	1.8	0.0	0.0	0.0	0.1	0.0	2.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.3	0.0	0.1	0.3	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.1	8.2	7.8	3.3	6.1	6.7	8.3	11.1	6.1	8.7	4.7
MAOB		ENSG00000069535	"Monoamine oxidase B"	P27338	X	43766611-43882447	"Enzymes, FDA approved drug targets, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 104.9"	"Group enriched"	"Detected in some"	7	"Hep G2: 20.2;SiHa: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002328, CAB037200"	Enhanced						3600000			"CAB037200: AB_1841012, HPA002328: AB_1854062"	"unprognostic (1.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.69e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.74e-2)"	"unprognostic (5.35e-3)"	"unprognostic (1.48e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.90e-3)"	25.0	18.2	24.8	3.9	34.8	0.5	16.5	5.5	24.5	12.0	18.9	20.3	15.6	24.9	38.0	20.0	11.4	34.9	15.4	32.4	21.2	46.9	41.8	104.9	10.9	2.3	24.4	19.9	56.0	4.1	15.6	8.9	9.4	26.8	30.1	6.3	3.0	38.0	55.9	34.8	3.0	30.5	35.9	39.1	1.3	8.4	5.2	21.3	0.2	1.8	8.2	2.8	12.1	8.5	0.0	0.0	0.0	0.1	0.0	1.0	1.2	0.0	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	2.6	2.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	20.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	1.8	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.5	39.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.2	24.8	34.8	5.5	24.5	21.2	46.9	24.4	19.9	26.8	21.3
NDP	"EVR2, norrin"	ENSG00000124479	"NDP, norrin cystine knot growth factor"	Q00604	X	43948776-43973504	"Disease related genes, Predicted secreted proteins"	"Sensory transduction, Vision, Wnt signaling pathway"		"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 40.4"	"Cell line enriched"	"Detected in some"	17	"U-87 MG: 40.3"	"Cancer enhanced"	"Detected in many"		"glioma: 25.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"memory CD4 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003095			Supported	Nucleoplasm,Nucleoli,Vesicles	"Secreted to extracellular matrix"			Vesicles	"Nucleoplasm, Nucleoli"	"HPA003095: AB_1079457"	"unprognostic (1.12e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.55e-3)"	"unprognostic (6.84e-3)"	"unprognostic (1.51e-1)"		"unprognostic (9.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.87e-3)"	0.9	0.6	17.3	0.6	18.6	0.5	3.6	14.6	15.0	19.1	0.7	12.6	0.2	0.6	13.6	19.9	0.6	18.0	0.9	1.4	14.0	7.8	0.7	0.5	0.6	0.7	11.0	10.9	40.4	0.6	0.8	0.2	5.3	13.1	6.8	0.7	1.4	0.6	12.4	1.5	1.1	0.6	10.7	7.5	0.6	0.7	1.4	12.2	0.0	1.2	0.0	0.7	1.0	1.7	0.1	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.9	0.0	0.1	1.0	0.7	0.0	0.0	1.1	2.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.1	0.0	0.0	0.0	40.3	0.4	2.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.3	18.6	14.6	15.0	14.0	7.8	11.0	10.9	13.1	12.2
EFHC2	"FLJ22843, MRX74"	ENSG00000183690	"EF-hand domain containing 2"	Q5JST6	X	44147882-44343672	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.6;fallopian tube: 20.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.1;HEL: 5.3;HMC-1: 17.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"pons and medulla: 20.6"	"Group enriched"	"Detected in some"	5	"basophil: 14.1;NK-cell: 6.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 14.1;NK-cells: 6.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034492, HPA057359"	Approved	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane"				"Nucleoplasm, Nucleoli fibrillar center"	"Plasma membrane"	"HPA034492: AB_10671227, HPA057359: "	"unprognostic (1.93e-1)"	"unprognostic (7.80e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.83e-3)"	"unprognostic (5.07e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.13e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.97e-2)"	0.7	0.6	4.0	0.8	6.2	1.9	1.2	1.6	3.1	4.6	1.6	6.5	3.7	0.6	5.4	12.6	2.9	20.8	3.0	6.0	4.8	3.9	2.0	0.1	4.5	0.5	1.5	2.0	5.2	0.3	0.9	6.9	1.3	20.6	2.9	0.6	0.6	9.6	5.8	0.1	4.7	0.8	2.6	1.4	0.6	1.6	10.1	3.1	0.4	3.7	1.4	0.9	1.7	1.4	0.1	0.4	14.1	0.0	6.6	2.1	1.4	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	5.1	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.1	5.3	0.0	0.0	0.0	0.0	17.6	0.3	0.3	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.3	0.6	0.1	0.3	0.0	0.0	1.4	0.0	0.3	0.5	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	14.1	0.0	0.0	2.1	0.0	0.8	0.1	0.8	0.1	0.4	0.1	0.7	1.0	1.9	6.6	0.0	0.0	0.0	1.4	4.0	6.2	1.6	3.1	4.8	3.9	1.5	2.0	20.6	3.1
FUNDC1	MGC51029	ENSG00000069509	"FUN14 domain containing 1"	Q8IVP5	X	44523639-44543001	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038773	Uncertain									"HPA038773: AB_10670789"	"unprognostic (1.04e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.93e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.88e-3)"	"unprognostic (6.40e-2)"	"unprognostic (2.85e-3)"	"unprognostic (6.63e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.08e-1)"	"unprognostic (2.49e-2)"	"prognostic favourable (8.35e-4)"	"unprognostic (6.67e-3)"	"prognostic favourable (2.58e-4)"	7.0	12.2	21.5	5.8	26.9	6.0	13.1	14.1	22.7	9.9	7.7	8.8	5.4	7.9	8.8	14.0	9.5	10.0	12.0	23.0	19.5	21.5	16.1	8.0	6.6	10.3	23.8	18.7	12.9	7.4	14.2	14.1	6.9	30.7	10.2	8.6	8.2	28.1	7.5	10.7	10.1	5.2	7.9	17.1	7.9	18.1	9.3	10.6	9.7	10.5	9.5	10.1	10.7	8.4	10.1	19.5	9.1	5.6	9.5	11.2	4.7	15.1	12.8	12.3	8.1	6.4	8.8	8.2	7.6	10.8	14.3	16.4	14.8	12.8	10.6	7.6	10.1	7.9	22.3	14.2	18.4	12.7	24.5	12.1	16.1	10.9	9.5	13.4	41.3	8.9	13.9	21.8	10.7	9.1	12.5	7.3	17.5	14.6	11.4	14.4	14.7	15.1	6.9	13.7	8.2	15.0	10.3	7.1	12.1	23.4	12.9	13.9	25.7	0.0	5.5	8.9	13.4	11.4	8.3	5.7	9.4	13.1	12.7	5.3	12.3	5.5	5.6	9.1	7.0	5.5	9.2	10.1	9.4	10.8	9.8	6.9	11.2	8.4	6.2	9.5	3.7	19.5	9.3	4.7	21.5	26.9	14.1	22.7	19.5	21.5	23.8	18.7	30.7	10.6
DUSP21		ENSG00000189037	"Dual specificity phosphatase 21"	Q9H596	X	44844004-44844888	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	36	"testis: 15.9"	"Group enriched"	"Detected in some"	5	"CACO-2: 1.7;K-562: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																												"unprognostic (5.17e-2)"			0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KDM6A	UTX	ENSG00000147050	"Lysine demethylase 6A"	O15550	X	44873177-45112602	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		"Chromatin regulator, Dioxygenase, Oxidoreductase"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000568, HPA001165, HPA002111"	Enhanced		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"			Nucleoplasm	Nucleoli	"HPA000568: AB_1858705, HPA001165: AB_1080541, HPA002111: AB_1858704"	"unprognostic (1.73e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.58e-3)"	"unprognostic (8.22e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.16e-2)"	12.3	12.1	16.5	17.6	24.5	47.9	21.4	26.1	22.0	16.9	11.8	16.7	12.0	13.1	22.6	11.3	15.4	16.9	15.2	9.1	18.2	6.5	11.6	13.5	19.7	15.1	28.8	11.3	23.8	14.9	21.3	20.2	13.3	18.3	10.3	11.3	10.3	16.1	12.6	15.1	21.3	17.6	13.5	14.9	18.1	15.0	17.7	26.1	19.1	14.5	6.9	13.6	14.9	22.8	5.5	7.1	15.7	7.5	6.2	7.9	3.5	8.9	7.8	11.6	11.7	8.3	8.6	24.9	7.0	5.0	8.4	8.8	18.4	7.7	5.9	3.8	6.5	19.3	14.8	12.3	7.8	8.5	15.9	7.3	9.9	6.8	5.9	3.9	20.7	4.6	10.2	13.8	14.5	6.5	10.1	14.6	5.2	5.8	8.1	11.5	9.7	9.0	9.0	11.1	1.0	4.8	16.8	10.0	5.4	22.3	11.2	9.5	10.8	0.1	5.5	8.0	6.2	8.0	3.6	9.2	11.1	8.9	5.6	4.1	4.6	15.7	3.8	3.5	5.3	7.5	6.0	5.5	7.2	7.9	7.1	3.8	7.0	6.3	7.3	6.2	7.2	3.8	5.6	3.5	16.5	24.5	26.1	22.0	18.2	6.5	28.8	11.3	18.3	26.1
CXorf36	"DIA1R, FLJ14103"	ENSG00000147113	"Chromosome X open reading frame 36"	Q9H7Y0	X	45148374-45200901	"Disease related genes, Predicted secreted proteins"			"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	143	"HUVEC TERT2: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA002806	Uncertain				"Secreted - unknown location"		370000			"HPA002806: AB_1078595"	"unprognostic (2.12e-1)"	"unprognostic (1.32e-2)"	"unprognostic (8.51e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.65e-2)"	"unprognostic (4.07e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.79e-3)"	"unprognostic (1.98e-1)"	"unprognostic (8.47e-2)"	"unprognostic (3.11e-2)"	42.1	3.2	3.8	6.2	4.4	0.8	47.7	1.4	3.2	17.9	7.3	2.9	6.7	2.4	28.5	10.2	8.0	9.9	7.5	23.6	4.7	3.7	4.5	2.1	9.3	12.1	6.8	1.2	7.9	4.2	4.3	3.7	39.6	4.2	12.0	3.5	4.3	4.4	7.7	14.4	4.9	4.7	17.7	6.4	5.0	4.2	5.6	2.0	0.3	12.3	12.0	3.7	10.6	26.5	0.5	0.2	2.4	0.2	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	42.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.3	0.1	0.3	0.4	0.4	0.4	0.0	0.5	0.4	0.3	2.4	0.1	0.0	0.2	0.1	0.1	3.8	4.4	1.4	3.2	4.7	3.7	6.8	1.2	4.2	2.0
KRBOX4	"FLJ20344, ZNF673"	ENSG00000147121	"KRAB box domain containing 4"	Q5JUW0	X	46446857-46497422	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA065295			Approved	Nucleoplasm				Nucleoplasm		"HPA065295: "	"unprognostic (4.12e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (2.87e-6)"	"prognostic favourable (4.67e-5)"	"unprognostic (1.73e-2)"	"unprognostic (2.61e-3)"	"unprognostic (3.27e-2)"	"unprognostic (4.75e-3)"	"prognostic unfavourable (1.98e-7)"	"unprognostic (7.94e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.00e-1)"	"prognostic favourable (2.17e-4)"	17.8	11.3	16.9	10.5	22.3	6.8	17.0	24.9	21.0	14.4	14.2	19.9	11.7	7.9	25.6	27.9	8.5	16.0	14.1	10.6	13.6	16.6	12.0	16.4	13.5	15.5	16.1	16.8	22.4	14.0	17.3	24.5	20.3	22.2	16.8	11.1	13.2	9.8	14.6	8.7	13.4	10.5	18.1	17.2	19.7	10.3	6.4	19.0	12.6	17.0	9.3	14.5	14.3	12.9	17.4	12.5	13.7	8.8	13.8	17.8	8.2	15.7	9.0	14.5	11.0	14.3	15.0	8.8	15.4	14.1	14.3	13.2	7.9	14.5	9.0	10.2	13.2	11.3	17.9	8.6	16.9	8.8	7.6	7.4	18.7	7.6	15.4	10.9	12.2	16.8	9.5	19.6	16.3	13.3	7.9	9.9	12.8	9.1	11.2	5.5	13.0	16.5	8.0	13.4	11.1	9.2	6.6	5.3	10.2	13.2	6.5	14.8	10.7	11.0	12.0	16.1	16.0	20.8	12.5	10.9	12.3	12.9	13.8	0.5	14.4	12.2	6.7	13.7	12.7	8.2	13.3	13.2	13.7	12.2	6.6	17.4	17.8	12.7	5.1	13.8	8.8	12.5	11.6	8.2	16.9	22.3	24.9	21.0	13.6	16.6	16.1	16.8	22.2	19.0
ZNF674	"MRX92, ZNF673B"	ENSG00000251192	"Zinc finger protein 674"	Q2M3X9	X	46497727-46545457	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA031026, HPA065295"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA031026: AB_10602690, HPA065295: "	"unprognostic (6.11e-4)"	"unprognostic (1.97e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.41e-5)"	"unprognostic (2.74e-4)"	"unprognostic (5.68e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.25e-4)"	"unprognostic (8.45e-4)"	6.7	5.1	5.7	4.0	10.1	3.8	5.5	12.6	9.8	4.7	4.5	6.8	1.9	4.2	6.3	6.5	4.1	3.7	4.9	4.9	5.7	6.3	5.6	8.1	4.3	5.1	6.4	5.8	7.2	7.4	4.8	11.2	4.5	9.6	8.2	5.1	6.8	4.5	5.7	5.0	5.4	4.6	6.9	6.8	5.8	3.9	3.7	7.0	6.0	6.9	1.8	4.6	4.5	5.1	2.3	2.5	5.8	3.5	1.9	2.7	2.1	2.7	3.6	3.6	4.5	3.3	3.2	3.5	3.0	4.1	3.9	4.2	2.4	2.3	3.0	1.9	5.0	2.7	4.8	3.6	4.3	2.6	3.0	1.4	3.9	2.0	4.4	3.3	5.6	3.1	5.8	2.9	9.5	3.1	1.6	4.7	3.5	1.8	3.3	1.5	5.8	3.4	1.6	6.0	3.5	2.6	1.1	1.4	3.0	4.6	1.5	9.4	3.8	2.4	2.7	5.0	5.7	3.0	2.8	5.5	4.8	1.3	2.1	1.7	5.0	2.5	2.2	2.9	1.9	3.5	2.0	2.3	2.7	1.5	2.1	1.4	2.2	2.3	5.8	1.9	0.8	2.5	2.2	2.1	5.7	10.1	12.6	9.8	5.7	6.3	6.4	5.8	9.6	7.0
CHST7	"C6ST-2, C6ST2"	ENSG00000147119	"Carbohydrate sulfotransferase 7"	Q9NS84	X	46573784-46598408	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 17.8;HHSteC: 13.2;NTERA-2: 15.8;PC-3: 13.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 15.4"	"Group enriched"	"Detected in many"	10	"granulocytes: 9.4;monocytes: 8.0;T-cells: 15.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003919, HPA030503"	Approved		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"			"Nucleoplasm, Vesicles"		"HPA003919: AB_10601258, HPA030503: "	"unprognostic (3.16e-1)"	"prognostic favourable (7.20e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-2)"	"unprognostic (7.85e-2)"	"unprognostic (9.82e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.39e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.85e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.39e-2)"	13.1	7.5	4.9	3.8	6.6	4.7	12.1	4.7	10.3	10.5	4.4	3.6	2.5	2.2	5.0	4.1	4.2	3.2	10.7	25.6	4.1	4.0	3.6	11.0	5.4	3.7	4.5	4.7	27.0	3.4	2.4	3.4	5.9	3.6	3.9	2.2	1.4	2.7	3.7	4.3	5.4	3.3	3.5	1.9	17.1	3.4	3.6	1.8	2.4	4.2	1.4	2.0	4.1	8.7	1.0	1.0	9.4	8.0	0.4	15.4	1.6	4.1	3.4	2.9	2.7	8.5	6.0	0.1	5.7	4.1	1.5	2.0	0.9	1.6	0.0	17.8	2.3	3.1	2.8	1.0	1.3	2.4	6.2	0.8	0.3	3.0	13.2	1.4	0.1	2.0	0.8	2.9	2.4	4.7	0.0	3.6	1.1	1.9	0.5	1.8	15.8	13.2	2.7	2.5	7.4	4.2	0.1	6.8	2.6	0.8	0.2	0.6	1.0	0.3	1.1	4.8	0.5	2.5	2.6	8.5	1.7	1.2	5.3	0.0	0.3	1.2	1.9	0.6	1.4	5.9	1.3	1.0	5.3	2.5	1.0	0.6	1.1	1.0	9.4	0.4	8.0	0.6	15.4	1.6	4.9	6.6	4.7	10.3	4.1	4.0	4.5	4.7	3.6	1.8
SLC9A7	NHE7	ENSG00000065923	"Solute carrier family 9 member A7"	Q96T83	X	46599252-46759172	"Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Potassium transport, Sodium transport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 42.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048938, HPA075385"	Approved		Supported	Vesicles				Vesicles		"HPA048938: , HPA075385: "	"unprognostic (2.77e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (8.58e-4)"	"prognostic unfavourable (8.14e-4)"	"unprognostic (2.16e-2)"	"unprognostic (2.73e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.28e-2)"	"unprognostic (9.25e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.08e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.13e-1)"	1.7	7.2	4.4	3.8	42.0	4.4	7.9	7.0	12.4	1.8	1.2	1.8	1.2	1.7	1.2	3.8	3.2	2.5	2.2	2.3	3.3	7.1	3.3	4.1	1.8	7.8	3.6	4.3	6.3	4.6	11.5	13.6	1.4	12.7	6.5	1.3	2.3	7.3	2.9	10.0	2.9	2.7	1.0	2.7	4.7	8.2	1.3	8.2	2.8	6.9	1.7	8.2	2.3	2.2	4.3	6.0	2.1	0.6	1.4	0.7	0.5	7.3	5.6	0.8	2.4	0.9	5.6	3.2	7.0	8.7	4.2	3.4	5.7	7.9	16.1	2.2	11.1	3.4	5.4	7.9	7.7	8.4	2.9	1.6	2.2	2.3	3.5	0.8	13.3	3.5	1.0	11.9	7.9	5.9	0.1	0.3	5.7	11.0	1.8	0.9	3.9	6.7	7.1	0.3	0.2	3.2	8.2	6.1	0.7	3.6	5.4	1.5	7.1	0.3	0.3	9.0	3.0	1.4	4.1	1.7	0.4	8.1	12.8	0.1	2.9	1.0	0.6	0.3	0.6	0.6	0.4	3.4	0.7	0.3	2.4	4.3	0.4	0.5	2.1	1.4	0.6	6.0	0.7	0.5	4.4	42.0	7.0	8.3	3.3	7.1	3.6	4.3	12.7	8.2
RP2	"NM23-H10, NME10, TBCCD2"	ENSG00000102218	"RP2, ARL3 GTPase activating protein"	O75695	X	46836940-46882358	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000234, HPA000909"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"			77000	"Nucleoplasm, Plasma membrane"	"Nuclear bodies"	"HPA000234: AB_1079831, HPA000909: "	"unprognostic (2.26e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.79e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-1)"	"prognostic unfavourable (7.97e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.76e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.79e-3)"	"unprognostic (9.75e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.96e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.28e-3)"	17.2	10.6	5.0	10.7	6.6	31.4	8.2	5.6	4.3	6.3	10.1	5.5	3.5	7.4	8.4	7.1	17.2	5.8	9.3	5.9	5.7	4.8	10.2	17.1	14.0	18.1	8.1	2.8	6.9	4.7	5.6	4.1	28.0	8.5	6.9	7.7	4.9	8.3	6.1	2.9	5.0	18.6	6.3	10.6	24.3	6.4	5.7	6.7	12.1	5.9	8.7	11.7	7.0	8.7	5.0	10.7	23.0	15.9	3.4	3.3	5.3	11.3	5.4	11.0	6.0	8.7	10.8	26.1	14.5	11.5	12.9	13.1	23.4	9.7	13.5	5.9	15.4	7.4	10.5	10.6	17.6	5.9	6.1	7.2	6.9	5.6	9.9	15.0	25.3	8.4	7.0	10.2	5.5	16.2	3.1	7.1	14.4	1.0	9.2	13.8	6.8	10.5	11.9	15.1	7.1	8.3	11.6	4.0	5.4	12.9	8.0	6.5	9.0	14.2	14.3	10.0	7.5	15.8	5.1	2.7	3.4	8.0	5.2	10.7	10.4	23.0	10.6	16.6	3.2	14.4	2.6	5.0	2.6	2.7	10.7	4.6	3.3	3.0	20.9	3.4	15.9	3.8	2.8	5.3	5.0	6.6	5.6	4.3	5.7	4.8	8.1	2.8	8.5	6.7
JADE3	"JADE-3, KIAA0215, PHF16"	ENSG00000102221	"Jade family PHD finger 3"	Q92613	X	46912276-47061242	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 36.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"memory B-cell: 4.8;naive B-cell: 3.7;plasmacytoid DC: 1.7"	"Group enriched"	"Detected in many"	9	"B-cells: 4.8;dendritic cells: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA006007, HPA064697"	Uncertain		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA006007: AB_1079605, HPA064697: "	"unprognostic (1.39e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.18e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.83e-3)"	"unprognostic (4.55e-2)"	"unprognostic (8.97e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.25e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.18e-2)"	"unprognostic (9.70e-2)"	4.9	12.6	3.5	2.7	5.1	1.5	6.2	3.3	4.9	5.7	4.5	7.1	14.0	1.9	9.5	16.3	4.7	4.3	3.2	5.2	3.9	3.3	3.7	7.7	4.3	4.1	9.2	1.4	7.2	8.7	3.0	2.1	15.9	4.7	5.4	3.2	2.1	4.3	12.2	3.3	3.8	3.5	6.0	8.5	9.8	4.7	14.5	8.4	8.4	4.2	1.4	7.5	7.6	13.1	4.8	1.7	0.0	0.3	0.2	0.2	0.4	6.3	5.7	9.4	6.5	3.5	2.6	36.2	3.8	3.2	4.3	4.8	6.5	5.6	0.0	2.7	2.8	2.5	11.4	3.1	6.2	17.1	7.5	5.0	6.5	6.3	5.7	3.8	2.7	2.0	4.3	3.0	9.8	8.0	3.4	3.0	3.3	6.6	13.7	4.6	7.4	4.9	14.2	10.6	8.9	3.6	5.9	8.2	7.3	11.0	10.2	6.0	6.7	4.0	5.0	4.5	8.0	6.4	2.5	2.3	2.0	12.2	1.2	3.2	4.4	0.0	0.1	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.1	3.7	0.0	0.0	0.0	0.2	0.3	1.7	0.0	0.4	3.5	5.1	3.3	4.9	3.9	3.3	9.2	1.4	4.7	8.4
RGN	"RC, SMP30"	ENSG00000130988	Regucalcin	Q15493	X	47078355-47093314	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 51.0;liver: 118.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 16.1;fHDF/TERT166: 5.1;Hep G2: 24.1"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 47.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029102, HPA029103"	Enhanced		Approved	Nucleoplasm			47000	Nucleoplasm		"HPA029102: AB_10599846, HPA029103: AB_10602097"	"unprognostic (1.80e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.56e-3)"	"unprognostic (8.22e-3)"	"unprognostic (1.32e-2)"	"prognostic favourable (7.55e-4)"	"unprognostic (2.60e-3)"	"unprognostic (2.23e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.14e-2)"	"prognostic favourable (5.10e-10)"	"unprognostic (1.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.82e-2)"	"unprognostic (5.22e-2)"	2.6	51.0	6.7	0.6	6.5	0.4	1.5	8.4	6.2	2.8	1.9	6.2	2.5	4.5	2.3	6.1	1.5	1.7	2.0	4.5	6.1	4.2	17.6	118.8	4.9	0.7	5.9	4.5	7.5	12.7	6.2	2.5	4.2	5.0	4.8	1.1	8.4	7.5	6.3	3.8	0.6	4.6	4.9	4.4	1.1	2.9	1.5	5.2	0.0	6.5	1.6	0.6	2.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.3	0.6	0.0	0.0	16.1	0.0	0.0	0.8	5.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	24.1	0.8	0.1	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.7	6.5	8.4	6.2	6.1	4.2	5.9	4.5	5.0	5.2
NDUFB11	"ESSS, Np15, NP17.3"	ENSG00000147123	"NADH:ubiquinone oxidoreductase subunit B11"	Q9NX14	X	47142216-47145504	"Disease related genes, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Cardiomyopathy, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 164.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA030367	Supported		Approved	Mitochondria				Mitochondria		"HPA030367: AB_10603882"	"unprognostic (2.20e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.80e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.46e-3)"	16.9	33.4	26.1	21.2	24.8	25.2	29.2	18.9	29.7	17.6	23.3	10.5	24.7	24.2	14.3	25.1	23.3	18.8	24.0	64.4	22.4	20.6	24.4	48.8	18.1	36.5	22.5	22.0	14.9	50.9	15.6	24.5	14.2	24.4	18.1	21.2	13.0	37.0	30.2	164.0	17.3	22.8	16.0	18.3	19.2	22.8	9.7	12.3	30.4	38.5	53.6	21.2	14.3	20.5	58.9	69.0	22.2	44.7	27.7	54.6	59.5	19.5	29.1	23.0	26.6	19.9	17.1	24.5	14.3	16.6	23.4	22.7	31.0	24.0	24.1	12.3	15.5	25.1	25.9	15.1	15.6	23.3	69.2	13.8	39.8	25.6	20.0	23.1	21.3	18.7	13.9	20.2	13.4	17.4	16.5	31.8	13.1	44.2	27.2	64.1	36.0	53.6	29.7	22.8	54.8	23.7	20.9	42.5	31.4	27.1	31.2	21.5	44.8	30.4	13.2	16.4	22.3	30.4	16.6	31.4	27.4	27.0	17.8	14.5	21.8	22.2	44.7	19.8	34.0	32.0	42.2	58.9	48.4	39.0	52.8	52.8	54.6	43.6	9.5	27.7	23.7	69.0	51.0	59.5	26.1	24.8	18.9	29.7	22.4	20.6	22.5	22.0	24.4	12.3
RBM10	"DXS8237E, GPATC9, GPATCH9, KIAA0122, ZRANB5"	ENSG00000182872	"RNA binding motif protein 10"	P98175	X	47144869-47186813	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034972, HPA057372"	Approved		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA034972: AB_10602919, HPA057372: "	"unprognostic (9.07e-2)"	"prognostic favourable (6.71e-4)"	"unprognostic (7.83e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.47e-3)"	"unprognostic (8.11e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.76e-1)"	"prognostic favourable (2.86e-6)"	"unprognostic (1.18e-1)"	"unprognostic (6.23e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.20e-3)"	18.1	22.2	19.8	38.0	21.9	34.0	17.1	41.2	22.9	19.9	20.5	25.7	22.7	21.8	22.1	17.3	23.7	26.2	29.1	21.7	19.8	18.3	18.4	21.6	17.1	27.2	20.1	19.2	36.4	27.4	20.1	28.3	24.9	17.9	23.5	14.2	18.5	25.1	28.8	20.6	23.8	23.7	18.9	17.2	24.7	20.5	8.7	21.4	32.9	26.8	18.0	22.7	17.6	20.9	15.9	14.6	14.4	19.2	12.3	18.3	11.5	20.7	22.5	21.6	25.5	11.6	9.5	25.1	15.8	9.3	16.4	16.0	19.6	17.1	25.4	9.7	10.9	20.3	28.1	19.9	9.0	25.7	25.5	19.0	27.4	20.5	16.9	19.1	22.9	12.5	9.6	27.0	22.0	17.5	15.8	20.4	9.9	31.7	35.0	32.4	35.6	25.3	31.0	18.0	26.2	12.1	18.4	25.6	19.5	23.9	17.9	15.2	22.0	19.1	15.3	19.3	24.5	20.8	16.6	21.5	17.4	20.9	17.1	13.8	26.9	14.0	10.8	14.4	18.3	14.5	17.0	15.9	14.7	15.3	12.3	15.6	14.8	14.1	10.1	12.3	19.2	14.6	16.6	11.5	19.8	21.9	41.2	21.9	19.8	18.3	20.1	19.2	17.9	21.4
UBA1	"A1S9T, CFAP124, GXP1, POC20, UBE1, UBE1X"	ENSG00000130985	"Ubiquitin like modifier activating enzyme 1"	P22314	X	47190861-47215128	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Ligase	"Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000289, HPA001506, CAB019435, CAB073410"	Approved		Enhanced	Nucleoplasm			16000000	Nucleoplasm		"CAB019435: AB_2211440, CAB073410: , HPA000289: AB_1080443, HPA001506: AB_2756305"	"unprognostic (7.18e-3)"	"unprognostic (1.52e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.40e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (6.10e-5)"	"unprognostic (7.22e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.17e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.38e-2)"	"prognostic favourable (1.78e-4)"	"unprognostic (1.21e-2)"	45.6	63.0	56.0	47.2	50.6	42.0	38.3	58.1	75.7	48.0	39.3	55.9	44.9	36.3	52.9	34.1	59.4	56.0	39.9	48.7	49.5	39.9	51.1	60.0	42.0	48.2	47.7	62.3	57.6	34.9	78.8	55.5	39.1	47.6	40.2	35.5	41.0	47.5	45.7	77.7	56.1	37.9	59.4	35.5	53.4	38.7	36.0	48.6	52.7	65.0	43.9	54.0	39.2	52.7	28.9	30.6	32.6	36.0	25.6	29.0	24.1	45.8	47.6	54.5	82.8	37.3	34.0	24.1	30.5	32.5	43.9	35.8	37.8	35.0	34.2	20.3	61.0	44.3	68.3	64.9	32.3	28.3	69.4	21.4	52.8	30.3	26.3	36.0	46.2	31.9	34.0	63.8	49.8	57.5	23.2	30.8	43.5	58.1	33.9	31.9	58.0	74.4	39.5	38.0	58.2	35.1	49.4	35.3	26.5	90.9	44.2	20.2	61.5	22.5	42.0	33.0	38.3	47.5	28.4	21.1	21.9	48.8	33.9	25.8	39.4	17.4	27.0	27.4	29.0	36.0	25.4	28.9	24.0	25.9	30.6	22.0	19.1	23.4	32.6	25.6	32.8	20.8	28.2	24.1	56.0	50.6	58.1	75.7	49.5	39.9	47.7	62.3	47.6	48.6
CDK16	"FLJ16665, PCTAIRE, PCTAIRE1, PCTGAIRE, PCTK1"	ENSG00000102225	"Cyclin dependent kinase 16"	Q00536	X	47217860-47229997	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 91.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000974, HPA001366, CAB016535"	Approved		Uncertain	"Plasma membrane,Microtubules,Cytosol"				"Plasma membrane, Microtubules, Cytosol"		"CAB016535: AB_785112, HPA000974: , HPA001366: AB_1079584"	"unprognostic (2.37e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.16e-3)"	"unprognostic (8.80e-2)"	"unprognostic (2.92e-2)"	"prognostic unfavourable (2.02e-6)"	"unprognostic (2.85e-1)"	"unprognostic (5.59e-2)"	"unprognostic (7.62e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.89e-3)"	"unprognostic (2.55e-1)"	22.0	20.1	32.3	13.9	25.0	26.6	17.6	51.5	49.0	17.2	19.3	15.5	17.0	16.4	14.8	12.8	23.8	18.8	14.1	47.3	29.2	18.0	19.9	12.7	14.0	10.8	22.0	21.1	16.7	18.6	22.8	14.9	18.6	28.5	12.7	14.7	13.7	20.1	16.1	91.2	17.0	15.3	18.2	14.8	12.0	14.7	28.7	12.1	10.4	20.9	36.3	12.6	12.9	12.1	8.5	13.5	8.5	10.7	6.3	7.7	5.7	41.2	31.7	30.4	44.9	22.3	19.2	30.4	19.6	24.2	29.9	22.3	35.6	20.0	9.9	12.5	35.2	23.4	32.3	41.8	20.2	11.9	51.3	10.8	44.5	27.7	29.0	11.3	25.2	23.9	26.8	42.4	51.2	26.7	16.0	16.9	26.1	35.9	9.8	26.0	23.8	34.2	10.5	24.1	17.4	22.5	32.7	25.7	19.4	53.3	41.3	20.2	36.8	13.9	26.8	20.0	32.8	30.5	23.4	13.3	13.0	9.7	17.6	52.7	22.4	3.1	8.8	8.5	4.8	10.7	6.2	3.8	6.2	7.7	11.6	8.5	5.6	5.8	4.2	6.3	9.6	13.5	6.0	5.7	32.3	25.0	51.5	49.0	29.2	18.0	22.0	21.1	28.5	12.1
USP11	UHX1	ENSG00000102226	"Ubiquitin specific peptidase 11"	P51784	X	47232690-47248328	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 74.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003103, HPA037536"	Enhanced	Supported	Supported	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA003103: AB_10671088, HPA037536: AB_10672904"	"unprognostic (1.60e-1)"	"unprognostic (2.77e-3)"	"unprognostic (5.84e-2)"	"prognostic unfavourable (2.95e-4)"	"unprognostic (3.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.11e-3)"	"unprognostic (9.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.52e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.74e-2)"	"prognostic favourable (4.13e-5)"	"unprognostic (3.14e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.51e-2)"	"unprognostic (7.11e-2)"	11.5	17.3	32.9	11.5	55.0	4.9	9.4	35.7	74.0	17.5	9.1	19.9	5.8	6.0	22.6	12.7	9.7	26.6	12.8	20.6	27.0	44.0	13.6	6.7	12.5	13.8	23.1	47.4	38.2	13.8	28.4	32.3	12.6	27.8	15.7	7.6	17.9	9.3	21.3	13.7	7.8	7.3	19.1	17.0	13.5	9.1	19.2	14.6	19.0	27.2	4.3	14.3	11.0	9.8	21.0	20.6	22.8	8.7	19.8	31.7	16.4	14.3	22.6	38.9	26.5	14.7	9.9	10.8	11.0	17.3	21.9	24.5	21.5	11.8	9.5	8.7	19.8	17.1	31.5	7.7	19.5	14.7	23.9	11.1	17.9	19.1	17.1	12.4	23.2	14.2	3.2	23.1	9.9	8.7	8.3	1.3	17.0	21.8	24.1	13.3	28.9	20.2	27.2	38.1	7.9	10.7	19.8	22.0	37.8	20.1	4.1	11.9	8.5	7.2	9.1	18.5	19.5	26.0	12.5	17.7	11.1	16.6	11.4	15.5	16.4	22.8	3.5	7.4	22.6	7.4	19.9	20.1	10.2	22.1	4.6	21.0	15.4	31.7	2.2	19.8	8.7	20.6	12.7	16.4	32.9	55.0	35.7	74.0	27.0	44.0	23.1	47.4	27.8	14.6
ZNF157	HZF22	ENSG00000147117	"Zinc finger protein 157"	P51786	X	47370583-47414305	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.4;epididymis: 4.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.5;SH-SY5Y: 2.9;U-266/84: 6.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA003319	Uncertain									"HPA003319: AB_1080677"	"unprognostic (1.85e-1)"	"unprognostic (3.99e-1)"		"unprognostic (7.24e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.02e-2)"		"unprognostic (7.38e-4)"	"unprognostic (2.99e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.59e-4)"	"unprognostic (5.36e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.51e-2)"	"unprognostic (7.15e-2)"	"unprognostic (4.92e-2)"	0.1	0.3	0.8	0.2	1.0	0.4	0.3	4.4	1.6	0.6	0.1			0.2	0.7	4.4	0.2	3.8	0.1	0.1	0.8	1.0	0.6	0.0	0.1	1.4	0.8		1.0	0.1	2.3	3.0	0.0		0.5	0.1		0.2	0.7	0.1	0.3	0.2	0.5	0.9	0.4	0.1	0.8			1.4		0.8	0.3	0.3	1.4	0.7	1.3	0.3	0.7	2.8	0.9	0.0	0.3	1.0	0.1	0.3	0.3	0.2	0.0	0.0	0.2	0.5	0.1	0.3	1.4	0.7	0.3	0.0	2.5	1.3	0.2	0.1	1.1	0.5	0.4	0.0	0.0	0.0	0.5	0.3	0.0	1.4	0.1	0.0	0.1	3.5	0.4	0.0	1.0	0.3	2.1	0.1	0.3	0.0	0.0	0.5	0.2	2.6	2.9	0.0	0.3	0.2	1.6	0.3	0.0	1.1	1.1	0.1	0.1	1.9	6.0	1.7	0.3	0.1	0.0	0.7	0.3	0.4	0.4	0.3	0.2	1.4	0.5	2.2	0.1	1.2	2.8	1.8	1.3	0.7	0.3	0.7	0.8	0.9										
ZNF41	"MGC8941, MRX89"	ENSG00000147124	"Zinc finger protein 41"	P51814	X	47445879-47482946	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA069102	Supported		Approved	Nucleoplasm				Nucleoplasm		"HPA069102: "	"unprognostic (9.63e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.72e-2)"	"unprognostic (6.87e-2)"	"prognostic favourable (8.32e-4)"	"unprognostic (3.72e-1)"	"unprognostic (5.66e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.23e-2)"	"prognostic favourable (6.95e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.92e-3)"	8.8	8.0	8.5	11.8	12.2	2.4	10.2	15.2	12.1	10.6	9.5	8.4	8.6	6.8	8.6	9.4	8.3	7.2	9.8	15.2	8.9	7.9	8.8	8.8	8.8	9.4	8.9	8.6	8.8	10.1	20.0	13.8	7.9	9.3	9.3	11.5	7.1	11.0	8.4	26.7	7.6	9.1	9.8	7.9	10.7	8.5	4.3	11.1	12.8	11.5	9.2	11.5	9.7	8.5	6.9	6.5	4.8	6.2	5.6	7.9	4.0	5.9	6.5	5.4	13.7	6.6	7.4	3.7	8.2	6.8	7.1	8.2	3.7	6.5	8.5	4.5	10.7	9.4	12.1	5.6	8.9	13.4	4.6	2.0	9.0	2.3	4.6	8.4	7.7	5.4	7.2	8.1	10.6	6.4	6.1	9.3	8.9	8.8	8.7	4.6	9.1	10.2	8.2	7.0	8.7	5.4	10.1	7.5	7.6	12.0	9.5	4.7	9.8	4.7	9.6	7.6	5.9	15.2	5.8	6.8	9.1	9.2	6.5	17.0	8.0	1.4	4.7	4.8	6.5	6.2	7.9	4.9	5.9	7.2	6.5	6.9	6.7	6.1	1.1	5.6	3.0	4.3	4.8	4.0	8.5	12.2	15.2	12.1	8.9	7.9	8.9	8.6	9.3	11.1
ARAF	ARAF1	ENSG00000078061	"A-Raf proto-oncogene, serine/threonine kinase"	P10398	X	47561100-47571920	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046188, HPA066326"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoli fibrillar center"	Nucleoplasm	"HPA046188: AB_2679578, HPA066326: AB_2685659"	"unprognostic (1.21e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.63e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.75e-2)"	"unprognostic (8.65e-2)"	"prognostic favourable (1.45e-6)"	"unprognostic (1.97e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.71e-2)"	22.2	24.2	10.9	16.5	15.5	41.9	19.5	16.0	13.7	18.0	23.2	21.1	24.1	17.8	21.3	18.4	19.4	18.7	21.0	28.6	12.8	7.3	28.0	49.6	21.8	20.2	16.4	9.5	23.4	35.1	28.1	16.9	25.3	13.5	23.5	15.8	25.4	22.1	18.5	60.8	18.9	23.8	18.6	11.2	27.4	24.2	10.2	16.3	27.7	23.1	23.9	27.3	20.2	16.9	23.9	34.3	36.1	38.4	22.4	29.1	27.5	19.9	28.8	12.3	19.9	18.8	15.0	16.7	16.8	17.8	25.2	23.3	23.4	24.5	11.9	13.9	22.6	28.2	21.8	23.3	14.5	21.8	25.6	11.9	30.5	12.1	26.5	23.6	36.5	19.7	23.7	24.0	21.1	19.4	22.0	23.5	17.0	33.8	17.1	25.4	17.7	32.2	15.9	16.1	26.8	14.4	19.1	14.0	10.8	18.2	16.8	9.9	31.6	17.8	18.4	16.4	18.4	32.7	17.0	30.5	19.5	9.2	21.8	26.7	13.0	23.9	29.0	36.1	29.1	35.4	26.9	21.4	25.5	26.7	34.3	23.9	22.7	26.7	23.6	22.4	38.4	24.7	25.1	27.5	10.9	15.5	16.0	13.7	12.8	7.3	16.4	9.5	13.5	16.3
SYN1		ENSG00000008056	"Synapsin I"	P17600	X	47571898-47619943	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"brain: 127.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 6.9;HHSteC: 6.4;NTERA-2: 13.5;SCLC-21H: 23.6;SH-SY5Y: 6.1"	"Cancer enhanced"	"Detected in many"		"glioma: 11.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000397, CAB021929"	Enhanced									"CAB021929: , HPA000397: AB_1080146"	"unprognostic (1.22e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.48e-3)"	"unprognostic (3.05e-3)"	"unprognostic (7.57e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.31e-1)"	"unprognostic (3.49e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.64e-4)"	"unprognostic (2.73e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.95e-3)"	"unprognostic (5.27e-2)"	1.7	7.1	31.8	2.9	33.3	2.0	1.3	34.4	127.0	1.7	1.9	2.1	0.0	1.4	1.6	1.9	1.5	2.1	2.5	7.6	33.6	24.9	1.4	1.8	1.7	1.3	13.3	27.1	2.5	2.0	2.1	6.1	3.4	24.0	2.0	2.1	0.9	1.3	2.0	1.5	1.7	2.0	2.0	3.7	1.3	1.9	2.4	2.1	0.0	1.2	0.0	1.5	1.9	0.1	0.0	0.8	0.0	0.6	0.0	0.9	0.0	0.0	0.0	3.8	0.5	0.1	0.8	0.0	0.6	0.1	1.1	0.3	0.0	0.0	0.0	1.2	0.1	6.9	0.3	0.0	0.3	0.5	0.1	0.3	0.0	0.0	6.4	0.0	1.7	1.5	0.0	1.1	0.3	0.0	0.4	0.2	0.2	0.2	0.2	0.2	13.5	0.1	0.0	0.0	0.2	0.0	0.0	23.6	6.1	0.0	0.0	0.1	1.7	0.0	0.2	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.9	0.0	0.0	0.6	0.8	0.0	0.0	31.8	33.3	34.4	56.9	33.6	24.9	13.3	27.1	24.0	2.1
TIMP1	"CLGI, EPO, TIMP"	ENSG00000102265	"TIMP metallopeptidase inhibitor 1"	P01033	X	47582313-47586789	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 293.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 161.3;ASC TERT1: 216.0;HSkMC: 148.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB022360, HPA053417"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	116666667	750000000	"Golgi apparatus"		"CAB022360: , HPA053417: "	"unprognostic (5.86e-3)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (2.09e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.07e-3)"	"unprognostic (4.99e-2)"	"unprognostic (8.24e-3)"	"unprognostic (9.12e-3)"	"unprognostic (9.69e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavourable (2.90e-11)"	"unprognostic (1.88e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.66e-1)"	80.2	82.3	6.3	154.0	12.8	9.2	31.8	3.3	8.4	63.5	29.1	6.5	27.2	6.1	48.9	109.6	34.9	53.5	110.9	105.7	9.2	5.5	71.2	115.9	144.8	293.3	8.4	4.8	149.3	22.2	41.8	48.7	125.5	29.5	62.9	19.0	33.4	45.9	42.0	26.1	11.6	13.2	64.5	14.6	69.3	19.3	71.9	4.6	8.8	98.6	14.6	34.8	121.0	46.8	2.3	56.8	57.1	91.5	9.4	26.4	39.7	9.4	15.8	7.7	91.3	161.3	216.0	1.9	102.5	84.8	32.0	25.9	6.2	17.8	0.1	13.5	131.9	9.4	4.2	43.5	20.7	19.1	10.0	9.7	11.5	9.6	107.4	6.5	124.3	148.0	11.1	97.4	20.7	14.3	15.0	7.2	52.9	18.4	0.1	25.0	8.6	33.2	0.1	15.9	8.4	51.5	6.6	0.1	0.4	60.8	0.4	12.9	0.8	12.6	13.8	47.9	50.5	56.5	10.0	3.0	6.4	0.3	139.3	15.7	31.1	29.5	54.6	0.8	16.2	91.5	16.0	2.3	26.4	14.3	56.8	1.2	8.6	7.7	57.1	9.4	83.6	1.6	10.7	39.7	6.3	12.8	3.3	5.3	9.2	5.5	8.4	4.8	29.5	4.6
CFP	PFC	ENSG00000126759	"Complement factor properdin"	P27918	X	47623172-47630305	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 106.7;bone marrow: 39.4;lymphoid tissue: 41.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 20.7;HEL: 4.5;HMC-1: 5.1;NB-4: 9.9;U-937: 6.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	9	"classical monocyte: 102.4;intermediate monocyte: 106.7;myeloid DC: 86.2;neutrophil: 64.3;non-classical monocyte: 70.6"	"Group enriched"	"Detected in many"	40	"dendritic cells: 86.2;granulocytes: 64.3;monocytes: 106.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"		8500000000				"unprognostic (2.77e-3)"	"unprognostic (2.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.15e-2)"	"unprognostic (9.66e-5)"	"unprognostic (9.90e-3)"	"unprognostic (1.30e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.17e-1)"	3.3	1.0	0.7	10.3	0.9	39.4	1.6	0.7	0.6	0.6	2.0	0.2	0.6	0.5	0.7	3.1	1.8	2.5	2.1	4.3	0.6	0.6	1.3	21.6	8.7	41.3	0.4	0.0	0.7	0.4	0.0	0.7	1.6	0.3	0.8	0.4	1.2	3.1	0.6	1.4	1.0	2.1	2.6	0.4	39.3	1.1	0.8	0.0	6.0	0.9	1.3	5.6	2.1	0.9	0.4	86.2	64.3	106.7	1.1	2.1	70.7	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.7	0.0	0.1	0.1	0.0	0.0	0.0	0.2	4.5	0.1	0.0	0.1	1.1	5.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	9.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.9	0.0	0.0	0.5	0.1	0.4	0.3	0.1	0.1	6.9	0.0	9.0	102.4	3.2	0.2	106.7	0.2	0.4	1.4	0.1	86.2	0.1	2.1	0.7	64.3	1.1	70.6	2.7	1.1	70.7	0.7	0.9	0.7	0.6	0.6	0.6	0.4	0.0	0.3	0.0
ELK1		ENSG00000126767	"ELK1, ETS transcription factor"	P19419	X	47635521-47650604	"Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003808, HPA036084, HPA064381"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB003808: AB_562282, HPA036084: , HPA064381: "	"unprognostic (2.25e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.39e-2)"	"prognostic unfavourable (3.25e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.67e-2)"	12.1	20.9	37.2	10.8	52.2	11.5	8.2	32.6	32.9	11.1	9.4	4.9	14.6	8.1	11.4	17.5	8.5	13.1	9.9	12.4	23.3	11.6	7.7	19.0	8.9	10.4	5.7	22.7	37.7	9.8	12.0	7.5	13.7	6.7	9.3	9.8	7.4	9.8	11.3	17.9	8.6	8.5	10.8	4.4	14.3	7.5	19.1	11.2	8.7	6.9	8.3	11.5	8.9	6.7	7.4	11.7	3.9	9.5	4.2	12.7	6.3	17.1	13.6	7.0	19.3	12.1	14.7	9.7	14.5	17.3	17.8	18.4	9.4	13.0	13.6	8.0	15.7	10.5	18.4	15.5	16.9	15.1	17.5	11.3	12.5	8.5	26.8	12.3	19.9	14.1	14.1	28.5	19.2	10.2	23.4	16.1	14.5	22.7	13.0	14.1	16.2	28.8	14.1	17.6	21.3	9.5	7.5	15.1	12.6	24.4	8.7	20.5	22.1	7.9	8.1	20.4	21.1	26.5	13.5	26.7	36.7	14.1	22.6	22.4	12.7	2.0	8.1	3.4	7.4	9.5	8.6	7.4	9.5	8.6	11.7	6.7	8.4	6.8	3.9	4.2	7.8	8.2	12.7	6.3	37.2	52.2	32.6	32.9	23.3	11.6	5.7	22.7	6.7	11.2
UXT	"ART-27, STAP1"	ENSG00000126756	"Ubiquitously expressed prefoldin like chaperone"	Q9UBK9	X	47651798-47659161	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Chaperone, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050499, HPA058400"	Approved		Supported	"Nucleoplasm,Centriolar satellite"				"Centriolar satellite"	Nucleoplasm	"HPA050499: , HPA058400: "	"unprognostic (1.12e-1)"	"unprognostic (3.85e-3)"	"unprognostic (9.08e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.09e-3)"	30.9	37.4	21.7	33.7	23.6	54.4	38.9	20.0	27.3	26.7	31.9	24.8	33.5	23.2	26.8	39.8	30.1	32.4	31.3	47.3	20.9	16.5	34.7	66.8	24.9	46.1	23.6	24.9	50.5	54.1	21.4	29.6	39.0	26.0	30.0	31.1	19.5	46.5	30.5	42.1	36.2	29.1	21.1	27.6	37.1	31.9	24.7	22.6	50.4	37.0	33.2	41.6	24.5	32.5	58.2	60.2	26.2	35.8	36.0	73.5	52.0	44.8	49.8	21.2	28.2	48.6	58.7	37.3	29.1	42.6	50.0	47.5	42.7	42.8	51.5	21.2	41.5	36.4	30.1	39.8	35.7	33.6	59.8	25.9	56.7	42.2	56.7	57.1	51.0	41.2	51.1	42.1	45.3	40.2	28.2	49.8	42.3	49.4	38.9	79.5	30.5	56.9	34.7	43.1	70.7	40.2	33.1	20.2	26.4	32.3	35.3	45.0	41.4	52.9	29.3	35.0	38.2	48.1	31.9	39.4	34.7	46.2	44.6	63.5	35.3	18.7	35.8	26.2	40.2	35.5	54.1	58.2	57.7	43.2	47.4	56.7	73.5	60.2	23.0	36.0	32.4	60.2	52.9	52.0	21.7	23.6	20.0	27.3	20.9	16.5	23.6	24.9	26.0	22.6
ZNF81	"HFZ20, MRX45"	ENSG00000197779	"Zinc finger protein 81"	P51508	X	47836902-48002561	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA001689	Approved									"HPA001689: "	"unprognostic (1.61e-1)"	"unprognostic (8.70e-2)"	"unprognostic (7.26e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.82e-4)"	"unprognostic (5.20e-2)"	"unprognostic (4.85e-3)"	"unprognostic (6.37e-2)"	"unprognostic (6.49e-2)"	"unprognostic (5.00e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.65e-2)"	5.5	5.6	8.8	6.9	12.2	7.7	6.0	9.3	12.4	6.4	6.6	9.8	8.0	4.6	8.2	7.0	6.6	5.5	5.3	9.6	7.7	5.3	7.4	5.8	7.1	6.4	12.3	7.3	8.5	4.9	16.8	23.5	5.8	10.4	7.2	8.5	6.1	6.1	7.1	6.6	12.3	6.3	7.0	12.5	7.5	5.1	3.5	11.3	7.8	8.7	3.1	8.0	6.7	7.4	2.3	3.7	6.8	3.8	5.6	3.0	2.5	2.5	8.9	5.1	4.1	4.5	5.3	2.7	3.7	2.6	3.9	3.2	4.0	2.6	4.9	2.2	2.8	3.7	7.6	3.4	3.3	6.9	6.4	6.3	6.2	1.0	3.3	7.7	5.3	3.3	3.0	5.9	4.0	3.3	6.8	5.8	4.1	4.8	5.4	1.7	5.8	3.5	3.9	6.8	4.6	1.3	3.2	5.4	7.4	9.3	2.1	2.5	4.4	2.2	7.8	3.4	6.2	6.3	2.7	5.4	17.3	4.1	5.0	5.9	3.5	3.5	3.7	6.8	3.0	3.8	1.0	1.4	2.4	2.2	3.7	2.3	2.8	1.4	4.5	5.6	2.7	2.3	1.7	2.5	8.8	12.2	9.3	12.4	7.7	5.3	12.3	7.3	10.4	11.3
ZNF182	"HHZ150, KOX14, Zfp182, ZNF21"	ENSG00000147118	"Zinc finger protein 182"	P17025	X	47974851-48003978	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059574	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA059574: "	"unprognostic (1.86e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.51e-3)"	"prognostic unfavourable (3.73e-4)"	"unprognostic (1.88e-3)"	"unprognostic (6.88e-2)"	"unprognostic (8.81e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.42e-2)"	"prognostic unfavourable (2.42e-5)"	"unprognostic (1.01e-1)"	"unprognostic (9.49e-2)"	"unprognostic (8.59e-2)"	"prognostic favourable (1.55e-7)"	6.8	6.9	10.2	7.3	15.2	8.7	8.8	22.1	12.9	8.3	6.5	7.1	5.4	5.7	8.1	9.7	4.7	7.6	6.5	5.0	9.1	6.4	7.7	7.3	7.0	11.9	10.2	7.1	9.9	9.4	11.0	16.9	6.7	9.9	8.4	7.1	4.7	6.1	7.7	4.2	7.3	7.9	6.1	7.7	12.6	7.3	5.8	12.9	16.1	13.2	3.5	12.1	7.0	8.7	7.9	4.3	7.4	8.5	4.9	9.0	4.4	3.7	5.0	6.4	6.1	3.7	4.1	2.5	4.8	5.7	7.1	8.5	3.9	5.1	9.7	3.6	3.1	4.7	10.4	2.8	8.6	6.8	6.1	4.9	6.4	4.9	4.6	8.9	7.9	3.5	6.0	5.9	7.2	4.2	4.1	7.3	6.5	2.8	6.9	16.0	10.0	5.9	5.9	12.0	10.6	6.2	2.6	5.9	8.1	7.9	2.6	4.5	6.4	7.8	4.2	5.7	6.2	8.0	4.0	9.6	7.8	7.6	3.9	7.7	3.7	3.1	3.4	7.0	6.2	3.4	7.0	7.9	5.6	5.7	4.3	5.6	9.0	7.5	7.4	4.9	8.5	3.2	5.2	4.4	10.2	15.2	22.1	12.9	9.1	6.4	10.2	7.1	9.9	12.9
ZNF630	"BC037316, dJ54B20.2, FLJ20573, MGC138344"	ENSG00000221994	"Zinc finger protein 630"	Q2M218	X	47983356-48071658	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SiHa: 7.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA001053, HPA068130"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA001053: , HPA068130: "	"unprognostic (1.03e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.86e-3)"	"unprognostic (5.83e-2)"	"unprognostic (9.06e-3)"	"unprognostic (8.68e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (7.51e-5)"	4.0	5.2	5.3	6.4	9.0	2.1	6.7	8.8	8.5	7.0	5.4	5.9	11.3	3.5	6.3	7.5	5.0	4.8	5.8	5.9	6.0	4.6	5.2	3.0	5.0	5.4	12.3	5.8	11.2	8.3	11.9	10.1	4.9	8.8	8.4	6.2	6.4	6.1	6.9	2.3	4.0	4.2	7.5	7.3	4.8	6.8	1.8	10.1	1.0	9.3	1.5	3.6	8.4	13.7	2.6	3.8	5.8	1.9	1.5	2.8	2.0	1.4	1.1	0.3	0.0	0.1	0.1	0.0	1.9	0.6	1.0	0.9	3.3	5.4	0.1	1.0	2.0	2.3	0.0	1.0	1.3	0.0	0.0	0.0	1.4	0.0	1.4	0.0	0.0	1.3	5.7	3.2	0.0	1.0	0.0	5.4	3.6	5.7	0.0	0.0	2.1	1.6	0.7	1.3	0.0	2.5	3.0	3.2	2.6	7.1	4.8	2.1	5.7	1.4	1.2	0.0	2.6	2.5	0.0	0.0	4.7	0.0	0.0	0.1	4.5	5.8	1.9	4.8	2.2	1.0	2.4	2.6	2.0	2.0	3.8	1.8	2.5	2.8	2.1	1.5	0.6	0.9	1.1	2.0	5.3	9.0	8.8	8.5	6.0	4.6	12.3	5.8	8.8	10.1
SPACA5	"dJ54B20.3, LYC5, LYZL5, PNPK6288, SLLP2, UNQ6288"	ENSG00000171489	"Sperm acrosome associated 5"	Q96QH8	X	48004336-48009729	"Enzymes, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 15.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.3;NB-4: 3.9;RPMI-8226: 1.1;T-47d: 1.1;U-266/70: 1.2;U-266/84: 2.0"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"T-reg: 1.9"	"Low lineage specificity"	"Detected in single"											"HPA044747, HPA047149"	Supported				"Secreted in male reproductive system"					"HPA044747: , HPA047149: "																		0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.2	0.4	0.0	0.0			0.0	0.2	0.8	0.0	0.3	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.5	0.4		0.3	1.4	0.0	0.0	0.0		0.2	0.0		0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.0	0.0	15.1			1.3		0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.9	0.9	0.0	0.4	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.4	0.0	0.7	0.0	1.2	2.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.8	1.9	0.3										
SPACA5B	LYZL5B	ENSG00000171478	"Sperm acrosome associated 5B"	Q96QH8	X	48130657-48132613	"Enzymes, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 18.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	19	"T-reg: 1.9"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.9"									"HPA044747, HPA047149"	Supported				"Secreted in male reproductive system"					"HPA044747: , HPA047149: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0										
SSX5		ENSG00000165583	"SSX family member 5"	O60225	X	48186220-48196763	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"testis: 4.3;thyroid gland: 2.9"	"Cell line enriched"	"Detected in some"	4	"BEWO: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045683	Uncertain		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA045683: "									"unprognostic (1.20e-1)"						"unprognostic (2.96e-1)"	"unprognostic (1.23e-1)"		0.4	0.0	0.1	0.1	0.4	1.0	0.1	0.1	0.1	0.1	1.2	0.1	0.1	0.0	0.5	0.2	0.1	0.8	0.1	0.8	0.1	0.1	0.1	0.1	0.2	0.3	0.1	0.1	0.3	0.1	1.6	0.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.6	0.2	0.1	0.1	0.8	0.0	4.3	0.1	0.1	2.9	0.1	0.1	0.1	0.1	0.5	0.2	0.9	0.2	0.6	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.6	1.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.2	0.4	0.3	0.4	0.1	0.5	0.1	0.4	0.9	0.6	0.0	0.2	0.2	0.0	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
SSX1	CT5.1	ENSG00000126752	"SSX family member 1"	Q16384	X	48255317-48267444	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	14	"testis: 12.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 28.1;Karpas-707: 40.8;U-2197: 9.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045683	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA045683: "					"unprognostic (2.25e-1)"		"unprognostic (3.51e-3)"		"unprognostic (2.36e-1)"	"unprognostic (4.32e-3)"				"unprognostic (3.38e-1)"	"unprognostic (5.41e-2)"	"unprognostic (6.94e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.9	0.4	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	40.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	9.5	0.0	0.0	2.0	0.0	2.3	0.0	0.0	0.9	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX3	CT5.3	ENSG00000165584	"SSX family member 3"	Q99909	X	48346428-48356707	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 18.0"	"Cell line enriched"	"Detected in some"	4	"Karpas-707: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											HPA045683	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA045683: "															"unprognostic (1.86e-1)"	"unprognostic (2.13e-2)"		0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	1.6	0.2	0.4	0.4	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.1	0.4	0.0	0.0	0.4	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	1.6	0.5	0.2	0.2	0.0	0.0	1.6	0.2	0.8	0.3	0.1	0.2	0.8	0.3	0.4	0.0	0.9	0.4	0.4	0.2	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX4	CT5.4	ENSG00000268009	"SSX family member 4"	O60224	X	48383516-48393347	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	14	"testis: 6.8"	"Group enriched"	"Detected in some"	10	"BEWO: 3.5;Karpas-707: 8.6;U-266/70: 5.1;U-266/84: 9.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045683	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA045683: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.3	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	8.6	0.0	0.0	0.0	0.0	0.3	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	5.1	9.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0										
SSX4B	OTTHUMT00000056510	ENSG00000269791	"SSX family member 4B"	O60224	X	48402078-48411910	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	14	"testis: 6.7"	"Group enriched"	"Detected in some"	10	"BEWO: 3.5;Karpas-707: 8.6;U-266/70: 5.1;U-266/84: 9.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045683	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA045683: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.1	0.0	0.4	0.0	0.3			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	6.7			0.0		0.0	0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	8.6	0.0	0.0	0.0	0.0	0.3	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	5.1	9.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0										
SLC38A5	"JM24, SN2"	ENSG00000017483	"Solute carrier family 38 member 5"	Q8WUX1	X	48458537-48470256	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pancreas: 87.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 53.2;HeLa: 52.4;hTCEpi: 39.6;Karpas-707: 46.8;RPMI-8226: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047411	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	Cytosol	"HPA047411: AB_10964355"	"unprognostic (2.81e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.92e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.75e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.80e-3)"	"prognostic unfavourable (2.13e-4)"	"unprognostic (2.99e-2)"	"prognostic unfavourable (2.22e-16)"	"unprognostic (1.27e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.20e-1)"	1.5	0.9	5.3	4.7	7.1	17.3	0.9	3.5	11.6	4.0	4.9	7.7	0.1	5.1	1.8	1.3	3.7	2.0	1.5	2.4	6.9	5.7	0.7	0.4	9.4	3.3	7.0	2.7	3.7	87.7	0.4	0.4	2.8	14.6	5.1	6.4	1.5	4.4	3.7	0.4	8.0	3.5	2.8	7.3	4.8	4.5	0.5	4.6	2.4	7.9	3.6	3.4	4.8	3.1	7.4	8.3	0.3	0.4	5.4	16.2	5.7	22.5	0.0	0.0	0.2	0.4	2.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	23.7	0.0	9.9	34.9	27.0	53.2	0.0	7.5	0.0	12.9	52.4	16.3	3.9	26.3	0.0	3.7	39.6	0.4	0.1	0.4	23.6	46.8	5.3	0.0	5.7	9.1	12.2	0.1	20.9	0.1	86.2	0.0	0.0	2.2	0.1	0.0	0.1	0.0	0.0	1.1	0.7	0.1	0.0	0.0	0.0	0.0	0.1	8.5	0.2	0.1	0.1	0.0	0.2	0.2	11.5	0.4	16.2	7.4	12.6	10.8	1.5	4.7	6.0	7.7	0.3	5.4	0.0	8.3	13.0	5.7	5.3	7.1	3.5	11.6	6.9	5.7	7.0	2.7	14.6	4.6
FTSJ1	"CDLIV, JM23, MRX44, MRX9, SPB1, TRM7, TRMT7"	ENSG00000068438	"FtsJ RNA methyltransferase homolog 1"	Q9UET6	X	48476021-48486364	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002718	Approved		Approved	Cytosol				Cytosol		"HPA002718: AB_1078914"	"unprognostic (2.56e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.77e-2)"	"prognostic unfavourable (1.74e-5)"	"unprognostic (1.95e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.96e-3)"	"unprognostic (2.06e-3)"	"unprognostic (7.82e-2)"	"prognostic unfavourable (5.24e-10)"	"unprognostic (2.61e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.23e-1)"	17.6	19.4	12.3	18.2	21.6	18.4	17.1	18.7	21.2	23.3	11.7	13.6	20.8	10.7	18.5	12.6	19.0	15.9	12.8	15.0	9.9	10.3	15.9	21.3	16.9	22.9	13.6	9.2	17.4	36.6	13.9	16.2	11.3	14.9	13.3	10.6	12.4	20.8	18.6	17.3	18.0	12.0	16.6	11.0	19.6	17.8	14.6	15.2	17.2	20.0	24.8	18.6	17.3	17.2	17.1	16.8	10.7	16.1	15.9	26.9	15.1	25.5	17.7	6.8	26.9	9.7	10.2	11.1	12.6	12.1	18.4	14.6	10.5	35.9	14.9	9.4	19.2	17.3	13.5	44.3	8.3	11.3	12.7	9.5	22.4	11.8	27.7	13.0	24.0	9.5	22.4	23.1	22.8	12.8	8.0	12.5	23.8	14.5	16.8	9.3	15.3	30.4	13.7	22.2	30.9	17.3	8.6	9.2	9.1	20.0	11.0	9.2	12.6	7.5	12.5	14.6	19.8	30.3	15.3	16.9	13.1	10.7	32.2	24.5	15.2	9.2	14.1	10.7	21.9	16.1	26.9	17.1	18.9	22.1	16.8	16.9	17.3	21.9	2.0	15.9	15.1	11.6	17.5	15.1	12.3	21.6	18.7	21.2	9.9	10.3	13.6	9.2	14.9	15.2
PORCN	"DHOF, MG61, por, PORC, PPN"	ENSG00000102312	"Porcupine O-acyltransferase"	Q9H237	X	48508962-48520814	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 59.9;LHCN-M2: 20.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049215, HPA058413"	Enhanced		Approved	Vesicles				Vesicles		"HPA049215: , HPA058413: "	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.35e-1)"	4.6	31.4	9.1	4.4	14.1	3.6	4.4	20.0	15.4	12.6	4.6	7.2	12.2	3.4	10.1	3.2	13.9	7.0	6.2	13.4	10.9	9.2	3.3	1.7	5.0	6.6	7.1	8.8	4.9	4.6	6.9	4.1	4.0	8.4	5.0	2.5	7.6	5.8	16.4	5.9	6.8	2.9	6.3	5.5	4.8	5.4	5.4	5.9	2.6	8.5	4.7	5.9	6.5	5.4	4.1	7.2	13.7	5.8	7.8	12.0	4.7	4.3	5.2	1.3	9.1	5.6	3.3	0.5	1.2	2.6	2.0	1.3	0.6	6.7	0.3	5.5	2.8	5.9	1.8	59.9	0.6	2.7	0.6	0.7	3.2	1.2	8.3	0.7	7.8	4.3	7.1	5.8	12.6	1.8	0.3	4.1	20.8	1.2	0.6	0.9	1.6	3.5	1.3	1.6	6.7	3.3	1.7	1.5	2.2	10.4	2.0	2.0	2.3	0.3	1.0	5.2	2.7	12.5	2.2	3.6	2.0	0.5	15.0	1.6	2.9	13.7	5.8	7.1	12.0	5.2	9.4	3.7	8.0	10.0	7.2	4.1	5.4	8.1	1.2	7.8	4.2	3.9	5.2	4.7	9.1	14.1	20.0	14.4	10.9	9.2	7.1	8.8	8.4	5.9
EBP	"CDPX2, CHO2, CPX, CPXD"	ENSG00000147155	"Emopamil binding protein (sterol isomerase)"	Q15125	X	48521158-48528716	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Isomerase	"Cataract, Disease mutation, Dwarfism, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003130	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA003130: AB_1078717"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.04e-2)"	"unprognostic (5.39e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.36e-1)"	3.7	33.2	5.3	4.3	5.7	10.5	10.5	10.1	6.3	8.6	19.6	2.8	3.4	17.2	4.0	3.7	20.6	3.9	4.5	21.7	4.7	4.3	12.8	74.1	14.9	13.0	3.5	8.0	4.8	11.7	6.0	3.7	4.2	8.8	8.6	15.7	5.2	8.7	4.8	3.5	9.1	30.0	5.6	7.0	7.9	8.1	5.4	2.8	9.0	4.6	9.8	10.4	5.0	10.0	17.1	22.9	21.5	12.6	13.3	29.9	18.1	33.0	7.0	18.6	11.1	10.4	7.7	6.0	8.5	7.1	11.3	16.3	13.9	55.3	17.9	6.0	5.9	37.3	31.1	45.9	8.6	13.7	15.5	9.0	9.4	11.9	7.6	33.2	22.4	7.5	16.7	15.1	11.2	7.5	11.5	17.0	9.2	14.5	18.4	20.4	18.6	23.0	12.8	1.8	50.7	27.6	5.9	15.8	8.0	31.3	16.1	4.4	17.7	7.9	7.8	5.8	9.8	22.4	9.2	7.3	11.4	18.1	13.5	33.5	5.5	17.4	8.9	21.5	29.9	11.7	25.1	17.1	22.2	27.5	12.3	12.6	20.1	25.5	1.8	13.3	12.6	22.9	22.4	18.1	5.3	5.7	10.1	6.3	4.7	4.3	3.5	8.0	8.8	2.8
TBC1D25	OATL1	ENSG00000068354	"TBC1 domain family member 25"	Q3MII6	X	48539457-48562609	"Predicted intracellular proteins"	Autophagy	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029197	Approved	Approved								"HPA029197: "	"unprognostic (2.16e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.19e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.75e-2)"	11.0	11.1	10.9	9.1	18.5	14.6	9.7	17.5	26.3	9.5	9.5	9.5	5.4	7.5	9.5	7.1	10.6	10.4	9.3	16.0	10.2	9.8	7.6	9.2	9.9	10.4	8.0	14.2	11.9	16.8	16.0	10.1	14.8	12.6	10.2	7.9	9.5	8.5	10.2	10.7	13.0	8.4	12.5	6.7	12.2	9.2	11.0	5.0	12.8	9.4	9.6	11.0	9.6	8.7	7.0	3.5	7.3	3.8	5.9	10.0	5.6	6.2	6.3	2.5	7.3	9.8	9.4	3.3	4.3	8.2	7.8	8.6	4.0	5.7	6.7	3.2	11.5	6.1	11.6	11.9	7.7	11.9	7.1	3.3	9.8	3.7	10.0	4.2	8.8	9.4	12.0	11.4	14.0	8.3	2.6	9.9	9.5	5.4	8.1	7.8	3.8	11.7	4.2	4.6	8.6	7.3	3.2	6.8	4.6	7.6	6.2	6.0	6.7	1.4	7.7	5.1	7.8	15.8	5.0	9.7	5.0	4.8	8.5	5.5	4.8	2.2	2.7	7.3	10.0	3.8	8.1	6.5	6.7	8.5	3.1	7.0	7.3	7.4	6.3	5.9	3.0	3.5	5.8	5.6	10.9	18.5	17.5	26.3	10.2	9.8	8.0	14.2	12.6	5.0
RBM3	IS1-RNPL	ENSG00000102317	"RNA binding motif protein 3"	P98179	X	48574449-48579066	"Predicted intracellular proteins"	"Stress response"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003624, CAB062559"	Enhanced		Enhanced	Nucleoplasm			24000	Nucleoplasm		"CAB062559: , HPA003624: AB_10602123"	"unprognostic (1.07e-2)"	"unprognostic (1.14e-3)"	"prognostic favourable (3.07e-7)"	"unprognostic (1.65e-3)"	"unprognostic (2.87e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-1)"	71.2	25.5	12.6	43.0	13.9	59.0	52.2	16.4	22.5	44.7	32.7	20.9	16.4	23.9	38.5	58.2	46.4	32.9	36.4	44.8	12.2	12.3	53.5	32.9	36.8	115.8	15.0	15.2	38.6	43.2	15.2	19.1	62.2	30.5	21.0	36.0	43.4	39.7	25.0	59.1	56.2	37.8	33.0	23.6	48.4	27.2	27.2	7.4	73.6	24.0	76.8	67.6	46.4	30.1	32.9	56.5	6.4	44.2	29.9	31.8	45.7	20.5	28.8	31.4	32.8	7.8	41.3	19.6	26.8	46.9	67.1	46.8	28.9	54.6	42.5	8.6	54.3	18.0	27.3	36.6	53.7	39.5	36.3	21.4	47.2	25.8	28.6	58.5	43.6	31.9	26.1	22.6	21.9	59.5	11.9	33.0	46.3	34.7	48.6	32.0	17.3	40.7	46.9	32.1	32.2	28.8	34.2	12.5	31.0	26.8	35.3	29.3	46.6	58.2	80.0	22.0	35.6	76.0	44.6	16.3	17.8	47.8	32.9	35.1	44.6	5.8	38.4	6.2	27.0	44.2	31.8	32.9	27.6	26.7	56.5	20.5	28.2	27.4	6.4	29.9	37.5	39.1	28.6	45.7	12.6	13.9	16.4	22.5	12.2	12.3	15.0	15.2	30.5	7.4
WDR13		ENSG00000101940	"WD repeat domain 13"	Q9H1Z4	X	48590042-48608867	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000913	Supported		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"				Nucleoplasm	"Plasma membrane, Centriolar satellite"	"HPA000913: AB_1858795"	"unprognostic (5.03e-2)"	"unprognostic (6.53e-3)"	"unprognostic (3.65e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.54e-3)"	"unprognostic (3.54e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.32e-2)"	24.5	30.4	39.9	13.9	36.9	15.7	19.1	14.4	33.9	18.6	25.5	17.6	41.5	23.0	26.0	41.2	23.1	30.8	21.1	49.8	30.2	18.9	24.2	50.2	19.3	11.1	20.0	35.8	35.0	74.7	21.8	24.4	23.9	17.0	19.6	14.4	16.5	30.4	35.8	48.5	21.7	22.0	20.2	17.5	17.4	22.7	11.0	20.5	8.6	21.9	21.1	10.5	17.9	19.7	16.8	21.1	29.2	28.2	17.3	13.8	15.9	14.9	22.0	11.0	34.0	15.2	22.4	8.4	10.4	19.0	12.1	11.1	13.0	24.1	10.4	10.0	21.2	12.9	5.5	22.7	4.3	12.3	9.7	7.1	25.9	23.6	34.6	6.1	19.4	21.1	32.5	17.1	31.5	16.5	7.0	13.3	16.7	21.5	8.4	10.7	7.9	17.3	8.1	11.7	18.8	21.3	11.9	12.8	15.9	11.7	24.5	24.0	15.6	11.9	27.3	12.6	18.7	19.8	9.9	15.5	5.7	3.8	18.6	9.2	17.3	29.2	23.1	12.7	11.9	24.7	9.5	16.8	12.6	11.3	21.1	13.4	10.0	11.4	16.0	17.3	28.2	13.3	13.8	15.9	39.9	36.9	14.4	33.9	30.2	18.9	20.0	35.8	17.0	20.5
WAS	"IMD2, THC, WASP, WASPA"	ENSG00000015285	"Wiskott-Aldrich syndrome"	P42768	X	48676596-48691427	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.7;lymphoid tissue: 55.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 21.3;HMC-1: 45.7;MOLT-4: 19.4;NB-4: 21.1;RPMI-8226: 26.0;U-266/70: 24.2;U-937: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 20.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002022, CAB004290"	Enhanced		Approved	"Plasma membrane,Cytosol"			320000	"Plasma membrane"	Cytosol	"CAB004290: AB_628445, HPA002022: AB_1080581"	"unprognostic (1.43e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.36e-2)"	"prognostic favourable (4.95e-4)"	"unprognostic (9.89e-2)"	"prognostic favourable (3.78e-4)"	"unprognostic (5.12e-3)"	"unprognostic (7.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.60e-1)"	"prognostic unfavourable (5.58e-6)"	"unprognostic (2.24e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.71e-1)"	7.6	4.0	4.9	28.9	7.8	30.7	3.3	2.0	5.1	2.7	4.4	5.9	0.5	4.8	2.4	5.6	3.7	4.5	4.4	3.0	4.6	4.1	4.1	5.0	12.6	29.9	7.6	1.3	2.6	2.2	0.7	2.6	5.4	6.0	3.2	3.2	3.5	5.4	1.9	1.4	2.2	14.3	3.7	12.8	55.9	4.1	1.7	7.3	53.2	2.8	1.4	33.2	5.8	2.5	2.1	3.5	20.3	5.3	2.1	3.2	2.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	21.3	0.0	0.0	0.7	0.0	0.0	0.0	12.2	0.1	18.8	0.2	0.0	0.2	9.6	45.7	0.0	0.0	0.0	0.0	0.0	0.2	13.1	0.0	2.1	19.4	21.1	0.1	0.1	16.9	0.0	26.0	0.0	0.0	0.1	0.2	0.3	0.2	0.2	0.1	19.2	0.1	0.0	0.1	0.3	0.0	24.2	11.8	14.9	0.1	24.4	0.0	1.8	4.6	20.3	3.0	5.0	2.2	1.8	2.3	2.5	3.5	2.1	2.1	2.3	18.1	2.1	5.3	1.8	3.2	2.0	4.9	7.8	2.0	5.1	4.6	4.1	7.6	1.3	6.0	7.3
SUV39H1	"KMT1A, SUV39H"	ENSG00000101945	"Suppressor of variegation 3-9 homolog 1"	O43463	X	48695554-48709012	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Differentiation, Host-virus interaction, rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (4.92e-2)"	"prognostic favourable (8.93e-5)"	"unprognostic (9.51e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (1.91e-7)"	"unprognostic (2.29e-3)"	"unprognostic (6.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (5.67e-2)"	5.7	3.3	6.5	6.4	7.6	18.0	4.9	8.7	12.5	7.0	5.1	9.3	6.0	5.1	5.7	20.7	7.3	5.3	3.4	6.0	6.0	8.3	5.0	9.2	4.6	10.8	8.8	6.9	6.5	4.4	3.6	4.7	9.3	6.7	4.5	5.4	8.3	6.5	5.4	6.9	7.0	6.0	4.7	6.2	9.5	5.2	6.7	5.9	21.2	3.9	6.4	10.7	4.8	3.5	5.8	2.8	7.1	6.4	10.7	11.7	6.8	14.7	18.1	7.1	7.5	1.8	2.2	14.6	7.1	5.5	13.9	11.4	11.0	9.9	16.3	4.3	5.2	10.4	17.6	10.1	8.4	12.4	18.0	6.4	16.7	8.9	1.1	15.7	3.6	1.9	2.0	12.3	6.3	9.9	16.2	11.5	7.5	17.0	13.5	16.5	8.4	17.6	9.9	13.2	17.3	4.6	8.2	9.4	6.2	9.7	9.4	5.2	13.9	13.2	5.3	8.6	14.8	11.9	12.0	7.9	11.9	13.8	6.4	22.7	9.4	4.5	3.0	7.1	9.8	4.4	7.2	5.3	6.5	10.3	2.4	5.8	8.1	7.7	2.1	10.7	6.4	2.8	11.7	6.8	6.5	7.6	8.7	12.5	6.0	8.3	8.8	6.9	6.7	5.9
GLOD5		ENSG00000171433	"Glyoxalase domain containing 5"	A6NK44	X	48761750-48773648	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 25.2;kidney: 10.2;liver: 7.8"	"Cell line enhanced"	"Detected in some"		"Hep G2: 2.2;K-562: 1.9;MCF7: 6.3;SCLC-21H: 1.3;T-47d: 1.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"eosinophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010667	Enhanced		Uncertain	Mitochondria				Mitochondria		"HPA010667: AB_1078975"	"unprognostic (1.03e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.78e-2)"	"unprognostic (7.04e-2)"		"unprognostic (3.14e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.80e-2)"		"unprognostic (2.64e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.05e-8)"	"unprognostic (2.08e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.07e-2)"	"unprognostic (6.79e-4)"	0.2	0.0	0.2	0.2	0.2	0.0	0.4	0.2	0.2	0.4	14.7	0.2	0.2	10.3	0.4	5.6	0.3	1.6	3.5	0.2	0.2	0.0	10.2	7.8	1.5	0.2	0.2	0.2	0.4	1.1	0.0	0.6	0.2	0.2	0.4	5.7	1.5	0.6	0.2	0.2	0.1	25.2	0.2	0.2	0.2	1.3	0.7	0.2	0.4	1.9	0.2	0.5	0.2	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.3	0.4	0.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
GATA1	"ERYF1, GATA-1, GF1, NF-E1, NFE1"	ENSG00000102145	"GATA binding protein 1"	P15976	X	48786554-48794311	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"blood: 78.3;bone marrow: 37.0"	"Group enriched"	"Detected in some"	9	"HEL: 49.6;HMC-1: 51.2;K-562: 52.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"eosinophil: 78.3"	"Lineage enriched"	"Detected in single"	784	"granulocytes: 78.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA000232, HPA000233, CAB009195"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB009195: AB_2232148, HPA000232: AB_1078949, HPA000233: AB_1078951"	"unprognostic (1.93e-1)"	"unprognostic (7.54e-2)"	"unprognostic (8.95e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.00e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.04e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.13e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.71e-2)"	0.7	0.2	0.1	2.4	0.7	37.0	0.3	0.0	0.3	0.7	0.3	0.0	0.0	0.6	4.9	2.4	0.4	0.3	0.6	2.3	0.1	0.3	0.4	0.8	5.6	0.2	0.6	0.0	0.1	0.1	0.1	0.5	2.8	0.3	1.4	0.4	1.6	0.3	0.2	0.1	0.6	0.8	2.4	0.3	4.9	0.5	3.1	0.0	1.5	0.6	1.1	0.6	0.9	0.6	0.0	0.0	78.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.6	0.0	0.0	0.0	0.0	51.2	0.0	0.0	0.0	0.0	0.0	52.8	0.1	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	78.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.1	0.7	0.0	0.3	0.1	0.3	0.6	0.0	0.3	0.0
HDAC6	"FLJ16239, HD6, JM21, KIAA0901, PPP1R90"	ENSG00000094631	"Histone deacetylase 6"	Q9UBN7	X	48801377-48824982	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation"	"Actin-binding, Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003714, CAB004236, HPA026321"	Supported		Supported	Nucleoplasm			39000	Nucleoplasm		"CAB004236: AB_627708, HPA003714: AB_1850544, HPA026321: AB_1850546"	"unprognostic (9.53e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.34e-1)"	"prognostic favourable (3.34e-4)"	14.6	13.7	23.4	12.8	29.8	19.0	14.4	34.2	30.1	12.7	14.1	24.4	14.9	16.9	16.0	14.7	13.1	15.7	11.7	11.9	21.7	24.8	32.8	43.3	15.1	13.9	27.2	22.4	18.7	15.5	26.7	24.4	15.1	27.0	12.3	15.9	15.1	12.2	15.3	18.2	11.3	16.1	15.0	20.9	15.3	14.2	24.7	22.4	19.0	15.7	9.5	14.0	11.7	12.1	5.7	9.7	6.3	12.4	4.0	5.8	5.0	16.0	13.6	26.7	10.2	10.8	9.8	18.1	7.7	6.5	14.8	14.6	13.1	13.7	15.4	7.4	8.7	11.5	16.2	8.2	12.8	14.4	10.2	21.1	16.2	13.4	10.2	9.7	32.7	14.2	13.3	11.6	14.0	12.3	23.1	17.1	9.3	5.6	13.8	15.3	9.9	13.0	11.9	28.8	15.9	8.5	6.9	13.8	13.6	15.4	4.6	9.2	19.3	9.1	10.0	11.5	14.9	15.8	7.3	15.8	15.6	11.2	11.7	12.5	11.4	0.0	5.8	6.3	5.8	9.7	4.1	4.3	4.0	4.2	8.6	5.7	3.9	3.7	2.9	4.0	12.4	9.7	4.4	5.0	23.4	29.8	34.2	30.1	21.7	24.8	27.2	22.4	27.0	22.4
ERAS	"HRAS2, HRASP"	ENSG00000187682	"ES cell expressed Ras"	Q7Z444	X	48826513-48830138	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.8;NB-4: 2.3;THP-1: 2.1"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"														"unprognostic (2.47e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.72e-4)"	"unprognostic (9.40e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.25e-2)"	0.1	0.2	1.7	0.0	1.7	0.7	0.0	4.2	2.7	0.2	0.2			0.0	1.0	0.3	0.1	0.4	0.1	0.0	1.1	5.5	0.5	1.1	0.4	0.0	1.2		0.7	0.0	0.9	1.4	0.2		0.2	0.0		0.7	1.1	0.6	1.0	0.4	0.6	1.0	0.2	0.0	2.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	1.2	0.3	0.2	0.0	0.5	0.5	0.0	0.0	0.3	0.0	2.8	0.5	0.0	0.1	0.0	0.2	0.5	1.6	0.4	0.0	0.5	0.0	0.8	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	2.3	0.8	1.0	0.4	0.3	0.0	0.3	0.1	0.1	0.4	0.0	0.3	0.6	0.0	2.1	0.0	0.0	0.8	0.5	0.0	0.6	0.6	0.4	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PCSK1N	"BigLEN, PEN, proSAAS, SAAS, SCG8, SgVIII"	ENSG00000102109	"Proprotein convertase subtilisin/kexin type 1 inhibitor"	Q9UHG2	X	48831094-48835633	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.9;kidney: 72.9;pituitary gland: 127.7"	"Cell line enhanced"	"Detected in some"		"HEK 293: 19.6;PC-3: 49.6;SCLC-21H: 19.7;SH-SY5Y: 18.2;SiHa: 17.2;U-266/84: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 3.0;memory CD4 T-cell: 6.5;memory CD8 T-cell: 6.3;naive CD4 T-cell: 2.7;naive CD8 T-cell: 8.2;T-reg: 2.1"	"Lineage enriched"	"Detected in single"	77	"T-cells: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003925, HPA064734"	Enhanced	Supported	Approved	Vesicles	"Secreted to blood"		5300000	Vesicles		"HPA003925: AB_1079582, HPA064734: AB_2685339"	"unprognostic (2.44e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (3.36e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.50e-3)"	"unprognostic (2.79e-3)"	"prognostic favourable (1.36e-4)"	"unprognostic (3.34e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.14e-1)"	4.1	27.5	49.1	2.6	72.7	2.1	2.2	15.6	70.3	3.2	9.8	10.8	1.5	12.4	4.4	10.9	2.1	2.3	2.8	2.7	38.5	74.9	72.9	2.1	2.6	2.2	33.5	29.0	2.2	20.0	12.4	127.7	2.3	32.9	4.6	2.7	6.6	2.8	3.1	2.2	2.8	8.5	2.7	18.3	2.4	26.0	3.8	9.8	0.0	2.2	0.0	2.1	2.1	0.5	0.1	0.0	0.0	0.0	0.0	8.2	0.8	0.0	1.8	0.0	5.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	3.5	0.0	0.2	0.0	0.3	0.0	0.0	19.6	0.0	0.0	2.9	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	2.7	49.6	0.0	0.0	0.1	0.4	0.0	19.7	18.2	17.2	0.0	1.4	0.0	0.0	0.0	0.0	7.6	0.0	1.6	4.5	22.9	0.0	0.1	0.0	0.5	0.0	0.0	0.0	1.1	0.0	3.0	0.0	6.5	6.3	0.0	0.1	2.7	8.2	0.0	0.0	0.0	0.0	2.1	0.8	49.1	72.7	15.6	70.3	38.5	74.9	33.5	29.0	32.9	9.8
TIMM17B	"DXS9822, JM3"	ENSG00000126768	"Translocase of inner mitochondrial membrane 17B"	O60830	X	48893447-48898143	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029093	Approved		Approved	Microtubules,Mitochondria				Microtubules	Mitochondria	"HPA029093: AB_10600913"	"unprognostic (7.87e-2)"	"prognostic favourable (6.63e-4)"	"unprognostic (8.44e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.67e-2)"	"unprognostic (9.40e-2)"	"unprognostic (5.24e-3)"	"unprognostic (8.67e-2)"	"prognostic favourable (7.88e-4)"	14.0	21.1	23.6	15.0	24.2	18.6	16.4	15.1	30.8	16.9	22.3	18.9	13.3	19.2	15.1	19.2	27.4	21.0	19.4	40.6	19.8	17.7	26.2	40.1	19.6	18.3	19.0	15.8	17.8	28.7	19.3	22.9	28.2	15.4	22.4	15.0	19.8	21.5	22.8	54.3	16.1	24.8	15.7	20.5	22.1	18.8	16.7	12.5	36.4	31.1	27.2	19.5	21.6	13.7	36.7	41.5	56.2	41.2	22.9	26.7	35.5	18.3	34.1	21.5	21.1	6.7	5.4	17.8	8.3	12.8	22.2	14.6	29.9	25.1	13.8	13.0	7.3	14.1	33.8	18.2	8.4	29.0	37.9	9.9	19.5	26.3	19.0	14.6	9.7	7.2	18.3	16.6	22.2	10.2	14.6	32.2	10.1	47.9	22.9	35.8	27.8	31.9	16.2	14.0	49.0	21.7	10.9	21.4	19.1	13.0	20.9	12.4	45.4	25.6	6.9	10.2	20.1	24.5	14.3	29.8	34.6	16.4	14.1	26.2	12.0	44.4	41.2	56.2	23.4	39.0	26.7	36.7	23.7	26.4	39.5	36.1	23.1	21.2	46.5	22.9	31.5	41.5	23.4	35.5	23.6	24.2	15.1	30.8	19.8	17.7	19.0	15.8	15.4	12.5
PQBP1	"MRX2, MRX55, MRXS3, MRXS8, RENS1, SHS"	ENSG00000102103	"Polyglutamine binding protein 1"	O60828	X	48897912-48903143	"Disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"		"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001880	Supported		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA001880: AB_1079671"	"unprognostic (7.25e-2)"	"prognostic favourable (1.48e-4)"	"unprognostic (5.98e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.48e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (2.68e-7)"	"unprognostic (2.68e-1)"	"unprognostic (2.52e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.70e-3)"	24.8	35.3	29.2	22.4	28.5	34.8	28.3	30.3	35.0	27.4	31.9	25.9	23.9	35.6	34.9	22.6	26.9	29.0	25.3	23.5	25.8	30.8	24.8	34.7	20.5	24.7	27.9	25.6	38.8	37.1	21.3	30.2	19.5	26.5	26.0	18.9	27.2	33.6	27.3	43.3	31.9	31.7	29.6	25.3	25.6	27.4	13.6	25.8	31.7	33.8	23.1	27.7	26.6	32.5	32.3	36.7	20.5	30.6	27.7	41.3	27.6	28.5	35.1	18.8	18.2	16.6	11.7	14.3	16.7	19.6	33.8	21.1	41.9	12.7	26.1	14.0	11.2	22.2	31.6	12.5	13.1	22.8	27.3	22.7	27.4	30.0	16.5	26.6	20.4	15.2	23.4	27.9	28.2	18.5	21.2	49.6	14.6	46.2	11.4	26.7	17.6	38.4	19.1	18.9	59.3	20.9	18.8	28.1	15.0	21.9	24.3	18.4	30.1	20.4	17.0	15.4	27.0	19.0	22.1	29.2	29.6	19.6	8.7	25.1	15.8	14.5	30.6	20.5	23.2	29.6	30.3	32.3	32.1	23.1	36.7	26.3	32.5	30.1	8.4	27.7	26.3	31.6	41.3	27.6	29.2	28.5	30.3	35.0	25.8	30.8	27.9	25.6	26.5	25.8
SLC35A2	"UGALT, UGAT, UGT, UGT1, UGT2, UGTL"	ENSG00000102100	"Solute carrier family 35 member A2"	P78381	X	48903180-48911958	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036087	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA036087: AB_10604093"	"prognostic unfavourable (3.16e-4)"	"unprognostic (3.34e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.15e-3)"	"unprognostic (4.25e-3)"	"prognostic unfavourable (9.64e-5)"	"unprognostic (3.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-3)"	"unprognostic (9.58e-2)"	"unprognostic (3.16e-2)"	"prognostic favourable (8.23e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.13e-2)"	11.4	17.2	10.5	9.7	12.2	10.9	21.9	5.9	18.4	16.2	22.7	20.5	13.4	13.5	11.5	24.2	17.2	23.1	14.3	12.8	10.3	10.9	18.8	43.6	14.5	18.9	12.0	9.7	10.6	30.6	18.8	16.2	29.8	12.7	14.1	23.1	10.3	16.9	14.7	12.9	15.9	13.0	9.0	13.8	12.1	19.8	8.8	10.3	8.8	13.3	12.5	13.0	11.3	11.4	7.5	18.5	24.2	15.7	7.8	10.9	6.9	20.4	23.7	8.0	11.5	17.3	14.1	11.9	21.1	20.6	21.2	25.6	25.5	36.2	7.7	10.0	23.2	29.5	21.7	16.3	17.6	10.1	14.7	8.5	14.9	19.9	20.2	16.1	18.4	15.0	27.5	18.6	17.7	12.4	16.1	12.8	15.6	19.5	7.9	13.3	16.8	28.8	8.5	14.4	23.5	19.2	16.8	9.4	15.2	22.0	23.9	12.0	35.2	12.7	8.9	12.8	13.1	23.0	11.9	19.9	13.5	8.4	15.5	13.3	15.7	11.4	14.4	24.2	10.2	15.7	10.9	7.5	9.2	9.6	17.5	7.3	5.8	10.6	15.9	7.8	10.6	18.5	8.8	6.9	10.5	12.2	5.9	18.4	10.3	10.9	12.0	9.7	12.7	10.3
PIM2		ENSG00000102096	"Pim-2 proto-oncogene, serine/threonine kinase"	Q9P1W9	X	48913182-48919024	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 63.4;lymphoid tissue: 71.2"	"Group enriched"	"Detected in many"	5	"HDLM-2: 58.9;Karpas-707: 73.0;RPMI-8226: 71.9;U-266/70: 133.0;U-266/84: 117.5"	"Cancer enriched"	"Detected in all"	6	"testis cancer: 171.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000285			Approved	Cytosol				Cytosol		"HPA000285: AB_1079619"	"unprognostic (2.34e-3)"	"prognostic favourable (4.05e-5)"	"unprognostic (8.04e-2)"	"unprognostic (7.30e-2)"	"unprognostic (6.41e-3)"	"unprognostic (2.74e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.73e-1)"	"prognostic unfavourable (1.17e-11)"	"unprognostic (3.36e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.38e-2)"	3.6	3.4	4.3	37.2	7.2	30.4	3.4	7.1	7.9	4.5	13.4	2.1	2.2	29.5	2.8	4.3	10.0	5.6	8.3	3.1	5.6	6.7	5.2	5.4	10.6	59.7	3.8	4.6	5.4	3.0	1.0	4.9	2.4	6.7	3.6	17.7	6.1	16.9	4.9	1.5	3.0	19.2	2.2	3.1	71.2	14.7	5.7	1.3	39.4	4.8	3.6	47.9	24.6	3.3	26.0	2.9	46.9	3.0	17.0	63.4	13.2	1.8	1.5	0.8	1.6	0.3	0.2	1.2	1.1	1.4	1.6	1.4	1.4	1.3	7.8	0.5	0.5	1.1	2.6	1.0	1.5	58.9	2.1	9.4	1.6	1.4	0.7	2.2	6.4	0.6	0.9	1.6	1.0	0.5	10.0	73.0	0.9	1.3	0.8	4.7	17.8	2.4	1.0	0.5	71.9	1.6	0.2	0.5	0.8	1.2	0.8	0.8	2.0	3.1	0.3	0.3	0.2	0.3	1.1	133.0	117.5	15.0	1.5	2.0	0.3	46.9	1.5	14.3	12.5	1.9	21.2	26.0	34.4	17.6	2.5	15.9	36.9	23.0	38.3	17.0	3.0	2.9	63.4	13.2	4.3	7.2	7.1	7.9	5.6	6.7	3.8	4.6	6.7	1.3
OTUD5	"DKFZp761A052, DUBA"	ENSG00000068308	"OTU deubiquitinase 5"	Q96G74	X	48922028-48958386	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"U-266/70: 182.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017375	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				Cytosol	"Nucleoplasm, Nucleoli fibrillar center"	"HPA017375: AB_1854844"	"unprognostic (9.73e-2)"	"prognostic favourable (9.57e-4)"	"unprognostic (2.67e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.33e-3)"	"prognostic favourable (1.48e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.14e-1)"	"prognostic favourable (8.20e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.05e-3)"	23.5	27.5	32.4	26.8	40.9	38.4	21.9	35.0	52.4	21.3	22.9	28.2	23.4	30.5	25.5	26.8	20.5	25.1	20.9	16.6	29.8	31.3	22.6	24.5	25.2	30.8	25.4	29.8	30.0	25.4	29.6	26.8	23.1	29.4	24.0	17.8	20.4	26.9	27.4	24.4	24.5	29.1	27.1	21.4	34.5	22.3	12.7	24.0	34.8	24.5	14.4	27.2	22.1	22.7	7.8	6.3	8.6	5.1	18.6	7.5	3.5	6.1	9.3	4.3	10.7	7.4	6.6	5.0	5.4	6.3	6.8	7.4	4.6	6.8	6.9	3.5	6.8	7.5	6.5	5.4	6.4	8.0	7.9	5.2	9.4	5.3	6.2	4.9	5.8	7.3	5.1	7.1	4.8	5.4	6.5	10.9	4.8	6.1	7.7	10.7	7.8	7.3	6.1	6.4	8.9	4.8	5.5	4.2	7.4	7.1	4.6	7.1	6.1	4.5	7.6	4.4	5.6	11.7	4.4	182.8	45.6	6.6	6.9	6.9	3.0	5.2	3.4	7.0	7.0	5.1	5.8	7.8	5.5	6.0	4.8	6.0	5.2	7.5	8.6	18.6	4.7	6.3	7.0	3.5	32.4	40.9	35.0	52.4	29.8	31.3	25.4	29.8	29.4	24.0
KCND1	Kv4.1	ENSG00000102057	"Potassium voltage-gated channel subfamily D member 1"	Q9NSA2	X	48961378-48971569	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.8"	"Cell line enhanced"	"Detected in many"		"HSkMC: 13.6;NB-4: 10.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000524, HPA001066"	Approved		Uncertain	Nucleoplasm				Nucleoplasm		"HPA000524: , HPA001066: AB_1079662"	"unprognostic (6.00e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.19e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.79e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.13e-2)"	"unprognostic (2.41e-3)"	"prognostic favourable (2.66e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.30e-11)"	"unprognostic (3.13e-2)"	"unprognostic (3.49e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.22e-3)"	4.9	2.4	4.2	3.4	4.7	6.0	2.2	16.8	7.8	5.1	2.2	6.3	1.9	2.0	5.0	3.8	1.4	7.4	6.3	2.9	6.9	2.5	2.5	1.8	3.0	3.1	3.1	3.5	4.6	1.4	1.8	3.0	2.5	10.4	3.3	2.1	2.6	1.2	6.0	0.7	1.6	2.6	6.6	6.5	4.2	2.5	3.0	2.7	1.1	2.3	0.5	3.6	3.0	3.0	0.6	1.3	1.4	0.1	0.0	0.8	0.1	0.4	2.0	0.8	4.8	6.6	5.2	1.6	1.0	4.2	2.9	1.9	1.3	0.6	1.6	3.5	3.2	0.6	0.8	0.4	2.8	2.7	3.2	1.5	2.0	0.1	2.4	0.4	3.0	13.6	1.8	5.3	0.6	1.0	1.1	3.7	2.1	3.6	0.4	10.8	2.6	0.7	1.3	0.9	1.6	3.2	1.5	0.5	2.2	0.9	0.0	2.2	2.1	1.6	2.5	0.6	2.7	0.6	0.2	3.0	3.9	3.9	1.8	3.9	2.1	0.0	0.1	0.0	0.5	0.0	0.3	0.6	0.2	0.8	0.0	0.1	0.2	0.0	1.4	0.0	0.0	1.3	0.0	0.1	4.2	4.7	16.8	7.8	6.9	2.5	3.1	3.5	10.4	2.7
GRIPAP1	"DKFZp434P0630, GRASP-1, GRASP1, KIAA1167, MPMGp800B12492Q3"	ENSG00000068400	"GRIP1 associated protein 1"	Q4V328	X	48973720-49002264	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000282, HPA000615"	Approved		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA000282: AB_1079022, HPA000615: AB_1079023"	"unprognostic (3.34e-1)"	"unprognostic (2.86e-3)"	"unprognostic (3.24e-3)"	"unprognostic (3.93e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.97e-3)"	"unprognostic (1.01e-2)"	"unprognostic (5.26e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.06e-2)"	"prognostic unfavourable (3.92e-7)"	"unprognostic (4.24e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"prognostic favourable (4.63e-7)"	7.3	10.1	12.4	10.0	19.5	14.0	7.1	24.8	20.6	7.3	7.3	7.4	6.8	8.3	7.5	12.0	7.0	9.9	6.4	7.8	9.4	8.6	6.6	8.5	9.0	10.5	9.7	20.8	8.8	7.7	11.7	12.9	7.0	12.9	7.5	6.9	8.7	7.7	7.4	7.0	10.9	11.1	7.0	10.7	13.1	8.5	8.0	9.0	7.4	8.6	3.2	10.6	7.5	8.6	11.5	10.0	21.2	12.2	12.9	9.1	7.0	12.7	20.3	14.6	30.5	8.8	6.8	13.1	10.4	13.0	13.5	12.9	11.0	11.2	19.3	6.0	10.3	18.3	18.1	11.4	10.9	22.5	9.2	15.5	25.8	11.5	15.2	16.6	27.9	7.0	16.5	18.0	13.4	12.3	11.3	25.5	12.4	23.5	14.4	22.4	17.2	11.1	16.1	22.0	15.4	13.5	15.8	12.9	14.4	22.1	8.9	13.0	20.2	33.4	14.5	7.1	11.3	14.6	8.5	15.5	12.1	13.5	12.5	25.3	12.2	18.8	12.2	16.9	8.9	10.9	7.5	9.4	9.1	8.4	9.8	11.5	8.0	8.3	21.2	12.9	9.9	10.0	7.2	7.0	12.4	19.5	24.8	16.8	9.4	8.6	9.7	20.8	12.9	9.0
TFE3	"bHLHe33, TFEA"	ENSG00000068323	"Transcription factor binding to IGHM enhancer 3"	P19532	X	49028726-49043486	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023881	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA023881: AB_1857931"	"unprognostic (2.68e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (6.03e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (2.19e-8)"	"unprognostic (1.93e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.19e-2)"	"unprognostic (6.25e-1)"	31.3	20.9	12.6	18.2	14.4	22.6	53.1	16.5	18.1	22.6	17.7	16.6	30.0	9.9	22.8	21.9	20.5	18.8	16.4	15.1	11.3	11.8	21.6	14.1	22.8	10.3	13.2	9.4	24.4	15.9	16.5	16.3	22.0	15.9	21.2	10.4	15.7	12.6	30.6	13.6	14.1	13.5	21.2	14.8	23.0	14.7	10.4	15.2	4.2	21.7	10.8	10.5	28.6	20.5	1.2	1.9	10.5	4.4	0.4	1.4	1.6	11.9	15.3	5.1	14.8	16.7	15.1	5.1	15.7	18.2	16.1	13.8	9.4	9.5	4.5	6.7	23.1	9.8	9.7	14.2	13.0	9.8	5.2	4.1	11.4	8.7	22.5	4.3	10.2	13.1	9.2	26.3	18.9	7.7	7.9	19.7	13.7	7.0	2.8	4.0	13.9	13.8	4.3	8.9	10.2	10.2	5.5	4.9	4.9	16.8	7.2	5.5	10.3	3.9	16.3	17.6	18.9	17.6	8.6	12.1	11.4	3.7	21.0	5.3	12.0	0.0	3.5	1.6	0.5	4.3	0.9	0.6	0.9	0.5	1.9	1.2	0.6	0.4	10.5	0.4	4.4	0.4	1.4	1.6	12.6	14.4	16.5	14.9	11.3	11.8	13.2	9.4	15.9	15.2
CCDC120	JM11	ENSG00000147144	"Coiled-coil domain containing 120"	Q96HB5	X	49053572-49069857	"Cancer-related genes, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 14.1;BEWO: 20.3;HaCaT: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000561			Uncertain	Mitochondria				Mitochondria		"HPA000561: AB_2244190"	"unprognostic (1.65e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.59e-3)"	"unprognostic (1.80e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.82e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.34e-3)"	3.3	3.1	5.8	3.1	4.7	2.9	5.0	17.3	5.8	8.4	6.8	1.6	10.4	12.0	5.5	9.9	27.6	5.1	4.1	2.1	4.0	1.6	7.0	4.8	4.4	2.6	1.5	3.3	6.5	7.0	6.1	12.2	13.3	4.0	6.0	3.3	4.7	11.4	10.2	1.5	26.1	12.5	2.5	1.8	3.8	7.7	5.8	1.5	6.0	5.6	8.8	15.1	7.4	12.2	2.5	2.2	3.9	0.8	1.6	1.5	0.4	14.1	1.9	3.1	0.1	0.0	0.0	20.3	0.5	0.7	1.1	1.7	4.7	6.1	0.5	2.2	0.8	13.7	2.4	8.0	0.1	3.6	4.6	1.3	3.3	1.6	1.0	0.0	2.4	1.8	6.4	1.3	0.4	1.7	1.9	0.2	0.0	11.9	4.9	0.3	3.6	0.1	4.4	2.3	1.3	6.1	7.6	4.3	3.3	2.5	5.1	1.4	12.4	1.9	0.8	0.1	3.7	0.1	0.1	4.6	3.1	0.1	0.1	0.0	0.6	2.9	0.8	1.5	1.4	0.2	0.9	0.8	1.5	1.3	0.3	2.5	1.5	1.4	3.9	1.6	0.4	2.2	0.5	0.4	5.8	4.7	17.3	5.8	4.0	1.6	1.5	3.3	4.0	1.5
PRAF2	"JM4, Yip6a"	ENSG00000243279	"PRA1 domain family member 2"	O60831	X	49071156-49074071	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 125.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA002859, HPA005504, CAB011655"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"				"Endoplasmic reticulum"	Vesicles	"CAB011655: , HPA002859: AB_1079672, HPA005504: "	"unprognostic (1.50e-1)"	"prognostic favourable (7.42e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.29e-1)"	"unprognostic (3.67e-1)"	"prognostic unfavourable (1.66e-6)"	"prognostic favourable (2.81e-4)"	"unprognostic (6.10e-2)"	"unprognostic (3.77e-1)"	"prognostic favourable (4.88e-6)"	"unprognostic (8.39e-3)"	"prognostic unfavourable (5.83e-6)"	"unprognostic (4.96e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	13.5	17.5	25.0	12.3	26.9	6.7	9.0	18.0	39.7	28.1	11.8	26.3	12.6	6.0	22.1	125.1	7.3	15.6	12.3	12.9	25.3	29.9	12.4	6.9	11.5	11.3	26.1	18.9	20.1	6.2	19.7	31.0	9.8	25.5	12.2	10.0	13.0	7.5	29.4	6.8	7.6	6.6	33.2	23.1	10.9	9.2	17.7	17.0	14.4	13.3	3.8	11.9	12.6	10.7	14.6	6.7	16.4	6.4	16.8	29.4	11.1	4.5	9.5	11.1	14.1	40.0	24.3	1.4	16.1	16.9	11.0	12.1	0.5	1.4	0.4	3.9	34.9	4.2	0.4	8.7	12.2	8.3	12.6	3.6	12.3	0.4	41.0	2.3	7.0	30.9	7.5	20.8	15.2	16.8	0.5	1.2	19.1	8.3	14.9	2.8	6.2	0.6	8.2	6.1	0.9	16.3	1.3	7.4	18.5	13.5	7.0	9.2	6.8	1.6	10.1	8.5	11.3	18.2	4.7	20.1	5.1	3.6	20.4	4.1	13.1	16.4	5.9	7.9	18.3	6.4	20.7	14.6	20.1	16.1	6.7	13.6	18.1	19.4	15.4	16.8	4.8	2.6	29.4	11.1	25.0	26.9	18.0	39.7	25.3	29.9	26.1	18.9	25.5	17.0
WDR45	"JM5, NBIA5, WDRX1, WIPI4"	ENSG00000196998	"WD repeat domain 45"	Q9Y484	X	49071470-49101170	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Autophagy		"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 124.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA027562	Uncertain		Uncertain	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"HPA027562: AB_10610565"	"unprognostic (1.39e-1)"	"prognostic favourable (1.21e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.32e-1)"	"prognostic favourable (1.61e-4)"	"unprognostic (4.30e-2)"	"unprognostic (6.66e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.57e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.06e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.27e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.11e-3)"	21.2	30.3	16.7	13.5	22.6	21.4	20.3	16.1	29.8	19.4	20.7	16.6	30.6	16.2	21.1	124.8	16.5	18.1	21.9	28.6	16.4	15.1	24.6	34.4	17.1	18.4	19.1	12.7	20.7	23.7	26.3	17.6	28.4	17.0	18.6	12.3	20.0	28.2	26.6	40.7	17.9	16.8	15.1	12.2	18.2	21.5	7.6	13.6	18.8	32.4	24.5	17.1	20.5	16.4	19.8	27.1	44.0	36.0	32.4	25.5	26.4	12.4	14.6	8.4	8.5	18.4	23.8	16.3	13.7	28.5	10.8	15.3	7.6	18.3	8.7	7.9	27.3	10.9	12.7	11.1	7.9	9.7	21.5	5.3	26.7	11.6	42.1	4.1	12.5	21.1	19.7	17.8	19.1	10.9	11.3	15.7	14.2	13.9	8.6	10.6	8.5	12.7	7.1	12.4	28.8	19.2	11.5	11.2	16.5	17.6	13.5	41.6	8.6	15.3	14.9	11.8	10.7	23.5	5.7	24.2	16.2	6.2	22.0	6.8	8.6	44.0	36.0	31.5	23.1	32.1	22.8	19.8	17.6	21.8	26.7	18.6	14.0	15.9	36.5	32.4	35.4	27.1	25.5	26.4	16.7	22.6	16.1	29.8	16.4	15.1	19.1	12.7	17.0	13.6
GPKOW	"GPATC5, GPATCH5, Spp2, T54"	ENSG00000068394	"G-patch domain and KOW motifs"	Q92917	X	49113389-49123801	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000287, HPA001894"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA000287: AB_1079015, HPA001894: AB_1079014"	"unprognostic (3.34e-2)"	"unprognostic (9.54e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.02e-1)"	"unprognostic (9.29e-2)"	"unprognostic (7.96e-2)"	"unprognostic (4.32e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.89e-2)"	14.9	14.6	20.1	11.8	23.1	15.0	13.8	24.3	25.3	14.5	14.8	22.6	11.7	15.3	15.5	13.4	14.7	17.0	11.3	17.0	17.6	20.1	12.3	15.8	12.8	14.1	22.9	28.9	14.3	11.5	22.4	15.8	14.7	20.0	13.8	13.9	12.1	13.4	19.3	31.9	16.9	14.1	15.3	20.3	14.0	13.5	8.0	22.3	15.7	14.2	9.0	14.9	14.8	12.1	21.3	17.0	20.7	24.8	17.8	29.5	14.6	20.3	21.7	14.5	12.1	12.9	11.2	15.8	13.2	14.9	21.1	22.4	15.7	20.4	8.5	10.2	16.2	14.5	16.1	15.6	13.8	17.9	17.1	8.9	18.2	11.1	15.4	10.5	18.9	12.2	20.0	16.8	17.2	15.8	10.9	13.4	13.7	33.1	14.3	17.5	10.3	17.3	18.0	16.0	23.1	10.8	26.0	12.2	14.2	15.4	14.7	14.2	28.1	13.8	17.5	12.2	18.6	17.7	12.4	20.8	14.1	11.6	15.7	17.5	18.8	19.3	16.8	20.7	29.5	23.1	24.0	15.4	23.2	22.0	17.0	21.3	19.7	18.5	13.3	17.8	24.8	15.5	22.7	14.6	20.1	23.1	24.3	25.3	17.6	20.1	22.9	28.9	20.0	22.3
MAGIX	"FLJ21687, JM10, PDZX"	ENSG00000269313	"MAGI family member, X-linked"		X	49162564-49168483	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 6.6;RT4: 15.2;SK-BR-3: 6.9"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"neutrophil: 7.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA007390, HPA035302"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA007390: , HPA035302: AB_10603015"	"unprognostic (1.11e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-3)"	"unprognostic (2.64e-6)"	"unprognostic (6.75e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-2)"	"prognostic favourable (6.91e-9)"	"unprognostic (4.35e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.73e-1)"	"prognostic favourable (2.10e-4)"	0.5	0.3	0.0	0.9	1.2	0.5	0.0	3.9	1.2	1.6	1.2	0.5	8.0	1.0	1.5	4.0	0.7	1.8	6.2	2.6	1.8		5.0	4.2	1.1	0.0	0.0	0.0	0.5	5.9	3.1	0.0	0.4	1.0	2.0	0.4	1.1	9.0	5.7	1.2	0.8	0.6	0.0	0.8	0.3	4.5	0.0	0.0	0.3	0.7	0.8	0.7	0.8	0.0	1.2	2.6	7.9	2.0	1.2	1.1	1.1	0.3	2.3	0.5	0.6	0.7	0.2	1.7	0.3	0.4	0.4	0.3	1.3	6.6	0.6	0.6	0.7	1.4	0.4	1.5	0.0	1.9	2.1	2.8	3.7	0.8	0.3	0.6	5.7	0.7	0.2	0.5	0.1	0.5	0.4	2.4	0.5	0.8	0.6	1.9	0.6	1.2	0.3	0.1	1.2	1.2	15.2	2.9	0.6	1.3	6.9	0.6	5.4	0.6	0.3	0.8	1.7	0.7	0.5	1.6	0.8	0.5	2.8	0.9	2.1	4.3	2.0	3.3	0.2	1.8	0.8	1.1	0.9	0.1	1.3	1.2	0.6	1.1	7.9	1.2	1.8	2.6	0.1	1.1										
PLP2	"A4, A4-LSB, MGC126187"	ENSG00000102007	"Proteolipid protein 2"	Q04941	X	49171926-49175239	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA042415	Approved						710000			"HPA042415: AB_10796907"	"unprognostic (1.40e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (3.32e-5)"	"unprognostic (3.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-3)"	"unprognostic (4.14e-2)"	"unprognostic (2.58e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.66e-1)"	"prognostic unfavourable (5.55e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.30e-1)"	32.2	39.3	2.6	24.8	3.5	61.7	29.1	4.4	2.9	64.3	40.1	5.9	20.7	13.4	50.7	31.0	123.4	22.2	24.4	26.7	3.0	4.1	30.8	33.0	42.5	40.3	4.9	3.1	44.8	116.5	5.8	28.3	22.8	8.1	46.7	25.7	13.1	24.2	25.1	46.2	74.9	36.4	65.9	6.8	26.3	23.5	17.8	3.2	34.9	12.6	121.1	93.8	59.2	48.5	34.6	102.5	55.6	40.5	9.7	37.3	27.1	68.4	43.1	0.0	0.1	17.9	53.5	0.4	37.0	29.5	45.5	34.5	15.8	32.7	25.1	9.2	27.1	58.2	34.3	68.1	28.9	63.2	13.9	9.3	62.4	0.4	28.8	17.2	41.4	23.9	67.4	59.2	69.6	34.4	7.0	31.8	32.8	45.2	1.9	44.2	0.4	60.7	6.3	40.1	71.5	61.0	49.6	9.3	16.2	51.7	20.6	31.3	45.0	9.9	38.5	26.2	25.2	45.8	60.5	13.7	12.6	6.6	62.1	46.4	60.8	55.6	40.5	20.9	9.3	14.7	15.8	34.6	33.4	17.5	43.6	21.1	17.2	14.4	47.8	9.7	9.0	102.5	37.3	27.1	2.6	3.5	4.4	2.9	3.0	4.1	4.9	3.1	8.1	3.2
PRICKLE3	LMO6	ENSG00000012211	"Prickle planar cell polarity protein 3"	O43900	X	49175264-49186528	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA000998	Uncertain									"HPA000998: AB_1079258"	"unprognostic (9.83e-3)"	"unprognostic (7.02e-2)"	"unprognostic (6.97e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.14e-3)"	"prognostic unfavourable (5.73e-6)"	"unprognostic (2.28e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-1)"	"prognostic favourable (4.84e-5)"	9.7	6.0	2.3	8.8	5.5	2.7	7.7	1.4	2.8	6.8	6.5	4.0	9.0	3.3	8.2	7.9	15.5	7.0	7.7	8.6	3.8	1.6	6.8	5.8	6.1	3.9	5.6	1.7	7.2	7.8	7.5	4.4	7.1	3.3	9.8	4.3	8.1	7.5	10.9	14.9	16.0	5.9	7.5	5.5	7.1	5.6	2.2	4.8	7.2	7.5	13.3	15.7	11.9	10.3	6.6	8.1	8.3	10.8	2.7	4.0	4.4	9.5	12.7	0.2	0.8	5.1	5.5	11.0	3.9	6.2	3.2	4.9	3.8	6.0	0.0	3.4	4.9	13.2	9.6	15.5	1.2	12.6	5.4	3.8	7.6	2.7	7.8	2.7	12.6	4.9	11.4	4.0	9.8	3.2	6.7	3.3	5.3	17.5	3.2	3.2	1.6	13.5	4.5	3.0	5.2	3.5	14.8	1.7	0.0	5.5	4.6	3.2	9.3	2.8	3.3	0.0	4.2	3.7	1.3	6.2	4.3	2.1	4.4	3.5	0.0	2.2	7.9	8.3	2.3	8.6	3.2	6.6	3.1	3.7	8.1	4.3	2.5	2.3	4.1	2.7	10.8	3.2	4.0	4.4	2.3	5.5	1.4	2.8	3.8	1.6	5.6	1.7	3.3	4.8
SYP	MRX96	ENSG00000102003	Synaptophysin	P08247	X	49187804-49200259	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 179.2"	"Cell line enhanced"	"Detected in some"		"K-562: 8.5;SCLC-21H: 45.7;SH-SY5Y: 16.5"	"Group enriched"	"Detected in many"	6	"glioma: 12.8;pancreatic cancer: 5.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000076, HPA002858, CAB055505, CAB078999"	Enhanced	Supported								"CAB000076: AB_2315411, CAB055505: AB_564017, CAB078999: , HPA002858: AB_1080153"	"unprognostic (2.08e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.37e-3)"	"unprognostic (4.37e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.46e-5)"	"unprognostic (8.52e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.44e-3)"	"unprognostic (8.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.94e-1)"	2.7	21.4	34.5	3.2	42.5	1.9	1.9	53.8	179.2	2.0	3.6	7.2	0.0	7.4	2.2	2.6	2.2	2.0	2.0	2.3	44.4	45.3	2.7	1.8	2.8	2.0	25.5	39.0	2.1	5.2	1.9	17.4	2.0	46.7	2.1	3.5	11.5	2.0	2.1	2.4	2.3	8.1	2.5	15.5	2.4	3.9	2.0	4.0	0.0	2.1	0.0	1.9	1.8	0.2	1.3	1.6	5.3	0.8	0.5	0.7	0.1	0.4	1.7	1.3	2.6	1.4	0.2	0.2	0.1	0.0	0.3	0.3	1.5	0.9	1.3	0.2	0.0	1.3	1.3	0.1	0.3	2.7	1.5	2.1	0.5	0.5	0.0	0.2	4.7	0.2	0.0	0.2	0.3	0.1	8.5	3.3	0.3	0.5	0.7	0.1	4.2	0.3	0.3	0.2	0.6	0.1	0.2	45.7	16.5	0.5	0.2	0.6	0.8	0.8	0.2	0.3	1.4	0.4	0.2	0.2	2.8	0.3	0.7	0.5	1.4	1.7	0.8	0.4	0.2	0.7	0.4	0.7	0.5	0.7	0.4	1.3	0.5	0.5	5.3	0.5	0.4	1.6	0.3	0.1	34.5	42.5	53.8	84.8	44.4	45.3	25.5	39.0	46.7	4.0
CACNA1F	"AIED, Cav1.4, CORDX3, CSNB2, CSNB2A, CSNBX2, JM8, JMC8, OA2"	ENSG00000102001	"Calcium voltage-gated channel subunit alpha1 F"	O60840	X	49205063-49233371	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Sensory transduction, Transport, Vision"	"Calcium channel, Ion channel, Voltage-gated channel"	"Cone-rod dystrophy, Congenital stationary night blindness, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"retina: 55.8"	"Cell line enhanced"	"Detected in some"		"A549: 2.5;BEWO: 2.5;MCF7: 2.8;U-266/70: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA068379	Enhanced									"HPA068379: "	"unprognostic (1.20e-3)"	"unprognostic (8.62e-2)"	"unprognostic (4.25e-3)"	"unprognostic (1.56e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.04e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.08e-7)"	"unprognostic (8.03e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.77e-3)"	0.7	0.8	1.8	0.7	1.5	4.0	1.8	5.3	2.0	0.7	1.0	0.7	0.7	1.9	0.7	2.7	0.7	1.0	0.7	0.7	0.8	0.6	0.7	0.7	1.4	2.7	0.7	0.7	0.7	1.4	0.0	0.7	0.7	0.7	0.7	1.5	55.8	1.2	0.9	0.7	2.4	3.7	0.7	0.7	1.8	1.0	0.7	0.7	0.7	1.2	0.7	0.9	0.7	0.7	1.4	4.6	2.0	0.9	0.5	1.0	0.2	0.2	2.5	0.2	0.0	0.6	0.0	2.5	0.4	0.2	0.0	0.0	0.1	0.9	1.4	0.5	0.5	0.1	0.4	0.0	0.0	0.1	0.0	0.7	0.0	0.5	0.5	0.1	0.8	0.6	0.0	0.4	0.0	0.7	1.0	0.3	0.0	2.8	1.3	1.5	1.1	0.0	0.1	0.0	0.5	0.4	1.5	0.6	0.0	0.0	0.1	0.0	0.9	1.5	1.0	0.2	0.3	0.2	0.1	4.6	1.6	0.0	0.8	0.4	0.0	0.9	0.7	0.6	0.6	0.5	0.5	0.7	0.8	0.4	0.8	1.4	0.5	1.0	2.0	0.5	0.9	4.6	0.7	0.2	1.8	1.5	5.3	2.0	0.8	0.6	0.7	0.7	0.7	0.7
CCDC22	"CXorf37, JM1"	ENSG00000101997	"Coiled-coil domain containing 22"	O60826	X	49235467-49250526	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport, Ubl conjugation pathway"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000229, HPA000888"	Uncertain	Approved	Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA000229: , HPA000888: AB_1078420"	"unprognostic (1.24e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.80e-2)"	"prognostic unfavourable (2.17e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.57e-3)"	"unprognostic (3.61e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-3)"	11.5	15.4	12.1	18.2	14.9	26.0	16.3	20.7	16.5	12.5	11.8	13.7	17.2	16.3	14.8	12.3	15.8	13.7	11.9	12.9	12.2	9.8	13.9	14.2	19.8	24.7	12.2	15.9	13.7	20.3	12.1	13.5	11.0	11.8	15.2	8.6	12.8	19.2	21.3	23.0	15.1	15.3	14.6	12.4	23.9	14.2	4.5	14.1	25.0	13.0	15.5	17.9	12.6	12.3	12.4	23.5	13.9	22.1	6.1	13.9	15.1	10.5	9.2	5.6	19.5	5.2	5.4	12.0	6.3	4.6	7.0	8.1	9.2	9.2	3.9	9.3	5.5	8.6	6.1	10.3	2.9	10.1	13.6	4.1	8.7	8.7	8.8	11.6	7.3	5.0	8.9	9.3	5.1	6.9	8.1	6.9	5.0	32.7	8.4	13.6	6.5	13.5	12.3	9.1	16.9	5.5	5.4	6.7	5.1	9.6	11.3	8.4	17.6	11.4	7.6	9.1	9.9	11.2	6.5	12.5	6.8	7.0	9.9	21.7	7.1	5.1	22.1	13.9	12.0	19.2	13.1	12.4	12.5	13.9	23.5	11.6	11.4	12.9	1.8	6.1	15.7	9.3	12.9	15.1	12.1	14.9	20.7	16.5	12.2	9.8	12.2	15.9	11.8	14.1
FOXP3	"AIID, DIETER, IPEX, JM2, PIDX, SCURFIN, XPID"	ENSG00000049768	"Forkhead box P3"	Q9BZS1	X	49250436-49264826	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.9;lymphoid tissue: 23.3"	"Cell line enhanced"	"Detected in some"		"MCF7: 8.1;SiHa: 4.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	11	"T-reg: 25.9"	"Lineage enriched"	"Detected in single"	260	"T-cells: 25.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB026301, HPA045943"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB026301: , HPA045943: "	"unprognostic (2.46e-2)"	"prognostic favourable (1.91e-4)"	"unprognostic (4.95e-3)"	"prognostic favourable (7.02e-4)"	"unprognostic (2.55e-4)"	"prognostic favourable (4.90e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.99e-3)"	"unprognostic (8.77e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.73e-14)"	"unprognostic (5.93e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.39e-1)"	0.4	0.4	1.4	20.2	1.3	1.4	0.6	2.2	1.2	0.7	0.8	0.5	1.0	0.6	1.1	7.2	2.6	0.3	3.3	0.4	1.3	1.0	1.1	4.7	1.9	23.3	0.9	0.4	0.6	0.4	0.1	1.2	0.4	0.4	0.9	0.6	0.6	4.0	0.6	0.4	2.5	4.0	0.4	0.7	4.7	1.8	2.7	0.4	23.3	0.8	1.8	20.6	4.9	0.6	0.0	0.0	0.0	0.0	0.0	25.9	0.4	0.3	0.5	0.5	1.2	0.2	0.0	1.5	0.3	0.0	0.4	0.1	0.4	0.3	0.9	0.4	0.4	0.4	0.9	0.0	0.3	3.0	0.4	0.4	0.6	0.1	0.7	0.7	0.9	0.3	0.5	0.7	0.8	0.0	1.5	0.8	0.1	8.1	0.3	0.6	1.2	0.8	0.6	0.3	0.6	0.4	0.5	0.7	0.4	4.8	0.5	3.0	1.8	0.7	0.1	0.1	1.6	0.8	0.2	0.8	1.6	1.0	0.5	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	25.9	0.4	1.4	1.3	2.2	1.2	1.3	1.0	0.9	0.4	0.4	0.4
PPP1R3F	Hb2E	ENSG00000049769	"Protein phosphatase 1 regulatory subunit 3F"	Q6ZSY5	X	49269843-49301461	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 17.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"T-reg: 15.3"	"Lineage enriched"	"Detected in single"	16	"T-cells: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000244, HPA000918"	Approved		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA000244: , HPA000918: AB_2268692"	"unprognostic (6.69e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.98e-4)"	"unprognostic (1.83e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.89e-1)"	"prognostic favourable (1.85e-6)"	"unprognostic (5.99e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.76e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.55e-1)"	3.0	7.6	15.9	3.7	13.8	2.7	2.3	17.2	21.2	4.3	3.5	7.6	4.5	2.4	4.7	15.9	5.4	6.7	3.6	16.1	16.0	13.1	3.3	2.8	3.4	4.6	12.3	5.4	7.5	2.6	4.4	8.6	2.4	9.1	4.6	1.7	5.3	5.3	6.1	24.0	3.1	3.1	4.1	11.3	5.1	2.9	4.5	7.3	3.5	5.5	1.9	3.0	3.5	4.8	0.4	0.3	0.0	0.9	0.4	15.3	0.5	2.6	5.4	4.8	5.3	6.6	4.7	2.3	3.1	4.8	2.1	3.3	3.8	3.1	3.1	0.6	2.3	4.2	1.8	1.3	1.1	17.0	5.9	0.3	3.1	0.3	4.3	0.4	1.9	3.3	3.9	2.2	1.7	0.5	0.8	1.3	2.5	9.3	1.2	4.2	14.7	10.2	6.9	4.1	1.0	2.1	1.2	5.6	4.8	1.6	0.6	8.0	4.8	2.7	2.5	5.9	1.2	5.2	2.3	3.9	4.8	2.1	2.0	6.6	7.5	0.0	0.2	0.0	0.2	0.4	1.0	0.4	3.0	1.0	0.2	0.1	2.4	1.1	0.0	0.4	0.9	0.3	15.3	0.5	15.9	13.8	17.2	19.3	16.0	13.1	12.3	5.4	9.1	7.3
GAGE10		ENSG00000215274	"G antigen 10"	A6NGK3	X	49303669-49319844	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"ovary: 3.9;pituitary gland: 3.1;testis: 2.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.0;BJ hTERT+: 1.4;T-47d: 1.3;WM-115: 2.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043232	Supported		Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "					"unprognostic (2.81e-2)"					"unprognostic (2.26e-1)"						"unprognostic (3.97e-1)"		0.0	0.0	0.6	0.0	1.8	0.1	0.8	0.5	0.3	0.0	0.2			0.0	0.5	2.0	0.0	1.7	0.1	0.5	0.5	0.5	0.0	0.0	0.0	0.6	0.4		3.9	0.0	0.0	3.1	0.0		0.4	0.3		0.2	1.1	0.2	0.0	0.0	1.4	0.2	0.3	0.0	2.9			0.8		0.2	0.0	0.1	0.0	0.7	0.0	0.5	0.1	0.5	0.3	0.0	0.0	0.6	7.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.3	0.0	0.1	0.5	0.7	0.3	0.3										
GAGE12J	GAGE11	ENSG00000224659	"G antigen 12J"	A6NER3	X	49322057-49329384	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 20.2"	"Group enriched"	"Detected in some"	5	"AN3-CA: 47.2;K-562: 47.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	20.2			0.0		0.0	0.0	0.0	0.8	0.6	0.4	0.7	0.8	1.6	0.0	0.0	0.0	0.0	47.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.8	9.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.2	0.4	0.8	0.7	0.9	0.0	0.7	1.6	0.4	0.4	0.8	0.5	0.6	1.4	0.0										
GAGE13	GAGE12A	ENSG00000274274	"G antigen 13"		X	49331616-49338952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	17	"testis: 26.8"	"Cell line enriched"	"Detected in some"	6	"AN3-CA: 126.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	26.8			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	126.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	4.6	0.6	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6										
GAGE2E	GAGE8	ENSG00000275113	"G antigen 2E"		X	49341192-49345922	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	52	"blood: 5.8;stomach 1: 18.4;testis: 4.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 141.3;K-562: 67.6;T-47d: 34.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"T-reg: 5.8"	"Low lineage specificity"	"Detected in many"											HPA043232	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0		0.0	18.4	4.9			0.0		0.0	0.0		2.5	2.6	0.7	1.2	0.7	5.8	0.2	0.0	0.0	0.0	141.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	67.6	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	34.2	0.0	0.4	8.7	0.3	0.0	0.0	0.1	2.6	0.0	0.1	0.0	14.8	0.7	1.2	0.3	1.0	0.0	0.0	1.5	0.4	2.2	0.0	2.5	4.9	0.0	0.7	0.7	0.0	2.6	5.8	0.2										
GAGE12B		ENSG00000236737	"G antigen 12B"		X	49529869-49529985	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	6	"intestine: 5.4;testis: 21.5"	"Group enriched"	"Detected in some"	16	"PC-3: 7.4;U-2197: 4.0"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in many"																																							0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0			5.4	0.8	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0		0.8	0.0	0.0	0.0	0.0		0.0	0.0		2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	21.5			0.0		0.0	0.0	0.1	0.0	0.3	2.0	0.5	0.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.8	0.7	0.0	0.0	0.1	0.8	2.0	0.0	0.5	0.3	1.8	0.2										
GAGE12C		ENSG00000237671	"G antigen 12C"	A1L429	X	49532211-49539538	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	57	"testis: 23.7"	"Group enriched"	"Detected in some"	11	"U-2 OS: 7.6;U-266/84: 27.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	1.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	7.6	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0										
GAGE12D		ENSG00000227488	"G antigen 12D"	A1L429	X	49541767-49549094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	57	"testis: 23.7"	"Group enriched"	"Detected in some"	11	"U-2 OS: 7.6;U-266/84: 27.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	1.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	7.6	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0										
GAGE12F		ENSG00000236362	"G antigen 12F"	"P0CL80, P0CL82, O76087"	X	49551278-49568218	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"blood: 16.2;testis: 58.6"	"Group enriched"	"Detected in some"	4	"AN3-CA: 133.5;K-562: 130.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.2	0.0	0.0	0.1	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	58.6			0.0		0.0	0.0	0.0	7.0	8.5	3.1	9.1	9.6	14.7	16.2	1.1	0.0	0.0	133.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	130.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.0	0.0	0.5	6.7	0.8	0.0	0.1	0.0	7.7	0.0	0.0	0.0	16.7	0.9	9.1	3.1	3.9	7.5	2.5	7.0	10.3	7.2	0.0	6.2	8.5	7.5	0.9	9.6	6.3	8.5	14.7	16.2										
GAGE12E		ENSG00000216649	"G antigen 12E"	A1L429	X	49551333-49558649	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	18	"testis: 9.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.3;HeLa: 4.0;Karpas-707: 1.9;T-47d: 1.7;U-266/84: 4.3;WM-115: 2.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043232	Supported		Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.5	0.8	0.0	0.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.7	0.0	0.0	0.5	0.3	0.0	0.0	0.7	4.3	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0										
GAGE12G		ENSG00000215269	"G antigen 12G"	"P0CL81, O76087, P0CL82"	X	49570434-49577754	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	33	"blood: 7.4;stomach 1: 14.0"	"Cell line enriched"	"Detected in some"	7	"AN3-CA: 145.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"T-reg: 7.4"	"Low lineage specificity"	"Detected in many"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.1	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0			0.0		0.0	0.0	0.0	2.6	1.4	1.3	2.5	0.4	7.4	6.2	0.0	0.0	0.0	145.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.4	2.5	1.3	0.8	2.2	1.3	1.5	3.6	0.5	0.0	2.6	0.6	3.2	0.0	0.4	1.8	1.4	7.4	6.2										
GAGE12H		ENSG00000224902	"G antigen 12H"	A6NDE8	X	49579983-49587301	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	223	"testis: 22.3"	"Group enriched"	"Detected in some"	52	"A-431: 19.2;U-266/84: 56.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	56.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GAGE1	CT4.1	ENSG00000205777	"G antigen 1"	Q13068	X	49589496-49608536	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	37	"testis: 36.8"	"Cell line enriched"	"Detected in some"	4	"AN3-CA: 243.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.8			0.0		0.0	0.0	0.0	0.6	1.0	0.7	0.8	0.1	0.7	0.0	0.0	0.0	0.0	243.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	56.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	22.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.7	0.1	0.3	0.3	0.7	0.0	0.2	0.3	0.3	0.0	0.0	0.6	0.1	0.3	0.7	0.1	0.8	1.0	0.1	0.0										
GAGE2A	"CT4.2, GAGE2"	ENSG00000189064	"G antigen 2A"	Q6NT46	X	49589529-49596827	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	34	"testis: 46.7"	"Group enriched"	"Detected in some"	5	"Karpas-707: 19.2;T-47d: 66.1;WM-115: 72.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "															"unprognostic (1.29e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.7			0.0		0.0	0.0	0.0	1.0	0.7	0.4	0.7	0.5	0.6	1.3	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.1	19.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	66.1	0.0	0.0	10.7	2.3	0.0	0.0	0.2	2.8	0.0	0.6	0.0	72.7	0.4	0.6	0.1	0.1	0.7	0.0	1.0	0.5	0.6	0.0	0.4	0.5	0.2	0.0	0.5	0.6	0.7	0.6	1.3										
PAGE1	"CT16.3, GAGE-9, GAGEB1, PAGE-1"	ENSG00000068985	"PAGE family member 1"	O75459	X	49687450-49695993	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	126	"testis: 18.2"	"Group enriched"	"Detected in some"	7	"A-431: 47.9;Karpas-707: 37.0;U-266/84: 57.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA003473	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"				"Nucleoli fibrillar center"	"Nucleoplasm, Mitochondria"	"HPA003473: AB_1079558"				"unprognostic (3.00e-1)"										"unprognostic (1.99e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	37.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.7	57.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAGE4	"CT16.7, GAGEC1, PAGE-4"	ENSG00000101951	"PAGE family member 4"	O60829	X	49829260-49833973	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"epididymis: 129.2;placenta: 199.4;prostate: 58.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.8;U-266/70: 8.4;U-266/84: 30.7"	"Group enriched"	"Detected in some"	17	"liver cancer: 14.8;prostate cancer: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA023880	Enhanced		Approved	"Golgi apparatus,Vesicles"				Vesicles	"Golgi apparatus"	"HPA023880: AB_1854930"				"unprognostic (8.56e-2)"			"unprognostic (1.47e-1)"			"unprognostic (1.04e-1)"		"unprognostic (4.82e-3)"			"unprognostic (5.37e-2)"			0.2	0.7	0.5	0.1	0.1	0.0	0.1	0.2	0.2	0.6	0.1	0.2	5.7	0.0	6.6	129.2	0.1	6.8	0.1	0.1	0.4	0.5	0.8	0.1	0.2	0.1	0.1	0.2	0.9	0.1	0.0	0.6	199.4	0.2	58.4	0.0	0.1	0.1	9.8	0.8	0.1	0.1	2.4	0.2	0.1	0.1	2.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	6.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.4	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.2	0.2	0.4	0.5	0.1	0.2	0.2	0.1
USP27X	USP27	ENSG00000273820	"Ubiquitin specific peptidase 27, X-linked"	A6NNY8	X	49879948-49882565	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077264			Approved	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA077264: "	"unprognostic (4.12e-2)"	"unprognostic (9.58e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (6.14e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.31e-2)"	"prognostic favourable (9.31e-4)"	"unprognostic (5.37e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.58e-1)"	1.8	3.3	1.8	5.9	2.9	0.3	7.7	1.7	7.4	3.9	5.9	4.8	2.2	1.1	12.7	4.1	3.1	4.7	3.8	3.9	2.2		3.5	3.5	6.1	1.9	1.3	3.2	8.8	3.2	4.1	0.8	15.5	2.8	4.1	1.7	4.1	5.2	3.9	7.5	2.6	4.7	3.9	1.3	2.0	1.9	3.8	1.9	2.8	3.2	3.6	2.2	3.7	3.1	1.7	1.0	0.7	0.7	0.3	1.3	0.4	2.1	5.6	6.5	7.5	6.2	5.0	5.4	2.4	4.1	2.8	2.3	10.0	2.5	1.4	2.3	6.4	3.6	9.3	6.2	4.1	2.9	4.3	2.3	1.6	9.2	4.2	0.7	5.1	7.0	4.2	4.0	4.0	3.9	4.6	2.4	4.5	5.3	3.5	2.0	7.0	3.9	3.7	5.6	0.5	4.6	2.1	1.7	4.9	4.8	4.5	5.8	5.2	1.7	2.9	3.3	6.4	5.7	0.9	2.2	0.5	1.0	3.8	2.0	3.6	0.7	0.4	0.1	0.6	0.4	0.8	0.6	0.5	0.3	1.0	1.7	0.8	0.6	0.7	0.3	0.7	0.4	1.3	0.4										
CLCN5	"ClC-5, CLC5, DENTS, hCIC-K2, hClC-K2, NPHL1, NPHL2, XLRH, XRN"	ENSG00000171365	"Chloride voltage-gated channel 5"	P51795	X	49922615-50099235	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 46.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 24.9;RH-30: 38.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 6.6"	"Group enriched"	"Detected in many"	8	"dendritic cells: 6.6;monocytes: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000401, HPA003213"	Uncertain		Supported	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus, Plasma membrane"	Cytosol	"HPA000401: AB_1078531, HPA003213: "	"unprognostic (3.33e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.60e-1)"	"unprognostic (5.21e-2)"	"prognostic favourable (5.20e-4)"	"unprognostic (3.59e-2)"	"prognostic favourable (2.05e-8)"	"unprognostic (7.87e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.60e-2)"	4.4	4.1	2.5	2.4	2.9	2.1	3.4	9.4	3.4	2.3	3.1	2.6	4.7	5.0	9.8	26.7	3.7	4.6	7.6	2.2	3.1	2.8	46.1	15.8	4.7	3.0	2.6	2.5	10.8	6.7	2.6	8.3	7.3	5.9	2.7	3.7	7.6	4.0	3.5	5.6	6.2	6.4	3.8	4.3	3.0	4.0	5.9	2.3	1.2	3.6	4.0	2.3	2.4	3.1	0.2	6.6	0.5	1.8	0.3	0.4	0.5	1.7	2.8	2.1	3.3	8.3	5.2	4.6	1.5	0.7	0.9	1.2	24.9	1.7	1.8	0.8	1.7	1.4	6.7	0.8	1.5	0.7	4.6	1.7	1.4	6.5	3.9	2.3	3.3	3.1	1.1	2.5	3.7	3.6	2.7	2.7	2.9	1.8	0.8	0.6	3.1	1.3	1.0	38.6	2.7	3.7	2.8	3.7	2.7	2.1	2.1	3.1	1.9	1.1	1.8	1.0	2.1	7.6	0.9	2.2	6.7	4.1	1.6	3.7	5.0	0.1	1.8	0.0	0.2	1.5	0.3	0.2	0.4	0.4	3.8	0.2	0.1	0.1	0.5	0.3	0.3	6.6	0.0	0.5	2.5	2.9	9.4	3.4	3.1	2.8	2.6	2.5	5.9	2.3
AKAP4	"AKAP82, CT99, Fsc1, hAKAP82, HI, p82"	ENSG00000147081	"A-kinase anchoring protein 4"	Q5JQC9	X	50190768-50201013	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	63	"testis: 86.0"	"Group enriched"	"Detected in some"	13	"NB-4: 1.4;U-2197: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005949, HPA020046"	Enhanced									"HPA005949: AB_1078120, HPA020046: AB_1844693"			"unprognostic (2.94e-2)"											"unprognostic (1.86e-2)"	"unprognostic (2.47e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCNB3		ENSG00000147082	"Cyclin B3"	Q8WWL7	X	50202713-50351910	"Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 6.1;epididymis: 11.6;pituitary gland: 3.7;testis: 14.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.8;Karpas-707: 3.9;U-2 OS: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			HPA000496			Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA000496: AB_1078605"	"unprognostic (1.57e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.96e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.48e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.63e-2)"	0.7	0.7	0.9	0.3	3.5	0.2	0.8	0.4	1.7	0.4	0.4	5.8	0.0	0.4	0.3	11.6	0.4	0.7	0.6	0.6	1.3	1.5	0.7	1.1	0.7	0.4	2.4	2.0	0.4	0.9	0.7	3.7	0.9	4.3	0.5	0.4	0.0	0.5	0.8	1.4	1.0	0.3	0.3	6.1	0.6	1.0	14.8	1.3	0.1	0.9	1.1	0.5	0.4	0.2	0.3	0.3	0.0	0.5	0.0	2.2	0.1	0.4	1.5	0.8	0.5	0.2	0.2	0.0	0.1	0.3	0.3	0.4	1.2	4.8	1.4	1.0	0.3	0.2	0.7	0.5	0.3	1.2	1.6	1.0	0.0	0.0	1.3	1.1	1.0	0.8	0.2	0.3	0.9	0.5	0.2	3.9	1.2	0.0	0.6	0.2	0.7	0.1	0.0	1.7	0.1	0.2	0.5	0.1	0.9	0.4	0.2	1.0	3.4	0.3	0.4	2.0	3.5	0.9	0.6	1.0	0.7	2.1	0.6	0.4	0.3	0.0	0.0	0.0	2.2	0.5	0.3	0.3	0.5	0.0	0.3	0.3	0.4	1.0	0.0	0.0	0.3	0.0	0.1	0.1	0.9	3.5	0.4	1.7	1.3	1.5	2.4	2.0	4.3	1.3
DGKK		ENSG00000274588	"Diacylglycerol kinase kappa"	Q5KSL6	X	50365409-50470738	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"adrenal gland: 9.8;brain: 29.6;pituitary gland: 33.5"	"Cell line enriched"	"Detected in some"	20	"Hep G2: 27.3"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	6	"gdT-cell: 2.4;memory CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.4"	"Region enhanced"	"Detected in some"		"hypothalamus: 12.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 3.5;hypothalamus: 1.8;midbrain: 4.3;pons and medulla: 1.1"												"unprognostic (3.99e-1)"		"unprognostic (1.18e-1)"	"unprognostic (4.18e-3)"	"unprognostic (1.23e-1)"		"unprognostic (5.83e-3)"	"unprognostic (9.58e-2)"		"unprognostic (2.41e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.28e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.64e-3)"	0.1	9.8	0.0	0.0	29.6	0.2	0.3	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5										
SHROOM4	KIAA1202	ENSG00000158352	"Shroom family member 4"	Q9ULL8	X	50591647-50814302	"Disease related genes, Predicted intracellular proteins"		"Actin-binding, Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 27.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 6.0;HUVEC TERT2: 22.8;RH-30: 4.4;RPTEC TERT1: 4.9;TIME: 8.6;WM-115: 4.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"basophil: 1.6"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010089, HPA010565"	Uncertain		Approved	"Vesicles,Focal adhesion sites"				"Focal adhesion sites"	Vesicles	"HPA010089: , HPA010565: AB_1079961"	"unprognostic (2.55e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavourable (8.37e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.30e-3)"	"unprognostic (4.55e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (4.66e-4)"	"unprognostic (7.30e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.75e-1)"	13.1	3.5	5.9	3.6	12.1	2.4	10.1	1.9	7.7	6.4	2.9	27.3	1.6	2.4	6.8	3.6	5.2	4.3	5.7	8.5	8.3	4.8	9.7	1.9	21.4	1.9	15.9	6.5	2.5	1.9	3.6	3.7	15.3	13.0	3.6	3.0	4.8	3.5	3.7	6.0	3.2	2.6	7.4	19.7	2.1	2.4	1.5	15.8	0.0	6.3	6.7	2.1	4.8	4.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.4	0.1	0.0	6.0	0.7	0.6	3.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.4	22.8	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	4.4	0.0	4.9	2.1	0.1	0.0	0.0	0.7	1.3	0.0	0.1	8.6	0.0	0.0	0.0	0.6	0.4	0.0	0.0	1.2	0.2	4.4	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.9	12.1	1.9	7.7	8.3	4.8	15.9	6.5	13.0	15.8
BMP15	GDF9B	ENSG00000130385	"Bone morphogenetic protein 15"	O95972	X	50910784-50916607	"Disease related genes, Predicted secreted proteins"		"Cytokine, Growth factor"	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 2.2;testis: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"																							0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1			0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0		0.1	0.0	0.0	0.0	0.2		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NUDT10	"DIPP3a, hDIPP3alpha"	ENSG00000122824	"Nudix hydrolase 10"	Q8NFP7	X	51332231-51337525	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 28.8;seminal vesicle: 36.3;testis: 27.2"	"Cell line enhanced"	"Detected in some"		"AF22: 6.1;HAP1: 11.4;HEK 293: 8.4;NTERA-2: 20.9;SH-SY5Y: 4.6;U-2 OS: 10.5"	"Group enriched"	"Detected in many"	6	"glioma: 5.0;prostate cancer: 5.4;testis cancer: 7.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1"	"Low lineage specificity"	"Detected in many"											"HPA047027, HPA057684"	Approved		Approved	Cytosol				Cytosol		"HPA047027: , HPA057684: "	"unprognostic (2.61e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.40e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.80e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.04e-5)"	1.0	2.3	9.3	1.4	10.7	1.8	1.4	6.0	13.1	4.4	2.0	0.9	28.8	1.1	5.5	18.3	1.7	3.4	2.0	0.9	4.9	13.6	3.1	1.9	0.7	0.9	5.3	8.0	19.2	0.6	0.5	4.5	0.5	6.2	17.9	1.3	0.8	1.0	36.3	0.5	1.0	1.2	4.9	1.9	3.1	1.1	27.2	1.2	0.0	0.8	0.0	0.9	2.8	2.9	0.8	0.1	0.0	0.7	2.1	1.0	0.3	0.0	0.0	6.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	11.4	0.5	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	20.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.1	0.0	0.8	1.0	0.0	0.1	0.3	0.0	0.6	0.0	2.1	0.5	0.0	0.0	0.3	9.3	10.7	6.0	11.7	4.9	13.6	5.3	8.0	6.2	1.2
CXorf67		ENSG00000187690	"Chromosome X open reading frame 67"	Q86X51	X	51406915-51408843	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"placenta: 14.3;testis: 21.4"	"Cell line enriched"	"Detected in single"	46	"U-2 OS: 27.0"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 11.4"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.8"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.1;naive CD4 T-cell: 1.2"	"Group enriched"	"Detected in many"	11	"B-cells: 1.1;T-cells: 1.2"									"HPA004003, HPA006128"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA004003: AB_2667113, HPA006128: AB_2667517"					"unprognostic (4.21e-2)"			"unprognostic (6.36e-2)"		"unprognostic (3.37e-2)"	"unprognostic (8.58e-3)"	"unprognostic (3.57e-4)"	"unprognostic (1.47e-6)"	"unprognostic (4.55e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.26e-1)"		0.1	0.2	0.3	0.2	0.6	0.1	0.1	2.8	0.4	0.1	0.1	0.1	0.1	0.0	0.3	0.4	0.1	0.1	0.1	0.1	0.3	0.5	0.1	0.1	0.2	0.2	0.2	0.1	0.7	0.1	0.0	1.5	14.3	0.1	0.4	0.1	0.1	0.9	0.2	0.1	0.2	0.2	0.1	0.4	0.7	0.1	21.4	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.1	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.7	1.2	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.6	2.8	0.4	0.3	0.5	0.2	0.1	0.1	0.1
NUDT11	"DIPP3b, FLJ10628, hDIPP3beta"	ENSG00000196368	"Nudix hydrolase 11"	Q96G61	X	51490011-51496596	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1;testis: 35.5"	"Cell line enhanced"	"Detected in many"		"HAP1: 33.1;NTERA-2: 20.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 17.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 3.7;MAIT T-cell: 1.4;memory CD4 T-cell: 1.2;memory CD8 T-cell: 1.9;naive CD8 T-cell: 3.1;NK-cell: 1.9"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.9;T-cells: 3.7"									"HPA047027, HPA057684"	Approved		Approved	Cytosol				Cytosol		"HPA047027: , HPA057684: "	"unprognostic (2.01e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.13e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.18e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.80e-12)"	"unprognostic (4.34e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.94e-4)"	1.2	5.4	11.2	1.4	21.9	1.6	2.8	7.4	26.1	3.8	2.6	0.8	4.4	1.7	5.9	4.3	1.9	1.6	2.2	0.8	7.0	17.9	0.9	0.6	0.8	1.1	5.3	12.7	10.0	3.8	0.5	2.8	0.6	5.3	10.1	1.4	0.5	1.3	11.9	0.6	1.7	1.5	5.0	1.8	0.9	0.9	35.5	1.1	3.6	1.0	0.2	1.1	1.7	1.6	0.5	0.4	0.0	0.2	1.9	3.7	1.0	0.0	0.5	10.0	0.0	8.6	11.0	0.0	4.6	1.3	0.2	0.2	0.0	0.0	0.0	0.2	5.6	0.7	33.1	11.3	0.1	0.0	2.2	0.0	0.0	0.0	4.1	0.0	2.2	6.7	4.5	3.0	11.0	7.8	0.0	0.0	9.3	0.2	12.5	0.0	20.6	8.4	0.0	7.0	0.0	2.0	0.0	0.0	6.5	2.0	0.0	1.8	0.0	0.0	4.5	2.3	10.9	0.6	0.0	4.3	2.0	7.0	1.5	0.0	0.9	0.0	0.0	0.0	3.7	0.0	1.4	0.5	1.2	1.9	0.4	0.3	0.2	3.1	0.0	1.9	0.2	0.2	0.0	1.0	11.2	21.9	7.4	14.9	7.0	17.9	5.3	12.7	5.3	1.1
CENPVL3	CENPVP3	ENSG00000224109	"Centromere protein V like 3"		X	51617024-51618968	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	4	"brain: 4.7;testis: 8.0"	"Group enriched"	"Detected in some"	8	"NTERA-2: 4.8;PC-3: 15.5;U-2 OS: 10.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																	"unprognostic (3.07e-2)"			"unprognostic (1.48e-1)"			0.0	1.4	0.6	0.0	4.7	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7		0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CENPVL2	CENPVP2	ENSG00000283093	"Centromere protein V like 2"		X	51681212-51682831	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	5	"brain: 1.6;testis: 2.5"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.1;PC-3: 2.8;SH-SY5Y: 1.6;U-2 OS: 2.9"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.0	0.0		1.6	0.0	0.0			0.4	0.0	0.3	0.0	0.0	0.4	0.0			0.0	0.0	0.0	0.0			0.0	0.3	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	2.5			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CENPVL1	"CENPVP1, PRR6L1"	ENSG00000223591	"Centromere protein V like 1"		X	51710512-51712131	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	5	"brain: 1.6;testis: 2.5"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.1;PC-3: 2.8;SH-SY5Y: 1.6;U-2 OS: 2.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.0	0.0		1.6	0.0	0.0			0.4	0.0	0.3	0.0	0.0	0.4	0.0			0.0	0.0	0.0	0.0			0.0	0.3	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	2.5			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GSPT2	"eRF3b, FLJ10441"	ENSG00000189369	"G1 to S phase transition 2"	Q8IYD1	X	51743431-51746232	"Predicted intracellular proteins"	"Cell cycle, Nonsense-mediated mRNA decay, Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 25.0;PC-3: 28.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044769, HPA074588"	Approved		Enhanced	Cytosol				Cytosol		"HPA044769: AB_10963577, HPA074588: "	"unprognostic (8.55e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.71e-3)"	"unprognostic (3.39e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.76e-3)"	"unprognostic (1.07e-1)"	8.6	11.1	11.6	8.6	17.6	3.6	9.3	14.1	18.3	8.2	7.3	6.5	3.4	4.8	8.3	11.5	4.2	8.8	7.6	9.8	11.5	19.5	9.6	16.0	7.9	12.0	9.2	13.0	15.3	7.3	7.1	14.9	3.6	8.8	10.5	5.5	6.7	8.9	9.7	7.8	4.0	7.6	8.0	6.7	9.0	6.5	18.4	8.8	18.4	9.1	3.8	12.1	7.7	4.1	9.5	9.7	2.7	4.1	7.2	8.3	4.2	0.0	5.1	10.4	0.0	7.3	6.4	0.0	5.9	1.0	4.2	5.3	3.2	5.2	14.9	0.0	5.0	1.6	0.0	2.7	4.9	0.0	6.6	0.2	0.0	0.0	5.4	0.0	6.5	8.4	1.3	3.7	3.7	6.1	3.9	1.1	7.4	0.0	1.3	0.9	25.0	28.1	7.1	9.8	0.0	7.6	5.4	0.0	8.8	0.0	0.0	5.0	0.0	4.8	3.8	4.2	8.6	3.9	3.8	0.0	8.5	0.0	5.6	1.0	4.6	2.7	2.9	1.8	5.7	4.1	5.7	9.5	5.1	5.3	9.7	9.5	8.3	7.1	0.3	7.2	3.1	8.2	6.4	4.2	11.6	17.6	14.1	18.3	11.5	19.5	9.2	13.0	8.8	8.8
MAGED1	"DLXIN-1, NRAGE"	ENSG00000179222	"MAGE family member D1"	Q9Y5V3	X	51803007-51902357	"Cancer-related genes, Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"	"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 82.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043645			Approved	Cytosol				Cytosol		"HPA043645: "	"unprognostic (5.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.04e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.42e-1)"	"unprognostic (6.10e-3)"	"unprognostic (2.14e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavourable (3.25e-4)"	"unprognostic (1.71e-3)"	15.4	57.6	35.3	16.8	52.9	6.9	18.6	34.6	61.8	50.9	18.8	25.9	38.9	15.2	27.6	67.4	13.1	31.6	28.1	32.4	42.2	58.4	22.5	48.6	17.5	13.6	32.2	38.0	30.7	37.2	42.9	69.6	53.5	39.4	35.1	19.3	34.7	38.1	45.5	19.6	12.7	13.4	36.3	25.7	15.9	25.8	33.8	16.1	24.6	35.4	12.5	17.9	23.9	15.8	10.1	28.8	1.5	3.2	7.7	11.6	6.9	3.2	11.8	37.9	32.6	30.0	54.2	20.4	43.8	56.3	24.3	38.6	24.2	11.1	4.6	8.6	82.7	2.4	33.8	15.6	18.3	4.8	13.1	3.1	0.0	31.3	23.0	11.5	5.7	50.9	5.6	20.5	4.7	29.1	4.7	9.1	48.8	29.6	13.1	3.8	29.8	24.4	13.4	24.6	0.6	25.0	5.8	9.8	54.5	0.0	12.8	6.4	23.0	2.8	28.9	10.6	27.3	37.3	4.8	6.0	8.8	9.4	41.5	1.0	27.5	0.7	2.2	1.5	11.6	3.2	10.3	9.3	7.6	10.0	6.8	10.1	9.6	11.3	0.7	7.7	2.8	28.8	10.5	6.9	35.3	52.9	34.6	61.8	42.2	58.4	32.2	38.0	39.4	16.1
MAGED4B		ENSG00000187243	"MAGE family member D4B"	Q96JG8	X	52061827-52069248	"Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.3"	"Cell line enhanced"	"Detected in many"		"AF22: 24.3;NTERA-2: 19.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"naive B-cell: 8.1"	"Group enriched"	"Detected in many"	30	"B-cells: 8.1;dendritic cells: 5.4;T-cells: 5.0"									HPA003554	Approved									"HPA003554: AB_1853497"					"unprognostic (7.75e-2)"			"unprognostic (2.19e-1)"		"unprognostic (2.37e-2)"				"unprognostic (7.01e-6)"	"unprognostic (6.45e-2)"			0.5	2.8	7.4	1.6	13.5	0.0	1.2	1.9	19.3	5.5	1.4			1.2	7.2	0.5	0.4	3.1	2.9	0.1	5.2	18.1	0.2	0.0	0.3	0.5	5.6		5.7	2.5	0.0	7.2	2.3		3.6	0.7		2.9	1.6	0.0	0.5	1.9	3.8	6.9	0.3	2.4	0.3			1.7		0.5	1.6	1.0	8.1	5.4	0.0	0.0	0.2	5.0	0.8	0.0	1.0	24.3	8.0	6.9	5.3	8.1	13.7	9.6	3.6	7.1	0.0	1.7	0.0	2.8	15.2	0.0	9.9	0.0	2.1	0.0	1.6	0.0	0.0	11.1	5.5	0.0	3.2	11.9	0.0	7.7	0.2	6.8	0.0	0.1	6.3	1.0	2.6	0.0	19.9	0.7	0.0	14.3	0.0	2.6	0.0	1.0	15.1	0.0	0.0	1.9	0.0	0.0	0.9	6.7	10.1	0.0	0.0	0.0	0.0	0.5	8.8	0.0	11.8	0.0	0.0	0.0	0.2	0.0	0.5	2.7	2.4	1.3	0.0	8.1	0.0	0.5	0.0	0.2	0.0	5.4	5.0	0.8										
MAGED4	"KIAA1859, MAGE-E1, MAGE1, MGC3210"	ENSG00000154545	"MAGE family member D4"	Q96JG8	X	52184823-52192268	"Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 6.1;pituitary gland: 7.5"	"Cell line enhanced"	"Detected in some"		"A549: 4.7;ASC TERT1: 4.4;Hep G2: 12.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.1"	"Group enriched"	"Detected in many"	21	"B-cells: 3.1;dendritic cells: 1.3;T-cells: 1.6"									HPA003554	Uncertain									"HPA003554: AB_1853497"					"unprognostic (7.71e-2)"					"unprognostic (8.21e-2)"				"unprognostic (4.07e-4)"	"unprognostic (6.15e-2)"			1.3	2.1	5.5	1.3	6.1	0.4	3.1	0.8	4.6	2.0	1.0	2.4	0.0	0.4	1.9	0.4	0.4	0.4	1.9	1.6	5.1	4.8	1.1	0.6	0.4	0.4	3.7	5.5	1.2	1.0	0.4	7.5	1.7	3.7	1.2	1.2	0.3	1.1	1.4	0.9	0.4	0.4	2.0	5.2	0.8	0.5	0.6	1.2	0.0	0.4	0.0	0.4	0.4	0.4	3.1	1.3	0.0	0.0	0.0	1.6	0.3	0.0	4.7	0.8	0.8	0.0	4.4	0.0	0.0	0.0	1.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.9	0.0	0.0	12.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.9	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	1.6	0.0	3.1	0.5	0.2	0.0	0.0	0.0	1.3	1.5	0.3	5.5	6.1	0.8	4.6	5.1	4.8	3.7	5.5	3.7	1.2
XAGE2	"CT12.2, GAGED3, XAGE-2, XAGE2B"	ENSG00000155622	"X antigen family member 2"	Q96GT9	X	52369030-52375680	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"placenta: 106.9"	"Cell line enriched"	"Detected in some"	4	"BEWO: 45.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA052507, HPA060900"	Supported									"HPA052507: , HPA060900: "								"unprognostic (1.21e-1)"		"unprognostic (9.67e-2)"	"unprognostic (1.49e-1)"				"unprognostic (4.47e-2)"			0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.0	4.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	106.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	45.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.7	0.5	9.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
XAGE1A	"CT12.1a, GAGED2, XAGE-1, XAGE1"	ENSG00000204379	"X antigen family member 1A"	Q9HD64	X	52495676-52500812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"testis: 28.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 73.0;NB-4: 71.1;THP-1: 73.0;U-2 OS: 53.3;U-266/70: 34.8;U-266/84: 94.4;U-937: 58.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046363			Approved	Nucleoplasm				Nucleoplasm		"HPA046363: "																		0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	73.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	71.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.4	0.0	0.1	0.2	5.0	73.0	0.0	0.0	53.3	0.0	10.2	34.8	94.4	0.1	0.0	58.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
XAGE1B	CT12.1b	ENSG00000204382	"X antigen family member 1B"	Q9HD64	X	52512077-52520803	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 28.8"	"Cell line enhanced"	"Detected in some"		"HMC-1: 76.7;NB-4: 74.6;THP-1: 72.5;U-2 OS: 55.6;U-266/70: 34.9;U-266/84: 95.3;U-937: 59.6"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	19	"plasmacytoid DC: 4.7"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 4.7"									HPA046363			Approved	Nucleoplasm				Nucleoplasm		"HPA046363: "																		0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.1	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	28.8			0.0		0.3	0.0	0.0	0.0	4.7	0.0	0.2	0.0	0.0	0.0	0.3	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	76.7	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.1	74.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.4	0.0	0.2	0.3	5.2	72.5	0.0	0.0	55.6	0.0	10.3	34.9	95.3	0.1	0.0	59.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0										
SSX7		ENSG00000187754	"SSX family member 7"	Q7RTT5	X	52644090-52654900	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in some"			"Cell line enhanced"	"Detected in some"		"HEL: 1.7;HMC-1: 7.9;RT4: 4.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"											HPA045683	Uncertain		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA045683: "																"unprognostic (1.29e-1)"		0.1	0.2	0.2	0.4	0.1	0.7	0.1	0.1	1.0	0.1	0.2			0.6	0.2	0.0	1.5	0.3	0.5	0.1	0.1	0.2	0.1	0.1	0.5	0.3	0.1		0.8	0.1	0.0	0.1	0.0		0.1	0.0		1.8	0.0	0.1	1.5	0.1	0.0	0.1	0.6	0.4	1.0			0.4		0.0	0.2	0.1	0.0	0.2	1.0	0.7	0.3	0.4	0.0	0.4	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.9	0.0	0.1	0.1	0.5	0.3	1.7	0.7	0.3	0.0	0.0	7.9	0.0	0.2	0.2	0.0	0.1	0.2	1.4	0.1	1.0	0.7	0.2	0.0	0.0	0.4	0.5	0.0	0.0	4.2	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.3	0.4	0.6	0.1	0.0	0.1	0.1	0.1	0.5	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.0	0.3	0.7	0.1	0.0	0.0										
SSX2	"CT5.2a, HD21, HOM-MEL-40, MGC119055, MGC15364, MGC3884, SSX"	ENSG00000241476	"SSX family member 2"	Q16385	X	52696896-52707189	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	57	"testis: 24.1"	"Cell line enhanced"	"Detected in some"		"PC-3: 3.1;U-2197: 1.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045683, CAB046020"	Enhanced		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"CAB046020: AB_2194010, HPA045683: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1			0.4		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.6	0.1	0.6	1.9	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0										
SSX2B	CT5.2b	ENSG00000268447	"SSX family member 2B"	Q16385	X	52751132-52790305	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	24	"testis: 13.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.8;HMC-1: 5.3;PC-3: 5.1;T-47d: 2.2;U-2197: 3.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045683	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA045683: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.9	0.0	0.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.5	0.1	0.0	0.0	0.2	5.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.0	2.2	0.0	1.0	0.0	0.5	3.2	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0										
SPANXN5	"CT11.10, SPANX-N5"	ENSG00000204363	"SPANX family member N5"	Q5MJ07	X	52796144-52798101	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	78	"testis: 15.8"	"Group enriched"	"Detected in some"	7	"HEK 293: 1.2;LHCN-M2: 1.0;U-2 OS: 2.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.1		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
XAGE5	"CT12.5, GAGED5, XAGE-5"	ENSG00000171405	"X antigen family member 5"	Q8WWM1	X	52812204-52818301	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	6	"testis: 5.1"	"Cell line enriched"	"Detected in single"	34	"U-2 OS: 22.2"	"Cancer enhanced"	"Detected in single"		"liver cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA052507, HPA055941"	Uncertain		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA052507: , HPA055941: "															"unprognostic (1.89e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	5.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.2	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
XAGE3	"CT12.3a, CT12.3b, GAGED4, PLAC6, pp9012, XAGE-3"	ENSG00000171402	"X antigen family member 3"	Q8WTP9	X	52862525-52868068	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	20	"placenta: 98.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.2;U-266/70: 5.7;U-266/84: 5.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	10	"memory B-cell: 1.7"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.7"									"HPA052507, HPA060900"	Supported									"HPA052507: , HPA060900: "							"unprognostic (6.04e-2)"						"unprognostic (2.30e-1)"		"unprognostic (2.92e-1)"			1.0	0.0	0.1	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	1.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	98.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.0	1.1	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.7	5.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0
FAM156B	TMEM29B	ENSG00000179304	"Family with sequence similarity 156 member B"	Q8NDB6	X	52891306-52908560	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 34.3"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA056640, HPA056643"	Uncertain									"HPA056640: , HPA056643: "		"unprognostic (2.91e-1)"			"unprognostic (1.31e-1)"					"unprognostic (2.66e-1)"			"unprognostic (3.24e-5)"	"unprognostic (2.97e-1)"				6.4	7.4	6.5	10.9	6.9	5.2	7.9	13.7	12.3	4.6	5.0	5.6	13.9	5.0	8.8	9.3	4.6	8.7	5.4	6.4	10.1	5.7	5.9	4.9	5.3	3.8	4.7	11.4	7.7	5.0	3.9	13.9	34.3	5.6	6.2	4.4	7.2	6.1	9.8	5.1	20.6	4.8	7.0	5.5	7.6	4.5	4.6	2.4	3.5	7.0	3.0	4.7	5.9	5.1	1.1	8.0	1.2	7.3	3.1	2.6	3.3	3.6	6.9	4.5	6.5	5.0	4.2	13.4	3.8	6.0	5.8	4.2	3.5	3.7	3.3	2.7	11.4	4.7	7.8	6.1	1.7	1.0	8.7	2.4	13.5	14.0	16.9	2.1	2.1	9.7	6.4	6.7	5.4	5.1	2.5	2.1	7.6	8.4	5.1	12.4	4.9	11.9	3.5	4.8	5.5	7.0	4.8	4.3	5.2	3.3	8.8	4.2	4.9	5.7	4.3	3.1	3.5	6.0	4.2	4.7	6.6	6.2	4.4	9.5	1.9	0.0	4.6	1.2	1.2	7.3	1.8	1.1	0.7	1.2	8.0	1.0	2.6	0.6	1.1	3.1	6.8	4.5	2.4	3.3	6.5	6.9	13.7	12.3	10.1	5.7	4.7	11.4	5.6	2.4
FAM156A	"PRO0659, TMEM29"	ENSG00000268350	"Family with sequence similarity 156 member A"	Q8NDB6	X	52926402-52995472	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA056640, HPA056643"	Approved									"HPA056640: , HPA056643: "	"unprognostic (1.80e-1)"	"unprognostic (5.58e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.99e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-3)"	"unprognostic (6.60e-3)"	"unprognostic (2.25e-1)"	"unprognostic (5.84e-2)"	"unprognostic (8.49e-5)"	"unprognostic (1.32e-1)"	"unprognostic (3.54e-13)"	"unprognostic (6.42e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.90e-2)"	7.5	6.9	5.8	4.0	6.4	2.8	2.7	12.1	8.3	3.3	3.3	7.2	8.0	5.7	6.6	3.5	2.6	3.5	3.2	3.3	5.9		1.8	1.1	3.3	4.3	5.4	6.0	4.6	3.4	6.2	11.4	9.0	7.6	3.3	5.0	6.2	2.8	4.7	3.7	13.4	5.6	6.3	4.3	6.4	5.2	4.2	6.8	3.6	3.2	1.8	3.5	2.9	4.7	4.9	14.4	2.5	9.5	6.8	8.7	5.2	6.6	8.9	8.1	16.3	6.1	20.2	35.7	12.8	8.2	11.2	10.3	7.8	8.5	8.8	4.8	15.5	12.1	11.2	10.7	9.6	9.1	9.7	5.8	44.3	8.8	6.4	7.2	6.2	17.1	5.5	12.8	5.0	5.2	8.1	9.3	16.3	10.3	6.3	16.2	7.7	12.7	12.0	9.1	10.8	4.3	8.1	7.2	8.3	8.8	9.8	4.4	11.7	4.7	6.6	25.4	9.1	23.6	6.3	13.8	15.4	8.7	16.6	14.2	9.0	0.0	9.5	1.4	6.3	6.0	4.8	4.8	5.3	5.3	14.4	4.9	8.7	4.0	2.5	6.8	6.5	8.0	4.0	5.2										
GPR173	SREB3	ENSG00000184194	"G protein-coupled receptor 173"	Q9NS66	X	53049091-53080615	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 23.2"	"Cell line enhanced"	"Detected in many"		"HAP1: 10.3"	"Cancer enhanced"	"Detected in many"		"glioma: 8.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 5.7;NK-cells: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003905			Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA003905: AB_1078922"	"unprognostic (2.68e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.95e-3)"	"prognostic unfavourable (2.88e-6)"	"unprognostic (3.87e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.70e-2)"	"prognostic favourable (2.33e-5)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (2.47e-4)"	"unprognostic (1.08e-4)"	"unprognostic (2.83e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.95e-2)"	2.5	5.2	8.2	3.0	9.4	2.2	3.1	15.4	23.2	4.2	2.8	11.6	0.8	1.8	6.4	5.0	2.4	7.7	3.3	4.2	7.9	10.0	2.4	1.1	2.8	2.1	7.3	11.2	15.0	1.3	1.3	14.6	4.5	9.7	3.2	2.6	6.4	2.0	5.4	4.6	3.9	2.1	4.5	6.5	4.0	2.1	2.4	9.6	0.7	3.1	0.1	1.5	3.3	2.8	0.9	0.7	5.7	0.4	1.8	0.7	0.0	0.0	0.0	8.2	0.5	4.7	2.8	0.0	1.3	3.0	2.2	2.6	0.8	0.1	0.2	2.0	2.8	0.7	10.3	0.0	1.9	0.6	1.0	0.5	8.4	0.3	6.8	0.5	0.1	6.6	0.0	3.3	4.7	3.5	0.0	5.7	3.2	4.2	0.0	0.0	6.3	3.6	0.1	2.5	0.3	0.5	0.4	5.9	8.3	0.0	0.4	0.0	1.1	0.1	6.5	3.6	5.2	2.3	1.1	0.2	0.3	0.7	2.5	0.0	2.0	5.7	0.2	0.3	0.7	0.1	0.5	0.3	0.2	0.1	0.1	0.9	0.5	0.4	1.2	1.8	0.4	0.7	0.0	0.0	8.2	9.4	15.4	15.1	7.9	10.0	7.3	11.2	9.7	9.6
TSPYL2	"CDA1, CINAP, CTCL, DENTT, HRIHFB2216, SE20-4, TSPX"	ENSG00000184205	"TSPY like 2"	Q9H2G4	X	53082367-53088540	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 91.4"	"Cell line enhanced"	"Detected in all"		"U-2197: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044133	Approved									"HPA044133: AB_10965838"	"unprognostic (3.29e-2)"	"unprognostic (2.68e-3)"	"prognostic unfavourable (3.23e-4)"	"unprognostic (3.87e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.99e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.59e-1)"	"prognostic favourable (6.74e-8)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (8.16e-7)"	"unprognostic (6.50e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.10e-2)"	15.2	34.9	27.9	12.6	91.4	31.8	11.2	49.3	46.6	16.3	14.5	9.6	18.4	5.5	32.5	34.5	12.2	16.5	17.7	14.0	26.2	27.7	7.3	7.6	11.3	17.3	14.1	33.4	68.0	11.7	10.8	46.5	6.3	23.8	24.4	7.1	12.6	8.0	32.9	13.4	10.2	11.0	17.9	8.3	15.9	12.7	40.7	18.2	4.8	17.7	3.7	12.2	15.2	12.4	7.0	12.5	2.8	1.0	6.1	12.7	4.8	1.7	5.6	5.8	23.9	4.5	5.5	8.3	12.2	13.0	8.1	7.9	8.2	3.9	12.9	2.3	6.4	5.1	4.7	4.8	7.4	3.2	10.3	3.2	22.0	10.6	13.2	5.2	4.1	10.6	8.9	10.9	18.6	5.7	2.5	12.1	4.4	7.7	7.4	6.3	8.7	10.5	5.9	7.3	9.4	1.4	9.6	7.1	4.3	9.7	3.6	6.3	5.3	1.6	8.3	3.7	6.2	47.6	2.3	13.1	8.1	12.2	6.2	8.7	7.6	2.8	0.1	1.7	6.6	0.6	8.1	5.3	9.2	5.2	0.1	7.0	12.7	9.0	1.0	6.1	1.0	12.5	6.6	4.8	27.9	91.4	49.3	46.6	26.2	27.7	14.1	33.4	23.8	18.2
KANTR	"LINC01155, Spasm"	ENSG00000232593	"KDM5C adjacent transcript"		X	53094145-53170914	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"brain: 11.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"eosinophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"																		"unprognostic (2.89e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.30e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.47e-6)"	"unprognostic (1.51e-1)"	"unprognostic (8.80e-2)"	"unprognostic (2.78e-3)"	"unprognostic (1.81e-3)"	1.5	2.4	4.9	1.5	5.9	5.7	2.2	11.9	11.7	2.3	1.6	3.0	2.5	1.5	2.6	2.9	1.5	2.0	1.6	1.5	3.4		1.6	1.5	1.7	1.5	3.9	4.5	2.4	1.4	2.0	6.8	2.2	4.0	2.1	1.7	2.1	2.0	2.6	1.5	2.0	1.5	2.1	2.8	1.6	1.5	2.4	4.4	1.1	1.8	0.0	1.5	1.6	2.5	0.6	0.6	1.6	0.8	0.0	0.4	0.0	0.7	0.2	0.8	0.7	0.9	0.9	0.7	0.1	0.2	1.3	0.8	0.2	0.4	0.8	0.5	0.3	0.4	1.4	0.4	2.0	0.2	0.2	0.3	0.2	0.3	1.5	1.4	1.0	1.1	0.5	2.6	1.2	1.0	1.2	1.0	0.2	0.4	1.2	1.6	1.2	0.9	0.6	0.7	0.4	0.3	1.4	2.9	1.3	0.6	0.3	0.1	0.5	0.2	0.6	0.7	1.7	2.4	0.3	0.8	0.9	1.2	0.0	1.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.3	0.3	0.4	0.0	0.0	0.8	0.6	0.0	0.0										
KDM5C	"DXS1272E, JARID1C, MRX13, SMCX, XE169"	ENSG00000126012	"Lysine demethylase 5C"	P41229	X	53191321-53225422	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038244, HPA046147"			Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038244: , HPA046147: "	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.10e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.00e-1)"	19.5	22.9	22.4	22.6	24.7	26.3	17.9	43.0	31.7	25.9	19.5	23.4	16.7	22.2	29.2	13.3	26.9	24.8	15.2	17.6	21.6	15.3	17.0	18.8	20.6	25.8	24.6	21.8	33.1	22.5	37.7	31.8	34.0	22.8	18.7	13.5	17.0	25.6	17.1	36.6	28.4	22.2	23.6	16.0	25.0	19.4	10.6	26.2	29.0	22.2	11.3	24.5	21.5	26.4	4.5	4.3	4.8	4.0	2.8	6.1	3.8	17.3	23.8	25.5	19.5	17.7	16.2	18.1	10.9	12.8	14.8	13.8	16.0	11.4	16.2	14.2	14.3	15.6	28.8	23.3	11.3	12.1	42.6	15.7	25.3	11.3	21.8	18.6	31.4	12.7	17.2	28.9	35.6	21.8	30.6	10.8	10.8	22.3	13.6	20.9	21.6	22.3	15.4	15.2	17.6	9.4	16.7	19.2	24.8	33.1	30.7	12.4	21.5	16.4	14.9	16.5	14.3	14.8	10.5	15.7	12.8	12.4	21.4	22.1	12.2	3.0	3.8	2.7	6.1	3.6	5.1	4.5	3.7	5.7	3.1	3.2	4.5	2.9	4.8	2.8	4.0	4.3	4.3	3.8	22.4	24.7	43.0	31.7	21.6	15.3	24.6	21.8	22.8	26.2
IQSEC2	"KIAA0522, MRX1, MRX18, MRX78"	ENSG00000124313	"IQ motif and Sec7 domain 2"	Q5JU85	X	53225828-53321350	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.2"	"Cell line enhanced"	"Detected in many"		"A549: 27.2;U-87 MG: 20.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 10.0;plasmacytoid DC: 10.2"	"Group enriched"	"Detected in many"	15	"dendritic cells: 10.2;monocytes: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003973			Approved	Vesicles				Vesicles		"HPA003973: AB_2280343"	"unprognostic (1.85e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.66e-3)"	"unprognostic (6.02e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.82e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavourable (2.00e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.30e-2)"	"prognostic favourable (2.38e-4)"	8.1	10.0	16.6	4.3	22.0	1.5	4.7	32.1	34.2	7.0	6.9	3.7	4.9	9.9	4.7	3.5	4.9	8.5	4.9	6.0	19.4	9.0	10.8	1.3	6.5	2.0	6.7	12.7	4.7	5.4	8.1	6.1	2.9	13.4	6.4	5.6	2.8	5.1	7.8	25.6	5.7	10.7	5.9	4.4	3.5	5.5	4.2	5.2	0.2	5.3	4.3	2.6	4.7	4.1	0.2	10.2	0.6	10.0	0.0	0.1	2.2	2.6	27.2	1.0	2.5	3.8	8.4	3.0	4.4	7.7	3.3	6.3	0.7	10.1	0.1	7.2	10.3	3.7	0.9	4.3	2.5	2.7	4.7	3.0	11.9	0.7	8.3	0.1	1.6	6.0	6.6	9.4	5.2	4.6	9.4	3.1	7.1	6.3	0.0	0.5	8.5	11.9	2.0	2.1	3.2	5.1	5.7	1.1	1.0	10.3	6.4	4.1	9.0	1.3	5.3	3.3	6.3	1.8	2.0	0.9	0.1	0.1	20.3	1.9	1.7	0.1	10.0	0.5	0.0	3.6	0.1	0.2	0.0	0.1	5.2	0.1	0.1	0.1	0.6	0.0	1.8	10.2	0.0	2.2	16.6	22.0	32.1	34.2	19.4	9.0	6.7	12.7	13.4	5.2
SMC1A	"DXS423E, KIAA0178, SB1.8, SMC1L1, Smcb"	ENSG00000072501	"Structural maintenance of chromosomes 1A"	Q14683	X	53374149-53422728	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"		"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005499, CAB025404"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB025404: , HPA005499: AB_1080028"	"unprognostic (2.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.80e-3)"	"unprognostic (9.49e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.18e-3)"	"unprognostic (6.28e-2)"	"unprognostic (2.89e-1)"	"unprognostic (9.39e-2)"	20.6	14.1	14.6	24.2	28.2	24.6	16.2	33.6	21.7	19.9	18.2	22.0	10.5	16.2	27.5	10.0	22.4	21.7	12.5	16.2	16.8	10.8	19.2	23.5	15.4	30.2	25.2	13.0	21.8	17.2	31.0	18.4	19.5	18.0	13.4	17.3	12.5	16.8	12.9	24.3	16.2	19.7	21.7	21.3	20.1	17.5	10.4	25.8	38.3	16.8	11.1	25.7	22.0	21.3	14.3	15.5	13.7	18.7	15.6	17.8	10.6	28.2	31.7	25.2	21.5	9.3	10.3	14.1	17.1	11.3	21.7	17.6	18.8	16.5	27.6	14.7	11.4	21.6	44.9	24.7	24.3	23.6	52.3	24.1	36.8	13.1	3.8	34.0	34.6	5.8	6.4	24.3	14.8	18.7	35.4	17.8	16.9	17.1	30.6	10.3	37.4	16.9	32.9	43.5	25.5	9.2	18.6	26.8	22.6	44.7	22.1	9.4	23.7	13.9	10.5	18.5	19.6	18.3	16.6	11.7	19.7	25.6	10.6	38.7	18.1	6.1	13.8	13.7	17.8	18.7	17.0	12.2	12.0	15.6	15.5	14.3	14.2	10.9	9.4	15.6	17.4	12.9	8.8	10.6	14.6	28.2	33.6	21.7	16.8	10.8	25.2	13.0	18.0	25.8
RIBC1	FLJ32783	ENSG00000158423	"RIB43A domain with coiled-coils 1"	Q8N443	X	53422690-53431120	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 12.7;fallopian tube: 24.5;testis: 37.6"	"Cell line enhanced"	"Detected in many"		"HeLa: 8.4;T-47d: 11.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 12.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA001150			Approved	"Nuclear bodies"				"Nuclear bodies"		"HPA001150: "	"unprognostic (1.08e-2)"	"prognostic favourable (1.90e-5)"	"unprognostic (1.25e-1)"	"prognostic favourable (9.66e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.39e-3)"	"unprognostic (9.88e-2)"	"unprognostic (3.97e-4)"	"unprognostic (2.25e-2)"	"unprognostic (7.89e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.29e-1)"	0.6	2.9	2.0	1.3	3.7	0.4	1.3	0.5	1.4	1.8	0.7	5.3	0.8	0.7	2.1	5.4	1.1	24.5	1.4	1.1	2.5	3.0	2.3	0.3	2.9	0.6	1.3	1.4	5.5	1.6	1.9	5.0	0.5	12.7	1.1	0.4	2.4	1.9	1.5	0.5	1.0	0.7	0.5	1.4	0.6	0.7	37.6	1.2	0.3	3.1	0.2	0.5	0.8	0.5	1.5	1.0	2.9	1.5	3.7	2.3	1.1	1.9	5.2	2.0	1.4	0.7	1.3	1.2	0.5	0.3	1.1	1.0	2.0	3.2	1.9	3.6	0.2	3.6	0.5	1.1	1.5	1.1	3.3	1.1	8.4	0.9	0.3	1.1	2.0	0.4	0.4	3.1	0.7	0.9	0.8	2.3	0.7	1.3	2.2	1.0	2.5	1.4	1.6	1.4	1.5	3.1	1.0	4.5	0.8	5.1	1.9	1.2	11.6	0.5	0.6	0.6	2.6	1.5	0.7	2.4	1.6	1.1	2.1	0.4	0.9	0.0	0.7	0.0	0.3	1.2	2.3	0.2	0.9	1.9	1.0	1.5	0.4	0.4	2.9	3.7	1.5	0.8	1.9	1.1	2.0	3.7	0.5	1.4	2.5	3.0	1.3	1.4	12.7	1.2
HSD17B10	"17b-HSD10, ABAD, CAMR, ERAB, HADH2, MHBD, MRPP2, MRXS10, SDR5C1"	ENSG00000072506	"Hydroxysteroid 17-beta dehydrogenase 10"	Q99714	X	53431258-53434373	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Oxidoreductase	"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001432	Approved						1800000			"HPA001432: AB_1078740"	"unprognostic (1.27e-1)"	"prognostic favourable (2.80e-4)"	"unprognostic (2.60e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.37e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.64e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.92e-1)"	"unprognostic (9.51e-2)"	20.9	29.8	13.2	19.1	14.5	16.4	15.9	7.9	14.0	16.9	20.6	16.2	20.2	17.2	17.1	19.0	31.3	14.8	19.6	42.6	11.9	14.0	33.9	96.7	12.7	21.6	16.1	9.7	21.0	32.7	12.5	18.4	25.0	14.9	15.3	19.4	13.0	23.2	17.8	35.4	22.9	17.4	18.6	14.8	19.7	17.4	8.6	14.0	25.6	28.4	39.0	26.0	16.1	17.9	30.4	53.2	12.8	38.2	27.7	33.3	32.9	22.0	37.8	18.5	34.2	18.2	8.0	27.9	13.7	13.7	36.6	24.1	38.8	19.1	37.7	12.5	15.7	23.2	59.4	27.7	20.1	29.9	33.3	17.7	54.2	32.1	30.5	33.5	27.8	17.0	26.4	28.3	15.9	26.7	25.4	29.9	16.9	77.9	29.6	50.3	51.1	48.9	30.3	34.1	66.7	28.1	24.5	32.7	43.1	39.5	47.3	25.0	49.8	31.2	11.9	15.7	25.0	32.7	20.7	24.5	34.1	46.6	21.8	70.5	23.1	12.8	38.2	11.4	27.0	36.7	27.8	30.0	25.1	26.7	53.2	30.4	21.1	22.2	3.2	27.7	26.8	29.0	33.3	32.9	13.2	14.5	7.9	14.0	11.9	14.0	16.1	9.7	14.9	14.0
HUWE1	"Ib772, KIAA0312, UREB1"	ENSG00000086758	"HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase"	Q7Z6Z7	X	53532096-53686729	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Differentiation, DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002548, CAB022718"	Approved		Enhanced	Nucleoplasm,Cytosol			3400	"Nucleoplasm, Cytosol"		"CAB022718: , HPA002548: AB_1080489"	"unprognostic (4.73e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.89e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	24.6	28.2	27.7	23.8	43.3	22.4	28.0	37.0	41.1	31.8	25.9	34.3	26.6	17.1	31.9	52.4	27.4	26.5	23.1	27.1	28.0	31.8	30.3	26.2	20.3	23.1	30.0	30.2	43.3	27.8	59.8	34.2	27.2	34.6	27.3	22.7	25.6	26.4	29.6	59.1	50.1	22.1	33.9	23.9	26.6	25.7	28.4	27.7	32.4	27.6	20.7	28.6	27.0	22.9	5.1	7.2	8.2	7.0	6.9	8.9	3.5	50.1	30.9	20.1	14.2	35.3	21.1	24.8	15.1	19.5	15.9	16.7	23.5	16.2	26.3	10.3	27.4	24.1	45.4	25.3	21.8	37.9	20.1	20.9	27.7	18.3	32.5	31.3	12.9	20.1	19.0	38.2	43.9	27.5	20.8	17.1	20.6	30.9	16.9	17.5	27.5	22.3	15.7	27.8	15.9	26.4	34.8	16.8	12.1	42.6	19.0	13.6	27.2	15.2	35.0	14.7	21.1	20.9	19.2	15.0	14.7	23.0	15.7	30.7	21.1	4.0	4.7	8.2	7.2	3.8	8.9	5.1	6.9	7.6	6.7	5.1	4.9	4.9	4.2	6.9	7.0	7.2	5.7	3.5	27.7	43.3	37.0	41.1	28.0	31.8	30.0	30.2	34.6	27.7
PHF8	"JHDM1F, KDM7B, KIAA1111, ZNF422"	ENSG00000172943	"PHD finger protein 8"	Q9UPP1	X	53936676-54048958	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, Oxidoreductase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038779, HPA062015"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA038779: AB_10675950, HPA062015: "	"unprognostic (6.35e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.85e-2)"	"prognostic favourable (3.74e-5)"	8.8	6.8	8.2	11.5	9.4	10.7	11.1	12.5	9.2	10.3	8.2	12.9	27.4	7.9	12.2	54.0	10.7	11.1	9.8	7.8	7.2	5.4	8.8	21.7	10.5	11.2	11.3	7.0	16.8	14.1	10.6	14.6	9.8	9.4	12.8	7.5	10.3	10.3	14.7	8.4	9.6	11.1	8.9	8.5	11.8	9.7	30.6	10.4	19.6	11.1	8.1	13.0	12.8	16.1	6.2	5.1	10.7	7.9	5.4	9.5	5.1	8.8	7.7	11.7	11.3	7.3	5.7	19.2	6.7	5.9	7.5	6.7	8.7	7.2	13.0	4.0	6.0	9.3	29.0	5.8	8.0	20.2	13.8	7.8	9.9	8.7	5.7	12.1	14.7	6.4	8.1	8.6	11.8	6.9	10.3	19.0	4.3	8.8	16.5	9.3	21.2	11.6	16.3	13.0	12.7	5.1	10.7	17.1	8.4	17.8	11.9	5.9	11.8	8.5	7.9	6.0	8.5	11.0	5.5	14.5	13.3	15.7	7.0	15.4	6.4	10.7	4.5	7.2	6.2	7.9	9.5	4.3	6.2	7.1	5.1	6.2	4.6	5.0	7.7	5.4	5.2	4.0	9.2	5.1	8.2	9.4	12.5	9.2	7.2	5.4	11.3	7.0	9.4	10.4
FAM120C	"CXorf17, FLJ20506, ORF34"	ENSG00000184083	"Family with sequence similarity 120C"	Q9NX05	X	54068324-54183281	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047677	Uncertain		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA047677: "	"unprognostic (4.70e-2)"	"unprognostic (2.58e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.21e-2)"	"prognostic favourable (4.48e-4)"	"unprognostic (1.86e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.74e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.76e-3)"	"unprognostic (5.21e-2)"	"unprognostic (5.28e-2)"	"unprognostic (3.28e-2)"	8.7	10.5	15.3	8.1	15.8	9.4	9.3	15.5	18.3	11.9	6.2	16.9	6.2	4.6	10.5	16.3	8.1	9.9	6.9	6.8	14.0	11.6	9.9	8.3	6.2	8.4	16.8	11.5	14.9	9.0	16.0	15.8	7.1	12.5	9.0	5.9	7.9	7.3	10.6	12.4	8.3	5.6	9.2	12.1	8.6	5.6	8.3	16.2	10.9	10.8	5.5	9.4	7.8	7.8	4.9	6.0	0.3	2.7	1.7	3.1	1.6	4.0	7.2	3.8	8.4	8.6	6.3	6.9	3.8	6.3	5.8	6.3	3.4	4.2	5.6	2.6	3.3	10.7	10.7	2.8	5.2	4.3	11.7	2.9	10.4	5.5	3.9	2.7	3.1	4.4	3.5	5.1	6.0	3.6	3.1	4.6	4.6	10.7	4.3	10.6	7.0	16.1	5.2	6.0	5.8	4.8	2.2	5.1	5.1	9.9	7.6	2.6	9.0	2.4	6.5	5.2	6.8	6.8	3.1	5.6	5.4	4.2	5.9	8.1	6.2	0.0	2.7	0.3	2.6	1.4	2.3	4.4	2.5	2.1	4.8	4.9	2.9	3.1	0.0	1.7	0.6	6.0	0.9	1.6	15.3	15.8	15.5	13.6	14.0	11.6	16.8	11.5	12.5	16.2
WNK3	PRKWNK3	ENSG00000196632	"WNK lysine deficient protein kinase 3"	Q9BYP7	X	54192823-54358642	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 31.6;testis: 26.7"	"Cell line enhanced"	"Detected in some"		"AF22: 5.8;AN3-CA: 4.4;HAP1: 6.7;NTERA-2: 11.9;SiHa: 5.8;U-2 OS: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.9"	"Group enriched"	"Detected in many"	10	"B-cells: 1.1;T-cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077678	Approved		Approved	Vesicles				Vesicles		"HPA077678: "	"unprognostic (1.86e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.44e-1)"	"unprognostic (7.87e-5)"	"unprognostic (4.82e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.85e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.78e-4)"	"unprognostic (2.22e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.61e-2)"	"unprognostic (9.99e-2)"	"unprognostic (7.63e-2)"	"unprognostic (8.74e-2)"	0.9	5.0	3.9	0.9	4.3	0.8	1.7	3.0	3.6	1.5	0.7	1.7	13.9	1.0	1.3	31.6	1.1	1.8	1.1	1.5	3.9	3.4	2.8	8.7	0.9	1.0	2.3	3.0	5.7	0.9	2.2	14.0	1.2	3.9	2.2	0.7	1.3	1.2	4.8	0.7	0.9	0.7	1.5	3.3	1.0	1.2	26.7	3.5	0.0	1.7	0.0	0.8	1.3	1.9	1.1	0.0	0.1	0.0	0.1	1.9	0.1	0.0	0.0	5.8	4.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.7	0.1	0.2	0.0	1.2	0.0	0.0	0.1	0.2	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.9	0.0	2.8	0.8	0.0	1.1	0.2	1.9	1.8	5.8	0.0	0.7	0.5	0.0	0.3	0.0	5.2	0.0	1.2	0.0	4.0	0.0	1.6	0.0	2.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	1.1	1.9	0.4	0.1	0.1	0.0	0.0	0.0	0.1	3.9	4.3	3.0	3.6	3.9	3.4	2.3	3.0	3.9	3.5
TSR2	"DT1P1A10, RP1-112K5.2, WGG1"	ENSG00000158526	"TSR2, ribosome maturation factor"	Q969E8	X	54440401-54445487	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"		"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030514	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"				"Nucleoplasm, Nucleoli"	"Cell Junctions, Cytosol"	"HPA030514: AB_10603457"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.91e-2)"	"unprognostic (7.15e-3)"	"unprognostic (8.29e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.94e-2)"	"unprognostic (6.19e-2)"	"prognostic favourable (1.21e-6)"	"unprognostic (2.27e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.80e-3)"	20.8	25.0	52.9	13.8	53.1	15.3	19.2	27.6	44.3	18.2	17.2	30.8	16.9	13.9	18.4	33.9	16.2	21.1	14.8	22.2	45.3	46.2	26.5	23.7	17.5	14.9	53.8	34.4	22.9	17.2	30.7	19.0	19.8	31.0	20.8	20.6	19.0	16.6	25.4	35.5	17.2	14.7	19.7	54.3	18.1	16.5	8.4	27.5	10.2	23.9	10.8	22.0	17.7	16.8	39.6	15.4	28.7	21.2	24.7	41.4	21.1	20.4	26.2	19.2	17.4	17.3	12.5	17.1	20.3	16.5	18.9	16.3	24.7	22.4	22.4	14.1	17.7	21.2	46.9	28.1	25.3	29.1	23.2	18.2	19.6	19.2	10.7	31.5	19.1	11.6	15.4	26.4	27.3	13.2	18.5	16.8	19.2	37.5	24.0	24.8	30.5	29.8	21.6	35.7	18.9	20.1	18.2	24.2	16.8	38.6	19.3	21.5	39.3	11.0	17.9	13.9	24.5	29.2	17.3	18.0	27.1	26.8	20.5	25.1	20.8	24.5	15.3	28.7	35.1	20.5	28.8	38.7	33.3	31.8	13.9	39.6	41.4	31.7	9.4	24.7	21.2	15.4	35.5	21.1	52.9	53.1	27.6	44.3	45.3	46.2	53.8	34.4	31.0	27.5
FGD1	"FGDY, ZFYVE3"	ENSG00000102302	"FYVE, RhoGEF and PH domain containing 1"	P98174	X	54445454-54496166	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000911	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA000911: AB_1078853"	"unprognostic (2.49e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.36e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.41e-2)"	"unprognostic (9.40e-3)"	5.9	7.7	15.6	5.9	10.9	1.6	7.1	16.3	15.6	12.3	7.2	3.7	3.4	4.5	12.4	4.4	9.3	7.6	7.8	9.2	9.6	7.1	5.1	1.9	4.6	4.0	4.8	11.2	13.7	6.9	6.9	5.4	9.4	5.7	6.5	3.8	6.8	7.7	7.9	3.3	11.8	5.5	11.9	3.7	5.8	5.2	4.6	4.8	0.0	5.6	7.3	4.3	7.6	7.8	1.6	0.6	0.5	2.6	1.2	3.2	1.1	13.8	5.9	11.4	14.9	5.3	9.5	5.5	8.3	8.4	7.0	5.7	1.8	1.2	0.8	6.8	12.8	5.4	9.6	5.9	3.9	1.4	8.4	0.5	4.5	2.1	5.7	0.7	0.5	7.7	3.7	10.7	5.1	6.3	2.2	0.5	5.5	2.9	1.6	1.5	11.2	9.3	8.0	6.5	0.5	6.0	0.8	10.6	10.0	9.1	0.8	13.7	10.0	1.2	6.1	8.8	7.8	19.3	7.6	1.0	2.0	1.5	9.7	1.6	4.8	0.0	0.6	0.5	2.0	1.3	2.0	1.5	1.6	2.2	0.6	1.6	3.2	1.8	0.0	1.2	2.6	0.2	1.4	1.1	15.6	10.9	16.3	15.6	9.6	7.1	4.8	11.2	5.7	4.8
GNL3L	"FLJ10613, GNL3B"	ENSG00000130119	"G protein nucleolar 3 like"	Q9NVN8	X	54530211-54561071	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036314, HPA036315"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA036314: AB_10669986, HPA036315: AB_2675055"	"unprognostic (9.71e-3)"	"unprognostic (6.58e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.46e-2)"	"unprognostic (8.44e-2)"	"unprognostic (9.97e-2)"	"unprognostic (4.91e-3)"	"unprognostic (7.87e-2)"	"unprognostic (8.05e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.10e-1)"	12.7	12.9	10.3	16.1	12.3	19.2	12.5	8.6	13.1	10.8	10.2	14.8	10.5	8.5	15.2	10.2	16.3	11.0	10.1	15.3	8.1	8.0	12.0	12.5	13.0	15.5	13.0	10.8	13.2	17.5	15.9	16.9	12.0	10.2	10.6	13.3	12.3	13.3	12.4	24.0	13.2	13.5	15.0	11.5	17.6	11.7	5.9	13.9	20.5	18.0	12.0	18.6	13.7	13.1	17.2	11.4	20.2	15.2	21.8	17.7	11.5	11.1	27.7	5.7	11.8	5.9	4.0	10.6	6.7	4.9	7.5	6.0	23.4	9.2	15.7	12.9	9.6	10.9	19.2	8.4	10.4	10.8	9.9	15.7	22.2	11.0	4.5	24.4	15.5	5.8	4.0	17.6	10.6	8.1	10.3	15.8	7.5	21.7	13.8	5.1	16.6	15.6	14.9	13.1	15.2	5.7	17.7	9.4	5.6	21.8	13.5	6.3	17.8	6.2	11.5	13.7	13.7	13.2	11.3	11.9	15.2	20.2	7.1	20.2	15.2	18.9	14.2	15.1	17.7	12.6	16.1	15.0	16.2	15.4	11.4	17.2	12.4	13.0	20.2	21.8	15.2	9.6	8.6	11.5	10.3	12.3	8.6	13.1	8.1	8.0	13.0	10.8	10.2	13.9
ITIH6	"ITIH5L, UNQ6369"	ENSG00000102313	"Inter-alpha-trypsin inhibitor heavy chain family member 6"	Q6UXX5	X	54748899-54798240	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.8;salivary gland: 3.5;skeletal muscle: 5.0"	"Cell line enriched"	"Detected in some"	19	"WM-115: 33.3"	"Cancer enriched"	"Detected in some"	7	"melanoma: 10.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA000506	Uncertain				"Secreted to blood"					"HPA000506: "	"unprognostic (3.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.73e-3)"	"unprognostic (7.24e-2)"		"unprognostic (2.83e-1)"		"unprognostic (5.38e-3)"	"unprognostic (9.81e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.14e-4)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-1)"		"unprognostic (2.35e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	3.5	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGED2	"11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386"	ENSG00000102316	"MAGE family member D2"	Q9UNF1	X	54807599-54816012	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Tumor antigen"	"Bartter syndrome, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031572, HPA031573"	Supported		Enhanced	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli, Cytosol"		"HPA031572: AB_10599819, HPA031573: AB_10602181"	"unprognostic (1.33e-1)"	"unprognostic (8.60e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.97e-1)"	"prognostic favourable (2.88e-4)"	"prognostic favourable (2.82e-4)"	"unprognostic (6.34e-2)"	"unprognostic (3.55e-3)"	"prognostic unfavourable (9.43e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.58e-1)"	22.1	38.4	26.9	14.8	26.5	8.2	50.2	24.4	43.0	55.7	27.3	27.8	21.4	16.2	41.1	31.8	21.9	45.9	28.5	40.7	23.8	38.2	42.7	17.3	24.0	13.5	30.3	36.0	79.7	23.5	34.5	57.6	58.6	57.1	63.9	16.4	43.1	32.0	53.7	25.6	16.5	17.6	41.6	24.7	17.5	22.5	21.8	18.3	23.4	45.1	17.3	22.0	31.9	29.2	17.1	11.7	43.1	37.0	28.5	35.5	32.5	5.5	10.3	61.7	18.8	29.4	40.0	11.4	23.1	41.2	18.3	32.6	10.2	14.2	7.7	60.6	46.4	7.6	17.5	17.4	13.2	13.8	14.5	16.1	12.2	20.0	25.2	4.1	12.4	52.4	7.3	18.6	9.4	34.8	3.9	9.5	35.0	15.4	9.1	6.9	22.8	12.3	6.1	22.1	11.0	25.1	4.2	9.7	25.1	9.2	10.7	53.4	44.0	7.0	29.9	15.6	24.4	23.3	6.5	6.1	5.1	5.6	22.8	10.8	79.7	43.1	9.1	35.5	35.5	22.4	27.3	16.3	29.4	33.1	11.7	17.1	29.7	34.1	3.4	28.5	37.0	7.2	29.2	32.5	26.9	26.5	24.4	43.0	23.8	38.2	30.3	36.0	57.1	18.3
TRO	"KIAA1114, MAGE-D3, MAGED3"	ENSG00000067445	Trophinin	Q12816	X	54920462-54931431	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 32.1"	"Cell line enhanced"	"Detected in many"		"AF22: 20.9;HEK 293: 12.9;HSkMC: 13.1;SCLC-21H: 14.0;SH-SY5Y: 18.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 5.2"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA053358			Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"HPA053358: "	"unprognostic (6.18e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavourable (4.41e-5)"	"unprognostic (9.09e-3)"	"unprognostic (2.72e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.18e-1)"	"prognostic favourable (1.93e-4)"	"unprognostic (1.17e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.67e-4)"	"unprognostic (6.33e-2)"	"unprognostic (3.27e-2)"	"unprognostic (6.86e-2)"	4.5	4.2	21.7	2.1	15.5	1.6	3.7	11.3	23.8	8.0	2.5	7.9	1.4	1.7	16.3	8.6	2.4	7.1	5.6	2.9	17.9	15.6	5.3	13.2	2.5	2.3	10.5	13.2	21.7	5.7	7.6	20.2	5.5	22.3	7.4	3.2	5.0	1.5	6.9	32.1	1.5	1.8	10.9	8.9	1.4	2.0	3.6	14.2	4.2	9.2	0.1	2.4	3.6	5.0	0.7	2.6	0.0	0.2	5.2	1.2	0.4	0.0	0.2	20.9	0.0	4.1	5.7	0.0	1.1	7.2	1.1	0.4	0.0	0.0	0.0	3.0	7.5	0.1	0.1	0.3	0.6	0.0	12.9	9.6	0.0	0.8	1.5	0.0	0.1	13.1	0.0	6.7	0.0	0.5	0.0	0.1	7.7	0.0	0.1	0.0	10.7	0.0	6.1	9.1	0.1	2.0	0.1	14.0	18.8	0.0	0.3	1.8	0.0	1.2	0.0	8.8	9.2	0.1	1.1	3.3	0.4	0.0	1.3	0.0	7.6	0.0	0.0	0.0	1.2	0.0	0.7	0.7	0.1	0.4	0.0	0.5	0.3	0.7	0.0	5.2	0.2	2.6	0.0	0.4	21.7	15.5	11.3	23.8	17.9	15.6	10.5	13.2	22.3	14.2
PFKFB1	PFRX	ENSG00000158571	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1"	P16118	X	54932961-54998534	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 24.2;liver: 24.4;skeletal muscle: 48.3"	"Group enriched"	"Detected in some"	4	"ASC diff: 13.6;Hep G2: 5.4"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 7.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (2.51e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.64e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.33e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.88e-1)"	"unprognostic (5.36e-3)"	"unprognostic (5.06e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.96e-3)"	24.2	0.2	0.1	1.6	0.1	0.1	13.1	0.1	0.2	0.1	1.7	0.1	0.1	0.0	0.1	0.2	0.5	0.0	0.1	0.1	0.1	0.1	0.4	24.4	0.1	1.6	0.1	0.1	0.1	0.6	0.2	0.2	0.1	0.1	0.3	0.2	0.1	1.3	0.1	48.3	0.3	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.5	8.3	0.6	0.2	2.0	1.5	0.1	0.0	0.7	1.3	2.1	0.3	0.3	0.2	0.4	0.6	13.6	0.3	1.0	0.0	0.1	0.2	0.0	0.8	0.2	0.6	0.2	0.1	0.5	0.1	0.3	0.4	0.4	1.1	0.4	0.1	5.4	0.0	0.1	0.5	0.2	0.6	0.1	0.4	0.0	0.1	2.1	0.2	0.7	0.6	0.3	0.3	0.3	0.5	0.2	0.1	0.0	0.4	0.4	0.2	0.5	1.5	0.2	0.4	0.0	0.1	0.1	0.5	0.4	0.2	1.1	1.7	0.4	0.2	0.4	0.1	0.0	0.0	0.0	0.2	0.7	2.1	1.5	0.2	0.0	0.0	0.8	0.0	0.8	0.0	1.3	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1
APEX2	"APE2, APEXL2, XTH2, ZGRF2"	ENSG00000169188	"Apurinic/apyrimidinic endodeoxyribonuclease 2"	Q9UBZ4	X	55000357-55009057	"Enzymes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair"	"DNA-binding, Endonuclease, Exonuclease, Hydrolase, Lyase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA048577			Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"				"Nucleoplasm, Nucleoli fibrillar center"	Vesicles	"HPA048577: "	"unprognostic (2.90e-2)"	"prognostic favourable (6.17e-4)"	"unprognostic (4.32e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.62e-2)"	"prognostic unfavourable (6.13e-7)"	"unprognostic (5.89e-2)"	"unprognostic (4.87e-2)"	"prognostic favourable (5.21e-4)"	"unprognostic (7.46e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.40e-1)"	"prognostic favourable (6.63e-4)"	11.1	12.8	8.6	12.0	12.3	11.9	10.2	8.7	11.8	10.0	12.3	13.7	8.2	12.3	11.5	12.6	20.8	10.7	13.9	10.6	8.7	7.2	15.4	18.5	10.3	14.2	9.7	6.0	14.4	10.7	10.7	12.7	17.8	8.8	11.0	15.1	9.1	10.4	10.0	10.3	16.7	18.7	10.0	9.9	18.0	10.8	7.7	8.9	21.9	10.6	10.2	27.4	11.6	12.7	6.7	9.4	9.2	9.9	26.6	7.5	6.3	22.0	19.8	7.9	11.4	11.5	7.7	13.4	9.1	12.3	17.6	17.3	10.8	18.6	14.6	14.3	8.5	16.6	18.0	17.3	13.4	11.8	13.7	17.7	19.8	10.9	7.4	10.9	16.8	7.6	14.2	24.9	9.0	14.0	9.1	9.9	13.1	21.5	14.7	14.3	15.6	24.0	13.1	13.1	15.9	9.5	11.1	7.3	8.0	17.2	20.9	8.8	16.4	8.5	8.1	10.5	15.2	21.1	11.8	10.3	13.3	12.1	11.2	18.7	12.4	9.2	7.8	8.5	7.5	9.9	6.2	6.1	7.1	7.4	9.4	6.7	6.4	6.2	2.9	26.6	8.3	5.1	7.5	6.3	8.6	12.3	8.7	11.8	8.7	7.2	9.7	6.0	8.8	8.9
ALAS2	ASB	ENSG00000158578	"5'-aminolevulinate synthase 2"	P22557	X	55009055-55031064	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 130.9;placenta: 53.5"	"Group enriched"	"Detected in some"	87	"HEL: 32.0;K-562: 35.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	6	"plasmacytoid DC: 2.0"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 2.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"								"Intracellular and membrane"						"unprognostic (7.82e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.68e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.89e-1)"	1.7	0.4	0.8	0.4	0.8	130.9	0.5	0.2	0.5	0.3	0.4	0.5	0.0	0.4	0.3	0.3	2.3	1.0	0.5	2.9	0.7	0.7	1.6	2.4	17.3	0.3	1.3	0.7	6.1	2.3	0.3	1.0	53.5	2.3	2.6	0.3	1.0	0.5	0.3	3.7	0.4	0.4	1.1	0.9	22.3	0.3	0.5	0.0	0.4	3.2	0.0	0.3	7.0	6.5	0.3	2.0	0.3	0.1	0.0	0.3	10.7	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	32.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	35.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.1	0.1	0.0	0.2	0.3	0.0	0.0	2.0	0.0	10.7	0.8	0.8	0.2	0.5	0.7	0.7	1.3	0.7	2.3	0.0
PAGE2B	CT16.5	ENSG00000238269	"PAGE family member 2B"	Q5JRK9	X	55075063-55078909	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 33.2"	"Group enriched"	"Detected in some"	8	"U-266/70: 137.1;U-266/84: 209.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA052619	Supported									"HPA052619: "	"unprognostic (1.32e-1)"	"unprognostic (2.85e-2)"		"prognostic unfavourable (3.02e-4)"	"unprognostic (1.40e-1)"		"unprognostic (1.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (3.52e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.81e-2)"		"unprognostic (2.05e-8)"		"unprognostic (1.41e-1)"		"unprognostic (8.84e-2)"	0.1	0.0	0.1	0.1	0.1	2.8	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.3	0.0	33.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.2	137.1	209.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PAGE2	"CT16.4, GAGEC2, MGC62094, PAGE-2"	ENSG00000234068	"PAGE family member 2"	Q7Z2X7	X	55089008-55092842	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 23.6"	"Group enriched"	"Detected in some"	5	"U-266/70: 118.4;U-266/84: 152.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"naive CD4 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.9"									HPA052619	Supported									"HPA052619: "										"unprognostic (3.49e-2)"					"unprognostic (7.73e-2)"			0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.0	23.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	29.0	0.1	0.2	118.4	152.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM104B	"CXorf44, FLJ20434"	ENSG00000182518	"Family with sequence similarity 104 member B"	Q5XKR9	X	55143102-55161310	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA049082	Approved									"HPA049082: "	"unprognostic (2.46e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.90e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavourable (2.23e-4)"	"prognostic favourable (1.22e-4)"	"unprognostic (9.35e-2)"	"unprognostic (5.12e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.81e-3)"	"unprognostic (9.32e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.65e-1)"	"unprognostic (5.27e-3)"	8.4	14.0	19.3	9.8	17.0	8.3	14.0	12.7	22.8	19.0	15.0	17.8	8.5	6.5	16.5	40.7	13.0	36.0	10.3	13.4	17.9	17.3	28.6	14.4	11.1	11.1	20.9	14.5	15.7	9.0	17.0	20.4	10.5	19.3	13.3	13.1	11.8	11.4	14.4	14.0	13.5	9.9	14.9	20.9	9.2	11.0	14.2	20.5	9.7	26.4	13.2	12.4	12.0	10.7	16.1	19.9	9.4	19.0	14.9	18.3	11.1	14.9	12.0	14.4	12.9	9.9	13.1	4.2	7.9	6.2	8.7	7.7	7.0	14.0	7.2	16.8	7.5	10.7	21.4	12.2	13.6	6.9	21.4	9.8	13.9	8.4	8.0	12.8	8.5	11.5	11.1	13.3	10.8	10.1	12.7	10.5	10.8	13.5	17.0	12.1	21.0	21.6	9.9	18.0	17.1	23.9	16.5	18.4	14.9	13.2	10.4	15.3	20.0	8.6	9.9	9.7	12.9	23.8	10.2	7.7	6.8	6.9	12.4	22.7	8.4	7.7	14.9	9.4	13.8	19.0	14.7	16.1	16.0	16.3	19.9	13.5	18.3	17.9	7.3	14.9	16.1	19.1	16.2	11.1	19.3	17.0	12.7	22.8	17.9	17.3	20.9	14.5	19.3	20.5
MTRNR2L10		ENSG00000256045	"MT-RNR2-like 10"	P0CJ77	X	55181391-55182920	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 60.2"	"Group enriched"	"Detected in many"	4	"A549: 22.2;HeLa: 81.9;Hep G2: 69.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"basophil: 16.9;eosinophil: 19.1;neutrophil: 60.2"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 60.2"														"Secreted to blood"						"unprognostic (4.42e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.10e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.01e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.01e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.97e-4)"	4.2	3.8	3.2	0.6	4.6	0.0	1.0	1.3	4.4	1.2	4.5	1.2	0.6	0.6	1.0	4.7	2.2	1.5	1.5	19.8	4.1	2.2	14.3	8.5	2.0	5.1	2.6	0.6	1.2	2.4	0.0	2.5	1.0	2.7	1.1	8.4	0.6	3.0	0.6	16.9	1.1	1.0	2.6	2.1	1.0	1.1	3.7	1.0	0.6	1.0	1.6	1.7	1.0	1.0	6.1	3.9	60.2	6.9	3.5	3.4	7.4	1.2	22.2	0.2	6.3	0.5	0.2	1.6	2.0	0.1	0.1	0.0	1.3	3.3	3.0	0.4	0.1	4.7	0.0	0.1	0.0	0.8	4.6	1.5	81.9	69.9	0.1	0.5	0.8	0.8	0.3	0.0	0.2	0.0	2.6	1.7	0.2	8.2	0.4	3.6	0.1	1.8	1.1	1.3	1.4	0.5	13.6	0.3	1.3	0.6	0.5	2.1	1.8	2.6	3.3	2.3	0.5	0.8	0.2	0.5	0.3	0.2	1.4	0.6	0.5	16.9	6.9	19.1	1.5	3.8	1.8	5.8	2.4	2.0	3.2	6.1	3.1	3.4	60.2	3.5	3.5	3.9	2.4	7.4	3.2	4.6	1.3	4.4	4.1	2.2	2.6	0.6	2.7	1.0
PAGE5	"CT16.1, CT16.2, PAGE-5"	ENSG00000158639	"PAGE family member 5"	Q96GU1	X	55220355-55224108	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 32.0"	"Group enriched"	"Detected in some"	164	"Karpas-707: 65.5;U-266/84: 138.3"	"Group enriched"	"Detected in many"	6	"liver cancer: 5.4;melanoma: 11.8;testis cancer: 6.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.5"	"Lineage enriched"	"Detected in single"	14	"T-cells: 4.5"									"HPA052619, HPA055869"	Supported		Approved	Mitochondria				Mitochondria		"HPA052619: , HPA055869: "					"unprognostic (4.03e-1)"		"unprognostic (4.51e-2)"	"unprognostic (7.86e-4)"	"unprognostic (1.39e-2)"		"unprognostic (7.21e-2)"		"unprognostic (1.06e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.94e-1)"		"unprognostic (3.44e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	32.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.0	4.5	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.5	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.6	138.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	4.5	0.3	3.8	1.6	0.0	0.0	0.8	1.4	0.0	0.0	0.0	0.3	3.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAGE3	"CT16.6, GAGED1, PAGE-3"	ENSG00000204279	"PAGE family member 3"	Q5JUK9	X	55258412-55264846	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	111	"testis: 11.1"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.0;PC-3: 1.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA062248	Uncertain									"HPA062248: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MAGEH1	APR1	ENSG00000187601	"MAGE family member H1"	Q9H213	X	55452105-55453566	"Predicted membrane proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"epididymis: 207.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA011324	Uncertain		Approved	Nucleoli				Nucleoli		"HPA011324: AB_1853499"	"unprognostic (2.50e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.07e-2)"	"prognostic unfavourable (1.37e-4)"	"unprognostic (3.95e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.93e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-3)"	"prognostic favourable (2.60e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.52e-1)"	8.3	13.2	21.5	7.6	21.6	3.0	8.1	19.9	29.7	13.5	7.5	14.4	13.8	5.2	13.3	207.1	5.2	19.2	8.3	10.2	22.8	32.1	11.4	8.7	10.2	9.0	19.8	20.6	16.1	11.9	9.0	22.5	9.2	17.9	20.8	5.9	11.4	8.9	19.6	5.7	5.6	6.3	11.8	17.2	8.1	9.3	18.2	15.3	10.8	12.4	5.2	7.5	8.5	10.0	9.4	14.0	9.5	8.5	8.3	26.0	9.4	0.0	2.5	14.8	0.0	23.9	14.5	0.2	16.0	14.8	4.4	11.9	0.0	3.3	0.0	22.0	16.0	2.2	5.6	6.0	7.0	18.4	0.9	4.9	0.0	2.0	7.9	0.2	6.4	12.0	0.5	2.5	1.8	6.7	2.7	19.8	4.8	9.5	13.1	4.2	4.2	3.0	8.3	1.8	10.4	8.0	0.0	0.1	11.2	0.0	4.3	6.6	2.1	3.7	7.8	6.1	7.1	3.7	0.8	11.8	14.8	2.0	11.4	6.9	7.7	5.0	4.4	9.5	11.3	6.8	10.1	9.4	18.7	12.9	6.7	8.8	26.0	16.1	0.6	8.3	8.5	14.0	24.7	9.4	21.5	21.6	19.9	28.4	22.8	32.1	19.8	20.6	17.9	15.3
USP51		ENSG00000247746	"Ubiquitin specific peptidase 51"	Q70EK9	X	55484616-55489202	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"epididymis: 34.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"eosinophil: 2.4;naive CD4 T-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA001942	Uncertain		Approved	"Nucleoli fibrillar center,Cytosol"				Cytosol	"Nucleoli fibrillar center"	"HPA001942: AB_1080536"	"unprognostic (1.19e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.02e-3)"	"unprognostic (8.08e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.07e-3)"	"unprognostic (5.69e-2)"	"prognostic favourable (5.70e-4)"	"unprognostic (1.01e-3)"	"unprognostic (1.27e-1)"	"prognostic favourable (2.63e-5)"	"unprognostic (2.81e-3)"	"unprognostic (5.92e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.63e-1)"	0.6	2.7	2.0	0.3	2.9	0.1	0.9	2.3	1.8	1.4	0.6			0.0	1.8	34.1	0.2	3.4	0.3	1.0	1.8	3.7	2.2	0.5	0.7	0.4	1.6		4.1	0.8	3.6	1.8	1.3		1.3	0.3		0.3	1.5	0.0	0.5	0.5	1.1	1.4	0.9	0.3	1.3			3.2		0.5	0.7	0.5	0.9	0.0	2.4	0.0	0.6	2.4	0.1	0.0	0.9	5.7	1.7	2.9	1.5	0.0	0.9	0.5	1.1	1.3	1.8	0.8	0.0	6.9	1.2	0.3	1.5	0.6	1.8	1.8	0.1	1.5	0.3	0.0	1.2	3.5	0.3	5.9	0.1	0.6	0.0	0.4	4.4	4.4	0.9	3.8	3.4	1.8	7.2	0.3	4.9	1.1	2.2	1.4	0.2	0.0	1.1	1.6	0.2	5.4	1.4	1.8	0.3	2.3	3.1	0.6	0.2	7.0	2.7	1.4	1.5	2.0	1.5	0.0	0.0	2.4	0.3	0.0	0.0	0.6	0.6	0.0	0.0	0.9	2.4	0.2	0.0	0.6	0.0	0.0	0.0	0.1										
FOXR2	"FOXN6, MGC21658"	ENSG00000189299	"Forkhead box R2"	Q6PJQ5	X	55623400-55625325	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	10	"testis: 6.0"	"Group enriched"	"Detected in some"	114	"NTERA-2: 11.4;SH-SY5Y: 10.1;U-266/70: 6.7;U-266/84: 17.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA034487, HPA057358"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA034487: AB_10795354, HPA057358: AB_2683418"															"unprognostic (3.81e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RRAGB		ENSG00000083750	"Ras related GTP binding B"	Q5VZM2	X	55717739-55758774	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 37.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003734	Approved		Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA003734: AB_1079851"	"unprognostic (2.01e-1)"	"unprognostic (2.82e-3)"	"prognostic unfavourable (7.60e-4)"	"unprognostic (2.44e-2)"	"prognostic favourable (3.31e-5)"	"unprognostic (2.58e-2)"	"unprognostic (2.36e-1)"	"prognostic favourable (3.64e-6)"	"unprognostic (8.89e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.74e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.00e-3)"	11.8	14.8	18.8	8.6	25.8	7.1	14.7	21.2	22.2	14.7	11.4	11.5	11.7	7.1	18.7	36.3	9.2	20.6	12.9	14.5	19.0	24.5	16.0	7.9	10.8	7.5	19.6	20.7	22.8	8.4	21.4	23.7	11.1	17.6	16.6	9.7	12.9	8.9	18.8	13.6	12.0	8.7	17.1	15.8	10.7	9.9	8.9	17.4	7.3	22.6	8.3	8.4	12.3	14.9	12.2	9.1	8.7	8.3	7.7	10.4	5.1	5.9	4.5	5.2	3.9	17.6	17.1	1.3	5.1	9.7	4.5	6.1	2.3	3.9	1.7	37.5	7.0	3.8	4.7	2.8	4.4	2.9	6.2	2.6	5.6	5.3	13.0	4.1	4.1	20.0	11.4	3.4	4.2	6.1	3.5	4.2	7.8	4.2	2.2	5.4	5.3	7.1	8.3	5.7	4.9	7.3	7.5	5.2	4.5	7.1	2.3	7.7	6.6	4.2	3.4	5.5	2.7	5.4	2.7	5.8	7.8	3.3	4.4	8.7	2.5	8.7	6.1	5.2	6.9	8.3	10.0	8.9	8.7	9.4	9.1	12.2	10.4	10.0	1.8	7.7	4.7	5.8	9.6	5.1	18.8	25.8	21.2	22.0	19.0	24.5	19.6	20.7	17.6	17.4
KLF8	"BKLF3, DXS741, ZNF741"	ENSG00000102349	"Kruppel like factor 8"	O95600	X	56232421-56287889	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 11.9;RT4: 10.4;SK-BR-3: 9.2;T-47d: 16.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071740			Supported	Nucleoplasm				Nucleoplasm		"HPA071740: "	"unprognostic (2.32e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.50e-8)"	"unprognostic (2.96e-1)"	"prognostic favourable (3.32e-4)"	"unprognostic (6.56e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.15e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.60e-2)"	15.1	2.0	2.9	7.9	7.4	0.4	15.0	6.7	5.5	12.9	5.0	0.8	5.2	1.2	19.2	8.6	24.8	6.8	4.8	4.3	2.4	1.8	8.8	0.9	8.3	2.7	1.3	3.3	10.3	2.0	4.0	2.0	7.9	2.9	5.3	4.0	5.2	8.8	4.7	3.3	28.4	4.9	11.6	1.9	5.0	3.4	5.3	0.9	0.7	5.5	16.6	14.3	9.7	14.3	5.0	2.1	0.6	0.2	4.1	1.4	0.5	2.1	0.0	0.1	0.0	1.9	0.5	1.3	0.2	2.3	0.0	0.0	0.0	0.0	0.0	2.8	0.0	5.1	0.0	0.0	0.0	4.0	4.9	1.4	0.0	0.0	0.1	0.0	0.0	0.1	11.9	0.0	1.8	0.0	1.2	0.6	0.4	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.1	5.6	10.4	0.0	0.0	4.4	9.2	0.0	16.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.3	0.2	0.4	5.0	1.2	1.4	2.1	4.6	0.3	0.3	0.5	4.1	0.1	0.8	0.5	0.5	2.9	7.4	6.7	5.5	2.4	1.8	1.3	3.3	2.9	0.9
UBQLN2	"Chap1, CHAP1/DSK2, Dsk2, LIC-2, N4BP4, PLIC-2, PLIC2, RIHFB2157"	ENSG00000188021	"Ubiquilin 2"	Q9UHD9	X	56563639-56567868	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Autophagy		"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006431, CAB013481"	Enhanced		Supported	"Plasma membrane,Cytosol"			200000	Cytosol	"Plasma membrane"	"CAB013481: AB_2533341, HPA006431: AB_1078707"	"unprognostic (1.23e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.08e-2)"	"prognostic unfavourable (2.29e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.42e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.88e-2)"	"unprognostic (8.42e-3)"	13.4	20.8	27.0	13.9	40.7	9.4	16.2	34.9	35.3	17.3	13.6	17.8	15.0	11.1	17.0	16.7	18.1	18.2	14.5	20.8	26.2	28.6	13.9	18.9	14.0	16.4	21.2	26.6	27.0	10.6	25.5	18.3	15.6	20.8	21.1	12.5	13.3	13.7	21.5	24.6	13.5	11.6	18.7	18.8	13.9	12.9	5.4	16.7	18.0	20.9	10.9	17.7	16.4	14.1	5.5	10.9	25.0	19.4	12.1	20.4	10.9	18.8	14.1	14.1	16.5	32.5	20.8	8.9	15.3	18.2	11.5	12.8	7.8	8.9	14.5	16.7	18.0	11.1	26.9	17.0	13.9	22.3	16.2	5.8	19.4	8.3	17.1	11.4	12.9	19.3	21.7	15.4	13.6	10.0	6.8	16.0	18.1	8.8	14.6	10.0	11.7	16.8	13.2	18.3	13.6	23.2	14.8	17.5	16.4	22.0	9.8	8.9	16.4	8.5	11.2	12.2	12.5	17.6	9.2	6.1	7.4	10.0	13.7	12.1	10.3	25.0	14.1	14.1	9.9	19.3	11.1	5.1	15.1	11.5	10.9	5.5	20.4	12.2	12.4	12.1	19.4	3.9	14.1	10.9	27.0	40.7	34.9	35.3	26.2	28.6	21.2	26.6	20.8	16.7
NBDY	"LINC01420, NoBody"	ENSG00000204272	"Negative regulator of P-body association"	A0A0U1RRE5	X	56729241-56818380	"Predicted intracellular proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 52.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"														"unprognostic (8.38e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.96e-3)"	"prognostic unfavourable (3.14e-5)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (3.11e-4)"	"unprognostic (1.01e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.51e-2)"	7.2	16.7	8.2	7.3	12.5	5.9	7.8	11.5	14.8	12.1	7.8	11.3	12.2	6.7	11.5	20.5	10.4	13.4	11.1	10.5	8.5		15.0	5.1	9.4	9.8	7.4	9.4	12.7	9.7	10.8	21.8	15.0	10.4	11.0	9.1	12.8	8.8	12.6	3.3	9.9	7.2	12.4	8.9	12.0	8.4	6.6	7.9	16.2	18.7	7.4	10.0	14.6	6.0	26.1	52.7	16.4	18.2	28.7	28.8	19.4	11.2	17.2	22.0	18.5	27.0	24.6	5.3	15.6	26.4	9.1	14.8	8.2	23.1	5.0	38.1	18.8	7.6	20.6	20.3	11.9	0.0	25.4	14.6	18.0	2.1	28.3	16.3	15.0	29.2	24.8	16.1	29.0	24.0	5.8	12.9	18.1	20.0	19.9	4.7	28.6	31.0	10.0	14.5	17.7	24.4	16.3	9.7	15.1	34.5	15.9	14.6	21.0	7.8	20.0	15.0	12.3	25.8	9.6	13.9	8.5	13.1	12.9	9.0	11.9	16.4	16.9	1.6	22.6	18.1	23.0	26.1	28.8	24.8	29.4	24.5	28.1	26.5	1.5	28.7	18.2	52.7	26.5	19.4										
SPIN3	TDRD27	ENSG00000204271	"Spindlin family member 3"	Q5JUX0	X	56818298-56995827	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 16.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA000727	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA000727: AB_2196121"	"unprognostic (3.12e-3)"	"unprognostic (2.32e-1)"	"unprognostic (7.45e-3)"	"prognostic unfavourable (3.49e-4)"	"unprognostic (1.20e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.85e-4)"	"prognostic favourable (6.79e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.53e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.98e-2)"	"prognostic favourable (6.30e-4)"	5.7	7.6	10.5	4.8	10.7	0.4	9.4	28.6	14.2	7.8	4.6	7.3	9.2	4.8	10.4	8.3	4.5	7.4	5.5	3.8	9.2	6.6	5.3	5.0	5.4	6.7	6.6	10.3	11.3	10.2	4.4	12.4	4.1	9.6	10.4	7.0	6.5	7.5	7.5	4.2	4.7	6.6	7.6	5.0	6.1	7.5	4.3	8.3	0.3	6.0	1.4	6.9	8.2	6.2	2.7	1.6	3.3	1.5	4.7	4.5	2.2	4.2	6.3	3.6	0.0	6.9	6.2	2.8	3.7	1.9	2.5	2.9	3.7	5.5	0.0	2.6	3.1	5.1	5.6	2.2	3.2	0.0	1.3	0.5	16.8	2.5	3.8	0.0	4.8	5.3	4.7	2.7	4.3	1.6	2.6	8.4	4.4	2.7	0.0	3.4	7.3	6.0	0.0	3.0	1.7	3.4	5.0	7.2	5.0	3.9	3.9	4.0	9.6	1.0	1.1	4.3	6.7	7.2	2.0	3.5	2.4	0.0	4.2	0.0	3.3	3.3	1.0	1.9	0.2	1.5	1.7	2.7	3.9	1.6	1.6	0.9	4.5	1.1	0.0	4.7	0.1	0.2	1.0	2.2	10.5	10.7	28.6	13.4	9.2	6.6	6.6	10.3	9.6	8.3
SPIN2B	"SPIN-2, TDRD26"	ENSG00000186787	"Spindlin family member 2B"	Q9BPZ2	X	57118551-57121546	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA000162, HPA069835"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA000162: AB_1080079, HPA069835: "	"unprognostic (3.21e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.30e-2)"	"unprognostic (8.42e-4)"	"unprognostic (1.73e-3)"	"unprognostic (2.24e-2)"	"prognostic favourable (3.43e-4)"	"prognostic favourable (3.39e-4)"	"unprognostic (9.04e-3)"	"prognostic favourable (1.78e-5)"	"unprognostic (3.41e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.26e-3)"	8.9	11.8	14.6	11.1	19.4	5.6	16.1	17.0	24.3	13.0	13.9	8.5	9.9	6.4	12.3	16.2	8.5	9.8	12.0	11.5	14.4	17.3	11.1	8.4	9.3	13.1	15.7	15.8	12.2	9.6	11.6	14.3	9.1	14.4	15.9	16.6	8.2	10.6	15.3	12.0	12.1	9.0	18.2	15.1	12.4	11.1	6.3	13.4	8.8	12.5	6.6	11.9	10.9	14.2	10.8	9.4	1.2	6.1	11.3	13.1	8.3	11.7	8.8	10.6	8.0	10.9	12.3	7.1	7.9	5.1	10.3	6.8	11.4	9.8	2.5	13.3	7.3	1.8	12.3	4.0	10.7	4.6	14.6	7.1	25.9	15.0	8.9	6.0	5.6	10.3	7.7	6.6	6.9	8.0	8.6	8.3	10.7	16.7	8.7	10.9	10.3	9.9	8.5	13.8	10.7	10.9	5.5	7.2	7.5	13.8	3.4	6.9	7.7	4.2	8.1	8.7	8.4	14.9	4.7	8.4	5.7	7.3	6.8	11.7	4.9	1.2	5.3	0.6	9.0	6.1	13.0	10.8	11.4	12.3	6.5	8.5	13.1	10.5	0.3	11.3	5.5	9.4	13.1	8.3	14.6	19.4	17.0	24.3	14.4	17.3	15.7	15.8	14.4	13.4
SPIN2A	"DXF34, SPIN2, TDRD25"	ENSG00000147059	"Spindlin family member 2A"	Q99865	X	57134530-57137625	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 5.7;HSkMC: 7.1"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											"HPA000162, HPA069835"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA000162: AB_1080079, HPA069835: "	"unprognostic (3.18e-1)"	"unprognostic (1.72e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.10e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.61e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.95e-5)"	"unprognostic (3.63e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.07e-3)"	1.8	1.4	1.8	2.3	1.6	0.2	1.7	5.0	2.9	2.4	1.5			1.9	2.1	0.7	1.0	1.4	1.7	0.9	1.9	1.9	1.7	1.1	1.5	3.2	1.2		3.2	1.4	1.6	2.7	1.2		2.1	2.0		2.1	1.7	0.5	3.5	1.5	2.2	1.2	2.7	1.9	0.8			2.5		2.1	1.5	2.7	1.4	0.5	0.0	0.8	0.0	0.8	0.2	0.9	1.8	4.9	0.9	0.9	0.9	1.3	1.8	0.7	0.4	0.8	0.8	1.5	0.4	0.8	3.1	1.2	1.1	1.0	0.4	0.6	0.7	0.7	5.7	0.9	1.7	0.8	1.0	7.1	0.8	0.3	0.3	0.5	0.7	2.4	1.0	1.2	0.5	2.3	1.8	0.8	0.9	1.2	0.7	0.8	0.9	3.2	0.9	0.9	0.5	0.2	0.8	0.9	0.7	2.5	1.1	1.1	0.5	2.3	0.3	0.3	0.7	2.0	0.9	0.0	0.8	0.0	0.5	0.3	0.8	1.4	0.3	0.5	0.0	0.4	0.7	0.1	0.0	0.0	0.3	0.5	0.7	0.2										
FAAH2	"AMDD, FAAH-2, FLJ31204, RP11-479E16.1"	ENSG00000165591	"Fatty acid amide hydrolase 2"	Q6GMR7	X	57286706-57489196	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 43.6;pituitary gland: 42.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 10.5;HDLM-2: 9.4;RPMI-8226: 19.0;U-266/70: 15.9;U-266/84: 8.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 18.0"	"Cell type enhanced"	"Detected in many"		"T-reg: 13.6"	"Lineage enriched"	"Detected in many"	8	"T-cells: 13.6"																				"unprognostic (1.37e-1)"	"unprognostic (1.78e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.93e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.94e-1)"	"prognostic favourable (5.99e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.03e-1)"	"prognostic favourable (2.47e-13)"	"unprognostic (9.16e-3)"	"unprognostic (2.27e-1)"	"prognostic favourable (2.66e-4)"	"prognostic favourable (6.83e-5)"	1.0	1.4	1.0	6.8	1.5	0.0	6.7	18.0	1.0	3.5	3.9	0.2	3.8	2.6	1.4	4.7	5.5	5.8	2.4	0.6	1.2	2.3	9.7	20.1	3.5	5.7	1.1	0.5	1.9	43.6	12.7	42.8	1.4	1.8	9.3	3.6	3.8	9.1	5.3	0.3	10.0	6.4	0.6	1.1	2.3	4.1	0.6	0.3	8.5	15.3	2.7	11.0	3.0	3.6	1.8	1.0	0.3	0.0	0.7	13.6	1.5	2.4	0.2	0.0	0.1	0.1	0.1	2.3	0.0	0.0	0.0	0.0	1.7	10.5	0.1	3.0	0.0	0.4	0.8	1.8	0.0	9.4	5.1	0.3	2.4	0.7	0.0	1.1	0.0	0.0	3.2	0.0	0.0	0.0	1.2	4.7	0.0	1.0	0.5	0.0	1.8	0.0	0.0	1.8	19.0	6.2	3.3	1.8	0.1	0.1	3.0	0.0	2.9	0.0	0.0	0.0	0.2	0.0	0.1	15.9	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	4.7	1.8	7.7	3.2	0.0	0.6	7.5	0.9	0.3	0.7	0.0	1.0	13.6	1.5	1.0	1.5	18.0	1.0	1.2	2.3	1.1	0.5	1.8	0.3
ZXDB	ZNF905	ENSG00000198455	"Zinc finger, X-linked, duplicated B"	P98169	X	57591652-57597545	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 24.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA043789	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA043789: "	"unprognostic (1.87e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.61e-3)"	"unprognostic (4.29e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.36e-1)"	"unprognostic (9.04e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.02e-3)"	"unprognostic (2.87e-3)"	2.6	2.1	2.4	1.9	3.0	5.1	3.4	6.3	3.4	3.5	2.5			1.6	4.0	2.0	2.1	4.1	2.8	2.3	2.4	3.2	2.4	11.2	2.3	2.9	2.3		4.5	4.3	5.3	1.9	1.4		3.6	2.5		2.8	3.1	3.6	3.9	2.9	4.2	2.4	2.9	3.2	0.5			3.8		2.9	4.1	2.3	1.3	1.3	0.0	0.6	0.5	2.4	0.3	3.6	4.4	2.8	3.8	4.9	4.8	3.9	2.6	3.3	2.1	2.3	1.8	2.7	3.2	3.9	4.7	4.2	8.1	13.9	4.2	7.8	4.4	1.7	5.7	4.9	6.3	2.9	2.0	4.2	24.2	5.5	15.0	6.5	1.9	3.4	5.8	2.6	2.6	2.4	11.4	5.5	3.3	10.4	1.8	2.9	5.8	2.4	4.5	5.3	3.9	4.0	4.0	3.3	5.6	4.7	9.3	4.0	2.6	0.0	1.4	4.4	3.3	2.6	2.1	0.0	0.3	0.0	1.5	0.5	1.3	1.3	1.1	2.4	0.4	1.2	2.1	1.1	0.0	0.5	0.6	1.3	0.9	0.3										
NLRP2B	"CLRX.1, NALP2P, NLRP2P, NOD24, POP4"	ENSG00000215174	"NLR family pyrin domain containing 2B"	P0DMW2	X	57677067-57680260	"Predicted intracellular proteins"	"Immunity, Innate immunity"	"Signal transduction inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"skeletal muscle: 1.8"	"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (3.37e-2)"	"unprognostic (1.07e-1)"		"unprognostic (6.67e-2)"	"unprognostic (3.84e-2)"		"unprognostic (1.80e-1)"	"unprognostic (5.78e-3)"		"unprognostic (3.49e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.39e-2)"	"unprognostic (7.56e-4)"	"unprognostic (7.92e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.75e-3)"	"unprognostic (9.00e-2)"	0.3	0.2		0.1		0.0	0.0		0.3	0.2	0.0			0.0	0.0	0.0	0.2	0.2	0.0	0.0			0.0	0.0	0.1	0.0			0.1	0.0	0.0		0.0		0.2	0.0		0.0	0.1	1.8	0.0	0.0	0.0		0.0	0.0	0.0			0.1		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0										
ZXDA	ZNF896	ENSG00000198205	"Zinc finger, X-linked, duplicated A"	P98168	X	57906708-57910820	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA043789	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA043789: "	"unprognostic (1.53e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.61e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.87e-1)"	"unprognostic (6.85e-3)"	"unprognostic (6.50e-2)"	"prognostic favourable (8.55e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.27e-2)"	3.5	2.5	1.9	1.4	2.4	3.1	3.5	2.8	2.9	3.3	2.2			1.1	3.6	2.1	1.5	4.3	2.1	2.4	1.9	2.2	2.3	1.6	2.0	3.1	1.6		6.3	3.3	3.7	2.4	0.7		3.3	1.4		2.6	2.9	3.4	2.9	2.4	2.6	1.9	3.5	2.8	0.5			3.6		2.8	2.9	2.4	0.9	0.4	0.0	0.2	1.7	2.3	0.2	2.8	2.5	0.8	3.0	3.0	4.5	2.0	1.6	3.0	2.2	2.5	0.5	2.2	6.2	4.2	4.2	2.6	3.0	3.9	1.9	5.0	4.6	0.8	2.3	0.0	5.1	0.0	0.3	3.6	6.7	3.2	6.5	3.6	0.9	0.2	4.1	2.1	3.1	1.1	3.3	2.3	3.2	2.3	1.9	1.7	2.4	0.4	2.8	3.6	2.4	2.4	3.5	2.2	3.0	3.7	8.2	1.1	1.8	0.0	0.0	3.3	2.5	2.6	2.2	0.0	0.2	0.0	2.3	0.2	0.8	0.2	0.6	1.0	0.2	0.9	1.5	0.2	0.0	1.7	0.2	0.4	1.3	0.2										
SPIN4	"FLJ44984, TDRD28"	ENSG00000186767	"Spindlin family member 4"	Q56A73	X	63347228-63351344	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 27.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA044559	Uncertain		Approved	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA044559: AB_10794171"	"unprognostic (9.66e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.22e-4)"	"unprognostic (3.30e-3)"	"unprognostic (9.44e-3)"	"unprognostic (8.62e-2)"	"unprognostic (3.65e-3)"	"unprognostic (9.39e-2)"	"prognostic unfavourable (3.56e-6)"	"unprognostic (1.74e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.09e-2)"	3.9	3.2	4.2	5.1	4.4	13.8	13.7	2.3	5.4	5.1	5.9	6.7	2.0	3.5	6.7	4.7	16.8	3.9	3.5	3.2	4.7	6.1	3.3	2.4	16.8	7.6	4.5	2.3	6.6	4.2	4.8	4.7	12.3	5.2	7.2	6.9	4.8	27.4	2.9	1.2	3.5	4.9	5.8	5.2	5.9	3.9	3.4	3.5	11.2	5.6	6.4	11.8	4.3	8.2	1.2	1.4	3.7	2.1	6.0	1.5	0.8	16.1	4.1	9.7	7.8	2.1	3.0	7.0	8.1	3.4	4.7	5.7	2.7	16.1	0.0	3.6	3.8	5.4	12.5	5.9	8.7	6.9	3.9	20.8	5.6	2.5	0.9	17.9	16.3	1.4	2.1	7.9	4.3	5.2	6.3	20.3	10.8	5.4	5.9	9.7	10.0	6.1	8.4	20.9	4.4	3.5	4.3	0.0	5.4	14.5	4.2	1.5	9.2	8.6	2.2	9.6	10.8	15.9	5.0	4.5	5.2	10.7	5.1	14.8	5.6	1.7	1.8	3.7	1.5	2.1	0.7	1.2	0.8	0.9	1.4	1.1	0.5	1.0	0.0	6.0	1.7	0.0	0.5	0.8	4.2	4.4	2.3	5.4	4.7	6.1	4.5	2.3	5.2	3.5
ARHGEF9	"KIAA0424, PEM-2"	ENSG00000131089	"Cdc42 guanine nucleotide exchange factor 9"	O43307	X	63634967-63809274	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035419, HPA055291"	Approved		Supported	Cytosol				Cytosol		"HPA035419: AB_10669859, HPA055291: "	"unprognostic (3.19e-1)"	"unprognostic (6.15e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.33e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.67e-1)"	"prognostic favourable (1.02e-5)"	"unprognostic (4.56e-2)"	"unprognostic (9.27e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.98e-2)"	5.7	9.6	22.6	4.5	42.6	3.2	6.9	19.5	38.2	6.0	8.2	7.1	1.2	10.9	6.2	4.2	7.7	5.4	6.0	22.0	24.6	22.4	6.8	4.1	4.3	4.6	12.5	28.3	10.4	4.8	11.8	8.3	4.4	17.4	8.2	8.7	9.9	4.5	7.0	3.9	7.0	8.1	8.4	8.5	4.9	6.9	2.2	9.9	2.1	6.1	0.8	5.4	7.3	3.2	5.4	3.7	1.8	3.6	11.5	8.5	2.8	4.5	7.0	11.0	7.0	5.0	6.8	0.9	8.3	6.9	7.7	6.7	0.5	4.9	9.6	6.1	5.1	0.1	4.9	10.1	7.5	13.1	5.0	8.1	3.1	0.4	2.5	4.1	3.5	8.3	4.5	3.8	12.6	5.1	1.1	15.8	7.5	6.5	8.3	2.3	7.6	8.1	12.6	22.6	9.5	4.8	4.1	0.2	3.1	3.9	7.5	4.2	5.3	4.8	2.6	5.1	5.2	24.1	3.5	5.4	4.1	7.5	6.1	7.4	3.6	1.0	2.8	1.8	8.5	3.6	5.6	3.5	4.6	4.9	3.7	5.4	5.6	5.2	1.6	11.5	2.4	2.9	4.1	2.8	22.6	42.6	19.5	37.2	24.6	22.4	12.5	28.3	17.4	9.9
AMER1	"FAM123B, FLJ39827, RP11-403E24.2, WTX"	ENSG00000184675	"APC membrane recruitment protein 1"	Q5JTC6	X	64185117-64205744	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065214, HPA065265"	Approved		Supported	"Nuclear bodies,Vesicles,Plasma membrane"				"Nuclear bodies"	"Vesicles, Plasma membrane"	"HPA065214: , HPA065265: "	"unprognostic (1.56e-2)"	"unprognostic (8.85e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.69e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-2)"	"unprognostic (2.89e-1)"	3.0	3.4	3.0	2.8	5.6	2.3	3.0	8.8	4.9	6.8	4.7	3.1	7.8	3.3	9.8	11.3	6.9	5.2	2.4	3.5	3.0	3.4	4.2	7.1	2.8	2.6	4.5	1.6	15.5	8.1	5.1	3.9	2.0	6.3	4.5	3.2	6.8	7.0	5.3	9.0	4.8	3.7	6.6	2.9	3.7	5.1	1.4	4.3	2.4	3.4	6.5	3.4	4.3	5.7	0.4	0.2	0.0	0.3	2.0	1.0	0.1	2.9	2.2	5.6	4.5	2.2	2.1	4.5	1.4	1.2	2.0	1.3	7.1	1.0	5.6	1.8	2.9	4.1	12.0	3.9	2.0	2.6	2.4	3.4	4.4	4.5	1.6	7.2	0.9	3.0	5.2	1.5	3.1	1.2	5.2	5.7	1.1	3.4	4.7	3.9	15.1	4.3	11.3	9.2	4.1	0.9	0.9	2.5	3.8	3.5	4.8	1.9	1.5	2.1	0.7	2.5	5.8	6.5	1.8	2.9	2.0	4.3	1.1	8.2	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.4	0.0	0.4	0.0	0.3	1.0	0.0	0.0	2.0	0.0	0.2	0.9	0.1	3.0	5.6	8.8	4.9	3.0	3.4	4.5	1.6	6.3	4.3
ASB12	FLJ39577	ENSG00000198881	"Ankyrin repeat and SOCS box containing 12"	Q8WXK4	X	64224196-64230631	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"skeletal muscle: 43.4;tongue: 11.5"	"Cell line enhanced"	"Detected in some"		"AF22: 3.8;HEK 293: 2.1;HL-60: 2.1;HMC-1: 2.7;NB-4: 2.2;NTERA-2: 2.3;REH: 2.1;THP-1: 3.5"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 4.0;naive B-cell: 1.1;T-reg: 1.0"	"Group enriched"	"Detected in many"	6	"B-cells: 1.1;granulocytes: 4.0;T-cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA049542	Uncertain									"HPA049542: "	"unprognostic (6.52e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.76e-2)"	"unprognostic (4.23e-2)"	"unprognostic (6.50e-2)"	"unprognostic (8.25e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.69e-3)"	"unprognostic (6.75e-3)"	"unprognostic (5.18e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.32e-2)"	"unprognostic (4.63e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.0	1.0	0.7	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.2	43.4	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.6	11.5	0.7	0.0	0.0	1.1	0.0	4.0	0.3	0.1	1.0	0.3	0.0	0.2	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.5	0.6	0.0	0.0	0.9	0.0	0.4	0.0	2.1	1.8	0.0	0.0	0.0	2.1	2.7	0.0	0.5	0.0	0.0	0.0	0.3	1.1	0.0	0.1	0.5	2.2	2.3	0.4	2.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.6	0.0	0.0	0.0	4.0	0.0	0.0	0.3	0.3	0.4	0.0	0.4	0.2	0.0	1.1	0.3	0.2	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MTMR8	FLJ20126	ENSG00000102043	"Myotubularin related protein 8"	Q96EF0	X	64268081-64395431	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 16.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 7.0;Karpas-707: 5.0;NTERA-2: 6.5;U-2197: 5.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"														"unprognostic (1.73e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.22e-2)"	"unprognostic (8.20e-2)"	2.8	2.6	1.2	3.1	2.2	1.9	2.2	6.1	2.0	4.2	4.0	2.5	4.1	1.7	6.0	2.9	3.8	8.1	2.0	1.8	1.5	1.7	3.2	1.4	2.1	3.0	2.4	0.7	6.6	2.5	2.7	6.8	0.5	2.0	3.4	4.9	16.4	2.8	6.5	1.5	2.1	5.3	6.7	2.4	4.3	4.1	1.3	3.0	5.5	2.4	1.6	6.1	4.9	3.1	3.2	0.2	0.7	1.4	0.8	4.0	1.6	0.0	1.4	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	1.5	7.0	1.0	0.0	0.0	3.9	0.8	1.7	0.0	1.6	2.2	0.3	0.0	0.0	4.8	3.0	0.0	1.0	0.1	0.3	0.0	5.0	5.0	0.0	0.3	2.5	0.8	6.5	0.6	3.9	0.0	1.7	0.4	1.1	0.0	0.7	0.0	0.1	0.0	1.3	2.5	0.0	0.0	1.7	5.7	0.0	0.0	0.5	4.3	0.0	0.0	0.0	0.4	0.4	0.1	3.2	1.2	3.1	3.0	3.3	2.0	0.2	3.2	4.0	3.5	0.7	0.8	1.4	0.2	1.7	1.6	1.2	2.2	6.1	2.0	1.5	1.7	2.4	0.7	2.0	3.0
ZC4H2	"HCA127, KIAA1166, WWS"	ENSG00000126970	"Zinc finger C4H2-type containing"	Q9NQZ6	X	64915802-65034713	"Disease related genes, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 17.1;NTERA-2: 27.8;REH: 20.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049584	Approved		Approved	Vesicles,Microtubules				"Vesicles, Microtubules"		"HPA049584: "	"unprognostic (9.55e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.40e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.29e-3)"	"unprognostic (9.71e-2)"	"unprognostic (1.64e-3)"	"unprognostic (9.72e-2)"	"unprognostic (2.98e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (3.51e-5)"	"unprognostic (5.34e-2)"	7.0	9.7	11.7	6.6	12.3	4.8	7.4	12.7	15.0	10.4	12.2	15.6	8.1	8.1	12.8	8.4	6.4	12.5	8.0	10.4	10.6	14.7	9.9	10.0	6.4	5.6	11.7	10.8	14.7	5.3	20.0	20.3	2.2	16.9	10.5	9.6	10.0	8.9	12.2	3.2	5.3	7.8	16.2	12.3	6.2	9.5	2.5	12.4	12.7	10.8	2.3	5.4	8.2	6.1	4.7	3.9	0.0	2.0	3.6	7.9	3.0	0.0	1.0	17.1	7.6	0.1	0.0	2.5	3.7	5.6	4.8	8.3	1.2	6.1	2.8	2.0	2.7	0.0	7.2	2.8	4.6	0.0	5.7	5.1	2.6	2.2	1.1	5.1	1.7	3.1	2.3	2.1	4.4	8.0	1.4	6.5	5.2	0.0	14.1	0.0	27.8	6.4	20.4	9.0	0.1	4.1	0.0	0.0	12.0	0.0	0.0	0.7	1.5	0.8	5.1	2.2	5.1	0.2	0.0	1.0	0.1	10.4	6.3	4.4	0.0	0.0	1.3	0.0	3.3	2.0	5.9	4.7	4.8	5.0	1.8	4.1	7.9	4.6	0.0	3.6	0.5	3.9	2.4	3.0	11.7	12.3	12.7	15.0	10.6	14.7	11.7	10.8	16.9	12.4
ZC3H12B	"CXorf32, MCPIP2"	ENSG00000102053	"Zinc finger CCCH-type containing 12B"	Q5HYM0	X	65366638-65507887	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 6.1"	"Cell line enhanced"	"Detected in many"		"AF22: 5.2;Karpas-707: 4.2"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA000836	Uncertain		Approved	"Endoplasmic reticulum,Golgi apparatus,Vesicles"				"Endoplasmic reticulum"	"Golgi apparatus, Vesicles"	"HPA000836: AB_2217374"	"unprognostic (1.91e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.44e-3)"	"unprognostic (7.86e-3)"	"unprognostic (5.46e-2)"	"unprognostic (3.32e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.71e-2)"	0.3	0.9	2.6	0.5	3.9	0.1	0.5	2.8	6.1	1.9	1.1			0.9	2.6	0.8	0.4	2.0	1.1	0.5	2.8	2.5	1.2	0.5	0.6	0.7	1.7		3.3	0.1	2.7	2.7	0.0		1.8	1.1		0.3	2.4	0.0	0.3	0.9	1.8	1.5	0.4	1.3	0.0			1.5		0.2	1.0	0.7	1.3	0.8	0.7	0.4	0.8	1.8	0.2	0.3	0.4	5.2	0.8	0.0	0.0	0.7	1.3	2.8	0.0	0.8	0.7	0.5	0.8	0.3	1.4	0.8	1.3	0.0	0.1	0.8	3.8	1.7	2.4	0.7	0.1	1.6	0.4	0.2	0.0	0.1	0.0	0.0	0.9	4.2	0.1	0.0	2.2	0.6	2.1	1.1	2.5	0.2	1.0	0.1	0.2	0.2	2.5	0.0	0.2	0.2	0.1	1.3	0.0	0.1	1.0	1.7	0.5	0.9	1.0	1.7	3.3	2.2	0.0	0.6	0.4	0.1	0.6	0.2	0.5	0.9	0.8	0.8	0.2	1.3	1.8	0.8	0.7	0.8	0.2	0.8	0.4	0.2										
LAS1L	FLJ12525	ENSG00000001497	"LAS1 like, ribosome biogenesis factor"	Q9Y4W2	X	65512582-65534775	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"		"Disease mutation, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044431, HPA061463"	Supported		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"				Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA044431: AB_10965695, HPA061463: "	"unprognostic (9.71e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.15e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.06e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.53e-1)"	16.4	14.7	22.6	17.8	26.4	27.9	21.4	38.3	26.1	18.0	17.9	30.1	14.1	11.1	21.9	17.4	17.1	23.8	14.2	14.0	24.2	22.0	15.7	24.4	15.5	23.2	26.4	23.4	26.2	19.8	29.0	13.8	16.3	26.0	17.8	17.2	19.7	19.5	22.5	20.4	23.9	13.4	20.4	29.7	17.8	14.6	23.7	25.7	26.7	16.4	15.4	26.7	15.3	16.2	20.7	22.0	12.4	20.8	17.8	22.5	17.3	20.0	33.3	15.9	13.2	6.9	8.8	15.5	12.1	7.8	18.9	16.7	16.3	15.0	31.3	17.4	9.1	14.2	31.9	21.3	21.4	11.9	26.1	14.1	29.1	16.0	8.4	36.1	12.8	9.1	12.6	18.9	13.5	12.5	33.0	32.7	11.2	23.8	27.4	27.6	23.5	30.8	23.6	22.1	34.7	13.0	9.1	12.6	14.5	19.3	14.2	8.8	10.6	19.2	9.0	11.7	23.2	35.7	18.2	11.9	14.0	34.4	11.4	38.2	6.2	12.4	15.7	7.8	18.8	20.8	20.8	20.2	17.6	22.3	22.0	20.7	22.5	18.5	1.7	17.8	15.0	16.4	17.6	17.3	22.6	26.4	38.3	26.1	24.2	22.0	26.4	23.4	26.0	25.7
MSN		ENSG00000147065	Moesin	P26038	X	65588377-65741931	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000263, CAB010898, HPA011135, HPA011227, CAB047336, CAB047337, CAB047338"	Enhanced		Enhanced	"Plasma membrane"			340000000	"Plasma membrane"		"CAB010898: AB_260635, CAB047336: , CAB047337: , CAB047338: , HPA000263: AB_1856043, HPA011135: AB_1854053, HPA011227: AB_1854054"	"unprognostic (1.03e-1)"	"unprognostic (7.89e-2)"	"unprognostic (7.64e-2)"	"unprognostic (5.38e-2)"	"unprognostic (4.08e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (1.60e-5)"	"unprognostic (5.68e-3)"	"unprognostic (7.75e-2)"	"unprognostic (7.21e-2)"	"unprognostic (6.81e-2)"	36.3	17.6	10.2	40.7	14.4	38.5	98.2	8.6	18.6	25.1	21.3	19.2	7.6	6.5	33.4	14.2	15.7	21.8	20.2	53.8	11.5	10.4	25.6	29.5	102.8	85.0	17.5	5.4	28.8	19.4	5.7	10.2	24.2	30.0	23.1	13.0	16.6	16.3	21.9	13.6	19.5	18.3	41.4	21.8	31.6	17.3	9.0	12.9	18.7	26.2	17.6	38.1	22.7	28.9	16.0	36.4	54.1	69.0	28.0	37.1	81.8	27.8	21.4	21.0	17.3	25.2	33.3	0.1	70.7	45.8	39.2	30.4	0.0	4.9	23.4	63.2	62.5	19.2	22.1	50.4	51.2	43.3	6.1	64.9	37.1	0.0	23.8	78.8	105.1	24.9	10.9	72.1	63.8	86.5	31.4	73.0	62.0	0.0	46.5	59.1	26.0	40.7	24.4	37.7	17.8	41.9	0.0	0.1	0.0	56.8	0.4	22.5	0.2	42.9	137.0	44.7	28.4	60.1	46.8	26.5	40.1	25.4	32.7	100.1	49.7	30.8	44.4	30.0	37.1	58.9	27.9	16.0	20.4	29.1	36.4	13.9	14.0	21.3	54.1	28.0	69.0	5.2	15.5	81.8	10.2	14.4	8.6	18.6	11.5	10.4	17.5	5.4	30.0	12.9
VSIG4	Z39IG	ENSG00000155659	"V-set and immunoglobulin domain containing 4"	Q9Y279	X	66021738-66040125	"Plasma proteins, Predicted membrane proteins"	"Complement alternate pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;HMC-1: 1.1;NB-4: 3.1;SH-SY5Y: 1.0;U-937: 2.7"	"Cancer enhanced"	"Detected in all"		"glioma: 88.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	26	"classical monocyte: 13.9;intermediate monocyte: 8.1;myeloid DC: 13.1"	"Group enriched"	"Detected in many"	30	"dendritic cells: 13.1;monocytes: 13.9"					"Low region specificity"	"Detected in many"			"HPA003903, CAB026000"	Enhanced		Uncertain	"Nucleoli,Plasma membrane,Cytosol"			41000000	"Plasma membrane, Cytosol"	Nucleoli	"CAB026000: , HPA003903: AB_1858776"	"unprognostic (6.87e-3)"	"unprognostic (4.79e-2)"	"prognostic unfavourable (1.34e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavourable (1.95e-6)"	"unprognostic (3.70e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.47e-2)"	67.1	28.1	15.9	17.6	16.6	2.6	19.0	1.8	10.4	6.3	18.0	5.6	1.0	9.2	6.1	14.2	9.3	28.7	15.5	15.9	11.5	3.5	18.5	22.9	61.4	37.0	17.9	3.4	8.2	8.2	3.7	7.9	52.4	12.0	10.9	12.6	8.1	11.3	4.0	10.5	4.0	14.6	39.9	16.7	28.5	9.4	13.5	17.8	0.0	10.7	1.7	1.8	14.4	9.0	0.1	13.1	0.4	13.9	0.0	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.1	3.1	0.2	0.0	0.4	0.0	0.5	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.0	0.8	2.7	0.0	0.0	13.9	0.0	0.0	8.1	0.0	0.0	0.0	0.2	13.1	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	3.3	15.9	16.6	1.8	10.1	11.5	3.5	17.9	3.4	12.0	17.8
HEPH	"CPL, KIAA0698"	ENSG00000089472	Hephaestin	Q9BQS7	X	66162549-66268867	"Predicted intracellular proteins, Predicted membrane proteins"	"Copper transport, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 68.7"	"Cell line enhanced"	"Detected in some"		"AF22: 14.0;HEL: 12.0;HSkMC: 18.2;K-562: 33.7;LHCN-M2: 13.9"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 37.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA000553, HPA005824"	Approved		Approved	"Nucleoplasm,Nuclear bodies"			1200000	"Nucleoplasm, Nuclear bodies"		"HPA000553: , HPA005824: AB_1850603"	"unprognostic (3.10e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.25e-1)"	"unprognostic (4.94e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (7.00e-6)"	"unprognostic (3.08e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.17e-2)"	4.0	12.2	8.3	10.9	9.3	0.0	3.9	3.7	10.1	11.6	38.4	9.7	8.9	32.9	18.3	9.0	7.5	8.7	21.4	14.8	8.1	5.0	3.7	1.4	7.1	1.3	9.2	10.2	10.2	1.0	0.9	2.5	0.9	8.5	11.0	33.5	11.4	3.0	14.5	0.5	2.8	68.7	34.8	6.7	4.4	8.6	3.2	8.8	0.0	3.2	2.7	1.1	11.2	6.4	0.0	0.2	0.0	0.0	0.0	0.6	0.5	0.0	0.0	14.0	1.1	0.0	0.0	0.4	3.5	0.1	0.0	0.0	8.3	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	3.9	0.0	12.0	0.0	0.0	0.1	0.1	0.0	18.2	0.0	0.0	0.0	0.0	33.7	0.3	13.9	0.0	0.0	0.3	6.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	8.1	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	8.3	9.3	3.7	10.1	8.1	5.0	9.2	10.2	8.5	8.8
EDA2R	"EDA-A2R, EDAA2R, TNFRSF27, XEDAR"	ENSG00000131080	"Ectodysplasin A2 receptor"	Q9HAV5	X	66595637-66639298	"Predicted membrane proteins"	Differentiation	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 14.2;BJ hTERT+: 13.6;HSkMC: 19.3;LHCN-M2: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.1;naive B-cell: 1.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA054522			Approved	"Cell Junctions"				"Cell Junctions"		"HPA054522: "	"unprognostic (1.31e-3)"	"unprognostic (3.17e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.49e-3)"	"unprognostic (4.15e-3)"	"unprognostic (3.63e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.17e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.12e-2)"	"unprognostic (8.23e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.08e-1)"	4.7	9.4	2.3	1.9	3.2	0.0	5.6	1.2	3.0	9.7	3.7	5.7	4.6	0.4	13.5	6.3	3.6	6.5	4.8	2.8	2.9	1.2	3.0	1.2	3.7	0.6	5.7	1.1	12.9	4.9	7.4	16.0	4.8	4.5	14.5	7.6	5.5	6.1	8.3	11.0	2.5	1.8	7.5	8.2	2.0	1.6	2.7	4.0	1.5	8.2	1.9	1.2	6.3	7.4	1.1	0.3	0.0	0.5	0.0	1.1	0.0	0.0	9.1	8.4	0.0	12.2	14.2	0.1	12.5	13.6	1.2	1.9	0.0	0.0	4.5	0.0	8.1	0.0	0.0	4.8	4.1	0.0	4.3	0.0	0.2	5.9	2.1	0.0	0.0	19.3	11.3	9.4	8.6	0.3	0.4	4.7	17.8	1.0	0.2	0.0	3.1	0.0	0.0	1.1	0.0	0.9	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.1	9.5	0.0	6.8	0.0	0.1	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.3	1.1	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.0	2.3	3.2	1.2	2.6	2.9	1.2	5.7	1.1	4.5	4.0
AR	"AIS, DHTR, HUMARA, NR3C4, SBMA, SMAX1"	ENSG00000169083	"Androgen receptor"	P10275	X	67544032-67730619	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Neurodegeneration, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 49.0"	"Cell line enhanced"	"Detected in some"		"AF22: 11.0;BJ hTERT+: 9.6;HAP1: 14.1;LHCN-M2: 12.4;RH-30: 20.5;T-47d: 8.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	16	"plasmacytoid DC: 5.4"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000001, HPA065701, CAB065764"	Enhanced		Approved	Mitochondria				Mitochondria		"CAB000001: AB_2060174, CAB065764: AB_10620739, HPA065701: "	"unprognostic (1.34e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.49e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.35e-2)"	"prognostic favourable (8.77e-4)"	"unprognostic (4.99e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.29e-1)"	"prognostic favourable (1.03e-8)"	"unprognostic (8.23e-3)"	"unprognostic (8.90e-2)"	"unprognostic (4.23e-2)"	"unprognostic (7.97e-2)"	10.1	1.2	0.9	1.6	0.9	0.1	10.7	0.4	1.6	34.4	1.9	2.4	25.4	0.2	20.5	20.5	2.2	17.5	4.3	5.7	0.9	1.5	6.3	49.0	1.5	0.2	1.2	0.7	14.4	1.0	0.1	2.3	0.3	1.9	28.0	0.5	3.8	1.6	36.1	8.1	3.9	1.1	7.6	1.9	0.9	1.6	9.3	1.2	5.4	3.1	2.0	1.2	6.3	13.1	0.0	5.4	0.3	0.0	0.1	0.0	0.1	0.0	4.6	11.0	0.0	0.0	0.1	0.0	5.8	9.6	0.4	0.1	0.2	0.0	0.0	0.0	0.7	0.0	14.1	0.0	0.1	0.0	1.8	0.0	1.1	0.0	0.6	0.0	0.0	4.5	0.0	1.6	0.0	3.4	4.0	1.8	12.4	1.2	0.0	0.0	4.4	0.0	0.0	20.5	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	8.6	5.2	0.2	0.2	2.0	0.1	2.9	0.0	0.0	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	5.4	0.0	0.1	0.9	0.9	0.4	1.6	0.9	1.5	1.2	0.7	1.9	1.2
OPHN1	"ARHGAP41, MRX60, OPN1"	ENSG00000079482	"Oligophrenin 1"	O60890	X	68042344-68433913	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Neurogenesis"	"GTPase activation"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002919	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA002919: AB_1079526"	"unprognostic (1.21e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.22e-1)"	"unprognostic (6.62e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.21e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.64e-3)"	5.8	8.2	21.9	2.4	22.6	3.6	7.1	12.3	21.6	9.9	4.9	10.7	3.2	3.5	9.7	4.8	6.1	5.3	4.5	4.1	19.5	9.7	7.0	1.7	6.6	2.0	9.6	12.2	7.1	4.0	6.6	4.8	20.7	9.1	16.2	5.1	7.9	7.2	8.0	7.8	8.6	4.1	6.3	6.2	2.9	5.9	2.9	12.4	0.1	7.2	2.0	2.3	3.9	6.2	2.7	3.3	4.1	1.7	1.7	1.2	0.3	15.1	3.8	2.4	5.9	5.5	5.7	3.9	2.8	3.9	5.3	6.4	2.4	3.1	0.7	10.8	3.4	4.1	2.1	1.2	8.2	0.4	1.5	3.2	4.3	2.4	1.8	0.8	3.8	3.2	3.9	4.9	4.8	4.3	2.1	1.4	3.1	7.8	0.5	0.8	4.6	3.2	0.4	4.8	0.7	6.9	5.8	0.9	2.3	5.5	7.0	12.4	4.7	1.3	4.7	3.6	5.8	12.7	3.6	2.1	2.5	0.5	2.7	1.9	2.6	1.1	1.7	0.6	1.2	0.9	1.0	1.3	1.0	0.8	0.7	2.7	1.1	1.2	4.1	1.7	1.2	3.3	0.7	0.3	21.9	22.6	12.3	18.6	19.5	9.7	9.6	12.2	9.1	12.4
YIPF6	"FinGER6, MGC21416"	ENSG00000181704	"Yip1 domain family member 6"	Q96EC8	X	68498323-68537285	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003720	Uncertain		Approved	Vesicles				Vesicles		"HPA003720: AB_1080626"	"unprognostic (5.07e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.17e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.85e-3)"	"unprognostic (8.48e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.32e-2)"	13.3	15.6	16.5	7.2	17.7	4.9	15.8	12.9	17.1	16.0	12.3	17.3	11.6	11.5	14.0	16.2	13.6	13.7	11.2	11.9	14.9	14.4	19.6	28.3	12.7	6.2	17.6	13.1	11.5	26.8	18.0	32.9	32.4	16.1	21.1	14.6	11.7	16.0	16.1	18.1	10.9	14.4	16.9	17.1	8.8	14.9	6.9	15.3	4.3	22.4	7.4	10.9	13.4	11.4	4.0	3.8	12.4	4.6	3.1	2.7	3.1	11.4	9.4	12.1	4.0	16.8	10.6	11.5	9.3	12.0	7.5	9.5	9.6	12.3	0.1	16.3	8.1	9.3	15.9	6.5	13.1	3.4	9.4	4.7	11.1	9.2	15.3	5.5	7.6	10.1	12.6	10.9	14.4	7.5	7.8	10.7	10.7	10.1	3.2	4.9	12.8	12.1	3.2	14.8	6.4	13.2	11.3	12.7	14.0	14.9	11.1	11.1	7.0	5.6	9.0	7.5	6.6	27.2	17.5	6.3	7.4	2.4	12.9	8.8	13.2	5.4	4.6	5.2	2.7	4.6	1.8	4.0	2.7	2.3	3.3	2.5	2.7	2.4	12.4	3.1	4.2	3.8	2.6	3.1	16.5	17.7	12.9	15.6	14.9	14.4	17.6	13.1	16.1	15.3
STARD8	"ARHGAP38, KIAA0189"	ENSG00000130052	"StAR related lipid transfer domain containing 8"	Q92502	X	68647666-68725842	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 12.7;K-562: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"classical monocyte: 2.4;intermediate monocyte: 5.2;myeloid DC: 5.2;non-classical monocyte: 6.5"	"Group enriched"	"Detected in many"	16	"dendritic cells: 5.2;monocytes: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA060788	Uncertain									"HPA060788: "	"unprognostic (2.00e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.94e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.09e-3)"	"unprognostic (9.72e-2)"	"unprognostic (9.58e-2)"	"unprognostic (5.19e-3)"	"unprognostic (4.89e-3)"	"unprognostic (9.46e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.07e-2)"	18.6	5.7	7.4	8.6	8.5	4.6	14.0	3.4	8.8	8.1	4.3	3.7	6.2	2.4	10.5	10.9	5.4	9.1	7.9	9.3	7.8	4.0	19.2	10.9	22.3	6.6	7.5	2.6	4.6	7.0	3.3	10.7	15.7	9.4	10.7	2.7	19.4	3.4	13.6	9.7	3.3	4.8	9.1	5.8	15.8	4.8	2.7	8.0	1.5	11.8	5.7	3.0	7.5	5.8	0.3	5.2	0.1	6.5	0.0	0.0	2.1	0.0	1.4	2.3	1.1	0.0	0.0	1.7	3.1	6.4	1.7	1.3	0.0	0.4	0.0	8.0	1.3	0.0	0.6	0.0	3.0	0.0	0.4	12.7	1.0	0.1	0.3	0.0	0.0	1.0	0.0	4.5	0.0	8.0	15.9	0.0	4.3	0.6	0.0	7.5	1.3	0.3	0.0	8.3	4.2	7.9	0.0	0.0	0.6	0.1	0.7	0.3	1.0	1.7	5.6	8.0	3.4	2.5	2.9	0.0	0.0	0.0	6.0	5.2	4.6	0.0	2.4	0.0	0.0	5.2	0.0	0.3	0.0	0.0	5.2	0.0	0.0	0.0	0.1	0.0	6.5	0.2	0.0	2.1	7.4	8.5	3.4	8.8	7.8	4.0	7.5	2.6	9.4	8.0
EFNB1	"CFNS, Elk-L, EPLG2, LERK2"	ENSG00000090776	"Ephrin B1"	P98172	X	68828997-68842147	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes, Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 35.4;hTCEpi: 27.6;PC-3: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 7.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB031489, HPA067188"	Uncertain		Supported	"Plasma membrane"			790000	"Plasma membrane"		"CAB031489: AB_631414, HPA067188: "	"unprognostic (2.00e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavourable (3.32e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.05e-3)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (8.68e-4)"	"unprognostic (3.94e-2)"	"prognostic unfavourable (4.29e-4)"	"unprognostic (1.29e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.86e-2)"	36.5	13.2	5.0	11.5	4.5	1.3	26.5	2.3	4.7	19.5	21.1	4.7	13.1	14.0	15.2	14.9	17.4	15.2	33.7	16.0	3.6	2.7	25.5	15.3	23.0	5.2	4.7	3.5	21.6	4.5	15.0	6.4	34.3	3.9	15.9	10.1	14.9	7.0	13.2	9.1	26.4	24.0	12.3	2.6	15.3	13.3	7.4	4.2	4.8	11.9	22.0	11.2	16.7	14.8	0.5	7.1	0.6	3.4	1.3	1.0	1.0	3.7	1.9	15.6	5.7	8.3	5.1	8.2	3.2	3.5	1.4	1.0	1.7	6.9	0.9	21.2	1.2	19.8	14.7	35.4	0.8	1.5	3.7	0.9	0.8	3.0	7.6	0.7	8.0	9.5	27.6	3.5	16.0	10.8	1.0	0.0	1.2	3.0	1.5	0.7	10.8	26.2	6.6	1.6	5.9	5.9	13.1	5.8	2.8	2.4	0.7	0.9	0.6	1.3	18.1	2.7	3.3	7.2	1.2	0.0	0.8	0.9	1.3	4.0	1.7	0.0	1.3	0.6	1.0	3.4	0.6	0.5	0.9	0.9	7.1	0.4	0.8	0.4	0.3	1.3	2.1	1.0	0.4	1.0	5.0	4.5	2.3	4.7	3.6	2.7	4.7	3.5	3.9	4.2
PJA1	"FLJ11830, RNF70"	ENSG00000181191	"Praja ring finger ubiquitin ligase 1"	Q8NG27	X	69160851-69165793	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 98.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 38.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000595	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA000595: AB_1079826"	"unprognostic (3.40e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.58e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.26e-3)"	"unprognostic (4.61e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.84e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (7.44e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.10e-1)"	12.6	9.9	21.6	5.5	35.7	2.6	7.9	13.4	23.7	12.2	5.8	8.9	19.3	4.7	9.2	98.7	5.7	10.2	7.1	7.5	18.4	23.4	7.5	4.4	7.4	5.9	14.9	16.7	16.2	6.0	27.1	12.5	10.7	11.7	9.9	5.3	7.2	6.4	20.3	4.7	7.1	4.4	9.8	12.0	5.9	6.5	13.7	9.5	3.0	13.8	2.9	7.4	7.8	7.9	11.2	4.3	2.7	4.5	14.8	17.8	9.0	10.4	8.0	25.1	17.5	8.8	9.3	7.5	7.0	8.4	6.6	8.9	6.5	9.9	1.6	10.9	11.0	9.1	38.5	13.6	8.3	7.8	13.7	3.1	6.6	4.3	11.0	1.8	6.0	9.7	9.1	11.2	6.7	7.4	2.9	1.1	6.7	5.6	0.8	3.5	17.1	13.1	7.5	11.2	2.5	10.6	8.8	18.6	12.1	11.2	1.9	8.5	3.1	2.6	6.7	5.7	9.2	16.9	3.2	0.0	0.1	3.8	6.2	5.1	7.6	2.7	3.3	1.0	15.5	4.5	17.8	8.7	13.7	14.2	3.6	11.2	14.4	16.6	1.1	14.8	2.9	4.3	8.3	9.0	21.6	35.7	13.4	23.7	18.4	23.4	14.9	16.7	11.7	9.5
FAM155B	"CXorf63, TED, TMEM28"	ENSG00000130054	"Family with sequence similarity 155 member B"	O75949	X	69505241-69532508	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 25.0;seminal vesicle: 6.7;thyroid gland: 10.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.8;HAP1: 15.2;Hep G2: 5.5;NTERA-2: 21.0;SCLC-21H: 10.0"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036093	Uncertain									"HPA036093: AB_10673613"	"prognostic unfavourable (4.61e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.09e-4)"	"unprognostic (7.07e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (4.94e-3)"	"prognostic unfavourable (1.83e-4)"	"prognostic favourable (6.63e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.21e-2)"	0.0	0.5	1.4	0.0	1.1	0.0	0.1	3.5	1.4	0.1	0.0			0.0	0.2	0.3	0.0	0.7	0.1	25.0	1.1	2.1	0.5	0.0	0.0	0.0	1.3		0.0	1.8	0.9	1.1	0.0		0.9	0.0		1.1	6.7	0.0	0.0	0.0	0.0	0.4	0.6	0.5	0.8			10.4		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.6	0.0	4.2	0.0	0.0	15.2	0.6	0.0	0.0	4.1	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.7	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.1	0.0	10.0	0.7	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
EDA	"ED1, ED1-A1, ED1-A2, EDA-A1, EDA-A2, EDA1, EDA2, HED, ODT1, XHED, XLHED"	ENSG00000158813	"Ectodysplasin A"	Q92838	X	69616067-70039469	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Differentiation	"Developmental protein"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.6;Hep G2: 18.2;Karpas-707: 5.1;RPMI-8226: 6.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.0"	"Group enriched"	"Detected in many"	6	"monocytes: 3.0;T-cells: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA037972, HPA037973"			Supported	"Vesicles,Lipid droplets"	"Intracellular and membrane"			Vesicles	"Lipid droplets"	"HPA037972: , HPA037973: "	"unprognostic (3.76e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.59e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.25e-4)"	"unprognostic (4.33e-4)"	"unprognostic (5.03e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.01e-1)"	"prognostic favourable (1.04e-9)"	"unprognostic (8.63e-4)"	"unprognostic (7.64e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.79e-1)"	6.8	11.7	2.2	3.1	3.0	0.3	3.9	0.9	2.4	10.3	3.4	3.9	7.4	0.9	6.3	5.7	5.0	4.4	7.0	13.3	2.6	2.1	6.9	3.1	4.3	5.8	4.3	2.0	7.9	6.3	18.4	1.9	2.7	2.9	8.3	1.7	5.0	5.4	10.4	3.3	5.4	1.6	5.4	4.6	2.0	4.7	2.7	2.3	0.8	8.9	5.0	1.2	4.4	8.1	0.0	0.0	0.0	3.0	0.6	4.0	0.3	0.0	0.6	0.3	2.9	0.6	0.1	0.2	0.0	0.1	0.0	0.0	1.4	0.1	0.3	5.6	0.2	0.4	4.0	1.5	0.0	0.0	4.6	0.0	0.1	18.2	1.1	0.0	1.2	2.4	1.4	0.0	1.0	0.5	0.0	5.1	0.0	1.2	0.0	0.0	3.0	0.4	0.0	1.3	6.1	0.1	0.0	1.6	0.0	0.1	0.4	0.1	0.3	0.1	0.5	1.9	2.4	2.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	3.0	4.0	0.0	1.8	0.9	0.0	0.0	1.1	0.2	0.0	0.6	2.0	0.0	0.0	0.3	2.2	3.0	0.9	2.4	2.6	2.1	4.3	2.0	2.9	2.3
AWAT2	"DGAT2L4, MFAT"	ENSG00000147160	"Acyl-CoA wax alcohol acyltransferase 2"	Q6E213	X	70040542-70049938	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	10	"breast: 5.7;skin 1: 14.0"	"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 2.3;PC-3: 2.6;SK-BR-3: 1.1"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA062748	Approved									"HPA062748: "	"unprognostic (3.41e-2)"			"unprognostic (1.06e-1)"	"unprognostic (2.99e-2)"			"unprognostic (4.11e-2)"		"unprognostic (1.11e-1)"					"unprognostic (8.60e-2)"	"unprognostic (4.55e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0			0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.6	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.9			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OTUD6A	"DUBA2, FLJ25831, HSHIN6"	ENSG00000189401	"OTU deubiquitinase 6A"	Q7L8S5	X	70062491-70064179	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"blood: 3.8;testis: 13.6"	"Cell line enhanced"	"Detected in some"		"MCF7: 2.0;U-2 OS: 1.9"	"Cancer enriched"	"Detected in single"	57	"testis cancer: 2.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053304	Enhanced									"HPA053304: AB_2682107"															"unprognostic (1.58e-1)"			0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	13.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.9	0.4	3.8	0.4	0.7	0.6	0.0	0.4	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.6	0.4	1.0	0.5	0.0	0.7	0.4	0.2	0.2	0.0	0.0	0.5	0.8	0.8	0.0	0.3	0.7	0.3	0.4	0.2	0.2	0.0	0.2	0.6	0.0	2.0	0.3	0.9	0.6	0.2	0.0	0.0	0.0	0.8	0.7	0.6	0.3	0.5	0.2	0.0	0.1	0.1	0.0	0.2	1.9	0.3	0.5	1.6	0.3	1.5	0.1	0.2	0.2	3.8	0.4	0.3	0.4	0.2	0.4	0.3	0.3	0.2	0.0	0.9	0.3	0.6	2.6	0.7	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGBP1	IBP1	ENSG00000089289	"Immunoglobulin binding protein 1"	P78318	X	70133449-70166324	"Disease related genes, Predicted intracellular proteins"	"B-cell activation"	Chaperone	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA000634, HPA001004, CAB034139"	Approved		Approved	Microtubules			8000	Microtubules		"CAB034139: AB_2295670, HPA000634: AB_1079102, HPA001004: AB_1079104"	"unprognostic (3.59e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.35e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.84e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.42e-2)"	"unprognostic (4.10e-3)"	35.3	20.4	19.1	21.2	17.7	22.6	25.7	22.2	20.8	34.3	38.8	16.4	17.3	26.3	27.7	30.1	34.8	35.0	22.7	23.8	17.4	17.7	26.4	13.1	21.1	24.1	19.4	13.2	57.7	55.5	18.9	19.5	25.5	20.7	36.6	26.3	16.8	39.2	20.0	54.2	26.8	46.6	25.8	22.0	24.1	29.8	14.4	17.3	43.1	48.4	28.3	30.5	37.9	36.4	28.7	28.7	23.2	25.5	20.8	40.9	24.3	12.5	14.7	9.5	10.9	38.5	51.9	13.7	10.7	30.3	14.8	17.8	13.5	16.9	23.4	18.2	18.6	17.3	22.4	17.8	19.0	9.2	16.2	7.4	17.1	24.4	26.4	17.3	13.5	49.8	44.1	13.6	19.6	24.9	14.9	21.2	16.0	12.5	14.1	29.5	11.4	22.4	12.4	20.0	23.2	23.8	20.1	10.9	13.4	14.0	12.2	25.1	6.5	18.2	19.7	8.0	12.6	14.1	8.0	20.0	15.4	11.8	11.3	15.0	9.4	23.2	25.2	22.4	20.4	25.5	24.6	28.7	28.6	26.7	28.7	22.3	32.9	29.2	17.8	20.8	20.7	14.4	40.9	24.3	19.1	17.7	22.2	20.8	17.4	17.7	19.4	13.2	20.7	17.3
DGAT2L6	"DC3, FLJ25989"	ENSG00000184210	"Diacylglycerol O-acyltransferase 2 like 6"	Q6ZPD8	X	70177483-70205545	"Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	19	"breast: 6.9;skin 1: 10.1"	"Cell line enriched"	"Detected in single"	6	"NB-4: 4.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.90e-2)"				"unprognostic (3.08e-1)"							"unprognostic (1.43e-3)"	"unprognostic (3.47e-3)"	"unprognostic (8.60e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.63e-3)"		0.0	0.0	0.0	0.0	0.0	0.1	6.9	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AWAT1	DGAT2L3	ENSG00000204195	"Acyl-CoA wax alcohol acyltransferase 1"	Q58HT5	X	70234655-70240627	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"breast: 3.8;skin 1: 6.1"	"Cell line enhanced"	"Detected in single"		"HEK 293: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA063412	Enhanced									"HPA063412: "	"unprognostic (1.12e-1)"			"unprognostic (1.78e-1)"						"unprognostic (1.96e-2)"				"unprognostic (4.90e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.78e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.4	0.0	0.0	0.0		0.0	0.0		0.2	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
P2RY4	"NRU, P2P, P2Y4, UNR"	ENSG00000186912	"Pyrimidinergic receptor P2Y4"	P51582	X	70258170-70259764	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"intestine: 14.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB022644	Uncertain									"CAB022644: "	"unprognostic (4.59e-2)"	"unprognostic (4.23e-1)"	"unprognostic (7.10e-2)"		"unprognostic (1.69e-1)"	"unprognostic (9.53e-4)"	"unprognostic (6.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.89e-3)"	"unprognostic (2.90e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.89e-1)"	0.3	0.1	0.2	0.2	0.2	0.1	0.4	0.2	0.2	2.1	2.9	0.2	0.2	0.7	0.2	0.6	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.3	1.6	0.2	0.6	0.2	0.2	2.1	14.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.4	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.8	0.3	0.5	0.0	0.2	0.4	0.1	0.3	0.1	0.6	0.0	0.0	0.3	0.0	0.2	0.3	0.0	0.5	1.8	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	1.0	0.3	0.8	0.2	0.6	0.1	0.3	0.7	0.3	0.0	0.0	0.4	0.1	0.7	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.8	1.1	0.1	1.2	0.3	0.6	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
ARR3	ARRX	ENSG00000120500	"Arrestin 3"	P36575	X	70268305-70281840	"Predicted intracellular proteins"	"Sensory transduction, Vision"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"retina: 62.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA063129	Enhanced									"HPA063129: "	"unprognostic (1.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.70e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.02e-3)"	"unprognostic (2.77e-7)"	"unprognostic (8.64e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.43e-1)"	0.3	0.5	0.3	1.0	0.3	0.7	0.3	0.3	0.3	0.3	1.2	0.3	0.3	1.4	0.7	0.3	0.3	0.4	0.7	0.7	0.3	0.2	0.4	0.3	0.3	1.9	0.3	0.3	0.6	0.7	0.0	0.4	0.4	0.3	0.4	0.2	62.9	0.4	0.3	0.5	5.6	3.6	0.3	0.3	0.9	0.8	0.4	0.3	0.3	0.9	0.3	0.3	0.8	0.3	1.3	0.7	0.5	0.4	0.0	1.6	0.3	0.4	0.7	3.2	2.1	0.0	0.0	1.8	1.8	0.0	0.0	0.0	0.6	1.1	1.3	0.4	0.0	0.7	0.0	0.0	0.0	1.4	3.3	0.4	1.1	0.0	0.0	0.7	1.6	0.1	0.0	0.0	0.0	0.0	0.4	5.9	0.0	0.5	1.2	0.6	0.9	0.7	1.1	0.6	0.1	0.0	1.5	0.4	1.0	0.6	0.2	0.1	0.1	0.4	2.5	1.5	2.0	1.4	0.1	1.4	0.8	0.8	1.4	2.0	1.4	0.0	0.4	0.5	0.9	0.2	0.0	1.3	0.4	0.0	0.5	0.4	1.6	0.1	0.1	0.0	0.0	0.7	0.2	0.3	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.3	0.3
RAB41		ENSG00000147127	"RAB41, member RAS oncogene family"	Q5JT25	X	70282093-70285002	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.4;testis: 7.3"	"Cell line enhanced"	"Detected in many"		"U-2197: 6.9;U-87 MG: 8.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA001510	Uncertain									"HPA001510: AB_1079733"	"unprognostic (1.32e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.36e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.46e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.04e-3)"	"unprognostic (7.63e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.78e-3)"	"unprognostic (8.42e-2)"	"unprognostic (9.89e-2)"	0.2	1.6	2.4	0.9	2.7	0.5	0.0	1.3	6.4	0.0	0.3			0.5	0.3	0.0	0.4	0.1	0.9	0.9	1.8	2.1	0.4	0.0	0.5	0.7	2.6		1.6	0.0	0.0	0.2	0.2		0.3	0.0		1.9	0.0	0.7	2.5	1.3	0.0	1.8	0.8	0.2	7.3			1.4		0.0	1.0	0.0	1.5	1.6	0.1	0.9	0.0	2.0	0.4	1.0	1.0	2.4	0.9	0.0	0.0	0.9	0.9	0.0	0.0	0.0	1.1	0.9	1.1	2.0	0.0	1.1	0.0	0.0	0.0	1.4	2.5	0.2	2.1	0.1	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	1.0	2.2	0.0	0.6	1.5	1.0	1.6	3.1	0.6	1.8	1.5	0.0	0.8	1.6	2.9	1.0	0.6	2.7	0.7	2.5	2.9	1.2	1.3	6.9	1.5	1.3	1.8	1.4	8.7	2.1	2.0	0.0	0.4	0.1	0.7	0.9	2.0	1.5	0.6	0.6	1.6	1.5	1.2	1.0	0.0	0.0	0.3	0.4	1.1	0.4										
PDZD11	PDZK11	ENSG00000120509	"PDZ domain containing 11"	Q5EBL8	X	70286595-70290514	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003972	Approved				"Intracellular and membrane"					"HPA003972: AB_1855165"	"unprognostic (1.51e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.75e-1)"	"unprognostic (3.52e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.72e-3)"	16.5	22.0	40.1	11.2	32.1	5.8	21.3	14.4	36.0	20.3	24.2	23.5	12.4	20.7	18.4	28.7	26.1	19.9	17.2	30.7	34.5	39.6	27.5	21.7	13.1	15.1	40.6	25.1	17.5	21.9	23.5	18.4	13.7	35.8	20.2	28.5	26.0	22.1	21.9	12.9	20.0	26.7	22.1	29.2	14.6	17.1	8.1	13.4	17.8	24.0	22.0	21.3	21.7	16.6	16.9	17.3	7.8	25.8	16.0	33.4	14.8	20.3	23.0	15.9	17.7	26.2	31.3	13.5	22.1	24.6	32.9	30.6	21.9	25.9	10.9	27.2	38.8	15.6	26.0	29.7	37.3	15.3	21.0	7.1	23.6	16.8	23.5	9.7	9.9	32.1	20.6	36.6	22.8	26.5	11.3	39.7	52.6	30.3	15.7	13.1	12.5	41.2	11.1	32.2	21.6	27.8	18.4	17.1	17.3	24.4	19.0	23.1	17.5	8.7	20.8	23.9	20.2	36.2	21.5	8.8	15.5	11.4	34.6	14.1	27.7	5.4	11.6	7.8	19.4	20.8	21.4	16.9	20.0	21.7	17.3	13.8	12.4	17.8	4.8	16.0	25.8	13.1	33.4	14.8	40.1	32.1	14.4	36.0	34.5	39.6	40.6	25.1	35.8	13.4
KIF4A	"FLJ12530, FLJ12655, FLJ14204, FLJ20631, HSA271784, KIF4, KIF4-G1, MRX100"	ENSG00000090889	"Kinesin family member 4A"	O95239	X	70290090-70420832	"Predicted intracellular proteins"		"DNA-binding, Motor protein"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.1;lymphoid tissue: 19.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.2"									"HPA034745, HPA034746, HPA061583"	Approved		Supported	Nucleoplasm,Midbody				"Nucleoplasm, Midbody"		"HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: "	"unprognostic (8.17e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (7.37e-6)"	"unprognostic (2.18e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (9.44e-6)"	"unprognostic (3.79e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.47e-1)"	0.9	0.6	0.8	3.3	1.0	11.1	0.5	0.4	3.4	1.2	4.1	0.4	0.4	3.4	0.8	0.4	7.4	1.5	2.5	2.0	0.8	1.3	0.7	0.7	1.5	5.8	0.5	0.9	0.4	0.4	0.0	1.3	2.4	0.8	0.7	5.2	0.4	1.2	0.4	0.8	2.3	3.6	1.2	0.5	4.9	2.1	7.5	1.1	19.3	0.4	0.4	7.2	1.1	2.0	0.7	0.0	0.0	0.2	0.2	3.2	0.3	22.4	15.7	23.8	11.7	1.1	2.0	9.4	17.1	9.2	23.4	20.4	17.6	13.2	13.8	10.8	8.4	13.5	25.7	9.3	26.4	15.8	12.9	15.6	19.2	12.5	0.2	17.3	10.9	0.6	0.5	19.4	11.1	14.3	19.8	30.8	22.0	14.4	15.8	8.6	24.0	16.7	17.6	32.1	13.0	5.6	8.9	15.7	13.1	27.9	11.8	7.3	9.5	6.8	9.9	15.5	20.2	16.6	20.3	8.9	15.2	20.0	8.2	19.1	23.3	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.4	1.3	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	3.2	0.3	0.8	1.0	0.4	3.4	0.8	1.3	0.5	0.9	0.8	1.1
GDPD2	"FLJ20207, GDE3, OBDPF"	ENSG00000130055	"Glycerophosphodiester phosphodiesterase domain containing 2"	Q9HCC8	X	70423031-70433390	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 22.5;intestine: 19.5;lymphoid tissue: 37.5;skin 1: 33.2"	"Group enriched"	"Detected in some"	7	"AF22: 9.2;NTERA-2: 19.7"	"Cancer enhanced"	"Detected in many"		"glioma: 10.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.53e-3)"	"unprognostic (5.79e-2)"	"unprognostic (5.37e-2)"	"unprognostic (5.00e-7)"	"unprognostic (3.15e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.86e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.91e-2)"	0.4	0.4	6.8	0.6	5.7	0.4	1.0	1.1	4.0	0.3	13.0	8.2	8.3	8.0	0.4	22.5	0.4	0.5	0.5	0.8	7.6	4.0	0.6	0.3	0.4	0.4	4.3	5.6	0.4	0.4	0.3	2.6	0.4	8.4	0.3	3.0	0.2	1.1	0.6	0.6	33.2	19.5	0.4	1.5	37.5	1.6	0.3	4.9	0.0	0.4	0.6	0.3	1.0	0.3	0.4	0.1	1.4	0.2	0.1	0.2	0.0	0.0	0.0	9.2	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.2	19.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.2	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.0	0.4	0.1	0.1	1.4	0.1	0.1	0.1	0.0	0.0	6.8	5.7	1.1	4.0	7.6	4.0	4.3	5.6	8.4	4.9
DLG3	"KIAA1232, MRX90, NE-Dlg, NEDLG, PPP1R82, SAP-102, SAP102"	ENSG00000082458	"Discs large MAGUK scaffold protein 3"	Q92796	X	70444861-70505490	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 20.6;SK-BR-3: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 2.1;MAIT T-cell: 1.8;memory CD4 T-cell: 1.7;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.8;NK-cell: 1.7;T-reg: 2.4"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.7;T-cells: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001733, HPA078130"	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA001733: AB_1078675, HPA078130: "	"prognostic unfavourable (1.69e-4)"	"unprognostic (1.87e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.98e-2)"	"prognostic favourable (1.72e-10)"	"unprognostic (3.36e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.97e-3)"	2.7	3.3	12.5	6.5	17.6	0.7	10.8	16.4	25.2	9.2	16.0	4.3	14.7	11.7	7.6	23.7	14.5	17.4	16.3	6.0	15.2	10.0	10.8	1.4	7.8	3.1	6.5	10.2	11.2	27.1	21.2	8.9	5.5	8.0	9.6	17.1	10.2	21.0	10.4	1.1	8.4	20.8	11.3	3.4	14.6	13.8	1.9	3.5	3.2	13.8	2.6	8.0	11.2	9.9	0.4	0.0	0.0	0.0	1.7	2.4	0.3	3.6	1.7	10.6	4.5	2.7	3.4	7.4	2.2	2.5	1.2	1.2	10.5	8.7	0.0	5.1	2.2	8.0	20.6	4.8	0.8	4.3	6.2	0.0	9.4	5.7	5.4	0.1	1.4	3.5	3.2	1.5	3.4	0.4	2.0	14.7	1.1	12.9	8.3	0.0	17.8	12.4	7.8	5.2	1.6	7.2	11.3	5.0	0.3	1.7	20.6	3.9	10.8	0.0	0.8	1.4	1.4	1.3	1.6	9.7	7.3	4.6	2.1	0.0	2.0	0.0	0.0	0.0	2.1	0.0	1.8	0.4	1.7	2.4	0.0	0.0	1.1	1.8	0.0	1.7	0.0	0.0	2.4	0.3	12.5	17.6	16.4	25.2	15.2	10.0	6.5	10.2	8.0	3.5
TEX11	"TGC1, TSGA3"	ENSG00000120498	"Testis expressed 11"	Q8IYF3	X	70528940-70908731	"Disease related genes, Predicted intracellular proteins"	Meiosis		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"pancreas: 36.4;testis: 22.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.3;K-562: 3.7;NTERA-2: 1.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.0"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002950	Approved									"HPA002950: AB_1080249"	"unprognostic (6.78e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.87e-3)"	"unprognostic (7.77e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.30e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.56e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.7	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	36.4	0.0	0.1	0.1	0.1	0.1	0.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.9	0.2	22.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	1.0	0.2	0.8	2.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.7	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.8	0.2	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.4	0.1	0.1	1.0	0.8	0.1	0.1	2.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SLC7A3	"ATRC3, CAT-3, FLJ14541"	ENSG00000165349	"Solute carrier family 7 member 3"	Q8WY07	X	70925582-70931125	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 45.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 8.8;HAP1: 24.5;MOLT-4: 9.6;NTERA-2: 50.3;REH: 10.5"	"Cancer enriched"	"Detected in some"	12	"testis cancer: 43.0"	"Region enhanced"	"Detected in many"		"hypothalamus: 6.7"	"Cell type enriched"	"Detected in single"	16	"naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA003629	Approved									"HPA003629: AB_2190964"	"unprognostic (1.42e-4)"	"unprognostic (4.30e-4)"	"unprognostic (3.59e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.45e-2)"			"unprognostic (1.45e-2)"		"unprognostic (3.66e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.89e-1)"		"unprognostic (7.99e-5)"	"unprognostic (1.31e-2)"	"unprognostic (5.42e-4)"	"unprognostic (3.57e-2)"	0.1	0.0	1.0	0.1	1.0	1.3	1.4	0.1	2.1	2.0	0.1	1.1	0.8	0.1	9.1	6.2	0.7	2.7	0.1	0.0	1.2	6.7	0.2	0.0	0.1	0.5	0.5	0.5	1.7	0.0	0.0	0.6	0.0	1.2	10.4	0.0	0.5	0.2	9.4	0.0	0.0	0.3	4.6	0.2	0.1	5.6	2.4	0.4	45.5	0.0	0.2	0.5	4.0	1.4	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.2	0.0	0.0	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	50.3	0.0	10.5	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	1.0	1.0	0.1	2.1	1.2	6.7	0.5	0.5	1.2	0.4
SNX12		ENSG00000147164	"Sorting nexin 12"	Q9UMY4	X	71056332-71073426	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB070423	Approved						28000			"CAB070423: AB_11153407"	"unprognostic (1.54e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-1)"	"prognostic unfavourable (1.17e-4)"	"unprognostic (4.83e-3)"	"unprognostic (9.88e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.15e-2)"	"prognostic favourable (1.51e-7)"	"unprognostic (3.52e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.59e-2)"	20.0	30.7	26.1	16.9	24.8	15.4	35.0	25.5	38.5	22.9	24.7	24.3	36.0	24.2	30.7	27.8	32.0	22.7	25.0	25.5	24.3	26.3	31.0	17.6	19.4	22.6	28.1	31.6	27.8	21.2	31.7	16.7	24.2	24.0	23.9	25.8	24.9	21.7	33.3	27.0	28.0	27.4	28.9	24.2	16.7	22.2	15.2	22.4	14.1	27.0	20.5	19.8	26.8	25.3	6.1	5.0	11.1	6.9	4.7	6.8	2.4	19.5	29.1	17.9	15.2	28.0	25.1	18.3	22.2	23.0	22.8	19.9	23.0	33.1	10.6	19.8	28.9	18.6	35.7	27.4	23.5	9.1	18.0	12.6	36.4	13.6	21.7	11.7	15.5	19.3	30.4	30.1	23.3	27.3	17.9	20.2	35.4	21.9	13.9	9.6	23.4	25.6	13.4	26.5	16.7	21.3	17.6	11.6	9.1	31.5	17.7	21.0	10.7	9.1	30.9	21.6	21.2	28.4	13.9	11.0	16.7	13.5	20.7	25.8	14.2	11.1	4.5	7.6	4.3	6.9	4.6	6.1	4.8	3.8	5.0	5.7	3.6	5.9	4.3	4.7	3.5	4.2	6.8	2.4	26.1	24.8	25.5	38.5	24.3	26.3	28.1	31.6	24.0	22.4
FOXO4	"AFX1, MLLT7"	ENSG00000184481	"Forkhead box O4"	P98177	X	71096197-71103535	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 98.6"	"Cell line enriched"	"Detected in many"	5	"BEWO: 60.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039560, HPA040232"	Enhanced		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA039560: , HPA040232: "	"unprognostic (4.64e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.79e-2)"	"prognostic favourable (4.61e-4)"	"unprognostic (1.09e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.16e-2)"	"prognostic favourable (3.46e-4)"	"unprognostic (2.45e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.75e-3)"	8.5	13.2	21.7	3.8	21.5	9.9	5.1	9.1	15.6	4.8	8.4	9.1	11.9	6.3	6.8	10.2	7.3	7.7	5.8	9.7	21.4	14.5	5.2	3.6	5.5	3.6	22.8	8.4	13.4	6.8	8.7	3.0	98.6	9.2	7.0	4.7	4.9	8.5	11.3	33.8	5.5	6.6	9.4	17.3	6.0	5.2	13.9	13.1	4.4	5.9	7.5	4.2	7.5	11.0	0.9	0.2	3.4	0.6	1.0	1.8	0.9	1.7	0.5	1.4	1.8	3.3	2.3	60.0	1.4	1.6	0.7	1.7	1.2	2.4	2.3	1.8	1.8	0.8	3.6	1.6	0.8	2.3	5.5	3.4	11.2	1.9	1.9	1.9	2.7	1.9	3.8	0.6	0.4	1.8	6.9	4.6	0.3	0.3	3.0	3.1	6.5	2.1	2.1	3.5	3.6	1.2	1.0	1.0	2.9	2.9	0.4	3.1	0.7	1.2	1.7	0.4	0.9	3.1	0.3	3.0	1.6	0.4	1.6	5.2	0.5	0.2	0.6	3.2	0.9	0.6	0.3	0.8	0.5	0.9	0.2	0.9	0.4	1.8	3.4	1.0	0.3	0.0	1.3	0.9	21.7	21.5	9.1	15.6	21.4	14.5	22.8	8.4	9.2	13.1
CXorf65		ENSG00000204165	"Chromosome X open reading frame 65"	A6NEN9	X	71103889-71106788	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"testis: 47.7"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.2;HEL: 2.7;K-562: 2.6;MOLT-4: 2.4;NB-4: 4.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	23	"naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	23	"B-cells: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047396	Uncertain									"HPA047396: "	"unprognostic (7.81e-3)"	"unprognostic (8.43e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.20e-2)"	"unprognostic (2.62e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.84e-4)"	"unprognostic (9.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-8)"	"unprognostic (1.12e-1)"	"unprognostic (3.49e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.25e-3)"	0.1	0.0	0.1	0.6	0.1	1.6	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.3	1.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.9	0.1	0.1	2.0	0.0	47.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.7	0.0	0.0	2.4	4.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
IL2RG	"CD132, CIDX, IMD4, SCIDX1"	ENSG00000147168	"Interleukin 2 receptor subunit gamma"	P31785	X	71107404-71112108	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease mutation, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 115.3;lymphoid tissue: 169.3"	"Cell line enriched"	"Detected in some"	6	"Karpas-707: 220.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA046641, HPA049691"	Enhanced		Approved	Vesicles				Vesicles		"HPA046641: AB_2679733, HPA049691: "	"unprognostic (2.97e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.23e-1)"	"prognostic favourable (1.73e-4)"	"unprognostic (8.25e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (2.28e-7)"	"unprognostic (1.73e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.54e-2)"	5.8	1.3	1.4	39.5	1.4	12.8	3.6	0.8	0.9	2.9	16.6	0.9	0.9	8.2	3.0	2.1	5.3	3.1	5.3	2.6	1.4	1.5	3.7	4.7	13.6	70.4	1.8	0.6	2.9	1.5	0.0	1.2	5.3	1.5	3.2	20.8	2.9	10.4	1.8	1.6	2.7	28.6	1.5	2.9	58.7	6.0	2.0	0.9	169.3	3.3	4.2	61.4	7.6	3.1	51.9	30.6	65.6	19.7	94.6	115.3	99.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	17.2	1.2	0.0	0.1	0.0	0.0	0.0	14.4	0.0	2.2	0.0	0.0	0.0	8.9	0.4	0.0	0.0	0.0	0.0	0.0	3.8	220.5	0.0	0.0	31.9	17.4	0.0	0.0	7.3	0.0	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	12.6	22.2	11.1	0.2	37.0	0.0	35.2	8.5	13.4	107.2	19.7	105.6	51.9	97.7	110.4	20.3	51.6	68.0	84.9	65.6	94.6	13.5	30.6	115.3	99.0	1.4	1.4	0.8	0.9	1.4	1.5	1.8	0.6	1.5	0.9
MED12	"CAGH45, FGS1, HOPA, KIAA0192, OKS, OPA1, TNRC11, TRAP230"	ENSG00000184634	"Mediator complex subunit 12"	Q93074	X	71118556-71142454	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003184, HPA003185"	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"HPA003184: AB_1079349, HPA003185: AB_1079350"	"unprognostic (1.39e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.89e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-1)"	"unprognostic (5.16e-2)"	18.2	31.3	12.3	15.3	14.7	16.6	18.1	18.0	15.1	16.8	12.8	19.8	21.3	10.2	21.7	16.5	13.1	17.7	14.2	12.9	12.9	8.5	13.3	9.8	14.0	15.3	15.7	10.7	28.8	14.2	20.1	17.9	23.0	11.6	16.5	11.8	18.6	14.6	20.3	14.9	17.6	14.8	16.4	11.2	27.3	14.2	15.3	12.9	33.1	17.8	12.6	15.9	15.4	16.4	4.0	5.1	9.7	3.7	5.0	7.4	3.6	8.6	10.2	16.1	9.6	11.8	10.6	23.8	6.1	8.8	9.8	7.0	12.2	8.2	11.4	8.2	10.6	8.6	18.8	7.7	7.8	11.9	14.6	18.8	23.0	16.5	9.3	17.3	16.7	12.3	8.4	12.8	14.9	15.0	17.5	19.9	9.6	14.5	18.1	9.9	9.2	13.4	17.1	18.0	8.6	7.4	17.2	9.0	10.8	14.1	7.2	8.0	8.7	8.6	13.1	10.7	12.7	9.8	4.3	9.8	5.5	8.3	6.3	9.7	7.1	9.7	3.7	7.2	5.9	3.6	5.0	4.0	4.1	5.4	3.9	4.0	4.6	3.9	7.7	5.0	2.4	5.1	7.4	3.6	12.3	14.7	18.0	15.1	12.9	8.5	15.7	10.7	11.6	12.9
NLGN3	"ASPGX1, AUTSX1, HNL3, KIAA1480"	ENSG00000196338	"Neuroligin 3"	Q9NZ94	X	71144831-71171201	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Asperger syndrome, Autism, Autism spectrum disorder, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.9"	"Cell line enhanced"	"Detected in some"		"AF22: 10.9;NTERA-2: 7.9;SH-SY5Y: 4.3"	"Cancer enriched"	"Detected in many"	19	"glioma: 37.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 3.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003183, HPA004066"	Enhanced		Supported	"Golgi apparatus,Cell Junctions"	"Intracellular and membrane"			"Golgi apparatus, Cell Junctions"		"HPA003183: AB_1079469, HPA004066: "	"unprognostic (4.06e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.87e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.18e-2)"	"unprognostic (4.27e-9)"	"unprognostic (4.28e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.22e-5)"	"unprognostic (9.01e-2)"	1.4	8.9	16.3	1.6	19.4	2.2	1.3	11.5	45.9	3.2	1.6	30.0	0.1	1.1	4.2	8.1	1.5	6.0	2.4	2.1	15.7	9.7	1.2	0.9	1.3	1.2	12.7	13.1	6.1	1.2	1.4	1.1	1.5	15.2	7.9	1.4	1.6	1.6	16.0	0.8	1.6	1.6	2.9	12.9	1.4	1.5	3.8	12.3	0.0	1.0	0.0	1.1	1.5	1.3	0.2	0.1	3.3	0.3	0.3	0.5	0.0	0.1	0.8	10.9	0.3	2.6	1.1	1.9	0.3	0.1	0.0	0.2	0.1	0.5	0.8	0.8	0.1	0.2	0.4	0.0	0.2	0.7	1.3	0.5	0.5	0.1	0.0	0.2	0.9	0.6	0.1	0.3	0.0	0.1	0.7	2.1	0.1	0.6	0.7	1.7	7.9	0.0	0.9	0.4	0.5	0.0	1.2	2.7	4.3	0.3	0.0	0.9	0.0	0.5	0.3	0.2	1.3	0.4	0.0	1.7	1.5	0.6	0.3	0.4	0.6	0.3	0.3	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.5	0.1	3.3	0.3	0.0	0.1	0.1	0.0	16.3	19.4	11.5	23.1	15.7	9.7	12.7	13.1	15.2	12.3
GJB1	"CMTX, CMTX1, CX32"	ENSG00000169562	"Gap junction protein beta 1"	P08034	X	71215194-71225516	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.4;liver: 114.4;pancreas: 37.1"	"Group enriched"	"Detected in some"	6	"Hep G2: 45.7;SK-MEL-30: 50.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 163.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012994	Uncertain									"CAB012994: AB_2533228"	"unprognostic (2.09e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.80e-1)"	"prognostic favourable (2.85e-6)"	"unprognostic (1.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.97e-2)"	0.4	0.4	7.2	2.5	9.3	0.3	2.6	1.9	14.4	3.3	12.0	46.3	2.5	14.6	0.9	8.1	0.5	9.5	19.8	0.4	13.4	8.0	14.8	114.4	1.2	0.4	22.4	5.6	0.4	37.1	0.3	0.4	0.4	23.0	4.3	8.3	0.5	19.6	8.7	0.4	0.6	11.7	1.0	52.4	0.4	5.7	3.1	12.1	0.0	0.4	0.0	0.4	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	50.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	9.3	1.9	14.4	13.4	8.0	22.4	5.6	23.0	12.1
ZMYM3	"DXS6673E, KIAA0385, MYM, ZNF198L2, ZNF261"	ENSG00000147130	"Zinc finger MYM-type containing 3"	Q14202	X	71239624-71255146	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003211, HPA075255"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA003211: AB_1080661, HPA075255: "	"unprognostic (2.17e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavourable (5.18e-4)"	"unprognostic (5.03e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.30e-3)"	7.3	23.7	22.5	7.9	20.6	6.2	7.9	16.6	22.7	10.8	10.4	13.6	10.3	7.0	14.0	19.2	8.0	19.8	11.3	9.3	19.5	14.6	10.6	9.6	10.8	10.9	16.8	20.6	36.8	8.2	15.3	14.4	7.8	14.0	14.3	8.0	10.5	11.2	18.0	9.5	11.1	8.8	14.8	14.1	12.1	9.0	15.9	17.3	13.9	12.6	6.4	10.4	11.9	10.0	9.4	13.5	6.8	7.3	6.0	6.8	5.0	7.2	13.3	32.3	17.1	9.4	9.5	8.2	6.7	10.0	14.6	13.7	14.7	11.0	18.3	16.8	12.0	6.8	27.6	10.1	11.0	6.1	14.8	15.9	11.8	13.0	4.4	14.8	9.9	11.2	5.9	10.6	6.6	12.2	18.3	10.1	10.6	11.9	17.8	19.0	32.1	11.7	22.3	9.9	13.5	10.8	8.8	15.5	10.6	11.4	7.2	6.6	10.5	9.7	9.3	7.2	13.4	10.5	6.0	9.3	5.5	15.6	8.7	20.3	7.9	6.8	7.3	5.6	6.1	6.3	6.8	9.4	6.8	5.6	6.4	9.0	6.0	5.9	0.5	6.0	5.1	13.5	6.3	5.0	22.5	20.6	16.6	22.7	19.5	14.6	16.8	20.6	14.0	17.3
NONO	"NMT55, NRB54, P54, P54NRB, PPP1R114"	ENSG00000147140	"Non-POU domain containing octamer binding"	Q15233	X	71283192-71301168	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022069, HPA054094, HPA054559"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Nuclear speckles"			150000	Nucleoplasm	"Nucleoli fibrillar center, Nuclear speckles"	"CAB022069: , HPA054094: AB_2682376, HPA054559: AB_2682522"	"unprognostic (2.39e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavourable (9.29e-4)"	"unprognostic (8.87e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.02e-3)"	"unprognostic (9.34e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.29e-3)"	"unprognostic (6.79e-2)"	"unprognostic (5.73e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.04e-2)"	37.2	55.9	30.2	37.7	30.8	51.2	37.2	54.8	38.6	45.4	33.4	36.0	38.4	29.9	52.4	40.5	41.0	40.5	37.2	30.5	27.5	29.0	40.1	43.3	37.3	45.7	28.8	31.7	69.2	61.0	39.4	48.2	42.4	27.5	40.8	37.5	42.5	39.8	41.4	37.2	38.4	35.2	40.5	38.3	45.9	40.3	34.4	29.0	98.4	51.0	39.1	57.4	43.6	36.8	44.1	47.3	35.3	51.8	45.4	51.8	58.9	58.5	64.8	89.7	49.2	36.6	37.8	49.1	48.0	44.7	65.0	57.4	51.4	43.5	66.6	53.5	44.2	43.8	133.8	41.7	71.6	50.7	89.4	54.6	68.0	51.1	31.0	76.6	48.0	40.0	29.8	65.7	44.1	53.3	69.6	69.9	59.9	52.0	99.0	69.8	111.6	52.6	89.1	94.0	57.1	49.8	51.8	62.3	77.3	62.2	40.6	55.1	38.2	49.6	48.9	42.1	63.2	58.8	55.5	40.3	76.3	75.8	31.4	89.1	60.1	35.3	44.8	34.9	45.8	47.6	51.8	43.7	46.6	44.9	47.3	44.1	50.8	50.2	20.8	45.4	51.8	41.2	50.1	58.9	30.2	30.8	54.8	38.6	27.5	29.0	28.8	31.7	27.5	29.0
ITGB1BP2	CHORDC3	ENSG00000147166	"Integrin subunit beta 1 binding protein 2"	Q9UKP3	X	71301734-71305371	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 43.0;skeletal muscle: 21.3;smooth muscle: 18.6;tongue: 19.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 13.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA040721			Approved	Cytosol				Cytosol		"HPA040721: AB_10805827"	"unprognostic (1.87e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.91e-5)"	"unprognostic (1.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.02e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.08e-11)"	"unprognostic (4.38e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.64e-1)"	0.7	0.3	0.2	1.0	0.3	0.6	0.3	0.6	0.2	2.7	2.8	0.0	2.3	0.4	12.8	3.4	4.0	1.8	4.8	43.0	0.2	0.2	0.4	0.6	0.5	0.5	0.3	0.0	2.4	0.3	0.0	0.3	0.2	0.2	3.2	0.9	3.5	0.7	5.8	21.3	0.3	1.0	18.6	0.3	0.6	1.1	1.6	0.1	0.0	0.4	19.6	0.7	5.6	0.8	0.2	0.2	1.5	0.2	0.0	0.5	0.0	0.7	2.1	3.1	2.8	0.1	0.1	0.7	1.0	1.4	0.7	0.8	1.6	1.6	3.1	0.3	1.6	1.5	2.8	0.8	1.7	1.0	1.3	1.9	1.9	0.6	0.4	0.6	13.7	1.7	1.2	0.5	0.4	1.2	1.4	0.8	1.6	0.9	1.2	3.4	4.6	1.3	2.0	2.5	1.1	1.5	2.0	1.5	0.5	0.7	0.1	0.8	0.9	0.4	0.0	1.4	2.7	0.3	0.5	2.9	3.7	4.7	0.4	2.4	0.6	0.0	0.2	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.2	0.2	0.2	0.3	0.0	0.2	0.1
TAF1	"BA2R, CCG1, CCGS, DYT3, DYT3/TAF1, KAT4, NSCL2, TAF2A, TAFII250"	ENSG00000147133	"TATA-box binding protein associated factor 1"	P21675	X	71366239-71532374	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Dystonia, Mental retardation, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA001075, CAB016283"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB016283: AB_671202, HPA001075: AB_1080179"	"unprognostic (2.95e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"prognostic favourable (6.54e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.59e-2)"	"prognostic unfavourable (6.03e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.56e-2)"	20.1	16.2	15.0	17.1	19.8	16.3	17.7	20.7	18.0	20.7	15.5	23.8	17.1	10.0	25.4	17.1	14.4	19.1	16.1	12.9	15.4	12.0	11.9	12.9	13.8	17.8	18.5	16.5	23.9	17.5	25.5	19.3	15.4	17.3	16.9	15.4	20.8	14.5	16.1	19.6	16.8	17.1	18.3	17.2	21.3	15.8	12.2	21.3	19.4	20.1	12.0	18.7	18.4	15.8	5.0	4.7	5.2	4.8	4.2	4.9	1.8	11.2	9.8	11.2	7.5	9.0	15.6	7.0	8.4	7.8	8.9	7.4	7.3	6.8	10.5	7.2	9.4	10.7	15.6	6.7	11.4	6.9	13.7	12.5	12.9	7.2	6.5	23.7	12.1	9.1	6.8	9.5	18.0	9.2	17.0	25.5	9.0	7.9	13.1	10.5	12.9	12.9	12.1	22.8	12.8	6.0	14.6	5.9	9.2	23.4	8.2	10.4	6.0	12.6	11.6	10.5	8.8	8.4	5.8	10.9	10.1	13.6	5.8	19.1	7.8	4.4	4.1	1.1	4.4	2.8	3.8	3.0	4.6	4.5	4.7	5.0	4.4	4.9	5.2	4.2	4.8	3.5	3.1	1.8	15.0	19.8	20.7	18.0	15.4	12.0	18.5	16.5	17.3	21.3
OGT	"FLJ23071, HRNT1, MGC22921, O-GLCNAC, OGT1"	ENSG00000147162	"O-linked N-acetylglucosamine (GlcNAc) transferase"	O15294	X	71533083-71575897	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	"Chromatin regulator, Glycosyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030751, HPA030752, HPA030753, HPA030754, CAB034099"	Approved		Supported	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"CAB034099: AB_2157067, HPA030751: AB_10600217, HPA030752: AB_10601445, HPA030753: AB_2673594, HPA030754: "	"unprognostic (1.37e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.32e-2)"	"prognostic unfavourable (8.33e-4)"	"unprognostic (3.40e-2)"	"prognostic favourable (1.97e-4)"	"unprognostic (9.56e-3)"	"unprognostic (1.96e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.74e-3)"	"prognostic unfavourable (2.36e-6)"	"unprognostic (2.99e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.03e-3)"	"prognostic favourable (6.85e-7)"	26.1	24.0	33.3	39.7	36.6	38.7	33.7	75.7	43.8	25.0	23.0	22.0	31.1	22.5	36.7	48.3	24.3	33.4	21.2	25.1	29.3	15.4	27.4	20.3	31.0	47.9	30.2	25.6	42.8	46.1	26.5	34.5	19.5	26.6	34.2	30.3	29.9	35.9	30.9	35.0	45.4	38.4	31.1	32.3	56.7	28.2	11.8	36.6	35.7	34.1	27.6	41.4	24.9	31.0	9.7	7.6	3.2	7.2	12.5	9.9	6.0	14.3	13.5	17.5	15.3	18.9	17.4	11.8	11.0	19.9	12.0	18.5	14.2	16.5	17.1	7.8	13.5	17.9	19.1	10.8	14.8	14.6	19.6	10.8	32.1	10.1	14.3	22.2	17.9	16.6	22.0	13.1	24.8	11.1	10.9	59.5	11.4	12.2	17.1	26.7	11.6	18.4	17.0	19.6	21.9	18.5	16.7	9.0	7.9	17.1	11.4	10.6	8.4	15.1	12.9	13.0	10.6	13.5	6.4	16.3	11.7	20.6	9.1	23.4	7.9	3.2	5.3	2.3	9.9	7.2	9.0	9.7	8.3	8.0	7.5	8.5	9.7	9.5	2.4	12.5	6.5	7.6	7.6	6.0	33.3	36.6	75.7	43.8	29.3	15.4	30.2	25.6	26.6	36.6
GCNA	"ACRC, NAAR1"	ENSG00000147174	"Germ cell nuclear acidic peptidase"	Q96QF7	X	71578411-71613583	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 29.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA023476	Enhanced		Approved	Vesicles				Vesicles		"HPA023476: AB_1844530"	"unprognostic (6.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.35e-4)"	"unprognostic (5.84e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.07e-10)"	"unprognostic (2.30e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.74e-1)"	"unprognostic (1.15e-5)"	1.4	6.9	1.2	1.7	1.7	1.6	1.2	3.7	1.7	1.2	1.2	1.2	1.2	1.0	1.2	1.4	1.2	0.9	1.2	1.2	1.3	2.5	1.2	1.8	1.4	2.6	1.2	1.2	1.5	1.7	0.4	1.2	1.2	1.7	1.2	1.0	1.2	1.2	1.2	3.1	1.7	1.5	1.2	1.2	3.9	0.9	29.4	1.2	1.2	1.6	1.2	1.4	1.2	1.2	1.4	0.6	1.1	0.6	1.4	3.3	0.5	0.6	1.1	2.2	2.0	4.5	4.1	1.3	3.6	1.9	1.2	2.1	2.0	1.3	5.5	2.7	1.9	2.6	4.3	0.2	1.8	0.9	2.9	1.1	4.9	0.5	1.2	1.0	5.1	1.6	6.9	1.0	0.9	0.8	1.5	3.4	2.5	0.7	0.4	3.9	2.2	2.5	1.0	0.1	4.0	2.8	1.5	1.3	0.2	1.2	0.6	3.0	0.4	3.4	1.4	1.3	2.6	1.8	1.0	1.0	2.5	2.2	2.5	2.1	2.2	0.6	0.6	0.1	0.7	0.3	1.3	1.4	1.7	3.3	0.3	0.5	1.0	1.1	1.1	1.4	0.1	0.6	3.0	0.5	1.2	1.7	3.7	1.7	1.3	2.5	1.2	1.2	1.7	1.2
CXCR3	"CD183, CKR-L2, CMKAR3, GPR9, IP10-R, MigR"	ENSG00000186810	"C-X-C motif chemokine receptor 3"	P49682	X	71615916-71618517	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Angiogenesis, Apoptosis, Chemotaxis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 61.7;lymphoid tissue: 24.5"	"Cell line enriched"	"Detected in some"	15	"RPMI-8226: 31.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 61.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 61.7;NK-cells: 38.1;T-cells: 26.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA045942	Enhanced									"HPA045942: "	"unprognostic (4.84e-3)"	"unprognostic (3.05e-3)"	"unprognostic (1.61e-1)"	"prognostic favourable (3.44e-6)"	"unprognostic (3.93e-2)"	"prognostic favourable (3.35e-4)"	"unprognostic (1.01e-2)"	"unprognostic (5.24e-2)"	"prognostic favourable (2.90e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavourable (1.67e-6)"	"unprognostic (4.67e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.76e-2)"	0.9	0.9	0.4	9.0	0.4	6.0	0.6	0.3	0.3	1.9	2.4	0.4	0.5	5.4	3.3	1.4	1.3	1.1	2.6	2.4	0.3	0.4	1.9	0.8	4.5	19.0	0.4	0.1	1.6	0.8	0.0	0.6	0.7	0.5	2.9	0.8	1.5	3.9	1.0	0.4	0.5	9.1	0.3	0.7	13.9	2.6	0.6	0.0	14.0	1.9	1.7	24.5	1.7	1.8	9.8	61.7	0.4	0.0	38.1	26.6	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	17.3	0.0	8.9	9.8	19.6	26.6	1.6	1.8	1.2	11.1	0.4	38.1	0.0	61.7	17.8	6.3	0.4	0.4	0.3	0.3	0.3	0.4	0.4	0.1	0.5	0.0
BX276092.9		ENSG00000283599			X	71667542-71671524	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	23	"testis: 10.7"	"Cell line enhanced"	"Detected in some"		"SK-BR-3: 4.6;U-87 MG: 2.7"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.0	0.0		0.4	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	10.7			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CXorf49		ENSG00000215115	"Chromosome X open reading frame 49"	A8MYA2	X	71714371-71718151	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	58	"testis: 5.8"	"Cell line enriched"	"Detected in some"	6	"A-431: 13.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	5.8			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CXorf49B		ENSG00000215113	"Chromosome X open reading frame 49B"	A8MYA2	X	71763424-71767204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	58	"testis: 5.8"	"Cell line enriched"	"Detected in some"	6	"A-431: 13.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	5.8			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NHSL2		ENSG00000204131	"NHS like 2"	Q5HYW2	X	71910818-72161750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.1"	"Group enriched"	"Detected in some"	4	"AF22: 16.5;EFO-21: 19.5;HUVEC TERT2: 18.0;TIME: 10.4;U-937: 13.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.5;granulocytes: 13.5;monocytes: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049771	Uncertain		Approved	"Plasma membrane,Cell Junctions"				"Cell Junctions"	"Plasma membrane"	"HPA049771: "	"unprognostic (9.71e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.72e-4)"	"unprognostic (5.46e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.27e-3)"	"unprognostic (9.99e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.37e-4)"	7.8	2.3	11.0	4.8	22.5	3.4	5.2	27.1	9.4	6.6	5.5	1.5	0.9	1.3	8.7	2.7	5.5	3.8	7.4	3.6	4.9	3.2	2.0	1.6	5.5	1.3	2.2	4.9	3.1	1.6	3.1	6.1	3.7	4.3	6.4	3.3	6.2	2.6	8.7	2.8	2.3	2.6	11.7	2.4	4.5	3.4	9.6	2.7	0.3	5.3	4.6	1.6	6.3	4.4	0.0	3.5	13.5	5.7	0.9	1.8	1.7	0.2	0.4	16.5	0.0	0.2	0.7	0.1	0.5	3.0	0.1	0.2	0.1	0.0	0.1	19.5	1.6	0.0	1.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.9	0.3	0.0	0.6	0.0	18.0	0.0	2.7	0.1	0.1	0.1	1.3	3.1	0.0	0.0	0.9	0.0	0.1	1.8	0.4	3.8	0.0	0.0	0.0	0.0	1.1	10.4	0.0	1.0	1.3	0.0	0.0	0.0	0.1	0.7	13.1	0.0	4.1	5.7	11.8	1.8	3.9	1.7	0.0	1.0	1.6	3.5	0.0	0.1	0.2	13.5	0.9	3.0	0.0	0.1	1.7	11.0	22.5	27.1	9.4	4.9	3.2	2.2	4.9	4.3	2.7
RTL5	"KIAA2001, Mar5, Mart5, RGAG4, SIRH8"	ENSG00000242732	"Retrotransposon Gag like 5"	Q5HYW3	X	72127110-72131901	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 5.5;AN3-CA: 6.1;SCLC-21H: 7.5;SH-SY5Y: 10.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003652	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA003652: AB_1079805"	"unprognostic (7.97e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.29e-3)"	"unprognostic (2.98e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.64e-1)"	"unprognostic (4.20e-1)"	"prognostic favourable (7.30e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.82e-1)"	"prognostic favourable (3.41e-4)"	"unprognostic (4.23e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.19e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.79e-2)"	5.4	7.2	7.0	2.7	12.5	1.9	7.7	22.7	14.2	4.9	4.5	3.5	6.2	2.8	9.6	10.1	2.6	4.9	6.0	4.0	10.3	8.9	4.4	4.2	5.5	2.4	5.2	11.2	10.5	1.1	7.4	16.3	5.2	6.3	5.7	3.0	3.0	3.7	6.9	2.3	2.1	3.2	6.7	9.5	2.7	5.4	12.4	4.8	0.0	11.7	0.8	2.0	5.5	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	5.5	6.1	1.4	1.7	0.3	2.0	0.7	0.3	0.8	0.3	0.0	0.0	0.9	0.4	0.0	1.1	0.1	1.1	0.0	0.8	0.2	0.1	0.0	0.1	0.0	0.7	3.3	0.1	0.9	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.6	2.7	0.0	0.0	0.0	0.0	0.1	0.0	7.5	10.4	0.4	0.0	0.0	0.2	0.0	0.6	0.7	0.7	1.4	0.0	0.1	0.0	0.0	1.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.0	12.5	22.7	14.2	10.3	8.9	5.2	11.2	6.3	4.8
PIN4	"EPVH, PAR14, PAR17"	ENSG00000102309	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 4"	Q9Y237	X	72181353-72302926	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 68.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054483, HPA064504"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA054483: , HPA064504: AB_2685274"	"unprognostic (2.47e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.77e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.14e-2)"	"prognostic favourable (6.37e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.92e-1)"	"prognostic favourable (2.58e-4)"	"unprognostic (3.34e-3)"	"prognostic favourable (2.66e-4)"	14.4	11.3	15.0	8.0	14.7	6.1	18.8	10.7	16.2	9.7	9.7	8.4	6.7	9.5	11.6	19.3	8.9	8.7	30.7	11.2	15.2	12.2	15.6	23.2	7.9	7.9	12.9	11.0	12.7	8.1	8.0	9.2	9.8	10.0	10.4	11.1	6.6	30.7	37.1	68.7	7.3	9.6	9.2	12.4	16.7	9.3	4.7	6.9	9.7	12.9	40.1	9.1	7.8	9.2	28.9	26.8	23.4	23.6	22.4	33.4	22.7	15.1	17.8	18.6	12.7	12.8	10.7	9.9	10.4	11.9	12.8	13.1	9.0	11.3	4.6	30.4	10.7	10.8	16.5	18.3	15.8	11.5	37.1	7.8	21.2	23.4	7.1	12.3	6.6	7.2	10.1	13.9	4.8	12.9	13.1	20.2	9.5	18.3	10.7	20.7	13.3	16.1	10.7	14.8	13.4	16.2	10.6	11.9	21.3	12.2	5.7	10.7	8.8	11.2	13.0	5.8	8.9	15.9	7.5	6.9	7.5	7.6	16.7	12.3	6.3	21.9	23.3	23.4	26.8	23.6	26.4	28.9	28.3	25.5	22.8	26.4	29.3	29.4	9.7	22.4	21.8	26.8	33.4	22.7	15.0	14.7	10.7	16.2	15.2	12.2	12.9	11.0	10.0	6.9
ERCC6L	"FLJ20105, PICH, RAD26L"	ENSG00000186871	"ERCC excision repair 6 like, spindle assembly checkpoint helicase"	Q2NKX8	X	72204657-72239047	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.1"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"NK-cell: 5.3"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050492	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				Centrosome	"Nucleoplasm, Cytosol"	"HPA050492: "	"prognostic unfavourable (1.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.76e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.23e-6)"	"unprognostic (8.63e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.68e-5)"	"unprognostic (4.61e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.97e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.41e-2)"	0.4	0.5	0.2	3.1	0.2	6.0	3.0	0.9	0.8	1.5	2.2	0.2	0.2	1.5	0.9	0.8	4.6	0.6	1.0	0.2	0.2	0.3	0.5	0.5	0.8	4.7	0.7	0.2	1.2	0.5	0.0	0.6	0.9	0.9	0.7	2.5	0.2	1.1	0.2	2.6	1.3	2.1	0.5	1.3	4.0	1.5	2.0	0.2	13.1	0.5	2.8	5.6	0.7	1.6	0.5	0.3	0.5	0.2	5.3	1.1	0.4	10.9	9.6	8.9	5.6	0.6	1.1	4.9	11.8	5.4	10.4	10.9	7.8	6.9	17.8	4.5	4.2	9.1	16.6	8.8	18.5	10.1	12.1	6.1	3.3	4.6	0.0	11.9	8.6	0.1	0.5	14.4	2.7	5.7	8.0	4.4	10.5	8.6	11.3	7.0	16.1	14.9	9.5	15.9	3.1	2.6	6.8	7.3	5.2	8.7	5.9	2.2	4.5	2.6	3.5	7.0	11.3	13.2	7.7	3.4	5.3	15.3	4.9	8.3	7.0	0.0	0.2	0.5	0.1	0.1	0.6	0.2	0.5	0.1	0.1	0.5	0.4	1.1	0.3	5.3	0.2	0.3	1.1	0.4	0.2	0.2	0.9	0.8	0.2	0.3	0.7	0.2	0.9	0.2
RPS4X	"CCG2, DXS306, FLJ40595, RPS4, S4, SCAR, SCR10"	ENSG00000198034	"Ribosomal protein S4, X-linked"	P62701	X	72255679-72277300	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA000857	Supported						160000			"HPA000857: AB_1079849"	"unprognostic (1.09e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.53e-3)"	"unprognostic (7.05e-3)"	"unprognostic (1.32e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.96e-2)"	"unprognostic (9.65e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavourable (4.50e-6)"	"unprognostic (1.03e-2)"	"unprognostic (9.78e-3)"	"prognostic favourable (4.22e-4)"	"unprognostic (6.87e-2)"	50.3	35.5	34.9	39.4	42.8	72.1	96.8	23.8	38.5	74.6	51.6	25.0	45.1	40.1	66.9	103.2	77.8	81.0	30.5	35.1	33.3	26.3	86.6	92.2	35.3	64.1	29.6	35.0	141.5	109.1	25.7	165.3	54.5	34.5	45.1	45.7	32.1	64.8	42.4	71.5	83.0	60.2	49.0	33.7	47.8	47.6	23.9	25.9	57.8	52.9	122.6	67.9	56.5	73.7	125.7	88.3	15.8	52.0	74.7	149.4	194.2	55.2	50.7	68.6	50.1	96.7	155.3	50.1	38.4	102.4	89.7	71.6	83.2	39.3	176.6	94.3	36.0	32.1	66.6	82.2	94.3	36.3	154.9	30.5	65.4	60.8	124.5	74.0	76.6	163.6	96.4	38.3	123.1	75.4	49.7	109.8	86.9	80.7	87.9	120.3	68.2	59.7	53.7	96.2	140.1	57.0	74.4	64.2	77.9	63.2	144.0	115.7	28.8	116.1	40.1	21.0	59.1	43.3	36.7	41.8	39.2	55.6	36.6	138.2	43.2	15.8	52.0	9.6	73.0	45.5	114.9	125.7	120.1	94.3	77.2	107.2	149.4	120.1	4.9	74.7	41.7	88.3	93.4	194.2	34.9	42.8	23.8	38.5	33.3	26.3	29.6	35.0	34.5	25.9
CITED1	MSG1	ENSG00000125931	"Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1"	Q99966	X	72301638-72307187	"Predicted intracellular proteins"	"Apoptosis, Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 247.1;pituitary gland: 62.8;testis: 89.9"	"Group enriched"	"Detected in some"	5	"AN3-CA: 17.5;SK-MEL-30: 69.6"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 134.9"	"Region enriched"	"Detected in many"	5	"hypothalamus: 18.9"	"Cell type enhanced"	"Detected in some"		"eosinophil: 2.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049051	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA049051: "	"unprognostic (7.04e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-3)"	"unprognostic (8.81e-2)"	"unprognostic (5.67e-4)"	"unprognostic (3.40e-1)"	"unprognostic (9.55e-2)"	"unprognostic (4.60e-3)"	"unprognostic (4.38e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.62e-1)"	"prognostic favourable (6.10e-4)"	"prognostic favourable (3.95e-4)"	"unprognostic (2.99e-2)"	0.5	0.6	3.5	0.5	2.2	0.4	6.0	0.9	2.8	1.3	0.5	0.3	5.3	0.5	1.0	247.1	0.4	0.5	0.4	0.4	2.4	18.9	0.6	0.4	0.5	0.4	1.1	0.9	0.5	0.6	0.4	62.8	0.4	2.7	2.1	0.4	27.8	0.4	1.2	0.4	0.4	0.5	1.7	0.5	0.4	0.4	89.9	0.0	0.0	1.7	0.0	0.4	0.4	0.0	0.0	0.8	2.2	0.5	0.0	1.1	1.1	0.1	0.1	0.7	17.5	0.8	0.0	0.6	0.0	0.2	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	6.3	0.4	0.0	1.8	2.5	0.3	0.1	0.0	0.0	0.1	3.4	0.3	0.2	0.2	0.3	0.0	0.7	0.1	0.1	0.2	0.0	1.3	1.0	1.2	0.0	1.2	0.9	0.0	0.2	7.9	4.1	0.1	1.5	69.6	0.5	0.4	0.0	0.1	0.7	0.1	0.2	0.1	0.1	0.1	0.1	0.2	1.6	0.0	0.5	2.2	0.4	0.0	1.1	0.0	0.2	0.6	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	3.5	2.2	0.9	2.8	2.4	18.9	1.1	0.9	2.7	0.0
HDAC8	"HDACL1, MRXS6, RPD3, WTS"	ENSG00000147099	"Histone deacetylase 8"	Q9BY41	X	72329516-72573103	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Disease mutation, FDA approved drug targets, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048560	Supported		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA048560: "	"unprognostic (1.42e-1)"	"unprognostic (6.62e-3)"	"unprognostic (3.20e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.64e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.17e-2)"	"unprognostic (9.68e-2)"	"unprognostic (8.42e-2)"	"unprognostic (2.33e-3)"	"unprognostic (9.10e-2)"	"unprognostic (7.15e-3)"	"unprognostic (2.12e-3)"	9.6	22.5	14.7	9.9	16.2	10.2	12.4	31.4	20.6	12.6	10.4	13.9	11.5	8.6	12.3	28.2	11.0	9.4	9.4	12.6	15.0	15.2	16.8	18.6	10.2	9.6	14.9	9.4	12.8	15.9	13.6	22.0	11.2	19.3	13.3	12.8	14.3	12.2	10.3	10.4	9.3	8.4	13.1	12.2	9.5	10.7	3.6	14.0	8.0	15.0	8.2	11.9	10.4	10.1	9.4	12.8	19.7	13.2	7.7	11.4	7.7	12.3	16.9	12.4	17.2	17.0	12.7	8.6	7.1	13.9	11.0	12.5	12.2	12.7	8.6	22.7	9.8	9.0	23.1	13.9	14.7	14.1	16.4	11.3	21.7	14.2	9.3	18.8	20.1	13.3	10.3	13.5	10.1	16.9	12.6	24.1	14.7	15.5	8.8	24.7	17.2	24.4	12.1	16.0	15.4	19.2	13.0	8.9	19.4	16.9	13.5	17.3	6.8	16.1	12.7	9.1	13.1	13.0	8.0	9.2	14.7	10.9	12.3	20.8	11.7	7.2	13.2	19.7	8.8	11.8	6.9	9.4	9.5	7.3	12.8	9.1	7.6	7.1	0.7	7.7	10.5	4.8	11.4	7.7	14.7	16.2	31.4	20.6	15.0	15.2	14.9	9.4	19.3	14.0
PHKA1	PHKA	ENSG00000067177	"Phosphorylase kinase regulatory subunit alpha 1"	P46020	X	72578814-72714319	"Disease related genes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Calmodulin-binding, Muscle protein"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 57.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 22.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001081	Enhanced		Approved	Vesicles				Vesicles		"HPA001081: AB_1079607"	"unprognostic (3.68e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (6.84e-4)"	"unprognostic (3.52e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.76e-1)"	"unprognostic (9.45e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.12e-1)"	2.7	10.3	3.8	1.9	7.2	0.7	3.4	3.2	3.5	2.2	2.1	2.0	7.8	1.0	2.7	4.7	4.8	2.8	2.6	5.5	3.0	3.0	2.1	1.8	1.6	1.0	4.2	1.6	5.8	4.2	16.9	14.2	1.8	4.7	4.3	2.5	6.5	6.8	5.1	57.4	2.5	1.3	3.4	3.1	2.3	3.7	3.5	2.7	0.8	6.5	12.6	2.8	3.1	3.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	8.6	12.1	0.7	7.2	4.3	4.1	7.6	1.6	1.5	0.3	0.1	3.5	7.7	0.0	4.8	0.2	3.4	14.4	5.9	0.4	22.0	14.6	4.0	9.9	3.2	4.5	0.0	0.0	5.5	6.0	1.4	9.9	8.4	6.1	0.0	7.9	6.2	6.1	0.4	9.6	16.3	0.0	0.0	0.0	2.1	4.1	7.6	9.0	7.7	10.1	0.1	3.6	0.3	4.3	0.0	3.7	1.5	4.1	10.1	9.3	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	7.2	3.2	2.9	3.0	3.0	4.2	1.6	4.7	2.7
DMRTC1B		ENSG00000184911	"DMRT like family C1B"	Q5HYR2	X	72777009-72848802	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 15.1;ovary: 12.1;pituitary gland: 12.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.1;SK-BR-3: 1.1;U-138 MG: 1.0;U-266/70: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 2.8"	"Group enriched"	"Detected in many"	12	"B-cells: 2.1;T-cells: 2.8"									"HPA046874, HPA046992"	Uncertain									"HPA046874: , HPA046992: "					"unprognostic (2.00e-1)"						"unprognostic (1.91e-2)"	"unprognostic (1.54e-1)"				"unprognostic (6.52e-2)"		0.3	4.6	11.0	1.7	15.1	0.1	0.7	4.5	14.3	1.7	0.6	2.2	1.4	0.5	2.2	9.6	0.3	3.3	0.6	0.2	8.6	14.2	1.6	0.2	1.1	1.4	4.9	9.1	12.1	5.2	1.5	12.1	0.2	2.2	3.8	0.8	2.4	1.0	1.9	0.2	0.5	0.5	0.6	2.2	1.3	1.2	7.1	2.9	0.7	3.9	0.2	2.1	0.3	0.2	2.1	0.0	0.0	0.0	0.2	2.8	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.8	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.4	0.0	2.1	2.1	2.8	0.0	0.2	0.0	0.0	0.0	0.2	11.0	15.1	4.5	11.4	8.6	14.2	4.9	9.1	2.2	2.9
FAM236B		ENSG00000268994	"Family with sequence similarity 236 member B"	A0A1B0GV22	X	72781865-72782660	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	52	"testis: 36.2"	"Group enriched"	"Detected in some"	24	"Daudi: 2.4;HDLM-2: 2.9;MOLT-4: 1.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.0	0.0		0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.2			0.5	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	36.2			0.7		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FAM236D		ENSG00000225396	"Family with sequence similarity 236 member D"	A0A1B0GTK5	X	72807425-72808210	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	15	"blood: 2.3;testis: 6.5"	"Group enriched"	"Detected in some"	15	"HaCaT: 1.3;U-2197: 1.5"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	11	"eosinophil: 2.3"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 2.3"																																					0.0	0.0		0.0		0.0	0.1		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.1	0.0	0.0		0.0		0.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	6.5			0.0		0.0	0.0		0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DMRTC1		ENSG00000269502	"DMRT like family C1"	Q5HYR2	X	72872025-72943814	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 4.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.7;Daudi: 3.7;NTERA-2: 1.2;U-266/70: 1.2;U-266/84: 1.4;U-698: 2.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.2"	"Group enriched"	"Detected in many"	17	"B-cells: 2.2;T-cells: 1.2"									"HPA046874, HPA046992"	Uncertain									"HPA046874: , HPA046992: "					"unprognostic (1.83e-1)"													0.0	1.3		0.0		0.0	0.0		4.0	0.6	0.1			0.0	1.1	0.0	0.1	2.1	0.2	0.0			0.0	0.0	0.0	0.6			1.3	0.0	0.0		0.0		0.0	0.3		0.0	0.2	0.0	0.0	0.1	0.6		0.7	0.0	1.1			2.0		0.8	0.0		2.2	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	1.4	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.5	0.0	2.2	0.7	1.2	0.0	0.0	0.0	0.0	0.4	0.1										
FAM236C		ENSG00000283594	"Family with sequence similarity 236 member C"	P0DP71	X	72912615-72913401	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	56	"blood: 2.3;testis: 8.8"	"Not detected"	"Not detected"											"Cell type enriched"	"Detected in single"	23	"eosinophil: 2.3"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.3"																																					0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	8.8			0.0		0.0	0.0		0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FAM236A	"DMRTC1-AS1, LINC00684"	ENSG00000275520	"Family with sequence similarity 235 member A"	A0A1B0GUQ0	X	72938163-72938958	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	38	"testis: 29.1"	"Cell line enhanced"	"Detected in some"		"AF22: 2.4;AN3-CA: 1.4;CAPAN-2: 3.5;U-266/70: 2.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.3		0.0	0.0		0.0	0.0	0.0			0.0	0.2	0.0	0.0	0.0	0.1	0.0			0.0	0.0	0.0	0.7			0.0	0.6	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	29.1			0.4		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0										
PABPC1L2B	RBM32B	ENSG00000184388	"Poly(A) binding protein cytoplasmic 1 like 2B"	Q5JQF8	X	73003517-73005713	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 12.2;prostate: 6.6"	"Group enriched"	"Detected in some"	30	"HAP1: 2.7;NTERA-2: 5.6;U-2 OS: 1.8"	"Cancer enriched"	"Detected in single"	23	"prostate cancer: 2.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA041573	Approved									"HPA041573: "					"unprognostic (1.73e-1)"							"unprognostic (2.26e-1)"			"unprognostic (3.31e-1)"			0.1	1.6	3.3	0.1	4.9	0.1	0.1	6.4	12.2	0.1	0.1			0.4	0.1	0.5	0.1	0.1	0.1	0.1	3.5	10.2	0.1	0.1	0.1	0.1	3.3		0.1	0.1	0.1	1.0	0.1		6.6	0.1		0.8	0.5	0.1	0.1	0.1	0.1	2.1	0.2	0.1	1.5			0.1		0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PABPC1L2A	RBM32A	ENSG00000186288	"Poly(A) binding protein cytoplasmic 1 like 2A"	Q5JQF8	X	73077276-73079512	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.6;prostate: 5.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 8.9;NTERA-2: 3.3;SK-MEL-30: 1.8"	"Cancer enriched"	"Detected in single"	15	"prostate cancer: 1.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA041573	Approved									"HPA041573: "					"unprognostic (4.30e-2)"							"unprognostic (2.19e-1)"			"unprognostic (3.22e-1)"			0.1	3.5	3.3	0.2	5.0	0.0	0.1	7.1	9.6	0.1	0.2			0.4	0.1	1.4	0.0	0.2	0.2	0.0	3.5	9.2	0.2	0.1	0.1	0.0	2.9		0.4	0.1	0.0	1.2	0.0		5.2	0.1		0.8	0.6	0.1	0.1	0.2	0.0	2.4	0.7	0.1	3.2			0.3		0.1	0.2	0.0	0.2	0.1	0.7	0.2	0.8	0.1	0.3	0.0	1.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.1	0.1	0.9	0.1	0.0	0.0	0.0	0.0	8.9	0.4	0.0	0.1	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	3.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.0	0.4	0.1	1.8	0.0	0.0	0.1	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.7	0.3	0.1	0.5	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.8	0.2	0.1	0.0	0.3										
NAP1L2	"BPX, MGC26243"	ENSG00000186462	"Nucleosome assembly protein 1 like 2"	Q9ULW6	X	73212299-73214848	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 49.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 12.0;Karpas-707: 10.0;NTERA-2: 12.8;U-2 OS: 7.5;U-2197: 10.4;U-266/84: 20.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054050, HPA057065"			Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA054050: , HPA057065: "	"unprognostic (1.12e-1)"	"unprognostic (6.64e-5)"	"unprognostic (4.22e-2)"	"unprognostic (9.64e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.51e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.66e-1)"	"prognostic favourable (5.41e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.54e-2)"	"unprognostic (6.95e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.45e-2)"	2.3	5.8	15.7	2.2	20.0	0.9	3.2	37.5	49.8	4.5	2.8	2.0	0.2	1.3	4.9	8.0	2.8	4.2	2.5	7.2	21.0	22.8	8.0	1.3	2.5	2.9	15.7	28.7	8.6	2.6	10.5	10.2	0.5	20.5	10.4	3.1	2.6	3.1	5.9	1.1	4.9	1.7	4.6	8.3	3.9	2.0	2.2	4.9	0.0	8.0	0.0	1.8	2.6	2.5	0.9	0.0	0.0	0.0	1.2	3.6	1.4	0.0	3.3	0.1	6.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	12.0	0.0	0.7	2.4	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.6	0.3	0.9	0.1	1.7	0.2	0.2	10.0	0.0	1.2	3.9	0.0	12.8	5.9	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.8	0.0	1.2	0.0	0.1	0.0	7.5	10.4	0.8	4.7	20.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.7	0.0	1.4	0.9	3.4	2.3	0.0	0.1	1.6	3.6	0.0	1.2	0.0	0.0	2.6	1.4	15.7	20.0	37.5	42.1	21.0	22.8	15.7	28.7	20.5	4.9
CDX4		ENSG00000131264	"Caudal type homeobox 4"	O14627	X	73447254-73455245	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"skin 1: 5.3;testis: 3.3"	"Cell line enriched"	"Detected in single"	8	"HEK 293: 2.1"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA056528	Uncertain									"HPA056528: "															"unprognostic (1.97e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.3	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHIC1	BRX	ENSG00000204116	"Cysteine rich hydrophobic domain 1"	Q5VXU3	X	73563200-73687102	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 18.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026782, HPA052062"	Uncertain		Approved	"Nuclear speckles,Vesicles,Cytosol"				"Nuclear speckles, Vesicles"	Cytosol	"HPA026782: AB_1846654, HPA052062: "	"unprognostic (9.85e-3)"	"unprognostic (3.91e-2)"	"unprognostic (3.10e-2)"	"unprognostic (9.95e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.65e-1)"	"prognostic favourable (2.75e-4)"	"unprognostic (1.37e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.76e-2)"	5.6	13.9	11.0	7.1	16.3	1.5	7.5	14.7	17.6	14.6	8.2	8.5	7.7	4.7	11.1	7.9	5.1	8.7	9.2	10.3	11.7	13.2	12.4	3.4	5.6	7.2	11.2	13.8	11.8	4.1	13.3	18.2	4.4	16.8	9.9	8.6	6.8	5.1	13.0	4.6	6.0	5.9	10.7	15.4	7.7	4.9	3.3	12.5	3.7	12.8	2.6	6.8	7.4	10.1	1.1	0.2	1.0	0.3	1.2	3.0	0.6	4.0	4.1	2.1	2.7	6.0	8.2	0.0	4.5	6.1	3.7	4.5	2.7	5.1	1.9	6.3	4.0	1.2	3.0	2.2	8.3	4.6	3.7	2.7	3.4	0.0	3.9	0.0	5.5	5.6	2.7	7.0	3.8	5.3	0.7	18.3	7.2	0.6	1.6	0.0	6.6	4.1	1.6	5.3	1.2	4.7	2.0	1.2	1.7	5.1	2.4	5.4	2.0	1.1	6.1	4.3	4.2	8.5	2.7	5.2	12.9	0.0	6.3	3.0	3.3	1.0	0.1	0.0	1.9	0.1	3.0	1.1	1.5	1.9	0.0	1.1	1.5	2.0	0.0	1.2	0.3	0.2	1.2	0.6	11.0	16.3	14.7	17.6	11.7	13.2	11.2	13.8	16.8	12.5
ZCCHC13	"4930513O09RIK, Cnbp2, ZNF9L"	ENSG00000187969	"Zinc finger CCHC-type containing 13"	Q8WW36	X	74304190-74305031	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	88	"testis: 27.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA003382	Enhanced									"HPA003382: AB_10967182"															"unprognostic (1.61e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC16A2	"AHDS, DXS128, MCT7, MCT8, MRX22, XPCT"	ENSG00000147100	"Solute carrier family 16 member 2"	P36021	X	74421461-74533917	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 43.6"	"Cell line enhanced"	"Detected in many"		"BJ: 35.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072719			Approved	"Plasma membrane"				"Plasma membrane"		"HPA072719: "	"prognostic unfavourable (8.88e-5)"	"unprognostic (2.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavourable (1.83e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.89e-3)"	"prognostic unfavourable (3.16e-4)"	13.5	24.4	10.9	5.4	12.2	0.7	4.9	5.9	14.3	9.9	5.5	8.4	1.8	4.1	9.4	2.7	5.2	6.7	10.5	10.7	8.0	5.9	9.4	43.6	6.0	1.6	4.2	8.0	14.7	6.6	12.7	12.6	10.0	8.2	9.2	2.6	11.1	5.8	7.0	3.5	2.2	3.0	7.6	4.1	1.9	4.2	1.8	5.1	6.4	13.6	4.3	3.0	5.0	5.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	3.3	4.1	3.0	16.9	8.1	4.2	0.0	35.2	10.9	14.3	8.2	0.0	0.3	0.0	0.5	13.6	0.6	0.4	14.9	8.4	2.3	1.3	0.0	0.0	0.0	0.6	0.0	0.0	6.3	3.6	7.4	8.7	0.0	0.0	0.0	3.3	0.0	0.2	1.0	11.2	3.1	6.7	8.1	0.0	7.0	0.0	0.7	5.3	3.9	19.7	0.1	0.2	0.4	0.0	13.9	3.7	15.2	17.4	0.0	0.0	0.0	15.3	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	10.9	12.2	5.9	14.3	8.0	5.9	4.2	8.0	8.2	5.1
RLIM	"MGC15161, NY-REN-43, RNF12"	ENSG00000131263	"Ring finger protein, LIM domain interacting"	Q9NVW2	X	74585217-74614617	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018895	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA018895: AB_1856323"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (6.04e-4)"	"unprognostic (1.20e-1)"	11.8	14.3	17.5	10.6	25.6	37.4	12.4	12.6	20.5	12.2	7.4	8.3	5.6	6.4	10.6	8.0	10.2	9.5	10.7	10.5	17.1	16.6	11.6	9.7	13.8	9.2	12.4	13.7	12.4	9.7	19.5	18.5	10.5	28.6	11.9	7.6	5.2	8.9	8.7	11.2	10.2	7.1	10.1	13.9	9.8	8.4	6.9	12.4	9.7	13.0	6.2	10.1	10.5	9.3	3.5	4.8	16.3	7.4	5.2	4.6	3.0	13.5	13.8	13.4	11.2	13.5	14.3	13.2	13.1	15.2	11.7	14.5	10.7	14.2	7.3	15.3	16.4	11.8	26.9	15.7	18.0	6.6	14.2	12.8	24.3	6.5	12.0	19.3	22.9	13.8	9.9	16.7	28.7	13.6	11.1	13.3	15.4	10.3	14.3	10.9	20.6	13.3	13.7	28.4	12.3	10.9	16.2	9.9	11.5	24.5	11.9	15.2	6.7	15.2	18.0	14.2	13.8	14.5	11.4	7.1	13.6	11.7	15.5	19.6	13.8	16.3	5.9	5.6	3.2	7.4	3.3	3.0	4.1	4.0	4.8	3.5	4.5	4.1	11.4	5.2	5.4	2.6	4.6	3.0	17.5	25.6	12.6	20.5	17.1	16.6	12.4	13.7	28.6	12.4
NEXMIF	"KIAA2022, KIDLIA, MRX98, XPN"	ENSG00000050030	"Neurite extension and migration factor"	Q5QGS0	X	74732856-74925485	"Disease related genes, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.2;parathyroid gland: 9.0"	"Group enriched"	"Detected in some"	9	"HAP1: 6.5;Karpas-707: 10.5;SiHa: 9.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000407	Uncertain		Supported	"Nucleoplasm,Midbody,Mitotic spindle,Cytosol"				Nucleoplasm	"Midbody, Mitotic spindle, Cytosol"	"HPA000407: "	"unprognostic (1.04e-3)"	"unprognostic (6.07e-5)"	"unprognostic (1.81e-2)"	"unprognostic (2.07e-5)"	"unprognostic (2.15e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.79e-4)"	"unprognostic (6.94e-4)"	0.6	3.0	5.4	0.7	6.2	0.4	1.3	10.2	9.4	1.7	1.9	0.7	1.0	0.6	1.7	0.9	1.8	1.3	0.5	0.3	5.0	6.2	2.4	0.2	0.9	0.5	1.8	5.0	1.7	4.4	9.0	7.5	0.5	1.9	3.2	1.1	1.1	2.5	2.5	0.4	1.8	1.1	2.6	1.2	0.6	1.6	0.9	1.5	0.0	1.5	0.0	0.5	0.7	2.8	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.2	0.3	0.1	0.9	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	9.3	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.2	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.4	6.2	10.2	6.8	5.0	6.2	1.8	5.0	1.9	1.5
ABCB7	"ABC7, ASAT, Atm1p, EST140535"	ENSG00000131269	"ATP binding cassette subfamily B member 7"	O75027	X	75051554-75156732	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034982	Approved		Supported	Mitochondria				Mitochondria		"HPA034982: AB_10601010"	"unprognostic (1.05e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.83e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.33e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.55e-2)"	"prognostic favourable (5.31e-6)"	"unprognostic (1.95e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.08e-1)"	15.1	18.0	12.3	14.7	14.3	13.0	14.6	26.0	16.2	11.6	15.2	12.0	13.7	19.0	14.7	13.6	14.7	11.7	10.0	21.4	11.7	7.1	15.6	22.4	12.2	15.9	13.0	8.5	16.4	12.4	14.7	22.6	11.5	14.0	10.6	15.4	9.5	12.9	15.5	34.6	15.3	15.9	14.9	12.2	13.9	14.8	5.4	16.2	19.7	12.4	19.3	16.0	13.9	13.3	19.4	19.3	7.0	18.7	12.2	21.5	12.4	11.4	11.2	11.5	14.5	7.6	18.9	5.5	8.1	9.1	7.4	12.7	13.9	17.0	18.0	15.6	6.6	12.0	22.2	10.3	12.6	19.3	18.4	12.1	22.5	10.3	6.3	19.6	10.5	13.4	9.8	10.0	13.1	16.0	13.1	23.3	8.0	6.9	14.8	14.4	19.5	15.7	15.0	22.1	21.0	9.6	11.4	13.8	9.1	19.1	17.5	10.9	7.8	13.8	8.3	7.6	14.8	15.8	7.8	7.6	19.3	16.3	7.4	23.6	8.0	5.9	18.7	7.0	11.5	17.7	12.3	18.1	12.8	12.4	19.3	19.4	21.5	16.0	2.2	12.2	13.4	11.9	17.4	12.4	12.3	14.3	26.0	16.2	11.7	7.1	13.0	8.5	14.0	16.2
UPRT	"DKFZp781E1243, FUR1, MGC23937, RP11-311P8.3"	ENSG00000094841	"Uracil phosphoribosyltransferase homolog"	Q96BW1	X	75274085-75304600	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000805	Uncertain		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA000805: AB_1080482"	"unprognostic (3.12e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.04e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.62e-1)"	"prognostic favourable (4.14e-4)"	"unprognostic (6.09e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.53e-3)"	8.8	15.3	14.6	7.9	15.8	14.9	10.7	20.3	18.7	11.5	9.9	10.8	10.8	14.2	10.0	12.5	13.0	10.2	8.4	12.0	13.1	17.7	15.5	11.3	10.0	10.7	14.9	9.6	8.7	14.1	18.7	19.5	7.6	13.2	12.8	11.0	9.1	13.1	8.6	13.3	7.4	10.5	14.0	10.9	11.0	13.9	3.0	12.4	10.6	13.9	6.5	11.9	9.1	7.9	8.3	11.1	8.9	16.4	14.7	13.3	7.4	7.7	5.5	6.1	5.7	6.6	7.1	5.8	5.4	6.4	5.9	6.6	4.8	5.2	10.8	4.7	5.6	3.4	14.0	4.9	9.5	9.8	5.6	6.8	5.8	6.1	6.4	13.3	14.1	5.4	3.4	8.1	4.2	10.2	7.9	10.9	15.3	3.3	15.0	8.1	12.4	9.0	7.1	16.1	5.2	15.0	4.5	0.4	6.4	7.6	7.9	7.4	3.6	8.5	8.5	7.4	4.5	13.6	4.6	7.4	24.1	10.5	7.9	14.6	4.7	5.1	7.4	8.9	8.3	10.7	9.5	8.3	8.3	8.5	11.1	7.2	10.5	9.3	1.3	14.7	16.4	5.0	13.3	7.4	14.6	15.8	20.3	18.7	13.1	17.7	14.9	9.6	13.2	12.4
ZDHHC15	"DHHC15, FLJ31812, MRX91"	ENSG00000102383	"Zinc finger DHHC-type containing 15"	Q96MV8	X	75368427-75523502	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 5.6;K-562: 3.5;LHCN-M2: 3.9;MOLT-4: 4.1;NTERA-2: 3.7;RH-30: 5.7;RPTEC TERT1: 3.1;SH-SY5Y: 4.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003618	Uncertain		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA003618: AB_2217686"	"unprognostic (8.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.62e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.00e-4)"	"unprognostic (1.96e-2)"	"unprognostic (3.19e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.78e-13)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.67e-4)"	3.0	5.4	4.9	1.5	6.8	1.1	5.3	6.2	9.9	5.8	3.4	3.9	2.4	1.3	6.5	3.7	3.2	4.5	3.3	5.4	5.9	8.7	5.3	1.2	4.1	1.6	4.8	5.3	8.5	4.7	5.0	8.7	0.7	7.0	4.0	2.3	5.4	12.7	6.9	1.6	2.8	1.8	5.2	6.4	2.9	2.1	2.6	3.1	2.0	6.6	2.1	1.5	2.6	3.1	0.3	0.4	0.7	0.2	0.5	1.6	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	5.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	3.9	0.0	4.1	0.1	3.7	0.0	0.0	5.7	0.0	3.1	0.0	1.6	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.5	1.0	0.0	0.7	2.8	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.0	0.1	0.3	0.6	0.0	0.0	0.2	1.6	1.1	0.7	0.5	0.1	0.4	0.0	0.3	4.9	6.8	6.2	9.6	5.9	8.7	4.8	5.3	7.0	3.1
MAGEE2	HCA3	ENSG00000186675	"MAGE family member E2"	Q8TD90	X	75782988-75785236	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 8.8"	"Cell line enhanced"	"Detected in single"		"U-2 OS: 1.1"	"Cancer enriched"	"Detected in single"	9	"glioma: 1.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030625	Uncertain									"HPA030625: AB_10601863"	"unprognostic (5.92e-2)"				"unprognostic (9.33e-2)"			"unprognostic (2.24e-2)"		"unprognostic (6.92e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.01e-3)"	"unprognostic (5.79e-3)"	"unprognostic (3.47e-2)"	"unprognostic (6.43e-2)"		0.5	3.6	2.6	0.5	6.4	0.3	0.7	8.1	8.8	0.9	1.0	0.3	0.0	0.8	1.2	1.2	0.8	0.6	1.0	0.8	2.5	6.7	1.0	0.4	0.9	0.3	2.0	3.8	1.6	0.3	0.3	1.9	0.3	4.1	1.1	1.4	0.4	0.8	1.1	0.3	0.9	1.1	1.3	2.0	0.4	0.4	0.5	0.9	0.0	0.5	0.0	0.4	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	6.4	8.1	7.2	2.5	6.7	2.0	3.8	4.1	0.9
PBDC1	"CXorf26, MGC874"	ENSG00000102390	"Polysaccharide biosynthesis domain containing 1"	Q9BVG4	X	76172936-76178204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003155	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol			88000	Nucleoplasm	"Nucleoli, Cytosol"	"HPA003155: AB_1078592"	"unprognostic (6.95e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.47e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.56e-3)"	"unprognostic (8.82e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.98e-2)"	"prognostic favourable (8.57e-4)"	"unprognostic (1.62e-1)"	24.9	25.4	12.7	15.1	14.3	28.9	17.1	15.3	14.9	21.3	31.5	10.0	14.8	28.5	21.3	18.4	26.9	15.1	14.2	14.7	12.5	12.5	36.3	39.1	16.6	17.0	17.6	8.8	23.1	16.1	15.2	22.8	21.9	15.0	22.3	20.9	10.3	18.0	14.3	19.2	19.5	48.9	22.3	22.7	23.8	17.8	8.4	14.6	21.1	22.5	21.2	18.2	20.8	17.6	28.1	24.0	17.0	27.8	27.1	30.6	17.1	12.1	17.8	15.2	10.4	19.5	19.5	13.1	21.6	18.6	20.0	17.2	17.0	16.9	16.7	14.6	21.8	17.6	25.4	24.2	26.1	12.3	16.1	12.3	10.0	25.4	30.7	36.2	18.1	15.5	20.0	27.3	23.3	25.3	17.4	8.3	24.3	14.3	17.0	26.5	42.3	27.9	14.6	16.0	2.1	29.1	22.6	8.9	11.5	9.6	15.9	0.1	9.7	13.7	21.8	14.9	15.0	17.7	19.8	14.7	25.8	9.9	16.6	12.7	11.7	6.7	17.6	17.0	30.6	25.6	22.2	28.1	27.5	29.7	22.5	23.7	28.2	26.9	3.3	27.1	27.8	24.0	22.5	17.1	12.7	14.3	15.3	14.9	12.5	12.5	17.6	8.8	15.0	14.6
MAGEE1	"DAMAGE, KIAA1587"	ENSG00000198934	"MAGE family member E1"	Q9HCI5	X	76427724-76431353	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"B-cells: 1.0;NK-cells: 1.5;T-cells: 2.4"	"Low region specificity"	"Detected in all"							HPA003047	Approved		Approved	"Cytokinetic bridge,Cytosol"				Cytosol	"Cytokinetic bridge"	"HPA003047: AB_1079298"	"unprognostic (9.30e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.94e-2)"	"unprognostic (5.61e-3)"	"unprognostic (8.72e-3)"	"unprognostic (2.41e-3)"	"unprognostic (1.43e-1)"	"prognostic favourable (3.95e-4)"	"unprognostic (7.91e-2)"	"prognostic favourable (6.86e-6)"	"unprognostic (4.60e-3)"	"unprognostic (2.71e-1)"	"unprognostic (6.03e-3)"	"unprognostic (5.99e-3)"	2.6	5.8	13.8	3.0	23.5	1.1	3.3	18.7	33.9	4.7	1.9	3.2	0.5	1.5	5.4	3.5	2.3	4.8	2.3	3.9	18.9	20.3	4.1	1.1	2.6	4.1	10.2	22.0	8.4	4.1	15.1	5.1	0.8	19.8	5.9	2.1	2.3	3.4	7.4	2.2	3.3	2.0	4.8	5.4	4.5	2.6	1.3	4.9	1.1	4.0	0.1	3.6	2.4	1.8	1.0	0.0	0.0	0.0	1.5	2.4	0.4	0.2	4.7	4.8	9.2	3.4	2.0	4.3	3.5	3.5	3.0	1.7	1.0	0.7	1.0	1.8	3.1	3.6	7.1	6.6	2.5	2.3	0.1	0.0	0.0	3.0	0.7	1.8	0.6	1.5	3.0	0.8	0.8	1.1	0.3	0.0	4.5	0.6	5.1	0.2	5.8	7.1	4.0	3.6	0.0	3.9	0.0	0.0	2.5	0.0	0.5	0.7	2.2	0.1	0.6	4.5	5.8	4.8	0.0	0.0	0.0	0.8	1.3	0.0	0.0	0.0	0.0	0.0	2.4	0.0	1.8	0.8	1.1	2.3	0.0	1.0	1.4	1.3	0.0	1.5	0.0	0.0	0.0	0.4	13.8	23.5	18.7	33.9	18.9	20.3	10.2	22.0	19.8	4.9
FGF16	MF4	ENSG00000196468	"Fibroblast growth factor 16"	O43320	X	77447405-77457278	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 3.2;seminal vesicle: 4.2"	"Cell line enriched"	"Detected in some"	5	"U-2197: 22.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"cerebral cortex: 1.5;hypothalamus: 1.1;pons and medulla: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basal ganglia: 3.7;hippocampal formation: 2.2;olfactory region: 8.3"	"Not detected"	"Not detected"								"Secreted in other tissues"						"unprognostic (4.01e-2)"					"unprognostic (5.30e-2)"		"unprognostic (1.12e-1)"		"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"			"unprognostic (2.31e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.49e-2)"		3.2	0.0	0.2	0.1	0.2	0.0	2.3	0.1	1.5	0.1	0.5	0.7	0.1	0.0	1.2	0.6	0.5	0.4	0.7	1.0	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.1	0.1	1.8	0.1	0.2	0.1	0.5	4.2	1.3	0.4	0.4	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	2.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	1.5	0.1	1.1	0.1	0.1	1.8	0.1
ATRX	"JMS, MRX52, RAD54, XH2, XNP"	ENSG00000085224	"ATRX, chromatin remodeler"	P46100	X	77504878-77786269	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001906, CAB009372, HPA064684, CAB068176"	Supported		Supported	"Nuclear bodies"				"Nuclear bodies"		"CAB009372: AB_2061023, CAB068176: , HPA001906: AB_1078249, HPA064684: "	"unprognostic (1.77e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.65e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.69e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.24e-1)"	16.4	16.6	24.5	18.9	29.3	24.3	16.3	48.2	26.4	20.6	15.4	7.1	18.9	10.2	20.2	17.1	13.5	13.8	13.4	15.1	22.9	15.8	16.6	12.2	15.9	18.6	21.1	21.3	25.4	18.3	35.7	28.1	15.9	20.2	18.4	12.6	7.1	15.8	16.5	20.1	14.1	13.5	22.3	15.3	20.1	15.6	6.5	22.4	23.7	19.8	12.7	16.5	19.9	21.1	21.9	12.8	21.5	11.5	14.6	17.7	5.7	15.1	24.4	25.1	16.8	12.5	16.8	8.9	13.1	12.1	9.7	11.5	8.3	13.3	21.0	13.5	13.9	13.5	20.0	7.8	16.6	11.8	13.1	12.7	29.0	6.1	6.8	16.5	4.4	11.1	7.7	14.3	13.7	17.1	14.9	24.2	12.1	11.9	12.7	8.6	18.1	18.9	20.6	34.6	10.8	9.5	20.3	14.3	24.7	26.4	10.4	8.7	8.3	8.4	23.6	13.7	21.3	15.4	9.2	7.2	22.3	18.9	10.1	13.1	12.1	21.3	6.9	13.8	17.7	8.7	17.1	19.2	16.3	13.7	5.1	21.9	16.8	13.5	21.5	14.6	11.5	12.8	12.8	5.7	24.5	29.3	48.2	26.4	22.9	15.8	21.1	21.3	20.2	22.4
MAGT1	"DKFZp564K142, IAP, MRX95, OST3B"	ENSG00000102158	"Magnesium transporter 1"	Q9H0U3	X	77826364-77895593	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049851	Approved				"Intracellular and membrane"		14000			"HPA049851: "	"prognostic unfavourable (1.30e-4)"	"unprognostic (3.32e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.81e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavourable (8.98e-4)"	"unprognostic (2.03e-2)"	"prognostic unfavourable (3.55e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.66e-1)"	17.3	17.1	11.3	11.7	15.4	9.2	18.3	4.7	10.1	21.4	15.5	25.9	17.5	12.7	17.5	28.1	18.4	14.2	13.1	22.3	11.5	9.5	29.0	69.5	20.4	20.3	19.3	8.2	19.8	49.8	20.0	21.3	28.6	14.0	17.3	13.8	13.6	28.9	17.6	13.7	14.1	22.4	13.4	22.6	21.0	14.5	11.1	18.2	19.8	45.3	11.0	17.6	18.2	15.4	14.3	23.6	13.2	21.3	18.5	20.8	17.3	22.7	13.4	16.1	18.1	27.7	19.1	24.8	24.7	24.6	19.4	21.3	16.7	37.8	16.3	33.9	26.6	21.3	33.7	18.1	30.7	12.1	20.4	11.0	19.9	14.8	24.6	22.8	12.2	16.8	15.7	25.7	21.4	27.4	13.2	47.8	23.0	14.5	13.4	8.2	20.7	15.1	16.4	26.9	30.6	22.3	16.8	5.4	9.8	34.0	23.2	20.4	16.6	12.2	27.9	17.7	20.2	27.4	12.3	16.8	37.4	21.3	19.5	21.3	22.9	12.8	14.2	13.2	20.6	21.1	20.8	14.3	17.9	18.9	12.4	12.3	17.8	20.7	11.9	18.5	21.3	23.6	13.0	17.3	11.3	15.4	4.7	10.1	11.5	9.5	19.3	8.2	14.0	18.2
COX7B		ENSG00000131174	"Cytochrome c oxidase subunit 7B"	P24311	X	77899438-77907373	"Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 81.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA058041	Uncertain									"HPA058041: "	"unprognostic (1.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.10e-2)"	"prognostic favourable (6.80e-6)"	"unprognostic (8.58e-2)"	"unprognostic (4.62e-1)"	"unprognostic (6.38e-2)"	"prognostic favourable (2.43e-4)"	9.4	11.5	23.7	9.2	26.8	18.0	18.2	15.4	32.3	13.1	22.5	4.1	19.8	18.0	8.1	16.4	17.1	10.4	10.7	81.4	21.9	20.6	34.6	28.8	9.7	9.9	24.0	22.9	7.2	15.1	11.1	11.7	8.6	21.3	9.6	22.9	6.9	14.5	18.1	69.4	9.2	19.7	15.9	19.0	8.1	14.5	3.0	12.9	4.8	12.2	62.7	10.8	11.3	9.7	16.5	23.0	19.4	25.9	17.2	22.2	19.1	8.1	20.7	11.8	12.1	13.4	11.4	8.1	6.7	10.3	13.2	15.4	24.1	13.8	12.6	10.2	10.9	13.3	31.9	18.4	15.6	5.7	31.3	13.7	29.3	22.9	11.2	21.4	8.6	14.5	15.7	15.8	14.0	14.0	15.8	22.8	14.1	24.0	12.8	20.6	12.1	56.4	11.6	17.6	34.7	35.8	26.3	11.5	7.5	17.4	22.5	10.6	8.7	11.6	9.2	5.9	8.8	13.0	5.9	5.1	13.1	15.8	13.9	28.5	7.7	19.4	20.8	14.0	15.6	25.9	21.1	16.5	20.1	19.0	23.0	13.4	20.7	22.2	15.5	17.2	24.5	17.1	18.4	19.1	23.7	26.8	15.4	32.3	21.9	20.6	24.0	22.9	21.3	12.9
ATP7A	MNK	ENSG00000165240	"ATPase copper transporting alpha"	Q04656	X	77910656-78050395	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"		"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012887, HPA048107"	Approved		Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA012887: AB_1845205, HPA048107: "	"unprognostic (3.14e-2)"	"unprognostic (3.48e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.14e-1)"	"prognostic favourable (8.38e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.52e-1)"	9.8	7.4	2.6	8.6	4.6	6.4	8.5	2.3	2.9	8.2	7.7	5.9	9.6	4.8	9.5	7.6	10.0	5.7	4.5	5.1	2.9	2.8	9.0	3.3	9.3	9.3	4.1	1.7	7.3	6.3	13.2	15.9	5.0	4.3	8.2	4.4	5.2	12.3	10.3	6.1	15.9	8.5	7.8	6.3	10.8	7.0	2.7	6.0	15.6	6.0	7.1	11.7	11.8	7.0	2.3	1.4	10.7	2.4	1.7	3.0	1.2	2.5	6.7	4.5	4.6	4.3	4.5	0.8	3.9	5.4	2.3	4.8	0.9	3.0	3.7	5.8	3.8	3.1	5.8	3.1	4.4	5.5	4.0	1.9	6.5	0.7	5.4	3.3	3.5	4.8	1.3	5.0	1.5	6.1	15.3	14.4	4.3	2.2	3.5	1.1	1.3	1.4	2.9	7.5	12.6	3.9	7.2	1.4	17.1	9.6	2.4	4.9	1.8	1.1	7.7	3.1	3.1	4.3	1.5	4.7	8.3	4.3	5.1	2.0	4.7	8.3	2.0	5.5	2.4	1.9	1.2	2.0	1.7	1.7	1.3	2.3	2.1	3.0	10.7	1.7	2.4	1.4	0.6	1.2	2.6	4.6	2.3	2.9	2.9	2.8	4.1	1.7	4.3	6.0
PGK1		ENSG00000102144	"Phosphoglycerate kinase 1"	P00558	X	77910739-78129296	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010065, HPA045385, HPA073644, HPA073656"	Approved						290000000			"CAB010065: AB_628116, HPA045385: , HPA073644: , HPA073656: "	"prognostic unfavourable (7.05e-8)"	"prognostic unfavourable (2.69e-5)"	"unprognostic (1.21e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (2.65e-6)"	"prognostic unfavourable (2.74e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.66e-2)"	"prognostic unfavourable (8.34e-4)"	"unprognostic (5.66e-2)"	"unprognostic (2.99e-1)"	"unprognostic (8.99e-3)"	"unprognostic (3.58e-1)"	"unprognostic (2.90e-2)"	"unprognostic (6.57e-2)"	45.0	50.9	29.2	41.3	38.4	62.2	29.9	43.8	67.9	31.9	36.6	24.2	27.5	35.5	25.7	23.3	62.1	25.6	32.4	69.4	28.6	35.0	71.8	58.5	37.5	47.6	32.1	32.7	26.8	21.2	45.7	29.0	43.7	49.9	28.3	42.8	40.0	38.2	32.0	115.5	38.7	41.9	33.9	30.1	43.7	29.7	11.3	24.9	51.8	39.1	61.1	52.4	42.2	38.0	20.9	53.7	49.2	79.0	21.0	26.3	77.0	98.9	45.9	15.4	31.0	26.6	21.6	36.6	50.7	35.3	44.6	74.9	41.6	31.2	39.7	52.5	35.0	43.1	68.0	78.8	89.5	24.2	26.8	30.7	75.7	36.1	29.2	70.3	34.3	26.9	33.3	40.4	21.5	45.5	32.0	60.7	60.8	39.1	61.4	53.2	47.5	87.4	44.5	41.3	121.5	46.5	41.4	23.0	31.7	52.5	44.8	44.0	23.5	36.9	36.6	47.8	33.0	47.7	34.9	67.5	126.1	41.7	134.5	80.0	31.2	22.7	54.6	49.2	20.8	59.9	23.2	20.9	25.0	22.6	53.7	15.8	23.0	24.4	45.7	21.0	79.0	20.9	26.3	77.0	29.2	38.4	43.8	67.9	28.6	35.0	32.1	32.7	49.9	24.9
PGAM4	"dJ1000K24.1, PGAM-B, PGAM1, PGAM3"	ENSG00000226784	"Phosphoglycerate mutase family member 4"	Q8N0Y7	X	77968874-77969638	"Enzymes, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 5.3"	"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA042528, HPA060483"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA042528: , HPA060483: "	"unprognostic (3.10e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.52e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.76e-3)"	0.9	2.1	0.9	2.6	1.5	3.0	0.4	0.8	2.1	1.9	0.6			2.4	1.4	0.7	2.9	1.3	0.0	1.3	1.0	1.5	0.9	1.2	0.4	1.2	1.5		1.0	0.1	0.7	0.7	0.7		0.5	0.7		0.6	0.2	1.1	0.8	2.0	1.3	0.4	1.0	1.3	0.5			0.3		0.7	1.6	1.2	0.7	1.9	3.7	2.4	0.8	1.6	3.5	5.3	3.1	0.3	0.9	0.4	0.0	2.7	0.5	0.1	0.6	0.8	0.0	0.5	0.8	1.4	0.3	2.3	0.2	0.0	0.7	0.6	0.3	0.0	1.1	0.7	0.0	1.6	0.9	0.4	0.2	0.2	0.0	0.5	0.0	0.6	0.8	0.9	2.6	3.9	1.1	0.7	0.8	0.9	2.0	0.0	0.7	0.1	2.6	0.3	0.0	1.3	1.0	0.6	0.0	1.0	1.8	1.6	3.0	2.7	1.4	0.7	3.7	1.5	0.5	0.6	2.4	3.7	1.4	2.2	1.1	0.7	1.1	1.3	1.9	0.7	0.6	0.9	1.5	0.8	2.1	0.5	1.6	3.5										
TAF9B	"DN-7, DN7, TAF9L, TAFII31L, TFIID-31"	ENSG00000187325	"TATA-box binding protein associated factor 9b"	Q9HBM6	X	78129748-78139706	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045275, HPA058961"	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA045275: AB_10962831, HPA058961: "	"unprognostic (3.62e-3)"	"prognostic favourable (5.40e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.20e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.68e-2)"	"unprognostic (9.56e-2)"	"unprognostic (8.42e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.34e-3)"	"unprognostic (9.47e-2)"	"unprognostic (2.62e-1)"	15.5	12.4	25.6	10.3	23.5	10.7	16.6	20.1	27.5	21.5	15.5	20.2	9.9	6.9	24.8	15.6	20.2	17.4	14.2	23.6	21.6	23.0	19.2	14.4	11.5	11.0	21.2	22.1	17.7	11.6	24.4	19.6	13.6	21.3	21.5	10.9	12.9	10.5	19.2	20.7	12.8	9.3	31.9	23.9	10.6	14.0	10.7	19.2	15.9	20.0	11.3	10.9	22.4	12.4	4.5	4.9	1.4	3.3	10.3	13.3	7.2	10.6	9.3	23.0	10.1	9.0	9.2	3.4	9.6	8.9	15.6	8.7	12.9	18.6	12.3	13.8	10.4	8.5	34.3	7.9	16.3	19.1	11.9	6.7	13.2	11.8	9.0	10.5	7.5	11.8	4.2	17.1	11.8	9.4	13.7	26.6	13.8	16.3	16.5	8.2	27.0	17.5	14.4	30.0	11.3	10.6	21.8	14.6	14.5	26.7	11.6	10.3	18.8	7.6	9.9	12.1	18.5	13.2	11.5	11.5	23.1	9.1	21.0	21.3	17.0	0.6	3.1	0.9	5.5	3.3	10.2	4.5	12.5	9.5	4.0	4.4	12.8	9.4	1.4	10.3	2.4	4.9	13.3	7.2	25.6	23.5	20.1	27.5	21.6	23.0	21.2	22.1	21.3	19.2
CYSLTR1	"CysLT(1), CysLT1, CYSLT1R"	ENSG00000173198	"Cysteinyl leukotriene receptor 1"	Q9Y271	X	78271464-78327691	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.9;esophagus: 24.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 11.3;Karpas-707: 7.4;NB-4: 15.9;RPMI-8226: 24.1;THP-1: 14.9;U-937: 16.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 33.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA010546	Approved									"HPA010546: AB_1078268"	"unprognostic (9.48e-2)"	"unprognostic (6.01e-5)"	"unprognostic (4.72e-3)"	"unprognostic (3.04e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.52e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.41e-4)"	"unprognostic (5.82e-2)"	"unprognostic (3.56e-2)"	"unprognostic (9.87e-2)"	"unprognostic (8.94e-2)"	7.3	2.0	1.7	7.8	1.7	2.8	5.4	0.8	2.2	3.0	3.3	1.7	2.9	2.2	2.3	4.4	24.6	2.3	5.6	3.1	2.3	1.9	4.8	2.7	6.9	19.5	3.8	0.8	1.7	2.0	1.7	1.5	3.3	2.9	3.7	4.8	3.1	5.4	0.8	1.7	3.1	7.1	4.2	5.1	22.8	5.2	2.3	4.0	4.7	4.5	4.8	11.3	9.8	3.5	8.1	7.4	33.9	11.9	4.1	3.7	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	11.3	4.7	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	15.9	0.0	0.0	3.2	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	16.4	0.0	5.8	6.3	33.9	0.0	10.9	0.0	8.1	2.4	0.1	4.8	5.8	3.7	0.0	18.4	4.1	11.9	7.4	0.5	2.8	1.7	1.7	0.8	2.2	2.3	1.9	3.8	0.8	2.9	4.0
RTL3	"FLJ38865, Mar3, Mart3, SIRH9, ZCCHC5, ZHC5"	ENSG00000179300	"Retrotransposon Gag like 3"	Q8N8U3	X	78656069-78659328	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"endometrium 1: 2.5;intestine: 2.6;smooth muscle: 2.7;stomach 1: 3.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 2.4;BJ hTERT+ SV40 Large T+ RasG12V: 2.6;fHDF/TERT166: 4.0;HBF TERT88: 5.4;hTEC/SVTERT24-B: 3.9;RH-30: 4.7;U-251 MG: 3.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA051991, HPA053174, HPA075136"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"				Nucleoplasm	"Golgi apparatus, Plasma membrane"	"HPA051991: , HPA053174: , HPA075136: "	"unprognostic (3.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-1)"			"unprognostic (6.74e-2)"		"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.85e-1)"	"unprognostic (4.00e-6)"	"unprognostic (1.53e-2)"	"unprognostic (3.64e-1)"		"unprognostic (2.49e-1)"	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	2.6			0.2	2.5	0.2	0.5	0.4	0.5	2.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0		0.2	0.2	0.0	0.0	0.0		0.2	0.5		0.7	0.0	0.1	0.3	1.1	2.7	0.0	0.0	3.2	0.0			0.1		0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.9	2.4	2.6	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.9	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.1	0.0	0.0	0.2	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	1.4	0.2	3.4	0.2	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LPAR4	"GPR23, LPA4, P2RY9, P2Y5-LIKE, P2Y9"	ENSG00000147145	"Lysophosphatidic acid receptor 4"	Q99677	X	78747709-78757094	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 15.8;ovary: 10.0"	"Cell line enhanced"	"Detected in some"		"AF22: 10.1;NTERA-2: 16.4;RH-30: 6.9;U-937: 3.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"basophil: 7.4"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA046563, HPA054951, HPA055571"	Uncertain		Supported	"Nuclear bodies,Vesicles,Plasma membrane"				"Plasma membrane"	"Nuclear bodies, Vesicles"	"HPA046563: , HPA054951: , HPA055571: "	"unprognostic (1.62e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.81e-4)"	"unprognostic (3.12e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.57e-1)"	"unprognostic (6.75e-2)"	"unprognostic (6.73e-2)"	"unprognostic (8.91e-2)"	"unprognostic (4.86e-4)"	"unprognostic (2.99e-5)"	"unprognostic (9.27e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.03e-3)"	1.5	0.2	6.0	1.0	2.1	0.6	2.0	4.9	3.7	1.8	0.9	7.4	0.7	0.2	2.9	0.8	1.8	1.1	2.1	1.9	15.8	1.4	0.3	0.3	0.3	0.2	2.4	4.0	10.0	0.7	0.1	0.7	0.2	3.6	0.6	1.2	0.5	1.0	1.6	0.2	1.6	0.9	1.3	3.8	0.4	1.5	0.8	5.6	0.0	0.6	0.8	1.2	1.4	0.9	0.0	0.5	7.4	0.0	0.0	0.0	0.1	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.6	1.1	1.4	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	2.3	0.0	0.4	1.8	16.4	0.2	0.8	6.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.2	0.0	0.6	1.4	0.0	0.7	0.7	3.9	1.6	7.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	6.0	2.1	4.9	3.5	15.8	1.4	2.4	4.0	3.6	5.6
P2RY10	P2Y10	ENSG00000078589	"P2Y receptor family member 10"	O00398	X	78945332-78961954	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 51.6;lymphoid tissue: 47.0"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 52.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 51.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036757, HPA065766"	Enhanced									"HPA036757: AB_10696786, HPA065766: "	"unprognostic (3.02e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.50e-6)"	"unprognostic (6.62e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-4)"	"unprognostic (3.33e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-2)"	"prognostic unfavourable (3.63e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.99e-2)"	1.9	0.5	0.4	19.1	0.5	5.7	1.0	0.4	0.4	1.4	3.8	0.0	0.1	1.7	1.0	0.5	2.6	0.8	2.2	0.8	0.5	0.5	1.4	1.0	6.2	47.0	0.5	0.0	1.1	0.5	0.0	0.6	0.1	0.1	0.9	2.5	0.8	3.9	0.3	0.5	0.8	11.0	0.4	0.7	31.2	2.3	0.5	0.0	23.3	1.5	1.8	30.0	9.9	1.3	19.3	0.9	51.6	2.3	4.0	9.7	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	52.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.6	0.0	0.1	0.0	51.6	0.0	36.8	3.2	0.2	2.9	17.8	7.3	6.4	0.9	19.3	6.8	5.0	6.8	4.0	2.3	0.7	9.7	3.2	0.4	0.5	0.4	0.4	0.5	0.5	0.5	0.0	0.1	0.0
GPR174	FKSG79	ENSG00000147138	"G protein-coupled receptor 174"	Q9BXC1	X	79144663-79175315	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 73.8"	"Cell line enriched"	"Detected in some"	7	"MOLT-4: 41.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA041025	Enhanced		Uncertain	Vesicles				Vesicles		"HPA041025: AB_10794260"	"unprognostic (6.38e-3)"	"unprognostic (9.87e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.48e-4)"	"unprognostic (7.12e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.53e-5)"	"unprognostic (2.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-2)"	2.2	0.5	0.4	20.3	0.4	2.6	1.3	0.3	0.4	2.4	5.1	0.0	0.5	2.1	1.6	0.9	2.6	0.9	1.9	1.0	0.4	0.4	1.9	1.7	8.2	16.6	0.5	0.0	1.0	0.7	0.0	1.1	0.3	0.2	1.7	2.0	1.6	3.8	0.1	0.5	0.7	9.1	0.2	1.0	21.0	2.2	0.5	0.0	73.8	2.5	1.6	28.1	5.1	1.8	4.0	1.8	6.0	9.1	6.5	8.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	41.8	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.1	0.0	0.0	0.0	6.0	0.0	4.7	5.7	3.4	1.7	4.0	7.5	8.6	0.1	3.9	6.1	6.8	0.4	6.5	9.1	1.8	7.6	2.7	0.4	0.4	0.3	0.4	0.4	0.4	0.5	0.0	0.2	0.0
ITM2A	"BRICD2A, E25A"	ENSG00000078596	"Integral membrane protein 2A"	O43736	X	79360384-79367667	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 100.7"	"Cell line enriched"	"Detected in some"	8	"MOLT-4: 187.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 26.5;eosinophil: 16.8;gdT-cell: 23.2;MAIT T-cell: 17.0;memory CD4 T-cell: 44.6;memory CD8 T-cell: 36.5;naive CD4 T-cell: 48.0;naive CD8 T-cell: 22.6;NK-cell: 25.2;T-reg: 32.4"	"Group enriched"	"Detected in many"	7	"granulocytes: 26.5;NK-cells: 25.2;T-cells: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000296			Approved	"Golgi apparatus,Vesicles,Plasma membrane"				Vesicles	"Golgi apparatus, Plasma membrane"	"HPA000296: "	"unprognostic (1.05e-2)"	"unprognostic (5.22e-3)"	"unprognostic (2.77e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-3)"	"prognostic favourable (3.66e-6)"	"unprognostic (1.57e-1)"	"unprognostic (4.94e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.30e-1)"	27.2	4.1	27.0	9.1	37.8	13.6	27.4	7.8	25.8	21.8	11.0	16.1	6.5	5.4	16.4	19.4	14.8	15.3	10.6	42.1	33.6	22.5	7.7	2.2	19.0	28.5	34.8	19.5	69.6	6.3	2.7	9.3	10.6	25.8	16.7	11.9	16.2	28.2	8.8	13.2	10.3	8.8	20.9	33.9	8.4	9.6	8.0	12.5	100.7	31.1	14.1	16.5	14.7	16.6	4.7	1.1	26.5	0.2	25.2	48.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.3	0.0	0.4	0.0	7.6	0.0	0.0	0.0	12.2	14.2	2.3	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	187.9	8.5	2.8	0.0	0.0	0.0	0.0	7.3	0.0	0.0	2.1	0.0	0.1	0.0	0.2	0.2	0.3	0.0	0.2	0.0	0.1	23.7	0.0	0.0	0.0	0.0	0.9	26.5	0.1	16.8	23.2	0.2	17.0	4.6	44.6	36.5	0.1	4.7	48.0	22.6	0.8	25.2	0.2	1.1	32.4	22.6	27.0	37.8	7.8	25.8	33.6	22.5	34.8	19.5	25.8	12.5
TBX22	"CLPA, CPX"	ENSG00000122145	"T-box 22"	Q9Y458	X	80014756-80031769	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Deafness, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	27	"testis: 25.6;thyroid gland: 6.6"	"Cell line enriched"	"Detected in some"	4	"HDLM-2: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 0.4"	"Low region specificity"	"Detected in many"																						"unprognostic (6.58e-2)"						"unprognostic (6.31e-2)"	"unprognostic (1.18e-1)"		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0
FAM46D	"CT1.26, CT112, MGC26999"	ENSG00000174016	"Family with sequence similarity 46 member D"	Q8NEK8	X	80335504-80445311	"Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	53	"testis: 8.9"	"Group enriched"	"Detected in some"	12	"AN3-CA: 4.5;K-562: 2.4;U-2 OS: 1.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059362	Uncertain									"HPA059362: "	"unprognostic (3.49e-1)"			"unprognostic (1.14e-2)"					"unprognostic (4.36e-1)"	"unprognostic (1.59e-1)"		"unprognostic (4.64e-1)"		"unprognostic (4.28e-2)"	"unprognostic (8.21e-3)"	"unprognostic (2.95e-3)"		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.1	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
BRWD3	"FLJ38568, MRX93"	ENSG00000165288	"Bromodomain and WD repeat domain containing 3"	Q6RI45	X	80670854-80809688	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012802	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA012802: AB_2066662"	"unprognostic (1.13e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.17e-3)"	"unprognostic (7.04e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.18e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.75e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.35e-1)"	7.7	5.7	7.5	9.1	7.7	10.5	13.0	20.9	8.5	9.3	8.2	5.6	8.6	8.5	8.0	6.2	10.8	8.1	6.3	5.0	7.4	4.6	5.6	7.5	12.7	9.3	5.3	5.5	11.9	7.8	7.3	12.5	8.6	6.5	6.7	8.1	7.7	8.2	11.3	3.7	14.0	10.3	5.8	12.7	8.9	7.3	9.3	7.1	10.1	9.0	6.0	9.1	10.7	12.7	1.1	0.7	2.8	1.1	0.5	1.2	0.5	4.7	5.2	7.9	5.2	3.2	4.0	5.8	2.8	2.4	3.6	4.9	2.3	6.6	5.1	6.5	2.6	8.5	12.0	4.7	4.8	4.4	4.9	10.4	8.4	3.6	2.3	6.0	7.1	2.7	3.2	4.1	5.7	5.4	7.6	13.0	4.1	0.8	3.4	5.5	12.1	2.2	3.1	13.8	3.0	4.1	4.1	1.8	4.5	6.8	3.7	3.0	1.7	5.9	4.9	4.2	5.3	3.9	3.0	5.8	6.0	6.1	3.4	12.1	2.8	0.5	1.1	0.7	0.8	0.9	0.8	0.7	0.8	0.7	0.6	1.1	0.6	1.2	2.8	0.5	0.8	0.7	0.6	0.5	7.5	7.7	20.9	8.5	7.4	4.6	5.3	5.5	6.5	7.1
HMGN5	NSBP1	ENSG00000198157	"High mobility group nucleosome binding domain 5"	P82970	X	81113701-81201942	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 44.5;Karpas-707: 65.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA000511, HPA076238"	Approved		Supported	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA000511: AB_1079505, HPA076238: "	"unprognostic (1.49e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.63e-3)"	"prognostic favourable (6.60e-4)"	"unprognostic (2.78e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.32e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.08e-1)"	5.2	11.4	14.7	3.1	15.6	12.5	6.5	6.0	12.0	8.6	10.6	5.1	12.3	10.2	7.7	30.9	9.8	7.5	4.8	5.4	16.1	14.3	16.2	9.9	3.9	2.0	13.2	10.1	9.5	5.6	11.9	39.8	2.0	10.4	7.0	7.9	3.5	5.6	9.3	3.6	5.2	10.8	7.3	22.1	8.2	5.9	48.6	19.6	10.9	8.1	8.6	2.7	7.8	6.0	6.5	11.0	2.8	3.1	3.4	10.2	3.4	0.2	2.2	5.8	28.5	5.0	1.5	1.2	1.6	2.5	0.4	0.7	0.7	10.8	44.5	5.0	0.7	1.9	34.4	4.1	1.0	26.0	13.7	18.6	21.0	0.3	0.5	30.9	18.4	1.2	1.1	1.7	1.7	2.2	24.5	65.6	2.9	1.0	28.1	11.0	25.9	7.5	1.0	24.3	21.0	7.0	0.8	0.2	0.6	0.2	0.6	1.9	3.5	7.3	2.6	0.9	7.6	4.5	6.0	4.6	1.9	7.2	2.7	12.2	1.6	2.0	3.1	1.4	8.5	1.6	7.7	3.6	5.2	4.6	5.3	6.5	10.2	8.7	2.8	3.4	2.5	11.0	1.7	3.4	14.7	15.6	6.0	12.0	16.1	14.3	13.2	10.1	10.4	19.6
SH3BGRL	MGC117402	ENSG00000131171	"SH3 domain binding glutamate rich protein like"	O75368	X	81201943-81298547	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051248	Approved		Approved	Vesicles			14000000	Vesicles		"HPA051248: "	"unprognostic (3.02e-3)"	"unprognostic (4.25e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (4.08e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.73e-1)"	46.5	35.9	48.6	32.9	40.4	43.2	51.5	11.7	40.4	60.0	70.4	27.3	43.5	25.0	66.2	45.0	49.3	45.0	43.1	24.2	42.4	46.3	41.4	17.6	37.7	46.3	56.7	29.0	40.1	23.1	29.7	59.8	24.3	40.7	55.6	32.1	27.8	34.8	88.1	9.7	19.1	33.6	77.4	67.1	52.7	41.0	26.7	36.0	46.5	33.4	21.4	34.8	81.7	34.9	31.5	41.1	83.4	71.1	23.2	32.6	51.1	0.1	7.0	25.5	29.2	33.7	45.8	1.7	15.6	29.8	5.7	11.8	2.2	21.5	20.9	13.5	22.8	3.8	18.0	11.2	9.2	17.7	6.3	27.7	11.7	1.3	8.1	19.4	54.5	26.5	8.1	8.1	7.2	25.2	9.5	52.0	31.3	9.4	20.2	25.3	20.0	11.3	18.6	11.6	11.0	29.6	9.6	0.0	11.3	0.0	0.7	14.1	8.5	59.5	25.5	16.0	6.4	14.6	6.4	12.1	10.4	19.2	18.3	39.9	11.8	83.4	49.5	71.9	17.6	63.9	19.0	31.5	22.3	20.7	41.1	26.0	20.7	21.6	17.1	23.2	71.1	19.4	32.6	51.1	48.6	40.4	11.7	40.4	42.4	46.3	56.7	29.0	40.7	36.0
POU3F4	"BRN4, DFN3, DFNX2, OTF9"	ENSG00000196767	"POU class 3 homeobox 4"	P49335	X	83508261-83512127	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"brain: 39.0"	"Cell line enriched"	"Detected in single"	145	"AF22: 14.7"	"Cancer enriched"	"Detected in single"	21	"glioma: 5.6"	"Region enriched"	"Detected in all"	6	"basal ganglia: 39.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA062295			Supported	Nucleoplasm				Nucleoplasm		"HPA062295: "					"unprognostic (5.73e-2)"										"unprognostic (2.00e-1)"			0.5	0.5	3.3	0.5	39.0	0.6	0.5	5.0	15.2	0.5	0.7	2.4	0.0	0.5	0.5	0.5	0.5	0.5	1.3	0.5	2.8	1.6	2.5	0.5	0.5	0.5	2.4	3.7	1.1	0.5	0.5	0.1	0.5	2.4	0.5	0.6	0.0	0.5	0.5	0.5	0.5	0.5	0.6	1.7	0.5	0.5	0.5	6.6	0.0	0.5	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	39.0	5.0	4.2	2.8	1.6	2.4	3.7	2.4	6.6
CYLC1		ENSG00000183035	"Cylicin 1"	P35663	X	83861126-83886699	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	69	"testis: 24.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA070355	Enhanced									"HPA070355: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RPS6KA6	RSK4	ENSG00000072133	"Ribosomal protein S6 kinase A6"	Q9UK32	X	84058346-84187907	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 20.7"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 10.8;PC-3: 11.7;RH-30: 14.4;SH-SY5Y: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002852, HPA003904"	Uncertain		Supported	Nucleoplasm,Nucleoli,Mitochondria				"Nucleoplasm, Mitochondria"	Nucleoli	"HPA002852: AB_1079854, HPA003904: AB_1079853"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.12e-9)"	"unprognostic (4.44e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.49e-3)"	0.7	2.9	5.9	1.0	12.2	0.0	2.3	4.7	5.1	3.1	4.5	1.1	20.7	1.7	2.7	4.0	1.5	4.0	1.9	1.2	5.1	2.9	9.2	0.9	0.8	0.2	1.5	3.3	4.9	3.4	13.5	9.1	0.5	4.4	4.3	3.7	1.5	3.0	15.0	1.4	2.3	2.0	1.7	1.0	0.6	2.4	2.6	2.7	0.8	14.5	0.9	0.6	3.3	2.3	1.2	0.8	2.4	0.5	0.7	2.8	0.1	0.0	3.6	3.5	0.0	3.4	3.4	0.0	7.5	4.0	3.4	2.8	2.7	3.0	0.0	0.0	4.1	0.1	9.0	6.0	7.9	0.0	4.5	0.0	0.1	0.0	3.0	0.0	0.0	1.9	0.0	0.0	3.7	0.8	0.0	0.1	2.7	0.0	1.3	0.1	10.8	11.7	0.0	14.4	0.0	0.5	8.3	0.0	11.5	0.0	4.2	0.0	1.9	0.0	0.0	0.1	4.3	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	2.4	0.4	0.5	0.5	0.3	0.4	1.2	0.4	0.7	0.8	0.6	0.4	0.4	1.1	0.7	0.5	0.4	2.8	0.1	5.9	12.2	4.7	5.1	5.1	2.9	1.5	3.3	4.4	2.7
HDX	"CXorf43, FLJ30678"	ENSG00000165259	"Highly divergent homeobox"	Q7Z353	X	84317874-84502479	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.1"	"Cell line enhanced"	"Detected in many"		"AF22: 9.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047189	Uncertain		Approved	Cytosol				Cytosol		"HPA047189: AB_10965463"	"unprognostic (7.26e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.51e-5)"	"unprognostic (3.23e-4)"	"unprognostic (5.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.40e-6)"	"unprognostic (1.14e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.86e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.66e-2)"	5.1	7.4	8.3	3.3	7.9	0.6	6.4	23.1	10.2	8.2	4.6	2.6	3.5	1.8	7.4	5.3	4.2	6.3	5.5	4.8	5.5	4.6	4.3	4.5	4.4	2.3	6.5	7.0	8.0	2.2	5.5	16.4	1.4	6.6	6.0	4.5	2.0	4.5	6.2	1.7	1.9	2.9	6.6	5.7	4.2	3.2	4.0	7.1	0.4	5.7	2.7	2.7	5.2	8.3	2.7	6.1	0.0	6.9	1.4	1.4	1.1	0.0	2.2	9.0	0.0	5.4	4.7	0.0	3.0	4.0	6.9	7.9	0.4	1.2	0.0	0.6	3.0	0.5	0.1	1.1	5.4	0.0	0.6	0.0	1.7	0.0	5.0	0.0	0.0	3.3	0.1	4.5	3.0	7.0	0.0	0.0	6.9	0.1	0.0	0.0	6.7	3.0	0.0	7.7	0.1	3.3	1.5	0.3	5.2	0.0	0.2	0.0	0.4	0.0	7.4	3.8	2.7	1.3	2.7	0.2	0.0	0.0	1.8	0.0	1.6	0.0	4.3	0.0	1.4	6.9	0.2	2.7	0.4	0.3	6.1	1.0	1.2	0.7	0.0	1.4	5.9	0.6	0.2	1.1	8.3	7.9	23.1	10.2	5.5	4.6	6.5	7.0	6.6	7.1
APOOL	"AAIR8193, CXorf33, FAM121A, Mic27, UNQ8193"	ENSG00000155008	"Apolipoprotein O like"	Q6UXV4	X	85003826-85093316	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA000612	Approved		Approved	Mitochondria	"Intracellular and membrane"			Mitochondria		"HPA000612: AB_1078594"	"prognostic unfavourable (2.68e-5)"	"unprognostic (2.72e-2)"	"unprognostic (6.16e-2)"	"unprognostic (5.71e-3)"	"unprognostic (4.27e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.77e-1)"	"unprognostic (8.20e-2)"	"prognostic favourable (1.35e-12)"	"unprognostic (2.67e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.11e-2)"	"unprognostic (7.51e-2)"	9.9	13.2	6.2	5.2	11.2	4.5	8.6	4.3	11.9	7.8	8.2	7.1	6.6	8.2	8.6	8.4	14.0	7.7	6.3	16.1	8.3	6.8	16.2	20.1	6.7	4.3	8.4	7.4	8.0	14.2	17.0	12.9	7.3	14.0	7.8	9.2	7.4	9.9	6.4	20.4	9.2	10.4	8.9	8.8	4.9	9.2	4.6	8.2	7.3	12.7	11.1	5.6	11.0	9.4	7.8	5.9	7.1	6.7	3.6	5.2	2.1	11.4	9.4	6.4	7.8	16.4	11.3	7.3	7.7	7.3	6.5	7.8	8.2	7.3	8.3	8.6	8.1	8.6	19.3	7.4	11.3	8.9	7.9	8.8	11.8	7.4	9.8	16.1	8.7	12.1	9.8	11.6	19.1	9.3	15.9	13.4	10.3	8.7	6.5	4.7	5.6	14.3	7.3	14.7	8.4	7.0	9.0	0.6	9.0	14.8	11.7	7.1	7.6	6.2	10.8	7.9	12.1	17.0	8.7	6.4	26.8	8.3	9.0	12.6	7.6	7.1	4.7	3.4	4.7	6.7	3.9	7.8	4.4	3.6	5.0	4.5	5.2	4.7	1.0	3.6	5.5	5.9	3.0	2.1	6.2	11.2	4.3	11.9	8.3	6.8	8.4	7.4	14.0	8.2
SATL1		ENSG00000184788	"Spermidine/spermine N1-acetyl transferase like 1"	Q86VE3	X	85092287-85243961	"Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 2.7;brain: 5.4;pituitary gland: 7.2;testis: 4.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.3;HAP1: 3.4;HEL: 1.1;RH-30: 1.5;SH-SY5Y: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060369	Uncertain									"HPA060369: "					"unprognostic (1.77e-1)"	"unprognostic (2.06e-1)"				"unprognostic (4.69e-3)"			"unprognostic (7.88e-2)"					0.3	2.7	2.9	0.4	2.6	0.4	0.4	5.4	4.6	0.4	0.4	0.2	0.0	0.3	0.4	0.3	0.3	0.4	0.3	0.5	2.2	2.0	1.1	0.4	0.3	0.3	1.1	2.7	0.4	0.3	0.3	7.2	0.4	2.2	0.5	0.4	0.0	0.4	0.3	0.7	0.6	0.3	0.3	1.4	0.4	0.3	4.8	0.4	0.0	0.4	0.2	0.3	0.4	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	3.4	0.0	0.0	0.0	0.6	1.1	0.1	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.0	1.5	0.0	0.0	0.1	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	2.6	5.4	4.6	2.2	2.0	1.1	2.7	2.2	0.4
ZNF711	"CMPX1, dJ75N13.1, MRX97, Zfp711, ZNF4, ZNF5, ZNF6"	ENSG00000147180	"Zinc finger protein 711"	Q9Y462	X	85244032-85273362	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 38.6"	"Cell line enhanced"	"Detected in many"		"AF22: 16.5;AN3-CA: 12.9;HAP1: 23.9;HEK 293: 22.0;Karpas-707: 14.7;MOLT-4: 12.8;RH-30: 20.1;SH-SY5Y: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.6;naive B-cell: 3.6"	"Group enriched"	"Detected in many"	7	"B-cells: 3.6;T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030654	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"HPA030654: AB_10670561"	"unprognostic (2.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.75e-2)"	"unprognostic (9.11e-3)"	"unprognostic (7.40e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.50e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.62e-3)"	1.4	13.6	11.6	2.1	11.9	5.8	5.4	10.8	19.2	5.9	2.4	4.4	0.0	3.0	8.9	2.9	2.1	4.7	4.0	3.8	11.1	8.3	5.1	0.7	1.9	2.2	6.5	8.1	9.3	4.3	1.5	16.0	7.1	12.6	4.1	1.9	3.3	4.0	2.8	1.6	11.2	4.2	3.4	9.8	4.5	2.8	38.6	9.5	14.4	4.2	1.6	2.5	3.0	2.5	3.6	0.2	0.0	0.0	0.3	1.3	0.3	0.0	1.5	16.5	12.9	0.0	0.0	1.2	0.2	0.0	0.0	0.0	3.4	1.4	0.0	0.5	0.2	0.3	23.9	0.0	0.0	0.0	22.0	7.6	0.4	0.9	0.6	0.0	0.2	1.5	0.1	0.0	3.1	0.1	2.3	14.7	2.9	0.8	12.8	0.0	8.0	0.3	0.0	20.1	0.0	0.0	1.1	4.8	12.5	0.0	0.4	0.0	2.1	2.1	0.0	0.0	5.4	0.0	0.0	5.5	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.1	0.4	0.1	3.6	1.3	0.8	0.0	0.3	0.0	0.2	0.0	0.3	11.6	11.9	10.8	15.1	11.1	8.3	6.5	8.1	12.6	9.5
POF1B	"FLJ22792, POF"	ENSG00000124429	"POF1B, actin binding protein"	Q8WVV4	X	85277396-85379743	"Disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 55.8;skin 1: 55.6"	"Cell line enhanced"	"Detected in some"		"A549: 11.0;CAPAN-2: 11.3;HaCaT: 11.5;RT4: 38.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 44.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 6.0;naive B-cell: 3.2"	"Lineage enriched"	"Detected in single"	7	"B-cells: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002033, HPA050027"	Approved		Supported	"Nucleoplasm,Golgi apparatus"			430000	"Golgi apparatus"	Nucleoplasm	"HPA002033: AB_1079650, HPA050027: "	"unprognostic (2.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.54e-3)"	"prognostic unfavourable (3.08e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavourable (2.03e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.57e-4)"	"unprognostic (1.01e-2)"	0.5	0.4	0.3	9.9	0.3	0.0	3.7	0.4	0.4	7.0	41.8	0.0	0.5	10.9	0.8	1.6	21.4	1.6	10.0	6.3	0.3	0.3	2.5	0.5	1.4	0.4	0.3	0.2	1.0	2.9	0.0	2.5	3.4	0.1	3.9	16.9	0.1	5.6	0.9	0.4	55.6	55.8	0.7	0.4	5.5	7.6	0.4	0.0	0.3	0.7	20.3	9.2	4.9	6.9	6.0	0.0	0.0	0.0	0.0	0.8	0.1	1.7	11.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.8	11.3	5.8	1.6	0.0	11.5	2.5	0.1	0.0	1.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.3	1.9	0.0	4.4	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	38.6	0.0	0.0	0.0	2.9	0.0	1.2	0.5	0.1	0.0	0.0	0.1	0.1	0.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.4	0.0	0.0	3.2	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.3	0.3	0.4	0.4	0.3	0.3	0.3	0.2	0.1	0.0
CHM	"DXS540, REP-1, TCD"	ENSG00000188419	"CHM, Rab escort protein 1"	P24386	X	85861180-86047562	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"GTPase activation"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003231, CAB016171"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB016171: AB_2229397, HPA003231: AB_1078518"	"unprognostic (6.50e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.40e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.97e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.60e-3)"	12.6	18.8	13.9	9.7	23.2	3.2	11.2	17.8	22.9	14.3	9.3	9.0	8.3	6.6	14.5	7.1	9.7	15.9	10.4	9.9	12.6	11.0	17.7	10.9	9.9	9.2	9.3	12.1	11.8	8.3	20.2	31.9	13.2	17.9	11.3	9.3	7.5	10.4	10.8	16.3	8.1	8.0	12.5	12.1	10.8	10.2	6.6	11.9	14.6	15.6	8.4	8.7	12.1	10.4	7.4	4.6	6.2	7.1	4.9	6.0	3.9	9.3	6.2	6.3	4.3	10.4	11.1	4.0	11.1	9.3	7.7	8.5	5.0	8.7	3.2	14.3	7.9	5.4	13.8	6.2	13.3	6.4	6.6	1.9	9.0	5.1	8.3	7.9	14.0	8.4	5.9	12.5	15.9	13.2	6.6	11.1	12.0	2.7	4.8	2.9	9.5	10.2	5.1	11.4	4.8	7.3	5.5	5.6	8.7	13.3	4.7	10.4	3.4	3.8	9.4	9.9	7.0	34.4	5.5	4.1	15.2	4.5	10.6	6.7	8.6	6.2	5.8	4.0	5.5	7.1	5.0	6.6	4.4	5.6	4.6	7.4	5.8	6.0	3.2	4.9	5.6	4.6	5.5	3.9	13.9	23.2	17.8	22.9	12.6	11.0	9.3	12.1	17.9	11.9
DACH2		ENSG00000126733	"Dachshund family transcription factor 2"	Q96NX9	X	86148458-86832604	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 29.5;epididymis: 9.3;fallopian tube: 8.0"	"Cell line enriched"	"Detected in some"	7	"HAP1: 11.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"							"HPA000258, HPA001367"	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA000258: AB_1078618, HPA001367: "	"unprognostic (5.73e-3)"		"unprognostic (3.22e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.66e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.34e-1)"	"unprognostic (7.71e-2)"	"unprognostic (6.48e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.01e-3)"	"unprognostic (2.63e-2)"	0.9	0.9	7.9	0.6	29.5	0.6	0.6	0.2	17.8	1.0	0.8	0.3	0.0	1.2	1.2	9.3	0.7	8.0	0.6	0.6	13.5	10.8	2.4	0.6	0.9	0.6	3.4	10.4	1.4	1.1	0.7	1.3	0.6	11.8	1.5	0.7	1.6	0.7	0.8	0.6	0.7	1.3	0.8	0.7	0.6	1.4	0.7	1.7	0.0	0.7	0.0	0.6	1.4	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.5	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	29.5	0.2	16.8	13.5	10.8	3.4	10.4	11.8	1.7
KLHL4	"DKELCHL, KHL4, KIAA1687"	ENSG00000102271	"Kelch like family member 4"	Q9C0H6	X	87517749-87670050	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 34.4;brain: 16.3"	"Cell line enhanced"	"Detected in some"		"AF22: 9.7;HHSteC: 8.2;HUVEC TERT2: 20.6;NTERA-2: 15.6;RH-30: 8.4;TIME: 22.6"	"Cancer enriched"	"Detected in some"	8	"glioma: 9.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.1;T-reg: 2.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029192	Approved		Supported	"Microtubules,Centriolar satellite"				Microtubules	"Centriolar satellite"	"HPA029192: AB_10602341"	"unprognostic (6.70e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.63e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (8.08e-5)"	"unprognostic (2.40e-4)"	"unprognostic (1.05e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.25e-4)"	2.3	34.4	6.8	1.0	12.1	0.5	1.9	1.1	11.2	2.4	1.0	16.3	0.9	0.7	4.8	1.4	1.3	3.7	2.5	1.5	7.0	4.0	2.1	1.4	1.8	1.0	15.9	7.4	11.7	0.9	0.6	0.6	0.6	11.9	1.1	1.1	0.0	0.5	2.8	0.8	0.6	0.9	8.0	12.7	2.4	0.9	9.7	16.2	0.0	1.4	0.2	0.7	1.9	0.7	0.0	0.0	0.2	0.0	0.0	2.0	0.2	0.0	2.9	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.9	0.2	0.0	2.0	0.0	8.2	0.1	0.0	1.3	3.9	4.2	1.0	20.6	0.1	1.7	5.6	0.0	0.0	0.0	15.6	4.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	22.6	0.0	4.8	0.0	0.3	0.1	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.2	6.8	12.1	1.1	11.2	7.0	4.0	15.9	7.4	11.9	16.2
CPXCR1	CT77	ENSG00000147183	"CPX chromosome region, candidate 1"	Q8N123	X	88747225-88754785	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	54	"testis: 12.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.4;Karpas-707: 3.4;U-266/70: 1.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.2	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TGIF2LX		ENSG00000153779	"TGFB induced factor homeobox 2 like, X-linked"	Q8IUE1	X	89921882-89922883	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 13.3"	"Group enriched"	"Detected in some"	11	"SH-SY5Y: 10.0;U-2 OS: 11.7;U-266/84: 18.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA034543	Supported		Approved	Nucleoplasm				Nucleoplasm		"HPA034543: AB_10603037"															"unprognostic (1.45e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	11.7	0.3	0.0	1.0	18.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PABPC5	PABP5	ENSG00000174740	"Poly(A) binding protein cytoplasmic 5"	Q96DU9	X	91434595-91438584	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 20.9"	"Cell line enhanced"	"Detected in some"		"AF22: 9.7;HSkMC: 4.0;LHCN-M2: 2.6;RH-30: 11.6;U-2 OS: 2.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000164, HPA000165"	Approved									"HPA000164: AB_1079551, HPA000165: AB_1079552"	"unprognostic (1.05e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.55e-2)"	"unprognostic (8.07e-2)"	4.3	14.1	5.3	1.9	4.3	0.4	7.3	2.2	6.2	8.1	4.0	5.7	1.3	1.2	10.3	5.2	2.8	3.9	2.9	3.6	3.7	3.7	2.0	1.0	2.4	1.8	5.1	2.4	20.9	1.3	1.5	11.7	1.8	4.9	5.5	1.9	3.8	1.9	4.3	1.3	1.3	1.9	5.8	5.2	3.4	2.3	3.3	4.9	0.0	4.5	2.1	1.4	4.9	6.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.2	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	4.0	0.0	1.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.2	0.1	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	4.3	2.2	5.9	3.7	3.7	5.1	2.4	4.9	4.9
PCDH11X	"PCDH-X, PCDH11, PCDHX, PPP1R119"	ENSG00000102290	"Protocadherin 11 X-linked"	Q9BZA7	X	91779261-92623230	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 7.0;ovary: 12.6;parathyroid gland: 5.2"	"Group enriched"	"Detected in some"	5	"AF22: 4.2;AN3-CA: 6.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA077495	Approved									"HPA077495: "	"unprognostic (4.22e-3)"	"unprognostic (1.16e-1)"		"unprognostic (1.39e-4)"	"unprognostic (1.18e-1)"			"unprognostic (8.20e-3)"		"unprognostic (6.32e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.19e-2)"		"unprognostic (4.58e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.86e-1)"	0.0	0.3	2.6	0.1	7.0	0.0	0.2	0.0	4.8	1.7	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	4.2	0.0	0.0	0.0	0.2	1.3		12.6	0.0	5.2	0.3	1.2		0.0	0.0		0.0	0.4	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0			0.1		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NAP1L3	"MB20, MGC26312, NPL3"	ENSG00000186310	"Nucleosome assembly protein 1 like 3"	Q99457	X	93670930-93673568	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 60.2"	"Cell line enhanced"	"Detected in some"		"AF22: 10.2;HAP1: 9.9;NTERA-2: 18.1;RH-30: 8.0;U-2 OS: 8.3;U-2197: 12.1"	"Cancer enhanced"	"Detected in many"		"glioma: 12.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 6.9"	"Group enriched"	"Detected in many"	24	"NK-cells: 4.5;T-cells: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026075			Approved	Vesicles				Vesicles		"HPA026075: AB_1854301"	"unprognostic (7.18e-2)"	"unprognostic (1.81e-2)"	"unprognostic (9.26e-2)"	"unprognostic (4.83e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.31e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.75e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.75e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.23e-4)"	2.3	10.4	24.4	2.4	25.7	1.2	2.4	44.9	60.2	16.0	2.4	5.3	0.0	1.6	9.5	4.7	1.5	8.1	4.4	8.4	22.0	42.3	2.9	1.4	1.8	2.1	18.5	31.0	13.1	1.5	1.1	7.9	1.6	20.9	3.9	2.3	2.4	1.6	4.6	0.8	1.7	2.0	6.5	13.1	3.6	1.4	11.9	7.0	0.0	4.6	0.0	1.5	3.3	1.2	0.0	0.0	0.2	0.0	4.5	6.9	1.6	0.0	0.1	10.2	7.4	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	5.6	0.0	9.9	0.0	0.0	0.0	0.2	4.7	0.0	0.1	0.5	0.0	0.3	4.7	0.0	0.5	4.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	18.1	4.2	0.0	8.0	0.0	0.3	0.0	0.1	1.1	0.0	0.0	0.1	0.0	0.5	0.0	5.7	8.3	12.1	0.5	7.7	3.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	3.0	0.0	1.1	0.0	4.3	1.6	0.0	0.0	6.9	4.8	0.2	4.5	0.0	0.0	1.3	1.6	24.4	25.7	44.9	60.2	22.0	42.3	18.5	31.0	20.9	7.0
FAM133A	"CT115, FLJ37659, RP1-32F7.2"	ENSG00000179083	"Family with sequence similarity 133 member A"	Q8N9E0	X	93674013-93712274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 14.8;pituitary gland: 8.2;testis: 16.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 21.8;U-2197: 11.3;U-266/70: 17.0;U-266/84: 37.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA066175, HPA069513"			Uncertain	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA066175: , HPA069513: "	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"		"unprognostic (1.67e-3)"	"unprognostic (4.45e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.86e-3)"	"unprognostic (4.22e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.39e-2)"	"unprognostic (7.12e-4)"	"unprognostic (1.67e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.99e-3)"	0.5	3.0	4.7	0.4	14.8	0.3	0.8	2.3	7.7	1.7	0.5	0.5	0.0	0.4	1.0	0.8	0.4	1.1	0.7	2.2	2.5	4.5	0.4	0.4	0.5	0.4	2.3	4.4	1.4	0.4	0.4	8.2	0.4	3.7	0.4	0.5	0.2	0.4	0.5	0.3	0.6	0.5	0.8	4.5	0.5	0.4	16.1	2.6	0.0	0.9	0.0	0.3	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	21.8	0.0	0.0	0.0	0.0	0.5	5.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.4	0.5	11.3	0.4	17.0	37.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	14.8	2.3	7.3	2.5	4.5	2.3	4.4	3.7	2.6
DIAPH2	"DIA, DIA2, POF, POF2"	ENSG00000147202	"Diaphanous related formin 2"	O60879	X	96684663-97604997	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Oogenesis"	"Developmental protein"	"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005647, CAB015461, CAB068183, CAB068184"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum,Vesicles"				"Endoplasmic reticulum, Vesicles"	Nucleoli	"CAB015461: AB_831223, CAB068183: , CAB068184: , HPA005647: AB_1078657"	"unprognostic (5.75e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (2.16e-5)"	"unprognostic (1.58e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (2.12e-4)"	"unprognostic (3.39e-2)"	"prognostic unfavourable (3.90e-4)"	"unprognostic (6.44e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.99e-3)"	"unprognostic (6.08e-3)"	25.3	5.7	8.2	16.5	13.6	19.9	12.0	1.6	4.6	17.8	18.5	2.9	15.1	5.5	10.7	9.1	16.3	10.4	12.6	13.0	6.6	3.0	6.1	15.7	16.8	6.9	4.1	4.4	14.2	6.6	8.7	5.5	37.2	7.1	16.0	11.4	4.7	9.4	17.2	19.9	9.3	12.0	18.5	7.3	9.8	9.9	12.3	5.1	9.4	7.5	12.0	4.9	19.8	26.9	2.7	4.3	5.7	5.8	1.4	2.8	1.0	0.0	4.0	1.9	3.9	11.0	18.4	0.0	6.9	7.3	3.7	7.9	3.3	7.6	11.3	5.5	5.9	0.0	10.3	1.1	4.9	0.3	5.9	0.0	4.8	3.5	9.2	14.5	5.2	9.2	3.7	5.0	15.7	7.2	0.0	9.3	6.9	3.2	5.4	5.9	15.3	5.9	0.0	10.4	0.0	2.1	6.0	0.0	4.0	0.0	2.0	5.5	1.7	8.0	9.1	8.1	3.7	6.6	4.4	0.1	0.0	9.5	6.8	14.8	4.7	0.0	5.8	5.7	2.3	5.4	1.8	2.7	2.4	2.8	4.3	2.4	1.6	1.5	0.6	1.4	4.5	4.1	1.3	1.0	8.2	13.6	1.6	4.6	6.6	3.0	4.1	4.4	7.1	5.1
RPA4	HSU24186	ENSG00000204086	"Replication protein A4"	Q13156	X	96883908-96885467	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 5.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.0;HL-60: 3.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA066010	Approved									"HPA066010: "	"unprognostic (6.23e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.66e-6)"	"unprognostic (1.33e-1)"	"unprognostic (6.33e-2)"	"unprognostic (9.75e-4)"	"unprognostic (3.15e-1)"	"unprognostic (7.61e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.47e-12)"	"unprognostic (8.95e-3)"	"unprognostic (6.05e-3)"	"unprognostic (8.17e-2)"	"unprognostic (4.59e-2)"	0.9	0.1	0.0	0.3	0.1	1.0	0.4	0.0	0.1	0.5	0.2			0.4	0.1	0.2	0.3	0.0	0.3	0.6	0.0	0.0	0.1	1.1	0.8	0.2	0.0		0.6	0.1	0.0	0.0	0.8		0.4	0.6		0.4	0.2	0.4	0.3	0.1	0.2	0.1	0.1	0.2	5.2			0.2		0.2	0.4	0.8	1.3	1.4	2.5	2.3	0.0	2.1	0.1	0.0	0.7	0.1	1.1	0.0	0.3	0.0	0.8	0.0	0.4	0.8	1.3	0.3	1.6	0.3	0.6	0.0	2.4	0.1	0.7	0.0	1.0	0.0	3.0	0.1	0.1	3.0	0.8	0.2	0.1	2.0	0.9	0.1	0.0	2.5	2.1	0.4	1.0	1.6	1.1	1.1	0.0	0.9	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.7	1.4	0.6	0.7	0.5	0.1	0.0	1.0	0.5	1.8	1.1	0.0	2.3	2.5	1.8	0.9	2.1	1.0	0.4	0.4	0.6	1.3	0.3	0.5	1.4	0.0	1.8	1.4	1.3	0.1										
PCDH19	"EFMR, EIEE9, KIAA1313"	ENSG00000165194	"Protocadherin 19"	Q8TAB3	X	100291644-100410273	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 27.1"	"Cell line enriched"	"Detected in some"	6	"AF22: 19.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027533	Approved		Approved	Cytosol				Cytosol		"HPA027533: AB_10602043"	"unprognostic (7.38e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.77e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.77e-3)"	"unprognostic (2.82e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.80e-4)"	"unprognostic (1.37e-1)"	4.9	1.1	19.8	1.3	10.5	0.7	3.7	1.0	22.5	5.5	4.0	1.9	0.0	1.2	3.8	1.3	2.9	2.2	2.0	1.6	27.1	12.8	1.4	0.9	1.0	1.3	3.7	14.2	3.6	1.1	1.2	2.1	1.0	7.3	1.4	5.5	6.4	2.1	1.6	2.4	3.3	1.8	3.1	3.7	0.8	2.0	2.3	1.0	0.0	1.1	0.7	0.9	2.3	2.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	19.6	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.3	3.4	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.2	0.0	0.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	10.5	1.0	22.5	27.1	12.8	3.7	14.2	7.3	1.0
TNMD	"BRICD4, ChM1L, myodulin, TEM, tendin"	ENSG00000000005	Tenomodulin	Q9H2S6	X	100584802-100599885	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 18.4;seminal vesicle: 25.0"	"Group enriched"	"Detected in some"	13	"HAP1: 7.2;NTERA-2: 17.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA034961, HPA055634"	Uncertain									"HPA034961: AB_10670285, HPA055634: "	"unprognostic (3.60e-2)"		"unprognostic (9.84e-3)"	"unprognostic (3.19e-2)"	"unprognostic (7.77e-3)"		"unprognostic (2.42e-1)"			"unprognostic (2.15e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.40e-2)"	"unprognostic (9.60e-4)"	"unprognostic (6.82e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.48e-1)"	18.4	0.1	0.1	0.4	0.0	0.0	10.9	0.0	0.1	0.4	0.6	0.0	11.1	0.0	0.2	8.9	0.4	0.2	0.3	0.7	0.9	0.1	0.7	0.0	0.0	0.0	0.6	0.0	1.7	0.0	0.0	0.0	1.9	0.6	1.1	0.4	4.7	1.3	25.0	5.9	2.9	0.5	0.5	0.0	0.1	0.1	0.2	0.0	0.2	0.1	2.6	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.1	0.6	0.0	0.6	0.0
TSPAN6	"T245, TM4SF6, TSPAN-6"	ENSG00000000003	"Tetraspanin 6"	O43657	X	100627109-100639991	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 88.4"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 42.7;RT4: 64.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"pons and medulla: 34.2"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 6.6"	"Lineage enriched"	"Detected in single"	8	"T-cells: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004109	Approved		Approved	"Nucleoli fibrillar center,Cell Junctions,Cytosol"				"Cell Junctions, Cytosol"	"Nucleoli fibrillar center"	"HPA004109: AB_1080301"	"unprognostic (7.71e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.71e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.04e-3)"	"unprognostic (8.76e-2)"	"unprognostic (3.83e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.54e-3)"	27.0	9.8	7.0	4.4	6.6	0.1	33.0	2.9	4.9	15.9	17.8	12.6	6.4	9.7	11.1	10.4	27.1	24.2	10.0	5.7	7.4	7.3	26.7	68.2	8.3	3.6	6.9	4.1	27.6	25.1	19.6	17.7	23.6	34.2	15.5	20.3	16.7	88.4	6.7	3.5	4.7	11.6	4.7	10.4	8.6	8.0	17.5	6.6	2.9	24.6	11.0	19.8	17.2	11.5	0.3	0.2	0.8	0.2	0.3	6.6	1.4	7.8	10.5	28.3	14.3	12.4	6.7	11.5	4.5	7.0	8.9	20.8	23.5	13.7	0.0	18.8	4.6	6.4	0.1	8.5	10.5	0.0	15.2	1.4	6.8	26.1	6.9	0.0	1.1	13.2	4.1	7.8	3.0	18.9	0.0	0.0	9.1	8.1	0.0	0.1	42.7	7.9	0.0	13.4	0.0	13.9	64.4	1.8	7.7	4.4	3.9	6.0	5.7	1.0	5.3	5.6	8.5	9.1	2.9	0.0	0.0	0.0	4.9	0.0	3.9	0.5	0.1	0.2	1.0	0.1	3.5	0.3	2.4	0.8	0.0	0.2	6.6	3.8	0.8	0.3	0.2	0.2	0.1	1.4	7.0	6.6	2.9	4.9	7.4	7.3	6.9	4.1	34.2	6.6
SRPX2	SRPUL	ENSG00000102359	"Sushi repeat containing protein, X-linked 2"	O60687	X	100644166-100675788	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 60.2;breast: 57.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 73.9;ASC TERT1: 31.6;HSkMC: 28.4;HUVEC TERT2: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA038786	Approved				"Secreted to blood"					"HPA038786: AB_10672724"	"unprognostic (4.10e-2)"	"unprognostic (4.55e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.59e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.29e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.84e-3)"	"unprognostic (1.69e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.85e-1)"	60.2	5.2	0.4	8.0	2.4	0.3	57.3	0.9	1.1	10.2	5.7	0.9	3.8	1.6	5.6	8.4	15.4	5.0	4.3	10.9	0.9	0.4	5.0	3.5	10.3	2.2	4.3	1.0	9.9	2.9	0.4	1.3	11.6	2.2	7.7	3.0	2.7	3.9	5.5	6.0	2.6	3.4	6.2	5.0	10.1	3.4	5.6	1.2	0.1	7.1	9.1	5.8	17.4	17.8	0.5	0.5	1.2	0.8	0.3	0.3	0.5	2.9	0.5	0.7	0.0	73.9	31.6	0.0	6.6	4.9	2.0	6.6	0.4	4.6	0.0	0.2	4.0	0.1	0.0	3.8	2.1	0.0	0.0	0.0	0.2	0.7	7.5	0.0	0.2	28.4	0.0	7.1	0.2	20.0	0.0	0.0	7.0	0.0	0.0	0.0	0.8	0.1	0.0	0.6	0.0	2.9	11.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.6	4.4	3.1	2.8	0.2	0.0	0.0	0.0	5.1	0.0	2.3	1.1	0.7	0.2	0.3	0.8	0.1	0.4	0.2	0.2	0.1	0.5	0.2	0.3	1.2	0.3	0.6	0.5	0.1	0.5	0.4	2.4	0.9	1.1	0.9	0.4	4.3	1.0	2.2	1.2
SYTL4		ENSG00000102362	"Synaptotagmin like 4"	Q96C24	X	100674491-100732123	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 36.2;ovary: 47.3;pituitary gland: 41.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 14.9;HMC-1: 30.9;RT4: 20.3;TIME: 17.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 5.1"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 5.1"	"Region enriched"	"Detected in single"	5	"hypothalamus: 35.1"	"Not detected"	"Not detected"			"HPA001475, HPA001589, HPA075138"	Approved		Approved	Vesicles			6100000	Vesicles		"HPA001475: AB_1080172, HPA001589: AB_1080174, HPA075138: "	"unprognostic (7.82e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.62e-2)"	"prognostic unfavourable (2.09e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.60e-2)"	3.8	3.1	9.1	2.8	9.5	1.6	4.4	4.3	8.4	18.1	5.3	6.6	4.8	1.7	36.2	5.4	2.6	10.0	2.9	2.1	11.9	6.0	4.2	7.1	3.0	0.7	9.8	2.7	47.3	8.8	1.3	41.9	2.6	9.4	9.2	6.8	1.3	3.8	6.0	4.5	1.4	3.0	22.5	7.8	2.3	5.3	7.8	9.5	0.0	6.2	1.1	1.4	4.3	9.4	0.5	0.3	5.1	0.3	0.5	0.4	2.3	0.1	3.0	0.8	0.0	4.4	2.5	0.0	3.8	2.5	4.1	7.4	0.3	3.8	0.0	1.0	2.7	3.4	14.9	1.3	4.4	0.0	1.3	0.0	5.1	0.2	1.1	0.0	30.9	0.9	0.3	3.7	0.2	10.4	1.4	0.0	1.9	1.0	0.0	0.0	0.6	0.0	0.0	1.2	0.0	3.7	20.3	7.5	0.3	1.5	5.9	0.8	3.6	0.3	17.5	2.1	4.7	10.7	0.9	0.0	0.0	0.0	2.7	0.0	2.4	1.1	0.3	0.5	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.5	0.4	0.2	5.1	0.5	0.2	0.3	0.1	2.3	9.1	9.5	4.3	8.4	11.9	6.0	9.8	2.7	9.4	9.5
CSTF2	CstF-64	ENSG00000101811	"Cleavage stimulation factor subunit 2"	P33240	X	100820359-100840932	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000427, CAB004680"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"CAB004680: AB_425385, HPA000427: AB_1078580"	"unprognostic (2.02e-2)"	"unprognostic (8.70e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.09e-2)"	"prognostic unfavourable (8.23e-6)"	"unprognostic (2.02e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.08e-3)"	"unprognostic (5.98e-3)"	"unprognostic (2.75e-1)"	"prognostic favourable (1.12e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.89e-1)"	8.6	11.1	10.1	14.1	14.6	12.2	10.5	18.8	14.5	10.0	14.9	9.1	15.8	11.4	11.9	11.8	30.1	11.3	8.8	7.8	12.7	10.5	10.3	7.9	9.1	14.7	11.2	11.6	9.8	8.1	11.9	12.7	9.5	10.8	10.3	16.5	9.7	13.0	16.8	7.2	11.8	12.7	10.7	12.5	11.8	9.1	18.9	11.2	20.6	9.0	9.4	24.2	11.3	12.8	15.8	19.6	14.6	20.9	19.1	21.2	12.7	17.1	20.2	12.8	12.6	7.4	6.3	18.8	13.7	12.2	22.8	34.2	22.2	15.2	16.8	16.9	8.8	17.6	31.6	17.3	26.0	15.8	20.4	15.3	19.2	15.2	10.5	20.2	17.1	6.0	8.5	24.6	15.4	13.7	24.4	16.9	13.4	20.7	16.8	15.4	37.2	19.9	17.5	22.2	20.2	8.9	15.7	11.7	15.0	21.9	10.2	9.6	10.3	11.3	11.3	13.5	22.0	17.4	17.6	10.9	22.2	20.8	11.5	24.4	16.3	14.6	14.6	10.1	21.2	16.5	16.6	15.8	18.7	20.0	19.6	13.4	16.4	16.2	2.4	19.1	20.9	13.5	20.3	12.7	10.1	14.6	18.8	14.5	12.7	10.5	11.2	11.6	10.8	11.2
NOX1	"GP91-2, MOX1, NOH-1, NOH1"	ENSG00000007952	"NADPH oxidase 1"	Q9Y5S8	X	100843324-100874345	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 15.0;intestine: 36.3;seminal vesicle: 18.0"	"Cell line enriched"	"Detected in some"	21	"CACO-2: 25.9"	"Cancer enriched"	"Detected in many"	18	"colorectal cancer: 82.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"olfactory region: 1.8"												"unprognostic (8.31e-2)"	"unprognostic (2.07e-3)"	"prognostic favourable (9.71e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.55e-3)"	"unprognostic (5.48e-3)"	"unprognostic (8.68e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.86e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-3)"	0.1	0.1	0.2	8.8	0.2	0.0	0.1	0.2	0.2	0.2	28.3	0.0	15.0	0.1	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.3	36.3	0.0	0.1	18.0	0.1	0.8	1.7	0.7	0.1	0.1	0.1	0.4	0.0	0.4	0.1	0.0	0.1	0.6	0.1	0.2	0.7	0.9	0.6	0.8	1.5	0.2	0.4	0.9	0.4	0.3	0.2	0.0	0.3	0.3	0.0	0.0	0.0	25.9	0.3	0.3	0.6	0.0	0.6	0.0	0.0	0.0	0.3	1.2	0.4	0.6	0.7	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	1.1	1.0	0.7	0.9	0.6	0.6	0.4	0.0	0.9	0.4	0.5	0.6	0.3	0.6	0.2	0.8	0.2	0.3	0.2	0.5	0.6	0.3	0.6	0.3	0.7	1.1	0.2	0.9	0.3	0.3	0.5	0.3	0.3	0.2	1.1	0.2	0.1	0.1	1.5	0.6	0.1	0.8	0.6	0.7	1.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.0
XKRX	"XKR2, XPLAC"	ENSG00000182489	"XK related, X-linked"	Q6PP77	X	100913445-100929433	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 12.0;placenta: 12.2;skin 1: 12.9;thyroid gland: 11.0"	"Cell line enriched"	"Detected in some"	5	"CACO-2: 13.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"naive B-cell: 5.0;naive CD4 T-cell: 3.7;naive CD8 T-cell: 2.8"	"Group enriched"	"Detected in many"	44	"B-cells: 5.0;T-cells: 3.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"														"unprognostic (3.35e-1)"	"unprognostic (2.38e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.37e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.60e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.60e-1)"	"prognostic favourable (3.52e-4)"	"unprognostic (1.18e-1)"	0.1	1.0	0.2	2.1	0.3	0.1	1.1	0.1	0.1	1.2	7.2	0.2	8.3	0.4	0.2	1.9	3.5	1.1	0.5	0.1	0.2	0.4	0.3	0.1	3.3	2.4	0.2	0.0	0.3	0.2	0.0	12.0	12.2	0.2	0.5	1.3	0.0	1.0	1.8	0.2	12.9	6.8	0.0	0.2	0.6	0.5	0.4	0.0	0.8	11.0	1.9	5.4	0.5	2.4	5.0	0.0	0.0	0.0	0.0	3.7	0.6	0.3	1.0	0.1	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.0	13.0	1.6	1.0	0.1	0.0	0.2	0.0	0.9	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	2.5	0.0	0.0	0.1	0.6	0.1	0.0	0.4	0.0	0.0	0.0	2.5	0.1	2.0	0.3	1.1	0.2	1.1	0.0	0.4	0.0	2.3	0.0	0.3	0.0	0.0	1.9	0.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.1	0.0	0.0	5.0	3.7	2.8	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.1	0.1	0.2	0.4	0.2	0.0	0.2	0.0
ARL13A	ARL13	ENSG00000174225	"ADP ribosylation factor like GTPase 13A"	Q5H913	X	100969708-100990829	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 16.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA037377, HPA037378"	Uncertain									"HPA037377: , HPA037378: AB_10670932"	"unprognostic (4.40e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.58e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.37e-4)"	"unprognostic (2.14e-1)"	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.1	0.1	0.6	0.0	0.5	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	1.2	0.4	0.1	0.1	0.2	0.3	16.6	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.8	0.2	0.0	0.4	0.1	0.5	0.0	1.0	1.9	0.1	0.6	0.0	0.0	0.5	0.3	0.1	0.0	0.0	6.5	0.7	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.4	1.1	1.1	0.7	0.0	1.6	0.1	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.1	0.7	0.0	0.2	0.0	1.5	0.0	0.1	0.7	0.0	0.4	0.0	0.1	1.2	0.3	0.0	0.3	1.9	0.6	0.3	0.0	0.0	0.3	0.2	0.2	1.2	0.3	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.5	0.1	0.0	0.1	0.4	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TRMT2B	"CXorf34, FLJ12687"	ENSG00000188917	"TRNA methyltransferase 2 homolog B"	Q96GJ1	X	101009346-101052116	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003745, HPA035120, HPA040814"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA003745: , HPA035120: AB_10601702, HPA040814: "	"prognostic unfavourable (1.58e-5)"	"unprognostic (6.72e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.44e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.16e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.80e-2)"	"unprognostic (2.78e-2)"	"prognostic favourable (2.30e-7)"	"unprognostic (4.58e-2)"	"unprognostic (4.82e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.60e-2)"	7.6	10.4	6.9	8.9	10.3	9.1	8.5	7.0	14.2	9.6	11.4	6.9	10.7	8.1	8.1	8.6	12.9	7.4	7.3	13.0	10.7	6.6	12.3	9.5	9.4	12.6	9.5	6.6	11.3	10.4	18.5	17.6	5.9	10.7	10.1	12.6	13.4	15.3	10.4	17.6	9.5	13.5	7.9	8.4	16.6	11.4	4.0	7.9	18.2	12.8	5.3	17.7	9.9	9.5	16.5	8.1	14.8	8.2	14.4	19.2	11.5	15.6	13.6	2.8	6.4	6.4	3.4	8.6	8.1	11.0	9.2	13.7	14.6	12.5	13.9	16.3	7.5	9.8	12.5	11.3	11.5	12.0	7.9	8.8	11.2	6.9	5.7	15.6	14.4	4.3	6.7	13.2	6.1	17.6	9.0	13.3	8.4	15.8	19.4	8.3	3.8	10.1	15.9	13.4	13.3	6.7	9.3	4.1	5.4	13.9	10.1	8.1	6.6	7.5	10.3	11.6	7.0	10.8	7.2	8.5	12.7	13.0	9.0	18.0	8.9	9.6	8.2	14.8	13.8	6.5	14.6	14.9	16.1	13.3	7.4	16.5	19.2	16.1	4.8	14.4	7.0	8.1	13.0	11.5	6.9	10.3	7.0	14.2	10.7	6.6	9.5	6.6	10.7	7.9
TMEM35A	"FLJ14084, TMEM35"	ENSG00000126950	"Transmembrane protein 35A"	Q53FP2	X	101078720-101096364	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.8;seminal vesicle: 46.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.3;HUVEC TERT2: 31.7;SH-SY5Y: 8.1"	"Cancer enhanced"	"Detected in many"		"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048583	Enhanced		Supported	"Vesicles,Focal adhesion sites,Cytosol"				Vesicles	"Focal adhesion sites, Cytosol"	"HPA048583: "	"unprognostic (7.98e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.34e-3)"	"unprognostic (9.20e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.49e-4)"	"unprognostic (5.91e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.37e-3)"	3.6	6.7	12.8	1.7	28.2	0.7	1.3	21.2	28.6	3.3	17.3	2.5	6.8	3.5	7.4	3.9	10.4	4.3	3.6	1.1	14.4	33.8	1.1	0.7	2.6	0.8	12.2	10.0	7.7	0.9	6.1	1.5	0.8	30.0	20.5	9.1	2.9	1.0	46.4	1.3	0.9	4.1	11.8	3.9	1.3	3.4	1.8	2.3	0.0	1.3	0.0	0.9	13.3	2.7	0.2	0.0	0.2	0.1	0.6	0.8	0.4	0.0	0.0	3.3	0.0	2.4	6.3	0.0	0.6	0.4	0.3	0.1	0.0	0.0	0.0	0.0	1.9	0.0	2.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	2.1	0.0	1.1	0.0	31.7	0.0	0.0	4.0	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	1.4	8.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.5	0.2	0.5	0.2	0.0	0.0	0.6	0.4	0.2	0.6	0.1	0.0	0.8	0.4	12.8	28.2	21.2	28.6	14.4	33.8	12.2	10.0	30.0	2.3
CENPI	"CENP-I, FSHPRH1, LRPR1, Mis6"	ENSG00000102384	"Centromere protein I"	Q92674	X	101098218-101163681	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 18.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA061297			Supported	"Nuclear bodies,Cytosol"				"Nuclear bodies"	Cytosol	"HPA061297: "	"unprognostic (3.10e-3)"	"unprognostic (9.71e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.46e-2)"	"unprognostic (5.78e-6)"	"unprognostic (2.96e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.62e-3)"	"unprognostic (1.20e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.50e-13)"	"unprognostic (1.25e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.42e-1)"	2.6	1.8	1.5	10.8	4.7	9.1	4.0	1.7	2.9	3.7	3.9	3.6	0.0	4.0	4.1	2.2	7.1	2.7	2.8	1.7	1.8	1.4	1.5	1.6	2.9	7.7	3.3	1.8	4.5	1.2	0.3	1.3	3.6	2.6	1.8	5.3	1.2	2.0	0.8	1.5	4.5	3.8	4.3	4.3	4.0	3.3	4.6	2.7	18.3	1.3	4.1	11.0	3.1	3.7	2.6	2.9	4.8	2.8	3.2	3.3	1.2	16.9	11.7	14.5	11.1	1.8	3.3	6.4	18.3	9.8	18.6	37.8	15.6	10.8	12.4	6.6	7.2	9.9	21.1	9.7	26.1	7.7	5.4	7.6	16.7	5.9	0.2	10.0	8.4	1.3	0.8	24.7	3.1	15.8	5.4	22.9	18.0	11.9	9.9	3.6	11.1	14.4	9.3	20.9	8.0	4.6	10.1	9.2	4.9	22.5	6.4	3.8	6.3	3.3	6.4	17.5	14.7	16.3	14.6	3.7	8.5	14.0	6.9	13.4	13.5	2.2	2.1	2.3	2.0	2.8	1.3	2.6	2.0	2.6	1.0	2.1	1.6	1.7	4.8	3.2	2.6	2.9	3.3	1.2	1.5	4.7	1.7	2.9	1.8	1.4	3.3	1.8	2.6	2.7
DRP2		ENSG00000102385	"Dystrophin related protein 2"	Q13474	X	101219769-101264497	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 20.3"	"Cell line enhanced"	"Detected in some"		"RH-30: 11.0;TIME: 18.5;U-87 MG: 4.5"	"Cancer enhanced"	"Detected in single"		"glioma: 1.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002949			Approved	"Nuclear speckles,Plasma membrane"				"Nuclear speckles, Plasma membrane"		"HPA002949: AB_1078706"	"unprognostic (8.47e-4)"	"unprognostic (3.56e-3)"	"unprognostic (1.01e-2)"	"unprognostic (5.58e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.93e-3)"	"unprognostic (2.94e-3)"	"unprognostic (1.27e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.44e-16)"	"unprognostic (3.71e-4)"	"unprognostic (4.22e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.25e-1)"	1.1	1.5	9.3	1.2	17.2	1.1	0.8	0.4	20.3	1.7	2.8	1.2	0.0	1.1	2.5	2.7	1.3	1.0	1.3	0.9	5.8	4.2	0.7	0.6	0.8	0.8	4.6	10.1	4.4	0.6	0.6	2.4	0.7	2.6	4.1	1.8	0.5	0.7	3.1	0.7	0.8	1.2	2.2	3.1	0.7	0.7	1.6	2.2	0.9	0.6	0.0	0.8	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	2.3	0.1	0.1	0.2	0.1	0.4	0.1	0.3	1.0	0.0	0.4	0.3	0.3	0.1	0.0	0.3	0.0	0.7	0.1	0.2	0.2	0.5	0.0	0.2	0.1	0.4	1.5	0.0	0.7	0.0	1.4	0.0	0.9	1.6	0.0	1.3	0.5	0.1	0.1	0.3	11.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.1	18.5	0.2	0.7	0.2	0.4	0.0	0.1	0.0	4.5	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	9.3	17.2	0.4	20.3	5.8	4.2	4.6	10.1	2.6	2.2
TAF7L	"CT40, TAF2Q"	ENSG00000102387	"TATA-box binding protein associated factor 7 like"	Q5H9L4	X	101268253-101293057	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 36.1"	"Cell line enriched"	"Detected in some"	17	"SiHa: 35.2"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.4"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	10	"basophil: 1.6"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.6"					"Low region specificity"	"Detected in all"			HPA001879	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA001879: AB_1857751"	"unprognostic (1.70e-2)"	"prognostic favourable (8.71e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.97e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.67e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.49e-3)"	"unprognostic (6.76e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.12e-2)"	0.1	0.0	1.4	0.1	1.7	0.2	0.1	0.1	0.6	1.6	0.5	0.2	0.1	0.0	0.7	3.5	0.1	0.0	0.1	0.1	0.8	0.2	0.3	0.5	0.1	0.1	0.1	0.8	0.1	0.1	2.5	0.2	0.4	0.3	1.8	0.0	0.4	0.1	1.8	0.1	0.6	0.3	0.1	0.4	0.1	0.1	36.1	0.1	0.1	0.1	0.1	0.1	0.2	0.5	0.1	0.1	1.6	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.1	0.1	0.0	0.6	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.1	0.6	0.0	0.1	0.2	0.1	1.7	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	35.2	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.4	1.7	0.1	0.6	0.8	0.2	0.1	0.8	0.3	0.1
TIMM8A	"DDP, DFN1, MTS"	ENSG00000126953	"Translocase of inner mitochondrial membrane 8A"	O60220	X	101345659-101349196	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone	"Deafness, Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 74.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003628	Supported		Supported	Mitochondria				Mitochondria		"HPA003628: AB_1080284"	"prognostic unfavourable (7.89e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.80e-1)"	"prognostic unfavourable (8.87e-5)"	"unprognostic (2.06e-1)"	"unprognostic (9.28e-3)"	"unprognostic (5.14e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.86e-3)"	"unprognostic (6.41e-2)"	"unprognostic (8.57e-3)"	"prognostic favourable (1.69e-4)"	"unprognostic (1.14e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.86e-2)"	6.8	6.9	7.6	7.5	12.2	7.0	8.0	5.2	13.3	5.6	7.8	6.1	3.1	6.9	6.5	5.7	10.4	6.2	4.1	11.8	7.6	7.2	12.1	27.7	4.9	8.4	8.6	8.2	7.2	17.0	5.5	4.5	6.9	11.9	7.5	8.6	5.7	6.7	4.2	10.1	8.1	7.4	5.4	6.1	6.3	5.6	4.0	6.5	6.5	7.1	16.4	9.4	4.9	6.5	14.1	11.6	1.9	5.3	5.8	11.1	4.8	10.6	9.3	5.3	9.9	4.2	4.5	6.9	7.4	3.6	6.7	13.3	8.3	6.7	11.0	10.1	5.7	8.3	14.0	8.2	9.8	5.1	9.4	21.4	12.3	13.8	3.9	12.1	74.9	4.3	6.6	9.5	5.9	6.7	15.3	12.6	8.5	15.8	5.8	12.0	17.9	15.6	9.5	9.7	15.5	5.8	7.2	7.0	6.2	9.3	7.1	6.7	6.0	6.1	5.0	8.7	10.7	12.1	8.3	6.1	13.9	14.6	4.7	16.3	6.6	1.9	4.4	0.2	6.7	5.3	7.8	12.2	7.3	7.7	5.1	14.1	11.1	9.3	0.6	5.8	3.0	11.6	3.8	4.8	7.6	12.2	5.2	13.3	7.6	7.2	8.6	8.2	11.9	6.5
BTK	"AGMX1, ATK, IMD1, PSCTK1, XLA"	ENSG00000010671	"Bruton tyrosine kinase"	Q06187	X	101349447-101390796	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 77.5;lymphoid tissue: 37.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 28.8;HEL: 40.0;HMC-1: 144.1;U-937: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 77.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001198, HPA002028, CAB016689"	Enhanced		Supported	"Plasma membrane,Cytosol"			610000	"Plasma membrane, Cytosol"		"CAB016689: AB_1611894, HPA001198: AB_1078305, HPA002028: AB_1078306"	"unprognostic (3.19e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.76e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.58e-3)"	"unprognostic (6.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.14e-2)"	7.3	2.4	3.3	23.5	5.6	14.0	2.6	0.8	3.6	2.3	3.0	4.7	0.3	2.2	1.9	2.6	2.4	2.0	3.7	3.3	3.3	2.5	2.2	2.5	10.7	25.1	5.4	1.2	1.2	1.5	0.2	1.4	3.2	4.1	2.5	4.5	1.5	3.2	1.0	1.0	2.5	12.9	3.3	10.8	37.0	3.1	1.3	6.3	4.0	1.7	1.8	36.7	5.8	2.0	13.7	13.2	77.5	20.7	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.0	0.0	0.0	16.0	144.1	0.0	0.0	0.0	0.0	0.0	8.4	0.3	0.0	0.0	0.0	11.2	0.2	0.0	12.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.3	0.1	13.7	0.0	20.9	0.0	77.5	11.3	19.3	0.0	18.1	0.0	13.7	0.0	0.0	13.2	13.7	0.0	0.0	4.5	0.0	20.7	6.0	0.0	6.1	3.3	5.6	0.8	3.6	3.3	2.5	5.4	1.2	4.1	6.3
RPL36A	"L36A, RPL44"	ENSG00000241343	"Ribosomal protein L36a"	P83881	X	101390824-101396154	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA063979, HPA077586"	Uncertain		Supported	"Endoplasmic reticulum,Plasma membrane,Cytosol"				"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"HPA063979: , HPA077586: "	"unprognostic (3.38e-2)"	"unprognostic (2.11e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.19e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavourable (8.81e-11)"	"unprognostic (1.87e-2)"	"unprognostic (4.50e-3)"	"unprognostic (3.57e-3)"	"unprognostic (4.06e-2)"	62.9	40.7	50.7	81.5	53.8	139.8	136.1	27.7	46.8	65.3	71.0	25.1	53.4	45.6	67.5	71.4	77.1	59.0	60.6	54.9	43.1	31.1	47.3	60.1	43.4	190.1	42.1	50.6	165.3	171.4	15.0	35.1	44.7	41.8	55.9	68.3	26.1	158.1	71.5	125.7	96.5	54.1	65.5	44.6	67.9	54.6	26.3	32.6	60.8	69.3	118.6	104.0	71.9	74.0	162.9	113.2	13.7	74.2	86.7	175.5	199.2	121.7	65.9	101.3	49.9	124.9	224.1	64.8	93.8	103.0	123.1	188.2	78.1	62.6	236.0	93.9	77.9	82.3	151.4	131.4	128.4	83.0	166.1	109.1	116.3	71.9	179.6	198.4	105.2	212.6	248.2	99.7	185.0	113.9	131.8	126.9	99.2	175.4	91.8	236.7	134.6	134.1	86.2	221.7	184.9	112.6	50.8	68.0	135.8	87.6	98.4	167.9	47.5	224.6	105.1	36.6	89.6	101.1	95.1	108.0	154.2	186.5	45.0	295.8	39.0	12.5	74.2	13.7	86.6	73.6	140.3	162.9	162.3	120.6	111.4	134.0	175.5	156.7	7.2	86.7	70.4	113.2	84.9	199.2	50.7	53.8	27.7	46.8	43.1	31.1	42.1	50.6	41.8	32.6
RPL36A-HNRNPH2		ENSG00000257529	"RPL36A-HNRNPH2 readthrough"		X	101391011-101412297	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 14.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA077586			Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"				"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"HPA077586: "	"unprognostic (3.69e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-1)"		"unprognostic (4.65e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.04e-4)"	"unprognostic (1.56e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.94e-1)"	6.7	6.0	3.7	8.5	5.0	7.2	6.1	15.3	5.2	5.9	9.9	1.4	4.9	1.5	6.7	7.2	6.9	4.5	5.8	5.1	3.7	5.4	4.3	5.8	4.5	22.1	4.6	4.6	12.7	19.7	1.5	3.6	4.2	3.5	5.2	4.5	1.5	18.1	7.2	14.0	5.3	4.4	6.4	5.0	6.5	4.3	2.5	2.3	5.9	6.9	13.1	6.2	7.3	7.5	16.2	19.8	13.6	16.1	10.6	14.3	22.4	3.7	0.0	5.1	1.0	2.3	5.1	1.7	14.6	0.7	3.0	2.2	0.0	2.2	3.4	4.5	2.0	0.4	4.3	0.6	1.0	4.3	1.7	4.1	2.7	1.3	3.9	3.5	1.7	5.5	2.8	1.6	1.1	1.8	1.4	4.3	3.9	0.6	5.6	2.2	0.3	2.0	7.1	5.3	2.8	1.3	0.6	3.1	4.5	1.8	1.6	1.8	1.7	2.0	2.1	0.5	2.8	2.5	2.5	3.7	6.3	1.2	1.4	3.4	3.1	7.5	14.9	13.6	13.1	16.1	11.5	16.2	12.3	12.4	19.8	15.4	14.3	13.6	4.7	10.6	9.9	10.7	9.0	22.4	3.7	5.0	15.3	5.2	3.7	5.4	4.6	4.6	3.5	2.3
GLA	GALA	ENSG00000102393	"Galactosidase alpha"	P06280	X	101397803-101407925	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 81.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000237, HPA000966"	Enhanced				"Intracellular and membrane"		910000			"HPA000237: AB_1078968, HPA000966: AB_1078969"	"unprognostic (7.27e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (5.62e-5)"	"unprognostic (2.53e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.73e-2)"	"prognostic favourable (6.16e-4)"	"unprognostic (1.13e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.21e-1)"	21.1	22.2	5.2	10.0	6.3	15.6	19.2	6.2	5.7	10.8	12.7	7.3	23.2	14.8	11.7	14.1	9.4	11.5	9.1	10.5	5.2	6.3	28.7	18.9	18.7	12.0	9.4	3.2	9.7	8.3	9.8	10.5	17.9	8.6	8.3	11.2	9.4	9.5	47.7	5.9	8.9	21.3	10.8	11.9	20.8	8.5	4.9	5.8	10.2	8.3	13.4	11.2	12.2	8.9	5.4	15.9	12.8	20.9	3.0	6.1	10.1	7.2	28.4	8.2	8.4	19.0	7.4	3.7	8.3	13.0	15.8	45.2	15.4	11.2	8.0	17.7	8.5	17.3	16.1	9.0	13.7	4.9	11.9	4.4	23.6	18.1	4.9	6.1	81.0	6.5	2.9	18.2	5.3	12.8	6.8	17.7	15.1	12.9	6.1	12.7	12.0	11.5	4.4	10.1	19.5	23.2	14.7	3.0	5.1	19.3	8.2	7.7	3.8	12.6	7.3	5.5	6.6	13.1	6.7	5.4	6.2	6.1	9.5	10.2	6.1	9.5	20.8	6.2	4.6	20.9	6.1	5.4	3.7	5.7	15.9	4.9	3.8	4.7	12.8	3.0	20.8	6.7	4.3	10.1	5.2	6.3	6.2	5.7	5.2	6.3	9.4	3.2	8.6	5.8
HNRNPH2	"FTP3, hnRNPH', HNRPH', HNRPH2"	ENSG00000126945	"Heterogeneous nuclear ribonucleoprotein H2"	P55795	X	101408295-101414133	"Disease related genes, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000914, HPA001359, CAB004436, HPA016884"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004436: AB_627737, HPA000914: , HPA001359: AB_1079076, HPA016884: AB_1856444"	"unprognostic (1.00e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.88e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.99e-1)"	"prognostic favourable (7.37e-4)"	"unprognostic (8.09e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (6.68e-2)"	49.5	44.2	43.4	34.6	51.9	38.3	42.7	49.1	53.9	37.0	32.2	33.8	33.3	34.1	36.6	39.7	36.7	32.7	28.2	35.9	40.3	42.4	49.8	46.1	34.5	30.1	37.1	46.4	47.8	28.4	77.5	50.0	44.9	48.8	37.9	35.9	25.0	30.4	45.2	54.8	40.0	43.6	39.7	36.7	42.2	30.6	18.9	34.2	44.0	44.1	39.9	39.9	41.7	34.4	16.7	28.8	65.9	32.1	22.1	19.4	22.6	31.2	21.7	42.7	25.6	37.6	32.9	20.4	26.7	37.3	25.3	51.6	18.4	28.0	32.2	27.3	37.4	28.7	48.6	36.9	34.6	31.3	23.8	23.9	52.7	24.8	32.2	29.5	23.4	33.3	34.0	24.9	24.5	34.2	24.1	46.5	38.3	39.9	24.2	26.0	26.9	21.3	23.2	45.5	31.3	54.4	41.7	19.6	35.8	39.8	19.0	30.1	24.2	28.3	37.2	14.1	25.9	40.2	10.9	15.7	22.5	22.7	29.1	34.3	17.5	29.3	29.4	43.2	18.1	32.1	19.4	16.7	17.7	18.2	28.8	15.6	18.7	19.2	65.9	22.1	30.4	12.1	16.3	22.6	43.4	51.9	49.1	53.9	40.3	42.4	37.1	46.4	48.8	34.2
ARMCX4	"CXorf35, GASP4, MGC40053"	ENSG00000196440	"Armadillo repeat containing, X-linked 4"		X	101418287-101533459	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"parathyroid gland: 10.8"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 9.8"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000429, HPA051930"	Uncertain		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA000429: AB_1078210, HPA051930: "	"unprognostic (1.92e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.81e-3)"	"unprognostic (7.28e-2)"	"unprognostic (3.67e-4)"	"unprognostic (2.33e-2)"	"unprognostic (4.29e-1)"	"prognostic favourable (8.20e-5)"	"unprognostic (1.94e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.92e-2)"	1.5	4.6	1.9	0.8	2.7	0.3	2.9	3.2	5.7	2.4	1.7			0.6	4.0	2.8	0.7	2.8	1.1	1.2	2.0	2.9	1.2	0.5	1.5	0.5	1.9		8.5	1.4	10.8	4.3	1.6		4.1	1.6		1.2	5.7	1.6	2.1	1.5	2.8	1.4	1.3	1.3	0.4			2.4		0.5	2.1	1.4	0.0	0.1	0.0	0.0	0.0	0.5	0.0	2.3	0.6	8.1	0.0	3.9	4.1	0.8	5.5	4.4	4.5	8.9	1.9	0.8	0.0	2.2	8.1	0.9	0.0	0.1	7.5	0.0	0.9	0.6	2.3	0.0	2.3	0.0	3.1	2.6	0.4	9.8	0.0	7.9	0.0	0.7	2.0	0.0	0.3	0.3	6.0	0.0	0.4	6.7	0.0	1.2	1.4	5.5	5.1	0.8	0.0	3.0	0.6	1.2	2.9	2.1	1.3	6.3	0.0	0.0	0.0	0.0	3.8	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0										
ARMCX1	"ALEX1, GASP7"	ENSG00000126947	"Armadillo repeat containing, X-linked 1"	Q9P291	X	101550531-101554700	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 26.4;ASC TERT1: 23.8;BJ hTERT+ SV40 Large T+ RasG12V: 27.3;LHCN-M2: 24.0;RH-30: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 9.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005685, CAB020695"	Supported		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria"	Cytosol	"CAB020695: , HPA005685: AB_10600781"	"unprognostic (2.31e-1)"	"prognostic unfavourable (3.62e-4)"	"unprognostic (2.65e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"prognostic favourable (7.32e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.20e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.09e-2)"	17.5	29.8	13.6	7.4	16.5	2.7	18.9	13.4	21.5	24.4	18.7	9.6	15.9	6.2	27.3	19.0	12.3	16.3	14.8	26.6	13.3	18.4	12.1	3.8	11.6	4.4	13.7	14.6	42.6	10.2	20.1	18.0	12.5	16.4	25.8	7.0	13.0	12.0	21.1	22.7	8.1	7.6	26.3	9.1	11.4	10.0	8.1	10.5	3.5	14.0	11.6	3.3	26.8	29.7	0.2	9.9	0.5	4.3	2.1	3.7	2.1	0.7	0.2	5.5	0.0	26.4	23.8	0.0	8.6	16.9	10.8	27.3	0.0	0.1	0.0	7.4	13.2	0.7	0.0	1.2	6.1	0.0	0.0	4.9	1.6	0.0	14.0	0.0	0.0	19.9	1.6	8.2	0.0	6.5	0.1	0.1	24.0	0.3	0.0	0.0	7.9	0.0	0.0	30.3	0.0	7.4	0.0	5.4	4.5	0.0	0.1	14.8	0.8	3.6	8.6	6.6	3.5	19.1	0.1	0.0	0.1	0.0	6.4	0.0	4.1	0.0	4.3	0.5	0.0	3.9	0.7	0.0	0.6	0.3	9.9	0.2	1.5	3.7	0.1	2.1	1.1	5.1	0.9	2.1	13.6	16.5	13.4	19.9	13.3	18.4	13.7	14.6	16.4	10.5
ARMCX6	"FLJ20811, GASP10"	ENSG00000198960	"Armadillo repeat containing, X-linked 6"	Q7L4S7	X	101615118-101618001	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043030, HPA048125"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				Cytosol	"Nucleoplasm, Nuclear membrane"	"HPA043030: , HPA048125: "	"unprognostic (1.20e-1)"	"unprognostic (2.80e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.92e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.82e-3)"	"unprognostic (2.38e-2)"	15.1	17.2	11.7	12.1	12.1	7.6	12.7	10.9	12.1	18.7	12.0	15.4	22.6	6.7	17.3	25.9	17.3	14.1	12.4	15.6	11.3	12.6	14.1	12.2	11.2	12.1	13.1	10.3	21.3	27.2	23.4	21.0	16.3	13.1	17.7	9.0	11.8	39.2	23.5	6.5	11.3	10.4	17.1	16.7	22.6	10.6	9.0	11.4	17.9	17.3	9.7	19.3	18.8	13.7	12.8	14.1	10.0	7.0	8.1	8.7	6.4	6.6	7.8	12.3	7.0	25.2	15.0	2.4	13.9	13.6	12.5	24.5	4.7	6.4	7.1	14.3	13.0	6.9	11.9	5.6	9.8	6.1	7.3	6.6	10.9	6.2	11.6	6.4	8.4	9.3	5.8	7.7	4.0	12.7	5.4	9.1	18.7	16.3	9.4	0.0	8.8	1.6	9.7	16.5	2.6	9.0	0.9	6.8	6.4	8.2	0.0	10.4	5.7	3.1	9.8	15.3	6.9	21.2	3.2	11.3	6.0	0.0	4.5	1.7	5.0	10.0	3.8	6.3	6.5	7.0	8.7	12.8	7.0	7.3	8.1	9.1	8.4	7.8	0.5	8.1	5.0	14.1	3.9	6.4	11.7	12.1	10.9	12.1	11.3	12.6	13.1	10.3	13.1	11.4
ARMCX3	"ALEX3, GASP6"	ENSG00000102401	"Armadillo repeat containing, X-linked 3"	Q9UH62	X	101622797-101627843	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000325, HPA000967, HPA001530"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA000325: AB_1078206, HPA000967: AB_1078208, HPA001530: "	"unprognostic (1.67e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.23e-2)"	"unprognostic (8.69e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.19e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.12e-2)"	"prognostic favourable (1.55e-5)"	"unprognostic (3.29e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.55e-2)"	21.0	39.2	26.6	14.8	32.9	8.5	20.5	20.5	36.9	30.6	18.8	21.0	37.1	13.3	26.9	67.8	12.7	17.1	22.0	31.7	28.0	26.6	24.0	17.8	19.1	12.7	27.8	29.6	26.7	38.2	62.0	37.9	28.5	35.4	29.1	14.8	13.6	34.8	31.6	25.5	7.9	13.8	24.6	25.7	24.1	19.0	9.2	22.8	8.2	31.9	17.1	13.7	21.4	21.3	11.6	18.8	25.2	11.8	10.2	14.8	9.4	8.7	6.0	16.2	9.0	37.5	41.8	3.6	19.3	18.7	8.5	24.7	7.1	8.2	3.4	11.1	22.5	1.7	12.2	7.1	10.4	6.7	7.7	6.2	20.2	10.1	29.7	6.0	14.9	23.1	9.5	10.2	11.0	16.1	4.8	30.0	23.1	3.9	5.0	0.2	8.3	1.3	6.4	21.2	3.0	11.9	3.6	7.6	6.4	9.3	0.6	20.0	7.1	6.2	22.5	11.3	7.4	25.5	3.7	24.3	6.5	0.0	17.2	4.9	9.5	25.2	11.2	9.5	10.9	11.3	14.8	11.6	10.8	9.5	11.3	7.9	12.2	8.5	4.1	10.2	11.8	18.8	6.6	9.4	26.6	32.9	20.5	36.9	28.0	26.6	27.8	29.6	35.4	22.8
ARMCX2	"ALEX2, GASP9, KIAA0512"	ENSG00000184867	"Armadillo repeat containing, X-linked 2"	Q7L311	X	101655281-101659891	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 92.7"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 48.4;NTERA-2: 34.8;RH-30: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005761	Enhanced		Approved	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA005761: AB_10600782"	"unprognostic (1.33e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.59e-2)"	"unprognostic (6.96e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.41e-2)"	"prognostic favourable (3.45e-5)"	"unprognostic (9.06e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (2.69e-4)"	"unprognostic (1.12e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.25e-1)"	7.7	21.5	12.5	6.7	19.9	1.0	14.2	17.6	17.5	17.1	11.4	8.2	38.8	3.7	18.4	92.7	6.2	16.7	12.5	18.8	13.2	17.1	13.3	2.6	8.3	4.9	11.8	13.3	28.8	9.8	34.1	38.9	15.4	12.4	17.6	5.3	9.7	23.6	41.8	3.8	3.2	6.2	19.3	9.0	10.9	8.3	6.3	10.7	1.4	35.1	3.6	4.3	13.9	18.9	7.6	1.6	0.0	1.4	4.3	4.4	1.9	0.0	0.0	15.0	0.1	13.4	12.2	0.1	16.4	20.6	0.4	0.4	0.0	6.3	0.0	0.0	21.5	0.4	0.0	0.3	0.1	0.0	0.5	0.0	17.6	0.0	14.1	0.1	0.0	19.2	5.2	12.8	0.1	17.4	0.0	0.1	48.4	0.0	0.0	0.2	34.8	0.1	4.1	26.7	0.0	0.8	0.0	6.0	11.1	0.0	0.0	0.4	7.6	0.0	3.8	18.5	19.7	11.5	0.1	0.0	0.0	0.0	16.9	0.0	0.3	0.0	0.7	0.0	1.6	1.4	0.7	5.1	1.5	1.5	1.1	7.6	4.2	4.4	0.0	4.3	0.9	1.6	0.9	1.9	12.5	19.9	17.6	17.5	13.2	17.1	11.8	13.3	12.4	10.7
NXF5		ENSG00000126952	"Nuclear RNA export factor 5"	Q9H1B4	X	101832112-101857577	"Disease related genes, Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"epididymis: 1.5"	"Cell line enhanced"	"Detected in single"		"PC-3: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA002079	Uncertain									"HPA002079: AB_1079515"	"unprognostic (1.23e-1)"				"unprognostic (2.85e-1)"		"unprognostic (2.73e-1)"				"unprognostic (1.44e-3)"	"unprognostic (9.58e-2)"	"unprognostic (5.65e-2)"		"unprognostic (2.24e-1)"	"unprognostic (2.91e-2)"		0.7	0.2	0.3	0.0	0.4	0.7	0.2	0.8	0.7	0.0	0.0			0.0	0.0	1.5	0.1	0.3	0.4	0.1	0.6	0.5	0.8	0.5	0.2	0.4	0.7		0.2	0.1	0.0	0.1	0.0		0.2	0.0		0.0	0.4	0.6	0.0	0.1	0.2	0.9	0.8	0.0	0.1			0.3		0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ZMAT1	KIAA1789	ENSG00000166432	"Zinc finger matrin-type 1"	Q5H9K5	X	101882288-101932031	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"epididymis: 38.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 12.4;U-266/70: 6.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA012827	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"HPA012827: AB_1859070"	"unprognostic (9.30e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.20e-3)"	"unprognostic (2.22e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.09e-2)"	"prognostic favourable (1.72e-5)"	"unprognostic (6.33e-3)"	"unprognostic (1.72e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.38e-2)"	6.1	13.0	11.4	9.9	12.4	10.0	9.9	7.1	12.8	5.0	4.9	16.5	7.0	4.0	7.4	38.7	3.0	7.3	7.2	7.6	11.1	9.6	9.6	6.5	10.8	10.9	10.2	11.4	11.9	7.3	14.5	31.4	2.3	9.2	9.3	3.4	13.6	7.9	14.2	5.1	4.3	5.4	8.3	12.0	10.7	4.1	5.9	11.3	7.0	18.8	3.2	7.5	3.3	3.7	3.7	3.2	2.6	1.1	0.6	1.6	0.6	0.4	0.0	1.4	1.5	0.0	0.0	0.2	0.6	0.1	0.0	0.7	0.0	1.8	2.7	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.4	0.7	0.0	0.0	0.0	0.3	1.1	0.0	12.4	0.9	0.0	0.1	0.2	1.9	0.2	2.1	0.0	0.1	3.3	0.0	0.6	1.7	1.0	0.0	0.1	2.1	3.0	3.0	0.9	0.0	0.0	0.1	6.2	0.4	0.0	0.6	2.9	0.9	2.6	1.1	1.7	0.9	0.4	1.6	2.0	1.3	1.4	0.2	3.7	1.6	1.4	0.8	0.6	0.7	3.2	0.6	0.6	11.4	12.4	7.1	12.8	11.1	9.6	10.2	11.4	9.2	11.3
TCEAL2	"my048, MY0876G05, WEX1"	ENSG00000184905	"Transcription elongation factor A like 2"	Q9H3H9	X	102125688-102127711	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.0;ovary: 46.5"	"Group enriched"	"Detected in some"	4	"HAP1: 7.2;SCLC-21H: 7.9;U-2 OS: 14.2"	"Cancer enhanced"	"Detected in many"		"glioma: 22.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.8;naive CD8 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	17	"T-cells: 2.1"									HPA076317			Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA076317: "	"unprognostic (2.34e-3)"	"unprognostic (1.35e-2)"	"unprognostic (7.59e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.80e-2)"	"unprognostic (3.47e-1)"	"unprognostic (3.26e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.11e-3)"	2.4	19.6	34.1	2.6	44.6	1.1	2.4	40.9	84.0	5.8	7.0	8.5	1.8	3.1	19.5	8.6	5.3	7.3	6.4	5.1	30.0	37.9	8.2	1.3	4.4	1.6	25.4	26.5	46.5	3.7	2.8	38.3	1.1	30.1	19.4	3.8	6.6	16.4	21.6	1.2	1.7	3.2	14.0	16.1	2.9	4.2	19.7	9.6	0.0	25.6	0.0	2.1	4.3	2.6	0.1	0.1	0.0	0.1	0.0	2.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.2	0.0	0.0	0.0	0.1	0.0	0.0	7.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.8	0.1	1.7	0.0	0.1	0.0	1.8	2.1	0.0	0.0	0.0	0.0	0.1	0.4	34.1	44.6	40.9	41.8	30.0	37.9	25.4	26.5	30.1	9.6
TCEAL6	WEX2	ENSG00000204071	"Transcription elongation factor A like 6"	Q6IPX3	X	102140476-102142970	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 14.3;brain: 48.4;pituitary gland: 20.7;testis: 21.9"	"Cell line enhanced"	"Detected in some"		"BJ: 1.1;SCLC-21H: 1.9"	"Cancer enriched"	"Detected in single"	9	"glioma: 3.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											"HPA045564, HPA058982"	Supported									"HPA045564: , HPA058982: "	"unprognostic (5.43e-2)"			"unprognostic (6.54e-2)"	"unprognostic (1.87e-3)"			"unprognostic (6.69e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.18e-1)"		1.1	14.3	16.6	1.3	15.2	1.0	1.1	31.4	48.4	1.2	1.4	2.5	0.0	1.3	5.3	2.8	1.1	3.2	1.1	1.1	11.3	26.0	1.2	1.0	1.0	1.0	15.2	7.5	6.1	1.3	1.1	20.7	1.0	12.5	1.9	1.3	2.0	3.1	1.9	1.0	1.0	1.3	1.9	7.5	1.0	1.0	21.9	2.8	0.0	1.8	0.0	1.0	1.0	1.7	0.7	0.6	0.1	0.5	1.3	0.7	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.3	0.0	0.0	0.7	0.0	0.3	0.1	0.5	0.1	0.5	0.3	0.7	0.4	0.2	0.3	0.5	0.7	0.4	0.6	0.0	1.3	0.0	0.6	0.6	0.6	16.6	15.2	31.4	26.0	11.3	26.0	15.2	7.5	12.5	2.8
BEX5	NGFRAP1L1	ENSG00000184515	"Brain expressed X-linked 5"	Q5H9J7	X	102153708-102156057	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 49.7"	"Group enriched"	"Detected in some"	4	"HAP1: 8.8;Karpas-707: 34.0"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 45.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 4.6;MAIT T-cell: 11.2;memory CD4 T-cell: 8.5;memory CD8 T-cell: 5.9;naive CD4 T-cell: 12.4;naive CD8 T-cell: 7.4;NK-cell: 6.5;T-reg: 7.9"	"Group enriched"	"Detected in many"	6	"NK-cells: 6.5;T-cells: 12.4"					"Low region specificity"	"Detected in all"			HPA059058	Enhanced									"HPA059058: "	"unprognostic (1.88e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.63e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.25e-2)"	"prognostic favourable (3.09e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.97e-3)"	"unprognostic (4.63e-2)"	"prognostic favourable (1.97e-4)"	"unprognostic (3.79e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.48e-2)"	2.7	12.1	35.4	2.9	28.1	1.8	6.0	18.7	49.7	3.6	4.0	3.5	2.9	3.3	4.8	24.8	1.8	4.1	9.5	2.4	31.2	41.7	13.4	2.6	5.7	3.6	22.5	26.1	10.5	13.0	15.3	25.1	0.5	26.1	5.1	4.8	3.7	7.8	3.5	0.8	2.2	2.7	3.0	15.7	3.0	5.8	9.2	3.7	0.0	15.6	0.0	5.6	1.9	1.2	1.6	0.6	0.0	0.0	6.5	12.4	2.3	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.7	8.8	0.2	0.0	0.0	0.4	2.9	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	1.3	0.1	1.2	34.0	0.1	3.7	0.2	0.0	4.0	1.4	0.0	0.0	0.1	3.1	0.0	4.9	0.5	0.0	0.0	0.0	0.8	0.0	3.2	0.2	2.3	0.3	0.0	3.9	2.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.6	0.0	11.2	1.6	8.5	5.9	0.0	0.7	12.4	7.4	0.0	6.5	0.0	0.6	7.9	2.3	35.4	28.1	18.7	47.2	31.2	41.7	22.5	26.1	26.1	3.7
TCP11X1		ENSG00000268235	"T-complex 11 family, X-linked 1"		X	102215301-102229532	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in single"		"adrenal gland: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048311	Uncertain									"HPA048311: "																		0.1	1.1		0.0		0.0	0.0		0.0	0.4	0.0			0.0	0.0	0.0	0.0	0.0	0.3	0.1			0.3	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.1		0.5	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.5			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NXF2	"CT39, TAPL-2"	ENSG00000269405	"Nuclear RNA export factor 2"	Q9GZY0	X	102247161-102326719	"Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"epididymis: 16.7;testis: 12.4"	"Cell line enriched"	"Detected in single"	52	"U-266/84: 27.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA002079	Uncertain									"HPA002079: AB_1079515"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	16.7	0.0	0.4	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	12.4			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NXF2B	bA353J17.1	ENSG00000269437	"Nuclear RNA export factor 2B"	Q9GZY0	X	102360396-102439932	"Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"epididymis: 18.9"	"Cell line enriched"	"Detected in single"	52	"U-266/84: 27.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA002079	Uncertain									"HPA002079: AB_1079515"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	18.9	0.0	1.0	0.0	0.0			0.0	0.0	0.2	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	1.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TCP11X2		ENSG00000215029	"T-complex 11 family, X-linked 2"	Q5H9J9	X	102456862-102471842	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 3.5;pituitary gland: 3.3;testis: 3.6"	"Cell line enriched"	"Detected in single"	6	"SCLC-21H: 5.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048311	Supported									"HPA048311: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0			0.0	0.0	0.7	0.0	3.5	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.0		0.0	0.0	0.2	3.3	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TMSB15A	"TMSL8, TMSNB"	ENSG00000158164	"Thymosin beta 15a"	P0CG34	X	102513676-102516784	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 16.1;prostate: 17.3"	"Cell line enhanced"	"Detected in some"		"AF22: 98.8;NTERA-2: 25.5;RH-30: 44.9;SH-SY5Y: 25.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 56.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"NK-cell: 2.5;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	11	"dendritic cells: 1.1;NK-cells: 2.5"																				"unprognostic (5.33e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.70e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.03e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.96e-4)"	"unprognostic (2.14e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.07e-1)"	1.6	1.0	1.9	1.0	2.2	0.7	5.1	3.4	2.6	4.9	0.8	0.7	2.7	0.3	5.4	1.3	0.9	1.4	1.5	2.2	1.9	1.4	2.7	0.2	16.1	3.8	1.6	0.7	6.1	0.8	0.0	1.0	1.8	1.9	17.3	1.0	0.7	4.0	1.6	1.2	0.5	0.7	2.3	1.7	0.6	0.5	4.7	1.8	7.8	6.1	0.9	2.6	0.9	6.0	0.1	1.1	0.0	0.0	2.5	0.1	1.1	0.0	0.0	98.8	18.4	0.4	0.0	0.0	2.1	0.1	0.2	0.8	0.0	0.1	0.0	0.2	0.3	0.0	18.5	0.1	0.2	0.0	0.9	1.7	0.3	0.0	0.0	0.0	1.7	0.2	0.0	0.1	0.0	1.1	0.1	0.0	6.9	0.0	18.5	0.0	25.5	0.2	0.0	44.9	0.0	1.9	0.0	16.9	25.7	2.3	0.1	0.0	0.2	0.5	0.4	0.0	11.1	0.2	1.7	2.0	0.3	0.0	1.1	0.0	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	1.1	0.0	1.1	1.9	2.2	3.4	2.2	1.9	1.4	1.6	0.7	1.9	1.8
ARMCX5	"FLJ12969, GASP5"	ENSG00000125962	"Armadillo repeat containing, X-linked 5"	Q6P1M9	X	102599168-102604159	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000996	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"				"Nuclear speckles, Cytosol"	"Plasma membrane"	"HPA000996: AB_1078212"	"unprognostic (7.71e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.05e-2)"	"unprognostic (4.07e-2)"	"prognostic favourable (6.58e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.24e-2)"	8.6	13.2	11.4	7.0	17.3	6.4	13.8	24.3	19.8	11.2	9.5	8.7	13.1	7.9	13.3	12.5	10.1	11.9	7.5	7.8	11.1	6.3	10.0	15.5	8.3	6.9	8.1	12.9	16.5	25.3	14.5	26.4	6.1	12.8	16.6	11.9	9.2	13.4	11.0	6.1	9.9	10.4	10.8	7.0	10.2	11.7	6.1	8.4	9.5	15.3	7.0	9.6	10.4	9.8	9.7	9.3	2.5	9.8	7.1	15.9	8.5	8.0	7.3	17.2	9.1	7.7	8.7	9.7	7.9	6.1	9.3	16.6	8.6	10.0	0.0	9.7	7.9	7.0	15.3	7.5	10.6	0.0	6.1	8.1	9.2	7.1	10.0	14.7	9.5	10.8	9.8	8.0	9.7	9.4	7.8	0.0	12.3	7.1	10.4	1.7	7.7	13.8	10.3	42.2	0.0	6.9	11.2	8.2	7.3	14.2	7.4	11.3	5.1	7.1	9.5	6.9	6.2	7.8	5.6	0.0	5.7	0.0	5.4	15.1	17.7	0.0	9.5	2.5	12.0	9.8	11.5	9.7	11.3	9.4	9.3	6.0	15.9	12.3	0.8	7.1	6.0	8.1	7.7	8.5	11.4	17.3	24.3	19.8	11.1	6.3	8.1	12.9	12.8	8.4
GPRASP1	"GASP, GASP1"	ENSG00000198932	"G protein-coupled receptor associated sorting protein 1"	Q5JY77	X	102651366-102659083	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 6.7;REH: 8.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 5.2"	"Group enriched"	"Detected in many"	5	"B-cells: 1.4;T-cells: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000161, HPA031061"	Uncertain		Supported	Cytosol				Cytosol		"HPA000161: AB_2247872, HPA031061: "	"unprognostic (3.92e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.07e-4)"	"unprognostic (1.42e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.71e-3)"	"unprognostic (3.57e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.82e-1)"	"prognostic favourable (1.77e-5)"	"unprognostic (3.34e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (7.38e-4)"	"unprognostic (1.23e-2)"	3.5	16.6	19.0	3.7	34.3	2.5	4.0	28.2	37.0	8.9	7.2	4.3	1.6	1.9	18.2	8.1	3.3	8.7	5.5	10.6	19.9	18.3	5.2	1.4	3.8	6.2	7.9	30.3	29.9	3.0	22.4	16.1	2.2	20.6	12.0	3.5	4.0	5.1	13.4	4.0	2.2	4.1	11.7	6.6	6.8	3.5	2.9	5.6	0.9	11.9	0.8	5.4	6.3	6.3	1.4	0.6	0.0	0.0	0.3	5.2	1.0	0.4	0.8	2.6	1.6	2.6	2.6	1.5	2.7	0.2	4.0	6.7	0.3	0.5	0.0	0.6	5.5	0.7	0.8	0.1	5.8	0.0	0.3	0.2	0.7	0.7	2.1	0.3	0.3	3.4	1.0	4.9	0.4	0.4	0.5	0.2	6.3	0.6	5.2	0.2	1.8	0.8	8.0	2.5	0.0	0.4	0.6	2.5	4.1	0.9	0.4	0.7	0.3	1.3	0.7	1.3	1.6	0.8	0.4	0.4	0.6	0.0	0.6	0.4	1.7	0.0	0.0	0.0	1.3	0.0	2.9	0.6	2.4	1.0	0.0	1.4	5.2	4.8	0.0	0.3	0.0	0.6	1.8	1.0	19.0	34.3	28.2	37.0	19.9	18.3	7.9	30.3	20.6	5.6
GPRASP2	"FLJ37327, GASP2"	ENSG00000158301	"G protein-coupled receptor associated sorting protein 2"	Q96D09	X	102712176-102717733	"Predicted intracellular proteins"			"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 4.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.6;NK-cells: 2.1;T-cells: 4.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017438	Enhanced		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA017438: AB_1849504"	"unprognostic (8.74e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.14e-3)"	"unprognostic (4.60e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.06e-1)"	"prognostic favourable (5.71e-4)"	"unprognostic (1.42e-1)"	"prognostic favourable (4.60e-6)"	"unprognostic (1.19e-2)"	"unprognostic (9.03e-2)"	"unprognostic (8.05e-2)"	"prognostic unfavourable (6.63e-5)"	3.7	12.2	13.8	1.5	22.6	0.2	6.1	16.9	30.0	7.7	3.7	3.4	1.7	1.3	13.8	7.4	3.3	8.8	4.0	10.9	15.8	22.3	8.1	5.2	3.9	1.2	8.7	22.5	24.8	7.1	13.3	11.5	2.8	18.7	10.2	2.5	3.6	6.6	9.8	5.2	4.4	1.8	8.3	7.2	3.0	2.2	3.6	4.1	0.8	12.0	1.3	1.3	3.6	3.8	0.4	1.6	0.0	0.6	2.1	4.7	1.2	0.4	5.0	13.5	10.4	4.3	5.1	1.0	7.7	6.9	6.6	12.9	1.7	2.3	0.0	2.6	7.9	1.8	16.1	4.1	8.4	0.0	6.2	0.7	1.5	0.4	3.1	1.2	1.0	5.3	4.4	7.3	0.3	4.7	1.9	0.5	7.9	2.3	3.5	0.5	6.7	7.0	4.7	2.2	0.0	4.1	1.8	3.0	9.3	7.7	1.5	1.0	4.3	2.6	4.1	4.7	9.9	9.5	7.3	0.2	0.3	0.0	6.3	0.8	2.6	0.0	0.4	0.0	0.9	0.6	0.8	0.4	1.1	1.3	0.8	0.4	4.7	1.9	0.0	2.1	0.2	1.6	1.6	1.2	13.8	22.6	16.9	30.0	15.8	22.3	8.7	22.5	18.7	4.1
BHLHB9	"GASP3, KIAA1701, p60TRP"	ENSG00000198908	"Basic helix-loop-helix family member b9"	Q6PI77	X	102720688-102753540	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 21.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 5.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000887			Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA000887: "	"unprognostic (4.07e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.70e-3)"	"unprognostic (6.42e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.40e-3)"	"unprognostic (5.06e-3)"	"unprognostic (2.65e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.74e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.46e-2)"	"unprognostic (4.95e-2)"	"unprognostic (8.88e-2)"	2.8	6.4	8.6	1.6	13.0	2.7	3.7	15.3	20.6	5.5	3.4	8.7	2.3	2.1	7.5	5.8	2.9	4.5	3.0	4.9	8.9	12.5	6.3	3.8	2.6	1.5	7.2	12.7	9.9	3.6	9.1	7.1	4.8	21.1	7.2	2.9	3.9	3.6	8.2	4.8	3.4	2.5	7.2	6.3	2.7	2.5	4.4	7.3	1.7	6.6	1.2	2.0	4.1	3.4	0.7	0.3	0.9	0.2	5.3	2.0	0.5	0.5	4.0	13.0	3.9	4.1	2.4	5.2	3.4	4.7	5.7	10.9	3.3	2.3	0.0	3.6	3.9	2.8	7.1	3.8	6.4	0.0	4.2	1.0	3.3	0.7	6.6	0.7	1.3	4.3	3.4	2.5	0.3	5.7	3.0	3.5	5.0	2.2	2.6	0.4	7.6	3.0	1.4	3.8	0.0	3.7	5.8	5.8	5.4	3.8	1.1	0.4	3.2	1.8	5.8	1.5	4.0	2.2	3.3	1.9	4.7	0.0	3.5	0.9	2.4	0.9	0.2	0.2	1.0	0.1	0.9	0.4	1.1	2.0	0.1	0.7	1.3	1.7	0.7	5.3	0.1	0.3	1.6	0.5	8.6	13.0	15.3	20.6	8.9	12.5	7.2	12.7	21.1	7.3
RAB40AL	"RAR2, RLGP"	ENSG00000102128	"RAB40A like"	P0C0E4	X	102937272-102938300	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Deafness, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 2.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;HEK 293: 1.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"											HPA076172			Uncertain	Vesicles				Vesicles		"HPA076172: "	"unprognostic (1.99e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.18e-2)"	"unprognostic (5.90e-10)"	"unprognostic (4.74e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.64e-2)"	0.3	1.0	0.2	0.2	0.3	0.7	0.4	2.1	0.4	0.3	0.4			1.0	0.8	2.9	0.2	0.3	0.7	0.3	0.3	0.3	0.2	0.5	0.5	0.0	0.2		1.0	0.2	0.0	0.9	0.6		0.8	0.1		0.2	0.5	0.0	0.2	0.1	0.6	0.4	0.2	0.1	0.3			0.8		0.2	0.0	0.5	0.0	1.2	0.0	0.3	0.0	0.7	0.0	0.5	0.6	0.8	0.2	0.0	0.0	2.3	0.0	0.2	0.0	0.5	0.0	0.5	0.0	0.6	0.0	0.0	1.2	0.0	0.6	0.2	1.9	0.0	1.5	0.0	0.0	0.5	0.0	0.0	0.3	0.3	0.4	0.3	0.3	0.0	0.0	1.4	0.6	0.9	0.6	1.6	0.0	0.3	0.0	0.2	1.0	0.0	0.1	0.7	0.0	0.2	0.0	0.0	0.0	0.3	1.4	0.5	0.4	0.3	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0										
BEX1		ENSG00000133169	"Brain expressed X-linked 1"	Q9HBH7	X	103062651-103064240	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 150.2;pituitary gland: 64.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 42.0;BJ hTERT+ SV40 Large T+ RasG12V: 62.4;HBF TERT88: 69.6;HL-60: 152.4;SCLC-21H: 47.7;THP-1: 43.1;U-937: 47.8"	"Cancer enhanced"	"Detected in many"		"glioma: 111.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 6.4"	"Low lineage specificity"	"Detected in many"											"HPA045384, HPA078630"	Approved		Approved	Cytosol				Cytosol		"HPA045384: , HPA078630: "	"prognostic favourable (6.43e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.28e-3)"	"unprognostic (2.09e-1)"	"prognostic favourable (8.16e-8)"	"unprognostic (1.14e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (6.88e-4)"	"unprognostic (7.34e-2)"	1.8	37.4	66.4	2.8	65.1	16.3	1.9	44.7	150.2	1.8	3.0	6.2	0.0	3.3	7.7	25.2	1.6	10.1	1.8	3.6	77.4	81.0	4.5	3.0	2.1	1.7	38.9	67.8	9.5	30.9	48.1	64.3	1.5	35.8	3.8	3.1	4.7	2.2	2.9	1.3	1.5	3.9	3.3	24.3	2.3	5.0	27.5	12.0	0.0	12.1	0.0	1.5	1.5	0.4	2.4	0.2	6.4	0.5	1.7	3.1	1.5	0.0	0.0	3.8	0.0	0.0	0.0	0.1	2.1	0.0	42.0	62.4	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	69.6	0.0	0.1	12.7	0.0	8.2	0.7	152.4	0.2	0.9	0.0	9.1	0.0	0.0	0.0	0.0	8.4	0.0	28.6	0.0	34.7	6.2	0.0	0.0	0.7	0.0	0.0	47.7	27.5	0.0	0.0	0.1	0.0	43.1	0.0	0.0	14.4	0.1	1.6	7.4	0.2	0.0	5.6	47.8	2.7	0.6	0.5	6.4	0.7	0.1	0.7	1.2	2.0	1.2	0.1	2.4	3.1	1.4	1.2	1.7	0.4	0.2	0.9	1.5	66.4	65.1	44.7	89.0	77.4	81.0	38.9	67.8	35.8	12.0
NXF3		ENSG00000147206	"Nuclear RNA export factor 3"	Q9H4D5	X	103075810-103093125	"Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 18.0;gallbladder: 16.4;testis: 50.0"	"Cell line enhanced"	"Detected in some"		"HEL: 16.4;HL-60: 15.5;NB-4: 14.5;THP-1: 11.2;U-2197: 47.7;U-937: 34.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA003132, HPA046757"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA003132: AB_1079514, HPA046757: "	"unprognostic (1.20e-3)"	"unprognostic (6.72e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.05e-2)"	"unprognostic (6.75e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.86e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.21e-10)"	"unprognostic (1.90e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.56e-1)"	1.3	0.5	0.1	0.0	0.3	2.4	0.2	0.1	0.2	0.9	0.3	0.0	1.0	0.2	0.2	8.2	0.6	18.0	16.4	1.1	0.2	0.1	0.7	2.1	5.7	1.3	0.3	0.0	4.4	0.7	0.0	0.1	0.2	0.1	0.3	0.6	0.4	4.2	0.3	0.1	0.1	1.9	0.2	0.3	0.4	0.2	50.0	0.0	0.0	0.2	0.9	0.2	0.2	0.3	0.0	0.0	0.5	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.0	16.4	0.1	0.0	0.0	15.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.0	0.3	0.0	0.0	14.5	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	47.7	0.0	0.0	0.0	0.0	0.2	34.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.9	0.1	0.3	0.1	0.2	0.2	0.1	0.3	0.0	0.1	0.0
BEX4	"BEXL1, FLJ10097"	ENSG00000102409	"Brain expressed X-linked 4"	Q9NWD9	X	103215092-103217246	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 37.4;HMC-1: 45.3;K-562: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA045105, HPA051935"	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA045105: AB_10966792, HPA051935: "	"unprognostic (1.45e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.75e-3)"	"unprognostic (3.69e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.03e-1)"	"unprognostic (6.33e-2)"	"prognostic favourable (9.41e-4)"	"unprognostic (1.62e-2)"	"prognostic favourable (2.54e-14)"	"unprognostic (1.62e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.33e-2)"	9.8	36.8	63.8	8.6	71.4	21.5	20.8	53.6	68.8	20.7	14.3	29.5	11.5	6.4	25.5	99.8	17.7	24.5	14.8	35.1	61.6	77.6	34.9	5.1	15.8	10.7	54.3	54.7	38.8	12.6	40.7	34.1	29.4	50.5	30.1	10.1	18.0	27.1	32.1	2.5	7.5	8.7	20.9	51.2	23.1	9.6	16.2	24.4	8.6	47.8	3.5	12.3	14.1	11.5	12.9	28.3	36.7	10.4	34.0	25.7	15.0	0.0	0.0	23.2	0.0	5.9	4.1	20.7	5.4	4.7	10.2	18.9	0.0	0.3	0.0	9.1	3.8	0.1	9.3	1.2	11.4	0.0	8.7	37.4	0.0	0.0	18.1	28.0	45.3	15.3	3.1	5.3	0.0	11.9	52.4	0.1	3.1	0.1	19.5	0.2	28.0	1.6	0.0	6.7	0.1	9.4	0.5	17.3	26.4	1.9	0.3	1.1	0.9	0.3	0.3	1.3	8.3	0.1	0.0	3.0	1.3	0.0	3.9	0.0	1.1	36.7	8.6	14.8	12.1	10.4	10.1	12.9	14.7	12.2	18.2	12.6	25.7	20.2	1.9	34.0	8.5	28.3	13.5	15.0	63.8	71.4	53.6	68.8	61.6	77.6	54.3	54.7	50.5	24.4
TCEAL8	"MGC45400, WEX3"	ENSG00000180964	"Transcription elongation factor A like 8"	Q8IYN2	X	103252995-103255203	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA059115	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA059115: "	"unprognostic (1.51e-2)"	"unprognostic (4.56e-2)"	"unprognostic (9.24e-2)"	"unprognostic (7.13e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (8.53e-6)"	"unprognostic (3.71e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.52e-2)"	"unprognostic (4.80e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.26e-2)"	"unprognostic (7.22e-2)"	"unprognostic (9.12e-2)"	"unprognostic (9.32e-2)"	24.6	30.9	37.3	16.8	32.5	12.4	30.0	34.5	38.5	34.8	25.1	25.6	25.8	14.9	29.6	67.9	26.7	22.7	27.9	43.9	33.4	32.4	33.9	20.2	20.8	20.6	34.5	25.8	36.7	25.0	32.2	64.5	32.9	39.4	31.6	24.7	26.0	29.7	28.6	8.8	19.8	19.9	31.1	34.6	24.3	21.5	21.0	22.5	30.7	35.2	18.8	20.9	31.7	22.4	17.5	28.7	16.3	9.4	33.3	30.3	15.2	9.8	5.1	23.7	11.3	35.0	59.2	11.4	20.3	31.7	18.3	29.9	4.0	20.4	4.8	13.6	24.2	6.7	4.0	24.5	24.4	0.1	12.7	22.2	7.0	6.1	21.9	22.2	22.9	40.3	14.8	16.4	0.0	26.2	27.2	5.3	46.1	0.0	18.5	9.3	26.4	10.8	7.6	31.6	1.5	26.3	7.6	12.6	16.6	11.2	4.0	26.3	7.2	7.8	16.5	11.9	15.2	35.2	6.8	5.3	8.8	0.2	19.1	12.3	18.9	16.3	9.4	5.5	19.7	8.2	23.5	17.5	23.9	21.2	16.9	14.8	26.5	22.8	0.9	33.3	6.2	28.7	30.3	15.2	37.3	32.5	34.5	38.5	33.4	32.4	34.5	25.8	39.4	22.5
TCEAL5	WEX4	ENSG00000204065	"Transcription elongation factor A like 5"	Q5H9L2	X	103273691-103276872	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.4;testis: 45.9"	"Group enriched"	"Detected in some"	7	"SCLC-21H: 7.3;SH-SY5Y: 22.8"	"Cancer enhanced"	"Detected in many"		"glioma: 13.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045564, HPA058982, HPA072199"	Supported		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA045564: , HPA058982: , HPA072199: "	"unprognostic (1.30e-3)"	"unprognostic (2.41e-1)"		"prognostic unfavourable (9.09e-4)"	"unprognostic (9.68e-2)"	"unprognostic (8.75e-4)"		"unprognostic (1.21e-1)"		"unprognostic (8.11e-2)"	"prognostic favourable (8.60e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.03e-4)"	2.0	11.2	21.9	2.1	31.8	1.3	3.3	32.7	56.4	4.7	2.2	6.6	0.0	1.9	6.0	7.8	1.5	1.6	2.0	2.0	22.3	23.1	1.5	1.3	1.5	1.3	13.0	24.0	5.0	2.1	1.3	23.1	1.3	19.8	3.7	2.0	1.4	2.3	5.4	1.4	1.3	2.4	4.3	11.0	1.3	1.5	45.9	8.4	0.0	3.4	0.0	1.3	2.1	1.1	0.7	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.2	0.0	0.2	0.0	0.1	0.0	0.0	21.9	31.8	32.7	31.9	22.3	23.1	13.0	24.0	19.8	8.4
BEX2	DJ79P11.1	ENSG00000133134	"Brain expressed X-linked 2"	Q9BXY8	X	103309346-103311046	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"brain: 79.2;epididymis: 67.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 30.7;NTERA-2: 29.6;SCLC-21H: 43.6;SH-SY5Y: 19.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 18.0;NK-cells: 21.3;T-cells: 26.8"									"HPA045384, HPA078630"	Uncertain		Uncertain	Cytosol				Cytosol		"HPA045384: , HPA078630: "	"unprognostic (7.56e-2)"	"unprognostic (7.08e-2)"	"unprognostic (3.46e-2)"	"prognostic unfavourable (8.54e-7)"	"unprognostic (3.21e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.27e-2)"	"prognostic favourable (1.52e-4)"	"unprognostic (7.36e-3)"	"unprognostic (6.82e-2)"	"unprognostic (8.22e-3)"	"unprognostic (6.63e-2)"	"prognostic favourable (3.05e-13)"	"unprognostic (4.14e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.38e-3)"	1.7	39.6	49.1	4.1	62.6	6.8	10.9	44.9	79.2	5.8	4.7	11.5	3.0	2.7	14.7	67.1	3.0	8.9	4.8	7.3	53.4	57.6	26.4	1.4	6.6	7.3	32.5	40.3	29.0	13.5	29.6	40.1	5.0	29.6	12.4	4.1	11.5	11.1	12.8	2.5	4.2	4.2	5.7	18.7	7.9	6.5	13.2	13.6	3.1	52.8	1.3	9.2	3.7	2.2	18.0	3.5	4.0	0.1	21.3	26.8	7.1	0.0	0.8	3.7	0.0	0.0	0.0	14.7	0.1	2.0	2.5	3.6	2.5	1.2	0.0	10.3	0.0	0.6	0.0	3.0	2.2	0.0	8.0	0.4	0.4	0.1	15.0	0.0	8.2	0.9	30.7	1.2	9.4	0.1	5.3	0.2	0.3	1.3	6.1	0.0	29.6	2.6	0.0	0.0	0.0	1.2	1.1	43.6	19.9	1.9	0.4	6.5	3.6	0.0	0.0	0.0	2.9	0.1	0.6	10.1	6.4	0.0	4.9	0.0	0.4	4.0	0.1	0.3	8.5	0.1	11.8	18.0	16.8	9.8	0.5	15.0	26.8	19.2	0.5	21.3	0.0	3.5	11.3	7.1	49.1	62.6	44.9	60.5	53.4	57.6	32.5	40.3	29.6	13.6
TCEAL7	"MGC23947, WEX5"	ENSG00000182916	"Transcription elongation factor A like 7"	Q9BRU2	X	103330196-103332326	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 70.4"	"Cell line enhanced"	"Detected in some"		"AF22: 23.2;BJ hTERT+ SV40 Large T+ RasG12V: 20.9;hTEC/SVTERT24-B: 23.2;LHCN-M2: 19.6;SCLC-21H: 58.6;U-87 MG: 21.8"	"Cancer enriched"	"Detected in many"	10	"glioma: 39.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"NK-cells: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA051507, HPA065080"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA051507: , HPA065080: "	"unprognostic (1.09e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.12e-2)"	"prognostic unfavourable (4.31e-4)"	"prognostic unfavourable (3.53e-4)"	"unprognostic (2.62e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.35e-3)"	4.9	22.1	31.7	3.8	33.4	1.0	7.8	33.0	70.4	16.8	6.4	20.1	1.8	3.9	36.4	14.7	5.1	5.4	9.7	9.5	31.1	44.2	4.6	2.6	3.8	2.5	34.4	27.4	23.2	1.3	1.3	14.0	2.5	51.8	10.3	6.9	2.0	2.9	11.3	2.9	1.5	4.9	23.3	45.1	5.0	2.6	3.2	19.4	0.0	3.0	2.2	1.9	7.5	5.7	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	23.2	0.0	10.2	15.8	4.1	3.3	17.0	7.3	20.9	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.4	12.6	0.0	0.2	0.1	0.0	0.0	5.1	0.0	0.0	13.2	0.0	23.2	0.0	7.5	0.1	0.0	19.6	0.0	0.0	0.0	0.1	0.0	0.0	14.7	0.0	0.0	0.0	58.6	15.7	0.0	0.1	0.0	0.0	0.0	0.0	10.8	0.4	0.1	0.0	0.0	0.0	0.0	21.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	31.7	33.4	33.0	46.7	31.1	44.2	34.4	27.4	51.8	19.4
TCEAL9	"DKFZp313K1940, WBP5, WEX6"	ENSG00000185222	"Transcription elongation factor A like 9"	Q9UHQ7	X	103356489-103358462	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 18.6"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011790	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA011790: AB_2214932"	"unprognostic (1.26e-1)"	"unprognostic (9.24e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.67e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.31e-3)"	"unprognostic (5.85e-2)"	"unprognostic (7.64e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.10e-3)"	"unprognostic (4.33e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.58e-2)"	28.2	61.0	17.9	14.7	20.9	3.7	42.1	20.7	24.0	30.8	20.6	10.9	35.0	7.6	32.3	59.6	21.4	20.1	25.6	29.4	19.5	20.5	38.8	12.6	25.9	9.5	23.7	15.0	93.4	15.7	19.6	54.5	67.1	40.3	27.6	17.7	15.2	15.7	45.4	7.8	12.1	11.7	30.2	44.1	26.4	23.1	27.5	23.6	5.4	58.6	18.5	7.6	35.5	75.7	1.8	18.6	0.9	1.3	1.1	3.5	1.3	17.8	8.8	27.9	14.2	60.6	59.0	20.9	37.6	50.4	26.7	43.7	16.9	19.0	0.0	55.8	30.7	10.8	4.8	23.9	36.0	0.0	10.4	18.3	21.5	10.8	41.7	0.0	0.0	40.4	23.3	35.6	35.7	44.3	16.1	1.3	63.3	0.0	8.9	0.1	17.3	16.9	0.0	55.8	0.0	32.2	33.2	12.6	15.2	23.6	0.7	24.5	3.8	1.0	36.1	23.9	10.4	71.7	10.4	0.0	1.0	0.1	57.9	0.0	18.9	0.9	1.3	0.0	0.2	0.7	0.0	1.8	1.5	0.5	1.0	1.0	3.5	2.9	0.0	1.1	0.1	18.6	0.9	1.3	17.9	20.9	20.7	24.0	19.5	20.5	23.7	15.0	40.3	23.6
BEX3	"Bex, DXS6984E, HGR74, NADE, NGFRAP1"	ENSG00000166681	"Brain expressed X-linked 3"	Q00994	X	103376340-103378077	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory CD4 T-cell: 18.8;naive CD4 T-cell: 40.8;naive CD8 T-cell: 18.8;T-reg: 32.3"	"Lineage enriched"	"Detected in many"	6	"T-cells: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018886	Approved		Supported	Cytosol				Cytosol		"HPA018886: AB_1854453"	"unprognostic (7.74e-2)"	"unprognostic (6.56e-2)"	"unprognostic (8.15e-3)"	"prognostic unfavourable (7.23e-5)"	"unprognostic (2.70e-1)"	"unprognostic (1.93e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.00e-1)"	"prognostic favourable (1.28e-4)"	"prognostic unfavourable (3.48e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.32e-2)"	"unprognostic (8.68e-2)"	21.1	66.1	73.2	9.4	84.2	6.7	22.2	47.1	92.1	28.9	15.2	22.7	30.8	7.7	35.4	134.6	16.0	36.8	18.8	42.9	71.3	87.4	49.8	23.0	22.0	6.7	63.7	75.8	92.7	28.4	39.7	51.5	49.3	82.6	40.8	14.4	18.5	23.4	59.1	4.7	9.0	9.8	29.8	65.2	20.0	13.3	28.1	33.5	10.6	57.0	8.9	7.3	22.7	20.0	1.2	3.5	3.7	0.9	6.4	40.8	17.1	23.5	35.4	68.6	25.8	62.0	69.9	29.1	26.8	47.1	34.7	55.7	37.0	27.6	0.0	49.5	33.2	9.8	47.3	33.3	37.8	0.1	32.0	10.7	56.2	10.3	46.2	0.1	4.4	71.9	29.8	46.2	43.3	53.7	0.0	0.1	65.7	56.2	25.0	0.3	85.3	26.1	0.0	39.7	0.0	38.3	44.4	44.8	44.8	29.5	0.3	39.8	16.5	3.7	31.8	22.2	14.5	42.9	12.1	0.2	0.1	0.1	45.4	0.0	21.5	0.0	0.9	0.2	1.0	0.2	0.6	1.2	18.8	5.0	1.5	0.3	40.8	18.8	3.7	6.4	0.1	3.5	32.3	17.1	73.2	84.2	47.1	79.7	71.3	87.4	63.7	75.8	82.6	33.5
RAB40A	"Rar-2, RAR2A"	ENSG00000172476	"RAB40A, member RAS oncogene family"	Q8WXH6	X	103499130-103519489	"Cancer-related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 34.0"	"Cell line enhanced"	"Detected in many"		"AF22: 6.4;NTERA-2: 7.1"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in single"	5	"basal ganglia: 4.2"	"Cell type enriched"	"Detected in single"	5	"memory B-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"B-cells: 1.2"									HPA076172			Uncertain	Vesicles				Vesicles		"HPA076172: "	"unprognostic (3.49e-1)"	"unprognostic (6.01e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.49e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.82e-2)"	"unprognostic (4.43e-1)"	"unprognostic (7.36e-4)"	"unprognostic (7.85e-3)"	"unprognostic (9.39e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.11e-3)"	2.0	1.4	0.6	0.6	4.2	0.0	0.8	0.6	1.1	2.8	0.8	0.6	11.9	0.5	5.5	34.0	10.6	2.6	2.9	0.6	0.6	0.9	1.3	0.6	2.0	1.7	0.6	0.6	5.4	0.6	0.6	2.4	0.8	0.8	5.5	0.4	0.6	0.6	6.2	0.6	0.7	0.9	1.3	0.6	0.8	0.5	7.8	0.6	0.6	0.6	0.6	0.6	1.5	2.0	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.4	1.7	6.4	0.2	1.4	1.9	3.1	1.9	0.4	0.3	0.5	1.3	0.9	1.6	2.4	0.3	0.1	0.4	0.1	0.3	0.0	3.7	0.5	2.9	0.3	0.6	0.1	0.2	1.5	0.3	0.6	0.4	0.3	2.3	1.0	0.6	0.4	0.4	0.2	7.1	1.0	0.0	0.5	0.1	0.1	0.6	2.7	3.3	0.6	0.1	1.3	0.0	0.2	3.2	2.6	1.5	4.0	1.8	1.1	0.7	1.2	2.9	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.6	4.2	0.6	0.6	0.6	0.9	0.6	0.6	0.8	0.6
TCEAL4	"FLJ21174, WEX7"	ENSG00000133142	"Transcription elongation factor A like 4"	Q96EI5	X	103576231-103587736	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"																						"unprognostic (2.21e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (3.11e-5)"	"unprognostic (1.08e-1)"	"prognostic favourable (2.75e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.16e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.49e-2)"	"unprognostic (3.35e-2)"	"unprognostic (5.46e-2)"	"unprognostic (7.63e-2)"	25.6	49.7	30.9	13.1	35.5	7.5	40.5	21.6	41.4	94.8	25.7	27.3	52.6	9.7	108.2	75.9	38.1	57.4	25.5	31.0	30.2	27.8	30.9	26.2	23.2	11.2	30.2	27.4	136.4	17.9	38.5	45.2	32.1	41.8	56.2	15.3	22.0	18.8	80.4	25.1	25.4	15.1	83.4	37.0	25.6	23.7	36.8	25.9	4.8	28.5	15.2	8.9	81.4	46.0	17.8	18.8	3.7	14.8	11.6	27.1	6.7	26.3	20.3	17.2	15.3	60.6	36.2	17.3	29.0	29.2	18.2	21.4	8.6	19.8	6.5	32.3	31.6	17.0	18.9	21.1	22.3	0.1	12.8	8.9	30.0	11.1	53.7	0.0	7.4	48.1	32.7	15.1	35.1	26.3	0.1	7.1	53.8	64.8	9.5	0.4	15.7	24.2	9.5	29.3	1.2	27.5	32.6	17.5	17.3	46.7	11.4	37.0	18.2	4.3	32.5	18.3	7.2	46.2	11.9	2.1	11.9	0.2	25.2	0.1	18.5	3.7	14.8	0.5	6.9	7.5	9.8	17.8	9.5	7.3	18.8	12.2	8.7	9.0	0.6	11.6	5.4	5.8	27.1	6.7	30.9	35.5	21.6	41.4	30.2	27.8	30.2	27.4	41.8	25.9
TCEAL3	"MGC15737, WEX8"	ENSG00000196507	"Transcription elongation factor A like 3"	Q969E4	X	103607451-103629690	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA045564, HPA058982"	Uncertain									"HPA045564: , HPA058982: "	"unprognostic (2.55e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.41e-1)"	"prognostic favourable (4.05e-4)"	"unprognostic (2.26e-1)"	"prognostic favourable (8.33e-4)"	"unprognostic (6.35e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-3)"	"unprognostic (7.19e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.64e-1)"	14.8	36.9	36.8	11.0	34.2	9.9	18.3	30.2	47.4	35.0	15.5	24.9	33.7	9.3	42.8	24.9	17.8	27.4	17.9	21.0	33.7	40.7	16.0	5.1	12.5	7.3	43.4	29.1	49.8	22.6	28.3	35.2	13.5	40.3	45.5	7.9	11.9	21.9	55.4	9.7	8.0	8.9	48.3	44.0	18.5	14.5	15.2	23.6	0.8	17.7	4.0	6.4	44.3	23.0	9.6	9.7	4.5	6.9	14.7	12.2	5.3	24.7	2.6	6.7	5.5	23.4	12.0	0.2	37.1	17.5	16.8	22.4	0.0	2.4	0.0	4.6	26.6	9.8	4.8	14.4	12.3	0.0	1.2	1.8	10.5	0.0	22.5	0.0	8.2	15.4	4.4	11.9	17.0	11.4	0.0	7.2	22.8	20.6	1.1	0.1	2.9	7.1	8.6	4.3	0.1	7.9	4.9	10.3	8.5	1.7	2.1	8.5	10.2	5.7	14.9	8.8	4.6	18.0	11.4	7.7	3.6	0.0	21.9	0.0	19.3	4.5	6.9	3.8	11.1	3.5	12.2	7.3	9.7	8.8	7.6	9.6	9.7	11.8	1.1	14.7	0.3	9.7	12.2	5.3	36.8	34.2	30.2	31.1	33.7	40.7	43.4	29.1	40.3	23.6
TCEAL1	"p21, pp21, SIIR, WEX9"	ENSG00000172465	"Transcription elongation factor A like 1"	Q15170	X	103628704-103630953	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057345, HPA060384"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA057345: , HPA060384: "	"unprognostic (1.98e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.60e-3)"	"unprognostic (6.09e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.85e-3)"	"unprognostic (6.54e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.56e-2)"	"unprognostic (8.76e-2)"	10.5	24.7	23.8	9.1	20.8	4.2	19.5	19.9	45.1	29.6	17.1	5.5	29.7	7.3	45.8	20.2	18.4	32.1	17.6	13.5	27.0	18.6	10.6	7.5	10.1	7.8	12.2	25.3	59.1	9.0	13.5	11.2	8.5	19.9	25.4	8.4	6.1	6.4	40.3	22.4	8.1	8.7	49.2	23.5	9.3	13.3	9.3	13.2	3.1	15.5	10.5	4.7	33.9	24.7	18.3	16.6	11.3	8.4	13.4	14.7	8.2	9.6	9.3	5.3	7.2	22.9	15.9	7.0	13.7	13.9	13.5	14.7	4.1	9.6	4.5	14.2	17.7	9.7	8.8	7.2	10.0	0.0	10.9	6.0	13.0	7.9	10.3	0.0	9.2	19.4	14.1	10.4	5.7	13.8	2.2	2.5	26.9	10.6	5.3	0.1	1.7	15.1	5.5	17.0	0.0	18.5	9.6	7.3	6.1	14.0	6.6	15.1	6.2	5.7	10.9	9.8	3.6	22.8	7.0	2.5	8.0	0.1	12.8	0.0	9.7	11.3	8.4	0.5	10.4	5.7	14.7	18.3	9.4	8.6	16.6	16.1	12.5	14.3	0.9	13.4	2.3	13.0	8.0	8.2	23.8	20.8	19.9	45.1	27.0	18.6	12.2	25.3	19.9	13.2
MORF4L2	"KIAA0026, MRGX"	ENSG00000123562	"Mortality factor 4 like 2"	Q15014	X	103675496-103688158	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031872, HPA054102"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA031872: , HPA054102: AB_2682379"	"prognostic unfavourable (9.83e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.14e-3)"	"unprognostic (2.59e-1)"	"prognostic unfavourable (4.29e-5)"	"unprognostic (5.27e-2)"	"unprognostic (6.34e-3)"	"unprognostic (2.41e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.10e-2)"	"prognostic unfavourable (7.86e-7)"	"unprognostic (8.54e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.05e-1)"	33.3	51.4	50.4	26.6	53.5	23.9	51.6	52.8	66.8	76.2	32.9	29.7	62.9	25.8	74.0	63.4	40.2	55.2	39.5	38.5	50.0	71.2	44.0	76.5	34.3	19.3	45.5	48.8	99.8	36.2	38.6	81.8	77.4	63.5	47.4	40.3	23.4	35.2	57.8	44.9	27.4	27.8	93.7	46.1	25.9	31.5	33.5	34.7	21.5	46.8	35.6	29.9	55.5	45.3	21.6	40.7	24.7	24.7	25.4	29.1	21.9	61.6	41.9	56.3	24.9	84.0	63.1	75.7	82.7	72.4	68.7	70.8	42.9	55.6	42.1	67.8	78.6	42.0	70.4	61.3	86.2	19.3	32.0	22.4	72.1	48.5	92.1	30.6	21.4	68.5	54.7	58.6	77.3	75.4	36.7	58.3	84.1	62.4	27.3	30.3	53.5	47.7	27.8	52.9	44.6	68.7	37.6	53.8	41.9	62.4	46.3	61.7	30.6	29.9	62.9	40.2	26.9	69.6	44.1	29.0	35.4	37.5	71.8	62.4	60.2	24.7	23.3	18.4	25.4	24.7	29.1	21.6	24.3	23.9	24.3	19.1	26.9	23.1	9.5	25.4	24.6	40.7	19.7	21.9	50.4	53.5	52.8	66.8	50.0	71.2	45.5	48.8	63.5	34.7
GLRA4		ENSG00000188828	"Glycine receptor alpha 4"	Q5JXX5	X	103707224-103728655	"Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 3.5;endometrium 1: 5.1;smooth muscle: 6.7"	"Cell line enriched"	"Detected in single"	13	"SCLC-21H: 7.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA044759	Uncertain									"HPA044759: AB_10795885"	"unprognostic (4.96e-2)"		"unprognostic (2.09e-2)"		"unprognostic (3.95e-1)"	"unprognostic (2.24e-1)"			"unprognostic (1.28e-1)"		"unprognostic (1.08e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.94e-7)"	"unprognostic (4.49e-1)"	"unprognostic (1.94e-1)"		"unprognostic (1.87e-1)"	0.0	0.0	0.9	0.1	1.5	0.0	0.3	2.8	3.5	1.9	1.4	0.9	0.0	2.2	5.1	0.1	0.2	0.6	0.1	0.1	1.5	1.8	0.0	0.0	0.0	0.0	0.5	1.0	1.2	0.0	2.4	0.2	0.0	1.2	0.5	1.8	0.0	0.0	0.4	0.1	0.3	2.3	6.7	1.5	0.0	0.1	1.4	0.0	2.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.5	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	1.5	2.8	3.5	1.5	1.8	0.5	1.0	1.2	0.0
TMEM31	MGC39655	ENSG00000179363	"Transmembrane protein 31"	Q5JXX7	X	103710909-103714028	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	22	"testis: 46.6"	"Cell line enhanced"	"Detected in some"		"AF22: 3.0;BEWO: 7.1;MCF7: 10.2;NTERA-2: 3.1;U-937: 3.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA052760			Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"HPA052760: "	"unprognostic (9.42e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.75e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.77e-1)"	"unprognostic (5.91e-5)"	"unprognostic (1.75e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.68e-2)"	0.2	0.0	0.3	0.2	0.6	0.0	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.0	0.4	1.4	0.2	0.4	0.2	0.2	0.5	0.8	0.2	0.2	0.2	0.2	0.6	0.2	0.8	0.2	0.4	0.2	0.6	0.2	0.3	0.0	0.2	0.2	0.2	0.6	0.2	0.2	0.2	0.7	0.2	0.0	46.6	0.2	0.2	0.2	0.2	0.2	0.2	0.2	2.0	1.8	0.0	0.9	0.0	0.8	0.1	0.0	0.0	3.0	0.1	0.2	0.0	7.1	0.1	0.1	0.3	0.5	0.0	0.3	0.1	0.2	0.0	0.0	1.2	0.0	0.4	0.0	2.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.3	10.2	0.3	1.9	3.1	0.0	1.2	0.0	0.1	0.0	0.0	0.9	0.6	0.7	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.8	0.0	3.8	0.3	0.0	0.3	0.0	0.2	0.0	0.0	0.9	0.2	0.0	1.4	2.0	0.8	0.4	0.0	0.0	0.9	1.8	0.0	0.1	0.3	0.6	0.2	0.2	0.5	0.8	0.6	0.2	0.2	0.2
PLP1	"GPM6C, PLP, SPG2"	ENSG00000123560	"Proteolipid protein 1"	P60201	X	103773718-103792619	"Cancer-related genes, Disease related genes, Predicted membrane proteins"			"Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"brain: 463.6"	"Group enriched"	"Detected in some"	5	"SK-MEL-30: 66.3;WM-115: 39.6"	"Group enriched"	"Detected in many"	22	"glioma: 160.5;melanoma: 75.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"plasmacytoid DC: 2.3"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004128	Enhanced									"HPA004128: AB_1079635"	"unprognostic (5.72e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.95e-2)"		"unprognostic (2.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.62e-5)"	"unprognostic (4.91e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.16e-2)"	3.6	5.6	90.6	2.8	109.9	1.9	3.1	8.9	463.6	3.9	5.7	208.1	0.0	3.3	3.6	3.5	4.2	2.5	4.0	5.0	143.8	73.8	2.1	2.1	2.1	2.0	174.8	42.2	3.0	2.2	17.9	0.3	1.9	124.4	3.6	5.4	0.0	3.4	9.3	2.2	7.3	5.1	7.0	453.8	2.0	2.8	9.2	145.2	0.0	2.0	0.0	2.0	2.7	0.8	0.0	2.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.5	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	39.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	90.6	109.9	8.9	68.1	143.8	73.8	174.8	42.2	124.4	145.2
RAB9B	RAB9L	ENSG00000123570	"RAB9B, member RAS oncogene family"	Q9NP90	X	103822322-103832228	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 27.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 6.0;RH-30: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061932	Approved				"Intracellular and membrane"					"HPA061932: "	"unprognostic (1.69e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.28e-5)"	"unprognostic (5.81e-2)"	"unprognostic (3.89e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.34e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.52e-4)"	"unprognostic (1.10e-1)"	"unprognostic (9.21e-4)"	"unprognostic (1.37e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.04e-1)"	2.7	4.3	7.8	1.6	19.1	0.6	2.2	20.0	12.6	2.8	5.9	1.3	5.4	1.8	7.2	3.7	11.4	6.7	3.5	27.6	7.2	11.0	1.0	0.7	1.3	1.2	5.0	9.3	9.9	1.7	6.6	7.2	0.8	10.8	10.0	3.5	1.8	1.8	13.2	11.0	1.0	1.9	14.8	7.6	1.2	2.6	2.7	4.3	0.0	2.4	1.4	1.0	7.6	1.8	2.2	0.4	0.6	0.2	2.9	0.8	0.4	0.0	0.0	5.1	2.6	1.5	0.3	0.2	1.3	3.2	3.2	3.0	0.3	0.0	0.3	3.0	2.5	0.0	0.8	0.2	2.9	0.2	3.3	0.2	0.0	0.0	0.4	0.4	0.2	0.8	0.0	1.4	0.0	0.2	0.0	1.9	0.2	2.2	6.0	0.0	0.9	0.9	5.3	5.7	0.2	1.8	0.5	5.2	3.7	0.3	0.1	1.0	0.6	0.3	0.2	0.2	0.9	1.7	1.0	0.3	0.0	0.4	2.8	0.3	1.6	0.0	0.1	0.6	0.2	0.2	0.0	1.9	0.2	0.0	0.4	2.2	0.8	0.2	0.0	2.9	0.0	0.3	0.4	0.4	7.8	19.1	20.0	12.6	7.2	11.0	5.0	9.3	10.8	4.3
TMSB15B	MGC39900	ENSG00000158427	"Thymosin beta 15B"	P0CG35	X	103918896-103966712	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 33.0;REH: 24.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA064607	Uncertain									"HPA064607: "	"unprognostic (7.47e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.58e-6)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.68e-2)"	"unprognostic (9.33e-4)"	"unprognostic (1.16e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.72e-1)"	"unprognostic (5.09e-3)"	3.9	1.6	2.9	9.4	6.7	4.7	7.4	9.9	6.7	9.1	4.9	2.5	1.4	2.4	11.7	5.7	2.2	5.8	3.8	2.9	7.8	4.3	2.0	0.5	3.0	10.3	3.8	3.3	15.9	2.7	3.7	8.2	2.3	4.0	6.0	4.5	2.5	2.2	4.9	0.9	3.2	3.2	7.9	2.6	3.0	3.6	4.0	2.2	15.6	2.0	0.9	5.8	4.3	7.0	10.6	11.1	3.2	1.6	4.2	7.1	1.9	0.0	1.7	33.0	14.4	3.2	3.3	0.9	3.0	3.2	8.9	15.1	2.4	1.0	3.0	2.3	3.4	0.1	0.4	0.5	9.0	1.2	12.7	4.6	0.0	0.1	2.6	0.7	0.5	2.4	2.7	5.2	1.5	14.9	2.1	10.4	10.5	0.5	10.1	0.1	5.4	3.9	24.7	8.8	1.2	6.1	3.8	7.4	11.6	0.4	0.2	4.3	1.5	2.6	17.8	4.4	5.1	3.9	5.0	1.3	0.6	12.4	5.5	0.6	1.1	3.2	1.0	2.5	2.6	1.6	1.7	10.6	3.0	1.9	2.2	9.3	6.4	4.0	0.9	4.2	0.5	11.1	7.1	1.9	2.9	6.7	9.9	6.7	7.8	4.3	3.8	3.3	4.0	2.2
H2BFWT		ENSG00000123569	"H2B histone family member W, testis specific"	Q7Z2G1	X	104011147-104013687	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in single"		"testis: 3.2"	"Group enriched"	"Detected in some"	5	"NTERA-2: 1.9;SiHa: 1.0;U-266/84: 3.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA056289	Uncertain									"HPA056289: "						"unprognostic (5.07e-2)"				"unprognostic (1.55e-1)"					"unprognostic (1.15e-1)"		"unprognostic (1.85e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.8		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2			0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0										
H2BFM		ENSG00000101812	"H2B histone family member M"	P0C1H6	X	104039949-104042454	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"testis: 19.0"	"Cell line enhanced"	"Detected in many"		"AF22: 5.5;Karpas-707: 7.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in many"																															"unprognostic (1.87e-1)"					"unprognostic (1.87e-1)"		"unprognostic (1.54e-1)"	0.4	0.3	0.6	0.4	0.7	0.7	0.9	0.5	0.5	0.4	0.4	0.4	0.4	0.0	2.4	1.5	0.4	1.4	0.9	0.4	0.6	0.5	0.4	0.4	0.4	1.2	0.4	0.4	4.0	0.4	0.4	0.4	0.4	0.4	0.8	0.2	0.4	0.4	1.0	0.4	1.0	0.4	2.0	0.4	0.6	0.3	19.0	0.4	0.4	0.4	0.4	1.1	0.5	0.4	0.3	1.1	2.6	0.0	0.4	0.4	0.1	0.0	0.6	5.5	3.8	1.0	2.0	0.5	0.7	0.5	1.2	1.6	1.2	0.2	1.2	0.4	0.4	0.0	0.5	0.0	2.4	1.4	2.7	0.7	0.0	0.0	1.3	0.4	0.8	0.3	0.5	1.7	0.4	1.1	0.0	7.1	2.4	0.9	3.4	0.0	2.6	0.5	1.8	2.3	0.7	1.8	1.3	1.1	4.7	0.0	0.0	0.0	0.0	0.8	1.7	4.1	0.7	0.8	1.3	0.4	0.0	2.4	0.7	0.4	0.8	2.6	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.3	0.4	0.2	0.0	0.4	0.0	1.1	0.0	0.1	0.6	0.7	0.5	0.5	0.6	0.5	0.4	0.4	0.4	0.4
TMSB15B		ENSG00000269226	"Thymosin beta 15B"		X	104063871-104076212	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"endometrium 1: 4.2;ovary: 6.7"	"Cell line enhanced"	"Detected in many"		"AF22: 11.2;AN3-CA: 10.6;Karpas-707: 11.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																						"unprognostic (5.95e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.89e-2)"		"unprognostic (1.04e-1)"	"unprognostic (3.12e-1)"	"unprognostic (6.46e-2)"	"unprognostic (9.11e-3)"	"unprognostic (2.61e-2)"	"unprognostic (4.07e-4)"	"unprognostic (1.93e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.07e-2)"	0.5	0.0		1.0		0.4	0.7		1.9	1.3	0.0			0.0	4.2	0.8	0.4	0.9	1.1	0.0			0.0	0.0	0.2	1.1			6.7	0.0	0.5		0.0		1.6	0.4		0.0	1.0	0.0	0.4	0.2	1.8		0.5	0.6	0.0			0.0		1.1	0.5		2.3	1.4	2.4	0.6	3.6	2.4	0.6	0.0	0.4	11.2	10.6	2.0	2.9	0.3	3.3	1.6	1.6	2.4	0.5	0.2	2.3	1.2	0.8	0.1	0.1	0.0	2.3	1.2	2.2	0.6	0.2	0.0	1.1	0.3	1.0	1.9	0.6	1.9	0.6	3.3	0.2	11.6	2.9	0.6	7.0	0.1	3.0	1.8	6.4	2.7	1.5	2.5	1.4	1.8	7.9	0.2	0.0	0.4	0.1	1.1	6.5	3.7	1.9	1.8	2.7	0.8	0.1	2.2	1.5	0.5	1.6	2.4	0.6	0.5	1.0	0.4	0.5	2.3	1.0	0.8	0.4	1.9	2.4	2.1	1.5	3.6	0.4	1.4	0.3	0.6										
SLC25A53	MCART6	ENSG00000269743	"Solute carrier family 25 member 53"	Q5H9E4	X	104099214-104157027	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Daudi: 7.0;Karpas-707: 16.7"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034959	Uncertain									"HPA034959: AB_10602025"	"unprognostic (4.70e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.16e-3)"	"unprognostic (5.94e-2)"	"unprognostic (2.68e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.49e-3)"	"unprognostic (4.45e-3)"	"unprognostic (7.94e-2)"	"unprognostic (9.76e-5)"	"unprognostic (1.83e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.76e-2)"	2.8	2.4	3.2	5.6	4.6	2.8	2.1	6.3	8.6	3.9	2.5	2.8	5.7	3.1	5.1	3.4	2.2	1.9	2.9	2.8	3.6		1.8	1.6	2.0	8.8	3.1	2.7	3.2	4.4	1.2	5.8	1.4	3.6	4.6	2.9	3.1	3.0	5.0	1.5	2.1	3.8	4.8	4.2	6.6	3.1	3.9	4.5	1.4	2.7	0.8	8.4	4.7	9.0	1.7	0.5	3.0	0.5	1.0	2.9	0.7	0.0	0.1	2.0	1.3	0.1	0.0	0.1	0.2	0.1	0.3	0.2	0.1	0.0	7.0	0.2	0.1	0.1	2.4	0.0	0.2	0.6	1.0	0.8	0.2	0.2	0.1	1.3	0.8	0.4	0.1	0.3	0.0	0.5	0.2	16.7	0.1	0.1	0.3	0.1	2.7	0.5	2.8	1.1	0.3	0.3	0.2	1.8	2.6	0.1	0.0	0.0	0.1	0.1	0.4	0.1	1.0	0.1	0.4	0.2	0.0	2.6	0.1	1.9	0.5	0.9	0.4	0.8	1.3	0.5	2.9	1.7	1.2	2.4	0.5	1.4	0.4	1.6	3.0	1.0	0.3	0.3	1.8	0.7										
ZCCHC18	"PNMA7B, SIZN2"	ENSG00000166707	"Zinc finger CCHC-type containing 18"	P0CG32	X	104112131-104115846	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"brain: 9.6;ovary: 9.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.5;Karpas-707: 8.4;SH-SY5Y: 5.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"B-cells: 3.0;T-cells: 2.2"					"Low region specificity"	"Detected in all"			"HPA034940, HPA078516"	Uncertain		Approved	Vesicles				Vesicles		"HPA034940: AB_10671098, HPA078516: "	"unprognostic (7.20e-2)"	"unprognostic (7.71e-4)"	"unprognostic (8.29e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.22e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.34e-1)"	"unprognostic (4.44e-6)"	"unprognostic (4.05e-2)"	"unprognostic (1.02e-6)"	"unprognostic (3.82e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.14e-3)"	0.9	2.3	3.4	3.3	9.4	1.1	2.6	9.6	9.2	1.7	0.9	1.2	0.5	1.1	3.6	1.1	1.0	1.6	1.4	1.2	3.1	7.7	0.5	0.3	1.0	4.9	3.8	4.9	9.4	2.6	0.3	2.3	0.7	4.7	1.5	1.1	1.2	0.5	1.8	1.0	0.5	2.6	1.9	2.5	3.4	1.4	2.2	2.2	0.0	0.4	0.2	5.1	2.0	1.1	3.0	0.0	0.0	0.0	0.1	2.2	0.3	0.0	0.2	3.5	2.4	0.3	0.0	0.2	0.7	0.1	0.6	0.6	0.1	0.0	4.5	0.1	0.2	0.0	2.1	0.0	0.3	1.3	1.7	0.8	0.2	0.0	0.4	2.5	0.8	0.2	0.0	0.4	0.0	0.7	0.0	8.4	0.2	0.0	0.0	0.1	1.9	0.6	3.0	0.8	0.0	0.5	0.3	2.4	5.7	0.2	0.0	0.0	0.0	0.3	1.5	0.1	1.1	0.2	1.0	0.2	0.0	2.2	0.1	2.5	0.7	0.0	0.0	0.0	1.4	0.0	2.2	2.5	1.1	1.7	0.0	3.0	1.2	1.6	0.0	0.1	0.0	0.0	0.8	0.3	3.4	9.4	9.6	7.2	3.1	7.7	3.8	4.9	4.7	2.2
FAM199X	CXorf39	ENSG00000123575	"Family with sequence similarity 199, X-linked"	Q6PEV8	X	104166620-104195902	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003093	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA003093: AB_1078597"	"unprognostic (2.03e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.13e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.08e-2)"	"unprognostic (4.73e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.39e-2)"	19.5	13.4	19.6	7.5	24.4	13.0	13.1	17.1	25.9	11.1	9.3	14.2	21.0	8.7	13.0	39.2	9.0	10.5	7.8	8.0	17.4	19.2	17.1	8.6	9.0	8.7	19.3	17.9	13.9	13.1	24.9	11.8	9.9	22.6	11.8	9.7	8.7	10.8	16.6	10.7	10.4	8.2	9.9	16.9	9.2	8.9	10.9	12.9	6.5	19.4	5.6	8.5	9.5	12.8	3.8	2.3	2.6	2.0	1.5	3.9	1.3	16.9	10.8	9.8	10.7	7.3	8.8	9.9	9.0	8.5	11.8	11.1	8.3	14.2	9.4	11.2	8.3	12.9	17.6	13.3	19.4	4.5	9.8	7.4	13.8	9.4	10.4	14.0	10.5	6.8	17.0	11.6	11.7	11.9	8.0	21.2	13.1	12.1	7.5	10.0	9.7	12.6	8.0	6.4	11.7	20.1	11.4	5.3	6.5	21.8	14.6	15.6	7.3	7.0	14.6	13.2	4.8	10.2	9.6	10.0	8.3	10.5	14.9	15.2	9.6	2.2	2.0	1.1	2.8	1.5	3.2	1.6	2.6	3.4	2.3	3.8	3.9	2.3	2.6	1.5	2.0	1.2	2.9	1.3	19.6	24.4	17.1	23.3	17.4	19.2	19.3	17.9	22.6	12.9
ESX1	"ESX1L, ESXR1"	ENSG00000123576	"ESX homeobox 1"	Q8N693	X	104250038-104254933	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	99	"testis: 25.4"	"Cell line enriched"	"Detected in some"	11	"TIME: 23.2"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051992	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA051992: "															"unprognostic (1.87e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
IL1RAPL2	"IL-1R9, IL1R9, IL1RAPL-2, TIGIRR-1"	ENSG00000189108	"Interleukin 1 receptor accessory protein like 2"	Q9NP60	X	104566315-105767829	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 8.0;parathyroid gland: 8.9"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 2.7;hTERT-HME1: 10.8;NTERA-2: 2.0;RT4: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036128, HPA036129"	Uncertain									"HPA036128: AB_10669983, HPA036129: AB_2674957"	"unprognostic (1.62e-1)"	"unprognostic (1.50e-1)"		"unprognostic (1.66e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.48e-4)"	"unprognostic (9.32e-3)"	"unprognostic (1.67e-1)"	"unprognostic (6.80e-5)"	"unprognostic (1.78e-2)"	"unprognostic (2.79e-3)"	"unprognostic (5.91e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.84e-2)"	0.2	4.2	1.5	0.0	5.0	0.0	1.2	1.1	8.0	0.4	0.6	0.0	0.8	0.4	0.1	0.2	0.2	0.4	1.9	0.5	0.4	0.8	0.4	2.8	0.1	0.0	1.1	2.2	0.9	0.2	8.9	0.1	1.1	2.2	0.4	0.1	0.0	0.8	1.1	0.1	0.3	0.2	0.4	0.3	0.1	0.4	1.9	0.5	0.0	0.2	0.0	0.1	2.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.8	0.0	0.0	0.0	0.4	0.4	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	3.7	0.7	0.2	0.1	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	5.0	1.1	8.0	0.4	0.8	1.1	2.2	2.2	0.5
TEX13A		ENSG00000268629	"Testis expressed 13A"	Q9BXU3	X	105218929-105220674	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	100	"testis: 9.9"	"Cell line enhanced"	"Detected in single"		"ASC TERT1: 2.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA072257	Enhanced									"HPA072257: "															"unprognostic (3.70e-1)"			0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	9.9			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NRK	DKFZp686A17109	ENSG00000123572	"Nik related kinase"	Q7Z2Y5	X	105822543-105958610	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 42.2;placenta: 64.8"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 32.4;HSkMC: 6.2;RH-30: 7.3;RPTEC TERT1: 19.9"	"Cancer enriched"	"Detected in some"	8	"testis cancer: 6.1"	"Region enriched"	"Detected in single"	10	"cerebellum: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	28	"cerebellum: 16.0"	"Low region specificity"	"Detected in many"			HPA017238	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA017238: AB_1854645"	"unprognostic (2.64e-4)"	"unprognostic (9.82e-2)"	"unprognostic (5.98e-3)"	"unprognostic (5.52e-2)"		"unprognostic (3.87e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.28e-2)"	"unprognostic (6.80e-3)"	2.6	12.7	0.4	2.7	0.4	0.0	0.8	4.3	0.3	3.5	1.5	0.1	4.6	0.0	4.3	15.6	1.6	1.3	7.5	2.9	0.4	0.4	9.9	0.4	0.5	0.0	0.3	0.0	42.2	0.5	0.0	2.9	64.8	0.2	22.0	0.1	0.0	2.1	1.6	0.4	0.4	0.5	2.8	0.4	0.3	0.9	10.6	0.0	0.0	0.5	3.1	0.3	1.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	6.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	7.3	0.0	19.9	0.4	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	4.3	0.3	0.4	0.4	0.3	0.0	0.2	0.0
SERPINA7	TBG	ENSG00000123561	"Serpin family A member 7"	P05543	X	106032442-106038738	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	414	"liver: 101.8"	"Cell line enriched"	"Detected in single"	474	"Hep G2: 47.3"	"Cancer enriched"	"Detected in single"	203	"liver cancer: 82.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA002803	Approved				"Secreted to blood"	19450000000	49000000000			"HPA002803: AB_1079915"			"unprognostic (6.22e-2)"				"unprognostic (1.63e-3)"				"unprognostic (3.34e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.15e-3)"		"unprognostic (2.95e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	101.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MUM1L1	FLJ33516	ENSG00000157502	"MUM1 like 1"	Q5H9M0	X	106168305-106208956	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 79.4;thyroid gland: 26.9"	"Cell line enhanced"	"Detected in some"		"AF22: 5.1;HHSteC: 2.8;HSkMC: 5.2;LHCN-M2: 9.4;NTERA-2: 3.6;T-47d: 3.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000168, HPA020464"	Enhanced									"HPA000168: AB_1079431, HPA020464: AB_1854209"	"unprognostic (2.79e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.83e-2)"	"unprognostic (6.08e-2)"	"unprognostic (5.06e-2)"	"unprognostic (4.12e-6)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-1)"		"unprognostic (3.86e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.43e-3)"	"unprognostic (2.11e-5)"	"unprognostic (1.66e-1)"	"prognostic unfavourable (5.95e-4)"	"unprognostic (2.53e-2)"	1.5	1.8	5.2	0.2	1.3	0.2	0.6	0.1	8.8	7.3	0.2	0.0	2.0	0.2	7.3	4.2	0.3	6.7	0.7	1.9	2.9	2.3	1.0	0.8	0.4	0.2	0.5	4.9	79.4	11.4	0.2	12.8	4.8	4.8	2.3	0.2	0.0	0.2	1.7	4.1	0.2	0.2	1.5	0.3	0.2	0.6	17.0	0.8	0.0	26.9	1.5	0.2	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.1	0.0	0.0	2.8	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.1	3.6	0.0	0.0	1.5	0.0	0.0	0.7	0.0	0.0	0.0	1.2	0.0	3.2	0.0	0.0	0.4	2.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	1.3	0.1	8.8	2.9	2.3	0.5	4.9	4.8	0.8
CXorf57	"FLJ10178, FLJ14191"	ENSG00000147231	"Chromosome X open reading frame 57"	Q6NSI4	X	106611930-106679442	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.8;pituitary gland: 32.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 22.2;Karpas-707: 11.4;RT4: 23.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"gdT-cell: 3.5;MAIT T-cell: 2.6;memory B-cell: 3.9;memory CD4 T-cell: 3.0;memory CD8 T-cell: 2.4;naive B-cell: 2.9;naive CD4 T-cell: 3.7;naive CD8 T-cell: 3.0;NK-cell: 2.1;T-reg: 1.1"	"Group enriched"	"Detected in many"	11	"B-cells: 3.9;NK-cells: 2.1;T-cells: 3.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA000896, HPA001374"	Uncertain		Approved	"Intermediate filaments"				"Intermediate filaments"		"HPA000896: AB_1078880, HPA001374: "	"unprognostic (3.30e-2)"	"unprognostic (5.59e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.46e-3)"	"unprognostic (4.85e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.02e-1)"	"unprognostic (5.49e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.23e-3)"	1.4	12.0	5.2	2.1	23.0	0.8	2.3	0.9	8.5	2.9	1.3	6.8	1.0	1.8	5.1	3.7	1.3	6.3	1.0	1.5	5.9	25.8	4.2	2.2	3.8	4.8	4.7	5.3	11.3	2.5	0.1	32.3	5.7	6.3	2.3	1.3	2.6	1.1	2.2	2.2	4.0	2.0	1.5	4.5	2.9	4.2	6.0	5.4	1.9	5.2	0.4	3.3	5.9	2.0	3.9	0.2	0.2	0.0	2.1	3.7	1.2	4.1	0.0	4.3	6.0	2.5	2.1	6.5	0.1	0.8	0.0	0.0	0.9	0.8	8.7	0.0	0.5	1.1	11.0	1.8	0.0	0.0	22.2	2.8	0.0	0.2	0.1	0.0	1.9	1.2	1.3	0.3	0.8	0.0	0.1	11.4	0.9	0.0	7.9	0.0	3.9	0.7	0.0	4.0	0.0	1.8	23.3	7.1	0.0	0.4	0.1	2.5	1.0	0.1	0.0	1.9	1.6	0.0	2.6	4.1	1.7	10.7	3.3	0.0	3.1	0.0	0.0	0.0	3.5	0.0	2.6	3.9	3.0	2.4	0.0	2.9	3.7	3.0	0.2	2.1	0.0	0.2	1.1	1.2	5.2	23.0	0.9	6.8	5.9	25.8	4.7	5.3	6.3	5.4
RNF128	"FLJ23516, GRAIL"	ENSG00000133135	"Ring finger protein 128, E3 ubiquitin protein ligase"	Q8TEB7	X	106693794-106796993	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 54.6;liver: 48.4;thyroid gland: 38.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 17.9;CAPAN-2: 14.8;Hep G2: 12.6;RPTEC TERT1: 13.0;RT4: 37.2;WM-115: 22.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019675	Uncertain									"HPA019675: "	"unprognostic (1.78e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.92e-4)"	"unprognostic (2.14e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavourable (1.07e-7)"	"unprognostic (1.11e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.30e-2)"	"unprognostic (5.30e-3)"	1.4	20.6	2.4	2.2	7.2	0.0	3.0	0.7	4.2	0.5	24.4	0.9	0.4	24.2	0.2	2.2	4.0	0.3	27.2	0.6	2.8	5.1	24.4	48.4	6.7	0.0	2.4	2.1	0.7	14.5	0.0	11.0	10.5	4.0	3.4	7.8	0.0	25.4	0.8	3.0	3.6	54.6	0.9	1.1	0.2	17.9	0.3	1.0	1.1	38.4	2.3	2.7	10.2	3.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	4.5	0.0	0.0	0.0	1.5	0.8	17.9	0.0	0.1	0.0	0.0	7.8	14.8	0.0	0.0	0.2	5.6	0.0	0.0	0.0	0.0	8.7	0.0	0.1	12.6	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	13.0	37.2	0.0	0.0	0.0	0.9	0.9	0.9	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	6.5	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	7.2	0.7	4.2	2.8	5.1	2.4	2.1	4.0	1.0
TBC1D8B	"FLJ20298, GRAMD8B, RP11-321G1.1"	ENSG00000133138	"TBC1 domain family member 8B"	Q0IIM8	X	106802680-106876145	"Predicted intracellular proteins"		"GTPase activation"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023883, HPA027527"	Enhanced		Approved	Cytosol				Cytosol		"HPA023883: AB_1857794, HPA027527: AB_2199395"	"unprognostic (6.69e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.19e-2)"	"unprognostic (4.69e-3)"	"unprognostic (8.15e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.97e-2)"	"unprognostic (5.16e-2)"	3.8	24.5	4.6	3.5	7.9	3.3	3.9	1.2	7.9	6.0	6.6	2.6	21.5	6.0	5.1	10.4	3.7	4.4	9.6	4.7	4.2	2.5	12.4	14.5	4.1	2.0	6.8	3.3	7.2	10.7	10.0	28.6	4.5	9.0	6.1	5.6	2.2	10.1	16.8	1.8	2.9	13.3	4.1	4.7	2.7	8.5	7.6	7.6	0.5	7.9	3.1	1.8	4.9	4.8	4.7	2.8	5.2	2.2	1.5	2.0	0.4	10.1	3.3	1.6	5.0	15.9	22.6	5.8	11.4	11.8	2.0	6.1	5.4	9.0	3.6	9.3	11.4	5.3	4.1	5.7	5.2	1.9	4.5	4.9	4.1	5.2	4.1	1.4	2.0	9.9	4.7	4.2	2.0	5.5	1.6	6.2	7.0	5.1	3.2	1.9	6.9	5.1	1.6	2.8	1.5	5.6	7.4	2.6	2.1	9.0	7.0	4.1	7.9	1.7	7.0	7.5	8.3	9.8	4.1	5.7	6.1	1.1	14.4	1.2	9.2	3.7	2.2	1.1	2.0	1.2	1.6	2.2	1.7	1.5	0.7	4.7	1.4	1.7	5.2	1.5	1.1	2.8	0.7	0.4	4.6	7.9	1.2	7.9	4.2	2.5	6.8	3.3	9.0	7.6
MORC4	"FLJ11565, ZCW4, ZCWCC2"	ENSG00000133131	"MORC family CW-type zinc finger 4"	Q8TE76	X	106813871-107000244	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"placenta: 94.5"	"Cell line enhanced"	"Detected in all"		"A549: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA000395, HPA015547, HPA050250"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA000395: AB_1079405, HPA015547: AB_2669216, HPA050250: "	"prognostic unfavourable (3.56e-5)"	"unprognostic (3.30e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.29e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.56e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.69e-2)"	8.7	20.0	3.2	6.0	4.8	5.1	6.2	4.9	3.6	8.0	5.3	4.6	12.7	4.6	8.8	8.5	6.8	7.3	6.7	5.3	4.3	2.8	4.9	9.7	6.0	2.2	4.9	2.2	12.3	9.1	6.0	4.9	94.5	5.8	7.7	4.9	4.2	8.7	8.8	9.4	8.6	4.9	7.4	5.4	2.6	5.6	12.5	5.0	2.3	7.6	7.5	5.2	6.3	15.1	6.0	4.6	10.5	3.8	2.8	4.0	0.7	11.5	46.3	4.6	10.6	14.1	16.3	24.2	11.3	12.0	5.7	7.3	24.5	5.3	1.8	5.9	11.6	9.1	15.4	9.9	6.9	2.7	8.9	2.8	15.7	10.3	10.4	2.0	5.9	8.6	9.6	7.8	11.4	5.1	1.6	17.6	12.7	10.2	4.2	2.8	4.1	17.6	2.0	9.3	2.0	18.5	9.2	4.0	5.1	13.7	13.4	8.9	8.0	2.0	5.3	9.2	9.3	18.2	6.2	5.0	6.5	4.6	9.8	1.8	6.6	10.5	3.8	3.1	3.7	3.0	3.2	3.3	3.6	2.8	1.6	6.0	4.0	3.4	8.2	2.8	3.6	4.6	2.6	0.7	3.2	4.8	4.9	3.6	4.3	2.8	4.9	2.2	5.8	5.0
RIPPLY1		ENSG00000147223	"Ripply transcriptional repressor 1"	Q0D2K3	X	106900063-106903335	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"kidney: 6.4;liver: 11.5"	"Cell line enriched"	"Detected in some"	8	"RH-30: 12.0"	"Group enriched"	"Detected in some"	6	"liver cancer: 2.2;renal cancer: 3.6;testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA052284	Uncertain				"Intracellular and membrane"					"HPA052284: AB_2681785"	"unprognostic (1.48e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.52e-3)"	"unprognostic (7.00e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.42e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.31e-1)"	0.2	0.9	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.4	0.2	0.1	0.2	0.2	0.2	0.0	6.4	11.5	0.2	0.2	0.2	0.2	0.2	0.4	0.0	0.2	0.2	0.2	0.2	0.0	2.4	0.2	1.8	0.4	0.0	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
CLDN2		ENSG00000165376	"Claudin 2"	P57739	X	106900164-106930861	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 31.7;gallbladder: 28.4;kidney: 46.1;liver: 25.2;seminal vesicle: 27.7"	"Group enriched"	"Detected in some"	20	"A549: 16.6;CACO-2: 13.4;RPTEC TERT1: 29.0"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 53.3;liver cancer: 24.6;pancreatic cancer: 48.5;renal cancer: 87.2;stomach cancer: 30.5"	"Region enriched"	"Detected in some"	6	"pons and medulla: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 4.6;hippocampal formation: 10.6;pons and medulla: 10.8;thalamus: 9.5"	"Not detected"	"Not detected"			"CAB002609, HPA051548"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"				"Nucleoplasm, Cell Junctions"		"CAB002609: , HPA051548: "	"unprognostic (2.31e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.07e-2)"	"unprognostic (7.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.67e-2)"	"unprognostic (8.83e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"prognostic favourable (1.70e-4)"	"unprognostic (9.76e-2)"	0.4	1.2	0.4	0.4	0.6	0.0	0.4	0.4	3.4	0.4	0.4	19.4	0.4	5.3	0.4	9.6	0.4	0.1	28.4	0.4	5.0	0.1	46.1	25.2	0.4	0.4	0.4	0.4	0.4	7.8	0.0	0.4	0.4	31.7	0.6	1.0	11.0	0.4	27.7	0.4	0.2	11.3	0.4	0.4	0.4	2.1	0.4	0.5	0.4	0.4	0.4	0.4	0.4	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.6	0.4	3.4	5.0	0.1	0.4	0.4	31.7	0.5
RBM41	FLJ11016	ENSG00000089682	"RNA binding motif protein 41"	Q96IZ5	X	107064420-107118823	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042881	Approved		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"HPA042881: AB_10794536"	"unprognostic (1.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.10e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (3.04e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.92e-1)"	10.0	10.3	9.2	9.1	10.8	5.0	9.5	23.7	14.2	13.4	11.9	10.1	8.2	12.7	12.2	11.5	11.1	12.4	7.6	8.8	8.7	6.8	11.8	13.7	8.3	8.9	9.7	9.4	9.7	10.6	21.0	14.1	12.0	11.6	10.8	11.2	9.0	10.7	9.0	14.6	11.6	15.5	11.2	14.2	11.5	8.2	15.6	12.8	12.2	15.7	8.0	9.9	12.4	9.8	6.3	4.8	10.6	7.0	8.6	6.3	3.4	14.1	11.4	7.3	5.9	4.9	8.6	8.5	8.4	8.3	6.2	8.4	7.5	11.9	7.8	15.9	6.1	11.8	10.6	7.8	9.5	9.6	15.7	9.5	20.6	9.2	5.5	9.6	7.5	6.0	15.6	7.5	7.6	9.3	16.3	10.9	7.5	6.8	8.1	5.5	10.8	13.1	6.6	6.1	6.7	9.2	9.0	6.1	9.6	10.5	7.6	6.7	6.9	5.0	9.0	8.7	5.1	10.3	6.6	5.1	9.4	8.7	4.9	4.4	6.5	10.6	7.0	10.6	6.3	3.7	3.9	6.3	5.5	6.3	4.7	6.3	4.1	2.8	1.0	8.6	3.7	4.8	4.9	3.4	9.2	10.8	23.7	14.2	8.7	6.8	9.7	9.4	11.6	12.8
NUP62CL	FLJ20130	ENSG00000198088	"Nucleoporin 62 C-terminal like"	Q9H1M0	X	107123427-107206433	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 40.6"	"Cell line enhanced"	"Detected in many"		"A549: 13.9;CAPAN-2: 15.0;HEK 293: 11.3;HeLa: 20.0;K-562: 14.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"pons and medulla: 18.3"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.3;NK-cells: 1.7;T-cells: 2.6"									HPA001884	Approved									"HPA001884: AB_1079512"	"unprognostic (1.62e-2)"	"prognostic favourable (5.66e-5)"	"unprognostic (8.80e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (1.56e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.82e-3)"	"unprognostic (4.52e-3)"	0.5	12.4	1.2	2.9	2.6	1.4	2.6	0.3	0.6	1.7	3.1	3.2	8.7	2.4	2.0	40.6	2.3	15.0	2.3	1.6	1.7	2.2	5.5	2.0	2.4	1.4	1.1	1.2	4.4	12.6	2.5	9.0	0.7	18.3	1.0	2.7	1.1	2.5	10.9	0.5	1.5	3.3	0.2	1.3	0.6	1.3	11.0	1.7	3.3	8.6	1.0	3.4	1.4	1.4	4.3	0.2	0.6	0.5	1.7	2.6	0.6	8.3	13.9	1.2	0.0	0.0	0.0	6.1	0.0	0.5	0.3	0.3	1.3	15.0	4.8	1.6	0.0	7.6	8.9	3.0	0.0	0.0	11.3	0.5	20.0	2.4	0.0	0.0	0.0	0.1	4.1	0.0	2.1	0.0	14.0	1.2	0.0	4.1	1.8	0.0	1.8	5.0	0.0	0.0	0.4	4.5	2.2	3.6	4.2	5.0	1.5	0.0	0.0	0.2	0.0	0.0	4.6	0.1	0.0	1.6	5.6	2.6	0.0	0.0	0.0	0.0	0.1	0.6	0.6	0.4	0.7	4.3	2.6	0.2	0.1	3.3	1.3	1.5	0.0	1.7	0.5	0.2	1.1	0.6	1.2	2.6	0.3	0.6	1.7	2.2	1.1	1.2	18.3	1.7
PIH1D3	"CXorf41, MGC35261, NYSAR97"	ENSG00000080572	"PIH1 domain containing 3"	Q9NQM4	X	107206632-107244243	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.0;fallopian tube: 16.2;lung: 7.0;testis: 13.9"	"Cell line enhanced"	"Detected in single"		"WM-115: 1.7"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Region enhanced"	"Detected in many"		"pons and medulla: 8.0"	"Cell type enhanced"	"Detected in some"		"basophil: 2.1"	"Low lineage specificity"	"Detected in single"							"Region enhanced"	"Detected in single"		"midbrain: 4.6"	HPA072496	Enhanced									"HPA072496: "	"unprognostic (8.66e-2)"	"unprognostic (2.75e-3)"		"unprognostic (7.73e-4)"	"unprognostic (3.37e-1)"			"unprognostic (8.61e-2)"		"unprognostic (4.27e-1)"			"unprognostic (3.37e-2)"			"unprognostic (1.77e-2)"		0.0	0.1	0.9	0.0	4.0	0.2	0.0	0.0	0.1	1.3	0.0	1.9	1.0	0.1	0.5	4.5	0.1	16.2	0.1	0.1	1.6	1.5	0.2	0.0	7.0	0.1	0.0	0.0	4.8	0.0	0.0	0.0	0.0	8.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.0	13.9	1.3	0.1	0.4	0.0	0.1	0.0	0.0	0.5	0.3	2.1	0.3	0.6	0.2	0.2	0.3	0.9	0.1	0.0	0.4	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.8	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.5	0.0	0.1	0.4	0.1	0.0	0.0	0.5	0.5	0.6	0.3	0.3	0.2	0.9	0.1	0.0	0.8	0.3	0.0	0.0	0.0	0.3	0.5	0.1	0.0	0.3	1.7	2.1	0.3	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.5	0.1	0.2	1.2	0.6	0.2	0.3	0.1	0.2	0.9	4.0	0.0	0.0	1.6	1.5	0.0	0.0	8.0	1.3
FRMPD3	"KIAA1817, RP5-1070B1.1"	ENSG00000147234	"FERM and PDZ domain containing 3"	Q5JV73	X	107522450-107605251	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.6;ovary: 10.3;thyroid gland: 6.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 10.6;SCLC-21H: 3.3;U-698: 2.9;WM-115: 3.9"	"Cancer enhanced"	"Detected in some"		"glioma: 2.6"					"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.7;naive B-cell: 1.2"	"Group enriched"	"Detected in many"	15	"B-cells: 1.2;T-cells: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003164	Uncertain									"HPA003164: AB_1078260"	"unprognostic (1.27e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.48e-4)"	"unprognostic (1.69e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.43e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.83e-9)"	"unprognostic (4.59e-2)"	"unprognostic (7.88e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.26e-1)"	0.0	0.5	2.5	0.7	1.8	0.1	0.5	8.6	6.7	0.2	0.1			0.0	0.9	0.0	0.1	0.4	0.4	0.0	3.1	5.0	0.0	0.0	0.2	1.3	2.6		10.3	0.1	0.0	0.4	0.0		0.6	0.2		0.4	2.6	0.0	0.0	0.0	1.1	2.2	0.2	0.0	0.5			6.0		0.9	0.1	0.0	1.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	2.1	0.7	0.0	0.0	0.0	0.8	0.0	0.4	0.2	0.0	0.5	10.6	0.0	0.1	0.0	0.5	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.3	3.3	0.2	0.6	0.2	0.0	0.4	0.0	0.0	1.0	1.2	0.1	0.0	0.0	0.0	2.9	0.1	0.0	3.9	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.2	1.0	0.0	1.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0										
PRPS1	"CMTX5, DFN2, DFNX1"	ENSG00000147224	"Phosphoribosyl pyrophosphate synthetase 1"	P60891	X	107628424-107651026	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Deafness, Disease mutation, Gout, Mental retardation, Neurodegeneration, Neuropathy, Non-syndromic deafness, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA043760	Uncertain						140000			"HPA043760: "	"unprognostic (4.47e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.30e-3)"	"unprognostic (2.56e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.25e-2)"	16.8	19.0	18.8	18.7	22.4	33.5	13.0	27.0	30.3	13.5	12.1	20.5	7.0	7.3	16.6	10.4	11.8	17.6	9.6	19.9	19.0	26.5	18.5	45.1	14.9	25.4	21.8	17.5	21.4	17.8	20.0	18.2	10.0	26.9	14.9	12.4	15.0	11.2	12.4	31.2	8.4	10.8	20.0	19.3	19.4	10.8	11.3	13.6	32.3	29.9	11.3	28.6	16.9	10.7	18.2	8.5	12.6	8.7	14.4	22.1	11.6	20.2	30.2	13.4	15.5	7.5	5.9	4.6	59.7	12.4	34.0	28.8	13.0	8.7	33.5	25.9	21.7	8.3	39.9	12.3	34.9	16.6	24.8	17.8	30.0	16.9	6.9	33.0	13.3	6.7	7.2	20.6	13.5	11.6	28.4	40.6	15.7	10.9	22.3	17.8	48.5	26.1	26.0	21.5	26.9	13.3	11.7	22.1	11.9	29.6	17.9	12.0	8.2	13.8	6.9	22.1	10.4	24.2	23.6	13.9	22.7	36.5	11.4	35.8	13.8	4.8	5.2	12.6	15.7	8.2	17.6	17.0	19.7	19.3	6.2	18.2	22.1	18.7	3.1	14.4	8.7	8.5	20.1	11.6	18.8	22.4	27.0	30.3	19.0	26.5	21.8	17.5	26.9	13.6
TSC22D3	"DIP, DSIPI, GILZ, hDIP, TSC-22R"	ENSG00000157514	"TSC22 domain family member 3"	Q99576	X	107713221-107777342	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 57.8;ASC TERT1: 39.8;HHSteC: 95.7;hTCEpi: 85.2;Karpas-707: 53.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001916, CAB034364"	Approved		Approved	"Nuclear speckles,Golgi apparatus,Cytosol"				Cytosol	"Nuclear speckles, Golgi apparatus"	"CAB034364: AB_2272198, HPA001916: "	"unprognostic (3.67e-2)"	"unprognostic (3.90e-3)"	"unprognostic (5.99e-2)"	"prognostic unfavourable (2.43e-4)"	"unprognostic (3.49e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.73e-3)"	"unprognostic (4.40e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.25e-1)"	"unprognostic (7.47e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.37e-3)"	"unprognostic (6.41e-2)"	"unprognostic (4.14e-1)"	"unprognostic (9.64e-2)"	69.1	48.4	18.2	72.7	21.0	72.4	142.4	31.8	32.7	53.3	49.0	10.6	36.7	16.7	37.2	26.6	58.7	45.4	47.8	42.6	18.8	12.2	33.8	20.9	83.3	98.8	22.0	16.2	54.6	20.0	7.1	18.8	31.3	20.8	51.8	37.2	39.8	172.4	40.7	163.5	65.2	54.6	45.4	22.9	55.7	49.3	20.3	19.2	29.7	59.8	36.1	62.7	75.3	89.6	47.9	31.7	191.5	62.4	69.0	82.4	105.1	1.5	2.6	1.3	3.7	57.8	39.8	0.5	2.4	2.0	1.1	1.2	0.0	5.2	3.3	6.0	1.9	7.8	2.8	7.8	0.5	1.0	1.3	1.6	11.0	0.1	95.7	0.3	5.6	36.2	85.2	0.9	23.8	4.3	0.5	53.8	9.8	5.3	0.1	5.7	2.4	1.7	0.1	3.4	7.0	3.8	1.0	0.3	3.0	2.4	13.2	18.1	2.5	7.5	6.4	3.5	1.0	0.7	0.4	11.8	5.1	1.5	1.8	6.7	0.9	42.7	34.0	126.9	55.2	40.4	40.6	47.9	63.4	53.6	31.7	45.5	59.6	55.4	191.5	69.0	62.4	6.4	82.4	105.1	18.2	21.0	31.8	32.7	18.8	12.2	22.0	16.2	20.8	19.2
NCBP2L		ENSG00000170935	"Nuclear cap binding protein subunit 2 like"	A6PVI3	X	107774899-107795829	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 8.7;testis: 6.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.3;MCF7: 1.4;SK-BR-3: 2.7"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	39	"basophil: 8.7"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 8.7"					"Low region specificity"	"Detected in single"			HPA010664	Uncertain									"HPA010664: AB_1079451"	"unprognostic (3.22e-1)"				"unprognostic (8.00e-2)"						"unprognostic (5.64e-2)"	"unprognostic (7.29e-2)"				"unprognostic (2.64e-1)"		0.0	3.1	0.3	0.0	0.2	0.0	1.1	0.2	0.1	0.2	0.0			0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.3	0.1	0.0	0.3	0.2	0.0	0.2		1.9	1.6	0.0	0.1	0.0		0.3	0.0		0.9	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	6.4			0.0		0.0	0.0	0.0	0.2	0.0	8.7	0.0	0.0	0.1	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	1.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4										
MID2	"FXY2, MRX101, RNF60, TRIM1"	ENSG00000080561	"Midline 2"	Q9UJV3	X	107825755-107927193	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 23.8;Karpas-707: 20.8;MCF7: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 4.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (8.28e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.69e-4)"	"unprognostic (6.40e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.87e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.19e-2)"	"prognostic unfavourable (3.73e-4)"	"unprognostic (2.07e-1)"	"unprognostic (3.77e-1)"	"unprognostic (5.97e-3)"	12.7	11.3	3.6	4.8	11.4	0.4	13.0	9.3	8.0	10.8	9.0	5.1	9.4	2.0	12.6	9.7	15.1	10.0	8.6	4.4	4.0	5.2	6.6	6.2	9.0	6.2	4.3	5.8	11.5	10.2	16.0	11.1	4.7	7.1	12.9	4.0	12.4	12.7	10.9	16.6	14.5	4.6	17.2	5.4	5.8	7.7	4.7	4.7	0.5	14.5	8.3	6.6	16.7	11.9	0.7	0.0	0.0	0.0	0.0	4.2	1.1	4.7	4.1	0.1	6.6	5.3	7.5	0.1	3.4	8.6	2.9	2.2	0.3	0.8	0.0	4.5	6.5	3.0	2.4	6.9	0.7	0.0	3.2	0.0	2.5	0.0	7.9	0.0	0.0	4.7	7.9	0.1	8.7	23.8	0.0	20.8	3.2	15.1	0.0	0.0	0.7	7.6	0.0	1.9	0.0	3.6	4.3	0.4	0.0	7.2	0.3	10.9	2.7	0.2	4.9	0.0	1.2	5.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	3.3	0.1	1.8	3.5	0.0	0.7	4.2	2.3	0.0	0.0	0.0	0.0	0.3	1.1	3.6	11.4	9.3	8.0	4.0	5.2	4.3	5.8	7.1	4.7
TEX13B	"TGC3B, TSGA5"	ENSG00000170925	"Testis expressed 13B"	Q9BXU2	X	107980864-107982370	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	14	"testis: 3.3"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.5;U-138 MG: 1.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																				"unprognostic (1.58e-2)"			0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
VSIG1	MGC44287	ENSG00000101842	"V-set and immunoglobulin domain containing 1"	Q86XK7	X	108044970-108079184	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"gallbladder: 29.5;stomach 1: 66.6;testis: 87.4"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 5.7;HUVEC TERT2: 11.6;PC-3: 3.9;TIME: 2.9"	"Group enriched"	"Detected in many"	17	"lung cancer: 8.7;pancreatic cancer: 17.7;stomach cancer: 31.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 11.7;T-reg: 11.2"	"Lineage enriched"	"Detected in many"	4	"T-cells: 11.7"	"Not detected"	"Not detected"							"HPA001445, HPA036310, HPA036311"	Enhanced		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA001445: AB_10669749, HPA036310: AB_10670795, HPA036311: AB_10673350"	"unprognostic (4.33e-3)"	"unprognostic (4.60e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.80e-2)"	"unprognostic (3.25e-2)"	"unprognostic (9.79e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.31e-7)"	"unprognostic (1.48e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-3)"	0.1	0.0	0.1	0.3	0.5	0.0	0.1	0.1	0.1	0.1	0.3	0.8	0.1	0.3	0.1	0.2	0.2	0.0	29.5	0.1	0.1	0.1	0.1	0.1	0.4	0.5	0.1	0.1	0.1	0.1	0.0	1.3	0.1	0.1	1.2	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	66.6	87.4	0.1	0.1	0.1	0.1	0.4	1.5	0.1	2.6	0.1	0.6	0.1	0.2	11.7	2.5	0.2	1.0	0.0	0.2	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.5	0.0	5.7	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.0	0.3	0.4	1.0	0.1	1.9	11.6	0.1	0.3	0.0	0.4	0.4	0.3	0.4	3.9	0.3	0.0	0.0	0.7	1.0	0.2	0.1	0.2	0.2	0.6	0.1	0.0	2.9	0.3	0.9	0.4	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.1	1.0	0.0	3.7	2.6	7.7	3.3	0.0	1.0	11.7	5.4	0.4	0.2	0.1	0.1	11.2	2.5	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
PSMD10	p28	ENSG00000101843	"Proteasome 26S subunit, non-ATPase 10"	O75832	X	108084207-108091618	"Predicted intracellular proteins"	Apoptosis	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002920, CAB010434"	Approved		Supported	"Intermediate filaments,Cytosol"			82000	Cytosol	"Intermediate filaments"	"CAB010434: AB_640866, HPA002920: AB_1079708"	"unprognostic (1.59e-3)"	"unprognostic (4.12e-3)"	"unprognostic (3.83e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.06e-2)"	"unprognostic (4.95e-2)"	"unprognostic (7.37e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.09e-1)"	15.8	23.6	35.5	14.3	32.1	14.2	20.9	27.4	31.1	21.7	19.0	30.3	13.4	14.8	22.4	29.8	21.6	27.1	15.1	14.7	32.0	50.2	20.5	19.0	16.5	18.0	38.9	29.6	19.9	11.1	20.3	20.9	26.1	39.0	19.4	19.8	17.1	14.6	19.0	13.3	15.3	17.4	21.6	38.9	14.8	15.7	15.6	23.8	21.2	24.3	12.2	21.8	22.0	16.1	28.1	30.7	40.2	38.8	32.2	32.4	35.1	31.0	31.6	21.7	19.5	33.0	24.9	19.7	25.6	21.3	23.2	20.3	18.8	20.0	26.5	39.3	24.4	16.9	34.1	24.7	35.8	28.7	29.4	15.5	30.7	23.6	16.8	24.0	17.4	18.9	27.0	21.5	26.1	57.2	29.9	36.0	28.9	40.7	22.6	21.0	39.4	43.1	22.9	31.1	28.0	24.9	20.2	14.0	13.4	39.2	16.3	25.7	17.6	20.8	41.0	18.5	10.7	31.1	18.9	28.8	39.5	28.1	25.6	33.5	21.7	38.3	26.9	40.2	28.2	33.0	30.2	28.1	28.6	30.1	30.4	27.2	28.8	32.2	13.2	32.2	38.8	30.7	32.4	35.1	35.5	32.1	27.4	31.1	32.0	50.2	38.9	29.6	39.0	23.8
ATG4A	"APG4A, AUTL2"	ENSG00000101844	"Autophagy related 4A cysteine peptidase"	Q8WYN0	X	108091668-108154671	"Enzymes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 40.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA036374, HPA064759"	Uncertain		Approved	"Actin filaments,Microtubules"				Microtubules	"Actin filaments"	"HPA036374: AB_10672354, HPA064759: "	"prognostic unfavourable (1.36e-5)"	"unprognostic (1.41e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.62e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.03e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.02e-3)"	"unprognostic (1.20e-2)"	8.2	11.8	6.4	6.1	8.0	6.1	7.4	9.7	6.2	6.8	10.0	5.5	8.6	10.3	6.9	10.4	10.6	5.4	6.5	10.9	4.3	3.2	15.3	23.4	10.8	8.2	6.9	5.7	4.7	22.3	8.2	13.1	7.9	7.2	6.6	11.3	6.7	17.2	6.2	18.8	6.3	18.7	7.2	6.7	10.5	12.9	3.1	8.2	12.0	12.0	7.4	10.5	7.4	7.8	8.7	9.8	18.7	9.9	10.0	11.9	7.4	5.8	2.9	1.9	3.6	18.4	6.3	2.3	8.2	5.1	4.2	5.0	2.3	3.3	6.4	7.4	6.5	2.8	5.5	6.0	6.4	10.8	6.1	2.7	5.1	1.5	4.0	5.7	8.9	6.5	6.3	5.2	2.1	40.1	8.3	20.5	7.7	5.3	5.4	5.3	3.5	8.4	3.7	3.2	9.3	6.2	5.2	2.7	2.1	5.2	6.4	3.4	3.2	5.3	11.0	2.5	1.2	9.0	4.4	9.5	10.8	6.9	5.2	6.6	3.7	18.7	7.0	13.1	11.6	9.9	8.3	8.7	8.9	10.9	9.8	7.6	7.0	11.9	2.2	10.0	6.7	4.6	9.2	7.4	6.4	8.0	9.7	6.2	4.3	3.2	6.9	5.7	7.2	8.2
COL4A6		ENSG00000197565	"Collagen type IV alpha 6 chain"	Q14031	X	108155607-108439497	"Disease related genes, Predicted secreted proteins"	"Cell adhesion"		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 60.9"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 18.1;HeLa: 15.9;HHSteC: 24.4;hTERT-HME1: 17.9;HUVEC TERT2: 16.5;TIME: 36.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"							HPA065393			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"			"Endoplasmic reticulum"		"HPA065393: "	"unprognostic (8.47e-3)"	"unprognostic (4.50e-3)"	"unprognostic (9.75e-3)"	"unprognostic (9.80e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.54e-3)"	"unprognostic (3.51e-1)"	2.1	0.4	0.4	0.8	0.5	0.0	1.7	0.2	0.4	12.1	1.0	1.3	8.0	0.7	22.9	17.1	25.0	11.3	35.8	3.6	0.6	0.6	3.0	0.3	2.1	0.0	1.0	0.9	6.4	0.3	7.6	11.3	1.9	0.9	16.5	1.3	8.3	1.4	15.6	1.0	4.1	1.8	60.9	1.4	1.1	10.4	2.1	0.7	0.2	0.6	1.4	0.5	24.7	6.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	12.1	3.9	0.0	9.9	0.7	0.0	0.0	0.7	0.1	0.1	6.9	0.0	0.0	0.0	0.0	2.3	4.1	18.1	0.3	0.1	3.4	0.3	15.9	0.1	24.4	0.0	0.0	1.0	11.2	2.6	17.9	16.5	0.0	0.0	0.2	0.0	0.0	0.0	5.5	1.5	0.0	0.0	0.0	0.7	1.3	0.0	0.0	0.9	0.0	0.0	0.3	0.0	36.9	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.2	0.4	0.6	0.6	1.0	0.9	0.9	0.7
COL4A5	"ASLN, ATS"	ENSG00000188153	"Collagen type IV alpha 5 chain"	P29400	X	108439844-108697545	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Alport syndrome, Cancer-related genes, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 28.6;HHSteC: 32.9;HUVEC TERT2: 30.9;TIME: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"								"Secreted to extracellular matrix"						"unprognostic (2.58e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.97e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (2.41e-5)"	"unprognostic (2.10e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.06e-1)"	3.3	2.7	13.1	1.7	27.7	0.3	5.8	1.8	16.1	16.9	3.7	47.2	9.5	2.7	31.4	18.2	6.9	19.3	12.6	5.9	13.9	6.2	5.9	1.7	5.9	0.9	46.6	15.7	11.5	2.8	22.3	10.2	9.7	19.5	18.0	4.1	5.8	3.7	23.9	4.8	17.5	3.1	32.8	20.5	2.8	17.7	2.8	40.5	0.0	5.4	0.9	0.9	23.9	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	8.9	15.9	5.0	6.2	3.6	0.1	0.9	3.9	4.8	7.9	7.9	0.6	1.4	0.0	0.6	7.2	4.4	14.9	6.1	2.1	3.9	1.1	28.6	0.9	32.9	0.0	4.5	17.0	18.2	5.9	12.7	30.9	0.0	0.0	4.6	0.6	0.0	0.1	4.7	5.3	0.0	0.0	0.0	12.0	8.8	0.0	0.0	23.1	0.7	1.9	4.3	0.0	29.2	3.2	1.0	2.1	1.3	0.6	0.0	0.0	2.8	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	27.7	1.8	16.1	13.9	6.2	46.6	15.7	19.5	40.5
AL035425.2		ENSG00000260548			X	108722070-108732687	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"ovary: 13.0;pituitary gland: 7.4;thyroid gland: 8.9"	"Cell line enhanced"	"Detected in some"		"HEK 293: 18.6;NTERA-2: 2.6;RT4: 4.8;WM-115: 4.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.6	2.9	0.0			0.0	3.9	0.9	0.0	0.5	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.5		13.0	0.9	0.0	7.4	0.0		0.1	0.0		0.0	0.7	0.0	1.1	0.0	1.5	0.1	0.0	0.4	0.0			8.9		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IRS4	"IRS-4, PY160"	ENSG00000133124	"Insulin receptor substrate 4"	O14654	X	108732482-108736409	"Cancer-related genes, Predicted intracellular proteins"		Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"pituitary gland: 56.0"	"Cell line enhanced"	"Detected in some"		"HEK 293: 13.6;NTERA-2: 1.7;RT4: 4.0;WM-115: 3.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	7	"hypothalamus: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 12.8;hypothalamus: 52.4"	"Group enriched"	"Detected in some"	6	"basal ganglia: 21.5;hypothalamus: 55.3"	HPA017372	Uncertain									"HPA017372: "	"unprognostic (3.74e-3)"				"unprognostic (3.27e-2)"			"unprognostic (1.32e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.65e-1)"		"unprognostic (1.05e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.28e-4)"	"unprognostic (8.71e-2)"	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.6	1.9	0.0	0.1	0.3	0.1	2.6	0.3	0.3	0.5	0.0	0.0	0.3	4.6	0.0	0.0	0.1	0.0	0.5	0.1	9.5	0.0	0.0	56.0	0.1	0.6	0.2	0.0	2.7	0.0	0.5	0.0	0.6	0.0	1.0	0.2	0.1	0.5	0.1	0.5	5.1	3.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.3	0.3	4.6	0.5	0.1	0.6	0.5
GUCY2F	"CYGF, GC-F, GUC2DL, RetGC-2, ROS-GC2"	ENSG00000101890	"Guanylate cyclase 2F, retinal"	P51841	X	109372906-109482072	"Enzymes, Plasma proteins, Predicted membrane proteins"	"cGMP biosynthesis, Sensory transduction, Vision"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"retina: 23.1"	"Group enriched"	"Detected in some"	5	"THP-1: 4.4;U-266/70: 1.6;U-937: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	"unprognostic (1.91e-1)"	"unprognostic (4.45e-2)"									"unprognostic (2.96e-1)"	"unprognostic (2.23e-1)"			0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.1	0.0	1.5	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0
NXT2	P15-2	ENSG00000101888	"Nuclear transport factor 2 like export factor 2"	Q9NPJ8	X	109535781-109544690	"Predicted intracellular proteins"	"mRNA transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.7"	"Cell line enhanced"	"Detected in all"		"HL-60: 47.8;U-937: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024199, HPA072010"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA024199: AB_1854738, HPA072010: "	"unprognostic (1.72e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.99e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.77e-2)"	"unprognostic (3.36e-3)"	"unprognostic (2.83e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.59e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.90e-2)"	10.1	6.5	10.4	6.0	9.7	12.3	12.9	3.7	8.4	8.1	6.2	9.0	1.3	7.4	4.7	6.1	10.1	5.8	5.0	3.3	9.9	6.9	7.7	9.6	6.4	9.2	10.1	6.3	5.5	7.9	5.5	2.6	17.4	10.6	6.9	7.0	3.8	8.8	3.6	2.6	10.0	9.1	5.9	11.4	7.6	6.7	38.7	9.1	14.0	7.3	6.3	11.1	7.4	7.2	7.4	11.4	4.2	11.6	12.3	11.6	9.3	4.3	3.8	3.7	6.5	5.6	4.5	8.2	2.8	4.7	3.6	4.7	3.0	6.2	5.6	8.8	3.4	3.3	4.9	4.3	5.5	7.2	3.0	4.7	3.7	4.9	2.3	47.8	19.7	3.3	3.8	3.4	2.1	3.1	4.9	23.0	3.5	4.5	7.2	5.1	5.9	5.7	2.9	5.3	6.6	3.3	4.3	1.5	4.7	11.9	6.8	3.7	2.9	16.2	2.4	5.2	3.0	6.8	2.9	4.8	5.8	8.6	4.5	52.6	5.3	3.9	8.5	4.2	11.6	11.6	7.5	7.4	8.7	9.5	11.4	6.8	8.6	8.4	1.8	12.3	9.2	7.0	9.9	9.3	10.4	9.7	3.7	8.4	9.9	6.9	10.1	6.3	10.6	9.1
KCNE5	KCNE1L	ENSG00000176076	"Potassium voltage-gated channel subfamily E regulatory subunit 5"	Q9UJ90	X	109623700-109625172	"Disease related genes, Predicted membrane proteins"			"Alport syndrome, Deafness, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 4.1;hTEC/SVTERT24-B: 5.4"	"Group enriched"	"Detected in some"	8	"glioma: 7.9;testis cancer: 2.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 5.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 5.6;monocytes: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042316			Uncertain	Cytosol				Cytosol		"HPA042316: AB_10795397"	"unprognostic (5.33e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.14e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.62e-3)"	"unprognostic (7.83e-2)"	"unprognostic (5.64e-6)"	"unprognostic (5.10e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.37e-3)"	4.8	1.1	6.4	1.3	11.3	6.8	1.2	6.0	6.6	1.0	0.6	8.2	0.0	0.7	0.8	1.3	1.2	0.5	2.4	2.2	8.9	8.1	0.7	0.7	0.8	0.8	14.3	1.6	1.7	0.4	0.4	0.2	2.5	29.5	1.9	0.5	0.1	0.6	2.3	3.2	1.1	0.8	0.9	7.3	1.4	0.6	1.2	0.3	8.5	0.6	2.6	0.8	0.8	0.2	0.0	5.6	0.0	1.7	0.1	0.8	0.3	0.9	0.0	0.2	0.4	0.1	0.1	0.1	1.9	0.4	0.7	0.7	0.1	0.4	0.4	0.0	0.4	0.8	0.0	2.2	0.9	0.2	0.4	2.6	2.6	1.8	0.1	0.0	4.1	0.6	1.4	5.4	1.3	0.4	0.0	0.1	0.5	0.0	0.8	3.3	0.0	0.1	0.2	0.1	0.1	0.7	0.1	0.2	0.4	1.2	0.0	1.1	0.0	2.5	1.2	1.8	0.9	1.0	2.4	0.5	0.6	0.3	1.2	1.2	0.5	0.0	0.7	0.0	0.8	1.7	0.0	0.0	0.1	0.1	5.6	0.0	0.0	0.1	0.0	0.1	0.1	1.2	0.0	0.3	6.4	11.3	6.0	6.5	8.9	8.1	14.3	1.6	29.5	0.3
ACSL4	"ACS4, FACL4, LACS4, MRX63, MRX68"	ENSG00000068366	"Acyl-CoA synthetase long chain family member 4"	O60488	X	109624244-109733403	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase	"Alport syndrome, Deafness, Disease mutation, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 80.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000286, HPA005552"	Supported		Approved	"Golgi apparatus,Mitochondria"			100000	"Golgi apparatus"	Mitochondria	"HPA000286: , HPA005552: AB_1078774"	"unprognostic (9.13e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.94e-2)"	"unprognostic (5.32e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.92e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.29e-2)"	"prognostic favourable (5.73e-4)"	29.5	31.1	16.3	25.5	18.0	9.2	30.0	13.9	22.8	34.7	10.5	8.8	4.6	10.0	13.7	11.7	11.2	10.7	20.1	20.3	27.6	20.3	31.2	9.6	27.8	29.6	15.2	19.0	13.1	8.8	16.7	12.9	33.9	21.1	9.7	9.7	8.0	10.7	11.0	42.5	9.1	9.0	15.8	24.6	17.0	12.9	17.7	9.7	9.5	12.8	8.5	11.9	19.5	21.0	2.2	6.5	20.3	10.9	2.2	4.0	3.8	13.7	4.4	5.5	5.9	20.7	13.0	4.3	20.1	22.3	19.7	20.5	4.3	9.6	9.8	7.8	14.5	3.9	4.7	19.4	31.0	3.4	4.9	38.7	6.3	45.8	9.5	9.2	80.3	11.2	7.6	22.5	16.4	14.7	1.1	12.1	22.5	0.9	8.0	12.1	6.9	8.0	5.8	10.1	8.1	28.2	4.4	3.6	2.8	24.0	0.0	12.4	0.3	9.8	27.2	18.0	5.1	28.4	18.4	6.0	6.9	9.2	31.7	20.6	11.4	15.5	7.0	20.3	2.8	9.8	2.0	2.2	2.5	2.2	6.5	2.2	2.0	2.4	19.8	2.2	10.9	2.6	4.0	3.8	16.3	18.0	13.9	22.6	27.6	20.3	15.2	19.0	21.1	9.7
TMEM164	"FLJ22679, RP13-360B22.2"	ENSG00000157600	"Transmembrane protein 164"	Q5U3C3	X	110002631-110182734	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 69.7"	"Cell line enhanced"	"Detected in all"		"HMC-1: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 25.9;eosinophil: 7.2;neutrophil: 8.8"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038784	Approved		Approved	"Vesicles,Cell Junctions"				Vesicles	"Cell Junctions"	"HPA038784: AB_10670790"	"unprognostic (2.14e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.65e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavourable (8.17e-6)"	"unprognostic (9.85e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.95e-1)"	"unprognostic (7.66e-2)"	"prognostic favourable (3.14e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.81e-2)"	"unprognostic (4.19e-3)"	15.0	8.6	9.2	6.1	10.9	11.1	9.2	2.6	6.8	3.9	17.0	6.0	36.3	14.5	4.5	4.1	10.5	5.5	8.8	14.7	6.6	5.9	8.4	1.7	35.8	7.6	4.6	3.5	11.9	17.2	11.1	8.7	6.6	7.0	6.2	14.8	18.7	7.6	69.7	32.0	15.2	33.1	4.6	2.9	6.9	9.9	2.2	5.1	4.5	11.4	6.0	5.8	5.0	5.1	0.4	1.4	25.9	1.7	1.1	0.9	0.8	4.7	10.9	9.0	5.8	11.1	8.2	5.5	2.4	5.6	5.1	3.3	8.5	7.5	3.8	16.3	3.7	7.0	7.7	12.6	5.0	10.5	5.3	25.9	5.9	3.5	6.6	11.4	37.1	11.3	22.3	9.1	12.7	9.9	8.0	4.6	9.0	9.5	11.9	14.5	8.0	7.9	5.5	6.9	3.2	8.1	5.0	8.4	9.4	15.3	15.1	7.0	4.4	11.4	22.0	4.3	3.2	5.0	3.4	2.7	3.4	3.1	11.3	14.3	11.5	25.9	1.7	7.2	0.3	1.5	0.9	0.1	0.4	0.3	1.4	0.4	0.2	0.3	8.8	1.1	0.9	0.2	0.5	0.8	9.2	10.9	2.6	6.8	6.6	5.9	4.6	3.5	7.0	5.1
AMMECR1		ENSG00000101935	"Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1"	Q9Y4X0	X	110194186-110440233	"Disease related genes, Predicted intracellular proteins"			"Alport syndrome, Deafness, Disease mutation, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA000590, HPA051762"	Uncertain		Approved	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA000590: , HPA051762: "	"unprognostic (7.77e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.66e-3)"	"unprognostic (6.55e-2)"	"unprognostic (5.98e-2)"	"prognostic favourable (6.62e-5)"	"unprognostic (3.61e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.02e-1)"	"prognostic favourable (8.44e-4)"	"unprognostic (7.82e-2)"	7.2	6.6	2.4	10.1	4.5	17.0	5.3	2.9	6.5	6.3	6.2	3.9	5.0	4.6	5.3	6.0	15.9	6.3	6.5	3.0	3.1	2.9	7.5	8.5	5.9	5.8	2.6	3.2	12.4	7.4	5.0	9.5	22.7	6.6	4.3	6.1	9.7	6.5	7.0	3.2	14.2	7.8	4.5	2.4	9.7	5.8	4.0	2.3	12.5	6.0	11.1	11.3	6.8	8.9	4.3	2.9	1.5	4.8	1.2	6.7	1.9	11.1	5.5	4.0	1.9	4.6	6.9	4.5	7.8	7.0	6.4	9.4	8.8	8.2	6.6	3.7	10.3	5.4	12.9	8.8	6.6	4.7	5.8	9.2	12.8	1.8	11.7	7.3	3.9	3.9	15.7	7.3	13.1	5.1	25.6	20.0	4.8	9.4	3.5	2.6	18.7	10.8	7.6	4.4	11.8	10.8	9.5	6.5	3.1	13.1	12.9	10.9	3.1	7.3	2.3	4.4	2.7	13.1	7.0	4.1	4.6	10.7	6.8	15.3	14.8	1.3	1.9	1.5	3.4	1.3	4.6	3.3	6.7	5.4	2.9	4.3	4.6	3.9	1.3	1.2	4.8	1.3	4.6	1.9	2.4	4.5	2.9	6.5	3.1	2.9	2.6	3.2	6.6	2.3
RTL9	"KIAA1318, Mar9, Mart9, RGAG1, SIRH10"	ENSG00000243978	"Retrotransposon Gag like 9"	Q8NET4	X	110358816-110456334	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	18	"testis: 38.5"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 5.4;U-2197: 4.2;U-87 MG: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001242	Enhanced									"HPA001242: AB_1079804"	"unprognostic (6.03e-2)"	"unprognostic (5.59e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.85e-4)"	"unprognostic (8.17e-2)"	"unprognostic (3.04e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.05e-3)"	"unprognostic (1.03e-1)"	"unprognostic (7.61e-3)"	"unprognostic (6.98e-4)"	"unprognostic (2.02e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.10e-2)"	0.1	0.2	0.4	0.1	2.0	0.0	0.1	0.7	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.4	0.5	0.1	2.1	0.1	0.4	0.1	0.1	1.1	0.1	1.1	0.1	0.0	0.2	1.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	38.5	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.4	0.3	0.1	1.5	0.8	0.6	1.9	0.2	0.0	0.0	0.8	2.1	0.0	0.4	1.6	0.4	0.3	0.1	0.1	0.0	0.0	1.6	0.0	0.2	0.8	0.1	5.4	0.8	0.0	0.7	0.0	0.5	0.0	0.1	0.0	0.6	2.1	0.0	1.9	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.7	4.2	1.3	0.0	0.1	0.0	3.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.0	0.7	0.1	0.1	2.1	1.1	0.1	0.1	0.1
CHRDL1	"CHL, MGC1, NRLN1"	ENSG00000101938	"Chordin like 1"	Q9BU40	X	110673856-110795819	"Disease related genes, Predicted secreted proteins"	"Differentiation, Neurogenesis, Osteogenesis"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"ASC diff: 93.7;ASC TERT1: 128.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	24	"plasmacytoid DC: 2.5"	"Lineage enriched"	"Detected in single"	24	"dendritic cells: 2.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000226, HPA000250"	Approved				"Secreted in other tissues"		620000			"HPA000226: AB_1078522, HPA000250: AB_1078521"	"unprognostic (5.13e-2)"	"unprognostic (6.31e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.42e-2)"	"unprognostic (4.89e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.56e-1)"	"prognostic unfavourable (2.36e-4)"	"unprognostic (4.75e-3)"	"unprognostic (7.91e-2)"	"unprognostic (5.01e-2)"	"prognostic unfavourable (2.23e-4)"	53.1	2.2	7.2	11.5	12.3	0.2	40.8	3.7	8.4	22.0	25.7	1.4	40.9	3.1	57.3	29.5	18.7	18.1	14.2	22.0	5.4	1.7	4.5	0.7	27.6	7.5	1.7	6.8	7.5	3.6	51.4	2.8	15.2	2.2	46.1	11.1	15.2	8.5	73.9	3.2	6.9	7.7	31.0	3.4	6.5	8.6	5.8	2.4	0.8	14.9	23.7	3.4	16.3	11.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	93.7	128.9	0.0	1.2	0.5	3.1	2.7	0.0	0.0	0.0	0.0	0.1	0.0	3.7	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	9.8	1.2	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	7.2	12.3	3.7	8.4	5.4	1.7	1.7	6.8	2.2	2.4
PAK3	"bPAK, hPAK3, MRX30, MRX47"	ENSG00000077264	"P21 (RAC1) activated kinase 3"	O75914	X	110944285-111227361	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Allosteric enzyme, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 26.2;pancreas: 46.5;pituitary gland: 37.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 9.7;HAP1: 8.7;HDLM-2: 10.9;NTERA-2: 8.5;SCLC-21H: 11.1;SH-SY5Y: 6.9;U-2197: 6.7;U-251 MG: 11.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"MAIT T-cell: 4.3"	"Lineage enriched"	"Detected in single"	7	"T-cells: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044791, HPA060219"	Approved		Approved	Cytosol				Cytosol		"HPA044791: , HPA060219: "	"unprognostic (1.80e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.27e-4)"	"unprognostic (2.46e-1)"	"unprognostic (5.63e-3)"	"unprognostic (7.29e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.89e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.30e-2)"	2.0	6.8	17.6	2.5	17.5	1.0	6.4	1.8	24.6	3.7	1.6	0.9	9.1	1.0	6.8	7.6	1.7	3.7	2.6	1.2	26.2	20.8	1.6	1.1	1.8	2.5	7.9	21.9	7.9	46.5	0.9	37.2	1.6	12.9	4.8	1.7	1.4	3.0	7.1	2.4	2.0	1.4	6.1	5.8	2.9	3.0	3.6	1.9	0.0	7.7	0.0	1.7	2.0	1.5	0.1	0.1	0.6	0.1	0.2	4.3	0.0	0.0	0.6	1.3	0.0	0.0	0.0	0.0	0.2	0.3	0.9	0.0	0.0	0.0	0.0	9.7	1.0	0.0	8.7	0.5	1.2	10.9	0.3	0.0	1.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	2.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	8.5	1.9	0.1	4.0	0.0	0.8	0.0	11.1	6.9	0.0	0.4	0.0	0.0	0.0	0.0	0.6	4.3	6.7	11.6	0.0	0.1	0.1	1.2	0.0	0.1	0.6	0.1	0.1	0.1	0.0	4.3	0.0	0.7	0.4	0.0	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.3	0.0	17.6	17.5	1.8	18.5	26.2	20.8	7.9	21.9	12.9	1.9
CAPN6	"CalpM, CANPX, CAPNX"	ENSG00000077274	"Calpain 6"	Q9Y6Q1	X	111245103-111270523	"Cancer-related genes, Enzymes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 62.9;placenta: 173.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.5;HDLM-2: 11.0;NTERA-2: 17.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 25.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 1.2;plasmacytoid DC: 2.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA040259			Approved	Vesicles				Vesicles		"HPA040259: "	"unprognostic (1.27e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.93e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.45e-3)"	"unprognostic (5.12e-1)"	"unprognostic (6.25e-2)"	"unprognostic (7.67e-2)"	"unprognostic (6.50e-2)"	"unprognostic (5.02e-3)"	"unprognostic (2.66e-1)"	"unprognostic (6.30e-2)"	1.7	0.0	0.2	1.7	0.2	0.0	6.0	0.3	0.3	3.9	4.2	0.2	23.4	0.2	18.2	62.9	2.4	2.9	2.6	0.4	0.2	0.0	5.1	0.4	0.3	1.1	0.2	0.4	1.9	4.1	0.0	0.2	173.5	0.3	3.6	2.2	2.1	5.6	21.7	1.7	1.0	1.3	2.0	0.3	1.0	7.2	2.8	0.2	0.5	1.7	4.7	2.9	1.4	2.6	0.1	2.0	0.8	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	17.3	0.0	0.0	0.0	0.1	1.5	0.0	0.1	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	2.0	0.1	0.0	0.2	0.2	0.3	0.3	0.2	0.0	0.2	0.4	0.3	0.2
DCX	"DBCN, DC, LISX, SCLH, XLIS"	ENSG00000077279	Doublecortin	O43602	X	111293779-111412429	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Disease mutation, Epilepsy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.1;testis: 6.4"	"Group enriched"	"Detected in some"	8	"SCLC-21H: 33.8;SH-SY5Y: 13.9"	"Cancer enriched"	"Detected in some"	5	"glioma: 5.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	9	"olfactory region: 90.9"	"Region enriched"	"Detected in all"	4	"olfactory region: 130.1"	HPA036121	Enhanced	Supported	Approved	Cytosol				Cytosol		"HPA036121: "	"unprognostic (1.36e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.24e-2)"		"unprognostic (2.33e-3)"	"unprognostic (3.67e-1)"	"unprognostic (4.90e-4)"	"unprognostic (5.02e-3)"	"unprognostic (1.27e-1)"		"unprognostic (1.85e-1)"	0.8	1.1	7.0	0.7	9.2	0.7	3.2	0.7	17.1	0.7	0.6	0.9	0.0	0.7	4.1	3.6	0.6	0.6	0.8	0.7	4.2	5.4	0.5	0.5	0.6	0.7	2.5	6.7	0.6	0.8	0.5	1.0	0.6	3.7	0.5	0.8	0.0	2.2	0.6	0.5	0.7	0.7	0.6	3.0	0.6	1.2	6.4	2.3	0.0	0.6	0.0	0.5	0.6	0.3	0.3	0.4	0.6	0.2	0.7	0.4	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	33.8	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.2	0.1	0.4	0.3	0.3	0.2	0.1	0.3	0.3	0.3	0.6	0.7	0.0	0.4	0.1	0.0	7.0	9.2	0.7	10.8	4.2	5.4	2.5	6.7	3.7	2.3
SERTM2	LINC00890	ENSG00000260802	"Serine rich and transmembrane domain containing 2"		X	111511662-111522399	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enhanced"	"Detected in some"		"epididymis: 60.2;seminal vesicle: 38.7"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 19.1"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 3.0"																"unprognostic (9.56e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.65e-1)"		"unprognostic (3.79e-2)"	"unprognostic (5.74e-2)"		"unprognostic (1.93e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.77e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.26e-1)"	"unprognostic (9.57e-3)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	15.2	0.5	0.0	9.1	0.0	14.2	60.2	0.0	0.0	0.0	0.0	0.0		0.0	1.7	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.6	1.7	0.5	4.6	0.0	0.1	0.0	38.7	0.0	0.0	0.0	2.2	0.0	2.3	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	1.0	0.0	3.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ALG13	"CDG1S, CXorf45, FLJ23018, GLT28D1, MDS031, TDRD13, YGL047W"	ENSG00000101901	"ALG13, UDP-N-acetylglucosaminyltransferase subunit"	Q9NP73	X	111665811-111760649	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Glycosyltransferase, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase"	"Congenital disorder of glycosylation, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA002853	Approved									"HPA002853: AB_1078131"	"unprognostic (4.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.97e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.26e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.73e-2)"	"unprognostic (4.62e-3)"	"prognostic unfavourable (1.10e-6)"	"unprognostic (1.19e-1)"	"unprognostic (1.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.45e-2)"	20.6	23.0	18.4	23.2	23.2	19.3	24.8	20.9	25.5	21.1	23.3	21.6	22.0	18.0	26.3	28.5	18.3	22.5	22.2	16.8	16.6	16.2	23.5	31.1	19.7	28.4	22.4	16.1	24.2	18.8	13.0	41.7	18.7	19.5	26.7	26.5	16.3	19.5	25.6	11.2	25.2	25.7	23.5	21.6	31.4	20.1	19.0	20.3	23.6	24.5	14.6	25.8	18.3	20.9	10.2	14.4	21.7	12.5	3.4	11.1	7.1	11.5	13.1	11.8	7.5	7.7	11.0	6.7	9.5	9.8	12.2	15.1	13.2	12.2	10.1	18.2	13.1	6.7	14.0	6.6	12.9	7.2	9.4	5.5	14.9	14.9	11.4	10.1	22.3	13.1	12.5	9.8	21.2	13.2	12.3	29.1	12.1	29.5	8.5	9.1	10.8	18.1	6.6	7.5	14.0	19.5	18.0	7.1	10.5	13.5	8.2	8.2	7.3	9.7	8.9	10.6	5.3	13.6	18.1	14.0	23.2	16.2	11.3	13.4	8.0	21.7	12.4	12.2	7.8	12.5	7.6	8.4	8.9	7.6	14.4	10.2	11.1	9.1	2.5	3.4	9.4	7.5	10.7	7.1	18.4	23.2	20.9	25.5	16.6	16.2	22.4	16.1	19.5	20.3
TRPC5	PPP1R159	ENSG00000072315	"Transient receptor potential cation channel subfamily C member 5"	Q9UL62	X	111774315-112082776	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"brain: 5.3;liver: 3.2"	"Cell line enriched"	"Detected in single"	6	"NTERA-2: 6.2"	"Group enriched"	"Detected in some"	23	"testis cancer: 0.8;thyroid cancer: 2.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"																		"unprognostic (3.29e-2)"		"unprognostic (6.15e-2)"	"unprognostic (7.32e-2)"			"unprognostic (2.60e-3)"		"unprognostic (3.68e-2)"	"unprognostic (5.69e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.78e-2)"		0.0	0.2	0.6	0.0	0.3	0.0	0.0	0.6	5.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.3	0.4	3.2	0.0	0.0	0.9		0.0	0.2	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TRPC5OS	TRPC5-AS1	ENSG00000204025	"TRPC5 opposite strand"	A6NMA1	X	111876051-111903990	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	58	"testis: 34.2"	"Group enriched"	"Detected in some"	4	"REH: 1.1;THP-1: 4.5;U-937: 4.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		"unprognostic (1.77e-2)"			"unprognostic (8.15e-2)"	"unprognostic (7.51e-2)"		"unprognostic (2.99e-1)"	"unprognostic (1.47e-2)"		"unprognostic (9.90e-2)"	"unprognostic (1.72e-1)"		"unprognostic (1.40e-6)"	"unprognostic (6.23e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.85e-3)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.5	0.4	1.1	0.0	0.0	0.7	0.0	0.2	0.1	0.0	0.0	0.3	0.0	4.5	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RTL4	"FLJ46608, Mar4, Mart4, SIRH11, ZCCHC16"	ENSG00000187823	"Retrotransposon Gag like 4"	Q6ZR62	X	112454500-112457112	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"kidney: 3.5;liver: 4.7"	"Cell line enhanced"	"Detected in single"		"NTERA-2: 2.0"	"Group enriched"	"Detected in some"	8	"testis cancer: 1.4;thyroid cancer: 3.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003272	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA003272: AB_2257414"							"unprognostic (9.86e-2)"						"unprognostic (2.04e-4)"		"unprognostic (6.35e-2)"	"unprognostic (5.33e-3)"		0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.4	0.6	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	3.5	4.7	0.0	0.0	0.7		0.0	0.4	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2			0.3		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LHFPL1		ENSG00000182508	"LHFPL tetraspan subfamily member 1"	Q86WI0	X	112630648-112680054	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 13.7;pituitary gland: 15.9;salivary gland: 8.2"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 1.4;NTERA-2: 2.5;REH: 1.5;SK-MEL-30: 7.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 2.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in many"	5	"olfactory region: 6.1"	HPA003029	Uncertain									"HPA003029: AB_1079248"	"unprognostic (2.23e-2)"	"unprognostic (2.78e-3)"		"unprognostic (2.49e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.41e-3)"	"unprognostic (5.19e-5)"	"unprognostic (1.33e-1)"	"unprognostic (7.63e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.92e-1)"	0.2	0.6	3.1	0.4	13.7	0.1	2.0	0.1	3.8	1.5	0.3	0.6	0.9	0.3	0.6	0.9	0.5	1.3	0.2	2.2	2.8	2.5	0.6	0.2	0.2	0.4	4.5	1.5	1.1	0.1	0.3	15.9	0.5	3.8	1.2	0.4	0.0	8.2	3.3	0.5	0.3	0.5	0.3	0.5	0.4	0.2	0.4	1.6	0.3	6.1	0.1	0.5	0.5	0.2	0.7	0.0	0.0	0.0	0.8	2.6	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	2.5	0.0	1.5	0.3	0.9	0.1	0.4	0.2	0.2	0.0	0.0	7.0	0.0	0.0	0.0	0.2	0.3	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.2	0.7	1.0	2.6	0.0	0.6	0.2	0.8	0.0	0.8	0.0	0.0	0.1	0.4	3.1	13.7	0.1	2.7	2.8	2.5	4.5	1.5	3.8	1.6
AMOT	KIAA1071	ENSG00000126016	Angiomotin	Q4VCS5	X	112774503-112840815	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 40.0;epididymis: 102.0"	"Cell line enhanced"	"Detected in many"		"AF22: 17.6;HAP1: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067290, HPA067853"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"				"Cell Junctions"	Nucleoplasm	"HPA067290: , HPA067853: "	"unprognostic (1.08e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.20e-1)"	"unprognostic (8.95e-2)"	"unprognostic (3.82e-2)"	"prognostic favourable (3.94e-4)"	"unprognostic (4.46e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.60e-2)"	"prognostic favourable (4.21e-9)"	"unprognostic (9.54e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.50e-2)"	"unprognostic (6.44e-2)"	3.7	2.3	18.4	2.0	17.9	1.3	5.5	3.0	14.0	8.1	3.5	13.9	40.0	3.1	4.7	102.0	3.8	9.7	3.1	3.7	15.4	10.9	8.2	2.5	3.0	1.6	14.4	10.3	5.4	2.7	8.4	7.0	14.9	18.0	5.6	4.3	1.2	6.9	27.6	25.2	2.7	3.6	3.5	15.7	2.1	3.3	2.7	13.5	0.1	3.8	9.3	1.8	3.2	4.3	0.5	0.2	0.0	0.6	1.9	1.5	0.2	3.0	0.0	17.6	0.7	0.3	0.3	6.5	0.6	0.0	0.0	0.0	7.4	0.6	0.4	3.6	2.7	6.4	19.0	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.1	0.0	0.8	0.2	0.0	3.9	0.5	0.1	0.0	0.0	0.4	0.3	4.8	0.2	7.8	0.1	6.1	5.4	0.1	8.2	8.1	0.0	6.0	0.1	0.0	6.8	0.6	0.1	0.1	2.2	5.2	0.0	7.0	0.5	0.0	0.0	0.8	0.1	4.5	0.0	0.0	0.0	1.1	0.4	1.5	0.5	0.7	1.0	0.2	0.2	0.7	0.6	0.0	1.9	0.6	0.2	1.0	0.2	18.4	17.9	3.0	14.0	15.4	10.9	14.4	10.3	18.0	13.5
HTR2C	"5-HT2C, 5HTR2C, HTR1C"	ENSG00000147246	"5-hydroxytryptamine receptor 2C"	P28335	X	114584078-114910061	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	20	"brain: 45.3"	"Group enriched"	"Detected in some"	4	"EFO-21: 4.9;RPMI-8226: 2.4;U-266/70: 8.7;U-266/84: 7.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Region enhanced"	"Detected in many"		"basal ganglia: 45.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"																		"unprognostic (2.14e-1)"	"unprognostic (6.09e-3)"		"unprognostic (9.54e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.89e-2)"		"unprognostic (3.42e-2)"		"unprognostic (9.22e-4)"	"unprognostic (1.37e-1)"		"unprognostic (6.84e-2)"	0.5	0.5	2.4	0.4	45.3	0.5	0.5	0.0	9.4	2.3	0.4	8.5	0.0	0.4	0.5	0.6	0.4	0.4	0.5	0.4	2.4	9.8	0.5	0.5	0.5	0.4	2.0	1.2	0.4	0.4	0.4	0.3	1.0	29.7	0.9	0.4	0.8	0.4	1.1	0.4	0.4	0.4	0.4	1.7	0.4	0.4	0.6	2.4	0.0	0.4	0.0	0.4	0.5	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	2.4	0.0	1.3	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.9	0.0	0.0	8.7	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.4	45.3	0.0	4.6	2.4	9.8	2.0	1.2	29.7	2.4
IL13RA2	"CD213a2, CT19, IL-13R, IL13BP"	ENSG00000123496	"Interleukin 13 receptor subunit alpha 2"	Q14627	X	115003975-115019977	"Cancer-related genes, CD markers, Predicted membrane proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 16.1;testis: 31.5"	"Group enriched"	"Detected in some"	9	"PC-3: 26.4;U-2197: 84.9;U-251 MG: 57.0;U-87 MG: 33.8"	"Cancer enhanced"	"Detected in many"		"glioma: 17.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"olfactory region: 8.7"	"Low region specificity"	"Detected in many"			"HPA045831, HPA067363"			Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"	"Nucleoplasm, Vesicles"	"HPA045831: , HPA067363: "	"unprognostic (1.97e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.62e-4)"	"unprognostic (7.39e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.80e-1)"	"prognostic favourable (3.55e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.53e-5)"	"unprognostic (1.58e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.20e-1)"	0.5	4.8	3.7	3.9	11.3	0.0	0.8	0.3	3.1	1.2	0.4	2.1	5.7	0.3	0.9	4.4	0.5	0.1	0.8	0.6	5.1	11.2	3.5	9.6	1.0	0.1	1.2	2.6	0.1	0.1	0.5	16.1	2.1	3.9	4.3	0.7	1.6	0.8	3.7	0.0	0.1	0.3	0.4	0.6	0.2	0.1	31.5	1.4	0.0	1.3	0.2	0.2	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.7	0.0	5.8	5.5	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.1	0.9	5.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	26.4	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.4	0.0	0.1	0.0	0.0	0.0	3.0	0.0	84.9	57.0	0.0	0.0	0.0	33.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	11.3	0.3	3.1	5.1	11.2	1.2	2.6	3.9	1.4
LRCH2	KIAA1495	ENSG00000130224	"Leucine rich repeats and calponin homology domain containing 2"	Q5VUJ6	X	115110616-115234072	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 17.8;U-266/70: 11.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003233	Approved		Approved	"Nucleoli,Plasma membrane"				Nucleoli	"Plasma membrane"	"HPA003233: AB_2265929"	"unprognostic (9.74e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.22e-5)"	"unprognostic (2.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.29e-5)"	"unprognostic (1.09e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.16e-2)"	5.1	8.7	11.6	3.4	10.2	0.7	3.3	11.2	10.6	11.2	11.6	5.5	4.0	1.6	9.9	4.5	3.6	4.6	5.3	4.7	7.9	8.9	2.6	1.0	5.7	1.8	5.7	4.6	13.8	1.6	1.3	20.9	13.7	7.6	16.4	4.2	2.5	1.3	14.5	1.2	1.1	3.2	13.7	6.4	3.7	3.6	4.3	7.9	0.0	4.8	0.4	1.1	11.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	3.9	5.5	4.6	0.0	3.5	7.6	3.4	7.9	0.0	0.0	0.1	0.0	4.6	0.3	17.8	0.0	5.2	0.0	4.8	0.0	0.0	0.0	4.4	0.0	0.1	2.7	0.0	1.4	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	5.1	5.2	0.0	3.8	0.0	4.3	0.5	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	4.9	11.8	2.0	0.0	1.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	10.2	11.2	8.4	7.9	8.9	5.7	4.6	7.6	7.9
RBMXL3	"CXorf55, FLJ40249"	ENSG00000175718	"RNA binding motif protein, X-linked like 3"	Q8N7X1	X	115189427-115192868	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	68	"testis: 6.8"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	25	"testis cancer: 1.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051842	Supported									"HPA051842: "															"unprognostic (1.05e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LUZP4	"CT-8, CT28, HOM-TES-85"	ENSG00000102021	"Leucine zipper protein 4"	Q9P127	X	115289727-115307556	"Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	142	"testis: 21.2"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 2.3;U-266/70: 1.1"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 13.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046436, HPA051999"	Enhanced									"HPA046436: AB_10964168, HPA051999: AB_2681688"															"unprognostic (1.84e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.1	0.4	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PLS3	T-plastin	ENSG00000102024	"Plastin 3"	P13797	X	115561174-115650861	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"NK-cell: 4.2;plasmacytoid DC: 13.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 13.1;NK-cells: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020433, HPA076083"	Approved		Approved	"Plasma membrane,Cytosol"			110000000	"Plasma membrane, Cytosol"		"HPA020433: , HPA076083: "	"unprognostic (1.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavourable (6.07e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (4.59e-4)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (1.01e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.54e-1)"	"prognostic favourable (3.72e-4)"	"prognostic unfavourable (7.04e-4)"	41.9	11.0	11.8	9.8	12.5	0.2	24.6	3.6	16.7	43.8	14.3	13.9	24.1	6.0	37.4	27.6	54.4	21.5	23.6	18.8	12.2	8.2	40.7	100.5	64.7	6.0	14.7	13.7	44.4	8.9	2.7	4.6	21.9	22.7	21.6	9.2	10.6	16.6	31.4	17.7	38.4	8.2	34.6	14.5	31.6	13.3	14.9	13.0	5.1	64.8	34.7	12.5	38.7	29.0	0.0	13.1	0.4	0.1	4.2	1.5	0.2	27.8	28.7	25.1	7.3	25.4	23.8	38.3	29.1	32.9	27.9	33.8	31.1	23.2	0.1	84.2	23.9	35.9	26.6	47.3	45.4	0.4	33.3	2.7	35.6	13.0	23.0	0.0	1.3	15.0	22.8	43.2	30.4	60.4	0.0	0.0	26.6	8.1	0.0	0.3	33.3	34.4	0.0	16.8	0.6	33.3	15.1	0.0	5.2	61.1	15.2	12.2	8.4	0.4	66.0	45.3	7.7	46.1	58.1	1.1	4.0	0.5	19.8	0.1	18.7	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.0	0.1	4.2	0.0	13.1	1.5	0.2	11.8	12.5	3.6	16.7	12.2	8.2	14.7	13.7	22.7	13.0
AGTR2	"AT2, MRX88"	ENSG00000180772	"Angiotensin II receptor type 2"	P50052	X	116170722-116174972	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"endometrium 1: 20.8;lung: 26.7;smooth muscle: 13.6"	"Cell line enriched"	"Detected in single"	6	"HSkMC: 1.3"	"Group enriched"	"Detected in some"	12	"endometrial cancer: 3.0;lung cancer: 1.9"	"Region enriched"	"Detected in single"	10	"cerebellum: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	9	"cerebellum: 3.8"															"unprognostic (2.13e-1)"				"unprognostic (1.71e-1)"			"unprognostic (3.22e-2)"				"unprognostic (4.37e-2)"			0.3	1.6	0.1	0.8	0.1	0.0	0.1	1.0	0.1	5.3	0.4	0.1	0.1	0.0	20.8	3.3	0.2	3.6	0.4	1.7	0.1	0.0	0.4	0.1	26.7	0.8	0.1	0.1	1.1	1.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	13.6	0.1	0.1	0.6	0.2	0.1	0.4	0.1	1.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SLC6A14		ENSG00000268104	"Solute carrier family 6 member 14"	Q9UN76	X	116436622-116461458	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		Obesity	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 17.8;pituitary gland: 14.4;salivary gland: 26.3;tongue: 23.5"	"Group enriched"	"Detected in some"	4	"HeLa: 3.8;Hep G2: 8.2"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003193	Uncertain		Approved	Vesicles				Vesicles		"HPA003193: AB_2190122"	"unprognostic (3.06e-2)"	"unprognostic (3.55e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.67e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.83e-2)"	"prognostic unfavourable (9.74e-4)"	"unprognostic (1.34e-2)"		"unprognostic (3.89e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	0.0	0.0	0.0	1.5	0.0	0.0	5.9	0.0	0.0	6.3	0.8	0.0	11.8	0.4	0.1	0.0	1.8	0.0	1.0	0.0	0.0		0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.2	0.5	0.3	0.0	26.3	5.8	0.0	1.1	0.2	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	23.5	1.2	1.0	1.0	0.4	0.2	1.1	0.4	0.3	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	3.8	8.2	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.2	0.0	1.4	0.5	0.0	0.0	0.1	0.0	1.1	0.4	0.5	0.4	0.1	0.3	0.4	0.2	0.2	0.1	0.4	0.3	0.3	0.4	0.3	0.2	0.2	0.1	0.0										
CT83	"CXorf61, FLJ20611, FLJ22913, KK-LC-1"	ENSG00000204019	"Cancer/testis antigen 83"	Q5H943	X	116461682-116463003	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"testis: 46.8"	"Cell line enhanced"	"Detected in some"		"HeLa: 29.2;RPMI-8226: 9.0;U-266/70: 41.3;U-266/84: 20.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"																					"unprognostic (1.59e-2)"						"unprognostic (1.69e-2)"	"unprognostic (8.70e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	46.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	41.3	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
KLHL13	"BKLHD2, FLJ10262, KIAA1309"	ENSG00000003096	"Kelch like family member 13"	Q9P2N7	X	117897813-118117340	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 35.6"	"Cell line enhanced"	"Detected in many"		"HeLa: 22.2;RH-30: 13.9;RPTEC TERT1: 39.9;SH-SY5Y: 35.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 3.2;eosinophil: 9.3;plasmacytoid DC: 5.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.6;granulocytes: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046039, HPA059901"	Approved		Approved	Cytosol				Cytosol		"HPA046039: , HPA059901: "	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.54e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.31e-1)"	2.4	5.5	3.4	3.9	11.9	0.2	19.0	2.5	3.7	24.9	5.3	3.1	6.6	2.2	35.6	5.6	5.4	8.1	10.1	9.0	2.3	4.0	15.4	3.3	1.4	0.4	4.7	2.1	7.7	3.3	3.5	5.0	1.7	6.6	7.3	3.0	5.6	2.6	9.7	2.3	1.5	4.9	22.2	3.5	1.1	3.5	2.8	4.9	3.6	1.4	3.1	1.2	8.2	5.0	0.0	5.6	9.3	0.1	1.4	0.9	0.4	0.4	0.1	2.6	5.4	0.0	0.0	0.1	0.2	0.0	0.1	0.0	3.3	0.0	0.0	6.2	0.0	6.2	12.5	2.0	0.0	0.0	4.8	0.1	22.2	0.0	0.3	0.4	0.8	0.6	0.9	0.0	0.2	9.5	0.0	0.0	0.0	0.5	2.1	0.5	5.0	3.5	0.0	13.9	0.0	39.9	1.4	0.0	35.6	0.1	0.4	0.3	7.7	0.0	0.2	0.9	1.1	0.7	3.1	0.1	0.0	0.0	3.8	0.0	1.5	3.2	0.1	9.3	0.0	0.0	0.0	0.0	0.1	0.1	1.3	0.0	0.9	0.8	0.0	1.4	0.0	5.6	0.4	0.4	3.4	11.9	2.5	3.5	2.3	4.0	4.7	2.1	6.6	4.9
WDR44	"DKFZp686L20145, RAB11BP, RPH11, SYM-4"	ENSG00000131725	"WD repeat domain 44"	Q5JSH3	X	118346073-118449961	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038084, HPA046719"	Approved		Supported	"Golgi apparatus"			1500000	"Golgi apparatus"		"HPA038084: AB_10675626, HPA046719: "	"unprognostic (1.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.52e-2)"	14.3	14.9	17.7	13.3	25.0	9.2	12.6	19.9	19.5	15.2	13.5	20.4	13.1	14.0	16.0	12.2	19.8	12.9	20.4	13.9	16.3	15.0	10.8	21.5	13.4	15.4	21.8	16.6	15.2	11.6	25.9	19.9	12.4	17.0	13.6	11.0	9.9	12.8	19.3	17.1	9.8	14.2	22.5	18.0	13.2	15.1	16.3	22.7	17.6	12.3	9.9	15.2	15.9	14.8	5.9	7.7	10.7	7.7	10.7	10.6	5.9	11.0	6.5	7.1	4.0	12.1	10.0	3.9	17.5	12.3	12.8	18.1	4.4	12.8	3.2	10.3	12.5	8.7	13.8	8.3	14.7	12.5	6.1	12.6	17.1	2.8	8.4	7.8	8.8	5.8	9.0	12.1	8.1	11.3	9.9	11.1	12.1	5.4	6.1	4.7	12.8	10.6	4.9	6.1	4.8	10.4	7.1	3.0	4.8	16.6	5.9	5.4	5.2	5.7	14.2	9.5	3.7	12.8	9.8	4.2	6.6	4.5	8.0	9.4	6.3	9.5	4.9	10.7	8.8	7.4	8.9	5.9	7.3	8.7	7.7	5.2	8.5	9.2	3.0	10.7	7.7	5.6	10.6	5.9	17.7	25.0	19.9	19.5	16.3	15.0	21.8	16.6	17.0	22.7
DOCK11	"ACG, FLJ32122, FLJ43653, ZIZ2"	ENSG00000147251	"Dedicator of cytokinesis 11"	Q5JSL3	X	118495898-118686163	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 27.2;HMC-1: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059695	Uncertain		Approved	"Nuclear membrane,Nucleoli"				"Nuclear membrane, Nucleoli"		"HPA059695: "	"unprognostic (4.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.32e-1)"	"prognostic favourable (4.87e-4)"	"unprognostic (1.50e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.37e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.11e-2)"	"unprognostic (8.16e-3)"	27.3	6.9	5.0	15.9	15.0	23.5	30.6	1.4	3.1	7.6	11.6	1.5	4.2	2.5	7.9	8.2	7.8	7.0	7.3	6.7	4.4	3.3	7.4	2.6	11.7	27.5	5.4	2.0	3.5	1.7	2.4	15.9	10.0	3.9	6.0	4.8	1.4	4.4	4.1	2.5	4.4	9.7	9.6	7.8	13.8	7.3	3.7	5.3	19.7	9.4	3.6	13.8	9.3	13.3	5.2	4.6	13.1	7.3	7.6	11.3	2.1	0.0	2.4	2.0	1.8	27.2	11.6	5.3	2.8	6.0	2.3	6.0	0.3	0.0	7.4	0.2	10.0	0.1	3.5	0.0	2.0	9.1	3.1	16.1	2.6	0.0	8.8	9.7	39.1	8.1	0.1	2.4	2.7	0.0	4.9	13.4	1.4	1.6	5.8	12.9	2.1	3.8	3.9	5.2	0.2	0.0	0.5	0.7	4.8	8.4	7.8	2.7	0.9	8.2	0.1	1.8	0.6	10.7	1.2	4.1	6.2	6.9	4.0	15.6	0.9	6.3	4.2	7.5	8.8	6.1	5.5	4.9	7.4	7.0	4.6	5.2	6.7	8.3	13.1	7.6	7.3	3.7	11.3	2.1	5.0	15.0	1.4	3.1	4.4	3.3	5.4	2.0	3.9	5.3
IL13RA1	"CD213a1, IL-13Ra, NR4"	ENSG00000131724	"Interleukin 13 receptor subunit alpha 1"	P78552	X	118727572-118794539	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 6.9;eosinophil: 7.1;myeloid DC: 10.9;neutrophil: 19.0"	"Group enriched"	"Detected in many"	6	"dendritic cells: 10.9;granulocytes: 19.0;monocytes: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001587			Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"		4500000	Vesicles	Nucleoplasm	"HPA001587: AB_1079133"	"unprognostic (5.14e-3)"	"unprognostic (4.72e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.75e-2)"	"unprognostic (8.81e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.21e-2)"	"prognostic unfavourable (1.19e-8)"	"unprognostic (1.88e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.82e-2)"	"unprognostic (5.08e-2)"	31.5	17.5	9.3	15.3	13.3	2.1	19.8	3.6	10.2	16.6	23.8	12.6	7.2	18.9	16.6	18.0	33.0	15.4	17.7	17.5	11.4	9.4	22.7	73.3	27.7	33.9	15.2	6.0	25.2	12.9	9.5	16.1	15.2	13.4	15.3	25.2	14.5	21.8	13.0	22.3	10.2	37.7	16.3	24.5	17.4	18.5	9.9	11.9	4.8	24.0	20.1	20.0	16.5	15.4	1.9	10.9	19.0	6.9	0.0	0.1	1.7	8.2	10.2	4.9	13.4	11.1	33.1	8.8	17.3	24.1	8.3	10.8	5.9	15.3	0.0	30.5	23.8	7.9	5.3	7.3	9.2	45.1	4.1	1.4	9.3	15.1	6.8	0.1	3.6	30.1	6.7	11.3	13.9	17.2	4.4	0.9	11.7	12.1	0.0	2.2	4.4	9.9	0.0	12.0	0.0	12.4	9.0	1.8	1.7	27.2	10.0	6.8	6.4	7.8	21.9	16.2	7.7	27.2	13.5	0.2	4.1	0.0	35.7	4.2	6.8	0.0	6.9	7.1	0.0	1.7	0.0	1.9	0.0	0.0	10.9	1.8	0.0	0.0	19.0	0.0	0.6	1.9	0.1	1.7	9.3	13.3	3.6	10.2	11.4	9.4	15.2	6.0	13.4	11.9
ZCCHC12	"FLJ16123, PNMA7A, SIZN, SIZN1"	ENSG00000174460	"Zinc finger CCHC-type containing 12"	Q6PEW1	X	118823790-118826968	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 51.3;endometrium 1: 53.4;fallopian tube: 60.7;smooth muscle: 72.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.4;HEK 293: 13.9;NTERA-2: 4.4;SH-SY5Y: 3.5"	"Cancer enriched"	"Detected in many"	76	"thyroid cancer: 256.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"naive CD8 T-cell: 4.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 4.1"									"HPA031016, HPA034940"	Uncertain		Approved	"Nuclear bodies"				"Nuclear bodies"		"HPA031016: AB_2673698, HPA034940: AB_10671098"	"unprognostic (1.29e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.34e-4)"	"unprognostic (9.18e-13)"	"unprognostic (4.14e-3)"	"unprognostic (1.63e-1)"	"prognostic favourable (3.42e-5)"	"unprognostic (1.18e-1)"	0.9	4.8	30.5	1.2	20.2	0.8	1.0	20.3	17.3	9.7	1.1	1.6	0.9	1.0	53.4	11.6	0.8	60.7	1.0	0.8	28.7	51.3	0.8	0.8	0.9	1.1	4.4	11.6	6.7	0.8	0.8	7.9	0.8	14.7	1.0	1.0	1.1	0.8	1.1	0.8	0.8	1.1	72.5	4.5	0.9	0.8	1.0	0.8	0.0	2.9	0.0	1.1	0.8	1.7	0.6	0.0	0.0	0.0	0.0	4.1	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.7	0.0	0.0	0.4	0.0	0.0	5.4	0.0	0.2	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.2	4.4	0.0	0.1	0.0	0.0	0.0	0.0	1.9	3.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.7	4.1	0.0	0.0	0.0	0.0	0.0	0.2	30.5	20.2	20.3	17.3	28.7	51.3	4.4	11.6	14.7	0.8
LONRF3	"FLJ22612, RNF127"	ENSG00000175556	"LON peptidase N-terminal domain and ring finger 3"	Q496Y0	X	118974614-119018355	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 9.3;K-562: 11.0;PC-3: 12.6;SiHa: 11.4;SK-MEL-30: 10.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 7.4"	"Lineage enriched"	"Detected in single"	8	"T-cells: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050422, HPA061162"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA050422: , HPA061162: "	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.01e-2)"	"prognostic unfavourable (4.32e-4)"	"unprognostic (4.29e-2)"	"unprognostic (2.31e-3)"	"unprognostic (6.34e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.27e-3)"	3.8	3.9	4.2	2.1	3.4	4.6	10.8	15.8	6.1	1.9	4.1	2.0	1.6	2.9	2.4	3.1	1.7	2.5	3.9	3.9	5.0	1.9	3.6	15.4	11.8	0.8	1.7	3.7	2.0	8.1	0.4	3.5	0.9	4.4	3.0	5.5	4.1	8.1	3.0	13.8	1.4	2.3	10.8	2.7	1.1	4.5	2.7	2.5	0.0	9.9	1.9	1.1	4.7	6.6	0.0	0.1	0.8	0.8	0.0	7.4	0.7	3.8	5.7	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	4.8	0.0	2.8	0.0	0.0	1.2	0.0	0.1	0.1	3.2	4.9	9.3	5.5	3.2	4.2	0.6	0.0	0.0	0.0	0.0	1.5	11.0	0.0	0.8	4.7	0.0	1.8	0.0	12.6	0.0	2.6	0.0	3.5	1.6	0.2	0.0	11.4	0.3	10.0	0.0	3.7	0.2	0.1	0.2	0.0	6.1	1.2	4.9	0.0	2.7	4.3	2.5	0.0	0.8	0.0	4.5	0.0	7.4	0.0	2.0	1.5	0.1	0.0	1.1	1.6	0.8	0.0	0.0	0.0	0.7	0.7	4.2	3.4	15.8	6.1	5.0	1.9	1.7	3.7	4.4	2.5
AL772284.2		ENSG00000277535			X	119073226-119076373	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in single"	55	"testis: 9.7"	"Cell line enhanced"	"Detected in single"		"U-266/84: 2.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	9.7			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0										
KIAA1210		ENSG00000250423	KIAA1210	Q9ULL0	X	119078635-119150579	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"epididymis: 24.6;seminal vesicle: 12.3;testis: 19.8"	"Group enriched"	"Detected in some"	9	"Daudi: 2.1;MCF7: 4.1;SK-BR-3: 2.2;U-2 OS: 2.5"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.3"					"Group enriched"	"Detected in some"	5	"basophil: 2.0;neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.0"									"HPA000551, HPA048322"	Enhanced									"HPA000551: AB_1079165, HPA048322: "	"unprognostic (2.48e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.26e-4)"	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.7	24.6	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.1	0.0		2.7	0.0		0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8			0.0		0.0	0.1	0.0	0.2	0.2	2.0	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	2.2	0.2	0.1	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.1	1.2	0.3	0.1	0.2	0.0	0.0										
PGRMC1	HPR6.6	ENSG00000101856	"Progesterone receptor membrane component 1"	O00264	X	119236245-119244466	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 163.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002877, HPA064724"	Enhanced		Enhanced	"Nucleoli,Endoplasmic reticulum"			6000000	"Endoplasmic reticulum"	Nucleoli	"HPA002877: AB_1079602, HPA064724: "	"unprognostic (6.97e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.35e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavourable (3.02e-4)"	"unprognostic (1.58e-3)"	"unprognostic (9.28e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	25.0	46.0	37.7	11.9	36.9	5.6	60.2	21.8	37.8	36.2	30.5	30.9	42.9	27.0	39.9	71.4	15.0	38.9	20.1	10.0	38.6	50.4	58.7	163.9	15.6	8.8	38.1	29.6	24.7	10.9	23.8	15.5	12.3	35.3	33.5	22.5	22.1	17.5	53.7	5.7	12.5	42.9	22.0	46.9	10.0	18.9	14.2	27.1	6.9	24.7	12.2	7.7	21.3	17.3	3.6	9.9	11.4	11.8	4.8	8.0	28.7	26.8	17.0	33.4	38.4	72.2	34.7	21.7	40.6	47.3	21.6	26.9	20.5	33.0	7.7	44.5	42.1	21.5	36.4	17.0	29.1	8.2	41.8	8.7	16.3	23.0	12.0	14.3	4.7	35.7	9.6	26.2	13.6	13.9	9.2	4.8	25.3	28.7	10.7	10.5	87.5	28.7	12.8	20.9	11.2	28.5	20.5	31.2	13.9	29.7	49.4	15.9	11.4	9.2	10.7	15.1	22.2	53.2	38.2	5.1	9.3	8.4	41.1	22.8	28.6	9.2	11.8	11.4	5.5	11.3	7.3	3.6	7.5	8.0	9.9	3.1	7.7	6.3	5.7	4.8	10.0	7.1	7.6	28.7	37.7	36.9	21.8	37.2	38.6	50.4	38.1	29.6	35.3	27.1
SLC25A43		ENSG00000077713	"Solute carrier family 25 member 43"	Q8WUT9	X	119399060-119454478	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA035188	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA035188: AB_10602400"	"unprognostic (6.05e-3)"	"unprognostic (1.48e-1)"	"unprognostic (9.92e-2)"	"prognostic unfavourable (3.76e-5)"	"unprognostic (4.99e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.74e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (5.06e-8)"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.92e-2)"	12.7	3.0	4.4	11.1	3.7	1.3	11.8	5.9	3.8	8.9	12.3	4.3	5.6	12.8	8.0	7.3	23.5	5.8	6.3	6.0	5.1	3.4	11.4	11.3	10.4	9.5	3.8	2.7	7.8	15.6	4.0	3.0	7.3	5.8	8.5	14.2	7.4	12.8	4.4	6.3	14.0	13.3	7.7	8.2	9.0	7.9	4.3	4.3	1.9	5.7	9.6	16.2	8.9	12.9	4.3	6.3	0.2	10.7	6.6	3.2	1.4	13.6	10.1	0.7	4.0	14.0	21.1	5.4	7.4	9.6	6.1	5.9	5.2	6.9	1.5	4.6	21.0	10.1	7.9	7.1	5.4	11.7	2.4	4.9	3.3	7.0	8.6	4.6	5.2	8.7	12.6	10.1	8.5	7.5	0.9	7.3	7.0	24.3	0.0	6.4	4.6	15.8	1.2	0.0	2.0	10.1	4.7	0.6	0.0	10.1	21.5	11.9	3.8	4.6	10.4	10.0	2.9	10.8	11.5	0.1	5.7	3.3	9.9	7.6	8.7	0.0	3.4	0.2	1.0	5.1	1.8	4.3	2.0	3.2	6.3	3.6	1.1	1.9	0.0	6.6	10.7	1.6	1.6	1.4	4.4	3.7	5.9	3.8	5.1	3.4	3.8	2.7	5.8	4.3
SLC25A5	"2F1, ANT2, T2, T3"	ENSG00000005022	"Solute carrier family 25 member 5"	P05141	X	119468400-119471319	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Chromosome partition, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria			7800000	Mitochondria		"HPA046835: , HPA071684: "	"unprognostic (1.25e-2)"	"prognostic favourable (7.35e-4)"	"prognostic favourable (7.47e-4)"	"unprognostic (1.48e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.17e-1)"	"prognostic favourable (8.06e-6)"	"unprognostic (1.41e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.36e-2)"	"unprognostic (3.03e-1)"	26.0	28.9	26.8	32.2	29.5	36.5	36.6	21.8	39.0	23.0	74.1	16.3	26.0	120.7	22.5	18.3	64.1	17.5	39.5	31.4	22.5	18.8	80.7	71.0	38.3	53.8	27.2	23.8	18.1	128.2	22.5	14.6	30.7	24.2	18.9	84.9	20.1	58.3	21.5	16.6	42.1	157.5	33.6	20.5	34.3	68.2	16.8	17.1	87.0	31.1	59.9	47.0	30.8	33.8	51.6	97.8	18.5	113.2	33.4	48.0	84.9	81.9	78.8	30.9	53.1	19.8	29.2	57.4	30.6	33.4	64.7	58.0	65.5	52.0	104.1	41.3	29.4	57.7	75.7	64.0	59.2	27.5	73.0	35.1	47.6	46.6	25.1	95.2	58.0	31.7	72.0	66.6	42.5	67.1	28.1	43.1	35.3	182.5	84.2	96.7	65.0	127.1	46.3	39.1	80.8	49.3	66.0	37.4	35.4	52.7	80.2	62.1	33.1	48.2	27.9	30.6	44.3	68.2	109.9	50.6	62.9	83.3	33.9	97.4	49.5	10.1	68.1	18.5	20.7	113.2	23.9	51.6	30.1	26.9	97.8	39.7	30.1	28.3	11.3	33.4	84.9	53.9	48.0	84.9	26.8	29.5	21.8	39.0	22.5	18.8	27.2	23.8	24.2	17.1
CXorf56	FLJ22965	ENSG00000018610	"Chromosome X open reading frame 56"	Q9H5V9	X	119538149-119565408	"Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038245, HPA038617, HPA064831"	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA038245: AB_10672407, HPA038617: AB_10674691, HPA064831: "	"prognostic unfavourable (3.45e-4)"	"unprognostic (3.88e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.03e-3)"	"unprognostic (8.92e-2)"	"unprognostic (7.74e-3)"	"unprognostic (6.38e-3)"	"unprognostic (3.89e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.68e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.68e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.90e-1)"	15.9	14.5	18.7	12.7	29.1	19.1	21.1	21.0	24.2	15.0	15.6	18.3	15.1	12.3	17.6	14.5	13.6	17.6	12.4	16.3	16.0	20.5	18.2	14.3	14.6	15.7	18.0	21.3	24.0	16.3	20.5	12.6	29.0	20.2	15.3	15.0	18.6	14.6	16.1	16.4	17.4	12.5	16.2	17.8	15.0	13.0	12.7	17.6	12.8	20.2	13.2	19.0	14.4	13.1	19.4	12.0	16.8	15.4	7.7	12.9	10.9	17.0	20.0	12.1	13.8	13.8	10.1	15.5	11.8	12.1	18.5	16.7	17.3	17.3	27.0	29.6	13.7	11.4	30.5	15.6	26.0	16.2	23.0	9.6	18.2	11.6	11.0	26.6	15.5	11.1	13.5	22.6	19.4	12.9	21.6	17.3	9.0	29.9	16.7	14.0	18.1	20.8	16.3	12.5	20.3	11.1	13.4	8.3	14.6	22.8	12.7	15.8	10.5	11.6	12.4	11.2	7.8	20.6	24.8	15.0	26.5	27.5	10.1	26.1	14.2	5.7	12.8	16.8	12.4	15.4	11.4	13.5	10.8	12.9	12.0	19.4	11.1	10.5	6.5	7.7	14.1	11.3	12.4	10.9	18.7	29.1	21.0	24.2	16.0	20.5	18.0	21.3	20.2	17.6
UBE2A	"HHR6A, RAD6A, UBC2"	ENSG00000077721	"Ubiquitin conjugating enzyme E2 A"	P49459	X	119574467-119591083	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Chromatin regulator, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA003875: , HPA051765: , HPA065898: "	"unprognostic (2.27e-3)"	"prognostic favourable (2.16e-4)"	"unprognostic (1.12e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (9.07e-4)"	"unprognostic (1.66e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.54e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (2.20e-6)"	"unprognostic (9.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.92e-2)"	24.8	20.6	26.7	23.1	24.6	16.8	32.5	20.2	24.2	23.7	32.8	23.9	20.2	21.7	23.8	26.7	37.2	20.3	21.2	42.2	23.6	22.1	32.2	26.6	22.8	26.3	26.8	19.7	18.7	17.2	24.3	18.2	112.4	24.7	20.4	30.2	20.0	21.0	22.6	46.8	23.6	29.2	27.9	29.1	25.1	20.4	17.0	19.5	36.3	23.2	32.8	31.5	26.7	24.0	21.0	29.0	34.1	36.3	12.8	21.2	17.4	32.5	27.5	17.3	14.6	30.3	37.4	16.2	33.8	30.2	40.3	38.3	14.2	22.4	25.8	34.4	37.2	23.5	24.7	17.9	38.9	35.8	14.6	11.4	22.0	12.7	27.8	28.5	19.6	25.5	25.6	38.6	16.8	27.9	14.0	23.1	45.6	34.5	43.9	26.9	28.8	31.1	22.4	18.4	24.0	32.5	21.4	13.3	13.7	45.0	20.7	24.6	18.0	24.9	27.2	25.9	11.6	51.1	38.1	22.4	36.4	25.3	27.5	36.1	20.2	16.5	22.7	34.1	18.1	35.4	14.3	21.0	15.7	15.8	29.0	18.8	10.0	14.3	30.1	12.8	36.3	23.0	21.2	17.4	26.7	24.6	20.2	24.2	23.6	22.1	26.8	19.7	24.7	19.5
NKRF	"ITBA4, NRF"	ENSG00000186416	"NFKB repressing factor"	O15226	X	119588337-119605895	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001476			Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA001476: AB_1079488"	"unprognostic (6.12e-3)"	"unprognostic (7.58e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.74e-3)"	"prognostic unfavourable (4.92e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.56e-3)"	"unprognostic (2.62e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.08e-3)"	3.8	7.9	14.5	6.2	24.3	7.6	6.5	11.4	34.9	4.9	4.0	4.4	1.1	4.7	4.8	5.6	5.6	5.2	4.1	3.8	15.4	14.0	6.9	6.9	4.1	9.7	8.1	24.6	7.4	3.9	8.3	6.5	7.5	25.7	4.9	4.5	2.9	4.6	4.3	4.8	6.4	4.4	4.7	6.0	6.4	4.0	1.9	3.5	7.4	5.4	1.4	9.7	5.2	4.8	3.8	2.7	2.8	2.2	1.3	5.5	1.7	10.8	11.1	6.6	7.6	5.7	5.8	10.0	6.6	5.4	9.0	9.7	11.8	9.4	19.4	11.7	5.7	12.8	27.4	10.2	11.0	9.7	18.7	10.2	13.2	7.8	5.4	19.7	7.9	6.1	8.4	10.4	12.2	9.1	11.0	8.2	8.0	16.8	12.6	15.8	14.6	12.5	9.9	9.4	19.9	11.9	8.1	10.8	9.0	9.3	14.5	9.8	6.1	12.0	7.4	5.8	6.2	12.2	16.6	6.7	8.1	20.5	5.9	22.2	6.4	2.8	1.3	1.5	3.3	2.2	3.1	3.7	3.6	3.7	1.3	3.8	5.5	4.8	0.2	1.3	1.1	2.7	4.3	1.7	14.5	24.3	11.4	34.9	15.4	14.0	8.1	24.6	25.7	3.5
SEPT6	"KIAA0128, MGC16619, MGC20339, SEP2, SEPT2"	ENSG00000125354	"Septin 6"	Q14141	X	119615724-119693370	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Host-virus interaction, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 145.4"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 56.9;REH: 52.4;SH-SY5Y: 79.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003459, HPA005665"	Supported		Approved	Cytosol			10000000	Cytosol		"HPA003459: AB_1856696, HPA005665: AB_1079910"	"unprognostic (6.35e-3)"	"unprognostic (1.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.23e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.24e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.60e-2)"	5.1	39.1	6.9	34.0	6.5	20.6	5.6	23.6	13.1	6.1	22.5	3.8	5.6	5.4	6.7	7.2	9.5	7.3	9.9	8.8	6.7	17.2	8.2	9.8	7.0	42.9	9.5	6.9	6.0	2.2	3.4	5.5	14.1	13.3	6.5	7.3	8.4	12.4	16.7	2.3	3.8	17.6	9.3	5.4	31.8	9.5	24.7	3.3	145.4	4.3	4.5	43.8	9.8	5.3	24.3	22.6	13.0	12.9	27.5	38.5	16.8	1.2	2.0	7.6	13.7	0.7	1.6	10.8	3.7	8.3	6.3	10.9	0.6	2.8	25.3	2.9	4.7	0.7	11.9	2.4	4.4	15.4	2.7	11.2	4.1	4.4	1.8	12.6	5.9	2.8	0.5	5.0	0.1	9.2	8.2	13.6	3.7	0.9	56.9	7.1	8.0	6.1	52.4	6.3	20.5	6.7	1.3	3.4	79.9	9.7	3.5	4.1	4.8	6.5	5.7	1.7	3.5	5.5	0.9	6.8	2.7	33.5	0.1	13.4	1.2	9.8	5.6	13.0	22.3	9.4	23.3	24.3	28.4	25.6	12.0	22.9	30.5	26.0	4.4	27.5	12.9	22.6	38.5	16.8	6.9	6.5	23.6	13.1	6.7	17.2	9.5	6.9	13.3	3.3
SOWAHD	ANKRD58	ENSG00000187808	"Sosondowah ankyrin repeat domain family member D"	A6NJG2	X	119758613-119760164	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 11.1;lymphoid tissue: 12.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.0;NB-4: 3.8;SK-BR-3: 4.5;THP-1: 11.2;U-937: 10.0"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 8.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 11.1"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in some"			HPA065955	Uncertain									"HPA065955: "	"unprognostic (1.78e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.04e-5)"	"unprognostic (5.82e-2)"	"unprognostic (3.14e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.74e-3)"	0.7	0.9	1.0	3.9	2.5	4.2	0.5	0.7	2.1	0.6	1.8	4.0	2.0	4.6	0.4	0.0	0.6	0.8	1.5	1.1	0.9	0.9	1.3	0.8	3.5	6.7	2.5	1.1	0.8	2.2	0.3	0.5	9.6	1.5	0.9	1.1	0.9	5.0	1.0	0.4	0.6	6.7	0.2	3.0	12.6	1.8	8.0	2.0	0.7	0.4	1.1	3.2	0.8	0.5	11.1	2.3	3.7	3.6	0.3	1.9	0.7	0.6	0.0	0.2	0.1	0.0	0.0	6.0	0.1	0.0	0.6	0.9	1.2	0.2	0.3	0.8	0.0	0.1	0.0	0.0	0.1	1.0	0.7	0.1	0.1	1.6	0.3	1.1	0.1	0.3	0.1	0.1	0.0	0.0	0.1	1.1	0.1	0.6	0.0	3.8	1.3	0.4	3.3	0.1	0.2	0.1	0.2	0.4	0.2	1.3	4.5	0.2	0.7	11.2	0.1	0.1	0.1	0.2	0.1	0.6	0.1	0.1	0.0	10.0	0.1	0.0	3.4	1.9	0.1	3.6	0.0	9.0	0.5	0.4	2.3	11.1	1.9	1.0	3.7	0.3	3.0	1.1	0.0	0.7	1.0	2.5	0.7	2.1	0.9	0.9	2.5	1.1	1.5	2.0
RPL39	"L39, RPL39P42"	ENSG00000198918	"Ribosomal protein L39"	P62891	X	119786504-119791643	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 403.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA047105	Uncertain									"HPA047105: "	"unprognostic (1.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.08e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.23e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.66e-2)"	"prognostic unfavourable (1.71e-9)"	"unprognostic (3.26e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.81e-2)"	"unprognostic (7.31e-3)"	78.3	56.7	39.3	73.7	42.7	121.2	154.3	48.9	52.9	73.4	68.8	17.1	67.4	44.3	50.3	83.0	80.3	61.3	55.6	149.7	32.5	27.7	50.8	74.6	159.8	403.2	40.3	42.5	139.3	190.8	9.0	31.1	41.7	38.8	54.7	65.2	33.7	68.3	63.6	86.9	104.5	59.5	97.6	56.8	84.3	57.0	31.5	33.5	87.2	72.7	125.9	97.1	65.7	71.9	224.4	140.6	53.6	118.6	94.2	236.1	246.4	145.0	92.1	132.9	107.6	227.1	292.3	126.7	136.5	155.3	156.4	139.6	94.2	109.5	227.4	142.9	134.1	120.1	204.7	176.5	159.2	81.2	319.9	108.6	136.3	135.1	192.5	189.3	90.0	279.6	315.0	120.7	226.7	176.7	133.0	161.6	141.4	195.8	130.2	343.6	210.0	206.7	122.8	174.2	280.0	175.5	115.9	79.1	162.3	175.4	158.7	231.9	83.5	205.1	137.8	57.3	57.0	154.1	218.1	102.7	173.8	242.7	85.5	273.8	67.9	53.6	118.6	38.7	91.9	82.0	146.2	224.4	202.4	138.0	126.3	208.8	236.1	183.4	28.0	94.2	73.6	140.6	128.7	246.4	39.3	42.7	48.9	52.9	32.5	27.7	40.3	42.5	38.8	33.5
UPF3B	"HUPF3B, MRX62, RENT3B, UPF3BP1, UPF3BP2, UPF3BP3, UPF3X"	ENSG00000125351	"UPF3B, regulator of nonsense mediated mRNA decay"	Q9BZI7	X	119805311-119852998	"Disease related genes, Predicted intracellular proteins"	"mRNA transport, Nonsense-mediated mRNA decay, Transport"	RNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001592, HPA001800, HPA001882"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA001592: , HPA001800: AB_1080476, HPA001882: AB_1080474"	"unprognostic (1.79e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.64e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (1.52e-6)"	"unprognostic (6.61e-2)"	"prognostic unfavourable (5.39e-4)"	"unprognostic (5.74e-2)"	"unprognostic (4.51e-2)"	"unprognostic (8.63e-3)"	"prognostic unfavourable (1.44e-7)"	"unprognostic (8.67e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.95e-2)"	9.7	10.3	19.4	11.5	21.9	14.5	10.8	34.1	24.0	10.2	13.0	9.3	12.8	14.2	14.6	13.5	13.0	8.8	8.4	7.8	16.9	17.5	10.0	12.4	9.0	17.2	16.5	21.7	14.8	8.7	14.3	26.7	10.5	17.2	12.4	13.2	9.1	9.7	14.4	14.5	18.6	11.1	14.2	21.7	12.9	9.9	15.0	21.0	9.9	12.5	11.5	18.3	12.6	12.9	17.5	10.0	7.1	5.9	7.9	8.1	2.7	11.6	7.1	14.8	12.0	6.7	4.4	9.5	11.3	6.3	8.8	7.8	13.3	8.4	21.1	9.6	4.7	11.2	19.1	6.7	11.3	12.0	14.0	19.5	23.5	6.9	7.7	21.1	9.7	3.8	5.1	15.1	18.5	8.2	18.8	17.6	7.3	14.2	14.8	26.5	28.5	19.4	14.5	16.9	15.4	7.2	5.9	19.7	13.6	23.0	9.3	16.8	4.9	12.3	7.1	9.2	7.1	14.7	23.8	9.7	10.8	28.5	7.4	31.0	10.7	7.1	5.3	6.8	7.5	5.1	5.7	13.8	7.0	5.9	3.8	17.5	7.6	8.1	5.9	7.9	5.9	10.0	7.8	2.7	19.4	21.9	34.1	24.0	16.9	17.5	16.5	21.7	17.2	21.0
RNF113A	"Cwc24, RNF113, ZNF183"	ENSG00000125352	"Ring finger protein 113A"	O15541	X	119870475-119871827	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, mRNA processing, mRNA splicing, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA000160, HPA076658"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA000160: AB_1079821, HPA076658: "	"unprognostic (2.85e-1)"	"unprognostic (4.38e-3)"	"unprognostic (5.55e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.02e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.83e-1)"	"prognostic unfavourable (7.93e-4)"	"unprognostic (7.99e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.91e-2)"	"prognostic favourable (6.23e-4)"	11.3	10.7	12.3	14.3	14.9	35.2	12.6	18.6	15.5	11.8	14.6	8.7	14.8	15.0	14.9	12.3	12.7	12.8	11.8	14.2	12.2	14.4	10.9	20.6	12.3	25.1	12.8	11.4	16.4	20.5	7.6	11.4	11.9	11.3	10.5	11.8	11.1	17.6	13.7	12.7	17.6	17.8	9.4	12.9	26.2	13.3	4.0	12.9	25.6	14.2	8.3	21.7	14.0	21.7	33.2	24.4	39.8	25.3	22.9	35.6	26.4	8.0	12.1	5.8	9.1	11.7	8.5	11.3	7.3	13.7	9.8	11.8	10.3	7.1	14.3	14.2	7.4	10.2	13.3	10.3	7.3	10.4	9.2	8.1	13.4	12.0	16.1	16.5	14.1	10.4	11.4	9.8	14.5	9.3	6.1	19.7	9.5	24.4	11.4	20.2	8.0	17.4	10.4	12.0	22.1	10.1	10.4	7.6	6.7	11.4	17.5	16.1	4.3	15.7	6.6	9.8	3.3	13.3	14.6	22.3	17.0	13.6	8.9	22.1	6.2	29.1	23.0	39.8	30.4	22.4	30.9	31.5	32.8	32.4	24.4	33.2	34.8	30.9	10.3	22.9	25.3	20.1	35.6	26.4	12.3	14.9	18.6	15.5	12.2	14.4	12.8	11.4	11.3	12.9
NDUFA1	"CI-MWFE, MWFE"	ENSG00000125356	"NADH:ubiquinone oxidoreductase subunit A1"	O15239	X	119871487-119876662	"Disease related genes, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 144.8;skeletal muscle: 138.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029768, HPA054359"	Enhanced		Supported	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA029768: , HPA054359: "	"unprognostic (1.72e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (4.77e-2)"	"prognostic favourable (3.48e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.78e-3)"	24.5	30.1	37.9	20.1	42.5	25.2	23.8	27.9	37.8	19.7	38.4	8.7	27.3	41.0	13.5	25.8	21.6	15.9	24.8	144.8	30.1	28.5	46.0	40.2	21.1	22.2	34.6	32.8	14.6	40.4	22.7	21.7	15.4	29.5	17.9	31.1	15.5	38.4	29.6	138.8	12.1	34.6	19.3	31.5	17.1	28.1	7.7	21.1	9.2	16.2	67.4	16.7	14.0	14.9	66.3	90.5	96.3	85.7	49.8	75.5	73.8	34.5	37.3	26.7	28.4	32.2	20.4	33.4	27.3	24.9	19.2	23.9	20.8	28.9	28.1	42.1	28.5	33.4	37.4	26.2	22.0	38.9	51.7	29.2	68.1	46.7	25.0	44.6	32.5	33.2	35.7	20.4	15.9	23.8	15.8	43.8	26.3	61.1	31.7	42.3	39.4	66.7	32.1	25.4	84.6	57.8	49.2	19.5	25.7	56.1	69.6	37.4	17.6	52.6	30.6	16.4	16.6	34.0	53.2	40.4	50.0	36.8	29.7	53.0	20.2	96.3	79.0	91.6	60.2	80.4	57.1	66.3	67.1	62.8	84.0	52.7	56.1	65.7	94.6	49.8	85.7	90.5	75.5	73.8	37.9	42.5	27.9	37.8	30.1	28.5	34.6	32.8	29.5	21.1
AKAP14	AKAP28	ENSG00000186471	"A-kinase anchoring protein 14"	Q86UN6	X	119895837-119920716	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 21.1;fallopian tube: 31.0;testis: 33.5"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.5;LHCN-M2: 2.0;REH: 1.6;SCLC-21H: 7.1"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.5"	"Region enriched"	"Detected in many"	7	"pons and medulla: 21.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060999	Enhanced									"HPA060999: "	"unprognostic (1.36e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.16e-1)"	"unprognostic (4.68e-2)"		"unprognostic (2.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.73e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.24e-1)"		"unprognostic (1.80e-1)"	0.0	0.0	2.6	0.1	1.5	0.2	0.1	0.2	0.6	1.0	0.1	2.4	0.0	0.3	0.6	9.0	0.0	31.0	0.0	0.0	1.3	2.9	0.1	0.1	7.5	0.1	0.6	0.2	4.2	0.0	0.0	0.3	0.1	21.1	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.4	0.1	0.2	0.1	0.0	33.5	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.4	2.0	0.3	0.0	0.6	0.2	0.0	1.6	0.0	0.0	0.0	0.7	7.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.6	1.5	0.2	0.6	1.3	2.9	0.6	0.2	21.1	0.5
NKAP	FLJ22626	ENSG00000101882	"NFKB activating protein"	Q8N5F7	X	119920672-119943772	"Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000916	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA000916: AB_1079486"	"prognostic unfavourable (4.20e-4)"	"unprognostic (4.28e-3)"	"unprognostic (9.14e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.66e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.49e-3)"	"unprognostic (4.18e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-2)"	13.9	17.5	12.2	11.2	16.8	15.9	14.0	11.6	16.9	13.0	13.2	15.6	9.9	10.1	16.2	12.4	12.0	15.2	14.0	15.5	12.9	14.0	14.8	19.5	12.6	14.1	14.5	9.7	23.9	13.5	14.1	21.7	18.1	16.6	16.0	8.5	10.3	13.9	15.0	23.9	13.5	13.7	12.0	19.5	15.8	12.3	11.8	16.7	20.1	16.4	11.6	12.2	17.9	15.3	11.8	9.7	16.5	8.0	7.0	8.1	4.4	6.2	7.5	6.1	5.4	4.9	8.2	8.2	4.8	4.5	6.1	4.6	4.5	4.9	6.4	7.7	4.4	4.5	11.3	4.5	5.4	8.8	10.8	3.0	5.3	4.0	6.4	7.2	6.2	5.7	7.9	5.8	4.9	4.2	7.4	6.2	4.7	7.7	7.9	10.3	5.9	9.7	8.2	6.6	8.3	3.4	2.4	6.8	8.3	9.6	4.6	9.9	4.1	6.5	6.4	4.4	2.2	10.3	6.2	7.9	6.3	7.3	6.1	6.8	6.4	11.3	8.0	10.8	6.9	5.9	6.8	9.7	8.1	6.5	6.0	11.8	8.1	7.5	16.5	7.0	6.6	9.7	7.5	4.4	12.2	16.8	11.6	14.6	12.9	14.0	14.5	9.7	16.6	16.7
RHOXF2B		ENSG00000203989	"Rhox homeobox family member 2B"	P0C7M4	X	120070672-120077705	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"blood: 2.6;testis: 9.4"	"Group enriched"	"Detected in some"	348	"HL-60: 46.0;K-562: 46.1;NB-4: 74.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA003314	Supported		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA003314: AB_1855193"																		0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0		0.3	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.2	0.0	9.4			0.0		0.0	0.0	0.0	1.0	1.6	2.6	1.3	1.7	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.0	0.0	0.0	0.0	0.0	0.0	0.0	46.1	0.0	0.0	0.0	0.0	74.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.7	0.8	0.5	0.9	1.0	0.7	0.5	0.7	0.7	1.0	0.7	0.7	1.4	1.7	1.3	1.6	0.5	0.2										
RHOXF1	"OTEX, PEPP1"	ENSG00000101883	"Rhox homeobox family member 1"	Q8NHV9	X	120109053-120115937	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 8.1;brain: 9.2;testis: 27.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.1;HEK 293: 3.8;NB-4: 2.7"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 9.2"	"Cell type enriched"	"Detected in some"	6	"T-reg: 8.1"	"Lineage enriched"	"Detected in single"	30	"T-cells: 8.1"									HPA056506	Approved									"HPA056506: "	"unprognostic (5.03e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.31e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.50e-4)"	"unprognostic (1.97e-1)"	"unprognostic (5.85e-4)"	"unprognostic (3.00e-1)"	"unprognostic (7.96e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.73e-3)"	2.8	0.5	0.9	0.5	1.1	0.3	0.9	9.2	1.7	0.5	0.7	0.5	0.5	0.2	0.5	0.5	0.5	1.5	0.5	0.5	0.8	2.4	0.8	0.5	0.5	0.6	0.8	0.5	2.2	0.5	0.8	0.9	1.1	0.5	0.5	0.1	0.5	0.8	0.6	0.5	2.4	0.5	0.5	0.5	0.5	0.2	27.8	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.1	0.2	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.7	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	3.1	3.8	0.4	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.2	8.1	0.0	0.9	1.1	9.2	1.7	0.8	2.4	0.8	0.5	0.5	0.5
RHOXF2	"CT107, PEPP-2, PEPP2, THG1"	ENSG00000131721	"Rhox homeobox family member 2"	Q9BQY4	X	120158561-120165630	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"testis: 23.0"	"Cell line enhanced"	"Detected in some"		"K-562: 60.7;NB-4: 45.0;THP-1: 16.9;U-266/84: 27.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA003314, CAB020794"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"CAB020794: , HPA003314: AB_1855193"					"unprognostic (1.60e-1)"										"unprognostic (5.04e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	1.0	0.5	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	60.7	0.0	0.0	0.0	0.0	45.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.2	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.0	0.0	1.0	0.3	0.4	0.4	0.4	0.4	0.2	0.3	0.2	0.2	0.3	0.3	0.4	0.7	1.1	0.5	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZBTB33	"kaiso, WUGSC:H_DJ525N14.1, ZNF-kaiso, ZNF348"	ENSG00000177485	"Zinc finger and BTB domain containing 33"	Q86T24	X	120250752-120258398	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000755, CAB001980, HPA005732"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"CAB001980: , HPA000755: AB_1079167, HPA005732: AB_1079166"	"unprognostic (9.14e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.08e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.59e-2)"	15.4	10.4	12.8	9.3	15.5	20.2	18.0	16.3	13.9	9.6	8.5	11.6	9.1	9.1	7.7	11.5	14.9	10.0	9.0	6.0	12.6	15.0	8.0	22.5	10.7	14.0	13.4	11.6	12.2	11.6	17.7	15.5	10.2	16.7	10.5	7.9	6.2	15.0	10.0	9.5	21.6	10.2	6.0	18.6	12.7	9.9	6.9	14.8	29.3	17.4	5.3	14.6	10.3	9.7	3.4	8.9	14.2	8.9	5.1	7.2	5.2	9.0	10.2	13.9	12.7	10.9	12.5	16.3	7.1	9.5	8.3	10.2	6.2	8.0	13.4	13.5	7.1	14.1	21.9	11.1	10.6	14.8	15.8	14.0	15.4	8.3	8.3	13.9	15.9	8.9	13.6	8.4	12.5	14.0	9.0	15.7	10.2	10.9	13.0	9.0	16.9	11.1	14.8	10.5	21.3	8.4	16.3	25.4	10.8	15.0	14.7	16.6	7.9	19.7	13.8	6.6	4.9	9.8	12.5	8.8	8.9	17.0	9.2	19.9	8.2	14.2	6.1	7.7	4.4	8.9	7.2	3.4	5.6	5.5	8.9	3.3	7.1	4.8	1.2	5.1	5.6	8.5	4.9	5.2	12.8	15.5	16.3	13.9	12.6	15.0	13.4	11.6	16.7	14.8
TMEM255A	"FAM70A, FLJ20716"	ENSG00000125355	"Transmembrane protein 255A"	Q5JRV8	X	120258650-120311556	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 30.4;ovary: 29.6"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 16.9;RPMI-8226: 10.8;SK-MEL-30: 17.7;U-2 OS: 7.6;U-87 MG: 19.3"	"Group enriched"	"Detected in many"	10	"glioma: 21.3;melanoma: 8.0;renal cancer: 7.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"gdT-cell: 5.9;MAIT T-cell: 3.3;memory CD8 T-cell: 2.2;naive CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	10	"T-cells: 5.9"	"Low region specificity"	"Detected in all"							HPA048470	Approved		Uncertain	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA048470: AB_2680406"	"unprognostic (3.41e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.55e-4)"	"unprognostic (7.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.55e-4)"	3.9	5.5	6.8	3.4	14.4	1.5	5.4	6.8	7.8	11.2	3.5	12.4	1.7	1.9	3.2	2.9	4.4	6.3	2.1	2.4	5.3	25.4	2.4	1.5	4.8	5.0	30.4	4.4	29.6	1.1	0.6	6.6	0.8	18.4	3.8	3.9	7.1	1.3	3.3	2.4	4.0	2.8	2.0	13.0	2.8	2.1	0.9	7.8	6.4	0.9	1.8	5.7	1.6	8.0	0.5	0.3	0.0	0.6	0.0	5.9	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.3	0.1	0.0	0.1	0.2	0.0	0.0	1.1	0.4	0.5	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	16.9	0.3	0.0	0.0	0.0	5.9	0.0	0.0	0.0	10.8	0.0	0.0	3.4	0.1	0.3	0.0	17.7	0.0	0.2	0.0	0.0	7.6	0.0	2.8	0.0	3.2	2.4	19.3	0.0	0.0	0.0	0.6	0.0	5.9	0.2	3.3	0.5	0.4	2.2	0.3	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.9	6.8	14.4	6.8	3.9	5.3	25.4	30.4	4.4	18.4	7.8
ATP1B4		ENSG00000101892	"ATPase Na+/K+ transporting family member beta 4"	Q9UN42	X	120362085-120383249	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"skeletal muscle: 47.3;tongue: 26.1"	"Cell line enriched"	"Detected in single"	4	"HSkMC: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		"unprognostic (2.59e-2)"	"unprognostic (6.02e-4)"						"unprognostic (5.78e-1)"		"unprognostic (5.29e-2)"				1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.2	1.7	0.1	0.0	2.4	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.4	0.0	47.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	26.1	2.5	0.0	0.0	0.7	0.2	1.4	0.3	0.7	0.3	1.0	0.1	0.1	0.1	0.4	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.7	0.3	0.3	0.5	0.1	0.2	0.3	3.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.4	0.2	0.1	0.2	0.0	0.2	0.2	0.1	0.0	0.1	0.3	0.2	0.1	0.1	0.0	0.6	0.0	0.6	0.5	0.4	0.3	0.2	0.0	0.0	0.3	0.4	0.4	0.1	1.3	0.3	0.3	0.3	0.1	0.2	0.3	0.1	0.2	0.1	0.7	0.3	0.3	1.4	0.7	0.3	0.2	0.2	1.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0
LAMP2	CD107b	ENSG00000005893	"Lysosomal associated membrane protein 2"	P13473	X	120427827-120469365	"CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Autophagy		"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 113.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 112.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 112.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005272, HPA029100, HPA029101"	Supported		Approved	"Vesicles,Plasma membrane"			820000000	"Vesicles, Plasma membrane"		"CAB005272: AB_647855, HPA029100: AB_10795022, HPA029101: "	"unprognostic (2.99e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.50e-2)"	"unprognostic (4.84e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.53e-3)"	21.8	33.6	39.9	16.1	87.9	22.6	27.1	16.2	55.5	33.0	18.3	88.7	27.9	25.1	20.8	37.5	34.6	22.4	43.3	20.9	52.5	30.3	55.0	83.7	25.3	14.3	131.0	36.9	22.7	27.4	28.8	20.2	35.4	58.6	37.3	19.7	17.2	47.8	32.9	32.4	26.9	20.5	21.1	84.3	17.9	23.6	11.9	116.9	21.2	33.7	14.3	15.4	21.1	27.0	3.7	11.6	112.9	21.7	5.4	5.8	10.5	11.8	11.7	8.6	11.1	113.5	38.8	23.9	20.5	35.8	20.0	37.4	9.7	21.2	8.4	18.1	35.6	20.0	12.5	15.5	32.6	9.4	8.9	6.6	13.0	13.0	37.8	29.0	18.4	42.0	31.2	26.6	17.6	27.2	7.6	30.0	32.3	21.9	8.0	14.8	6.7	10.4	6.2	14.6	15.0	29.2	8.8	2.9	4.6	22.0	22.4	43.8	13.3	32.4	28.1	28.7	13.9	36.9	55.3	15.1	14.4	5.5	27.4	35.1	68.7	4.9	21.7	41.3	5.0	18.7	4.0	3.1	4.8	4.7	11.6	3.7	4.3	4.1	112.9	5.4	17.3	6.3	5.8	10.5	39.9	87.9	16.2	55.5	52.5	30.3	131.0	36.9	58.6	116.9
CUL4B		ENSG00000158290	"Cullin 4B"	Q13620	X	120524609-120575794	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Ubl conjugation pathway"		"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003046, HPA011880, CAB017786, HPA058979"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB017786: , HPA003046: , HPA011880: AB_1847340, HPA058979: "	"unprognostic (2.34e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.69e-2)"	"unprognostic (7.73e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.88e-3)"	"unprognostic (8.99e-2)"	"unprognostic (8.12e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.87e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.84e-1)"	20.9	24.0	19.0	19.2	28.1	12.2	25.3	28.9	25.7	32.6	20.5	12.1	25.7	14.0	24.2	47.2	29.3	19.6	18.5	19.4	18.5	20.2	19.1	20.4	23.8	23.5	17.3	20.4	30.1	18.8	34.4	48.3	17.0	18.4	30.8	17.2	15.7	17.3	27.3	10.8	17.7	16.3	36.0	20.5	19.9	17.0	34.0	17.3	29.8	18.8	13.9	24.1	40.4	22.5	7.6	12.5	15.4	4.3	5.5	8.3	4.9	12.0	10.2	8.5	9.0	37.5	19.0	6.9	27.3	32.8	22.6	23.7	9.2	34.2	12.1	9.4	62.8	9.0	17.4	8.0	25.8	7.0	9.0	5.9	14.8	6.5	16.2	6.3	8.4	21.3	6.1	13.0	11.3	40.4	9.1	9.4	21.8	6.4	8.3	6.6	12.9	10.3	7.0	8.4	12.3	7.5	6.0	9.7	8.1	20.2	9.9	10.0	8.4	5.8	53.2	16.3	9.0	21.7	24.4	6.0	10.4	15.1	17.6	8.6	14.6	5.8	4.3	9.0	7.2	3.8	7.7	7.6	7.0	6.6	5.1	5.7	7.9	8.3	15.4	5.5	2.7	12.5	8.2	4.9	19.0	28.1	28.9	25.7	18.5	20.2	17.3	20.4	18.4	17.3
MCTS1	MCT-1	ENSG00000232119	"MCTS1, re-initiation and release factor"	Q9ULC4	X	120594010-120621074	"Predicted intracellular proteins"	"Cell cycle, DNA damage, Growth regulation, Protein biosynthesis, Transcription, Transcription regulation"	"Initiation factor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA001045			Supported	"Plasma membrane,Cytosol"			52000	Cytosol	"Plasma membrane"	"HPA001045: "	"prognostic unfavourable (1.38e-4)"	"unprognostic (1.44e-1)"	"unprognostic (4.50e-1)"	"unprognostic (9.37e-3)"	"unprognostic (7.29e-2)"	"prognostic unfavourable (3.27e-5)"	"unprognostic (2.94e-3)"	"unprognostic (9.59e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (4.35e-5)"	"unprognostic (1.95e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	20.2	26.8	23.7	22.5	29.3	16.9	27.4	16.8	33.8	20.7	24.0	14.3	26.6	23.2	17.4	30.7	31.7	16.6	16.8	24.6	25.2	22.4	22.7	37.9	17.2	31.1	22.6	25.0	14.7	42.0	21.1	38.2	20.7	22.3	16.6	29.7	13.4	31.0	27.3	20.9	18.1	21.2	19.2	20.8	24.1	22.9	13.1	19.0	28.5	23.1	32.1	36.1	20.5	19.1	28.2	32.0	13.7	24.4	17.7	24.5	15.5	33.6	23.7	19.3	19.3	24.7	35.9	26.2	25.3	23.3	31.9	30.6	20.6	33.4	36.2	36.4	31.2	22.4	33.8	32.2	46.3	22.8	22.5	11.7	26.2	16.2	28.1	29.3	22.5	24.6	28.6	27.8	30.3	38.5	31.9	24.2	39.2	38.6	28.1	39.3	21.5	46.9	21.7	17.8	43.8	34.0	16.8	24.4	22.8	17.7	28.8	22.8	21.2	27.2	26.3	25.9	15.8	28.0	46.4	18.3	24.7	49.3	30.1	43.4	28.1	11.9	20.1	13.7	15.1	24.4	24.5	28.2	19.8	19.3	24.8	20.7	18.3	18.5	9.9	17.7	22.4	32.0	22.9	15.5	23.7	29.3	16.8	33.8	25.2	22.4	22.6	25.0	22.3	19.0
C1GALT1C1	"C1GALT2, COSMC"	ENSG00000171155	"C1GALT1 specific chaperone 1"	Q96EU7	X	120625793-120630150	"Disease related genes, Predicted membrane proteins"		Chaperone	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 83.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 72.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA015632	Approved		Approved	Cytosol				Cytosol		"HPA015632: AB_1845625"	"prognostic unfavourable (5.66e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.26e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.18e-2)"	"unprognostic (8.10e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (3.78e-2)"	16.5	28.0	8.4	11.1	9.2	3.0	21.1	9.0	9.9	19.2	16.7	10.8	16.5	12.7	13.0	23.1	15.0	15.1	11.6	17.7	9.0	10.9	25.9	35.2	12.4	12.9	11.0	7.5	13.2	18.8	18.7	83.5	13.3	11.5	14.1	19.4	10.9	19.4	15.5	7.4	5.8	20.6	12.4	12.0	16.5	14.6	9.6	10.6	16.3	19.8	12.3	12.4	13.9	12.3	17.2	23.0	31.3	22.3	15.1	23.8	16.2	8.5	8.3	4.6	7.9	72.7	13.9	7.3	15.6	22.1	8.3	15.7	5.4	27.5	5.5	7.8	31.4	12.0	9.0	7.6	13.2	9.4	10.9	3.5	7.7	7.9	11.3	6.2	5.6	12.0	6.8	10.3	3.4	26.0	2.2	6.5	9.7	11.6	2.1	5.9	5.1	8.3	0.9	3.6	15.2	16.7	5.7	5.1	4.8	14.8	10.2	7.7	8.8	6.1	23.8	3.8	4.7	15.2	14.6	2.8	4.2	4.4	13.9	12.3	8.3	13.3	17.7	27.0	17.6	22.3	19.4	17.2	22.9	19.0	20.1	10.6	23.8	18.9	31.3	15.1	17.5	23.0	21.0	16.2	8.4	9.2	9.0	9.9	9.0	10.9	11.0	7.5	11.5	10.6
CT47B1	CT47.13	ENSG00000236446	"Cancer/testis antigen family 47, member B1"	P0C2W7	X	120872603-120875929	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	61	"testis: 10.7"	"Cell line enhanced"	"Detected in single"		"U-266/84: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC008162.2		ENSG00000278646			X	120877496-120878924	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	5	"testis: 6.3"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 9.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	1.1		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	6.3			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6										
CT47A12	CT47.12	ENSG00000226685	"Cancer/testis antigen family 47, member A12"	Q5JQC4	X	120930250-120932301	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"testis: 5.4"	"Cell line enhanced"	"Detected in some"		"U-2197: 1.1;U-266/70: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.2	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.0	3.1	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT47A11	CT47.11	ENSG00000226929	"Cancer/testis antigen family 47, member A11"	Q5JQC4	X	120933840-120937158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	68	"testis: 6.7"	"Group enriched"	"Detected in some"	7	"EFO-21: 1.6;U-87 MG: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT47A10	CT47.10	ENSG00000224089	"Cancer/testis antigen family 47, member A10"	Q5JQC4	X	120938701-120942023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"testis: 5.0"	"Cell line enriched"	"Detected in single"	14	"U-266/70: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT47A9	CT47.9	ENSG00000226600	"Cancer/testis antigen family 47, member A9"	Q5JQC4	X	120943561-120946883	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"testis: 5.0"	"Cell line enriched"	"Detected in single"	14	"U-266/70: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT47A8	CT47.8	ENSG00000230347	"Cancer/testis antigen family 47, member A8"	Q5JQC4	X	120948422-120951744	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"testis: 5.0"	"Cell line enriched"	"Detected in single"	14	"U-266/70: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT47A7	CT47.7	ENSG00000228517	"Cancer/testis antigen family 47, member A7"	Q5JQC4	X	120953288-120956600	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	12	"testis: 1.2"	"Cell line enhanced"	"Detected in single"		"U-138 MG: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT47A6	CT47.6	ENSG00000226023	"Cancer/testis antigen family 47, member A6"	Q5JQC4	X	120958165-120961487	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	31	"testis: 3.1"	"Group enriched"	"Detected in some"	12	"U-266/70: 4.1;U-266/84: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT47A5	CT47.5	ENSG00000237957	"Cancer/testis antigen family 47, member A5"	Q5JQC4	X	120963026-120966348	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"testis: 5.0"	"Cell line enriched"	"Detected in single"	14	"U-266/70: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT47A4	CT47.4	ENSG00000230594	"Cancer/testis antigen family 47, member A4"	Q5JQC4	X	120967886-120971208	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"testis: 5.0"	"Cell line enriched"	"Detected in single"	14	"U-266/70: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT47A3	CT47.3	ENSG00000236126	"Cancer/testis antigen family 47, member A3"	Q5JQC4	X	120972746-120976068	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"testis: 5.0"	"Cell line enriched"	"Detected in single"	14	"U-266/70: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT47A2	CT47.2	ENSG00000242362	"Cancer/testis antigen family 47, member A2"	Q5JQC4	X	120977606-120980928	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"testis: 5.0"	"Cell line enriched"	"Detected in single"	14	"U-266/70: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT47A1	CT47.1	ENSG00000236371	"Cancer/testis antigen family 47, member A1"	Q5JQC4	X	120982476-120985788	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	43	"testis: 4.2"	"Cell line enriched"	"Detected in single"	8	"U-266/70: 7.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GLUD2	GLUDP1	ENSG00000182890	"Glutamate dehydrogenase 2"	P49448	X	121047588-121050080	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 11.3;testis: 31.9"	"Cell line enhanced"	"Detected in some"		"HAP1: 7.8;K-562: 8.6;SK-MEL-30: 11.1;THP-1: 5.5;WM-115: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA042492, HPA044839, HPA061369"	Uncertain		Supported	Mitochondria				Mitochondria		"HPA042492: , HPA044839: , HPA061369: "	"unprognostic (1.44e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.35e-1)"	"prognostic favourable (1.98e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.96e-2)"	3.1	2.5	4.8	0.8	7.3	0.5	1.6	2.2	3.5	1.1	0.7	2.0	0.6	0.6	1.0	5.2	0.7	1.0	1.6	1.5	5.7	1.8	4.7	11.3	0.9	0.9	2.7	6.2	0.7	1.5	0.7	0.7	2.7	4.3	0.8	0.6	0.2	0.9	3.1	0.7	0.8	1.0	1.0	1.5	0.5	0.9	31.9	4.1	0.0	1.4	0.0	0.8	0.8	0.6	0.8	1.2	0.7	1.1	1.2	0.7	0.4	0.0	2.1	0.5	0.0	0.0	0.0	0.1	0.6	0.6	0.1	0.3	0.0	1.1	0.0	0.8	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.9	2.1	0.0	0.0	0.0	0.0	8.6	0.0	0.0	1.7	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	11.1	2.7	5.5	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.5	0.6	0.8	0.7	0.4	1.1	0.7	0.8	0.7	0.7	1.2	0.4	0.7	0.5	0.0	1.2	1.1	0.2	0.7	0.4	4.8	7.3	2.2	3.5	5.7	1.8	2.7	6.2	4.3	4.1
GRIA3	"GluA3, GLUR3, GLURC, MRX94"	ENSG00000125675	"Glutamate ionotropic receptor AMPA type subunit 3"	P42263	X	123184153-123490915	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.8"	"Cell line enhanced"	"Detected in some"		"BJ: 14.1;BJ hTERT+: 20.4;fHDF/TERT166: 26.9;U-2197: 9.0"	"Cancer enriched"	"Detected in some"	11	"glioma: 10.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"naive CD4 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058659, HPA073344"	Enhanced				"Intracellular and membrane"					"HPA058659: , HPA073344: "	"unprognostic (2.14e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.94e-3)"	"unprognostic (5.09e-2)"	"unprognostic (4.29e-4)"	"unprognostic (2.42e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.78e-3)"	"unprognostic (8.05e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.03e-1)"	1.5	10.7	31.4	1.0	27.4	0.7	2.3	3.5	40.8	9.1	1.3	3.7	0.1	0.9	3.0	4.9	1.1	2.0	1.9	2.7	26.1	8.1	3.4	9.3	1.0	1.1	10.2	21.2	5.6	2.6	0.6	0.6	1.1	4.9	2.1	1.5	0.7	0.9	3.0	0.9	1.2	1.0	2.9	8.4	0.7	3.0	1.4	7.8	0.0	0.8	0.0	1.5	1.3	1.8	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	14.1	20.4	0.2	0.5	0.0	0.0	0.0	0.0	26.9	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	9.0	0.1	0.0	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.4	27.4	3.5	27.5	26.1	8.1	10.2	21.2	4.9	7.8
THOC2	"CXorf3, dJ506G2.1, MRX12, MRX35, THO2"	ENSG00000125676	"THO complex 2"	Q8NI27	X	123600561-123733056	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047921	Supported		Approved	Nucleoplasm				Nucleoplasm		"HPA047921: AB_10960388"	"unprognostic (2.12e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.08e-1)"	"prognostic unfavourable (5.77e-5)"	"unprognostic (1.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.29e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.43e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.35e-1)"	25.9	22.7	25.2	23.3	28.2	21.6	26.6	36.0	29.8	30.1	22.5	17.8	24.8	22.5	27.4	39.8	24.7	21.6	19.9	17.7	25.2	19.2	28.0	20.3	24.0	29.4	28.9	21.9	30.1	23.6	28.3	45.4	22.8	24.9	26.3	23.4	17.2	18.9	24.6	20.6	29.0	31.1	27.0	31.7	27.4	20.0	15.2	29.7	45.3	26.2	20.7	26.3	27.0	21.2	13.5	15.2	9.7	12.7	11.7	16.0	8.2	21.1	17.7	22.8	24.5	16.8	16.1	12.2	14.5	14.3	16.0	21.5	12.4	21.8	21.7	16.7	15.8	16.2	27.5	10.8	27.3	20.7	24.9	30.4	24.9	16.8	15.6	35.1	21.8	31.9	13.6	18.3	21.2	14.8	45.4	19.8	16.2	22.3	30.2	34.5	12.6	17.6	30.8	14.2	17.9	25.1	24.0	17.6	15.6	40.6	11.2	13.5	11.2	21.6	15.2	14.5	7.5	20.6	24.3	13.7	20.1	18.7	12.9	31.5	15.8	9.6	9.2	9.7	13.4	12.4	15.6	12.3	14.6	14.4	8.9	13.5	16.0	15.4	5.6	11.7	12.7	15.2	11.1	8.2	25.2	28.2	36.0	29.8	25.2	19.2	28.9	21.9	24.9	29.7
XIAP	"API3, BIRC4, hILP"	ENSG00000101966	"X-linked inhibitor of apoptosis"	P98170	X	123859724-123913979	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway, Wnt signaling pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB009203, HPA042428"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009203: AB_2257167, HPA042428: "	"prognostic unfavourable (9.21e-4)"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.95e-2)"	"unprognostic (8.51e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.90e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.15e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.65e-2)"	17.4	14.4	20.0	18.1	20.2	12.0	15.9	21.3	18.9	17.2	19.4	14.5	22.9	16.1	17.4	17.0	18.9	12.6	14.7	15.7	18.9	22.1	19.8	19.4	16.5	15.5	18.8	14.6	13.9	19.7	36.6	26.1	18.2	15.9	15.6	16.8	16.9	14.6	22.9	21.5	14.2	23.4	17.0	19.0	15.8	16.2	7.0	12.3	13.9	24.3	11.4	14.0	15.4	20.5	5.7	4.3	11.1	3.9	3.3	5.5	1.9	11.5	9.9	7.8	6.7	9.2	11.9	10.2	12.6	9.4	6.9	5.9	4.4	13.6	10.8	18.7	10.7	4.3	11.5	7.9	12.7	11.2	6.3	7.3	8.3	6.7	11.7	13.2	15.2	8.2	12.3	11.4	14.7	9.5	11.5	12.5	13.3	12.0	7.3	6.4	6.4	7.8	7.9	9.1	11.4	10.4	16.8	5.3	7.7	17.2	10.0	10.1	6.1	6.5	11.7	0.3	4.7	20.6	14.0	10.5	10.5	12.0	14.2	9.4	8.7	11.1	2.6	3.5	5.0	2.3	4.7	4.6	3.8	5.5	1.4	5.7	4.4	3.0	8.2	3.3	3.9	4.3	2.5	1.9	20.0	20.2	21.3	18.9	18.9	22.1	18.8	14.6	15.9	12.3
STAG2	"SA-2, SA2, SCC3B"	ENSG00000101972	"Stromal antigen 2"	Q8N3U4	X	123960212-124422664	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002857	Supported									"HPA002857: AB_1079861"	"unprognostic (1.62e-1)"	"unprognostic (1.01e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.67e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.97e-1)"	24.0	18.8	21.5	23.9	23.7	39.7	30.1	35.4	23.5	28.1	25.1	16.4	25.2	14.9	24.3	21.0	24.3	20.0	16.3	15.7	21.4	17.9	22.2	18.1	23.4	26.2	24.9	17.5	31.1	19.7	46.1	27.6	25.5	20.6	25.9	18.3	14.2	20.7	27.8	27.6	18.9	21.9	25.9	30.6	26.7	17.6	9.3	26.4	69.3	32.0	19.7	27.1	37.7	37.8	12.8	12.5	30.3	14.4	12.1	15.5	6.7	17.2	16.3	24.5	15.4	10.5	15.9	15.8	16.4	17.7	17.0	21.5	15.1	18.5	31.9	23.2	14.7	15.8	50.1	13.9	24.2	22.6	21.4	29.5	32.6	9.9	10.9	38.5	23.2	12.5	13.8	20.1	32.6	14.2	28.7	34.0	12.5	18.8	49.2	17.4	12.8	24.2	34.9	32.4	26.6	13.2	33.0	22.1	17.7	37.0	13.8	19.4	8.2	17.7	17.3	0.1	9.1	20.0	18.6	14.7	22.1	40.1	10.7	23.7	17.1	16.8	10.2	18.1	10.8	13.1	12.6	10.0	11.2	10.1	12.5	12.8	15.5	12.4	30.3	12.1	14.4	11.2	8.7	6.7	21.5	23.7	35.4	23.5	21.4	17.9	24.9	17.5	20.6	26.4
SH2D1A	"DSHP, EBVS, IMD5, LYP, MTCP1, SAP, XLP, XLPD"	ENSG00000183918	"SH2 domain containing 1A"	O60880	X	124227868-124373197	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 163.1"	"Group enriched"	"Detected in some"	5	"HDLM-2: 23.7;Karpas-707: 53.2;MOLT-4: 63.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	53	"gdT-cell: 27.3;MAIT T-cell: 36.5;memory CD4 T-cell: 20.6;memory CD8 T-cell: 40.1;naive CD4 T-cell: 21.0;naive CD8 T-cell: 25.2;NK-cell: 31.7;T-reg: 25.3"	"Group enriched"	"Detected in many"	67	"NK-cells: 31.7;T-cells: 40.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"prognostic favourable (2.03e-4)"	"unprognostic (1.18e-3)"	"unprognostic (4.35e-3)"	"unprognostic (9.66e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.86e-3)"	"unprognostic (9.25e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.80e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (4.94e-6)"	"unprognostic (1.27e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.14e-3)"	2.5	0.5	0.4	5.8	0.6	2.5	1.0	0.2	0.3	0.8	1.0	0.4	0.5	0.6	0.7	0.8	0.9	0.6	2.6	0.6	0.5	0.4	1.1	1.7	4.1	21.3	0.6	0.2	0.6	0.3	0.0	0.4	0.4	0.3	1.0	0.7	0.7	1.9	0.3	0.3	0.4	4.0	0.3	1.0	12.2	1.3	0.4	0.3	163.1	1.3	0.7	10.2	4.2	1.1	0.2	0.1	0.5	0.2	31.7	40.1	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.2	0.0	0.0	63.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	8.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	27.3	0.1	36.5	0.2	20.6	40.1	0.1	0.0	21.0	25.2	0.5	31.7	0.2	0.1	25.3	17.2	0.4	0.6	0.2	0.3	0.5	0.4	0.6	0.2	0.3	0.3
TEX13D		ENSG00000282419	"TEX13 family member D"		X	124246249-124336862	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	64	"testis: 6.4"	"Cell line enriched"	"Detected in single"	5	"NB-4: 3.6"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	6.4			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TENM1	"ODZ1, ODZ3, TEN-M1, TNM"	ENSG00000009694	"Teneurin transmembrane protein 1"	Q9UKZ4	X	124375903-124963817	"Predicted membrane proteins"	"Stress response, Transcription, Transcription regulation"	"Neuropeptide, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.0;liver: 10.5"	"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 2.7;MOLT-4: 9.9;RPTEC TERT1: 3.5;SCLC-21H: 3.5;U-138 MG: 5.9"	"Group enriched"	"Detected in many"	5	"glioma: 1.6;prostate cancer: 2.2;renal cancer: 1.6;testis cancer: 1.4;thyroid cancer: 7.0"	"Region enriched"	"Detected in many"	4	"cerebellum: 17.0"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002848	Uncertain									"HPA002848: AB_1079523"	"unprognostic (1.71e-3)"	"unprognostic (8.25e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.68e-4)"	"unprognostic (5.76e-3)"	"unprognostic (3.51e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.68e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.58e-1)"	"unprognostic (2.71e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.25e-3)"	"unprognostic (4.44e-2)"	1.9	3.0	1.4	0.4	2.4	3.5	1.0	17.0	4.4	0.4	1.1	0.9	0.4	0.1	1.4	2.3	0.4	1.5	2.0	0.4	2.3	2.7	1.8	10.5	0.9	0.9	1.0	4.2	0.4	0.4	0.0	3.5	0.4	3.3	4.8	0.3	1.5	0.9	3.8	0.5	1.6	0.7	1.1	2.6	0.6	0.5	2.3	0.4	0.4	3.1	0.4	0.7	0.4	0.4	0.0	0.0	2.4	0.1	0.6	1.6	0.1	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	2.7	0.0	0.0	1.2	0.0	0.0	9.9	0.0	0.5	1.5	0.0	0.0	0.1	3.5	0.0	3.5	0.0	0.0	0.7	0.0	0.8	0.0	0.0	5.9	0.2	0.0	0.4	0.3	0.7	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.6	0.0	0.9	0.0	0.9	1.0	0.0	0.0	1.6	1.1	2.4	0.6	0.0	0.0	0.2	0.1	1.4	2.4	17.0	3.9	2.3	2.7	1.0	4.2	3.3	0.4
TEX13C		ENSG00000282815	"TEX13 family member C"	A0A0J9YWL9	X	125320120-125325214	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	7	"testis: 5.9"	"Cell line enhanced"	"Detected in some"		"SK-BR-3: 1.4;U-2 OS: 3.2;U-266/70: 1.1;WM-115: 1.2"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	5.9			0.0		0.0	0.0		0.2	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.7	0.0	0.0	0.1	3.2	0.9	0.0	1.1	0.6	0.0	0.0	0.0	1.2	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0										
DCAF12L2	WDR40C	ENSG00000198354	"DDB1 and CUL4 associated factor 12 like 2"	Q5VW00	X	126163499-126166097	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 15.7;epididymis: 53.6;testis: 15.8"	"Group enriched"	"Detected in some"	6	"HAP1: 5.7;NTERA-2: 4.8;U-2 OS: 7.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044737, HPA048981, HPA053138"	Approved		Uncertain	Cytosol				Cytosol		"HPA044737: , HPA048981: , HPA053138: "	"unprognostic (1.16e-4)"			"unprognostic (8.83e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.52e-2)"		"unprognostic (2.72e-1)"		"unprognostic (3.02e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.47e-4)"	"unprognostic (1.56e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.51e-1)"	1.1	1.2	1.1	0.1	1.9	0.1	2.3	0.5	2.1	1.9	0.9	0.0	15.7	0.1	2.4	53.6	0.5	3.0	0.2	0.4	1.0	3.9	0.4	0.1	0.2	0.2	1.0	1.7	1.9	0.2	2.4	1.3	0.1	1.3	2.0	0.2	0.2	0.6	5.6	0.4	0.5	0.5	2.0	0.8	0.2	0.7	15.8	0.1	0.0	0.4	0.0	0.3	2.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.9	0.5	2.1	1.0	3.9	1.0	1.7	1.3	0.1
DCAF12L1	"KIAA1892L, WDR40B"	ENSG00000198889	"DDB1 and CUL4 associated factor 12 like 1"	Q5VU92	X	126549383-126552851	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 22.6;testis: 30.9"	"Group enriched"	"Detected in some"	15	"EFO-21: 17.2;U-2 OS: 9.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044737, HPA048981, HPA053138"	Approved		Uncertain	Cytosol				Cytosol		"HPA044737: , HPA048981: , HPA053138: "				"unprognostic (2.62e-5)"						"unprognostic (2.88e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.74e-1)"		0.2	0.1	0.2	0.0	0.1	0.0	0.7	0.1	0.1	0.5	0.1	0.0	6.2	0.0	0.6	22.6	0.1	4.3	4.3	0.1	0.1	0.4	3.3	0.1	0.1	0.0	0.1	0.0	1.5	0.1	0.0	0.6	0.0	0.3	1.0	0.0	0.5	0.1	3.9	0.1	0.1	0.1	2.5	0.1	1.5	1.6	30.9	0.0	0.3	0.9	0.2	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.3	0.0
PRR32	CXorf64	ENSG00000183631	"Proline rich 32"	B1ATL7	X	126819764-126821786	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"heart muscle: 8.9;tongue: 26.7"	"Cell line enriched"	"Detected in single"	13	"THP-1: 1.3"	"Cancer enriched"	"Detected in single"	5	"glioma: 0.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 3.5;hippocampal formation: 12.0;pons and medulla: 14.2;thalamus: 8.8"	"Low region specificity"	"Detected in many"			HPA048386	Uncertain									"HPA048386: "					"unprognostic (7.10e-3)"	"unprognostic (7.97e-2)"				"unprognostic (3.79e-1)"						"unprognostic (2.98e-2)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.3	0.0	0.0	0.4	0.0	1.1	3.4	0.0	8.9	0.2	0.1	0.0	0.3	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	1.7	0.0	3.1	0.1	0.0	0.3	0.5	0.3	0.0	0.0	0.1	0.0	0.0	26.7	3.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.2	0.9	0.1
ACTRT1	"AIP1, ARIP1, Arp-T1, KIAA0705"	ENSG00000123165	"Actin related protein T1"	Q8TDG2	X	128050962-128052398	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	83	"testis: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA003119	Supported									"HPA003119: AB_1078219"															"unprognostic (3.68e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SMARCA1	"hSNF2L, ISWI, NURF140, SNF2L, SNF2L1, SNF2LB, SWI"	ENSG00000102038	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1"	P28370	X	129446501-129523500	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 4.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003335, HPA064712"	Uncertain		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA003335: AB_1080024, HPA064712: "	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.06e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.16e-2)"	"unprognostic (5.44e-2)"	"unprognostic (7.15e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.53e-1)"	"prognostic favourable (3.03e-4)"	"unprognostic (9.26e-2)"	"prognostic favourable (5.09e-4)"	"unprognostic (1.87e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.33e-2)"	10.4	44.6	14.5	5.0	15.2	0.4	11.8	12.0	12.0	17.1	11.4	7.7	25.5	3.9	15.8	31.4	9.6	12.0	12.3	19.3	13.9	17.9	13.9	34.1	9.2	2.5	13.1	8.4	42.2	9.0	34.8	29.9	21.0	14.6	23.8	4.3	9.7	9.8	42.9	8.7	4.6	4.8	17.7	14.0	6.9	10.0	33.0	13.1	2.0	26.0	6.8	2.6	16.8	15.3	0.3	0.8	0.0	0.0	1.6	4.3	0.5	6.7	15.1	31.3	20.4	22.8	20.7	10.8	13.8	40.0	20.6	23.4	5.2	24.1	0.0	21.5	25.9	6.4	19.4	8.1	23.3	0.0	3.6	0.0	13.7	28.4	10.0	0.0	0.0	25.9	2.3	14.7	2.8	15.0	3.5	1.7	22.2	0.0	0.1	0.0	12.5	8.7	0.0	16.9	0.0	20.3	8.3	7.5	20.6	1.9	0.2	3.4	14.0	0.1	10.4	13.8	7.1	9.0	7.5	0.0	0.0	0.0	12.2	0.0	8.5	0.0	0.0	0.0	0.5	0.0	0.2	0.3	0.2	0.0	0.0	0.3	4.3	1.3	0.0	1.6	0.0	0.8	0.0	0.5	14.5	15.2	12.0	12.0	13.9	17.9	13.1	8.4	14.6	13.1
OCRL	OCRL1	ENSG00000122126	"OCRL, inositol polyphosphate-5-phosphatase"	Q01968	X	129539849-129592561	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Hydrolase	"Cataract, Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 6.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;monocytes: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012495	Approved		Approved	"Microtubules,Centriolar satellite,Cytosol"				Cytosol	"Microtubules, Centriolar satellite"	"HPA012495: AB_1851804"	"prognostic unfavourable (2.93e-5)"	"unprognostic (3.17e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.34e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.08e-3)"	"unprognostic (2.56e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.10e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	12.1	20.5	10.7	6.0	18.2	5.3	10.8	13.4	23.1	12.7	13.4	10.1	28.8	9.1	15.8	19.7	13.3	12.8	13.8	8.6	13.0	20.5	10.9	11.3	8.6	6.0	12.9	15.1	33.0	12.4	37.3	20.3	13.2	17.8	21.7	14.1	15.3	8.5	27.7	11.4	9.6	9.8	21.5	8.0	6.3	11.4	23.2	6.4	4.3	19.0	5.6	4.1	18.0	9.2	0.4	2.4	0.3	6.6	0.0	0.7	0.7	9.6	11.2	9.2	10.4	16.4	13.6	9.0	14.9	11.9	15.4	14.3	7.5	7.1	0.8	25.7	12.6	6.1	17.0	11.3	16.1	0.0	11.5	3.0	10.1	7.5	12.2	3.0	0.3	11.4	15.0	15.1	15.1	11.4	4.0	7.4	16.0	12.7	2.2	4.2	3.3	16.7	2.2	9.6	5.8	8.8	10.1	11.3	14.3	7.0	10.0	7.8	7.2	5.3	9.6	12.6	5.8	13.1	14.8	2.1	1.6	2.0	8.8	11.1	9.9	0.0	2.1	0.0	0.2	2.4	0.7	0.3	0.1	0.1	2.4	0.4	0.6	0.2	0.3	0.0	6.6	0.9	0.1	0.7	10.7	18.2	13.4	23.1	13.0	20.5	12.9	15.1	17.8	6.4
APLN	"apelin, XNPEP2"	ENSG00000171388	Apelin	Q9ULZ1	X	129645259-129654937	"Predicted secreted proteins"	"Angiogenesis, Gastrulation, Host-virus interaction"	"Developmental protein, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 21.8;placenta: 52.0"	"Cell line enriched"	"Detected in some"	6	"HUVEC TERT2: 104.4"	"Group enriched"	"Detected in all"	6	"glioma: 44.2;renal cancer: 21.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (1.50e-1)"	"prognostic unfavourable (2.92e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.50e-2)"	"unprognostic (5.94e-2)"	"prognostic unfavourable (9.32e-4)"	"prognostic unfavourable (6.09e-4)"	"unprognostic (4.71e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.30e-1)"	"unprognostic (9.12e-2)"	"prognostic unfavourable (9.61e-5)"	"unprognostic (1.55e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.42e-2)"	3.8	9.7	10.0	2.8	8.0	0.7	2.3	2.0	10.9	0.9	1.2	21.8	0.0	1.5	1.4	1.0	1.3	0.9	1.1	8.3	9.7	10.3	5.2	1.0	13.6	0.8	13.9	7.6	12.5	0.9	0.9	4.3	52.0	14.5	1.5	1.0	0.0	1.3	1.2	2.9	1.2	1.0	2.5	19.3	1.1	1.1	1.6	10.7	0.0	1.6	0.2	0.9	1.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.3	0.1	0.4	0.7	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.2	2.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.3	1.6	0.0	1.5	0.0	104.4	0.0	0.4	0.5	0.0	0.0	0.1	0.3	5.6	0.0	0.1	0.1	0.0	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.1	17.7	0.4	0.0	7.6	0.4	0.1	0.0	0.0	7.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	8.0	2.0	8.1	9.7	10.3	13.9	7.6	14.5	10.7
XPNPEP2		ENSG00000122121	"X-prolyl aminopeptidase 2"	O43895	X	129738974-129769538	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"intestine: 145.6;kidney: 49.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 6.2;ASC TERT1: 32.6;HSkMC: 16.5"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 5.3;liver cancer: 18.3;stomach cancer: 3.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 7.3;intermediate monocyte: 2.1;MAIT T-cell: 2.2;memory CD4 T-cell: 2.4;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.6;non-classical monocyte: 4.4;T-reg: 2.2"	"Group enriched"	"Detected in many"	7	"monocytes: 4.4;T-cells: 7.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA000339, CAB025136, CAB025269, HPA064568"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"		8900000	"Plasma membrane, Cytosol"		"CAB025136: , CAB025269: , HPA000339: AB_1858894, HPA064568: "	"unprognostic (7.95e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.28e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-3)"	4.7	0.5	0.0	1.1	0.1	0.0	3.2	0.0	0.1	1.7	57.4	0.1	0.8	37.0	1.2	1.7	4.2	3.4	1.3	2.6	0.0	0.0	49.7	8.0	1.0	1.2	0.0	0.0	3.5	0.9	0.0	0.0	0.6	0.1	3.6	2.0	0.7	0.7	0.3	1.6	2.1	145.6	2.5	0.1	0.2	1.7	1.2	0.0	0.1	0.9	1.4	0.3	4.0	10.7	0.4	0.8	0.2	4.4	0.0	7.3	1.3	0.0	0.0	0.4	0.0	6.2	32.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.8	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	7.3	2.1	2.2	0.0	2.4	4.8	0.3	0.4	0.7	3.6	0.2	0.0	4.4	0.8	2.2	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
SASH3	"753P9, CXorf9, HACS2, SH3D6C, SLY"	ENSG00000122122	"SAM and SH3 domain containing 3"	O75995	X	129779979-129795201	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 61.8;bone marrow: 33.2;lymphoid tissue: 85.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 43.9;HL-60: 15.4;MOLT-4: 31.3;NB-4: 23.8;REH: 23.5;U-698: 40.0;U-937: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001085	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"				"Plasma membrane"	"Nucleoplasm, Nuclear bodies"	"HPA001085: AB_2184289"	"unprognostic (1.88e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.49e-3)"	"prognostic favourable (3.15e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.23e-3)"	"unprognostic (7.92e-3)"	"unprognostic (3.45e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (6.51e-5)"	"unprognostic (3.30e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.53e-1)"	7.8	3.4	2.8	34.6	5.2	33.2	2.7	0.7	2.2	2.0	3.3	4.0	0.2	3.9	1.9	2.1	2.9	3.4	3.6	2.0	3.3	2.4	3.3	3.0	10.6	38.2	5.2	1.1	1.3	1.8	0.2	1.8	2.5	4.2	2.7	3.5	1.6	7.8	0.8	0.9	1.1	18.8	2.4	6.2	55.7	4.2	0.8	4.0	85.3	2.5	2.0	38.6	7.0	2.0	22.0	27.6	53.7	44.2	33.4	46.9	61.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	31.3	23.8	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.1	0.0	0.1	0.0	0.0	0.0	8.9	40.0	0.0	31.1	0.0	7.9	29.4	53.7	46.9	44.1	38.7	19.1	26.7	43.1	27.6	22.0	19.3	30.0	29.1	33.4	44.2	12.7	32.3	61.8	2.8	5.2	0.7	2.2	3.3	2.4	5.2	1.1	4.2	4.0
ZDHHC9	"CGI-89, CXorf11, ZDHHC10, ZNF379, ZNF380"	ENSG00000188706	"Zinc finger DHHC-type containing 9"	Q9Y397	X	129803288-129843909	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031814	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"				"Endoplasmic reticulum, Golgi apparatus"	Cytosol	"HPA031814: AB_10610700"	"prognostic unfavourable (9.77e-5)"	"prognostic unfavourable (4.64e-5)"	"unprognostic (2.83e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavourable (2.45e-4)"	"unprognostic (4.01e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.11e-2)"	18.2	7.3	16.7	6.7	24.7	3.2	14.2	7.8	33.9	14.1	14.7	78.3	5.1	21.1	8.4	8.4	9.8	7.9	10.4	7.4	24.1	15.2	25.4	27.0	15.6	3.0	24.9	13.9	8.0	17.4	19.6	7.1	11.5	28.4	13.4	17.3	3.8	13.2	8.3	7.4	19.7	22.2	10.4	32.7	2.4	12.8	2.8	25.3	1.2	9.6	5.7	4.3	10.8	9.4	4.6	7.8	2.6	6.8	3.4	7.6	3.3	15.2	8.0	11.5	23.2	39.9	31.4	9.4	15.1	17.3	7.2	9.1	12.6	19.9	0.5	25.8	16.0	10.3	13.0	15.1	10.5	0.8	8.1	3.0	8.4	16.6	15.8	2.0	5.5	34.1	24.7	11.8	17.6	13.6	3.3	6.1	11.7	13.3	2.9	3.8	6.2	13.9	2.7	7.4	9.0	10.5	8.5	9.1	7.7	4.3	22.3	7.0	9.5	3.4	11.1	7.4	2.5	17.3	12.1	5.7	4.1	1.8	13.3	8.4	3.7	0.0	3.3	2.6	4.8	2.9	6.1	4.6	5.8	4.7	3.7	2.7	7.6	4.3	0.0	3.4	6.8	7.8	2.5	3.3	16.7	24.7	7.8	33.9	24.1	15.2	24.9	13.9	28.4	25.3
UTP14A	"NY-CO-16, SDCCAG16, Utp14"	ENSG00000156697	"UTP14A, small subunit processome component"	Q9BVJ6	X	129906121-129929761	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA047217, HPA054023"	Uncertain		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA047217: , HPA054023: "	"unprognostic (6.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.95e-1)"	"prognostic unfavourable (7.67e-4)"	"unprognostic (3.00e-3)"	"unprognostic (8.24e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.28e-2)"	"unprognostic (6.99e-3)"	"prognostic unfavourable (8.12e-8)"	"unprognostic (4.77e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-2)"	"unprognostic (9.99e-2)"	15.1	11.4	8.2	13.3	11.2	10.2	15.8	12.7	13.8	13.3	13.4	8.4	8.5	8.5	17.6	13.9	16.9	13.9	9.0	10.0	7.1	7.2	13.2	14.9	10.7	14.8	7.6	9.8	17.4	22.7	13.1	13.8	12.5	10.6	13.5	14.7	8.6	13.2	10.6	19.6	11.8	11.0	15.3	7.7	16.1	13.3	4.3	7.7	20.7	12.4	16.3	19.5	16.0	13.5	11.1	11.8	16.2	14.3	15.5	14.6	7.7	14.2	15.9	8.6	22.5	14.4	14.7	14.4	15.8	12.1	15.9	12.7	16.2	14.1	33.8	31.9	11.4	18.3	34.2	17.2	19.6	11.2	17.0	19.3	13.6	12.3	16.3	27.2	14.8	18.0	15.2	21.6	22.9	12.5	19.1	10.6	13.7	23.4	19.6	20.8	17.8	17.9	15.4	12.9	23.1	11.0	10.9	9.0	23.6	9.0	16.6	18.6	8.9	15.9	10.8	7.0	9.2	19.6	30.3	13.3	15.4	30.1	10.6	33.8	15.8	16.2	8.0	4.0	12.7	14.3	14.6	11.1	10.7	11.8	11.8	10.9	13.5	12.4	1.0	15.5	12.0	9.4	14.4	7.7	8.2	11.2	12.7	13.8	7.1	7.2	7.6	9.8	10.6	7.7
BCORL1	"CXorf10, FLJ11362"	ENSG00000085185	"BCL6 corepressor like 1"	Q5H9F3	X	129981107-130058083	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.0;HAP1: 30.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031775, HPA031777, HPA068568"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA031775: AB_10602332, HPA031777: AB_10671578, HPA068568: "	"unprognostic (8.07e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavourable (2.20e-5)"	"unprognostic (4.58e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.96e-3)"	"unprognostic (5.56e-3)"	"unprognostic (2.39e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (5.00e-4)"	"unprognostic (9.18e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.41e-2)"	7.5	7.9	7.7	5.2	9.1	9.8	9.1	19.8	10.5	8.7	8.3	10.7	8.1	5.4	9.2	5.4	5.8	9.3	4.2	6.9	8.4	4.5	7.5	4.7	6.7	5.3	7.6	5.9	11.4	8.9	13.4	15.0	28.9	7.5	8.1	4.5	6.0	6.5	8.4	6.0	6.5	6.0	8.8	5.3	7.7	6.6	26.1	8.1	6.8	10.3	2.2	5.1	6.7	8.5	1.2	1.6	3.5	1.3	0.8	1.3	0.7	2.2	5.4	12.7	20.0	7.5	5.4	3.5	2.9	3.5	3.8	4.4	6.5	1.4	1.0	6.6	5.9	1.3	30.1	1.2	3.6	2.2	4.4	10.3	2.6	2.2	3.7	2.5	3.0	3.3	2.5	7.5	0.4	4.6	4.9	10.6	2.5	1.3	3.8	7.8	3.5	3.8	8.1	5.1	1.4	2.1	0.3	2.1	7.2	1.6	0.4	1.9	4.4	3.9	3.8	3.1	4.0	3.8	2.8	3.4	6.2	1.6	2.1	5.3	1.4	0.1	1.3	2.8	1.3	0.2	1.0	1.2	0.9	0.8	1.6	1.0	0.6	0.7	3.5	0.8	0.5	0.7	0.2	0.7	7.7	9.1	19.8	10.5	8.4	4.5	7.6	5.9	7.5	8.1
ELF4	"ELFR, MEF"	ENSG00000102034	"E74 like ETS transcription factor 4"	Q99607	X	130064874-130110716	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058595, HPA060277"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"HPA058595: , HPA060277: "	"unprognostic (1.33e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.43e-3)"	"unprognostic (7.86e-3)"	"unprognostic (3.50e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavourable (6.49e-6)"	"unprognostic (1.43e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.51e-1)"	"prognostic favourable (1.42e-4)"	16.9	3.6	2.0	18.1	2.5	27.6	16.9	0.5	3.0	7.7	10.8	3.1	7.0	8.4	10.5	8.1	10.5	9.5	11.0	7.3	3.1	1.2	5.9	2.5	21.9	33.3	3.8	0.9	12.7	4.5	3.8	4.2	23.5	3.0	6.6	10.9	3.6	5.4	7.9	5.7	9.1	16.3	6.4	4.2	18.9	12.3	3.5	2.9	18.1	3.9	7.4	11.5	11.7	14.4	3.9	6.1	9.4	10.3	8.4	10.3	5.1	22.5	8.4	1.5	0.1	3.9	8.4	22.0	10.5	13.4	12.8	14.2	11.6	16.1	11.6	21.1	14.2	14.7	8.4	12.4	12.6	12.4	7.0	22.7	11.2	5.4	8.7	19.8	29.1	8.7	13.9	20.5	20.3	12.3	8.7	3.2	6.9	13.1	3.2	11.3	1.0	8.3	7.0	2.7	4.9	7.8	26.1	5.8	2.5	9.4	9.1	2.9	4.5	19.1	11.4	9.0	7.1	16.7	19.4	1.7	0.7	9.3	10.6	18.2	2.0	1.6	5.4	7.8	10.3	10.3	8.3	3.9	6.2	8.8	6.1	3.5	6.2	7.2	9.4	8.4	7.0	3.7	6.3	5.1	2.0	2.5	0.5	3.0	3.1	1.2	3.8	0.9	3.0	2.9
AIFM1	"AIF, CMTX4, NAMSD, PDCD8"	ENSG00000156709	"Apoptosis inducing factor mitochondria associated 1"	O95831	X	130129362-130165887	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"DNA-binding, Oxidoreductase"	"Charcot-Marie-Tooth disease, Deafness, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 66.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003764, HPA030611"	Enhanced						160000			"CAB003764: AB_289587, HPA030611: "	"unprognostic (3.00e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.81e-3)"	"prognostic favourable (4.42e-10)"	"unprognostic (1.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.11e-2)"	9.9	28.9	7.1	11.3	8.6	5.3	7.1	7.5	8.9	10.4	14.2	8.4	10.0	19.6	9.9	11.7	8.6	13.0	11.4	34.2	7.2	7.0	66.8	50.5	5.8	9.8	8.2	7.1	7.3	14.6	16.8	7.7	6.1	8.8	6.9	14.2	12.3	13.1	9.4	35.7	5.8	23.2	8.9	6.4	8.7	14.9	14.9	7.2	19.5	7.9	16.1	9.7	8.4	6.0	10.8	22.0	9.8	18.3	15.8	12.8	8.0	16.7	31.0	12.7	31.8	14.5	10.4	16.8	10.6	9.2	16.4	13.3	22.0	12.4	36.2	37.1	9.7	16.2	39.2	13.8	17.5	13.8	23.9	22.9	23.4	29.9	18.5	20.1	24.2	12.8	13.6	17.4	14.9	13.8	19.7	16.8	11.5	40.4	20.4	31.6	9.1	24.1	18.5	14.3	41.9	37.1	17.0	16.4	9.6	12.4	28.8	27.7	14.8	18.2	10.0	7.8	7.5	21.3	20.2	9.0	14.5	16.9	10.1	33.7	11.7	2.9	14.8	9.8	9.1	18.3	9.6	10.8	9.7	11.2	22.0	8.1	9.6	9.7	2.1	15.8	15.5	10.6	12.8	8.0	7.1	8.6	7.5	8.9	7.2	7.0	8.2	7.1	8.8	7.2
RAB33A	RabS10	ENSG00000134594	"RAB33A, member RAS oncogene family"	Q14088	X	130171649-130184870	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.3;brain: 32.4"	"Cell line enhanced"	"Detected in some"		"HMC-1: 31.6;Karpas-707: 35.9;U-266/70: 26.3;U-937: 14.9"	"Group enriched"	"Detected in many"	6	"glioma: 10.7;melanoma: 2.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059737	Uncertain		Uncertain	Vesicles				Vesicles		"HPA059737: "	"unprognostic (5.40e-2)"	"unprognostic (6.64e-3)"	"unprognostic (3.48e-2)"	"unprognostic (8.47e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.03e-2)"	"unprognostic (8.28e-2)"	"unprognostic (7.00e-6)"	"unprognostic (2.51e-1)"	"unprognostic (6.35e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.61e-1)"	1.8	2.3	12.5	4.9	11.6	6.8	1.6	15.8	32.4	2.0	1.7	20.8	0.0	1.6	2.1	1.4	1.4	2.2	3.5	10.3	15.9	9.9	1.1	1.5	1.9	11.9	13.0	12.6	2.5	0.8	3.2	1.6	2.3	10.1	1.1	1.9	0.6	1.5	1.0	0.8	1.0	1.9	1.6	21.5	3.3	2.3	1.5	17.3	1.2	1.0	0.0	13.1	3.3	0.6	7.1	3.3	27.3	1.7	5.7	22.9	5.9	0.0	0.0	2.1	0.0	0.9	0.2	0.0	0.2	0.6	0.5	0.9	0.0	0.2	1.6	0.0	0.1	0.0	2.5	0.0	0.5	8.2	0.0	9.4	0.0	0.0	8.8	7.6	31.6	0.3	0.0	0.1	0.3	0.2	0.0	35.9	0.0	0.0	3.5	2.7	0.3	0.3	0.0	0.0	0.4	0.0	0.0	6.9	5.7	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.0	0.1	0.0	26.3	7.8	0.0	1.1	14.9	0.0	9.4	0.4	27.3	11.2	0.2	7.0	7.1	10.1	11.1	3.3	2.6	9.8	13.9	1.3	5.7	1.7	0.3	22.9	5.9	12.5	11.6	15.8	18.5	15.9	9.9	13.0	12.6	10.1	17.3
ZNF280C	"FLJ20095, SUHW3, ZNF633"	ENSG00000056277	"Zinc finger protein 280C"	Q8ND82	X	130202711-130268899	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051494, HPA055788"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"HPA051494: , HPA055788: "	"unprognostic (2.97e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.97e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.98e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.16e-6)"	"unprognostic (1.96e-2)"	"unprognostic (3.33e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.27e-8)"	"unprognostic (1.71e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.66e-2)"	"unprognostic (6.85e-2)"	5.4	4.5	3.9	7.1	6.8	6.2	4.9	5.6	6.8	7.6	4.4	5.4	2.9	3.7	10.6	13.3	4.6	5.0	5.1	3.3	3.8	4.2	4.0	4.1	4.1	5.7	4.2	4.2	6.8	4.6	4.9	12.5	4.8	5.8	5.5	4.0	5.1	4.1	3.8	4.5	4.5	4.4	5.0	5.8	6.0	3.8	21.5	2.8	8.2	4.9	3.6	6.8	4.9	5.4	4.0	2.3	2.7	2.9	4.5	4.9	1.1	3.4	4.3	11.5	10.3	3.5	4.8	4.3	3.2	4.3	3.5	5.3	2.6	5.5	8.1	13.0	2.3	3.4	7.9	2.6	6.2	7.1	2.2	3.5	3.3	1.9	2.8	11.3	3.3	3.5	1.2	4.9	5.2	3.9	1.7	5.0	4.0	4.3	6.1	4.6	6.7	3.6	8.5	3.9	3.1	3.6	5.5	5.6	7.7	3.1	1.8	3.7	2.0	3.9	3.9	3.9	3.2	6.3	8.5	2.1	1.3	4.6	3.6	10.3	3.5	2.7	1.4	1.5	3.0	2.2	4.9	4.0	3.8	3.5	1.9	3.2	2.7	3.7	0.8	4.5	2.9	2.3	4.8	1.1	3.9	6.8	5.6	6.8	3.8	4.2	4.2	4.2	5.8	2.8
SLC25A14	"BMCP1, UCP5"	ENSG00000102078	"Solute carrier family 25 member 14"	O95258	X	130339888-130373361	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060316			Approved	Mitochondria	"Intracellular and membrane"			Mitochondria		"HPA060316: "	"unprognostic (1.65e-2)"	"prognostic favourable (1.72e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.36e-3)"	"unprognostic (8.92e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.95e-3)"	"prognostic favourable (1.78e-4)"	"unprognostic (2.18e-2)"	"prognostic unfavourable (5.52e-6)"	"unprognostic (6.05e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.92e-2)"	"prognostic favourable (1.39e-5)"	3.1	9.3	9.2	3.4	18.3	3.7	5.5	13.6	20.6	4.8	3.8	6.1	4.2	2.2	6.7	11.0	4.3	9.7	4.6	7.7	8.7	15.8	5.2	4.1	4.6	4.1	7.3	11.4	6.8	4.5	5.6	15.0	3.6	11.2	5.1	4.1	5.7	5.1	6.7	3.4	4.7	3.6	7.7	5.3	3.5	4.8	10.2	4.2	4.2	5.7	4.6	5.3	3.1	3.8	7.5	9.3	8.7	7.2	8.1	9.5	4.9	6.8	9.0	6.5	4.7	4.4	4.1	3.5	5.2	6.9	10.0	10.1	3.6	4.1	4.7	18.0	6.9	3.9	9.3	3.8	10.0	5.9	11.8	1.5	8.3	8.4	6.1	5.9	2.8	3.8	4.7	12.7	3.8	5.5	4.1	6.6	15.9	10.5	6.1	8.2	5.4	14.8	5.2	8.4	9.3	5.8	3.0	8.1	7.2	5.5	5.5	8.7	3.5	3.3	3.7	5.4	3.5	12.3	10.4	6.2	15.9	4.1	9.8	7.2	4.8	5.8	7.2	5.2	6.4	5.8	7.8	7.5	5.4	6.1	7.5	4.6	4.2	7.0	8.7	8.1	5.2	9.3	9.5	4.9	9.2	18.3	13.6	15.6	8.7	15.8	7.3	11.4	11.2	4.2
GPR119	"GPCR2, hGPCR2"	ENSG00000147262	"G protein-coupled receptor 119"	Q8TDV5	X	130384440-130385447	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 3.5;pancreas: 8.0"	"Group enriched"	"Detected in some"	20	"CACO-2: 2.7;Hep G2: 5.8"	"Cancer enriched"	"Detected in single"	11	"pancreatic cancer: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"																								"prognostic favourable (6.93e-4)"							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBMX2	"CGI-79, Snu17"	ENSG00000134597	"RNA binding motif protein, X-linked 2"	Q9Y388	X	130401969-130413343	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026609	Approved		Approved	"Nuclear membrane,Nucleoli"				"Nuclear membrane"	Nucleoli	"HPA026609: AB_1846601"	"unprognostic (2.54e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavourable (7.04e-4)"	"prognostic favourable (9.15e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.86e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (8.44e-9)"	"unprognostic (1.06e-1)"	"unprognostic (4.78e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.63e-3)"	19.4	16.7	22.3	16.7	20.0	17.1	25.0	22.7	22.9	25.1	19.9	18.9	19.1	17.0	29.4	29.5	18.7	19.8	18.8	17.8	21.0	18.7	17.7	21.1	16.9	21.2	18.6	22.1	28.2	21.9	17.9	24.4	17.3	21.0	23.0	20.0	16.3	20.5	23.7	21.0	21.4	15.9	23.0	18.9	21.1	18.4	10.8	19.0	26.4	23.0	17.9	26.7	27.2	20.2	12.6	10.5	11.0	9.5	9.4	19.3	5.4	13.8	14.5	14.6	15.1	14.6	27.4	14.9	13.0	13.4	14.9	16.2	10.8	17.0	13.4	31.4	9.9	15.1	23.3	12.0	21.7	12.2	20.7	12.0	13.4	11.3	13.2	18.5	14.3	19.8	17.3	16.6	23.2	16.6	10.4	11.7	16.6	24.1	21.2	23.1	11.0	23.7	16.4	14.5	18.1	15.1	11.1	17.1	20.4	8.2	17.6	23.0	11.4	13.7	10.8	12.0	9.8	28.0	27.2	15.5	16.9	19.1	14.6	30.3	15.2	11.0	9.4	10.8	11.1	9.5	11.1	12.4	13.8	14.0	7.8	12.6	15.1	14.2	8.0	9.4	9.4	10.5	19.3	5.4	22.3	20.0	22.7	22.9	21.0	18.7	18.6	22.1	21.0	19.0
ENOX2	"APK1, COVA1, tNOX"	ENSG00000165675	"Ecto-NOX disulfide-thiol exchanger 2"	Q16206	X	130623369-130903317	"Predicted intracellular proteins"	"Biological rhythms, Electron transport, Growth regulation, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000514, HPA003027"	Uncertain		Supported	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"		"HPA000514: AB_1078558, HPA003027: "	"unprognostic (1.34e-2)"	"unprognostic (7.02e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.27e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.44e-1)"	"prognostic favourable (1.09e-5)"	"unprognostic (6.42e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.38e-1)"	13.1	14.6	13.5	14.8	17.6	4.7	11.4	7.6	11.0	13.2	11.6	13.9	10.7	8.0	15.6	12.9	13.3	13.2	11.2	18.9	14.6	13.1	10.4	23.6	8.8	16.0	14.7	8.8	14.6	7.4	12.5	12.3	11.7	12.2	12.9	9.3	8.5	10.3	15.1	11.2	8.6	11.1	14.5	13.4	17.7	9.2	9.7	17.7	17.4	11.0	11.7	15.9	14.2	9.7	12.8	11.9	15.0	16.7	11.3	13.3	9.7	12.3	9.1	14.0	5.8	12.0	11.4	5.6	10.5	12.1	7.1	4.4	4.3	10.7	8.7	25.4	8.8	8.7	9.1	9.7	8.8	11.5	10.0	20.2	6.2	5.7	9.3	14.7	14.2	9.0	16.6	7.7	9.6	10.6	12.4	7.1	5.5	17.2	9.2	3.2	7.3	12.7	6.6	8.7	9.6	8.2	8.7	4.2	8.5	9.1	6.0	14.7	3.9	8.1	8.6	6.8	4.1	10.9	21.3	7.4	3.6	5.7	19.8	15.4	11.5	8.0	12.0	15.0	10.4	16.7	11.1	12.8	12.2	10.8	11.9	11.6	13.3	11.7	2.1	11.3	7.8	5.7	13.2	9.7	13.5	17.6	7.6	11.0	14.6	13.1	14.7	8.8	12.2	17.7
ARHGAP36	FLJ30058	ENSG00000147256	"Rho GTPase activating protein 36"	Q6ZRI8	X	131058242-131089883	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 58.4;brain: 25.5;pituitary gland: 50.3"	"Cell line enriched"	"Detected in single"	164	"SH-SY5Y: 62.9"	"Cancer enriched"	"Detected in some"	21	"thyroid cancer: 62.5"	"Region enriched"	"Detected in many"	5	"hypothalamus: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hypothalamus: 104.3"	"Group enriched"	"Detected in many"	5	"basal ganglia: 19.8;hypothalamus: 57.8;midbrain: 27.1;pons and medulla: 20.1"	"HPA002064, HPA076209"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane"				Nucleoplasm	"Vesicles, Plasma membrane"	"HPA002064: AB_1078891, HPA076209: "	"unprognostic (2.92e-2)"			"unprognostic (7.71e-9)"	"unprognostic (2.19e-1)"	"unprognostic (8.15e-2)"				"unprognostic (1.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.73e-1)"		"unprognostic (1.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.31e-1)"		6.9	58.4	1.4	0.2	3.6	0.1	1.0	0.0	2.7	0.5	0.2	0.0	0.0	0.1	0.1	2.0	0.3	0.2	0.2	0.1	1.0	25.5	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.1	0.1	50.3	0.3	5.4	0.3	0.2	0.6	0.2	0.2	13.7	0.1	0.1	0.1	0.8	0.1	0.2	0.6	0.0	0.5	0.5	4.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	62.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.6	0.0	0.4	1.0	25.5	0.5	0.0	5.4	0.0
IGSF1	"IGCD1, IGDC1, INHBP, KIAA0364, MGC75490, PGSF2"	ENSG00000147255	"Immunoglobulin superfamily member 1"	Q8N6C5	X	131273506-131578899	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"pituitary gland: 138.7"	"Group enriched"	"Detected in some"	5	"Hep G2: 23.0;SH-SY5Y: 20.7"	"Cancer enriched"	"Detected in many"	8	"thyroid cancer: 65.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA012732, HPA035582"	Enhanced		Approved	Cytosol	"Intracellular and membrane"		430000	Cytosol		"HPA012732: AB_2732404, HPA035582: AB_2674687"	"unprognostic (1.40e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.11e-1)"	"prognostic unfavourable (4.25e-8)"	"unprognostic (1.01e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.52e-3)"	"unprognostic (8.03e-3)"	"unprognostic (9.36e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.13e-2)"	0.8	11.9	1.4	0.4	5.3	0.0	2.7	0.6	6.2	2.7	0.5	3.3	1.2	0.2	1.1	1.5	1.3	1.6	0.8	5.6	3.3	15.4	0.5	1.5	0.2	0.0	3.8	1.9	1.0	1.7	0.0	138.7	0.6	4.7	3.9	0.2	2.2	2.0	6.4	0.3	0.6	0.4	3.2	2.7	0.2	0.5	11.8	1.9	0.2	5.3	0.8	0.5	0.6	0.5	0.6	0.4	1.5	0.3	0.3	0.3	0.2	0.3	0.4	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.1	0.0	0.0	1.2	0.0	0.0	4.0	0.3	0.0	1.7	23.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	1.9	20.7	0.0	0.2	0.0	0.4	0.0	0.0	0.3	0.6	0.0	2.3	0.7	0.3	0.0	0.0	0.0	0.0	1.5	0.3	0.2	0.2	0.1	0.2	0.3	0.3	0.3	0.1	0.6	0.3	0.2	1.2	0.3	0.1	0.4	0.3	0.2	1.4	5.3	0.6	2.3	3.3	15.4	3.8	1.9	4.7	1.9
OR13H1		ENSG00000171054	"Olfactory receptor family 13 subfamily H member 1"	Q8NG92	X	131543976-131545056	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"NTERA-2: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"																															0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.2	0.9		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
STK26	"MASK, MST4"	ENSG00000134602	"Serine/threonine kinase 26"	Q9P289	X	132023265-132075943	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 40.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059921	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"				Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA059921: "	"unprognostic (6.53e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.42e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavourable (6.82e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (6.87e-5)"	"unprognostic (4.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	5.4	1.4	1.1	13.5	5.1	25.9	3.3	3.8	1.1	18.0	6.4	0.3	34.8	3.7	42.3	29.6	11.7	6.0	5.2	1.9	1.2	2.3	3.5	3.2	6.7	12.8	1.2	0.3	4.7	4.0	10.2	5.8	50.7	1.2	11.5	4.8	2.2	6.3	22.4	1.2	5.1	6.1	19.1	1.5	8.5	4.7	5.2	0.8	44.7	2.3	6.8	10.2	18.0	6.6	8.4	6.2	26.4	11.6	22.0	13.3	10.2	9.0	3.1	0.3	0.0	1.5	1.4	20.7	0.3	1.1	0.1	0.1	8.3	8.2	12.3	5.6	2.0	10.3	23.0	14.4	0.0	10.6	18.8	17.7	7.8	7.8	1.4	37.0	1.4	2.0	8.6	0.0	9.8	4.0	7.8	11.6	3.4	7.9	38.0	34.4	18.4	1.2	27.5	11.4	15.8	9.3	14.5	7.7	8.5	5.4	4.9	0.2	6.3	9.8	0.1	3.7	4.0	11.2	13.2	8.9	14.0	13.7	3.4	40.3	1.8	26.4	5.1	16.6	13.3	6.7	13.0	8.4	9.1	11.3	6.2	7.3	11.8	12.2	10.0	22.0	11.6	2.3	4.0	10.2	1.1	5.1	3.8	1.1	1.2	2.3	1.2	0.3	1.2	0.8
FRMD7	"FLJ43346, NYS, NYS1"	ENSG00000165694	"FERM domain containing 7"	Q6ZUT3	X	132076993-132128020	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	Neurogenesis		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"endometrium 1: 7.4;kidney: 6.6;smooth muscle: 5.5"	"Cell line enhanced"	"Detected in some"		"AF22: 1.1;HSkMC: 1.7;U-87 MG: 5.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	29	"olfactory region: 80.8"	"Region enriched"	"Detected in single"	100	"olfactory region: 45.5"	HPA000886	Uncertain									"HPA000886: AB_1079269"	"unprognostic (3.08e-2)"	"unprognostic (1.27e-1)"			"unprognostic (1.36e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.54e-2)"			"unprognostic (3.00e-1)"			0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0			0.0	7.4	1.1	0.0	1.1	0.0	0.1	0.0	0.1	6.6	1.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.5	0.0		0.0	1.1	0.0	0.5	0.0	5.5	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0										
RAP2C	DKFZp313B211	ENSG00000123728	"RAP2C, member of RAS oncogene family"	Q9Y3L5	X	132203024-132219480	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 65.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.37e-2)"	"unprognostic (8.80e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.95e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.04e-2)"	"prognostic unfavourable (3.81e-5)"	"unprognostic (2.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.00e-1)"	8.2	7.3	5.7	8.1	7.6	20.0	6.4	3.4	4.7	14.7	9.2	6.4	4.5	7.1	65.2	14.4	9.0	9.5	6.8	10.9	5.2	5.1	13.6	19.8	9.2	9.7	6.9	3.2	8.6	7.0	3.1	3.2	12.7	5.6	6.8	6.5	6.9	6.4	7.4	17.4	6.6	8.6	27.7	8.0	12.4	6.6	7.6	5.6	10.5	8.4	7.4	11.3	12.0	6.8	6.0	5.4	11.3	16.3	7.4	7.5	4.6	12.2	9.5	14.1	15.6	12.1	19.8	21.9	13.9	17.4	13.5	13.8	9.5	16.3	17.4	22.1	15.5	9.1	12.9	13.5	17.7	31.2	11.7	13.4	11.0	13.5	18.5	22.2	18.9	15.7	15.6	15.1	16.4	15.0	10.7	20.6	14.8	19.5	12.5	17.6	9.6	13.8	9.7	10.8	17.5	17.8	9.0	2.9	15.8	8.3	9.9	14.8	17.1	12.1	13.3	13.9	8.1	28.4	25.2	19.2	15.1	17.8	15.7	21.5	12.3	6.5	4.8	11.3	6.0	10.3	6.9	6.0	6.8	6.2	5.4	5.0	6.3	7.5	9.6	7.4	16.3	2.6	6.8	4.6	5.7	7.6	3.4	4.7	5.2	5.1	6.9	3.2	5.6	5.6
MBNL3	"CHCR, FLJ11316, MBLX39, MBXL"	ENSG00000076770	"Muscleblind like splicing regulator 3"	Q9NUK0	X	132369317-132489968	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 67.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 38.9;Hep G2: 53.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA001584	Enhanced		Approved	"Golgi apparatus,Vesicles"				Vesicles	"Golgi apparatus"	"HPA001584: AB_1079326"	"unprognostic (3.38e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (1.57e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.67e-3)"	"unprognostic (8.74e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.19e-2)"	"unprognostic (5.77e-3)"	"unprognostic (4.36e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.37e-1)"	6.6	10.4	1.8	14.7	1.9	5.1	7.5	0.9	1.6	3.8	5.9	2.8	10.8	4.0	4.8	25.8	9.6	4.6	4.6	14.2	1.6	1.9	5.6	23.5	12.0	16.2	3.0	1.1	5.5	10.4	2.4	6.3	67.0	1.8	5.4	4.7	2.8	5.5	6.1	1.6	5.5	9.7	6.7	3.5	15.2	5.2	23.8	1.9	18.6	3.5	7.9	10.8	8.3	8.3	18.1	12.3	7.2	14.0	13.4	12.5	6.2	2.2	0.0	2.8	0.4	0.5	1.2	5.1	0.1	1.0	0.3	0.0	38.9	7.2	10.2	0.2	0.4	2.5	6.3	2.6	0.2	1.0	2.4	9.1	8.4	53.4	0.5	10.1	3.3	0.5	2.3	0.0	1.1	0.3	0.8	2.9	0.5	6.0	17.2	3.8	0.4	0.5	16.5	3.4	5.8	1.8	5.9	1.0	3.4	4.7	2.7	1.4	1.0	2.6	1.2	2.0	0.4	2.6	2.1	5.9	3.9	15.0	0.4	6.8	6.4	7.2	5.9	3.7	12.5	6.9	11.1	15.0	7.7	8.6	6.2	18.1	7.8	8.7	0.9	13.4	14.0	12.3	1.5	6.2	1.8	1.9	0.9	1.6	1.6	1.9	3.0	1.1	1.8	1.9
HS6ST2		ENSG00000171004	"Heparan sulfate 6-O-sulfotransferase 2"	Q96MM7	X	132626016-132961395	"Predicted intracellular proteins, Predicted membrane proteins"		Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.5;kidney: 17.3;ovary: 18.2"	"Cell line enhanced"	"Detected in some"		"HEK 293: 19.3;HeLa: 13.1;RH-30: 28.0;RT4: 13.9;SH-SY5Y: 34.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 29.5"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.8"	"Lineage enhanced"	"Detected in single"		"NK-cells: 1.8"	"Low region specificity"	"Detected in all"							"HPA034625, HPA034626"	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm		"HPA034625: AB_10612119, HPA034626: "	"unprognostic (7.62e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-1)"	"unprognostic (8.39e-5)"	"unprognostic (1.36e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.54e-1)"	"prognostic favourable (6.03e-4)"	0.4	3.2	6.5	0.9	29.5	0.1	2.6	3.0	6.7	1.0	0.8	0.8	0.6	0.3	4.5	3.2	5.0	2.5	0.5	0.4	4.1	9.1	17.3	0.2	1.0	0.3	3.5	0.9	18.2	6.5	0.1	1.3	9.9	3.3	5.4	1.2	0.0	1.1	1.6	6.7	0.3	0.2	2.0	3.3	0.2	1.1	7.9	0.7	0.7	0.6	1.7	2.7	2.3	0.6	0.0	0.0	0.0	0.0	1.8	0.6	0.0	4.3	0.0	6.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.0	0.0	0.0	6.4	0.0	0.2	9.1	0.0	0.0	0.0	19.3	0.0	13.1	0.0	0.0	0.0	0.0	0.3	8.5	0.0	0.0	0.4	0.0	0.0	0.0	3.1	0.1	0.0	4.9	0.2	0.0	28.0	0.0	5.6	13.9	0.7	34.9	6.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	4.0	9.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	6.5	29.5	3.0	5.8	4.1	9.1	3.5	0.9	3.3	0.7
USP26		ENSG00000134588	"Ubiquitin specific peptidase 26"	Q9BXU7	X	133024631-133097109	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	7	"testis: 3.8"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"														"unprognostic (7.92e-4)"		"unprognostic (3.59e-2)"											"unprognostic (1.99e-2)"	"unprognostic (2.08e-1)"			0.1	0.1	0.1	0.1	0.1	0.3	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.4	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.4	0.1	0.1	0.1	0.1	0.1	3.8	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.5	0.1	0.2	0.3	0.0	0.0	0.5	0.4	0.5	0.4	0.1	0.1	0.2	0.2	0.7	0.1	0.2	0.1	0.7	0.1	0.1	0.1	0.7	0.1	0.2	0.3	1.0	0.3	1.0	0.3	0.1	0.1	0.0	1.5	0.6	0.4	0.1	0.1	0.4	0.4	0.2	0.2	0.1	0.7	0.4	0.3	0.4	0.1	0.0	0.9	0.5	0.5	0.2	0.1	0.1	0.2	0.1	0.7	0.3	0.9	0.1	0.3	0.4	0.9	0.3	0.1	0.2	0.4	0.3	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.5	0.2	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
TFDP3	"CT30, E2F-like, HCA661"	ENSG00000183434	"Transcription factor Dp family member 3"	Q5H9I0	X	133216669-133218348	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	68	"testis: 17.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (1.57e-1)"								"unprognostic (2.17e-1)"					"unprognostic (3.22e-1)"	"unprognostic (2.91e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPC4	K-glypican	ENSG00000076716	"Glypican 4"	O75487	X	133300103-133415490	"Plasma proteins, Predicted membrane proteins"			"Deafness, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"AF22: 50.7;EFO-21: 17.4;HAP1: 29.1;NTERA-2: 26.6;RPTEC TERT1: 66.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA030834, HPA030836"	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"		170000	"Plasma membrane"	Nucleoplasm	"HPA030834: , HPA030836: AB_10601327"	"unprognostic (9.60e-2)"	"unprognostic (8.67e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.21e-2)"	"unprognostic (8.51e-3)"	"unprognostic (5.90e-3)"	"unprognostic (5.68e-2)"	"prognostic favourable (3.51e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.87e-3)"	"unprognostic (1.30e-1)"	"prognostic favourable (1.25e-5)"	"unprognostic (1.97e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.72e-1)"	39.7	9.9	16.3	10.7	5.3	0.3	6.8	3.7	4.9	14.6	21.6	8.2	3.4	10.0	11.7	16.3	18.6	11.2	23.7	9.6	9.5	5.0	39.6	2.4	25.6	7.1	5.1	6.6	12.4	12.5	9.4	20.4	26.9	9.5	10.3	10.7	9.3	12.2	11.6	20.3	4.3	11.3	16.9	7.9	6.5	19.8	7.2	6.4	5.2	12.4	11.6	2.0	17.1	11.7	0.9	0.6	0.1	0.7	0.0	0.0	0.2	0.0	0.0	50.7	2.0	2.2	0.3	6.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	17.4	0.2	0.0	29.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	26.6	0.7	0.1	4.6	0.0	66.9	1.9	0.0	0.3	0.2	0.0	0.0	0.7	0.7	0.0	5.2	6.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	16.3	5.3	3.7	4.9	9.5	5.0	5.1	6.6	9.5	6.4
GPC3	"DGSX, OCI-5, SDYS, SGB, SGBS, SGBS1"	ENSG00000147257	"Glypican 3"	P51654	X	133535745-133985895	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Protease inhibitor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"placenta: 262.7"	"Group enriched"	"Detected in some"	8	"HAP1: 53.1;Hep G2: 209.8"	"Cancer enhanced"	"Detected in all"		"liver cancer: 269.0"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"naive CD4 T-cell: 5.0;naive CD8 T-cell: 3.5;NK-cell: 1.7"	"Group enriched"	"Detected in many"	12	"NK-cells: 1.7;T-cells: 5.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006316			Supported	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"		"HPA006316: AB_1078994"	"unprognostic (2.06e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.51e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.92e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.81e-3)"	"prognostic unfavourable (4.83e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.60e-1)"	30.1	5.9	0.4	3.6	0.7	0.0	50.2	0.6	0.4	3.3	4.5	0.5	2.2	0.5	2.5	11.7	2.0	3.4	9.2	8.0	0.4	1.1	21.2	1.1	37.0	1.9	1.6	0.4	6.0	4.6	0.3	16.9	262.7	1.6	3.6	1.0	6.3	3.8	2.3	4.1	5.5	1.8	3.3	2.1	0.9	4.0	2.1	0.3	2.3	7.2	11.2	3.0	7.6	8.0	0.0	0.2	0.0	0.0	1.7	5.0	0.6	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	53.1	0.0	0.0	0.0	2.4	0.0	0.1	209.8	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	14.5	0.6	1.7	4.3	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.5	0.2	0.0	5.0	3.5	0.0	1.7	0.0	0.0	0.0	0.6	0.4	0.7	0.6	0.4	0.4	1.1	1.6	0.4	1.6	0.3
CCDC160		ENSG00000203952	"Coiled-coil domain containing 160"	A6NGH7	X	134237047-134246207	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 21.9"	"Group enriched"	"Detected in some"	5	"AF22: 25.1;RPTEC TERT1: 7.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA044684	Uncertain									"HPA044684: AB_10806506"	"unprognostic (7.45e-3)"	"unprognostic (2.79e-2)"		"prognostic favourable (2.31e-4)"	"unprognostic (1.98e-1)"	"unprognostic (5.11e-4)"		"unprognostic (4.22e-2)"	"unprognostic (2.07e-2)"	"prognostic favourable (7.62e-6)"	"unprognostic (3.32e-2)"	"unprognostic (4.51e-2)"	"prognostic favourable (2.21e-4)"	"unprognostic (5.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.44e-3)"	0.5	0.3	4.2	0.5	3.5	0.5	6.0	2.8	3.6	4.6	0.5	2.5	7.1	0.4	1.3	4.2	0.8	5.0	1.9	0.4	5.1	5.2	9.6	0.3	3.1	0.8	7.7	3.0	2.2	2.0	8.0	1.2	0.5	7.5	3.5	0.4	0.9	21.9	11.7	1.5	0.6	0.3	0.4	5.8	0.8	1.6	3.0	6.5	0.0	0.6	0.5	0.4	1.4	0.6	0.3	0.2	0.2	0.1	0.1	0.5	0.0	0.0	0.0	25.1	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	7.0	2.0	0.0	0.1	0.0	0.3	0.3	3.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.5	0.0	0.2	0.3	0.4	0.0	0.0	0.3	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.0	4.2	3.5	2.8	3.6	5.1	5.2	7.7	3.0	7.5	6.5
PHF6	"BFLS, BORJ, CENP-31, KIAA1823, MGC14797"	ENSG00000156531	"PHD finger protein 6"	Q8IWS0	X	134373253-134428791	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation, Epilepsy, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001023	Enhanced		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA001023: AB_1079606"	"unprognostic (2.38e-3)"	"unprognostic (8.21e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.04e-3)"	"unprognostic (6.03e-3)"	"unprognostic (5.20e-3)"	"prognostic unfavourable (3.38e-4)"	"unprognostic (1.81e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (9.96e-4)"	"unprognostic (1.09e-1)"	"unprognostic (5.96e-2)"	"unprognostic (4.84e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	7.4	19.3	10.2	14.1	12.2	6.5	9.7	18.2	13.5	8.7	8.0	11.6	20.3	7.8	9.0	30.1	11.5	7.3	6.1	7.2	11.0	11.1	9.9	7.5	8.4	20.4	12.5	9.3	30.7	10.4	24.1	18.1	8.2	13.3	8.6	9.5	5.4	11.3	16.8	6.2	7.4	10.2	8.1	17.1	17.8	8.1	8.3	14.4	30.2	11.8	6.0	25.0	8.9	9.8	18.4	11.0	5.3	7.4	9.6	9.9	5.0	11.3	9.4	41.3	16.9	7.7	9.9	7.8	11.4	9.1	12.2	15.2	5.6	11.8	18.2	26.2	6.9	10.2	28.8	12.9	20.6	14.8	13.4	17.6	16.1	6.4	8.3	17.5	9.8	6.5	9.8	13.3	16.6	17.0	12.9	9.0	14.9	7.4	28.2	8.7	12.6	12.7	27.9	15.1	13.8	13.0	13.7	14.3	16.9	8.7	8.1	11.9	7.5	9.7	12.9	11.4	8.2	14.3	17.4	4.6	10.7	24.6	7.5	20.9	14.2	5.3	6.1	3.7	7.9	6.0	8.5	18.4	8.2	7.1	8.8	12.8	9.9	8.2	2.5	9.6	7.4	11.0	8.3	5.0	10.2	12.2	18.2	13.5	11.0	11.1	12.5	9.3	13.3	14.4
HPRT1	"HGPRT, HPRT"	ENSG00000165704	"Hypoxanthine phosphoribosyltransferase 1"	P00492	X	134460153-134520513	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease mutation, FDA approved drug targets, Gout"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA006360, CAB012200"	Enhanced		Supported	Cytosol			15000000	Cytosol		"CAB012200: AB_297217, HPA006360: AB_1079082"	"unprognostic (2.02e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-3)"	"unprognostic (8.55e-2)"	"prognostic unfavourable (1.35e-5)"	"unprognostic (1.58e-2)"	"unprognostic (4.77e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.00e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.51e-1)"	7.9	14.9	31.0	12.6	30.2	25.3	11.3	24.2	49.8	7.5	13.7	5.8	9.8	11.0	7.9	36.2	10.3	9.4	8.1	12.8	27.6	37.3	18.4	24.7	7.3	15.9	23.5	28.9	9.8	20.2	9.9	18.6	8.8	34.4	8.8	13.2	9.7	7.1	9.5	10.7	8.0	14.2	9.5	9.8	8.7	17.1	39.7	4.9	13.7	12.3	8.6	15.9	10.8	7.5	13.5	19.7	10.1	18.5	19.9	29.3	12.6	31.0	15.0	4.2	8.7	9.5	13.7	12.8	16.6	16.0	21.3	28.0	13.4	19.9	35.2	37.9	10.8	19.1	27.4	22.8	36.8	29.2	51.3	19.1	21.3	13.6	9.4	41.0	17.6	10.1	8.6	18.9	30.3	24.5	14.6	0.9	16.6	31.7	31.6	35.6	8.7	40.3	19.0	21.6	36.1	25.6	15.1	26.9	14.7	12.0	9.7	11.3	8.3	17.2	12.1	14.5	10.9	41.4	41.2	13.4	23.2	0.2	17.8	45.6	7.9	2.2	11.6	10.1	11.6	18.5	16.7	12.3	17.3	15.3	19.7	13.5	14.3	15.1	2.9	19.9	17.2	8.2	29.3	12.6	31.0	30.2	24.2	49.8	27.6	37.3	23.5	28.9	34.4	4.9
PLAC1	"CT92, OOSP2L"	ENSG00000170965	"Placenta specific 1"	Q9HBJ0	X	134565838-134764322	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"placenta: 90.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 18.3;hTCEpi: 14.4;hTERT-HME1: 5.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA063425	Enhanced				"Secreted in female reproductive system"					"HPA063425: "	"unprognostic (2.93e-1)"	"unprognostic (2.50e-3)"	"unprognostic (2.89e-4)"	"unprognostic (1.35e-7)"	"unprognostic (3.83e-3)"	"unprognostic (2.07e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.33e-16)"	"unprognostic (7.64e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.91e-2)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.1	90.4	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.5	0.0	0.0	0.1	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.8	0.0	1.1	0.0	0.2	1.0	0.3	0.3	0.9	0.0	0.2	0.1	1.7	0.3	0.4	18.3	0.0	0.1	0.2	2.2	0.0	0.0	0.8	14.4	0.1	5.8	2.1	0.1	1.6	0.1	0.9	0.0	0.2	0.0	2.4	0.0	0.3	3.2	0.0	0.0	2.8	0.0	0.0	3.4	0.6	0.1	0.0	0.0	0.4	0.7	0.2	0.0	0.4	0.0	0.3	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM122B	"DKFZp686L20116, RP11-308B5.5"	ENSG00000156504	"Family with sequence similarity 122B"	Q7Z309	X	134769566-134797232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000266	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"HPA000266: AB_1078801"	"unprognostic (2.10e-3)"	"unprognostic (1.55e-2)"	"unprognostic (4.53e-3)"	"prognostic unfavourable (7.19e-5)"	"unprognostic (1.67e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.26e-3)"	"unprognostic (2.60e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.19e-3)"	13.4	18.5	24.5	18.4	41.5	27.1	14.8	20.9	29.6	15.7	15.4	22.3	13.4	15.5	23.0	27.7	16.2	20.3	13.6	13.9	22.5	21.8	15.2	9.8	15.5	27.2	22.9	24.7	29.3	15.9	29.0	27.8	17.4	21.3	17.3	23.6	13.3	18.8	17.4	10.3	19.4	19.5	20.3	21.8	26.1	18.5	34.5	20.5	21.4	20.7	11.1	26.5	16.3	16.3	1.6	3.8	5.9	1.2	2.7	3.3	1.1	17.5	16.2	13.0	9.3	6.7	8.8	9.2	13.9	12.3	15.9	15.1	14.3	15.7	17.3	27.7	10.1	11.8	19.2	11.5	28.9	21.3	13.3	17.3	32.4	4.6	4.1	31.7	22.2	5.7	11.4	17.4	7.6	9.2	11.3	22.2	16.7	23.7	19.7	27.6	7.1	17.5	20.0	14.2	15.0	9.7	18.3	11.9	8.4	7.4	10.1	5.1	5.4	16.4	6.5	13.2	8.6	33.6	30.2	12.3	14.1	22.3	14.2	37.0	16.4	0.1	1.2	5.9	2.1	0.5	2.8	1.6	2.0	2.8	1.2	1.5	2.4	3.3	1.3	2.7	1.1	3.8	2.0	1.1	24.5	41.5	20.9	29.6	22.5	21.8	22.9	24.7	21.3	20.5
FAM122C	RP3-473B4.1	ENSG00000156500	"Family with sequence similarity 122C"	Q6P4D5	X	134796395-134854835	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 15.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA059961	Approved		Uncertain	Nucleoplasm				Nucleoplasm		"HPA059961: "	"unprognostic (1.32e-2)"	"unprognostic (3.50e-2)"	"unprognostic (7.63e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.76e-3)"	"unprognostic (3.50e-2)"	"unprognostic (7.20e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.16e-3)"	4.2	3.8	4.1	4.7	6.0	8.7	4.1	2.9	5.0	4.6	3.8	7.9	3.8	1.8	11.5	4.2	3.5	4.7	3.4	3.9	4.0	4.2	3.6	3.2	5.6	7.1	6.3	4.6	22.0	2.1	2.9	5.5	2.9	5.3	4.4	3.2	11.5	6.6	3.2	2.9	3.3	4.0	7.9	6.2	6.4	4.7	12.0	5.2	9.1	3.8	2.1	6.5	5.9	3.5	4.8	7.0	7.3	5.8	4.5	3.8	2.1	1.1	1.5	4.6	4.6	1.2	1.8	2.7	3.9	3.4	3.5	4.9	3.3	4.6	1.6	5.9	1.7	1.7	3.8	1.4	2.5	3.9	1.5	2.7	15.4	1.4	1.4	4.0	2.4	1.9	0.7	3.4	2.2	2.9	11.3	9.0	2.5	7.0	4.1	3.3	2.5	3.4	7.1	3.1	3.3	1.1	1.0	1.8	3.1	2.4	0.7	3.9	1.1	1.1	0.9	2.1	1.4	3.2	2.4	3.4	3.0	6.7	3.0	4.5	2.3	2.7	2.8	7.3	2.6	3.1	2.7	4.8	3.0	3.8	1.9	4.1	3.7	3.3	5.3	4.5	5.8	7.0	2.7	2.1	4.1	6.0	2.9	5.0	4.0	4.2	6.3	4.6	5.3	5.2
MOSPD1	dJ473B4	ENSG00000101928	"Motile sperm domain containing 1"	Q9UJG1	X	134887626-134915267	"Predicted intracellular proteins, Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031158	Approved		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA031158: AB_10603874"	"unprognostic (2.23e-3)"	"unprognostic (3.37e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.36e-1)"	"unprognostic (6.78e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.20e-3)"	"unprognostic (4.27e-2)"	"unprognostic (6.45e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.15e-1)"	11.0	19.7	6.2	6.5	8.0	12.3	7.9	7.8	10.4	11.1	6.9	8.8	5.5	5.4	19.3	12.5	20.5	25.1	6.6	17.4	7.3	6.2	11.8	10.3	8.0	5.5	9.9	7.4	12.9	8.9	10.3	8.1	23.2	21.2	8.1	7.0	10.3	14.6	7.6	17.6	14.5	6.9	10.7	9.0	8.3	7.5	16.4	7.5	10.2	9.1	13.5	10.1	9.5	12.0	6.2	8.3	12.3	6.8	6.0	14.3	5.1	7.9	6.3	5.3	3.6	8.4	4.9	11.6	13.4	24.4	12.9	12.6	15.3	3.2	2.7	18.7	8.5	2.9	8.2	6.9	17.1	8.9	4.8	2.2	16.6	6.2	35.8	6.3	3.9	8.9	8.5	14.5	6.3	9.4	2.8	10.9	15.6	11.1	4.4	2.8	5.4	14.3	3.3	9.4	5.0	5.5	22.8	3.1	3.9	6.8	6.8	23.1	2.7	3.9	4.7	6.4	3.9	23.7	11.9	8.5	11.4	4.3	8.7	10.8	8.3	6.0	6.8	12.3	7.6	5.0	10.0	6.2	9.0	8.3	7.5	5.1	10.2	9.8	4.0	6.0	5.5	8.3	14.3	5.1	6.2	8.0	7.8	10.4	7.3	6.2	9.9	7.4	21.2	7.5
SMIM10	CXorf69	ENSG00000184785	"Small integral membrane protein 10"	"Q96HG1, P0DMW3"	X	134990938-134992473	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 6.6"	"Low lineage specificity"	"Detected in many"																						"unprognostic (2.66e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.22e-4)"	"unprognostic (3.63e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavourable (3.69e-6)"	"unprognostic (1.59e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.28e-2)"	12.6	10.8	6.9	4.7	7.1	10.0	14.8	2.8	4.4	15.5	9.8	5.3	4.3	2.9	12.9	11.0	13.7	11.5	9.9	13.5	6.8	8.1	7.8	1.9	5.9	7.4	11.2	7.8	17.1	2.7	41.0	7.4	3.7	11.6	22.6	4.6	12.5	5.2	11.6	6.9	2.6	5.7	20.2	18.6	13.6	5.4	31.4	6.0	0.2	8.5	4.3	2.1	19.1	17.7	1.5	0.2	3.5	0.6	6.6	0.4	0.2	0.0	0.0	0.0	0.0	9.0	10.9	3.2	4.5	14.8	2.7	4.0	3.7	0.0	0.0	12.0	4.5	0.0	8.3	0.0	3.9	12.3	8.0	13.1	17.1	0.0	7.9	11.7	2.7	14.4	0.0	8.0	0.0	2.1	6.4	0.0	9.4	0.0	0.0	19.0	0.0	0.0	0.0	1.1	0.0	0.7	2.4	2.3	0.0	5.5	0.0	8.1	0.0	8.6	0.4	6.8	4.5	14.3	6.3	0.0	0.0	0.0	5.3	13.1	2.4	2.8	0.6	3.5	0.0	0.4	0.4	0.0	0.0	0.1	0.2	1.5	0.0	0.2	0.0	6.6	0.3	0.0	0.0	0.2	6.9	7.1	2.8	4.4	6.8	8.1	11.2	7.8	11.6	6.0
RTL8B	"CXX1c, FAM127C, MAR8B, SIRH4"	ENSG00000212747	"Retrotransposon Gag like 8B"	Q17RB0	X	135020504-135022529	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 24.0;U-2197: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 4.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.2;monocytes: 4.3;T-cells: 1.4"																				"prognostic unfavourable (2.41e-5)"	"unprognostic (1.13e-2)"	"unprognostic (8.78e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.32e-3)"	"unprognostic (4.34e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (3.72e-4)"	"unprognostic (2.56e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.80e-2)"	16.7	21.4	9.6	7.3	15.8	1.2	14.8	10.4	13.3	19.3	15.3	17.9	11.6	4.6	20.4	12.3	19.8	14.4	12.8	20.3	8.1	9.4	15.6	3.7	12.8	6.6	12.9	9.3	24.1	10.6	16.1	13.0	16.2	12.3	18.7	6.2	16.7	21.3	21.5	9.6	18.4	6.5	19.9	11.7	9.6	11.4	7.7	12.9	0.9	11.8	12.7	8.3	17.7	16.0	0.1	2.2	0.5	4.3	0.0	1.4	1.8	0.0	2.6	8.8	7.1	6.6	4.3	0.0	9.6	13.4	7.8	8.3	4.7	0.3	0.0	24.0	14.0	0.4	1.7	1.2	5.8	0.0	4.7	1.1	8.6	0.0	10.9	0.0	0.0	18.8	1.1	5.9	0.0	5.5	0.0	0.0	13.1	11.3	0.0	0.7	2.5	11.2	0.0	10.1	0.0	8.9	2.1	6.0	14.4	7.4	4.7	3.7	4.0	5.0	7.4	0.0	4.3	30.4	0.2	0.0	0.0	0.0	11.8	0.0	4.8	0.1	4.3	0.1	0.2	2.6	0.0	0.0	0.4	0.5	2.2	0.1	1.4	0.9	0.5	0.0	3.7	1.4	0.0	1.8	9.6	15.8	10.4	13.3	8.1	9.4	12.9	9.3	12.3	12.9
RTL8C	"CXX1, FAM127A, Mar8, MAR8C, Mart8, SIRH5"	ENSG00000134590	"Retrotransposon Gag like 8C"	A6ZKI3	X	135032366-135033546	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"																						"unprognostic (2.89e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.94e-3)"	"prognostic unfavourable (2.69e-4)"	"unprognostic (3.64e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavourable (5.99e-4)"	"unprognostic (8.76e-2)"	"unprognostic (6.77e-2)"	"unprognostic (5.65e-2)"	"prognostic favourable (1.97e-4)"	"unprognostic (2.06e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.02e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.13e-2)"	"unprognostic (6.09e-3)"	50.8	51.4	57.3	20.8	56.4	6.3	20.8	33.0	85.1	45.9	26.9	51.2	16.1	13.9	33.3	24.3	46.6	36.4	26.2	129.8	49.8	63.0	27.3	14.2	27.5	11.1	55.9	49.6	49.6	21.2	21.3	36.2	34.4	78.3	39.8	12.9	31.3	31.9	50.5	75.5	29.0	16.2	54.3	46.1	18.9	19.1	16.1	29.5	1.9	17.8	38.4	10.5	33.9	25.6	13.8	24.1	27.1	37.8	19.9	21.4	15.5	11.9	14.2	14.3	20.6	50.9	59.1	10.1	32.1	25.1	18.8	26.0	11.7	4.6	0.0	40.3	42.5	12.5	13.2	12.9	7.2	8.0	20.8	3.1	24.7	6.5	30.2	0.0	6.5	63.6	17.2	21.2	5.5	22.5	5.0	0.0	31.5	23.0	0.0	8.7	5.9	26.8	0.0	15.2	0.1	19.8	5.6	10.7	25.6	11.0	8.3	14.8	5.4	5.5	26.9	26.2	9.6	63.1	23.3	4.0	3.0	0.0	36.4	3.1	13.9	10.4	30.9	27.1	19.7	37.8	15.1	9.6	16.1	20.1	22.4	13.8	19.1	21.4	7.7	19.9	30.7	24.1	15.8	15.5	57.3	56.4	33.0	84.7	49.8	63.0	55.9	49.6	78.3	29.5
RTL8A	"CXX1b, DKFZP564B147, FAM127B, MAR8A, SIRH6"	ENSG00000203950	"Retrotransposon Gag like 8A"	Q9BWD3	X	135050932-135052196	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 53.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"																						"unprognostic (2.10e-2)"	"prognostic favourable (5.35e-4)"	"unprognostic (2.07e-3)"	"prognostic unfavourable (2.83e-4)"	"unprognostic (9.91e-2)"	"unprognostic (1.63e-2)"	"prognostic unfavourable (1.10e-5)"	"unprognostic (2.16e-2)"	"unprognostic (4.48e-1)"	"prognostic favourable (2.71e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.57e-2)"	26.6	22.1	24.1	13.3	33.5	9.0	26.6	32.7	35.2	24.3	21.1	27.7	14.6	20.1	27.6	17.6	34.1	25.9	20.8	31.8	22.5	26.7	27.6	15.7	21.8	12.9	23.2	21.2	42.7	22.0	15.2	28.6	20.7	24.4	28.6	12.4	21.9	31.5	36.2	17.6	36.8	18.5	27.5	24.5	18.5	23.8	11.5	19.3	8.0	27.2	19.2	14.9	27.5	23.1	4.1	9.0	16.5	19.6	2.6	6.3	5.3	15.3	17.6	8.6	18.9	9.1	7.8	14.6	7.0	5.3	13.9	15.2	18.2	6.0	0.0	17.1	8.6	9.6	4.4	9.9	4.5	5.1	20.0	3.5	17.7	0.0	22.4	0.9	4.3	15.1	16.8	14.2	6.4	10.2	4.9	0.0	6.3	53.3	1.0	9.4	4.8	19.9	3.2	10.1	0.0	2.7	7.9	17.4	23.3	7.8	4.7	14.8	5.4	2.4	12.0	10.5	10.2	21.5	14.3	2.5	3.9	0.0	6.2	4.3	8.3	16.5	13.1	13.2	5.0	17.3	4.0	3.0	5.0	6.0	9.0	4.1	5.8	6.3	3.2	2.6	19.6	7.5	3.3	5.3	24.1	33.5	32.7	35.2	22.5	26.7	23.2	21.2	24.4	19.3
SMIM10L2B	"LINC00087, NCRNA00087, RP11-85L21.2"	ENSG00000196972	"Small integral membrane protein 10 like 2B"	P0DMW5	X	135094987-135098634	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 17.5;heart muscle: 9.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.2;HHSteC: 4.4;HSkMC: 6.9;NTERA-2: 3.7"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (2.60e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.18e-3)"	"unprognostic (7.25e-3)"	"unprognostic (9.55e-2)"	"unprognostic (5.90e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.54e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.13e-2)"	"prognostic favourable (2.41e-5)"	"unprognostic (2.03e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.98e-2)"	1.0	3.6	4.9	0.2	8.6	0.0	1.0	2.8	17.5	1.8	0.4	1.3	0.0	0.2	2.2	2.2	0.9	2.7	0.6	9.5	6.6		2.9	0.5	1.2	0.1	0.0	7.5	5.0	0.7	5.0	0.0	0.1	12.3	3.4	0.2	1.3	3.0	2.3	0.6	1.5	0.1	1.3	1.6	0.6	0.5	3.6	0.9	0.0	1.5	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	3.0	2.7	4.2	0.6	1.4	0.9	0.5	0.4	0.7	1.3	0.0	0.0	0.5	0.5	0.3	1.0	1.0	0.1	0.0	0.9	0.1	0.2	0.1	4.4	0.0	0.2	6.9	0.4	0.1	0.3	0.3	0.1	0.0	0.3	0.1	0.8	0.1	3.7	0.4	0.0	0.8	0.1	1.7	0.5	1.4	0.4	0.6	0.3	0.0	0.0	0.5	0.0	0.2	1.1	0.4	0.1	0.3	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0										
ETDB	LINC00633	ENSG00000224107	"Embryonic testis differentiation homolog B"		X	135118955-135120526	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	29	"testis: 13.5"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.0;SH-SY5Y: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.4	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	13.5			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT55	"CXorf48, FLJ20527"	ENSG00000169551	"Cancer/testis antigen 55"	Q8WUE5	X	135156536-135171398	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"testis: 9.2"	"Cell line enriched"	"Detected in single"	14	"K-562: 12.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059575			Approved	Vesicles	"Secreted in male reproductive system"			Vesicles		"HPA059575: "	"unprognostic (6.20e-2)"				"unprognostic (1.39e-1)"			"unprognostic (8.36e-2)"		"unprognostic (5.86e-3)"			"unprognostic (3.47e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.49e-1)"		0.1	0.2	0.5	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0			0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.1	0.2		0.1	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	9.2			0.2		0.0	0.0	0.0	0.8	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	12.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.2	0.6	0.8	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0										
ZNF75D	"D8C6, ZKSCAN24, ZNF75, ZNF82, ZSCAN28"	ENSG00000186376	"Zinc finger protein 75D"	P51815	X	135248920-135344087	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA004705	Supported		Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"HPA004705: AB_1080749"	"unprognostic (1.56e-3)"	"unprognostic (7.96e-3)"	"unprognostic (3.07e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.00e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.32e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.13e-2)"	"prognostic favourable (1.31e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-1)"	"prognostic favourable (7.42e-5)"	8.4	18.8	8.2	14.6	9.7	9.2	9.9	11.4	10.5	11.8	10.6	9.2	10.4	6.9	10.7	12.8	7.6	9.8	7.9	7.6	5.6	7.7	10.6	13.4	9.7	11.2	6.2	7.7	10.1	12.9	12.6	14.7	8.0	9.2	15.0	8.4	7.5	10.0	11.8	6.6	9.9	10.6	7.5	5.9	18.6	9.7	3.4	6.7	16.6	13.2	9.3	13.3	8.0	8.6	3.7	1.8	4.1	2.1	5.2	6.5	2.9	3.4	4.6	5.0	8.0	8.5	10.4	7.6	5.9	8.0	4.8	10.3	2.8	4.4	3.6	8.7	5.0	4.8	16.3	2.6	4.6	3.5	4.3	2.5	8.3	3.6	3.7	4.2	7.2	5.1	6.4	3.0	3.7	4.9	2.1	5.8	4.2	8.3	5.1	7.7	2.4	6.2	4.9	5.0	3.2	5.4	4.8	1.7	5.7	3.3	5.7	0.9	2.0	6.1	5.1	4.6	1.1	7.7	5.5	2.9	4.1	2.7	2.9	4.7	2.9	4.1	2.1	3.7	4.9	1.5	4.5	2.9	5.2	5.6	1.8	3.7	6.5	5.9	2.6	5.2	1.5	1.6	6.3	2.9	8.2	9.7	11.4	10.5	5.6	7.7	6.2	7.7	9.2	6.7
ETDA		ENSG00000238210	"Embryonic testis differentiation homolog A"		X	135252061-135253583	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	11	"testis: 11.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.3;Daudi: 1.4;HEL: 1.1;MCF7: 1.1;PC-3: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																															"unprognostic (5.34e-1)"								0.0	0.0		0.0		0.4	0.0		0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.2	0.0			0.0	0.0	0.1	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.1	0.0	0.0	1.0	0.0	0.0		0.0	0.0	11.4			0.1		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.4	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ETDC		ENSG00000283644	"Embryonic testis differentiation homolog C"		X	135309480-135309659	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"bone marrow: 2.2;seminal vesicle: 2.9;skin 1: 3.9"	"Group enriched"	"Detected in some"	30	"HeLa: 3.6;SK-MEL-30: 3.6;U-937: 1.7"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		2.2	0.0		0.0	0.0	0.9			0.0	0.0	0.0	0.5	0.0	0.0	0.0			0.0	1.2	0.0	0.3			0.6	0.0	0.0		0.0		0.1	0.0		0.0	2.9	0.0	3.9	0.0	0.0		0.2	0.2	0.0			1.1		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9										
ZNF449	"FLJ23614, ZSCAN19"	ENSG00000173275	"Zinc finger protein 449"	Q6P9G9	X	135344796-135363152	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018079	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"			"Nucleoplasm, Cytosol"		"HPA018079: AB_1859277"	"unprognostic (5.51e-3)"	"unprognostic (1.64e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.61e-2)"	"unprognostic (4.22e-2)"	13.7	15.8	5.3	6.7	10.4	1.9	11.6	7.5	10.8	10.1	7.2	6.0	4.8	5.0	14.0	10.9	7.5	6.0	8.6	8.3	5.0	6.1	6.1	5.0	7.3	5.8	6.3	9.6	9.7	16.1	12.5	9.8	11.0	12.2	9.6	5.5	6.6	8.6	7.5	7.6	5.8	5.3	12.4	5.0	9.5	7.6	4.8	4.7	5.3	10.6	4.6	6.4	12.1	8.9	1.5	2.6	3.6	6.6	5.6	5.7	2.2	2.8	4.2	8.5	7.0	7.8	15.6	4.2	5.6	4.3	3.6	8.8	1.4	3.9	1.7	7.3	4.4	3.3	6.0	2.5	5.8	2.4	5.0	2.4	4.1	2.1	5.9	1.9	3.6	5.9	7.5	3.0	9.0	6.8	2.3	2.0	10.2	1.6	2.4	2.1	2.9	4.6	2.0	5.7	2.7	5.3	1.7	2.0	5.1	1.3	4.1	4.2	3.0	2.1	6.6	8.3	3.1	5.6	4.9	1.6	1.9	1.4	3.3	3.2	5.3	1.7	2.7	3.6	3.0	3.4	5.7	1.5	2.7	4.1	2.6	1.1	2.6	2.6	0.6	5.6	6.6	1.5	2.4	2.2	5.3	10.4	7.5	10.8	5.0	6.1	6.3	9.6	12.2	4.7
SMIM10L2A	"LED, LINC00086, LINC0086, MGC39606, NCRNA00086"	ENSG00000178947	"Small integral membrane protein 10 like 2A"	P0DMW4	X	135421943-135428074	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 15.2;brain: 16.3;epididymis: 13.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.7;CACO-2: 3.3;HAP1: 13.5;hTCEpi: 7.2;PC-3: 3.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 15.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (4.22e-2)"	"unprognostic (4.72e-2)"	"unprognostic (4.50e-2)"	"prognostic unfavourable (6.78e-4)"	"unprognostic (8.62e-3)"	"unprognostic (5.83e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.36e-1)"	"prognostic favourable (8.28e-8)"	"unprognostic (5.29e-2)"	"unprognostic (3.26e-1)"	"unprognostic (7.37e-3)"	"unprognostic (2.28e-2)"	0.4	15.2	3.6	0.1	9.6	0.0	1.4	1.6	16.3	0.9	0.0	1.9	0.2	0.0	1.1	13.3	0.6	1.9	0.2	2.4	4.5		3.8	0.0	1.6	0.2	0.4	7.2	4.1	2.5	2.1	0.2	0.0	5.7	1.7	0.1	0.7	2.3	1.5	0.0	1.8	0.0	0.5	1.3	2.3	0.7	5.3	1.4	0.0	3.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.2	0.3	6.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	1.0	0.1	0.0	13.5	1.7	0.0	0.0	1.2	0.2	0.0	0.0	0.2	0.0	0.5	0.6	7.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.0	1.4	3.1	0.1	0.0	0.0	2.0	0.2	0.4	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0										
INTS6L	"DDX26B, FLJ41215"	ENSG00000165359	"Integrator complex subunit 6 like"	Q5JSJ4	X	135520643-135582510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 16.1;U-937: 15.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA001552, HPA013200, HPA013335, HPA030747"	Uncertain		Approved	"Nuclear bodies,Centrosome,Mitochondria"				Centrosome	"Nuclear bodies, Mitochondria"	"HPA001552: AB_1078659, HPA013200: , HPA013335: AB_1847553, HPA030747: "	"unprognostic (2.03e-1)"	"prognostic favourable (5.39e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.33e-3)"	"prognostic favourable (5.54e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavourable (4.28e-8)"	"unprognostic (2.87e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.37e-2)"	"prognostic favourable (2.94e-4)"	4.2	9.8	5.5	10.6	6.7	15.4	5.4	22.6	6.1	8.4	7.8	7.4	3.8	3.6	7.8	4.6	6.4	8.6	6.6	5.9	4.8	3.2	4.4	1.7	5.6	15.6	6.8	6.2	11.5	2.9	3.7	11.5	4.5	6.5	6.5	10.0	5.3	18.2	7.9	1.5	8.3	9.3	5.4	4.9	13.3	4.5	9.7	10.4	17.8	4.6	2.8	15.0	8.6	7.5	5.5	3.6	2.2	2.7	2.7	9.0	4.0	0.1	0.0	6.1	7.1	1.8	2.1	0.0	1.5	3.2	1.8	5.5	0.5	2.6	6.1	5.2	1.3	4.5	6.8	2.0	1.3	4.5	2.5	5.0	0.5	0.0	1.6	5.2	0.4	2.7	2.0	2.1	2.0	2.3	3.2	9.6	1.3	4.4	5.1	16.1	2.8	2.5	4.2	2.1	4.9	1.4	2.5	1.0	2.2	2.0	2.1	0.2	2.2	9.8	1.2	4.7	2.7	0.0	1.7	11.1	8.7	9.0	1.5	15.0	0.9	0.0	2.5	2.2	5.1	2.2	6.1	5.5	5.8	5.9	3.6	4.9	9.0	5.8	1.6	2.7	2.7	3.5	3.1	4.0	5.5	6.7	22.6	6.1	4.8	3.2	6.8	6.2	6.5	10.4
CT45A1	"CT45-1, CT45.1"	ENSG00000268940	"Cancer/testis antigen family 45 member A1"	Q5HYN5	X	135713453-135723539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	17	"testis: 12.5"	"Group enriched"	"Detected in some"	7	"HMC-1: 68.4;Karpas-707: 31.7"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA044735: , HPA044757: , HPA046872: , HPA046987: "										"unprognostic (6.58e-3)"					"unprognostic (2.14e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.4	0.0	0.0	0.0	0.0	0.0	0.5	31.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	6.4	0.0	0.0	0.5	6.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT45A3	"CT45-3, CT45-4, CT45.3, CT45.4, CT45A4"	ENSG00000269096	"Cancer/testis antigen family 45 member A3"	Q8NHU0	X	135759846-135768191	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	13	"testis: 15.6"	"Cell line enhanced"	"Detected in some"		"HMC-1: 29.2;T-47d: 17.1;U-266/84: 88.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA044735: , HPA044757: , HPA046872: , HPA046987: "																		0.0	0.0		0.0		0.0	0.0		0.5	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	1.1	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	15.6			0.0		0.0	0.0		0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.1	0.0	0.0	0.6	0.0	0.0	0.1	88.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT45A5	"CT45-5, CT45.5"	ENSG00000228836	"Cancer/testis antigen family 45 member A5"	P0DMU8	X	135777130-135785298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	14	"testis: 10.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 17.9;Karpas-707: 12.5;U-266/84: 64.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA044735: , HPA044757: , HPA046872: , HPA046987: "																		0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.5			0.0		0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.0	1.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	2.4	0.0	0.0	0.9	64.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT45A6	"CT45-6, CT45.6"	ENSG00000278289	"Cancer/testis antigen family 45 member A6"	P0DMU7	X	135794706-135802656	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	5	"testis: 2.9"	"Cell line enriched"	"Detected in some"	9	"U-266/84: 46.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA044735: , HPA044757: , HPA046872: , HPA046987: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0	0.0	0.6	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	2.9			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT45A2	"CT45-2, CT45.2"	ENSG00000271449	"Cancer/testis antigen family 45 member A2"	Q5DJT8	X	135811668-135820012	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	42	"testis: 4.2"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 32.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA044735: , HPA044757: , HPA046872: , HPA046987: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	4.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.0	0.0	0.0	0.0	0.0	0.0	3.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT45A7		ENSG00000273696	"Cancer/testis antigen family 45 member A7"	P0DMV0	X	135829247-135837268	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	5	"testis: 4.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 4.0;Karpas-707: 3.4;PC-3: 1.0;THP-1: 1.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA044735: , HPA044757: , HPA046872: , HPA046987: "																		0.4	0.0		0.0		0.0	0.0		0.8	0.0	0.0			0.1	0.0	0.0	0.5	0.0	0.0	0.0			0.0	0.0	0.6	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	4.1			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.7	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT45A8		ENSG00000278085	"Cancer/testis antigen family 45 member A8"	P0DMV1	X	135846499-135854538	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	16	"testis: 3.9"	"Group enriched"	"Detected in some"	5	"AN3-CA: 13.8;HMC-1: 29.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA044735: , HPA044757: , HPA046872: , HPA046987: "																		0.0	0.0		0.0		0.0	0.0		0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	3.9			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT45A9		ENSG00000270946	"Cancer/testis antigen family 45 member A9"	P0DMV2	X	135863776-135871812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	17	"testis: 4.0"	"Cell line enriched"	"Detected in some"	9	"HMC-1: 54.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA044735: , HPA044757: , HPA046872: , HPA046987: "																		0.0	0.0		0.0		0.0	0.0		0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	4.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT45A10		ENSG00000269586	"Cancer/testis antigen family 45 member A10"	P0DMU9	X	135881063-135889086	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	21	"testis: 14.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 32.5;K-562: 9.7;Karpas-707: 36.1;U-266/84: 30.3"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA044735: , HPA044757: , HPA046872: , HPA046987: "					"unprognostic (3.55e-1)"					"unprognostic (7.08e-3)"					"unprognostic (2.08e-1)"			0.0	0.0		0.0		0.0	0.0		0.6	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	14.1			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	9.7	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	7.1	30.3	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SAGE1	"CT14, SAGE"	ENSG00000181433	"Sarcoma antigen 1"	Q9NXZ1	X	135889205-135913061	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"testis: 10.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 14.7;K-562: 10.6;Karpas-707: 18.4;U-2 OS: 5.2;U-266/70: 6.4;U-266/84: 16.1"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA003033, HPA003208"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA003033: AB_1079865, HPA003208: AB_1079863"				"unprognostic (1.11e-1)"	"unprognostic (5.26e-2)"			"unprognostic (1.15e-1)"		"unprognostic (1.02e-2)"	"unprognostic (2.37e-1)"		"unprognostic (7.12e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.10e-1)"			0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3		0.0	0.0	0.0	0.4	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	10.9			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	6.4	16.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MMGT1	"EMC5, TMEM32"	ENSG00000169446	"Membrane magnesium transporter 1"	Q8N4V1	X	135962070-135974063	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA032037	Approved									"HPA032037: AB_10670705"	"prognostic unfavourable (8.54e-4)"	"unprognostic (2.18e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.23e-3)"	"unprognostic (8.94e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.87e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.38e-1)"	"prognostic favourable (1.94e-5)"	"unprognostic (6.08e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.29e-2)"	25.6	13.4	12.2	11.4	21.3	25.6	16.7	13.7	22.7	19.5	18.7	17.0	10.0	12.5	24.8	17.9	18.5	17.0	15.4	18.0	12.1	18.0	19.4	10.7	18.8	19.2	14.4	12.3	18.6	14.8	18.4	20.8	13.5	15.8	17.5	17.1	17.2	16.5	15.6	28.0	14.2	13.9	21.0	18.8	14.5	16.5	7.2	9.8	23.3	23.6	12.9	14.2	24.6	15.3	8.6	11.7	9.7	14.3	10.7	15.3	9.7	13.6	8.2	8.4	13.2	17.5	16.9	10.9	15.4	14.9	13.0	25.9	9.6	21.3	9.0	30.6	16.6	12.4	21.1	11.5	20.3	10.1	12.1	5.6	10.6	6.1	12.9	12.6	9.9	13.7	20.8	21.9	16.0	9.7	7.6	18.9	14.7	14.2	9.3	8.5	5.9	12.9	8.6	13.4	16.9	12.0	7.4	12.3	11.2	8.2	9.9	21.1	8.3	7.7	9.9	16.0	9.5	23.3	20.7	11.6	16.2	9.8	13.7	18.8	18.3	9.7	12.3	7.2	9.5	12.5	12.5	8.6	13.1	11.5	11.7	6.2	12.8	12.2	6.2	10.7	14.3	8.0	15.3	9.7	12.2	21.3	13.7	22.7	12.1	18.0	14.4	12.3	15.8	9.8
SLC9A6	"KIAA0267, NHE6"	ENSG00000198689	"Solute carrier family 9 member A6"	Q92581	X	135973841-136047269	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059445, HPA059590"	Enhanced		Supported	Vesicles				Vesicles		"HPA059445: , HPA059590: "	"unprognostic (1.35e-1)"	"unprognostic (8.28e-3)"	"unprognostic (4.36e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.07e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.49e-2)"	"unprognostic (5.06e-2)"	4.3	5.7	16.4	4.7	27.6	4.0	3.1	15.3	35.1	5.2	5.2	7.8	1.6	7.5	5.7	3.2	5.6	5.2	4.8	7.2	19.1	24.3	6.2	3.9	5.7	4.7	15.0	15.6	7.4	3.3	9.3	8.6	4.0	22.3	3.6	5.5	4.6	3.3	4.6	5.5	4.1	6.5	6.5	9.5	4.8	5.2	5.1	4.0	3.6	5.9	1.7	5.8	4.7	3.2	5.3	6.8	3.2	8.4	5.9	13.9	6.0	13.0	6.9	7.3	2.7	10.4	10.1	13.1	10.5	11.3	9.1	19.3	6.0	10.5	9.7	24.1	12.1	7.8	9.4	9.4	13.2	7.6	8.6	2.6	11.0	3.5	5.5	7.6	9.2	5.6	8.4	15.0	7.5	7.7	4.8	14.0	10.0	5.8	10.0	2.2	4.1	9.4	6.8	10.9	9.9	6.5	6.6	6.5	4.9	7.6	0.8	6.1	3.2	5.9	10.9	11.3	8.1	16.8	13.6	6.7	14.9	8.6	6.9	13.0	6.3	2.2	6.0	3.2	8.1	8.4	13.9	5.3	9.5	7.9	6.8	4.0	10.6	7.9	2.6	5.9	6.6	4.3	8.0	6.0	16.4	27.6	15.3	25.9	19.1	24.3	15.0	15.6	22.3	4.0
FHL1	"bA535K18.1, FHL1B, FLH1A, KYO-T, MGC111107, SLIM1, XMPMA"	ENSG00000022267	"Four and a half LIM domains 1"	Q13642	X	136146702-136211359	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease mutation, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 557.6;tongue: 239.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 57.7;fHDF/TERT166: 52.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 20.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 12.5;NK-cells: 20.6;T-cells: 11.4"	"Low region specificity"	"Detected in all"							"HPA001040, HPA001391, CAB020817"	Enhanced		Supported	"Plasma membrane,Cytosol"			18000000	Cytosol	"Plasma membrane"	"CAB020817: , HPA001040: AB_1848541, HPA001391: AB_1848542"	"unprognostic (2.16e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.34e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (4.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.05e-3)"	"prognostic unfavourable (2.11e-4)"	61.9	4.1	7.6	11.0	9.5	0.7	30.6	6.3	7.2	31.5	30.6	3.9	10.0	5.0	25.5	27.7	43.2	14.2	11.7	79.0	6.1	8.1	3.3	2.5	13.7	2.5	5.5	8.1	6.7	2.4	13.4	5.0	13.5	4.4	23.4	10.0	13.5	16.5	30.1	557.6	4.9	11.4	77.7	4.3	2.5	22.1	5.7	3.0	0.6	18.2	239.4	22.1	47.0	14.3	3.4	12.5	0.7	0.4	20.6	11.4	6.2	0.0	9.4	13.1	12.3	28.5	11.5	0.2	36.7	57.7	7.3	17.8	0.0	2.7	0.1	12.8	52.2	0.1	25.3	31.3	6.2	0.1	29.2	0.1	7.8	0.0	26.7	0.0	6.1	21.4	5.1	8.9	28.1	7.7	0.0	5.5	17.2	0.4	5.1	0.3	4.0	11.1	14.4	0.5	7.8	0.2	0.0	9.2	13.8	1.3	0.0	2.6	0.0	0.5	21.6	34.1	15.8	1.3	9.2	1.4	3.2	0.2	2.5	0.2	3.8	0.0	0.4	0.0	3.2	0.0	8.6	3.4	11.4	4.5	1.8	2.3	7.6	2.3	0.7	20.6	0.0	12.5	1.2	6.2	7.6	9.5	6.3	7.2	6.1	8.1	5.5	8.1	4.4	3.0
MAP7D3	FLJ12649	ENSG00000129680	"MAP7 domain containing 3"	Q8IWC1	X	136213220-136256482	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA035598, HPA058101"	Approved		Enhanced	Centrosome				Centrosome		"HPA035598: AB_10671108, HPA058101: "	"unprognostic (2.89e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavourable (9.00e-5)"	"unprognostic (8.83e-3)"	"unprognostic (3.77e-3)"	"unprognostic (4.16e-5)"	"unprognostic (5.35e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.20e-2)"	"unprognostic (9.91e-2)"	"prognostic unfavourable (7.91e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (5.38e-5)"	26.1	4.8	2.9	9.3	3.8	4.5	21.2	0.9	2.2	14.3	9.0	1.7	6.8	2.2	11.4	12.3	10.6	13.7	6.7	17.7	2.7	1.9	9.9	6.5	6.9	6.4	4.1	1.1	23.6	2.8	8.3	14.1	32.6	5.5	9.4	3.5	4.6	3.8	8.6	27.9	5.3	6.2	15.3	6.5	11.8	6.5	16.0	3.1	9.5	9.6	10.2	4.9	13.9	14.6	9.8	6.2	5.9	9.2	8.4	9.3	3.9	15.4	5.5	4.2	7.2	9.5	10.0	5.8	15.0	8.3	12.3	17.0	5.5	7.8	8.0	24.3	13.1	7.5	12.2	8.0	16.9	7.3	12.2	4.8	8.8	0.0	10.5	11.8	5.0	20.3	4.6	12.6	15.7	9.6	4.1	12.7	9.1	9.8	13.9	4.5	5.9	0.1	13.8	11.4	4.0	0.4	2.4	3.0	6.3	8.7	3.3	5.4	0.0	5.4	28.5	13.2	7.6	16.7	19.0	8.6	10.3	9.2	9.0	19.8	6.2	5.9	4.8	1.4	7.5	5.5	9.3	9.8	7.1	8.2	5.8	8.5	7.6	6.0	1.0	8.4	9.2	6.2	5.0	3.9	2.9	3.8	0.9	2.2	2.7	1.9	4.1	1.1	5.5	3.1
ADGRG4	"GPR112, PGR17, RP1-299I16"	ENSG00000156920	"Adhesion G protein-coupled receptor G4"	Q8IZF6	X	136300963-136416888	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	21	"intestine: 23.6"	"Cell line enhanced"	"Detected in single"		"TIME: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA035324	Uncertain									"HPA035324: AB_10671512"											"unprognostic (3.40e-3)"		"unprognostic (7.68e-5)"	"unprognostic (7.61e-2)"				0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	12.9	0.0	0.0	7.1	0.7	1.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.0	23.6	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BRS3	"BB3, BB3R"	ENSG00000102239	"Bombesin receptor subtype 3"	P32247	X	136487887-136493780	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"epididymis: 27.4"	"Cell line enhanced"	"Detected in single"		"U-266/70: 1.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basal ganglia: 3.6;hypothalamus: 2.8"	"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.2;naive CD8 T-cell: 1.0"	"Group enriched"	"Detected in many"	11	"B-cells: 1.2;T-cells: 1.0"	"Group enriched"	"Detected in some"	9	"basal ganglia: 1.6;hypothalamus: 7.1"	"Low region specificity"	"Detected in all"															"unprognostic (1.49e-1)"			"unprognostic (1.31e-1)"					"unprognostic (2.07e-1)"	"unprognostic (1.79e-2)"		"unprognostic (3.73e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.86e-1)"		"unprognostic (5.59e-2)"	0.1	0.1	0.1	0.1	3.6	0.0	0.5	0.4	0.4	0.3	0.1	0.1	0.1	0.0	0.2	27.4	0.1	2.4	0.1	0.1	0.1	2.8	0.1	0.1	0.1	0.1	0.1	0.1	2.9	0.3	0.0	0.3	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.2	0.1	0.0	0.9	0.1	0.1	0.1	0.1	0.1	0.2	0.1	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	0.4	0.4	0.1	2.8	0.1	0.1	0.3	0.1
HTATSF1	TAT-SF1	ENSG00000102241	"HIV-1 Tat specific factor 1"	O43719	X	136497079-136512346	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000504	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA000504: AB_10752094"	"unprognostic (3.56e-2)"	"prognostic favourable (3.78e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.72e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.37e-2)"	"prognostic favourable (8.13e-8)"	"unprognostic (7.12e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.05e-1)"	14.5	40.9	26.2	11.8	24.7	18.3	19.6	29.5	22.2	15.2	13.4	19.4	12.9	9.6	15.9	24.7	12.3	14.5	11.5	25.2	23.8	29.9	17.5	12.7	10.4	12.1	26.9	17.6	25.5	10.9	25.6	71.7	21.2	21.4	15.1	14.2	11.9	10.6	16.6	72.2	13.6	9.8	14.4	28.1	10.2	12.4	15.8	19.0	14.5	19.4	22.6	13.3	12.7	12.9	17.1	14.1	19.2	16.1	23.6	24.9	13.1	42.8	22.9	29.1	20.6	21.7	16.4	25.7	19.9	17.7	17.0	16.6	13.6	19.3	32.3	48.4	19.3	18.6	35.2	14.8	22.2	24.6	29.9	20.1	29.0	16.7	12.0	37.8	16.4	14.5	19.4	18.7	11.5	17.3	18.5	23.9	21.9	31.9	37.6	32.5	16.8	34.1	29.7	36.2	29.4	18.3	30.4	20.6	32.0	18.8	15.8	15.6	11.7	27.2	16.6	20.8	15.7	23.5	35.6	14.0	19.2	26.9	13.3	53.9	14.6	19.2	10.1	16.4	21.9	10.5	24.4	17.1	24.1	22.2	14.1	15.9	24.9	22.2	3.4	23.6	16.1	10.3	24.0	13.1	26.2	24.7	29.5	22.2	23.8	29.9	26.9	17.6	21.4	19.0
VGLL1	"TDU, TONDU"	ENSG00000102243	"Vestigial like family member 1"	Q99990	X	136532152-136556807	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 124.6"	"Cell line enhanced"	"Detected in some"		"A-431: 24.7;BEWO: 38.1;CAPAN-2: 13.9;RT4: 65.4;SK-BR-3: 64.3"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 47.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA042403, HPA064616"	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA042403: , HPA064616: "	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavourable (4.54e-4)"		"unprognostic (5.16e-2)"		"unprognostic (1.80e-1)"	"unprognostic (4.28e-1)"	"unprognostic (6.14e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.37e-2)"		"unprognostic (5.53e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	2.6	0.1	0.1	0.5	0.1	0.1	0.2	0.0	0.1	0.7	1.4	0.4	0.3	0.1	0.1	0.0	3.7	0.1	0.9	0.1	0.1	0.1	0.2	0.6	0.0	1.3	124.6	0.1	2.8	0.0	0.1	5.0	2.3	0.1	0.1	0.1	0.6	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.7	19.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	38.1	0.0	0.0	0.0	0.0	3.7	13.9	0.0	0.0	0.0	1.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.4	0.0	0.0	0.0	64.3	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CD40LG	"CD154, CD40L, gp39, hCD40L, HIGM1, IMD3, TNFSF5, TRAP"	ENSG00000102245	"CD40 ligand"	P29965	X	136648193-136660390	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 29.2;intestine: 8.7;lymphoid tissue: 33.7"	"Cell line enriched"	"Detected in single"	72	"MOLT-4: 22.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdT-cell: 9.4;MAIT T-cell: 22.9;memory CD4 T-cell: 29.2;naive CD4 T-cell: 28.1"	"Lineage enriched"	"Detected in single"	58	"T-cells: 29.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045827	Enhanced				"Secreted to blood"	433000				"HPA045827: AB_10959606"	"unprognostic (1.94e-5)"	"unprognostic (1.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.71e-2)"	"unprognostic (3.56e-5)"	"unprognostic (3.66e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.14e-4)"	"unprognostic (1.87e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.70e-4)"	"unprognostic (2.15e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.36e-3)"	"unprognostic (2.92e-2)"	2.0	0.5	0.3	22.4	0.3	1.4	1.2	0.3	0.3	2.0	3.3	0.1	0.0	1.7	1.5	1.3	1.6	1.6	2.6	1.1	0.4	0.4	1.6	1.1	4.0	14.6	0.4	0.0	0.7	0.6	0.0	0.4	0.2	0.3	1.0	3.1	1.0	4.9	1.3	0.4	1.1	8.7	0.5	0.6	9.9	1.7	0.6	0.1	33.7	1.4	2.0	26.1	3.0	1.4	0.0	0.0	0.5	0.0	0.2	29.2	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	9.4	0.0	22.9	0.0	29.2	4.1	0.0	0.0	28.1	0.2	0.5	0.2	0.0	0.0	3.3	4.7	0.3	0.3	0.3	0.3	0.4	0.4	0.4	0.0	0.3	0.1
ARHGEF6	"alpha-PIX, alphaPIX, Cool-2, Cool2, KIAA0006, MRX46"	ENSG00000129675	"Rac/Cdc42 guanine nucleotide exchange factor 6"	Q15052	X	136665547-136782088	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 21.7;HL-60: 27.0;HMC-1: 103.2;U-937: 29.0"	"Cancer enhanced"	"Detected in all"		"glioma: 24.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003578	Approved		Approved	Cytosol				Cytosol		"HPA003578: AB_1078203"	"unprognostic (9.64e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.06e-3)"	"unprognostic (9.08e-2)"	"unprognostic (7.87e-3)"	"unprognostic (4.21e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.69e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.28e-3)"	22.0	10.4	16.9	15.3	15.4	14.8	13.9	6.4	14.6	6.4	8.3	12.8	3.7	4.0	8.4	6.1	4.4	4.5	9.5	27.0	21.7	13.6	5.0	4.5	13.8	20.6	20.7	10.2	9.5	2.7	8.8	4.8	24.4	15.1	6.4	6.3	8.4	6.2	5.1	37.5	4.3	9.6	9.3	14.6	20.2	6.4	3.2	14.6	2.6	4.1	8.6	20.5	8.8	7.9	3.1	8.8	31.5	8.8	5.5	9.9	6.2	0.2	0.0	1.0	0.0	2.2	5.8	0.0	0.3	1.8	0.3	1.6	0.0	0.0	1.0	0.4	1.5	0.1	1.2	0.0	0.3	5.0	0.3	21.7	0.0	0.0	0.8	27.0	103.2	6.2	0.0	1.0	0.0	0.5	0.1	4.3	3.9	0.0	12.7	16.6	0.9	0.4	4.8	7.3	0.0	0.3	5.4	0.0	1.3	0.0	0.2	0.7	0.6	11.3	0.1	1.5	0.2	1.8	1.3	0.7	0.0	10.4	6.9	29.0	2.0	20.2	7.2	31.5	6.8	8.8	8.0	3.1	7.6	5.5	8.8	2.6	7.0	6.1	4.2	5.5	6.8	2.8	9.9	6.2	16.9	15.4	6.4	14.0	21.7	13.6	20.7	10.2	15.1	14.6
RBMX	"hnRNP-G, HNRNPG, RNMX"	ENSG00000147274	"RNA binding motif protein, X-linked"	P38159	X	136848004-136880764	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"	"Cancer-related genes, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057707	Supported		Approved	Nucleoplasm				Nucleoplasm		"HPA057707: "	"unprognostic (1.53e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.62e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavourable (5.16e-6)"	"unprognostic (5.59e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.68e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.64e-3)"	31.0	25.0	30.6	57.1	41.1	48.0	40.6	28.7	33.0	44.2	28.3	32.5	32.7	24.6	45.9	31.7	26.7	38.9	22.1	31.4	26.5	18.0	25.6	20.9	34.4	64.6	34.0	29.3	81.9	39.1	30.1	30.1	25.3	30.5	28.4	33.4	27.5	29.9	29.4	50.0	27.6	27.3	43.0	44.2	27.4	30.1	23.6	29.2	70.1	31.5	34.4	44.8	36.1	33.4	47.1	41.9	25.0	44.9	39.4	60.7	62.9	39.9	43.7	80.1	35.6	20.0	34.0	46.8	39.9	43.5	55.3	58.7	46.6	40.2	72.8	41.3	28.5	26.8	85.0	41.7	64.1	31.4	40.0	55.7	43.0	49.6	17.6	60.7	51.3	27.8	20.2	43.0	60.3	44.5	49.9	37.4	44.9	50.9	88.6	41.0	50.8	36.6	73.7	53.6	44.9	41.0	47.9	46.8	50.6	31.8	28.8	36.9	33.1	41.0	28.2	31.4	34.1	21.7	50.7	26.8	35.7	77.1	22.4	44.4	42.7	25.0	37.5	20.8	36.4	44.9	50.3	47.1	47.4	43.1	41.9	45.0	60.7	49.6	6.0	39.4	39.2	25.4	46.8	62.9	30.6	41.1	28.7	33.0	26.5	18.0	34.0	29.3	30.5	29.2
GPR101		ENSG00000165370	"G protein-coupled receptor 101"	Q96P66	X	137030148-137031674	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	16	"brain: 11.1"	"Cell line enriched"	"Detected in single"	4	"HEK 293: 2.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hypothalamus: 44.7"	"Low region specificity"	"Detected in many"			HPA001084	Uncertain									"HPA001084: AB_1078920"																		0.0	0.0	0.0	0.0	11.1	0.1	0.0	0.0	1.7	0.0	0.0			0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.1	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1			0.0		0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ZIC3	"HTX, HTX1, ZNF203"	ENSG00000156925	"Zic family member 3"	O60481	X	137566142-137577691	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 50.6"	"Group enriched"	"Detected in some"	40	"AF22: 24.4;NTERA-2: 27.3"	"Cancer enriched"	"Detected in single"	14	"testis cancer: 5.0"	"Region enriched"	"Detected in all"	8	"cerebellum: 50.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052936, HPA069523"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA052936: , HPA069523: "					"unprognostic (3.55e-5)"					"unprognostic (3.82e-1)"		"unprognostic (1.95e-1)"			"unprognostic (3.31e-1)"			0.3	0.2	1.4	0.4	2.5	1.1	0.4	50.6	5.8	0.3	0.4	2.7	0.0	0.5	0.5	0.2	0.3	0.3	0.4	0.3	1.9	2.2	0.3	0.3	0.4	0.4	2.4	1.2	0.4	0.5	0.4	1.1	0.4	6.1	0.5	0.3	3.9	0.7	0.3	0.5	0.8	0.5	0.2	1.9	0.5	0.4	3.9	2.2	0.0	0.5	0.0	0.4	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	27.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	2.5	50.6	2.6	1.9	2.2	2.4	1.2	6.1	2.2
FGF13	"FGF2, FHF2"	ENSG00000129682	"Fibroblast growth factor 13"	Q92913	X	138614731-139222777	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.7;parathyroid gland: 44.3;skeletal muscle: 37.0"	"Cell line enhanced"	"Detected in some"		"AF22: 19.5;fHDF/TERT166: 16.8;HAP1: 17.8;RPMI-8226: 15.1;U-2197: 31.4;WM-115: 16.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 7.4"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002809			Supported	Cytosol				Cytosol		"HPA002809: AB_1078855"	"unprognostic (3.23e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.87e-3)"	"unprognostic (9.92e-3)"	"unprognostic (2.97e-3)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-3)"	"unprognostic (5.22e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.96e-4)"	"unprognostic (4.36e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.48e-2)"	11.1	1.9	30.0	1.9	29.5	2.7	4.2	0.9	22.9	7.9	3.1	1.5	2.4	2.7	7.0	2.8	4.4	2.6	4.1	1.3	36.7	22.3	4.9	1.4	1.7	3.1	19.7	12.9	6.0	0.9	44.3	2.4	8.4	7.8	11.6	3.3	4.8	6.5	3.5	37.0	1.1	3.1	4.5	3.3	3.8	2.9	2.7	4.1	0.0	3.6	7.9	1.6	3.5	5.7	0.5	0.9	7.4	0.5	0.2	0.3	0.1	0.0	0.2	19.5	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	16.8	1.2	17.8	0.0	0.0	0.2	5.0	0.1	0.1	0.7	0.7	0.1	0.2	0.2	0.4	0.0	0.0	0.0	0.7	5.6	2.0	0.1	0.0	0.1	2.0	6.4	2.9	1.2	15.1	2.8	0.1	0.1	0.0	0.0	0.1	11.9	0.0	0.1	0.4	0.6	0.8	31.4	8.3	7.4	4.1	0.0	7.0	5.6	16.8	2.7	0.5	1.6	0.2	0.3	0.1	0.5	0.2	0.1	0.1	0.4	0.3	0.2	7.4	0.2	0.5	0.9	0.2	0.1	30.0	29.5	0.9	22.9	36.7	22.3	19.7	12.9	7.8	4.1
F9	FIX	ENSG00000101981	"Coagulation factor IX"	P00740	X	139530758-139563458	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets, Hemophilia, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2334	"liver: 233.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.7;RH-30: 1.9;SiHa: 1.5;U-698: 1.1"	"Cancer enriched"	"Detected in single"	1354	"liver cancer: 67.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"								"Secreted to blood"		11000000000										"prognostic favourable (6.69e-4)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	233.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MCF2	"ARHGEF21, DBL"	ENSG00000101977	"MCF.2 cell line derived transforming sequence"	P10911	X	139581770-139708227	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 30.7;brain: 23.1;seminal vesicle: 18.8;testis: 18.2"	"Cell line enriched"	"Detected in some"	11	"U-251 MG: 28.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (2.42e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.11e-4)"	"unprognostic (8.95e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.33e-3)"	"unprognostic (3.68e-2)"	"unprognostic (2.92e-2)"	"unprognostic (4.62e-4)"	"unprognostic (4.02e-2)"	0.7	30.7	5.2	0.8	8.1	1.0	0.5	3.3	12.4	0.5	0.5	0.9	12.5	0.5	0.5	13.4	0.5	1.2	1.1	1.4	7.1	11.3	2.0	0.6	0.5	1.0	8.9	5.7	11.5	0.7	0.5	3.3	0.5	23.1	1.8	0.5	2.8	1.3	18.8	0.6	0.6	0.5	0.5	6.3	1.3	0.6	18.2	2.4	0.0	1.6	0.0	0.6	0.6	0.1	0.1	0.3	0.6	0.1	1.0	0.7	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.3	2.4	0.0	0.4	0.4	1.9	0.0	0.1	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	28.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.2	0.6	1.0	0.0	0.3	0.0	0.0	5.2	8.1	3.3	12.4	7.1	11.3	8.9	5.7	23.1	2.4
ATP11C	"ATPIG, ATPIQ"	ENSG00000101974	"ATPase phospholipid transporting 11C"	Q8NB49	X	139726346-139945276	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030830	Approved									"HPA030830: AB_10601336"	"unprognostic (8.94e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.42e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.65e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.18e-2)"	12.8	7.0	4.8	7.6	10.6	4.6	9.6	8.0	5.8	13.1	8.8	5.3	30.2	4.8	12.0	9.5	7.3	9.1	7.4	5.2	6.7	4.5	10.8	41.4	6.7	11.2	9.6	3.2	13.1	4.6	6.8	4.2	4.6	9.5	11.5	6.4	10.7	5.8	21.4	6.6	5.6	7.8	11.3	6.3	14.4	7.1	7.9	9.7	14.9	6.1	4.0	7.4	12.7	12.2	2.8	2.1	5.1	1.7	3.5	2.5	0.5	9.4	4.0	8.3	13.5	12.4	16.9	10.6	11.3	15.2	9.2	12.8	3.5	7.7	13.6	25.6	16.0	7.9	20.0	5.1	14.5	12.4	11.7	6.8	8.9	6.9	13.8	11.9	4.4	11.1	3.4	9.9	8.5	15.8	7.7	10.4	12.1	5.1	10.9	8.1	14.1	7.7	10.9	9.0	11.3	7.7	15.7	6.5	10.8	4.4	0.5	5.9	3.4	6.6	17.7	12.6	4.1	15.2	15.4	3.0	2.9	10.7	5.7	14.9	6.2	5.1	1.5	0.4	1.2	1.0	2.5	2.8	1.4	1.1	1.2	2.7	1.4	2.2	2.8	3.5	1.7	2.1	1.0	0.5	4.8	10.6	8.0	5.8	6.7	4.5	9.6	3.2	9.5	9.7
CXorf66	"RP11-35F15.2, SGPX"	ENSG00000203933	"Chromosome X open reading frame 66"	Q5JRM2	X	139955725-139965520	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	21	"testis: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																												"unprognostic (3.87e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SOX3	PHP	ENSG00000134595	"SRY-box 3"	P41225	X	140502985-140505116	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 18.2;testis: 12.4"	"Group enriched"	"Detected in some"	10	"AF22: 7.6;HEK 293: 8.2;NTERA-2: 18.2"	"Cancer enhanced"	"Detected in some"		"glioma: 2.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA054720, HPA075003"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA054720: , HPA075003: "					"unprognostic (6.04e-2)"					"unprognostic (3.75e-1)"			"unprognostic (8.62e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.27e-3)"		0.3	0.5	2.6	0.3	2.7	0.3	0.3	0.6	2.6	1.5	0.3	5.0	0.0	0.3	0.6	0.3	0.3	18.2	0.3	0.3	2.2	5.0	0.3	0.3	0.3	0.3	2.0	1.8	4.7	0.3	0.4	3.2	0.3	3.6	0.3	0.3	0.5	0.3	0.3	0.4	0.3	0.3	0.3	2.3	0.3	0.3	12.4	0.6	0.0	0.5	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.7	0.6	2.6	2.2	5.0	2.0	1.8	3.6	0.6
CDR1	"CDR, CDR34, CDR62A"	ENSG00000184258	"Cerebellar degeneration related protein 1"	P51861	X	140782405-140784871	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"brain: 56.2"	"Cell line enhanced"	"Detected in some"		"AF22: 3.3;BJ: 6.5;MOLT-4: 4.1;U-87 MG: 23.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA073147			Approved	"Nucleoplasm,Golgi apparatus,Centrosome"				"Nucleoplasm, Golgi apparatus, Centrosome"		"HPA073147: "	"unprognostic (7.10e-2)"				"unprognostic (2.87e-2)"	"unprognostic (2.85e-1)"		"unprognostic (3.49e-2)"		"unprognostic (1.44e-1)"	"unprognostic (1.03e-2)"		"unprognostic (2.41e-3)"	"unprognostic (1.46e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.84e-1)"		3.2	1.3	9.1	0.5	26.3	0.0	0.0	56.2	28.7	0.0	0.1			0.2	0.4	0.0	0.6	0.2	1.5	1.5	9.2	2.8	0.1	0.0	0.6	0.1	3.7		0.1	3.9	0.0	7.1	0.4		0.1	0.0		0.6	0.0	0.2	9.4	0.1	0.0	3.6	0.9	0.5	0.1			0.7		0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.6	3.3	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.1	0.0	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.4	0.0	1.2	0.0	0.0	0.0	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SPANXB1	"CT11.2, SPANXB2, SPANXF1, SPANXF2"	ENSG00000227234	"SPANX family member B1"	Q9NS25	X	141002591-141003706	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	40	"testis: 38.5"	"Group enriched"	"Detected in some"	26	"A-431: 40.4;U-2 OS: 14.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046423, HPA073647"	Supported		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA046423: , HPA073647: "															"unprognostic (8.55e-2)"			0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	40.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.1	1.0	0.3	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LDOC1	"BCUR1, Mar7, Mart7, RTL7, SIRH7"	ENSG00000182195	"LDOC1, regulator of NFKB signaling"	O95751	X	141175745-141177125	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 29.2;MCF7: 39.3;PC-3: 49.3;U-251 MG: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 19.2"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 21.5"	"Low region specificity"	"Detected in all"			"HPA051768, HPA061842"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA051768: , HPA061842: "	"unprognostic (4.09e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.76e-2)"	21.1	24.2	24.4	5.9	31.8	2.0	9.9	18.3	51.2	24.2	5.5	21.0	11.0	5.1	17.3	12.1	10.0	30.3	10.4	6.7	27.3	25.6	15.6	3.1	9.7	5.5	23.2	23.3	31.8	18.3	13.0	54.9	1.8	30.2	23.1	3.5	13.5	47.9	36.4	3.8	17.9	5.2	12.5	19.5	9.3	7.8	6.6	16.6	1.8	22.6	3.7	5.7	11.2	9.9	8.2	4.8	8.2	0.0	19.2	8.9	3.0	0.0	29.2	4.5	12.5	7.9	9.6	0.0	7.0	8.7	9.5	13.4	0.0	11.5	0.0	5.5	11.4	13.7	4.9	10.2	6.8	0.0	9.1	0.0	15.8	0.0	3.0	0.0	2.7	16.9	5.3	8.2	4.4	8.1	0.2	0.0	8.5	39.3	0.0	0.0	4.7	49.3	0.0	4.1	0.0	11.7	6.9	0.0	3.9	0.0	6.1	0.0	7.8	0.0	14.5	0.0	9.5	0.0	29.3	0.0	0.0	0.0	4.9	0.0	0.0	8.2	0.0	0.1	4.3	0.0	3.1	3.3	8.9	3.3	0.8	8.2	7.9	5.1	0.2	19.2	0.0	4.8	8.1	3.0	24.4	31.8	18.3	47.4	27.3	25.6	23.2	23.3	30.2	16.6
SPANXC	"CT11.3, CTp11"	ENSG00000198573	"SPANX family member C"	Q9NY87	X	141241463-141242496	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	24	"testis: 27.3"	"Group enriched"	"Detected in some"	5	"A-431: 13.0;U-2 OS: 6.3"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046423, HPA073647"	Supported		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA046423: , HPA073647: "															"unprognostic (3.56e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	13.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	6.3	0.0	0.5	0.0	0.0	0.2	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPANXA1	"CT11.1, NAP-X, SPAN-Xa, SPAN-Xb, SPANX"	ENSG00000198021	"Sperm protein associated with the nucleus, X-linked, family member A1"	Q9NS26	X	141583674-141585011	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	28	"testis: 14.1"	"Cell line enhanced"	"Detected in some"		"PC-3: 1.5;U-2 OS: 5.7;U-2197: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046423, HPA073647"	Supported		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA046423: , HPA073647: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1			0.0		0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	1.2	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SPANXA2	SPANX	ENSG00000203926	"SPANX family member A2"	Q9NS26	X	141589435-141590772	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	22	"testis: 15.5"	"Cell line enhanced"	"Detected in some"		"PC-3: 1.5;U-2 OS: 5.7;U-2197: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046423, HPA073647"	Supported		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA046423: , HPA073647: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	1.2	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPANXD	"CT11.4, SPANXE"	ENSG00000196406	"SPANX family member D"	Q9BXN6	X	141697411-141698739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	216	"testis: 21.5"	"Group enriched"	"Detected in some"	10	"A-431: 5.0;U-2 OS: 9.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046423, HPA073647"	Supported		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA046423: , HPA073647: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	9.6	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MAGEC3	"CT7.2, HCA2, MAGE-C3"	ENSG00000165509	"MAGE family member C3"	Q8TD91	X	141838316-141897832	"Cancer-related genes, Predicted intracellular proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.9;epididymis: 3.0;testis: 3.1"	"Group enriched"	"Detected in some"	4	"U-2197: 1.9;U-266/70: 2.9;U-266/84: 6.3"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA052067	Approved									"HPA052067: "	"unprognostic (3.45e-1)"				"unprognostic (2.39e-1)"			"unprognostic (4.01e-1)"		"unprognostic (2.95e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.35e-11)"		"unprognostic (3.21e-2)"	"unprognostic (4.29e-2)"		0.1	0.1	1.6	0.0	2.5	0.1	0.5	0.5	2.5	0.2	0.0			0.0	0.2	3.0	0.1	0.4	0.2	0.0	3.3	2.0	0.1	0.1	0.2	0.0	2.8		0.4	0.0	0.0	0.7	0.0		0.3	0.0		0.5	0.3	0.0	0.1	0.2	0.3	4.9	1.1	0.1	3.1			0.5		0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.9	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	1.9	0.3	2.9	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MAGEC1	"CT7, CT7.1, MAGE-C1, MGC39366"	ENSG00000155495	"MAGE family member C1"	O60732	X	141903894-141909388	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 23.5"	"Cell line enhanced"	"Detected in some"		"K-562: 22.3;Karpas-707: 22.4;U-2 OS: 15.1;U-2197: 28.5;U-266/70: 20.4;U-266/84: 18.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA004622, CAB015452"	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB015452: AB_784404, HPA004622: AB_1853495"	"unprognostic (5.63e-2)"				"unprognostic (1.59e-1)"		"unprognostic (1.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.47e-1)"					"unprognostic (8.56e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	15.1	28.5	0.0	20.4	18.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEC2	"CT10, HCA587, MAGE-C2, MAGEE1"	ENSG00000046774	"MAGE family member C2"	Q9UBF1	X	142202345-142205290	"Cancer-related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	319	"testis: 31.8"	"Group enriched"	"Detected in some"	8	"K-562: 34.9;U-266/84: 39.4"	"Cancer enhanced"	"Detected in many"		"melanoma: 19.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA062230	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA062230: "					"unprognostic (1.25e-1)"		"unprognostic (5.68e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.82e-1)"						"unprognostic (1.04e-1)"		"unprognostic (4.00e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	34.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	1.5	0.0	0.0	0.1	2.4	0.4	4.8	0.0	0.0	39.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPANXN4	"CT11.9, SPANX-N4"	ENSG00000189326	"SPANX family member N4"	Q5MJ08	X	143025918-143034702	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 23.7"	"Cell line enhanced"	"Detected in some"		"HEL: 2.4;HeLa: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	16	"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 1.5"									HPA045730	Uncertain									"HPA045730: AB_10961036"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	4.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPANXN3	"CT11.8, SPANX-N3"	ENSG00000189252	"SPANX family member N3"	Q5MJ09	X	143508735-143517475	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	31	"testis: 28.4"	"Cell line enriched"	"Detected in some"	5	"U-2 OS: 6.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045652			Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoli fibrillar center"	Nucleoplasm	"HPA045652: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLITRK4	DKFZp547M2010	ENSG00000179542	"SLIT and NTRK like family member 4"	Q8IW52	X	143622790-143635777	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 15.7;brain: 21.8"	"Cell line enhanced"	"Detected in some"		"HeLa: 8.0;HHSteC: 4.2;LHCN-M2: 3.0;T-47d: 12.3;U-2 OS: 4.7"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	21	"basophil: 11.4;classical monocyte: 4.7;intermediate monocyte: 3.0;myeloid DC: 3.7;non-classical monocyte: 3.2"	"Group enriched"	"Detected in many"	67	"dendritic cells: 3.7;granulocytes: 11.4;monocytes: 4.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000431	Enhanced		Uncertain	Microtubules			320000	Microtubules		"HPA000431: "	"unprognostic (1.72e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.15e-3)"	"unprognostic (4.09e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.64e-2)"	"unprognostic (9.61e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.02e-5)"	"unprognostic (1.29e-2)"	"unprognostic (7.75e-2)"	"unprognostic (9.23e-3)"	5.9	15.7	13.6	0.6	12.1	1.7	3.3	21.3	21.8	8.5	1.0	0.2	0.1	0.3	2.1	4.7	1.1	1.1	0.6	3.0	17.0	1.2	5.1	0.8	1.1	0.6	1.2	16.1	6.1	1.5	0.1	0.8	0.7	5.0	2.6	0.6	0.0	1.7	2.3	6.9	3.3	1.0	1.6	2.7	0.9	1.0	1.8	1.7	0.0	1.3	0.0	0.2	1.1	1.1	0.0	3.7	11.4	4.7	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	4.2	0.6	0.8	2.0	0.0	1.5	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.3	1.3	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	4.7	0.0	0.0	3.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.9	13.6	12.1	21.3	21.8	17.0	1.2	1.2	16.1	5.0	1.7
SPANXN2	"CT11.7, SPANX-N2"	ENSG00000268988	"SPANX family member N2"	Q5MJ10	X	143711955-143721423	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	57	"testis: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045652			Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoli fibrillar center"	Nucleoplasm	"HPA045652: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	5.6			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SPANXN1	"CT11.6, SPANX-N1"	ENSG00000203923	"SPANX family member N1"	Q5VSR9	X	145246828-145256112	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	17	"testis: 4.7"	"Group enriched"	"Detected in some"	4	"HDLM-2: 1.0;U-138 MG: 2.4;U-2 OS: 1.7;U-251 MG: 2.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7			0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.7	0.0	2.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SLITRK2	"CXorf1, CXorf2, KIAA1854, SLITL1, TMEM257"	ENSG00000185985	"SLIT and NTRK like family member 2"	"Q9H156, O96002"	X	145817832-145829856	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.1"	"Cell line enriched"	"Detected in single"	35	"HAP1: 21.2"	"Cancer enhanced"	"Detected in some"		"glioma: 5.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										26000				"unprognostic (2.13e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.79e-6)"	"unprognostic (3.39e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.89e-4)"	"unprognostic (6.23e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.53e-2)"	"unprognostic (4.13e-8)"	"unprognostic (3.12e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.14e-2)"	1.6	1.5	12.8	1.2	16.4	0.9	1.2	4.3	25.1	1.7	1.2	13.3	0.0	1.1	1.1	1.1	1.1	4.9	1.1	1.6	12.1	3.5	1.4	1.0	2.2	1.6	11.3	9.2	1.1	1.8	0.9	1.1	0.9	10.4	1.4	1.4	5.6	1.3	8.5	1.2	3.9	1.3	1.5	12.6	7.4	1.0	1.2	11.5	0.0	1.1	0.0	0.9	1.3	1.1	0.3	0.3	1.5	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.4	0.2	0.2	0.3	0.1	0.2	0.2	0.0	0.3	0.3	0.2	0.6	0.4	0.3	0.3	0.2	0.0	12.8	16.4	4.3	14.6	12.1	3.5	11.3	9.2	10.4	11.5
CXorf51B		ENSG00000235699	"Chromosome X open reading frame 51B"		X	146809784-146810409	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	37	"testis: 36.8"	"Group enriched"	"Detected in some"	36	"RPMI-8226: 2.5;U-138 MG: 4.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CXorf51A	CXorf51	ENSG00000224440	"Chromosome X open reading frame 51A"		X	146814106-146814726	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"				"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 2.2;U-138 MG: 3.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.8	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FMR1	"FMRP, FRAXA, MGC87458, POF, POF1"	ENSG00000102081	"Fragile X mental retardation 1"	Q06787	X	147911951-147951125	"Disease related genes, Predicted intracellular proteins"	"DNA damage, Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Neurogenesis, RNA-mediated gene silencing, Translation regulation, Transport"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"	"Disease mutation, Mental retardation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012444, HPA050118, HPA056084"	Approved		Enhanced	Cytosol				Cytosol		"CAB012444: AB_732400, HPA050118: , HPA056084: "	"unprognostic (4.11e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.89e-3)"	"prognostic unfavourable (1.32e-4)"	"unprognostic (4.58e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.15e-3)"	"unprognostic (6.56e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.98e-2)"	14.9	13.3	24.8	14.9	21.1	28.3	14.3	32.6	25.7	16.0	14.5	17.7	14.4	13.3	21.2	33.2	13.9	18.3	12.3	15.0	22.2	19.0	26.5	30.3	15.3	15.7	23.3	22.8	23.4	11.5	27.8	20.5	49.9	18.9	15.4	15.0	14.0	12.7	19.6	7.8	17.7	15.9	18.3	23.1	20.1	13.2	14.5	19.2	21.7	29.0	9.8	16.1	17.1	27.3	5.3	3.4	7.3	3.5	4.9	7.4	2.4	14.8	13.3	13.9	9.3	8.6	6.9	11.1	8.0	8.5	12.9	23.4	14.6	14.1	29.6	33.3	9.9	25.7	22.1	9.9	14.5	11.6	15.4	8.3	24.8	13.7	8.8	9.2	5.2	7.5	5.7	10.9	10.2	10.7	5.2	19.6	11.5	19.3	10.3	6.7	6.2	7.5	11.6	39.8	12.5	15.1	39.8	12.2	8.0	9.2	8.4	11.9	7.5	8.3	10.2	10.5	9.1	12.9	20.1	21.2	21.0	31.8	9.5	15.8	5.5	2.8	2.7	6.6	6.0	3.5	7.4	4.7	3.9	6.6	3.4	5.3	5.0	5.8	7.3	4.9	3.2	2.8	4.7	2.4	24.8	21.1	32.6	25.7	22.2	19.0	23.3	22.8	18.9	19.2
FMR1NB	"CT37, FLJ25736, NY-SAR-35"	ENSG00000176988	"FMR1 neighbor"	Q8N0W7	X	147981329-148026667	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	87	"testis: 38.0"	"Group enriched"	"Detected in some"	23	"U-266/70: 34.3;U-266/84: 26.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA011284, CAB026403"	Enhanced									"CAB026403: , HPA011284: AB_1078898"				"unprognostic (2.22e-3)"			"unprognostic (1.05e-1)"			"unprognostic (1.83e-1)"					"unprognostic (4.38e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.85e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AFF2	"FMR2, FRAXE"	ENSG00000155966	"AF4/FMR2 family member 2"	P51816	X	148500619-149000663	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.6;brain: 13.6;epididymis: 15.1;pituitary gland: 17.4;placenta: 17.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 29.6;HL-60: 12.5;U-698: 43.2;U-937: 9.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"basophil: 1.7;eosinophil: 2.5;neutrophil: 4.5"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003139	Approved									"HPA003139: AB_1078107"	"unprognostic (5.68e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.00e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.08e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.80e-2)"	"unprognostic (9.78e-5)"	"unprognostic (2.54e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.34e-2)"	1.9	0.6	4.2	5.3	3.7	13.6	1.1	13.6	5.9	4.8	0.4	0.2	1.2	0.2	0.8	15.1	0.5	0.6	2.9	1.3	10.7	5.2	0.7	0.3	3.6	6.3	2.3	5.9	2.0	0.5	0.2	17.4	17.4	3.9	1.0	0.3	0.2	0.8	2.1	0.4	1.3	0.5	0.3	2.4	0.8	0.4	2.8	0.0	5.5	1.1	0.0	7.3	1.0	0.7	0.1	0.0	4.5	0.1	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.6	0.0	1.7	0.0	4.6	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	12.5	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.6	3.8	1.1	0.0	3.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.5	0.0	1.3	0.1	0.1	43.2	0.0	9.2	0.0	1.7	0.1	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	4.5	0.0	0.0	0.0	0.0	0.0	4.2	3.7	13.6	5.9	10.7	5.2	2.3	5.9	3.9	0.0
IDS	SIDS	ENSG00000010404	"Iduronate 2-sulfatase"	P22304	X	149476990-149521096	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 107.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA078003	Approved				"Intracellular and membrane"		8900000			"HPA078003: "	"unprognostic (9.88e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.52e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.76e-3)"	"unprognostic (3.61e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.87e-1)"	11.6	20.4	92.9	12.1	81.5	16.0	12.0	30.4	107.9	13.1	9.3	15.0	8.1	9.1	17.8	29.5	11.3	14.8	12.3	16.2	83.6	42.7	10.5	7.0	17.9	12.5	36.7	51.8	22.6	10.6	19.5	17.8	7.4	33.0	14.0	10.7	7.7	9.1	19.5	8.9	12.9	11.6	14.1	21.0	14.1	10.6	3.8	14.7	1.9	13.2	4.9	14.7	11.4	8.6	8.7	11.7	63.4	16.6	8.5	18.2	13.3	14.3	16.3	7.2	4.2	7.9	14.1	3.0	8.3	21.8	7.7	14.8	3.3	10.8	34.5	22.2	12.3	8.4	6.9	13.0	10.0	12.4	5.9	3.7	5.3	1.9	6.1	5.9	33.3	7.7	7.0	16.7	11.0	12.2	1.7	25.2	11.4	18.3	5.9	3.1	5.6	11.2	3.9	6.5	6.6	9.9	3.6	9.6	22.2	3.2	7.4	10.2	2.3	2.6	14.3	10.2	10.4	16.5	22.4	17.7	13.9	25.2	45.9	14.2	7.2	23.9	13.8	39.6	18.2	14.9	13.5	8.7	11.2	13.6	11.7	6.6	7.5	11.3	63.4	8.5	16.6	8.8	16.9	13.3	92.9	81.5	30.4	90.7	83.6	42.7	36.7	51.8	33.0	14.7
AC244197.3		ENSG00000241489			X	149482543-149533935	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"pituitary gland: 17.9"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"																						"unprognostic (1.57e-2)"	"unprognostic (2.77e-2)"	"unprognostic (5.48e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.81e-2)"	"unprognostic (9.16e-3)"	"unprognostic (4.51e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.01e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.37e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.90e-2)"	"unprognostic (3.27e-4)"	1.6	2.6	0.3	0.9	1.0	1.1	2.6	1.1	0.9	3.4	2.8			1.5	5.2	16.4	3.1	7.5	2.1	3.8	0.5	1.0	3.3	1.7	3.6	1.4	0.4		6.4	2.9	4.2	17.9	1.3		5.6	3.3		3.3	5.0	1.0	4.1	2.2	3.0	0.7	2.2	2.2	1.8			5.3		1.9	3.2	3.6	1.5	1.8	14.0	4.3	2.6	5.5	4.3	4.7	16.5	9.5	3.5	5.6	5.3	1.6	3.1	3.9	2.7	7.3	2.3	7.8	8.7	7.7	7.1	13.0	1.6	5.8	2.6	9.2	4.7	1.5	11.0	1.1	2.3	1.9	12.1	8.7	4.8	6.9	5.3	3.4	1.2	10.8	3.6	12.1	1.7	1.3	0.8	5.2	1.8	2.4	5.1	7.6	4.7	5.4	5.4	2.2	4.1	1.0	3.3	1.5	7.1	5.0	6.3	4.9	3.4	8.3	3.6	3.4	8.1	3.9	2.4	0.2	2.7	14.0	5.5	2.6	2.9	1.5	1.9	2.7	1.8	0.8	0.9	0.9	10.4	2.6	4.3	1.7	4.9	4.3										
CXorf40A	"CXorf40, EOLA1"	ENSG00000197620	"Chromosome X open reading frame 40A"	Q8TE69	X	149540355-149550510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA060897	Approved									"HPA060897: "	"unprognostic (1.37e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.93e-2)"	"unprognostic (7.19e-2)"	"unprognostic (5.16e-3)"	"unprognostic (5.67e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.18e-3)"	"unprognostic (2.73e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.37e-3)"	"unprognostic (8.98e-3)"	"unprognostic (3.02e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.06e-2)"	9.9	38.5	13.3	11.0	15.5	19.0	16.4	11.6	24.2	9.7	12.5	12.6	18.9	11.5	9.8	24.8	10.5	10.2	14.8	17.4	14.5	12.8	16.2	16.0	15.4	12.6	14.4	12.2	15.1	15.9	21.5	23.9	16.1	14.4	11.9	15.6	13.2	22.9	28.2	21.1	11.9	11.7	10.7	14.3	17.1	14.2	8.6	13.9	12.6	20.2	15.3	13.5	12.5	12.8	9.4	27.9	14.7	9.6	21.0	15.0	10.4	8.4	11.9	5.7	8.0	9.6	9.7	5.9	8.5	8.2	8.8	11.5	3.8	7.2	17.9	25.5	8.1	10.0	13.3	7.9	8.0	15.4	13.0	4.4	18.6	5.1	10.9	12.6	13.1	10.4	12.6	9.9	9.9	10.0	3.7	15.1	7.8	35.3	9.8	15.2	2.2	18.1	7.9	9.1	18.3	8.4	10.8	11.4	6.6	4.1	11.7	10.4	5.8	8.9	8.0	5.4	3.7	15.0	16.2	11.6	8.6	25.3	11.0	17.5	6.4	14.7	9.6	6.3	15.0	9.4	11.7	9.4	11.6	12.1	9.7	7.2	14.2	10.3	8.9	21.0	8.1	27.9	13.5	10.4	13.3	15.5	11.6	24.2	14.5	12.8	14.4	12.2	14.4	13.9
HSFX3		ENSG00000283697	"Heat shock transcription factor family, X-linked member 3"	A0A1B0GWH4	X	149548210-149549932	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"testis: 13.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.5;HEK 293: 1.3;HeLa: 1.5;NB-4: 2.3;PC-3: 1.5;SK-BR-3: 1.0;U-87 MG: 1.0"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	2.8		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	13.9			0.0		0.0	0.0		0.4	0.2	0.0	0.2	0.4	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.2	0.0	0.0	0.2	1.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	2.3	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.5	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.2	0.0	0.4	0.1	0.3	0.0	0.4	0.2	0.2	0.2	0.1										
MAGEA9B		ENSG00000267978	"MAGE family member A9B"	P43362	X	149581653-149587453	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	35	"testis: 14.2"	"Group enriched"	"Detected in some"	14	"RT4: 48.6;U-266/70: 21.1;U-266/84: 26.0"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 1.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045401, HPA051687"			Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"HPA045401: , HPA051687: "															"unprognostic (6.12e-3)"		"unprognostic (3.26e-1)"	0.2	0.0		0.1		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.1	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1			0.0	0.0	0.0		0.4		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	14.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	48.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	21.1	26.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
HSFX2		ENSG00000268738	"Heat shock transcription factor family, X-linked 2"	Q9UBD0	X	149592515-149594716	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"testis: 9.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 2.6;hTCEpi: 3.3"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 1.7;naive CD4 T-cell: 1.8"	"Low lineage specificity"	"Detected in many"											HPA063040	Supported									"HPA063040: "					"unprognostic (7.64e-2)"					"unprognostic (6.92e-3)"				"unprognostic (2.00e-1)"				0.0	0.0		0.0		0.0	0.3		0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.7	0.0	0.0			0.0	0.1	0.3	0.1			0.2	0.0	0.5		0.1		0.1	0.3		0.6	1.3	0.1	0.5	0.0	0.1		0.0	0.0	9.3			0.0		0.0	0.1		0.2	0.5	1.7	0.2	0.2	1.8	0.3	0.6	0.0	1.8	0.3	0.0	1.1	0.2	1.0	0.8	1.2	0.1	1.6	0.0	0.4	0.0	0.0	2.6	0.0	0.9	0.8	0.0	0.9	0.8	0.0	0.2	0.2	0.2	0.8	1.6	3.3	1.2	0.0	0.0	0.0	0.0	0.0	1.0	0.2	2.4	0.9	1.3	0.1	0.0	0.4	1.4	0.8	0.0	0.4	0.0	0.5	1.1	0.3	0.9	1.4	2.3	0.0	0.1	0.0	0.2	0.0	0.3	0.6	0.5	0.5	1.7	0.2	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.2	0.2	1.8	0.1	1.1	0.2	0.2	0.5	0.0	0.3										
TMEM185A	"CXorf13, FAM11A, FRAXF"	ENSG00000269556	"Transmembrane protein 185A"	Q8NFB2	X	149596556-149631912	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048295, HPA071744"	Uncertain		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA048295: , HPA071744: "	"unprognostic (9.76e-2)"	"unprognostic (2.83e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.71e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.40e-1)"	4.3	5.0	6.8	4.8	6.2	1.7	4.1	7.2	8.2	5.1	3.8	3.1	7.3	2.3	6.2	7.4	5.8	5.8	5.3	12.0	4.4		4.4	3.1	3.4	3.3	3.0	3.3	13.8	5.4	7.3	4.8	10.8	6.0	5.5	3.5	6.3	4.8	7.2	4.5	6.2	3.3	6.6	3.7	7.8	2.7	12.3	4.0	3.8	3.8	4.5	4.3	4.6	5.8	5.3	7.7	12.2	5.0	13.5	10.4	6.3	11.0	11.2	12.9	7.6	17.6	11.9	5.1	10.9	13.3	11.0	16.7	6.8	19.1	13.5	24.3	12.0	14.0	14.9	10.3	12.0	8.7	11.1	7.8	13.0	7.3	12.7	11.3	8.0	11.3	17.5	11.4	7.1	9.5	3.2	8.8	7.9	18.0	7.8	7.8	9.6	12.5	7.6	19.6	7.7	12.7	14.5	4.5	6.4	8.3	14.3	14.2	7.6	6.5	11.4	8.4	7.7	15.4	13.3	8.3	7.3	19.8	14.9	13.4	11.5	2.2	5.0	12.2	10.1	3.0	9.0	5.3	7.3	10.4	7.7	5.0	10.3	9.2	7.1	13.5	2.5	5.7	9.0	6.3										
MAGEA11	"CT1.11, MAGE-11, MAGE11, MAGEA-11, MGC10511"	ENSG00000185247	"MAGE family member A11"	P43364	X	149688228-149717266	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 36.5;testis: 9.3"	"Cell line enriched"	"Detected in some"	4	"U-2 OS: 22.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA052687			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA052687: "	"unprognostic (4.06e-3)"	"unprognostic (2.05e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.09e-2)"		"unprognostic (9.64e-2)"		"unprognostic (1.32e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.16e-1)"				"unprognostic (6.67e-4)"	"unprognostic (1.14e-1)"		"unprognostic (1.33e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	36.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	22.9	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
HSFX1	LW-1	ENSG00000171116	"Heat shock transcription factor family, X-linked 1"	Q9UBD0	X	149774068-149776867	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 6.3"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"											HPA063040	Approved									"HPA063040: "	"unprognostic (3.50e-2)"	"unprognostic (2.86e-1)"			"unprognostic (2.30e-2)"	"unprognostic (6.32e-2)"		"unprognostic (3.38e-2)"	"unprognostic (3.78e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.10e-1)"	0.7	0.7	1.9	0.4	2.4	0.0	1.2	3.1	3.1	1.9	1.6			1.1	1.8	5.9	1.4	2.0	0.7	3.7	1.7	1.6	0.7	1.0	1.1	0.3	1.1		6.4	1.5	1.6	1.2	1.9		2.1	0.2		2.1	2.3	2.4	3.1	0.8	1.2	0.9	3.4	0.9	5.7			1.2		0.4	2.1	0.9	0.6	0.2	0.1	0.8	0.0	1.5	0.1	0.9	3.0	1.9	2.7	3.7	2.6	0.6	0.5	0.8	0.6	1.4	1.4	1.8	1.7	3.8	1.2	1.3	1.5	0.8	0.1	0.4	2.2	0.2	2.1	0.2	2.2	0.4	1.0	0.6	2.1	0.8	1.6	0.9	0.1	0.6	0.3	6.3	0.3	0.8	0.5	1.2	0.7	2.0	0.0	2.0	1.0	1.3	0.4	0.3	1.7	1.3	0.5	0.1	0.0	2.8	1.9	0.5	1.1	0.6	0.0	0.4	1.2	1.0	0.9	0.0	0.0	0.0	0.2	0.8	0.0	0.3	0.8	0.0	0.0	0.6	0.2	1.5	0.1	0.0	0.0	0.2	0.0	0.1										
MAGEA9	"CT1.9, MAGE9, MGC8421"	ENSG00000123584	"MAGE family member A9"	P43362	X	149781930-149787737	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"testis: 9.3"	"Group enriched"	"Detected in some"	7	"U-266/70: 28.9;U-266/84: 19.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045401, HPA051687"			Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"HPA045401: , HPA051687: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.9	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MAGEA8	"CT1.8, MAGE8, MGC2182"	ENSG00000156009	"MAGE family member A8"	P43361	X	149881141-149885835	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"placenta: 24.6"	"Group enriched"	"Detected in some"	24	"U-2 OS: 19.1;U-266/70: 35.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA003998	Enhanced									"HPA003998: AB_10965020"	"unprognostic (6.81e-2)"	"unprognostic (7.56e-2)"		"unprognostic (1.02e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.89e-2)"	"unprognostic (2.49e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.80e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	24.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	35.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CXorf40B		ENSG00000197021	"Chromosome X open reading frame 40B"	Q96DE9	X	149929527-149938811	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA060897	Approved									"HPA060897: "	"unprognostic (5.44e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.03e-2)"	"unprognostic (7.57e-2)"	"unprognostic (6.38e-2)"	"unprognostic (5.94e-2)"	"unprognostic (4.66e-2)"	"prognostic unfavourable (1.02e-4)"	"unprognostic (7.14e-3)"	16.1	48.4	15.1	16.7	21.5	40.1	21.4	15.2	27.7	16.8	17.0	17.4	23.0	14.9	18.4	27.8	16.4	14.9	20.7	19.9	15.2	13.6	19.2	23.4	16.0	18.3	19.5	20.7	25.4	28.4	16.0	25.5	33.1	17.3	18.4	15.4	16.7	24.6	25.6	13.8	28.2	15.7	15.0	14.4	22.2	17.1	15.7	18.1	15.8	18.6	13.9	20.0	15.9	15.0	17.2	22.3	20.9	15.7	32.2	23.3	16.9	13.1	19.0	10.9	9.4	10.2	15.0	11.7	13.4	14.0	16.5	20.5	14.7	10.9	17.5	36.6	14.0	7.2	15.3	14.4	12.0	11.0	16.1	7.9	22.8	14.3	19.5	15.6	14.9	15.6	20.0	20.0	19.6	16.3	9.4	22.4	14.7	35.3	12.2	16.5	8.0	22.7	11.6	11.1	21.3	10.0	18.2	8.4	7.4	5.9	14.4	15.1	9.6	10.8	12.5	13.2	8.1	22.2	27.0	16.9	8.8	42.4	14.5	20.8	11.9	17.0	15.7	20.9	23.3	12.2	20.9	17.2	17.3	22.1	17.1	15.6	17.4	20.9	6.6	32.2	10.3	22.3	20.8	16.9	15.1	21.5	15.2	27.7	15.2	13.6	19.5	20.7	17.3	18.1
HSFX4		ENSG00000283463	"Heat shock transcription factor family, X-linked member 4"	A0A1B0GTS1	X	149929645-149931287	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	11	"adrenal gland: 5.5;testis: 13.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.6;HeLa: 1.6;RT4: 1.9;U-266/70: 2.4"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	5.5		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0	0.0	0.0	0.0			0.0	0.2	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0		0.0	0.0	13.3			0.0		0.0	0.1		0.0	0.4	0.0	0.8	0.6	0.1	0.1	0.2	0.6	0.9	0.7	0.0	0.0	0.4	0.6	0.0	0.0	0.0	1.6	0.0	0.4	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.3	1.6	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.2	0.0	1.9	1.3	0.2	0.0	0.0	0.2	0.4	0.2	0.9	0.5	0.9	1.3	0.9	2.4	0.0	0.2	0.2	0.2	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.4	0.0	0.1										
MAMLD1	"CG1, CXorf6, F18"	ENSG00000013619	"Mastermind like domain containing 1"	Q13495	X	150361422-150514178	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 15.3;U-2197: 23.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003923	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA003923: AB_10602034"	"unprognostic (4.18e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.16e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.08e-2)"	"unprognostic (9.74e-2)"	"unprognostic (9.86e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.41e-3)"	"unprognostic (9.76e-3)"	7.6	4.6	9.1	2.6	15.5	2.6	10.0	5.2	11.7	5.8	3.7	5.7	5.7	1.8	9.0	5.9	3.2	7.8	4.2	3.9	9.3	9.5	2.6	3.2	5.9	2.8	3.5	6.9	21.8	6.0	3.0	6.0	3.2	5.7	5.6	2.3	6.4	3.2	11.7	6.6	2.4	1.8	5.6	5.6	2.5	2.6	15.3	5.2	0.0	1.6	1.7	2.1	2.9	3.5	2.2	0.1	0.8	0.1	0.6	3.0	0.8	4.5	1.8	2.5	4.9	7.2	2.7	0.0	4.3	9.1	6.7	15.3	0.0	0.2	0.0	2.3	10.3	0.1	2.8	2.0	9.1	6.9	0.2	0.1	5.8	0.1	5.3	0.2	0.0	3.7	0.5	7.5	0.9	1.4	0.1	0.1	6.3	0.8	0.0	0.1	0.5	3.5	0.3	9.5	0.2	1.0	0.1	0.6	0.5	1.5	0.1	2.4	0.1	0.0	1.7	3.6	4.5	23.8	7.7	0.3	0.3	0.1	9.9	1.8	4.8	0.0	0.0	0.2	1.1	0.0	1.6	2.2	1.8	1.5	0.1	0.9	1.7	3.0	0.8	0.6	0.1	0.1	2.0	0.8	9.1	15.5	5.2	11.0	9.3	9.5	3.5	6.9	5.7	5.2
MTM1		ENSG00000171100	"Myotubularin 1"	Q13496	X	150568619-150673322	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Protein transport, Transport"	"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010008, HPA010665"	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"HPA010008: AB_1079426, HPA010665: AB_1079425"	"unprognostic (3.66e-3)"	"unprognostic (8.43e-3)"	"unprognostic (3.52e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.74e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.59e-2)"	"prognostic favourable (7.40e-7)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.46e-1)"	10.7	17.9	15.0	10.2	16.4	11.1	9.2	10.6	10.8	9.1	21.5	12.5	12.7	12.8	10.9	10.9	11.1	11.1	8.0	9.0	14.3	12.0	17.9	19.9	12.2	12.4	17.3	9.3	13.8	7.5	21.4	11.9	21.5	12.9	9.5	21.6	8.3	10.2	12.9	11.2	10.2	21.0	8.0	17.2	15.3	8.6	12.1	16.4	14.5	12.7	8.3	13.9	8.5	9.1	6.9	7.9	18.4	7.2	10.1	7.7	4.6	8.5	3.9	5.5	2.0	5.0	5.0	3.5	4.1	5.6	4.7	5.2	3.0	4.7	13.8	7.3	5.2	6.1	4.0	7.9	5.8	3.7	3.5	3.7	3.7	9.1	3.8	15.3	12.5	3.0	9.5	3.8	8.1	6.1	2.3	12.8	5.7	2.8	4.2	15.8	2.8	5.1	5.1	3.1	2.7	8.1	4.8	1.4	1.5	3.5	7.4	5.2	2.6	22.3	5.3	3.1	1.9	8.1	4.2	2.6	5.9	13.1	4.0	9.4	5.1	17.6	6.3	18.4	1.5	7.2	4.9	5.5	6.8	5.2	7.9	6.9	6.5	3.9	8.5	10.1	6.2	5.1	7.7	4.6	15.0	16.4	10.6	10.8	14.3	12.0	17.3	9.3	12.9	16.4
MTMR1		ENSG00000063601	"Myotubularin related protein 1"	Q13613	X	150692971-150765103	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 43.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002977, HPA018502"	Approved		Approved	Centrosome				Centrosome		"HPA002977: , HPA018502: AB_1854185"	"unprognostic (2.37e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.35e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.19e-1)"	"unprognostic (8.40e-2)"	6.9	6.8	20.4	14.0	17.9	9.9	11.8	14.5	15.6	8.3	8.6	8.7	7.2	8.3	9.4	9.2	19.7	9.3	9.0	12.0	17.8	13.4	8.1	10.2	9.7	18.7	12.1	11.5	7.4	11.7	16.3	10.2	37.9	8.8	10.8	9.1	7.9	12.1	13.0	22.2	19.8	10.9	8.3	8.2	18.0	9.7	11.0	9.3	32.6	9.6	10.7	23.1	10.4	7.7	3.3	7.8	7.4	1.5	6.2	4.8	1.8	12.9	8.3	9.0	7.3	2.1	2.4	12.1	11.5	14.9	11.8	16.7	8.0	10.3	28.4	17.1	9.3	11.8	18.1	16.8	18.4	11.5	10.9	1.8	13.0	3.4	6.2	8.3	6.2	6.7	11.7	12.9	0.2	7.1	5.4	7.3	8.4	11.1	12.1	2.1	4.1	12.6	6.5	14.3	12.5	9.2	14.9	13.4	8.4	4.4	9.9	3.7	12.6	4.7	8.9	7.8	6.2	1.0	17.1	9.4	9.6	43.2	1.5	5.4	5.9	0.0	0.9	7.4	3.5	1.5	2.6	2.7	3.9	3.2	2.2	3.3	3.5	4.7	2.4	6.2	1.3	7.8	4.8	1.8	20.4	17.9	14.5	15.6	17.8	13.4	12.1	11.5	8.8	9.3
CD99L2	"CD99B, MIC2L1"	ENSG00000102181	"CD99 molecule like 2"	Q8TCZ2	X	150766337-150898816	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 72.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038782, HPA038783, HPA061400"	Enhanced		Supported	"Plasma membrane"			790000	"Plasma membrane"		"HPA038782: AB_10795139, HPA038783: AB_10794734, HPA061400: "	"unprognostic (2.10e-2)"	"unprognostic (2.62e-3)"	"unprognostic (3.12e-3)"	"unprognostic (6.03e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.66e-1)"	"unprognostic (5.56e-2)"	"prognostic favourable (4.96e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"	"prognostic favourable (2.74e-5)"	"unprognostic (5.50e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.74e-2)"	"unprognostic (9.23e-2)"	"prognostic unfavourable (8.74e-4)"	27.1	16.5	23.3	9.2	30.1	4.5	17.8	27.5	56.7	19.2	12.6	21.0	5.5	6.7	17.6	16.5	9.7	17.6	12.4	32.1	26.3	32.0	14.0	17.0	14.9	9.6	30.5	26.6	26.0	8.4	9.7	8.7	21.5	43.1	13.9	7.4	11.9	8.3	22.0	72.2	6.7	8.0	20.8	31.9	12.5	8.0	7.6	13.3	3.0	7.3	6.9	7.0	10.7	7.7	7.2	10.7	9.4	15.1	8.8	8.9	8.4	2.2	22.6	8.6	10.7	45.6	28.5	2.5	18.6	21.9	9.4	13.6	1.6	2.9	8.2	45.3	32.4	3.7	11.7	12.6	7.8	19.1	9.1	3.5	5.4	2.2	12.3	5.9	6.8	26.9	4.2	6.9	13.3	11.1	2.4	21.6	11.8	4.8	5.2	8.6	3.6	12.3	5.2	7.0	11.2	9.2	1.5	11.4	5.8	7.3	6.3	8.3	1.8	10.2	13.0	14.0	4.3	18.1	13.4	18.4	30.4	8.0	17.6	11.9	10.5	9.4	11.2	7.6	8.8	9.9	7.8	6.4	8.2	8.9	10.7	7.2	8.3	8.5	2.8	8.8	15.1	7.8	5.9	8.4	23.3	30.1	27.5	55.2	26.3	32.0	30.5	26.6	43.1	13.3
HMGB3	"HMG2A, HMG4, MGC90319"	ENSG00000029993	"High mobility group box 3"	O15347	X	150980509-150990775	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	DNA-binding	Microphthalmia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 54.3"	"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 107.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA062583	Enhanced		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA062583: "	"unprognostic (2.85e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.66e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.70e-2)"	"prognostic favourable (9.85e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.96e-2)"	"prognostic favourable (6.15e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	4.4	5.4	7.9	4.8	7.1	20.3	4.1	2.8	10.3	10.8	12.0	4.7	3.9	7.3	6.3	13.4	10.2	4.4	3.2	4.5	9.8	7.6	9.0	41.6	5.9	6.3	6.1	7.3	3.1	7.1	18.7	1.6	54.3	9.7	3.7	9.2	5.3	9.7	4.3	20.5	6.8	7.6	3.6	5.0	8.4	4.0	26.0	3.2	18.2	6.2	5.1	9.5	4.9	3.7	3.1	6.5	11.8	5.3	0.9	6.2	2.3	37.1	16.5	52.0	27.0	2.2	6.5	64.7	16.3	10.8	19.0	9.9	13.0	15.4	26.0	52.6	12.5	17.9	47.3	107.0	21.4	17.7	13.8	22.6	15.9	20.4	3.2	34.0	11.5	5.1	25.3	7.7	19.6	24.5	11.7	15.5	22.5	28.5	37.5	26.2	30.8	20.2	46.0	42.3	14.7	13.9	17.8	37.5	24.5	24.2	26.2	8.1	23.1	22.6	18.4	7.9	18.7	25.1	35.9	14.1	17.5	96.4	9.4	17.4	16.0	0.0	4.8	11.8	0.5	3.2	0.1	3.1	2.4	3.3	6.5	0.6	0.0	0.2	0.6	0.9	5.3	3.3	6.2	2.3	7.9	7.1	2.8	10.3	9.8	7.6	6.1	7.3	9.7	3.2
GPR50	"H9, Mel1c"	ENSG00000102195	"G protein-coupled receptor 50"	Q13585	X	151176653-151181465	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"pituitary gland: 64.9"	"Cell line enriched"	"Detected in some"	8	"HEK 293: 10.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"hypothalamus: 16.8"	"Region enriched"	"Detected in single"	9	"hypothalamus: 6.4"	"HPA049862, HPA054678"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA049862: , HPA054678: "						"unprognostic (8.84e-3)"		"unprognostic (5.59e-2)"							"unprognostic (1.15e-1)"			0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.3	1.4	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	64.9	3.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.0
VMA21	"MEAX, XMEA"	ENSG00000160131	"VMA21, vacuolar ATPase assembly factor"	Q3ZAQ7	X	151396515-151409364	"Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA010972	Uncertain									"HPA010972: AB_1853034"	"unprognostic (1.17e-1)"	"prognostic favourable (2.30e-5)"	"unprognostic (6.75e-2)"	"unprognostic (9.78e-3)"	"unprognostic (6.48e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.88e-3)"	"unprognostic (4.36e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.30e-2)"	"unprognostic (7.88e-2)"	"unprognostic (4.17e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.76e-1)"	14.7	18.0	22.2	11.3	21.5	27.9	30.1	23.3	40.8	15.2	9.4	13.7	8.3	9.3	13.7	21.6	13.4	20.5	10.1	27.9	23.0	28.7	19.1	14.1	20.3	39.8	23.4	18.6	16.4	19.0	17.2	16.4	17.4	20.6	13.3	10.2	13.8	12.1	13.1	11.1	18.1	9.4	14.9	20.3	13.7	10.3	14.2	11.6	14.9	19.8	14.1	17.5	11.4	11.0	8.7	14.5	9.7	14.9	13.9	13.6	11.1	9.1	10.2	11.9	12.5	11.8	11.3	11.7	10.3	11.1	9.5	9.5	7.7	12.1	27.1	33.9	10.5	8.4	16.5	9.8	15.0	9.4	8.2	11.8	12.2	13.8	15.8	22.2	13.6	11.7	12.2	10.8	15.3	10.9	6.3	14.3	17.9	8.6	15.0	22.1	14.7	10.8	15.3	14.2	17.5	11.3	7.5	4.3	9.1	8.0	10.9	12.1	6.6	14.6	11.1	15.6	7.0	19.7	16.5	12.1	21.1	40.2	15.9	27.5	15.5	9.7	13.5	8.0	7.5	14.9	9.9	8.7	9.9	9.5	14.5	7.2	13.6	12.0	3.2	13.9	12.9	13.2	9.9	11.1	22.2	21.5	23.3	40.8	23.0	28.7	23.4	18.6	20.6	11.6
PASD1	CT63	ENSG00000166049	"PAS domain containing repressor 1"	Q8IV76	X	151563622-151676739	"Predicted intracellular proteins"	"Biological rhythms"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	301	"testis: 30.0"	"Group enriched"	"Detected in some"	7	"BEWO: 19.5;HMC-1: 31.1;U-266/84: 14.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA011122, HPA011152"	Enhanced		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA011122: AB_1854990, HPA011152: AB_1854991"										"unprognostic (3.34e-1)"					"unprognostic (1.02e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRRG3	TMG3	ENSG00000130032	"Proline rich and Gla domain 3"	Q9BZD7	X	151695124-151705924	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 12.4;epididymis: 10.3"	"Cell line enhanced"	"Detected in some"		"HeLa: 2.7;HMC-1: 2.2;NTERA-2: 4.1;U-2197: 2.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA060566	Uncertain									"HPA060566: "	"unprognostic (1.85e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.77e-2)"	"unprognostic (4.42e-4)"	"unprognostic (7.24e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.98e-2)"	"unprognostic (7.69e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.84e-2)"	3.1	0.2	5.6	1.2	12.4	0.4	2.0	1.0	10.2	9.2	1.1	1.0	0.1	0.3	3.0	10.3	4.0	1.0	3.3	1.6	5.3	11.6	0.4	0.1	2.0	0.2	3.2	5.3	3.9	0.1	0.4	1.3	1.3	5.3	1.1	1.0	1.4	1.3	0.4	3.3	2.5	0.5	2.4	1.2	2.6	0.6	0.6	0.7	0.1	0.7	0.6	0.4	1.4	2.4	1.2	1.4	3.8	1.8	2.4	1.4	1.0	0.2	0.2	0.3	0.3	0.2	0.0	0.3	0.2	0.0	0.0	0.0	1.2	0.4	0.3	0.2	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.1	2.7	0.4	0.2	0.3	2.2	0.3	0.0	0.1	0.2	0.0	0.1	0.5	0.2	0.3	0.1	0.5	4.1	0.1	0.2	0.0	0.1	0.1	0.5	1.0	0.4	0.0	0.3	0.1	0.2	0.2	0.1	0.5	0.5	2.3	0.1	0.1	1.4	0.1	0.3	0.2	0.1	3.8	1.3	1.3	1.2	1.2	1.4	1.1	0.9	0.9	1.0	1.2	1.3	1.1	3.1	2.4	1.8	1.4	1.1	1.0	5.6	12.4	1.0	10.2	5.3	11.6	3.2	5.3	5.3	0.7
FATE1	"CT43, FATE"	ENSG00000147378	"Fetal and adult testis expressed 1"	Q969F0	X	151716035-151723194	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	155	"testis: 100.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;U-2197: 1.6;U-266/70: 1.4;U-87 MG: 1.3"	"Group enriched"	"Detected in some"	9	"renal cancer: 1.2;testis cancer: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA034604	Enhanced									"HPA034604: AB_10602318"	"unprognostic (1.82e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.89e-3)"	"unprognostic (8.40e-5)"	"unprognostic (2.10e-1)"	"unprognostic (3.70e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.07e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavourable (2.88e-4)"	"unprognostic (4.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.34e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	100.9	0.0	0.6	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	1.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0
CNGA2	"CNCA, CNCA1, CNG2, FLJ46312, OCNC1, OCNCa, OCNCALPHA"	ENSG00000183862	"Cyclic nucleotide gated channel alpha 2"	Q16280	X	151738451-151745304	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Olfaction, Sensory transduction, Transport"	"Calmodulin-binding, Ion channel, Ligand-gated ion channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	26	"testis: 2.5"	"Cell line enhanced"	"Detected in single"		"SK-BR-3: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"olfactory region: 0.6"	"Not detected"	"Not detected"			HPA015065	Uncertain									"HPA015065: AB_1847034"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MAGEA4	"CT1.4, MAGE-41, MAGE-X2, MAGE4, MAGE4A, MAGE4B, MGC21336"	ENSG00000147381	"MAGE family member A4"	P43358	X	151912509-151925170	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"placenta: 12.1;testis: 23.5"	"Cell line enhanced"	"Detected in some"		"A-431: 61.4;AN3-CA: 38.3;HMC-1: 73.1;U-266/84: 113.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA021942, CAB040535"	Enhanced		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"CAB040535: , HPA021942: AB_1853490"						"unprognostic (7.90e-3)"		"unprognostic (6.66e-3)"	"unprognostic (5.39e-1)"	"unprognostic (1.36e-1)"				"unprognostic (5.81e-2)"	"unprognostic (2.94e-2)"		"unprognostic (4.10e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.4	0.0	0.0	38.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	73.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	19.6	0.0	0.3	15.6	113.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0
GABRE		ENSG00000102287	"Gamma-aminobutyric acid type A receptor epsilon subunit"	P78334	X	151953124-151974680	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"placenta: 36.4;vagina: 27.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.3;EFO-21: 14.6;HeLa: 6.5;SiHa: 6.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"hypothalamus: 21.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA045918	Uncertain									"HPA045918: AB_10961281"	"unprognostic (1.33e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.39e-3)"	"unprognostic (2.43e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.44e-2)"	"unprognostic (6.73e-2)"	"prognostic unfavourable (4.05e-11)"	"unprognostic (1.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.28e-2)"	14.8	1.0	1.5	2.2	2.8	0.3	16.5	1.0	1.6	8.9	5.8	0.0	2.2	1.4	6.0	4.1	5.0	1.5	4.2	16.3	1.0	21.8	1.1	0.9	2.3	0.7	1.1	0.6	1.6	2.5	0.4	4.1	36.4	4.5	5.9	0.8	3.8	2.0	6.3	0.9	5.6	10.1	2.5	1.1	0.9	1.0	0.9	0.4	0.0	2.5	5.9	3.5	2.9	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	4.3	0.0	0.0	0.6	0.0	1.1	0.5	2.2	0.8	0.0	14.6	3.0	2.3	0.0	0.8	0.7	0.0	0.5	1.6	6.5	0.8	0.2	0.0	0.2	1.0	0.6	1.2	0.3	0.6	0.5	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.9	1.0	0.0	0.0	0.0	1.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.8	1.0	1.3	1.0	21.8	1.1	0.6	4.5	0.4
MAGEA10	"CT1.10, MAGE10, MGC10599"	ENSG00000124260	"MAGE family member A10"	P43363	X	152133310-152138578	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 48.7"	"Group enriched"	"Detected in some"	7	"PC-3: 9.3;SH-SY5Y: 5.9;U-266/84: 6.3;WM-115: 14.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA003333, HPA070780"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA003333: AB_10962837, HPA070780: "		"unprognostic (1.92e-1)"				"unprognostic (1.06e-1)"		"unprognostic (2.02e-1)"	"unprognostic (6.95e-2)"	"unprognostic (9.91e-2)"				"unprognostic (5.97e-3)"	"unprognostic (1.11e-1)"		"unprognostic (1.25e-1)"	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	48.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	6.6	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.9	0.8	2.6	0.8	1.2	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.4	0.0	0.0	0.1	0.0	9.3	0.0	0.1	0.0	0.0	0.0	0.2	5.9	0.0	0.1	0.0	0.1	0.2	0.2	0.1	0.2	0.0	0.0	1.2	6.3	0.0	0.5	0.0	14.9	2.6	0.8	0.7	0.4	0.7	0.4	0.7	0.5	0.4	0.3	0.9	0.6	0.7	2.6	1.2	0.5	0.8	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0
GABRA3		ENSG00000011677	"Gamma-aminobutyric acid type A receptor alpha3 subunit"	P34903	X	152166234-152451358	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 30.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 7.8;Karpas-707: 13.2;PC-3: 7.6;U-2 OS: 6.5;U-266/70: 7.1;U-266/84: 11.7;U-87 MG: 7.7"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 16.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA000839	Approved	Supported								"HPA000839: AB_1078929"	"unprognostic (9.63e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.07e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.34e-6)"	"unprognostic (1.24e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.29e-6)"	"unprognostic (7.42e-3)"	"unprognostic (6.20e-2)"		"unprognostic (8.13e-2)"	0.7	0.7	7.7	0.6	15.2	0.7	0.7	1.3	30.1	2.2	0.8	3.3	0.0	0.8	1.2	0.8	1.3	0.7	0.7	0.7	10.9	15.9	0.7	0.7	0.7	0.7	4.7	10.5	0.6	0.7	0.6	0.9	5.2	6.2	0.8	0.8	0.4	0.7	1.8	0.8	1.1	0.9	0.8	2.1	0.7	0.7	1.8	1.1	0.0	0.7	0.0	0.9	1.8	0.4	0.0	0.1	1.5	0.3	0.3	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	1.3	13.2	0.0	0.0	0.0	0.0	2.4	7.6	0.0	0.0	0.0	0.0	0.0	0.2	4.8	0.0	4.9	0.4	0.1	1.2	0.0	5.0	6.5	0.3	1.4	7.1	11.7	0.0	7.7	0.0	4.9	1.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.3	0.1	0.2	0.0	7.7	15.2	1.3	28.4	10.9	15.9	4.7	10.5	6.2	1.1
GABRQ	THETA	ENSG00000268089	"Gamma-aminobutyric acid type A receptor theta subunit"	Q9UN88	X	152638183-152657534	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 28.9;cervix, uterine: 16.2"	"Group enriched"	"Detected in some"	7	"HeLa: 8.8;SiHa: 8.6;U-87 MG: 28.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"hypothalamus: 61.6"	"Region enhanced"	"Detected in many"		"midbrain: 24.9"												"unprognostic (3.68e-3)"	"unprognostic (7.78e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.17e-4)"	"unprognostic (3.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.45e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.73e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.10e-5)"	"unprognostic (3.43e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.70e-2)"	0.2	4.4	10.5	0.2	5.7	0.1	0.1	0.0	7.5	16.2	0.2	1.5	1.0	0.2	2.6	0.5	1.1	0.3	0.1	0.2	23.4		0.2	0.1	0.1	0.2	0.0	13.6	0.1	0.1	0.1	0.0	0.3	28.9	0.9	0.2	0.0	0.1	1.7	0.1	0.7	0.5	1.6	7.2	0.2	0.1	4.7	1.0	0.0	0.3	1.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.2	0.2	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.0	2.2	0.0	0.0	0.0	0.0	1.2	8.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MAGEA3	"CT1.3, HIP8, HYPD, MAGE3, MGC14613"	ENSG00000221867	"MAGE family member A3"	P43357	X	152698752-152702347	"Cancer-related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	22	"testis: 12.8"	"Cell line enhanced"	"Detected in some"		"HMC-1: 23.4;K-562: 35.6;PC-3: 33.2;SH-SY5Y: 33.0;SK-BR-3: 37.6;U-266/70: 52.7;U-266/84: 58.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																										"unprognostic (1.29e-1)"	"unprognostic (9.34e-2)"	"prognostic unfavourable (3.58e-4)"	"unprognostic (4.20e-2)"	"unprognostic (2.48e-1)"					"unprognostic (2.53e-3)"	"unprognostic (3.95e-2)"		"unprognostic (2.92e-1)"	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.2	0.0	0.0	23.4	0.0	0.0	0.0	0.0	0.0	35.6	3.6	0.0	0.0	0.0	0.0	0.0	33.2	0.0	0.0	0.6	0.0	0.0	7.1	33.0	0.0	37.6	1.8	0.3	2.2	0.2	2.3	4.4	2.1	3.1	52.7	58.6	0.0	0.2	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CSAG2	"CSAG3B, CT24.2, TRAG3"	ENSG00000268902	"CSAG family member 2"		X	152708261-152714549	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.1;skin 1: 2.7;testis: 1.9"	"Cell line enhanced"	"Detected in some"		"HMC-1: 16.8;SK-BR-3: 6.9;U-266/70: 5.6;U-266/84: 6.9"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (5.87e-2)"				"unprognostic (3.82e-2)"		"unprognostic (1.44e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.81e-2)"				"unprognostic (3.35e-2)"	"unprognostic (1.55e-1)"		"unprognostic (1.50e-2)"	0.1	0.0		0.0		0.0	0.0		0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.2	0.0	0.2			0.0	0.0	0.0	3.1			0.0	0.0	0.0		0.1		0.0	0.0		0.0	0.1	0.0	2.7	0.0	0.0		1.0	0.0	1.9			0.0		0.2	0.7		0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.7	2.5	0.0	0.0	0.0	0.0	0.4	2.1	0.0	0.0	2.4	0.0	0.0	1.4	3.0	0.0	6.9	2.9	0.0	0.3	0.1	0.1	2.4	0.6	0.2	5.6	6.9	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0										
MAGEA2B	"MAGE2, MAGEA2, MAGEA2b, MGC16973"	ENSG00000183305	"MAGE family member A2B"	P43356	X	152714586-152718607	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"testis: 5.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 18.4;HMC-1: 19.3;K-562: 16.2;SH-SY5Y: 26.0;U-266/70: 13.6;U-266/84: 20.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																														"unprognostic (1.20e-1)"									0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.7		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.9			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	16.2	5.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	6.0	26.0	0.0	7.8	0.9	0.0	0.6	0.0	0.0	0.7	0.1	0.2	13.6	20.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CSAG1	"CSAGE, CT24.1"	ENSG00000198930	"Chondrosarcoma associated gene 1"	Q6PB30	X	152727484-152733735	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 4.2;lymphoid tissue: 3.3;testis: 6.3"	"Cell line enhanced"	"Detected in some"		"HMC-1: 25.7;K-562: 16.4;PC-3: 23.3;SH-SY5Y: 14.5;U-266/70: 40.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (2.37e-1)"	"unprognostic (4.66e-2)"		"unprognostic (8.96e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.83e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.21e-1)"	"unprognostic (6.68e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.07e-6)"	"unprognostic (5.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-3)"	"unprognostic (8.70e-3)"	0.2	0.2	3.3	1.1	4.2	0.2	0.2	1.6	4.1	0.2	0.3	1.5	0.0	0.2	0.8	0.2	0.2	0.4	0.2	0.2	3.2	1.8	0.3	0.4	0.3	3.3	3.0	0.9	0.2	0.2	0.2	0.0	0.3	2.0	0.4	0.3	0.0	0.5	0.5	0.2	0.5	0.6	0.7	1.3	0.5	0.4	6.3	2.7	0.1	0.9	0.0	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	3.4	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	1.2	0.0	0.0	0.0	25.7	0.0	0.1	0.0	0.0	0.0	16.4	0.2	0.0	0.0	0.1	0.0	0.0	23.3	0.0	0.0	0.1	0.0	0.0	2.6	14.5	0.0	8.6	6.8	0.4	0.0	0.1	1.6	0.3	8.3	2.7	40.8	0.6	0.0	0.3	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	4.2	1.6	4.1	3.2	1.8	3.0	0.9	2.0	2.7
MAGEA12	"CT1.12, MAGE12"	ENSG00000213401	"MAGE family member A12"	P43365	X	152733779-152737669	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"brain: 4.1;testis: 8.3"	"Cell line enhanced"	"Detected in some"		"HMC-1: 21.7;K-562: 31.6;PC-3: 15.4;SH-SY5Y: 18.1;U-2 OS: 33.0;U-266/70: 26.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 10.8"	"Region enhanced"	"Detected in some"		"cerebral cortex: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																										"unprognostic (3.47e-2)"	"unprognostic (4.54e-1)"	"prognostic unfavourable (3.22e-4)"	"unprognostic (1.82e-1)"	"unprognostic (3.25e-1)"		"unprognostic (1.60e-3)"		"unprognostic (8.57e-4)"	"unprognostic (4.61e-2)"	"unprognostic (1.78e-1)"		"unprognostic (4.06e-2)"	0.2	0.0	0.7	0.0	1.1	0.0	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	8.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.0	31.6	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.4	0.0	0.0	1.2	18.1	0.0	9.0	4.7	0.2	0.0	0.1	0.0	33.0	4.7	2.3	26.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.1	4.1	0.5	0.4	1.1	0.0	0.0	0.0
MAGEA2	"CT1.2, MAGE2, MAGEA2A"	ENSG00000268606	"MAGE family member A2"	P43356	X	152749863-152753884	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	69	"testis: 9.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 16.4;K-562: 22.0;SH-SY5Y: 17.7;SK-BR-3: 17.3;U-266/70: 43.3;U-266/84: 29.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																														"unprognostic (3.67e-1)"									0.0	0.0		0.0		0.0	0.0		0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	9.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	22.0	9.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	7.0	17.7	0.0	17.3	4.7	0.0	1.9	0.1	0.2	1.3	0.4	0.1	43.3	29.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CSAG3	CSAG3A	ENSG00000268916	"CSAG family member 3"	Q9Y5P2	X	152753921-152760222	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"lymphoid tissue: 3.4;skin 1: 2.4;testis: 5.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 11.1;HMC-1: 11.9;Karpas-707: 9.5;SH-SY5Y: 15.4;SK-BR-3: 14.2;U-2 OS: 11.2;U-266/70: 36.8;U-266/84: 18.6"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (1.56e-1)"			"unprognostic (9.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.12e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.02e-2)"		"unprognostic (7.06e-2)"		"unprognostic (7.06e-2)"	"unprognostic (1.84e-1)"		"unprognostic (2.91e-2)"	0.2	0.0		0.0		0.1	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.1	3.4			0.0	0.0	0.0		0.1		0.0	0.0		0.0	0.0	0.0	2.4	0.0	0.0		3.3	0.0	5.5			0.0		0.2	0.0		0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.1	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	5.6	9.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	3.2	15.4	0.0	14.2	0.5	0.0	0.6	0.0	0.0	11.2	0.0	0.0	36.8	18.6	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0										
MAGEA6	"CT1.6, MAGE-3b, MAGE3B, MAGE6"	ENSG00000197172	"MAGE family member A6"	P43360	X	152766136-152769747	"Cancer-related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	20	"testis: 11.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 39.1;K-562: 31.8;PC-3: 36.1;SK-BR-3: 34.2;U-2 OS: 25.1;U-266/70: 43.7;U-266/84: 27.2"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (3.09e-1)"			"unprognostic (5.94e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavourable (1.93e-4)"	"unprognostic (3.50e-2)"	"unprognostic (1.74e-1)"					"unprognostic (5.33e-2)"	"unprognostic (8.33e-2)"		"unprognostic (6.00e-2)"	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0			0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.1		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.2	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	13.1	0.2	0.0	0.0	39.1	0.0	0.0	0.0	0.0	0.0	31.8	18.5	0.0	0.0	0.0	0.0	0.0	36.1	0.0	0.0	2.0	0.0	0.0	1.9	14.3	0.0	34.2	4.7	0.5	2.4	0.1	16.0	25.1	0.9	4.7	43.7	27.2	0.0	0.3	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CETN2	"CALT, CEN2"	ENSG00000147400	"Centrin 2"	P41208	X	152826973-152830777	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 97.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA028956	Approved									"HPA028956: AB_10601798"	"unprognostic (3.32e-1)"	"prognostic favourable (7.54e-6)"	"unprognostic (7.73e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.73e-3)"	"unprognostic (9.58e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-1)"	"prognostic favourable (9.97e-4)"	"unprognostic (5.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.32e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.20e-1)"	11.7	17.1	26.6	7.8	26.4	9.1	16.7	7.5	25.3	27.3	16.7	11.4	23.8	6.3	27.5	48.3	16.6	97.3	13.0	13.5	30.0	30.8	29.4	12.6	15.9	6.7	21.2	24.0	24.2	8.6	14.8	26.7	11.1	54.2	21.1	10.9	9.9	10.4	33.0	10.2	7.3	7.0	22.1	19.8	8.0	10.5	11.2	10.3	9.9	34.6	11.7	8.6	17.9	12.4	9.1	15.4	26.2	10.1	8.8	11.5	8.7	40.0	18.3	22.8	17.1	30.3	33.0	9.1	17.5	21.1	23.2	17.8	8.2	21.6	14.4	46.1	23.4	15.7	15.8	21.7	27.6	6.4	11.4	3.2	9.9	24.0	11.4	13.4	3.6	19.8	28.7	21.4	11.4	18.2	8.4	6.0	22.4	18.7	9.9	14.6	7.9	23.6	8.8	16.6	14.7	42.0	9.9	11.2	14.5	11.6	12.2	10.2	13.0	10.3	16.9	16.4	13.2	32.3	19.4	6.1	8.0	22.6	34.6	8.1	8.0	12.9	8.8	26.2	9.6	10.1	11.5	9.1	9.4	10.5	10.3	7.8	10.2	10.3	8.4	8.8	10.0	15.4	8.0	8.7	26.6	26.4	7.5	25.3	30.0	30.8	21.2	24.0	54.2	10.3
NSDHL	"H105e3, SDR31E1, XAP104"	ENSG00000147383	"NAD(P) dependent steroid dehydrogenase-like"	Q15738	X	152830967-152869729	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000248, HPA000571"	Enhanced		Enhanced	"Endoplasmic reticulum,Lipid droplets"				"Endoplasmic reticulum"	"Lipid droplets"	"HPA000248: AB_1079507, HPA000571: AB_1079506"	"unprognostic (1.84e-1)"	"prognostic favourable (5.65e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (5.04e-4)"	"unprognostic (1.03e-1)"	"unprognostic (5.70e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.63e-1)"	"prognostic favourable (6.09e-5)"	"unprognostic (3.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.79e-2)"	17.4	24.8	11.0	7.7	10.5	6.0	20.4	7.7	15.0	13.4	23.4	13.9	20.5	13.3	10.4	35.7	36.2	11.9	7.4	16.7	14.3	11.4	11.6	38.1	9.9	8.7	9.7	10.4	9.8	7.9	9.8	6.9	7.9	18.9	12.0	10.7	7.9	12.2	17.7	6.9	14.5	24.0	9.9	14.2	7.3	9.6	8.6	9.3	6.0	11.0	22.2	17.0	7.5	16.1	16.2	17.5	16.4	17.7	17.0	17.3	13.0	43.6	16.1	21.9	11.4	18.9	14.4	12.4	8.7	11.7	15.9	20.3	22.2	23.9	21.6	29.4	11.8	22.5	28.5	40.2	14.1	7.2	16.3	8.8	15.7	22.4	13.8	8.8	7.2	17.6	15.6	31.1	7.9	14.7	14.6	9.8	12.0	19.3	8.7	11.5	8.7	19.4	6.5	15.9	17.7	33.0	18.1	7.9	9.0	7.8	11.7	9.2	7.7	11.3	12.4	7.4	12.3	17.8	16.7	13.9	9.3	37.2	13.7	13.8	7.0	16.4	17.7	15.8	15.6	16.2	15.7	16.2	15.6	13.5	17.5	12.9	11.4	12.6	1.9	17.0	12.1	15.6	17.3	13.0	11.0	10.5	7.7	15.0	14.3	11.4	9.7	10.4	18.9	9.3
ZNF185	SCELL	ENSG00000147394	"Zinc finger protein 185 with LIM domain"	O15231	X	152914442-152973480	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 93.5;esophagus: 67.6"	"Cell line enhanced"	"Detected in many"		"A-431: 31.0;EFO-21: 36.9;HBEC3-KT: 25.6;PC-3: 22.7;TIME: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 21.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 21.6;monocytes: 13.9"					"Low region specificity"	"Detected in all"			"HPA000400, HPA016438"	Enhanced		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol"			5400	"Plasma membrane, Cytosol"	"Actin filaments, Focal adhesion sites"	"HPA000400: AB_1080685, HPA016438: AB_1859109"	"unprognostic (1.34e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.75e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.49e-2)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (7.94e-2)"	"unprognostic (6.28e-2)"	"prognostic unfavourable (3.30e-5)"	"unprognostic (5.18e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-1)"	3.9	1.7	1.8	2.0	3.2	0.8	1.8	2.7	2.0	14.3	1.8	1.4	10.7	0.0	3.8	93.5	67.6	3.1	2.0	1.9	1.7	0.8	2.0	1.1	3.3	3.1	2.1	1.1	1.2	0.9	0.1	2.3	4.0	1.7	4.2	0.3	1.3	10.1	28.1	1.5	9.9	1.2	1.4	1.2	3.7	0.8	1.9	2.0	1.2	3.9	1.4	6.6	2.1	22.8	0.4	3.8	21.6	13.9	0.2	0.6	10.2	31.0	6.6	0.6	0.4	0.8	1.0	1.4	1.5	0.1	3.9	0.5	0.2	9.4	0.4	36.9	2.3	4.4	0.9	25.6	15.9	0.3	0.6	2.0	2.7	1.0	1.8	0.1	0.1	0.7	18.4	0.4	15.1	19.7	0.1	0.3	0.1	7.3	0.1	0.1	0.4	22.7	0.1	0.1	0.2	2.0	2.9	0.2	2.1	0.0	5.9	0.9	6.0	0.6	60.4	0.2	13.4	0.7	1.1	0.3	0.2	0.2	0.4	2.2	0.4	21.6	13.9	5.7	0.5	12.9	0.3	0.4	0.4	0.6	3.8	0.3	0.6	0.3	9.5	0.2	10.2	2.5	0.5	10.2	1.8	3.2	2.7	2.0	1.7	0.8	2.1	1.1	1.7	2.0
PNMA5	KIAA1934	ENSG00000198883	"PNMA family member 5"	Q96PV4	X	152988824-152994127	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"brain: 21.6;testis: 16.8"	"Group enriched"	"Detected in some"	573	"HMC-1: 62.0;U-266/70: 97.6;U-266/84: 58.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											"HPA044690, HPA073946"	Enhanced									"HPA044690: , HPA073946: "	"unprognostic (5.25e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavourable (2.25e-4)"	"unprognostic (1.66e-1)"	"unprognostic (2.93e-3)"	"unprognostic (9.98e-3)"	"unprognostic (3.55e-2)"	"prognostic favourable (3.16e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.76e-9)"	"unprognostic (1.00e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.41e-2)"	0.4	0.3	8.2	0.5	21.6	0.4	0.3	0.0	11.6	0.3	0.4	0.3	0.0	0.5	0.4	0.5	0.4	0.4	0.4	0.4	3.9	19.1	0.4	0.4	0.4	0.6	1.0	6.6	0.3	0.3	0.3	0.6	0.7	2.4	0.3	0.4	0.0	0.4	0.4	0.3	1.2	0.4	0.4	0.5	1.1	0.7	16.8	0.0	0.0	0.4	0.0	0.5	0.5	0.0	0.8	0.7	0.1	1.2	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	97.6	58.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.8	0.0	0.8	0.6	0.0	0.7	0.0	0.2	0.0	0.1	0.0	1.2	0.4	0.6	0.2	8.2	21.6	0.0	11.6	3.9	19.1	1.0	6.6	2.4	0.0
PNMA3	"MA3, MA5, MGC132756, MGC132758"	ENSG00000183837	"PNMA family member 3"	Q9UL41	X	153056409-153060467	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 17.4;epididymis: 35.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.8;NTERA-2: 8.0;SCLC-21H: 2.6;SH-SY5Y: 2.0;THP-1: 2.0"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA047920	Approved									"HPA047920: "	"unprognostic (1.66e-2)"	"unprognostic (8.97e-3)"	"unprognostic (8.70e-2)"	"prognostic unfavourable (4.14e-5)"	"unprognostic (9.43e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.77e-4)"	"unprognostic (2.84e-2)"	"unprognostic (6.20e-2)"	"unprognostic (7.62e-4)"	"unprognostic (1.93e-1)"	"unprognostic (5.92e-3)"	"unprognostic (2.93e-3)"	"unprognostic (7.25e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.07e-2)"	0.4	1.4	4.8	0.8	6.8	0.4	0.3	3.0	17.4	0.5	0.3	0.2	0.0	0.4	0.5	35.5	0.3	1.2	0.4	1.4	4.9		1.0	0.3	0.3	1.4	0.0	13.7	0.6	0.5	0.4	0.7	0.3	11.2	0.5	0.3	0.7	0.4	0.6	0.3	0.6	0.5	0.3	1.3	0.8	0.3	5.9	0.0	0.0	0.9	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.0	0.0	8.0	0.0	0.1	0.0	0.3	0.0	0.0	2.6	2.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0										
PNMA6A	"MGC15827, PNMA6C"	ENSG00000235961	"PNMA family member 6A"	P0CW24	X	153072482-153075018	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.3"	"Cell line enhanced"	"Detected in some"		"HHSteC: 7.9;HMC-1: 6.8;SK-MEL-30: 6.6;U-2 OS: 15.2;U-266/70: 5.8;U-698: 8.2"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in single"	15	"eosinophil: 5.3"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 5.3"									"HPA045007, HPA052115"	Uncertain		Uncertain	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"HPA045007: , HPA052115: "	"unprognostic (2.14e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.33e-2)"	"unprognostic (4.12e-3)"	"unprognostic (4.39e-2)"	"unprognostic (3.44e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.76e-4)"	"unprognostic (5.75e-3)"	"prognostic favourable (1.93e-5)"	"unprognostic (4.61e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.22e-2)"	1.3	2.0	7.2	0.1	6.2	0.2	0.3	7.0	16.3	3.7	0.2			0.5	1.8	7.0	0.1	1.5	0.9	2.1	6.5	11.0	6.2	7.9	0.1	0.2	5.5		3.1	0.7	0.4	3.9	0.1		0.1	0.1		0.9	0.7	0.0	0.3	0.3	0.6	1.6	0.5	0.5	0.8			1.8		0.2	0.1	0.0	0.0	0.0	5.3	0.0	0.0	0.1	0.0	0.0	5.3	0.1	1.6	0.0	0.0	0.0	0.9	0.2	0.3	0.0	0.0	0.5	0.0	1.8	0.4	0.0	2.9	0.0	0.0	0.0	0.6	0.0	0.3	0.2	7.9	3.2	6.8	1.2	0.0	0.1	0.0	0.2	1.3	0.0	0.1	0.4	1.1	0.0	3.4	0.0	0.0	0.0	0.0	0.3	0.0	3.3	1.9	0.4	0.0	6.6	0.0	4.1	0.0	0.0	15.2	0.0	0.0	5.8	4.3	8.2	0.0	0.0	0.4	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0										
MAGEA1	"CT1.1, MAGE1, MGC9326"	ENSG00000198681	"MAGE family member A1"	P43355	X	153179285-153183880	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	18	"testis: 13.5"	"Cell line enhanced"	"Detected in some"		"HEL: 17.4;HMC-1: 30.3;RPMI-8226: 15.0;U-2 OS: 29.0;U-266/70: 43.3;U-266/84: 69.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB002620	Enhanced		Supported	Cytosol				Cytosol		"CAB002620: "						"unprognostic (8.65e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"				"unprognostic (1.15e-1)"	"unprognostic (1.18e-1)"		"unprognostic (2.35e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	3.2	0.0	0.0	0.0	30.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.1	0.0	0.0	29.0	0.1	0.1	43.3	69.0	0.0	2.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0
PNMA6F	PNMA6BL	ENSG00000225110	"PNMA family member 6F"	A0A0J9YX94	X	153317681-153321822	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"adrenal gland: 2.5;brain: 8.4"	"Cell line enriched"	"Detected in single"	6	"AN3-CA: 2.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																										"unprognostic (6.52e-2)"										"unprognostic (7.19e-2)"			0.0	2.5	1.7	0.1	6.5	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.5		0.0	0.0	0.0	0.0	0.0	6.6	0.2	0.1	0.9	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ZNF275		ENSG00000063587	"Zinc finger protein 275"	Q9NSD4	X	153334155-153360110	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 38.6"	"Cell line enhanced"	"Detected in many"		"U-266/70: 35.4;U-698: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000566	Approved		Approved	Nucleoli				Nucleoli		"HPA000566: AB_1080700"	"unprognostic (6.96e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.11e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.59e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.33e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.14e-2)"	6.5	38.6	5.9	3.4	5.9	2.2	11.5	5.9	6.9	5.8	3.5	7.0	20.4	2.8	5.9	12.6	2.5	5.4	4.9	3.0	6.8	6.9	3.8	8.5	3.3	7.0	8.8	5.3	30.3	8.5	5.8	6.9	2.1	6.2	5.1	3.2	3.8	6.3	27.9	3.1	2.5	4.5	5.6	10.7	6.8	4.1	10.5	6.5	3.9	4.7	1.7	5.3	4.0	2.6	4.5	2.7	0.7	1.7	2.8	5.0	2.0	5.8	2.6	5.2	3.6	5.9	5.9	2.6	4.1	6.8	2.7	4.0	2.7	1.3	10.1	8.5	7.7	1.0	5.9	3.7	3.9	2.3	4.7	3.3	2.5	3.8	8.0	4.1	3.0	6.9	2.7	2.3	4.2	3.2	5.0	0.0	4.7	4.3	4.8	3.4	2.3	4.2	5.9	5.5	3.5	2.0	3.9	2.6	3.6	2.1	0.2	5.0	0.9	7.3	3.5	4.0	4.8	6.6	5.3	35.4	9.4	20.2	3.6	8.3	2.8	0.7	1.7	0.2	3.7	1.5	4.4	4.5	3.4	3.3	1.6	4.4	5.0	4.2	0.1	2.8	1.4	2.7	4.6	2.0	5.9	5.9	5.9	6.5	6.8	6.9	8.8	5.3	6.2	6.5
PNMA6E		ENSG00000214897	"PNMA family member 6E"	A0A0J9YXQ4	X	153395640-153401420	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 8.0;ovary: 6.5;testis: 26.2"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 2.7;THP-1: 1.1;U-937: 2.1"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																									"unprognostic (5.82e-2)"						"unprognostic (1.71e-1)"		"unprognostic (2.99e-2)"			"unprognostic (1.77e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ZFP92	ZNF897	ENSG00000189420	"ZFP92 zinc finger protein"	A6NM28	X	153418322-153426481	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 6.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.0;HMC-1: 5.8;U-937: 9.9"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.2"					"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.8"	"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"hypothalamus: 10.3"	"Low region specificity"	"Detected in all"			HPA003030	Uncertain									"HPA003030: "	"unprognostic (6.94e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.57e-4)"	"unprognostic (1.01e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.51e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.49e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.66e-3)"	2.0	2.8	1.1	0.4	1.5	4.0	0.8	3.6	2.5	1.1	0.5			0.1	1.8	4.3	0.0	5.4	0.4	0.7	0.9	1.9	0.8	0.2	2.3	0.3	0.9		6.7	0.8	1.3	1.8	0.8		0.5	0.0		0.0	2.5	0.0	0.0	0.6	1.5	0.2	0.6	0.4	0.7			0.4		0.4	0.0	0.0	0.4	0.0	0.1	1.8	0.0	0.9	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.8	1.4	1.3	1.3	0.7	0.1	0.0	0.8	0.9	0.7	0.6	0.7	1.1	6.0	0.0	2.2	0.0	0.0	2.5	0.7	5.8	0.4	0.9	0.0	0.0	2.3	1.8	0.0	0.0	0.0	1.4	0.5	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.5	1.5	0.0	0.0	1.5	0.1	3.8	0.0	0.0	2.9	0.0	0.0	1.4	0.0	1.5	0.0	9.9	0.6	0.0	0.7	0.0	0.9	1.8	0.2	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.3										
TREX2		ENSG00000183479	"Three prime repair exonuclease 2"	Q9BQ50	X	153444720-153470587	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 39.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 7.4;U-698: 10.1;U-937: 9.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"basophil: 3.9;eosinophil: 5.7"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 5.7"	"Not detected"	"Not detected"							HPA054060	Uncertain									"HPA054060: "	"unprognostic (2.32e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.13e-3)"	"unprognostic (7.18e-4)"	"unprognostic (6.05e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.34e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.23e-2)"	3.2	1.5	2.1	3.4	3.0	1.9	2.1	1.1	3.6	4.3	2.6	1.9	15.5	1.4	2.5	2.2	4.5	2.6	2.2	3.5	1.6	1.2	2.8	4.6	2.4	3.1	2.4	2.4	2.1	2.2	1.5	1.7	2.6	2.7	2.5	1.4	1.4	4.5	7.4	2.0	39.6	2.3	1.9	1.2	4.3	1.7	2.1	1.9	5.8	3.3	6.2	4.7	2.2	5.2	0.4	0.3	5.7	0.1	0.2	0.4	0.2	2.8	3.5	0.3	1.3	0.5	0.7	0.3	0.9	0.8	0.7	2.0	1.0	0.7	0.3	1.8	0.8	3.1	1.2	2.0	0.0	3.1	7.4	0.3	0.7	0.4	0.3	0.8	1.9	0.8	1.8	0.8	0.7	0.3	0.4	3.5	0.2	3.3	2.0	2.2	1.1	2.4	4.8	1.0	2.2	0.3	1.0	0.8	0.4	0.3	0.3	1.0	0.5	0.9	0.0	1.3	2.3	2.8	1.0	3.9	2.7	10.1	0.3	9.4	1.5	3.9	0.0	5.7	0.3	0.0	0.2	0.4	0.1	0.3	0.3	0.3	0.4	0.1	0.0	0.2	0.1	0.0	0.1	0.2	2.1	3.0	1.1	3.6	1.6	1.2	2.4	2.4	2.7	1.9
HAUS7	"UCHL5IP, UIP1"	ENSG00000213397	"HAUS augmin like complex subunit 7"	Q99871	X	153447666-153495516	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003614			Approved	"Nucleoli,Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Centrosome, Cytosol"	Nucleoli	"HPA003614: AB_1080368"	"unprognostic (2.06e-1)"	"prognostic favourable (6.12e-4)"	"unprognostic (3.81e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.84e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.65e-3)"	"unprognostic (6.28e-2)"	"prognostic unfavourable (3.94e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.09e-2)"	13.1	9.4	16.1	10.3	16.4	9.4	7.9	9.1	19.3	12.7	9.3	8.9	20.3	7.9	10.8	17.1	7.0	9.9	15.1	11.9	20.3	9.1	13.3	11.9	9.4	12.1	12.0	16.5	9.3	4.3	3.1	6.4	12.6	11.1	11.8	6.2	7.8	8.5	17.4	7.2	46.9	7.4	12.1	8.9	16.4	8.8	6.1	18.4	14.2	10.8	8.8	9.8	7.5	11.8	20.2	22.3	10.1	31.1	16.7	18.5	15.8	13.7	22.2	9.8	19.1	3.5	4.8	13.7	9.5	5.4	11.0	19.7	16.1	7.7	13.2	30.7	6.5	11.7	14.1	9.6	8.6	15.8	23.2	9.6	20.6	12.0	3.1	15.8	13.9	7.3	2.5	9.8	6.2	7.8	12.0	6.8	6.5	26.5	14.8	19.1	6.1	22.2	13.9	16.2	19.9	3.5	8.7	10.9	8.3	5.2	11.3	3.9	4.5	7.6	5.0	9.5	19.0	22.2	17.4	9.9	26.2	51.5	5.1	28.4	13.1	4.7	26.2	10.1	17.0	31.1	17.8	20.2	18.5	17.1	22.3	16.6	18.4	16.7	3.4	16.7	27.1	12.6	15.5	15.8	16.1	16.4	9.1	19.3	20.3	9.1	12.0	16.5	11.1	18.4
BGN	"DSPG1, SLRR1A"	ENSG00000182492	Biglycan	P21810	X	153494939-153509554	"Disease related genes, Predicted secreted proteins"			"Aortic aneurysm, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 45.5;BJ hTERT+: 58.9;fHDF/TERT166: 82.2;HSkMC: 43.2;hTEC/SVTERT24-B: 34.9;HUVEC TERT2: 82.4;U-138 MG: 37.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003157, CAB003678"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to extracellular matrix"		2500000	"Golgi apparatus"	"Endoplasmic reticulum"	"CAB003678: AB_425325, HPA003157: AB_1078282"	"unprognostic (1.74e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-3)"	"unprognostic (3.60e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavourable (6.00e-8)"	"unprognostic (7.05e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.57e-3)"	41.1	39.7	8.1	23.2	14.6	0.4	20.2	5.6	14.3	76.7	12.0	18.7	16.7	6.0	63.4	31.7	21.1	23.6	86.7	133.0	8.9	5.2	67.6	78.1	77.6	29.4	8.9	16.3	39.6	16.8	5.1	26.7	131.1	15.0	33.6	7.0	48.3	20.4	38.2	17.0	31.0	8.6	56.9	5.9	101.3	10.0	28.0	15.8	3.9	45.3	29.9	14.6	34.5	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	4.7	10.8	0.1	45.5	58.9	8.4	2.8	5.7	0.0	0.0	8.4	82.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.5	4.1	0.0	0.0	43.2	0.3	34.9	1.6	82.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	17.4	37.5	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	14.6	5.6	14.3	8.9	5.2	8.9	16.3	15.0	15.8
ATP2B3	"CFAP39, CLA2, PMCA3, SCAX1"	ENSG00000067842	"ATPase plasma membrane Ca2+ transporting 3"	Q16720	X	153517676-153582939	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	Calmodulin-binding	"Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 18.6;brain: 23.2"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 14.3;SH-SY5Y: 4.2;THP-1: 3.5;U-937: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001583	Enhanced									"HPA001583: AB_1079641"	"unprognostic (1.35e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.28e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.68e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.71e-12)"	"unprognostic (1.44e-3)"	"unprognostic (2.04e-1)"		"unprognostic (2.42e-2)"	0.8	18.6	5.4	0.9	11.3	0.8	0.8	16.1	23.2	0.8	0.9	3.9	0.0	0.9	0.9	2.6	0.8	3.1	0.8	0.8	7.8	5.5	1.0	0.8	0.8	0.8	4.3	11.5	0.8	0.9	0.8	1.2	1.7	13.6	0.8	0.8	1.4	1.3	1.3	0.8	0.9	0.9	0.9	1.4	0.8	0.8	1.1	0.9	0.0	0.8	0.0	0.8	0.8	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	14.3	4.2	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.4	11.3	16.1	20.7	7.8	5.5	4.3	11.5	13.6	0.9
CCNQ	FAM58A	ENSG00000262919	"Cyclin Q"	Q8N1B3	X	153587919-153600045	"Disease related genes, Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA050137, HPA059843"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA050137: , HPA059843: "	"unprognostic (3.94e-1)"	"unprognostic (1.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.12e-1)"	"unprognostic (8.50e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.25e-2)"	3.1	5.7	4.2	6.1	12.8	4.2	9.7	3.7	11.1	4.5	5.2	6.4	4.2	6.1	3.7	10.5	5.1	5.1	4.0	14.7	7.9		6.5	6.3	5.0	10.9	9.5	6.1	4.1	9.5	3.0	6.4	6.4	7.3	5.7	6.1	3.5	8.0	6.8	10.3	4.0	5.0	4.9	6.7	7.3	5.4	2.7	7.4	3.9	4.9	4.2	8.7	5.2	4.5	7.4	1.9	6.8	2.3	1.1	4.8	1.4	19.9	15.6	6.0	21.4	11.1	5.7	9.5	12.0	10.5	11.5	11.8	14.9	7.1	16.2	23.3	12.8	12.9	19.9	11.4	11.9	9.9	20.2	3.9	9.4	11.4	9.8	13.6	9.4	7.5	10.3	7.8	8.6	9.7	4.8	7.8	9.8	23.2	9.6	16.7	7.6	26.3	10.9	9.7	8.4	8.7	8.6	8.0	10.5	6.2	9.8	14.1	3.6	12.5	7.0	10.2	14.3	22.4	18.2	11.3	10.7	20.5	9.1	21.3	7.5	0.0	2.3	6.8	4.0	2.1	1.8	7.4	3.7	2.8	1.9	6.2	4.0	2.8	1.4	1.1	1.0	1.9	4.8	1.4										
DUSP9	"MKP-4, MKP4"	ENSG00000130829	"Dual specificity phosphatase 9"	Q99956	X	153642492-153651326	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"kidney: 23.0;placenta: 63.1"	"Cell line enriched"	"Detected in some"	9	"Hep G2: 88.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	7	"amygdala: 4.4;basal ganglia: 2.7;cerebral cortex: 3.5;hippocampal formation: 3.7;hypothalamus: 3.6"	HPA003336	Enhanced		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA003336: AB_1078709"	"unprognostic (4.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavourable (1.60e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.74e-3)"	"unprognostic (9.36e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.68e-7)"	"unprognostic (4.49e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.52e-2)"	0.2	0.1	3.2	0.2	4.4	0.1	0.3	0.2	2.0	0.2	0.1	0.7	0.0	0.2	0.1	0.3	0.3	0.2	0.1	0.2	2.5	0.6	23.0	0.7	0.2	0.2	1.1	0.6	1.9	0.5	0.1	0.0	63.1	0.9	0.2	0.1	0.0	0.8	1.5	0.1	0.2	0.2	0.1	0.5	0.2	0.2	1.1	0.8	0.0	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	8.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.5	0.5	0.0	3.9	0.0	1.8	9.8	0.2	0.0	0.2	1.8	0.0	0.7	88.7	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.0	0.1	0.2	3.6	0.0	0.0	0.0	0.0	2.2	0.1	0.3	0.5	0.7	0.3	0.1	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	4.4	0.2	2.0	2.5	0.6	1.1	0.6	0.9	0.8
PNCK	"CaMK1b, MGC45419"	ENSG00000130822	"Pregnancy up-regulated nonubiquitous CaM kinase"	Q6P2M8	X	153669730-153689010	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.4;seminal vesicle: 38.5"	"Cell line enriched"	"Detected in some"	8	"AN3-CA: 26.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 15.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007458	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA007458: AB_1079644"	"unprognostic (1.56e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.95e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.15e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (1.04e-6)"	"unprognostic (2.86e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.26e-3)"	1.6	1.8	21.4	2.2	35.4	0.6	0.9	3.7	24.9	0.9	21.9	0.9	6.9	3.8	4.2	3.1	14.5	2.9	2.9	3.8	19.5	17.0	1.0	0.5	0.7	0.6	6.1	15.5	0.7	0.5	1.4	0.3	2.4	3.8	12.6	4.2	0.4	0.7	38.5	2.2	1.4	5.2	15.3	2.6	0.7	5.5	4.7	1.7	0.0	0.5	0.0	0.7	10.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	26.5	0.0	0.0	2.8	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.4	0.0	0.0	0.0	3.2	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.1	0.0	0.1	2.1	0.2	0.3	0.0	0.2	1.1	0.0	0.2	0.2	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	35.4	3.7	23.2	19.5	17.0	6.1	15.5	3.8	1.7
SLC6A8	"CRTR, CT1"	ENSG00000130821	"Solute carrier family 6 member 8"	P48029	X	153688099-153696593	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 42.0;SK-BR-3: 43.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 2.6"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.6"																				"unprognostic (5.80e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (1.53e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (7.39e-4)"	"unprognostic (2.87e-1)"	17.6	19.5	26.3	5.8	39.0	19.3	7.3	23.9	31.9	6.1	26.8	36.6	7.6	32.4	11.2	9.1	20.0	10.6	20.2	53.1	29.3	16.1	27.3	1.9	3.1	1.9	55.6	22.0	5.1	8.3	17.0	7.2	22.6	25.8	12.8	20.2	20.9	31.8	24.9	76.4	28.0	48.3	13.5	28.2	5.1	11.0	16.7	38.9	4.6	2.8	11.0	5.0	40.4	10.1	0.5	0.0	2.6	0.2	0.0	0.0	0.1	39.8	1.7	12.3	42.0	3.9	2.7	2.9	6.0	9.9	7.8	9.7	5.1	0.5	0.0	4.6	7.2	14.9	24.5	20.6	4.8	0.7	23.4	0.1	13.9	15.2	13.6	0.2	2.8	5.8	4.4	7.7	28.2	3.9	9.7	0.6	4.3	2.3	0.2	0.9	12.6	17.6	1.9	1.4	0.5	8.4	7.8	15.9	17.7	8.7	43.6	28.3	8.4	6.1	3.8	12.9	20.5	16.5	17.6	1.5	0.7	0.4	28.8	1.2	12.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	26.3	39.0	23.9	30.4	29.3	16.1	55.6	22.0	25.8	38.9
BCAP31	"6C6-Ag, BAP31, CDM, DXS1357E"	ENSG00000185825	"B cell receptor associated protein 31"	P51572	X	153700492-153724746	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, ER-Golgi transport, Host-virus interaction, Protein transport, Transport"		"Deafness, Dystonia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003906, CAB015350, CAB015424"	Supported	Approved	Enhanced	"Endoplasmic reticulum"			6800000	"Endoplasmic reticulum"		"CAB015350: AB_2243544, CAB015424: AB_781567, HPA003906: AB_1078270"	"unprognostic (1.02e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.36e-2)"	"prognostic unfavourable (9.87e-4)"	"unprognostic (3.25e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	60.7	43.4	38.3	20.3	38.8	27.4	71.3	22.2	48.1	28.7	31.8	27.1	27.5	28.8	30.2	48.6	42.4	31.0	26.8	26.7	34.1	36.5	41.6	52.4	42.2	50.0	38.1	26.0	29.1	67.6	36.0	27.4	43.6	44.5	34.3	36.6	30.7	44.5	37.7	15.6	37.3	37.8	32.4	33.6	36.7	24.8	31.6	21.1	25.4	53.1	27.2	37.1	38.1	30.8	72.7	109.7	104.4	97.5	68.2	89.8	150.4	54.7	51.7	14.4	71.8	63.8	19.4	33.3	26.6	30.6	31.8	40.8	41.6	40.3	32.1	121.7	43.1	55.6	35.8	55.9	26.6	15.8	53.4	20.2	40.9	35.7	31.3	32.9	43.9	25.8	48.6	30.9	36.4	38.8	27.4	58.6	35.5	57.3	21.1	44.8	16.4	53.5	23.0	16.0	71.9	49.7	60.2	18.8	26.6	11.9	59.3	40.0	21.7	37.2	40.4	27.9	27.5	37.7	53.3	60.1	115.8	42.6	54.5	44.6	24.4	80.3	80.6	77.5	89.0	86.1	79.5	71.2	89.8	88.1	69.9	72.7	79.4	86.4	104.4	68.2	97.5	109.7	72.4	150.4	38.3	38.8	22.2	48.1	34.1	36.5	38.1	26.0	44.5	21.1
ABCD1	"adrenoleukodystrophy, ALD, ALDP, AMN"	ENSG00000101986	"ATP binding cassette subfamily D member 1"	P33897	X	153724868-153744762	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 46.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 32.4;PC-3: 22.9;SK-BR-3: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"														"unprognostic (1.90e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.19e-3)"	"unprognostic (5.57e-3)"	"unprognostic (8.81e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.34e-1)"	"unprognostic (6.14e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.17e-2)"	"prognostic unfavourable (5.50e-4)"	"unprognostic (4.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.23e-2)"	13.8	20.3	2.1	6.0	2.7	5.0	8.9	1.1	2.5	6.2	15.9	2.7	12.7	12.5	21.4	9.7	4.7	6.1	8.8	10.4	2.0	2.0	7.0	14.3	7.5	10.1	3.0	1.9	6.0	11.7	2.2	6.5	23.1	2.0	7.1	2.3	9.3	6.1	7.3	14.7	3.0	46.2	8.3	2.7	9.1	4.6	24.0	1.7	12.1	3.8	6.5	4.9	7.8	9.8	1.9	4.8	4.1	5.4	1.4	7.7	3.4	5.8	1.8	1.2	5.1	3.5	1.5	15.8	2.8	3.1	1.9	3.4	1.1	3.2	1.5	32.4	3.9	0.7	0.7	0.6	0.2	5.2	0.9	4.6	18.2	15.0	4.6	2.8	10.4	2.9	0.8	2.2	0.2	3.0	2.6	5.7	2.7	2.0	1.9	2.7	1.5	22.9	3.4	2.9	2.5	1.4	0.6	1.3	5.3	7.4	22.7	11.6	1.7	4.8	3.5	2.6	3.5	6.6	3.1	5.7	2.4	3.7	3.2	9.7	3.6	0.7	4.8	4.1	1.6	5.4	7.7	1.9	1.9	2.3	4.8	1.5	2.1	1.5	3.1	1.4	4.7	3.0	0.6	3.4	2.1	2.7	1.1	2.1	2.0	2.0	3.0	1.9	2.0	1.7
PLXNB3	"PLEXB3, PLEXR, PLXN6"	ENSG00000198753	"Plexin B3"	Q9ULL4	X	153764196-153779346	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.3;salivary gland: 28.9"	"Cell line enhanced"	"Detected in many"		"WM-115: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.7"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 2.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA048046	Enhanced						17000			"HPA048046: "	"prognostic unfavourable (6.13e-4)"	"unprognostic (2.60e-1)"	"unprognostic (9.10e-4)"	"unprognostic (2.30e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.68e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.98e-2)"	3.7	17.4	15.5	2.9	34.9	1.5	4.5	16.1	46.3	3.5	14.8	45.8	1.8	3.3	8.1	5.3	6.4	3.8	6.1	3.1	19.9	9.4	1.3	1.3	2.1	1.4	39.7	17.3	1.3	5.6	1.1	0.6	1.4	18.4	9.0	3.2	2.8	28.9	10.7	1.4	11.3	3.4	8.9	25.6	1.3	4.4	7.2	40.2	0.0	1.3	0.2	1.2	6.8	3.8	0.1	2.7	0.0	0.0	0.7	0.0	0.7	4.8	0.5	0.6	0.4	0.6	0.4	0.3	4.5	0.9	0.6	1.6	0.0	0.1	0.0	2.9	1.2	0.5	0.0	3.8	0.5	0.1	0.0	3.0	5.4	3.4	1.3	0.0	0.3	1.0	2.8	2.8	1.8	1.8	0.2	1.7	1.2	3.9	0.0	0.7	0.1	7.5	1.4	0.5	0.0	0.7	2.2	1.3	4.1	0.2	4.2	10.1	5.6	0.0	7.9	4.7	2.4	3.7	5.6	1.6	0.4	0.1	10.2	0.2	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	2.7	0.0	0.7	15.5	34.9	16.1	20.8	19.9	9.4	39.7	17.3	18.4	40.2
SRPK3	"MSSK1, STK23"	ENSG00000184343	"SRSF protein kinase 3"	Q9UPE1	X	153776412-153785732	"Enzymes, Predicted intracellular proteins"	"Differentiation, Myogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 73.4"	"Cell line enhanced"	"Detected in many"		"RH-30: 30.8;U-266/70: 12.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.47e-4)"	"unprognostic (2.83e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.10e-4)"	"unprognostic (8.70e-2)"	"unprognostic (5.38e-7)"	"unprognostic (1.97e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.07e-4)"	1.6	1.8	1.3	0.9	1.8	0.8	0.3	7.7	1.5	0.9	4.5	1.1	0.2	1.3	2.5	3.3	2.6	0.7	1.7	16.7	2.0	1.8	0.2	0.2	0.4	0.8	2.0	0.7	0.7	0.7	1.0	5.8	0.3	1.1	2.8	0.8	0.9	2.9	0.5	73.4	2.3	1.3	4.0	2.0	0.8	1.3	0.5	0.9	0.3	0.6	18.3	1.6	2.0	0.8	0.4	2.6	0.9	0.3	0.1	0.6	0.3	3.2	4.3	0.7	2.2	0.0	0.1	1.0	0.4	0.0	0.2	0.0	3.6	0.6	3.2	0.4	0.3	0.9	0.0	0.1	0.0	2.8	3.0	1.7	2.7	0.5	0.0	0.8	5.0	2.7	0.0	0.0	0.0	0.0	2.1	3.8	0.8	6.9	0.6	4.7	0.8	1.2	1.5	30.8	0.9	0.0	1.4	5.2	2.5	0.0	2.3	1.0	2.9	3.7	0.0	1.2	2.8	2.3	0.4	12.8	2.0	2.2	0.6	6.1	1.6	0.8	0.3	0.2	0.5	0.1	0.6	0.2	0.1	0.1	0.0	0.4	0.1	0.1	0.9	0.1	0.0	2.6	0.0	0.3	1.3	1.8	7.7	1.5	2.0	1.8	2.0	0.7	1.1	0.9
IDH3G		ENSG00000067829	"Isocitrate dehydrogenase 3 (NAD(+)) gamma"	P51553	X	153785766-153794523	"Citric acid cycle related proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000425, HPA002017"	Supported		Approved	Nucleoli,Mitochondria				"Nucleoli, Mitochondria"		"HPA000425: AB_1079097, HPA002017: AB_1079096"	"unprognostic (4.24e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.96e-1)"	"prognostic favourable (5.73e-6)"	"unprognostic (1.50e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.46e-1)"	24.5	34.0	27.7	26.8	47.2	37.1	24.1	37.2	61.5	25.0	28.8	25.7	24.6	34.7	26.6	21.3	31.8	29.4	25.6	50.8	35.0	25.2	40.6	29.5	20.9	25.6	27.3	35.6	31.8	40.5	29.1	24.9	22.5	40.5	21.4	25.2	26.0	34.5	29.8	54.9	36.3	34.9	24.8	20.1	26.9	24.8	16.0	23.3	31.2	24.3	37.1	28.2	24.4	21.1	20.6	45.5	43.7	44.4	23.7	28.8	33.6	28.9	26.7	15.8	22.2	24.8	20.5	19.4	15.1	21.3	26.8	28.5	22.1	22.1	36.9	26.2	24.2	21.7	23.9	20.6	9.9	12.1	30.5	13.8	36.3	17.7	28.1	19.2	29.2	23.1	14.9	20.7	22.6	20.5	7.6	20.3	21.6	40.5	21.8	22.6	7.1	35.4	19.3	13.5	32.2	29.9	18.0	20.2	13.8	9.4	32.0	15.0	13.3	16.6	18.1	17.0	10.7	25.0	35.7	27.9	6.9	47.0	27.8	23.9	18.8	42.5	43.9	43.7	21.5	44.4	19.9	19.1	22.0	20.9	45.5	20.6	17.6	19.2	16.3	23.7	43.1	27.9	28.8	33.6	27.7	47.2	37.2	61.5	35.0	25.2	27.3	35.6	40.5	23.3
SSR4	TRAPD	ENSG00000180879	"Signal sequence receptor subunit 4"	P51571	X	153793516-153798505	"Disease related genes, Plasma proteins, Predicted membrane proteins"			"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 699.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045209	Enhanced						600000			"HPA045209: AB_10961407"	"unprognostic (3.56e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.00e-3)"	"prognostic favourable (1.76e-4)"	"unprognostic (8.74e-2)"	"unprognostic (5.57e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.10e-1)"	"unprognostic (5.04e-3)"	"unprognostic (5.74e-3)"	"unprognostic (8.76e-2)"	"prognostic unfavourable (5.51e-6)"	"unprognostic (8.18e-2)"	"unprognostic (2.24e-1)"	"unprognostic (6.01e-2)"	"unprognostic (5.33e-2)"	17.4	30.0	13.2	29.5	22.6	37.5	46.0	12.2	20.6	30.4	31.7	9.0	152.0	30.7	19.1	81.4	21.4	18.3	30.2	40.7	23.0	17.7	21.8	48.0	42.1	136.9	14.5	11.6	18.4	699.0	7.2	67.7	30.3	26.0	24.0	24.0	11.7	83.7	192.6	12.1	16.9	24.1	19.5	26.3	37.9	43.6	19.6	8.2	15.3	22.6	21.0	29.4	27.7	20.0	67.1	171.0	50.7	58.6	62.0	78.7	108.1	34.3	44.2	15.0	84.2	80.9	43.1	31.4	29.4	43.5	30.6	41.7	54.9	30.4	48.9	77.8	44.5	34.0	26.1	27.3	11.1	19.9	22.3	13.8	41.4	43.0	70.1	37.8	36.7	53.6	38.0	26.3	35.9	32.8	15.1	104.0	23.7	61.4	21.5	56.4	9.1	72.1	24.2	19.5	90.6	38.6	41.0	29.3	24.2	17.4	30.1	31.8	19.5	81.7	27.2	18.0	19.9	34.7	38.1	154.4	75.5	57.3	38.3	64.7	30.1	50.7	58.6	26.1	63.6	44.4	78.7	67.1	65.5	62.9	58.5	56.6	57.0	58.4	9.3	62.0	35.5	171.0	47.9	108.1	13.2	22.6	12.2	20.6	23.0	17.7	14.5	11.6	26.0	8.2
PDZD4	"FLJ34125, KIAA1444, LNX5, LU1, PDZK4, PDZRN4L"	ENSG00000067840	"PDZ domain containing 4"	Q76G19	X	153802166-153830565	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 71.6"	"Cell line enhanced"	"Detected in some"		"AF22: 15.8;NTERA-2: 8.0;RH-30: 11.3;SCLC-21H: 19.2;SH-SY5Y: 18.7;U-2 OS: 9.4"	"Cancer enhanced"	"Detected in many"		"glioma: 20.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.5"	"Group enriched"	"Detected in many"	25	"NK-cells: 1.5;T-cells: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003878	Enhanced									"HPA003878: AB_2162807"	"unprognostic (9.18e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.11e-4)"	"unprognostic (1.07e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.32e-3)"	"unprognostic (5.90e-2)"	"prognostic favourable (2.96e-5)"	"unprognostic (2.27e-1)"	"unprognostic (2.54e-4)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.87e-2)"	3.3	5.8	42.8	2.6	36.7	2.5	2.0	40.1	71.6	2.3	3.5	5.1	0.4	2.5	4.4	2.2	3.3	7.9	2.8	3.3	40.8	14.8	1.6	1.7	3.0	2.6	9.9	24.9	1.7	2.6	1.5	7.4	1.2	9.0	4.5	2.3	1.8	4.3	10.5	3.6	4.8	3.3	5.0	7.0	7.0	2.3	3.4	6.4	0.0	1.6	0.0	1.6	2.4	1.4	0.0	0.0	0.0	0.0	1.5	3.5	0.6	0.0	1.0	15.8	4.1	0.0	0.1	0.0	0.4	0.0	0.5	0.5	0.4	0.0	0.0	0.2	0.0	0.1	2.8	0.0	0.1	0.0	0.5	0.0	1.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.1	0.1	0.5	8.0	0.2	0.0	11.3	0.0	0.0	0.0	19.2	18.7	0.8	0.0	5.6	1.8	0.1	0.0	0.0	9.4	0.2	1.1	0.0	0.0	0.0	0.1	0.0	5.0	0.0	0.0	0.0	3.5	0.0	0.8	0.0	1.5	2.0	0.0	0.0	0.1	0.9	0.0	1.5	0.0	0.0	0.0	0.6	42.8	36.7	40.1	49.2	40.8	14.8	9.9	24.9	9.0	6.4
L1CAM	"CD171, HSAS, HSAS1, MASA, MIC5, S10, SPG1"	ENSG00000198910	"L1 cell adhesion molecule"	P32004	X	153861514-153886174	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein"	"Disease mutation, Hereditary spastic paraplegia, Hirschsprung disease, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 29.6;brain: 54.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 72.2;BJ hTERT+ SV40 Large T+ RasG12V: 39.7;HeLa: 52.1;RPTEC TERT1: 42.4"	"Cancer enhanced"	"Detected in many"		"melanoma: 34.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 1.0;naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	7	"B-cells: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010896	Enhanced		Approved	"Nucleoplasm,Plasma membrane"			59000000	Nucleoplasm	"Plasma membrane"	"CAB010896: AB_609903"	"unprognostic (1.33e-3)"	"unprognostic (3.43e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavourable (8.51e-10)"	"unprognostic (2.04e-2)"	"prognostic unfavourable (3.81e-4)"	"unprognostic (9.44e-2)"	"prognostic unfavourable (2.36e-6)"	"unprognostic (1.13e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.52e-3)"	"unprognostic (8.02e-2)"	"prognostic unfavourable (1.17e-4)"	"unprognostic (3.07e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.47e-3)"	4.4	29.6	19.9	8.0	21.9	1.2	1.7	54.5	43.6	2.8	16.3	1.5	2.0	4.9	1.7	3.0	5.3	2.6	3.2	5.2	11.2	20.6	12.3	1.3	1.3	3.7	7.3	22.4	1.4	3.0	1.0	6.1	1.4	19.3	3.5	5.7	6.2	5.9	10.8	1.6	9.9	7.6	6.1	3.5	1.7	4.8	1.5	3.4	0.0	1.2	1.3	2.6	2.3	3.9	2.2	0.0	0.0	0.0	0.0	0.3	0.2	17.6	1.3	5.4	0.0	0.0	0.0	2.3	25.0	72.2	24.2	39.7	7.1	0.1	0.0	23.9	0.1	0.7	0.6	0.4	12.7	0.0	0.1	0.0	52.1	1.1	0.0	0.0	4.0	0.1	0.3	3.6	2.5	0.0	0.0	0.0	0.1	23.9	0.0	0.5	1.2	0.9	0.0	31.7	0.1	42.4	0.3	15.9	10.4	14.0	12.5	10.2	1.3	0.3	0.0	0.0	10.6	1.1	11.9	0.2	0.3	0.1	0.1	0.2	20.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	19.9	21.9	54.5	30.2	11.2	20.6	7.3	22.4	19.3	3.4
AVPR2	"DIR, DIR3, V2R"	ENSG00000126895	"Arginine vasopressin receptor 2"	P30518	X	153902531-153907166	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Diabetes insipidus, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 8.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 5.5;SCLC-21H: 6.5;U-266/84: 5.8;U-698: 6.1"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	26	"intermediate monocyte: 6.2;non-classical monocyte: 5.3"	"Lineage enriched"	"Detected in single"	28	"monocytes: 6.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	18	"cerebellum: 7.9"												"unprognostic (3.05e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.99e-4)"	"unprognostic (2.50e-4)"	"unprognostic (2.76e-1)"	"unprognostic (7.10e-6)"	"unprognostic (3.80e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.56e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.38e-1)"	"unprognostic (9.83e-2)"	8.9	0.1	0.0	0.1	0.0	0.9	7.1	1.2	0.0	2.1	1.5			0.7	2.7	0.0	0.8	2.6	1.4	6.3	0.0	0.0	4.7	0.0	1.9	1.1	0.0		0.1	0.6	0.2	0.0	0.1		1.1	0.0		1.2	0.8	4.3	2.2	1.3	1.0	0.0	0.0	1.2	0.0			1.9		0.2	1.8	2.1	0.0	0.2	0.0	6.2	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	2.8	5.5	0.0	0.0	0.0	0.0	0.0	1.9	0.2	2.1	0.9	0.0	0.1	2.7	2.2	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.1	1.4	1.6	0.2	0.1	2.4	1.0	2.5	0.1	0.0	6.5	1.2	0.1	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.2	1.1	5.8	6.1	0.0	1.6	0.1	0.0	0.1	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.2										
ARHGAP4	"C1, KIAA0131, p115, RhoGAP4, SrGAP4"	ENSG00000089820	"Rho GTPase activating protein 4"	P98171	X	153907367-153934999	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 44.8;lymphoid tissue: 48.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 25.7;Karpas-707: 26.4;MOLT-4: 24.8;RPMI-8226: 48.8;THP-1: 23.8;U-698: 22.7;U-937: 21.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001012, HPA001083"	Enhanced		Approved	"Nucleoplasm,Focal adhesion sites"				"Focal adhesion sites"	Nucleoplasm	"HPA001012: AB_1078201, HPA001083: AB_1078199"	"unprognostic (3.54e-2)"	"prognostic favourable (3.94e-5)"	"prognostic unfavourable (1.97e-5)"	"unprognostic (5.79e-2)"	"unprognostic (9.42e-2)"	"prognostic favourable (3.31e-4)"	"unprognostic (5.72e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.81e-3)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (2.49e-4)"	"unprognostic (8.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	7.0	4.8	5.3	24.3	5.8	44.8	5.0	4.5	3.2	3.1	6.5	5.2	2.1	6.0	3.9	7.0	4.4	5.2	6.5	4.2	4.5	3.2	7.4	4.9	13.4	29.1	5.2	0.9	2.6	2.3	0.9	3.5	9.0	4.8	4.2	3.0	5.7	7.5	1.8	1.6	1.8	18.0	3.9	5.9	48.4	4.9	3.6	4.2	43.2	4.2	1.6	29.0	7.1	3.6	10.8	17.7	18.7	30.5	8.5	15.7	12.6	0.4	0.1	0.2	1.7	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.1	12.3	25.7	1.5	0.0	0.2	1.3	0.0	0.0	6.9	1.0	9.9	0.1	0.4	1.0	18.2	16.9	0.0	0.1	0.0	0.1	2.6	0.0	26.4	0.1	1.3	24.8	0.3	0.8	0.0	11.8	3.5	48.8	0.1	0.2	2.4	3.5	0.2	0.6	0.2	5.7	23.8	0.5	0.1	0.3	0.2	0.1	16.0	13.6	22.7	0.2	21.3	0.0	5.1	14.1	18.7	15.7	23.1	10.9	10.8	11.2	12.4	14.1	10.4	10.1	10.1	12.0	8.5	30.5	17.7	12.6	12.6	5.3	5.8	4.5	3.2	4.5	3.2	5.2	0.9	4.8	4.2
NAA10	"ARD1, ARD1A, DXS707, TE2"	ENSG00000102030	"N(alpha)-acetyltransferase 10, NatA catalytic subunit"	P41227	X	153929242-153935223	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006269, HPA030711"	Supported		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"CAB006269: AB_425759, HPA030711: "	"unprognostic (7.57e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.01e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavourable (3.29e-8)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.48e-3)"	18.9	21.2	17.7	20.3	14.0	12.5	31.8	15.5	20.8	12.4	15.3	8.1	19.2	16.7	17.2	17.6	19.7	16.5	17.6	26.4	15.0	14.2	16.3	18.6	20.7	30.0	15.0	18.0	14.1	33.3	12.3	12.0	13.7	17.5	13.6	11.7	9.3	19.0	17.9	57.8	14.1	14.7	21.7	14.7	14.9	17.7	7.1	11.8	11.4	12.2	25.3	16.3	17.1	22.1	33.7	34.8	35.0	31.9	27.6	44.8	29.0	31.8	33.6	6.3	20.6	9.1	9.5	18.0	11.2	6.6	15.3	13.5	21.8	10.1	24.2	37.4	9.3	15.3	13.3	13.5	6.0	10.1	61.9	8.7	23.5	21.9	12.4	16.9	19.3	7.2	15.2	14.3	14.8	17.3	17.4	10.3	10.1	41.9	27.0	25.3	10.6	46.6	21.5	16.4	26.6	11.2	14.7	13.6	16.4	4.4	17.7	26.5	9.5	14.1	10.0	6.4	22.1	22.3	34.0	21.8	24.3	45.5	8.7	21.9	18.7	12.0	24.2	35.0	29.0	28.0	38.0	33.7	31.2	31.7	31.6	32.6	18.7	28.0	22.6	27.6	31.9	34.8	44.8	29.0	17.7	14.0	15.5	20.8	15.0	14.2	15.0	18.0	17.5	11.8
RENBP	"RBP, RNBP"	ENSG00000102032	"Renin binding protein"	P51606	X	153935263-153944691	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 32.7;lymphoid tissue: 36.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 12.9;HMC-1: 43.9;SK-MEL-30: 29.0;U-266/84: 25.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 57.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA000428, HPA000522"	Enhanced						42000			"HPA000428: AB_1079799, HPA000522: AB_1079798"	"unprognostic (3.08e-1)"	"prognostic favourable (3.95e-4)"	"unprognostic (1.12e-2)"	"unprognostic (3.29e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.99e-1)"	"prognostic favourable (3.08e-5)"	"unprognostic (2.39e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.25e-2)"	"unprognostic (8.51e-2)"	12.7	11.1	7.8	11.2	16.8	8.6	8.4	2.3	11.5	4.2	6.2	11.3	1.1	7.4	2.1	6.0	3.0	2.5	5.7	8.7	9.4	9.1	32.7	4.6	12.8	12.1	16.9	7.4	1.2	1.6	1.8	3.4	8.1	11.6	3.6	3.0	9.6	3.4	2.0	1.4	5.2	7.5	4.5	12.7	36.5	4.4	1.4	13.5	3.0	2.9	1.1	4.4	5.7	2.9	1.1	0.6	5.3	3.1	0.3	0.9	0.7	0.0	0.0	1.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.9	0.0	0.0	2.5	0.0	0.0	0.0	0.5	9.8	0.0	0.8	7.6	0.0	43.9	0.3	0.0	0.0	0.0	0.0	2.8	3.4	0.0	0.2	2.0	0.1	0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	29.0	0.0	3.4	0.4	0.0	0.3	0.0	0.0	4.4	25.2	1.7	0.9	4.6	3.4	2.9	2.0	5.3	0.3	1.4	0.3	1.1	0.1	0.1	0.2	0.6	0.9	0.4	4.5	0.3	3.1	0.6	0.0	0.7	7.8	16.8	2.3	11.5	9.4	9.1	16.9	7.4	11.6	13.5
HCFC1	"CFF, HCF-1, HCF1, HFC1, MGC70925, MRX3, PPP1R89, VCAF"	ENSG00000172534	"Host cell factor C1"	P51610	X	153947553-153971807	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction"	"Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018312			Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA018312: AB_1850522"	"unprognostic (2.05e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavourable (4.31e-6)"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (9.62e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.80e-1)"	16.0	19.2	18.2	23.7	18.5	48.3	14.2	24.4	23.3	13.9	20.0	17.3	14.1	16.8	26.3	13.6	18.2	18.8	20.8	14.7	17.0	12.7	15.6	17.2	19.0	24.9	14.6	16.1	20.4	15.6	21.9	26.4	13.8	15.8	17.7	11.2	13.8	21.5	20.6	27.8	18.2	18.3	19.7	20.0	25.2	18.0	15.3	17.9	52.3	16.4	15.6	17.6	17.4	18.3	4.8	8.0	1.7	5.6	2.8	6.7	3.5	15.2	19.9	13.5	17.1	5.7	4.1	19.9	6.3	4.9	7.5	6.8	21.0	10.3	27.8	16.2	8.1	12.6	14.6	10.3	3.9	14.7	17.2	16.6	15.9	16.5	3.9	20.4	27.6	6.3	6.7	13.0	5.7	7.9	23.1	17.6	5.2	21.4	28.2	26.4	17.6	12.2	33.0	11.1	16.8	5.6	14.2	15.1	16.4	11.6	12.1	6.4	11.1	18.5	10.4	14.3	17.6	12.3	20.2	28.1	38.3	34.8	11.6	19.9	13.4	1.7	4.0	1.7	6.0	5.6	4.3	4.8	4.8	4.6	4.5	4.4	4.9	6.7	0.8	2.8	4.0	8.0	3.2	3.5	18.2	18.5	24.4	23.3	17.0	12.7	14.6	16.1	15.8	17.9
TMEM187	"CXorf12, DXS9878E, ITBA1"	ENSG00000177854	"Transmembrane protein 187"	Q14656	X	153972327-153983195	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA038134	Uncertain		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA038134: AB_10669517"	"unprognostic (1.51e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.08e-1)"	"unprognostic (7.88e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.09e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (7.41e-2)"	"prognostic favourable (9.14e-8)"	"unprognostic (6.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.04e-2)"	8.8	13.0	9.2	6.8	10.2	3.4	10.5	13.2	9.0	7.6	9.0	10.5	13.9	6.8	8.8	9.3	9.5	12.0	6.8	8.1	9.6	6.0	7.6	10.2	7.7	10.2	10.4	9.0	10.9	24.4	7.5	13.0	7.3	11.0	10.3	4.5	6.7	14.1	10.1	8.5	10.7	10.9	6.8	8.0	10.0	8.0	5.9	8.7	8.4	10.8	2.9	9.9	7.9	7.4	13.4	19.6	17.8	9.8	10.1	22.5	10.9	8.3	9.5	2.1	7.6	8.2	7.4	1.1	3.4	1.7	1.0	3.4	1.9	14.4	1.3	19.7	2.7	7.6	2.9	5.0	0.8	10.7	3.9	2.3	5.0	3.1	7.0	1.1	2.6	8.3	7.6	2.9	4.3	2.6	2.0	10.8	4.3	9.0	4.4	1.5	1.5	10.6	4.1	1.1	13.9	5.3	2.7	2.8	2.8	5.0	4.2	3.6	8.0	2.7	4.8	1.7	1.8	6.9	1.9	7.6	5.1	1.7	5.1	5.0	0.9	17.8	9.8	11.9	14.7	7.3	14.7	9.7	18.1	15.9	7.4	13.4	22.5	13.9	9.5	10.1	6.9	19.6	17.6	10.9	9.2	10.2	13.2	9.0	9.6	6.0	10.4	9.0	11.0	8.7
IRAK1	"IRAK, pelle"	ENSG00000184216	"Interleukin 1 receptor associated kinase 1"	P51617	X	154010500-154019980	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004461, HPA054476"	Supported		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB004461: AB_2249106, HPA054476: "	"unprognostic (4.46e-3)"	"unprognostic (9.32e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.04e-3)"	"unprognostic (7.09e-3)"	"unprognostic (4.43e-3)"	"prognostic unfavourable (3.03e-4)"	"unprognostic (7.89e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.64e-2)"	"prognostic unfavourable (2.06e-4)"	"unprognostic (2.76e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.04e-1)"	22.3	23.7	12.1	25.0	11.4	48.3	38.5	7.7	14.8	11.1	24.8	10.8	13.4	29.9	13.2	12.4	25.5	12.2	23.1	14.1	9.9	12.3	23.7	46.9	18.5	37.5	12.6	7.9	15.1	34.6	8.1	15.2	14.3	11.9	18.0	11.0	10.1	31.9	15.9	32.6	15.9	34.6	11.5	12.7	34.0	19.3	14.3	9.8	17.0	12.6	20.4	26.7	17.2	15.3	10.0	13.0	6.7	10.6	6.3	6.7	3.4	76.3	29.7	4.2	34.3	8.4	6.7	18.3	11.4	10.8	17.6	16.4	23.5	34.0	32.6	64.3	12.2	20.9	9.7	18.6	6.9	25.6	29.0	11.9	26.7	14.0	19.4	28.1	20.5	9.3	16.4	16.8	18.6	10.5	20.9	37.8	12.3	28.1	11.5	25.1	10.4	59.3	30.0	21.3	54.8	11.7	14.5	23.6	17.0	13.6	15.2	22.5	5.9	29.9	14.3	21.4	33.9	48.9	70.7	47.6	30.4	59.8	31.3	33.8	22.2	1.3	8.7	6.7	6.7	10.6	5.9	7.5	5.3	5.3	5.4	10.0	3.1	6.1	5.9	6.3	8.1	13.0	2.5	3.4	12.1	11.4	7.7	14.8	9.9	12.3	12.6	7.9	11.9	9.8
MECP2	"MRX16, MRX79, RTT"	ENSG00000169057	"Methyl-CpG binding protein 2"	P51608	X	154021573-154137103	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000593, HPA001341, CAB037264"	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"CAB037264: AB_477252, HPA000593: AB_1079348, HPA001341: AB_1079347"	"unprognostic (1.27e-3)"	"unprognostic (2.60e-3)"	"unprognostic (2.16e-3)"	"prognostic unfavourable (8.35e-5)"	"unprognostic (2.35e-1)"	"unprognostic (3.66e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.18e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.84e-3)"	"unprognostic (4.22e-1)"	"prognostic favourable (7.32e-9)"	"unprognostic (7.63e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.05e-2)"	18.6	21.4	29.2	17.0	27.1	33.8	17.6	39.1	33.5	20.2	19.2	17.6	15.9	13.9	20.0	15.1	18.8	21.1	19.5	23.1	22.5	14.0	17.1	16.4	22.8	19.7	22.5	26.7	29.0	21.2	24.3	22.9	13.9	25.4	23.0	8.0	20.8	18.7	23.7	31.6	14.1	15.3	16.2	21.1	23.3	15.0	9.7	24.4	13.8	19.1	8.7	14.3	18.7	28.6	5.6	4.2	22.4	4.9	2.9	6.8	1.8	19.2	11.5	9.7	12.1	8.4	6.0	8.2	9.7	10.9	11.9	19.4	8.9	9.4	23.2	23.0	8.5	9.2	14.5	11.3	6.0	17.6	17.6	8.9	10.5	5.6	10.2	11.2	18.8	6.1	6.5	11.1	13.1	9.2	9.6	19.8	7.1	11.5	13.5	12.8	7.6	12.9	11.7	10.6	7.6	8.4	8.8	13.7	7.9	7.6	8.8	18.5	5.7	14.6	9.6	9.1	17.9	18.3	19.5	23.8	17.7	26.4	13.1	22.1	15.5	22.4	3.5	13.3	6.8	3.2	4.8	5.6	4.8	5.5	2.4	4.9	4.6	4.4	16.9	2.9	4.9	4.2	5.0	1.8	29.2	27.1	39.1	33.5	22.5	14.0	22.5	26.7	25.4	24.4
OPN1LW	"CBBM, CBP, COD5, RCP"	ENSG00000102076	"Opsin 1, long wave sensitive"	P04000	X	154144224-154159032	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	11	"retina: 14.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																															"unprognostic (6.05e-2)"								0.3	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.1	0.0	1.2	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OPN1MW	"CBBM, CBD, COD5, GCP, OPN1MW1"	ENSG00000268221	"Opsin 1, medium wave sensitive"	P04001	X	154182596-154196135	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.5"	"Cell line enhanced"	"Detected in single"		"HEK 293: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.6		1.5		0.0	0.7		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.4	0.3		0.1	0.0	0.1			0.0		0.0	0.0		0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0										
OPN1MW2		ENSG00000166160	"Opsin 1, medium wave sensitive 2"	P0DN77	X	154219756-154233286	"Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	4	"skin 1: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.2		0.0	0.0		0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OPN1MW3		ENSG00000269433	"Opsin 1, medium wave sensitive 3"	P0DN78	X	154257538-154271805	"Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	4	"blood: 2.2;skin 1: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"gdT-cell: 2.2"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.2"																																					0.0	0.0		0.0		0.2	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	1.8	0.0	0.0		0.0	0.0	0.4			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0										
TEX28	"CXorf2, fTEX"	ENSG00000278057	"Testis expressed 28"	O15482	X	154271265-154295853	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"testis: 8.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.6;naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																															0.0	0.0		0.0		0.3	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.3	0.0	0.0		0.0	0.0	8.7			0.0		0.0	0.0		0.0	0.3	0.0	0.2	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.1	0.0	0.2	0.2	0.3	0.5	0.0										
TKTL1	"TKR, TKT2"	ENSG00000007350	"Transketolase like 1"	P51854	X	154295671-154330350	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	50	"blood: 28.6;testis: 103.6"	"Cell line enriched"	"Detected in single"	157	"THP-1: 100.4"	"Cancer enriched"	"Detected in many"	8	"testis cancer: 44.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"eosinophil: 28.6;gdT-cell: 12.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 28.6;T-cells: 12.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA000505, CAB032191"	Enhanced		Supported	Cytosol				Cytosol		"CAB032191: , HPA000505: AB_1858022"	"unprognostic (2.69e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.38e-1)"	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	103.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.6	0.1	3.3	12.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	100.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.8	0.0	28.6	12.0	0.1	1.8	0.0	1.4	1.1	0.0	0.0	3.1	2.7	0.4	3.3	0.1	0.1	1.5	2.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0
FLNA	"ABP-280, FLN, FLN1, OPD1, OPD2"	ENSG00000196924	"Filamin A"	P21333	X	154348524-154374638	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cilium biogenesis/degradation"	Actin-binding	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 396.7;urinary bladder: 276.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB000356, HPA000368, HPA001016, HPA001115, HPA002925"	Enhanced	Approved	Enhanced	"Plasma membrane,Actin filaments,Cytosol"			2900000000	"Plasma membrane, Actin filaments, Cytosol"		"CAB000356: , HPA000368: , HPA001016: , HPA001115: AB_1078871, HPA002925: AB_1078869"	"unprognostic (1.39e-1)"	"unprognostic (9.40e-3)"	"prognostic unfavourable (7.37e-4)"	"unprognostic (3.68e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.58e-2)"	"prognostic unfavourable (1.54e-6)"	"unprognostic (5.49e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (3.88e-4)"	42.8	8.8	2.9	46.4	3.9	22.9	30.7	2.0	5.2	106.5	204.2	6.3	86.0	13.1	158.9	54.4	140.2	79.9	121.0	18.8	3.2	2.2	17.2	5.5	29.1	21.1	3.4	5.9	77.4	7.3	1.6	4.8	20.0	9.4	129.3	13.4	19.0	12.6	98.8	13.7	15.0	50.2	396.7	3.6	25.5	82.7	29.9	2.9	12.1	11.7	16.3	15.1	276.1	64.5	6.3	13.1	7.1	19.7	5.9	22.6	24.1	87.2	67.8	23.9	30.8	20.9	27.7	39.4	58.4	65.1	53.6	47.7	43.9	16.2	7.5	151.6	90.7	50.1	21.5	51.2	15.1	30.8	7.5	24.2	88.7	15.2	38.5	28.6	31.8	26.5	12.4	79.8	31.9	39.8	6.8	52.3	38.3	20.0	13.6	9.9	25.2	45.1	13.7	21.7	6.7	20.8	18.2	5.3	12.1	48.8	7.9	39.3	7.6	9.0	95.2	61.2	59.0	62.0	107.6	32.8	19.2	15.2	56.9	19.2	61.2	4.1	11.5	7.1	22.6	15.2	14.3	6.3	10.5	18.7	13.1	3.0	4.0	9.1	2.6	5.9	19.7	1.7	12.8	24.1	2.9	3.9	2.0	5.2	3.2	2.2	3.4	5.9	9.4	2.9
EMD	"LEMD5, STA"	ENSG00000102119	Emerin	P50402	X	154379197-154381523	"Disease related genes, Predicted membrane proteins"		Actin-binding	"Cardiomyopathy, Disease mutation, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000609, CAB001545, CAB002029, CAB058694, CAB062552"	Supported		Enhanced	"Nuclear membrane,Endoplasmic reticulum"			520000	"Nuclear membrane, Endoplasmic reticulum"		"CAB001545: AB_2100047, CAB002029: AB_442088, CAB058694: , CAB062552: , HPA000609: AB_1078736"	"unprognostic (2.92e-1)"	"unprognostic (6.59e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.12e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.06e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.99e-1)"	25.0	17.5	14.0	17.6	16.0	21.0	26.5	15.8	21.8	24.8	21.3	13.7	22.3	14.0	32.3	25.7	22.9	27.2	28.7	29.5	13.1	14.1	18.2	21.2	22.0	37.4	13.3	16.5	35.9	29.4	20.5	22.8	15.4	11.9	25.5	11.4	20.7	24.5	29.1	62.0	18.1	13.7	40.4	13.1	17.6	20.1	16.1	9.7	16.6	28.1	24.4	18.3	31.7	20.6	23.2	30.5	24.5	19.7	14.7	26.9	15.8	31.2	11.8	8.2	9.0	7.4	14.9	14.7	15.4	16.5	19.7	20.7	10.5	6.1	24.9	23.5	15.8	17.4	15.6	19.1	8.4	14.6	34.1	11.7	17.4	6.2	20.2	11.2	12.9	13.0	15.2	17.6	21.9	13.7	9.6	10.8	13.4	13.3	19.6	20.6	13.7	37.0	16.3	12.2	23.7	10.6	6.0	10.4	12.9	8.0	13.4	18.8	9.3	8.4	12.3	9.8	18.7	22.1	22.1	35.1	26.0	44.9	11.9	19.0	10.6	16.6	16.9	24.5	26.9	19.7	25.0	22.5	25.7	25.7	13.5	23.2	23.1	22.4	18.1	14.7	14.0	30.5	23.9	15.8	14.0	16.0	15.8	21.8	13.1	14.1	13.3	16.5	11.9	9.7
RPL10	"DXS648, DXS648E, FLJ23544, L10, NOV, QM"	ENSG00000147403	"Ribosomal protein L10"	P27635	X	154389955-154409168	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Developmental protein, Ribonucleoprotein, Ribosomal protein"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB010339, HPA011311"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"			130000	"Endoplasmic reticulum, Cytosol"		"CAB010339: AB_2181277, HPA011311: AB_1856431"	"unprognostic (2.46e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.11e-2)"	"unprognostic (9.01e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.39e-2)"	"unprognostic (3.37e-1)"	"prognostic unfavourable (7.67e-6)"	"unprognostic (6.84e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.65e-2)"	"unprognostic (5.68e-2)"	103.6	65.3	41.4	108.0	48.5	103.7	152.6	82.4	70.7	118.2	80.6	44.6	107.8	51.3	100.4	75.5	105.2	122.3	52.6	82.5	38.2	31.9	112.1	155.0	97.6	190.2	48.2	37.4	223.5	242.3	35.0	51.9	87.4	53.1	83.6	77.1	66.7	109.9	101.5	125.9	121.8	108.9	78.7	51.4	93.9	90.5	33.9	47.2	158.9	198.9	137.9	134.4	86.9	119.3	252.9	168.6	64.4	124.1	149.1	304.9	445.3	187.8	87.1	87.3	66.8	198.2	375.4	77.2	72.2	167.6	139.1	177.0	77.2	84.5	372.4	175.0	120.5	73.0	170.8	173.0	119.6	81.8	135.4	50.2	62.4	84.6	233.1	107.9	74.4	283.3	274.0	83.6	261.3	218.2	70.7	119.0	135.8	94.3	117.5	105.0	68.7	150.6	140.9	82.7	206.9	151.8	67.1	70.0	117.0	17.4	153.8	213.5	56.0	150.9	105.0	48.7	92.6	109.6	159.9	283.6	204.8	370.4	74.0	155.8	60.8	64.4	124.1	18.1	149.9	107.7	256.2	252.9	251.6	186.2	151.2	243.2	304.9	231.1	13.0	149.1	94.9	168.6	178.0	445.3	41.4	48.5	82.4	70.7	38.2	31.9	48.2	37.4	53.1	47.2
DNASE1L1	"DNAS1L1, DNASEX, DNL1L, XIB"	ENSG00000013563	"Deoxyribonuclease 1 like 1"	P49184	X	154401238-154412112	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA072635	Approved				"Intracellular and membrane"		60000			"HPA072635: "	"unprognostic (5.27e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.57e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.82e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.98e-1)"	"prognostic favourable (2.19e-4)"	"unprognostic (7.02e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.75e-2)"	12.3	11.8	5.6	6.9	7.4	10.1	9.9	3.3	7.7	7.5	7.7	4.5	7.8	7.5	6.9	15.5	9.6	6.8	10.2	16.3	5.5	6.5	11.4	9.0	10.5	11.7	5.6	5.8	6.1	9.7	9.0	8.7	13.0	4.6	6.2	6.0	12.9	9.1	6.1	76.7	4.5	10.2	5.5	4.7	12.7	7.0	3.8	4.1	3.9	10.2	24.3	9.0	6.7	6.8	4.5	10.7	12.8	16.1	3.0	3.6	4.2	6.7	7.1	2.2	4.2	20.9	27.5	2.9	19.4	29.8	6.2	12.3	1.9	10.0	11.0	24.7	35.7	3.2	2.5	10.7	4.6	3.1	4.7	1.6	7.3	2.4	14.4	2.9	11.9	20.5	12.5	13.8	14.5	26.3	2.2	11.5	21.5	11.4	1.1	1.4	1.7	8.3	2.3	10.4	17.4	10.6	3.4	7.0	4.1	5.9	10.5	7.8	4.0	2.7	38.7	6.2	7.4	9.2	3.8	21.9	4.8	11.2	9.6	5.0	7.7	10.1	8.8	12.8	2.7	16.1	3.1	4.5	2.5	2.4	10.7	3.4	1.9	1.6	5.2	3.0	15.4	6.1	3.6	4.2	5.6	7.4	3.3	7.7	5.5	6.5	5.6	5.8	4.6	4.1
TAZ	"BTHS, CMD3A, EFE, EFE2, G4.5, TAZ1, XAP-2"	ENSG00000102125	Tafazzin	Q16635	X	154411518-154421726	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039557	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA039557: AB_10672899"	"unprognostic (1.14e-1)"	"prognostic favourable (5.70e-4)"	"unprognostic (4.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (8.29e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.21e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.68e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavourable (1.22e-7)"	"unprognostic (4.00e-3)"	"unprognostic (4.20e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.79e-2)"	11.9	8.7	12.1	15.0	13.6	36.8	11.7	12.4	13.5	10.9	15.4	15.6	12.1	13.9	10.8	13.0	15.1	9.9	14.1	25.9	11.0	8.4	13.3	14.0	14.3	17.3	16.7	9.6	12.6	16.3	10.7	8.9	9.1	13.1	11.1	10.8	12.2	12.7	14.5	27.9	18.6	15.0	11.7	12.8	25.4	12.8	3.4	15.1	17.2	11.8	13.4	14.4	10.8	19.5	16.7	14.7	13.8	10.3	12.3	17.2	7.8	11.0	12.5	4.6	5.1	9.0	5.4	8.8	3.9	7.7	6.0	8.3	4.1	13.8	13.1	21.3	5.7	16.8	6.5	7.2	4.2	11.2	9.6	2.6	8.0	6.4	10.1	5.0	6.2	5.5	13.2	5.2	11.8	9.0	5.2	13.9	5.2	6.7	12.7	15.8	1.3	13.1	10.5	7.0	17.6	8.2	3.2	5.8	8.2	2.5	7.4	10.7	4.5	8.9	6.5	4.9	6.3	12.0	5.9	32.5	12.8	27.3	6.0	17.6	5.6	5.7	10.3	13.8	12.1	9.3	11.0	11.3	17.2	15.5	14.7	16.7	14.4	12.5	9.4	12.3	7.4	7.3	12.2	7.8	12.1	13.6	12.4	13.5	11.0	8.4	16.7	9.6	13.1	15.1
ATP6AP1	"16A, Ac45, ATP6IP1, ATP6S1, CF2, ORF, VATPS1, XAP-3, XAP3"	ENSG00000071553	"ATPase H+ transporting accessory protein 1"	Q15904	X	154428632-154436516	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015218	Uncertain		Approved	"Plasma membrane,Microtubules,Cytosol"			160000	"Plasma membrane, Microtubules, Cytosol"		"CAB015218: "	"prognostic unfavourable (2.40e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavourable (8.94e-4)"	"unprognostic (1.84e-3)"	"unprognostic (4.99e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.84e-1)"	"prognostic favourable (7.83e-4)"	"unprognostic (1.07e-1)"	"prognostic favourable (5.26e-8)"	"unprognostic (2.45e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.62e-1)"	29.8	37.8	36.6	20.0	50.3	27.5	22.1	59.2	82.7	28.4	26.5	39.4	27.4	24.0	20.6	43.2	29.1	29.6	23.0	35.1	40.8	47.5	42.4	26.9	37.9	21.8	36.5	40.5	24.4	42.6	67.1	41.5	66.1	60.1	41.6	24.7	29.8	35.9	29.4	18.4	30.2	24.2	22.9	39.4	36.4	27.6	21.2	24.2	22.1	39.7	20.9	21.4	27.3	21.1	20.1	68.4	64.0	56.6	23.7	28.9	33.8	22.4	21.4	18.3	31.1	29.7	16.4	34.4	16.6	23.6	25.9	37.8	20.2	28.1	13.3	70.4	35.6	24.1	26.9	15.4	14.3	12.1	27.8	7.6	27.5	20.0	37.4	12.3	56.5	21.8	26.4	24.3	14.0	35.9	9.1	37.6	16.9	32.9	8.9	18.6	6.8	21.9	13.8	12.2	34.5	27.4	18.8	18.3	19.0	14.5	59.3	31.1	26.1	30.4	27.7	18.9	17.1	32.2	27.0	54.3	58.3	15.7	22.6	26.7	19.0	37.4	53.9	64.0	28.6	56.6	28.9	17.5	23.7	24.7	68.4	20.1	21.4	23.5	60.0	23.7	43.4	39.0	26.9	33.8	36.6	50.3	59.2	82.7	40.8	47.5	36.5	40.5	60.1	24.2
GDI1	"FLJ41411, GDIL, MRX41, MRX48, OPHN2, RABGDIA, XAP-4"	ENSG00000203879	"GDP dissociation inhibitor 1"	P31150	X	154436913-154443467	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 122.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012979, HPA049290, HPA057668"	Enhanced		Approved	Vesicles			70000000	Vesicles		"CAB012979: AB_2533970, HPA049290: , HPA057668: "	"prognostic unfavourable (6.84e-4)"	"unprognostic (1.13e-2)"	"prognostic unfavourable (3.83e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.98e-3)"	"unprognostic (3.86e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.70e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.72e-1)"	19.8	27.1	51.7	16.2	65.3	10.5	12.0	61.3	122.3	16.7	13.6	46.2	6.5	11.5	20.1	15.7	14.4	23.0	15.2	25.7	53.7	54.3	13.7	10.3	16.9	15.1	45.1	49.6	27.7	16.2	18.8	26.9	19.0	65.3	19.6	13.9	13.8	13.6	24.0	14.3	17.2	13.1	25.6	46.4	17.1	13.5	12.9	31.3	6.8	12.7	6.2	15.7	13.9	11.8	7.6	8.3	20.6	13.4	5.6	13.0	4.9	20.3	18.9	42.7	35.2	17.5	20.7	13.4	29.5	19.8	31.1	32.5	11.0	10.8	16.3	30.9	29.9	16.1	37.4	18.0	21.6	29.4	18.4	5.1	27.7	7.3	25.8	4.9	18.6	21.2	22.3	36.0	22.1	20.0	6.2	25.9	36.9	20.6	15.6	12.4	11.3	34.5	15.6	11.1	9.3	21.7	9.6	59.1	45.7	14.2	18.5	22.4	11.0	8.9	22.6	28.7	24.9	29.7	43.1	36.7	38.9	25.9	31.2	11.1	35.2	14.9	5.7	17.2	8.9	8.6	13.0	7.3	9.6	8.6	4.7	7.6	7.6	7.5	20.6	5.6	13.4	8.3	10.8	4.9	51.7	65.3	61.3	96.6	53.7	54.3	45.1	49.6	65.3	31.3
FAM50A	"9F, DXS9928E, HXC-26, XAP5"	ENSG00000071859	"Family with sequence similarity 50 member A"	Q14320	X	154444126-154450654	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003585	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA003585: AB_1080603"	"unprognostic (1.95e-1)"	"prognostic favourable (2.05e-4)"	"prognostic unfavourable (9.52e-5)"	"unprognostic (5.39e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavourable (3.15e-5)"	"unprognostic (2.56e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.64e-3)"	"unprognostic (6.35e-2)"	"unprognostic (3.28e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.14e-1)"	33.0	29.9	31.4	23.3	46.1	21.7	22.6	42.7	45.3	23.0	27.0	25.6	22.2	24.8	22.2	38.1	18.9	16.4	17.4	31.9	32.6	23.5	24.7	23.2	23.1	16.6	43.5	29.5	20.3	25.1	32.1	41.3	30.5	35.6	23.1	20.2	24.3	27.9	26.6	54.7	16.1	22.9	26.5	31.4	24.1	23.1	7.0	42.9	11.7	25.6	12.4	16.9	24.8	39.9	16.5	24.5	19.4	35.1	19.6	30.3	14.6	26.0	32.4	10.8	15.4	40.5	29.2	21.5	33.8	30.7	33.2	50.6	29.5	12.2	1.3	35.2	35.7	10.2	25.5	23.6	25.8	18.9	16.3	8.3	38.9	18.6	59.3	7.5	24.8	33.4	17.0	51.0	26.3	27.1	10.7	21.3	32.1	17.8	8.9	10.0	7.3	20.3	13.0	27.2	18.7	20.9	26.3	19.5	13.9	12.3	20.0	40.5	17.3	14.8	32.9	22.9	18.7	37.4	41.4	49.4	28.3	9.3	30.9	26.4	25.4	14.2	26.6	19.4	22.5	33.9	30.3	16.5	23.4	21.5	24.5	14.0	13.2	18.0	14.4	19.6	35.1	18.8	24.9	14.6	31.4	46.1	42.7	45.3	32.6	23.5	43.5	29.5	35.6	42.9
PLXNA3	"6.3, Plxn3, PLXN4, SEX, XAP-6"	ENSG00000130827	"Plexin A3"	P51805	X	154458281-154477779	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 19.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058989			Approved	"Nucleoplasm,Vesicles,Plasma membrane"			58000	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA058989: "	"unprognostic (2.79e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.04e-3)"	"unprognostic (8.04e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.30e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.33e-2)"	"unprognostic (5.73e-2)"	6.9	7.6	9.8	6.6	9.3	3.5	13.3	25.9	7.4	8.1	6.2	13.8	7.3	7.2	8.6	9.2	5.3	8.3	7.9	6.6	10.5	8.0	5.1	2.5	7.2	7.1	8.7	3.6	16.4	9.9	5.1	35.2	7.4	8.2	9.2	4.8	6.1	13.8	7.5	2.9	19.5	7.2	8.2	8.4	7.0	10.0	5.8	9.8	4.6	9.3	1.8	7.2	6.3	16.4	1.8	0.5	2.7	0.5	2.1	1.0	0.3	8.1	1.6	4.8	12.2	5.1	6.5	6.5	11.7	2.5	2.7	3.8	6.1	3.5	1.5	6.3	12.5	7.2	4.9	5.7	1.0	0.7	3.6	1.5	19.1	3.3	4.0	0.7	6.8	8.8	4.2	4.1	0.3	3.1	3.8	1.3	4.3	10.1	1.4	6.2	1.5	3.7	5.3	0.4	0.5	3.7	5.4	10.2	5.3	4.3	7.8	1.9	4.7	1.7	7.7	6.0	5.5	0.6	4.9	0.9	0.1	2.1	11.2	1.1	1.6	2.7	0.5	0.8	0.8	0.4	0.6	1.8	1.0	0.8	0.1	1.2	0.6	0.8	1.4	2.1	0.3	0.5	0.7	0.3	9.8	9.3	25.9	7.4	10.5	8.0	8.7	3.6	8.2	9.8
LAGE3	"CVG5, DXS9879E, DXS9951E, ESO3, ITBA2, Pcc1"	ENSG00000196976	"L antigen family member 3"	Q14657	X	154477769-154479257	"Disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA036122, HPA036123"	Approved		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA036122: , HPA036123: AB_10601926"	"unprognostic (1.70e-1)"	"prognostic favourable (5.29e-6)"	"unprognostic (1.09e-2)"	"prognostic unfavourable (7.60e-4)"	"unprognostic (2.28e-1)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (8.63e-5)"	"unprognostic (1.99e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.88e-3)"	"unprognostic (6.73e-2)"	"prognostic unfavourable (5.42e-5)"	"unprognostic (7.37e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.80e-1)"	10.9	18.3	24.6	9.1	23.0	20.1	7.9	12.4	27.4	10.0	9.7	9.4	5.3	8.5	6.1	11.1	6.8	7.3	7.9	11.0	22.3	15.6	6.7	12.3	7.3	11.3	16.3	20.7	11.3	20.2	5.1	16.6	6.9	12.1	9.7	6.2	8.6	17.5	9.0	22.0	12.2	7.5	7.4	12.3	10.9	11.2	5.0	10.4	16.7	6.2	8.1	10.8	8.4	6.3	14.5	27.5	10.8	10.8	18.4	36.5	15.6	12.4	11.9	4.4	9.3	4.8	4.0	13.1	3.8	2.7	5.8	6.5	7.6	6.8	26.7	35.0	5.0	5.4	10.9	3.8	2.0	15.1	17.4	9.7	11.1	4.3	8.2	12.8	14.4	6.1	2.5	8.7	2.3	4.1	9.4	13.0	7.9	29.4	17.1	37.6	8.3	29.0	15.1	7.6	29.7	3.3	3.4	12.3	11.4	8.9	21.5	15.5	9.3	9.5	4.5	4.2	12.4	17.4	14.4	30.7	31.9	40.1	7.3	23.1	9.6	10.8	10.8	4.2	11.7	9.8	14.8	14.5	16.2	17.1	14.8	12.2	36.5	18.7	1.2	18.4	8.0	27.5	12.3	15.6	24.6	23.0	12.4	27.4	22.3	15.6	16.3	20.7	12.1	10.4
UBL4A	"DXS254E, GDX, GET5, MDY2, TMA24, UBL4"	ENSG00000102178	"Ubiquitin like 4A"	P11441	X	154483717-154486670	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003617	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA003617: AB_1080450"	"unprognostic (2.75e-2)"	"unprognostic (3.39e-3)"	"unprognostic (5.52e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavourable (8.64e-4)"	"unprognostic (4.83e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.26e-3)"	"unprognostic (4.50e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.49e-2)"	11.5	15.3	14.1	7.3	16.0	6.6	12.4	11.9	28.2	11.7	12.2	8.7	11.0	12.2	10.2	13.8	14.0	10.9	10.5	26.5	14.1	11.0	10.6	13.7	10.9	12.1	11.2	16.9	11.2	25.4	11.3	8.3	9.4	13.6	15.4	9.0	8.0	18.8	15.7	59.2	13.3	9.3	14.8	8.6	9.8	10.9	4.3	6.1	8.2	12.2	20.6	11.7	14.9	10.4	10.1	9.9	32.9	10.0	14.3	22.9	17.9	28.8	18.2	5.5	14.9	11.6	11.5	18.3	12.9	9.3	13.3	14.3	18.1	11.5	22.3	38.9	11.7	11.2	27.2	14.1	7.4	14.6	17.3	15.9	17.4	10.6	14.3	18.8	17.3	9.0	16.9	8.9	15.4	9.5	17.5	11.1	10.8	23.9	17.0	18.8	6.3	30.5	15.2	16.3	23.5	11.3	12.5	10.5	15.9	7.2	23.8	20.6	11.0	14.3	9.5	13.6	15.4	21.8	26.8	22.5	21.7	39.6	14.3	32.6	15.7	32.9	10.0	9.6	16.5	8.5	22.9	10.1	15.4	17.3	9.9	8.3	13.3	14.9	3.4	14.3	7.1	5.8	15.0	17.9	14.1	16.0	11.9	28.2	14.1	11.0	11.2	16.9	13.6	6.1
SLC10A3	"DXS253E, P3"	ENSG00000126903	"Solute carrier family 10 member 3"	P09131	X	154487306-154490690	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	9	"basophil: 51.2"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 51.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021656	Approved		Approved	"Intermediate filaments"				"Intermediate filaments"		"HPA021656: AB_1856955"	"unprognostic (1.60e-1)"	"prognostic favourable (4.53e-4)"	"prognostic unfavourable (4.15e-5)"	"unprognostic (8.00e-3)"	"prognostic unfavourable (9.97e-4)"	"unprognostic (5.47e-2)"	"unprognostic (2.28e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (7.22e-4)"	"unprognostic (3.42e-1)"	"unprognostic (2.52e-3)"	"unprognostic (6.23e-2)"	"unprognostic (2.99e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.99e-2)"	14.5	14.6	3.6	11.6	5.1	22.5	13.4	5.0	8.1	21.5	15.3	8.1	16.3	10.6	25.0	36.1	22.8	15.4	21.1	19.5	6.0	4.6	17.7	6.7	16.3	14.0	5.8	6.2	32.3	25.7	6.1	12.7	40.1	7.6	23.7	6.4	12.4	11.7	13.3	13.7	26.2	13.6	20.1	5.3	13.1	12.6	11.6	4.7	12.6	15.7	23.3	18.6	23.3	18.3	1.6	2.7	51.2	1.7	2.2	3.8	1.8	24.6	10.6	2.8	14.5	10.0	10.9	18.8	18.4	11.2	12.4	12.6	9.4	12.0	18.8	35.0	17.6	21.3	9.3	9.4	3.3	12.2	4.4	5.8	14.0	7.4	18.4	6.9	9.5	13.6	10.7	11.6	6.3	8.5	6.5	18.5	8.1	32.8	3.7	6.2	2.2	20.5	6.1	7.6	14.2	9.4	9.2	2.6	4.7	11.6	21.0	4.8	6.8	5.5	11.1	14.9	9.3	34.4	23.2	13.2	12.7	19.4	15.8	14.5	7.6	51.2	1.3	5.6	3.8	1.7	2.9	1.6	2.6	2.8	1.1	1.6	1.9	1.8	1.7	2.2	1.5	2.7	1.8	1.8	3.6	5.1	5.0	8.1	6.0	4.6	5.8	6.2	7.6	4.7
FAM3A	"2-19, DXS560S, XAP-7"	ENSG00000071889	"Family with sequence similarity 3 member A"	P98173	X	154506159-154516242	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025016, HPA035268, HPA056991"	Uncertain		Approved	Nucleoplasm,Nucleoli	"Secreted - unknown location"			Nucleoli	Nucleoplasm	"CAB025016: , HPA035268: , HPA056991: "	"unprognostic (1.60e-1)"	"unprognostic (2.72e-2)"	"prognostic unfavourable (1.76e-4)"	"unprognostic (3.19e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.04e-1)"	"unprognostic (9.71e-2)"	18.9	18.9	18.9	14.7	20.9	13.7	17.3	13.4	25.7	22.3	21.2	31.1	16.3	37.0	18.2	16.2	19.3	19.1	25.3	31.4	21.3	18.7	19.8	28.5	16.1	16.7	23.0	16.4	29.1	35.5	18.2	22.1	21.0	18.5	20.6	9.9	17.3	29.4	34.7	33.4	15.3	33.7	14.4	25.4	18.4	23.6	10.7	16.8	13.5	28.8	16.1	12.2	16.9	16.9	8.0	13.3	21.2	11.5	8.5	13.3	8.9	16.3	15.8	4.0	13.3	12.0	6.1	11.2	8.4	5.8	5.8	6.9	7.2	10.0	10.7	42.8	14.0	12.0	6.2	7.4	1.4	8.7	8.4	4.2	13.8	5.1	18.9	2.8	6.7	7.5	6.7	12.0	8.4	4.0	7.9	7.9	6.6	17.1	5.1	12.1	1.7	19.9	6.4	4.0	29.3	6.3	6.8	7.9	6.0	3.8	9.4	13.8	7.1	4.3	4.5	7.8	4.7	21.1	11.3	30.3	16.6	13.0	14.4	7.3	7.9	21.2	9.9	12.5	13.3	11.5	12.9	6.2	8.2	9.3	9.9	8.0	10.2	11.9	5.0	8.5	9.5	13.3	8.5	8.9	18.9	20.9	13.4	25.7	21.3	18.7	23.0	16.4	18.5	16.8
G6PD	G6PD1	ENSG00000160211	"Glucose-6-phosphate dehydrogenase"	P11413	X	154531391-154547572	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 83.1"	"Cell line enhanced"	"Detected in all"		"A549: 225.5;MCF7: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 77.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 77.3"					"Low region specificity"	"Detected in all"			"HPA000247, HPA000834"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"			12000000	Cytosol	"Centriolar satellite"	"HPA000247: AB_1078978, HPA000834: AB_1078977"	"unprognostic (1.73e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavourable (9.45e-13)"	"unprognostic (2.78e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.25e-2)"	21.9	29.4	10.4	15.6	10.7	51.4	18.2	8.4	14.7	12.2	7.5	13.6	4.8	7.2	14.0	13.2	29.0	11.0	24.7	10.1	8.8	10.1	15.4	3.7	20.8	31.0	10.3	8.0	19.8	7.9	5.9	20.7	9.2	10.9	11.3	7.3	17.8	13.9	8.6	4.4	11.3	7.3	17.5	11.1	20.3	9.9	83.1	9.5	22.5	24.6	44.8	25.7	24.1	19.0	3.6	7.6	77.3	16.2	12.7	10.3	11.8	15.4	225.5	4.6	17.8	19.5	26.7	4.1	10.8	31.0	11.0	19.1	10.3	5.8	10.0	16.8	24.7	13.8	7.2	18.3	5.7	10.2	5.0	10.6	51.0	23.2	38.2	10.6	36.4	12.9	5.4	21.6	4.6	22.9	6.3	4.4	19.9	85.5	6.8	7.6	3.3	16.7	6.7	2.6	10.9	33.2	19.3	4.7	5.9	10.8	42.1	9.0	6.3	8.9	27.2	7.0	24.7	9.7	16.6	5.3	6.9	17.1	19.4	7.0	14.3	29.3	16.2	77.3	10.3	13.6	6.6	3.4	2.7	7.4	7.6	3.6	3.5	5.9	27.1	12.7	11.1	3.5	3.5	11.8	10.4	10.7	8.4	14.7	8.8	10.1	10.3	8.0	10.9	9.5
IKBKG	"FIP-3, FIP3, Fip3p, IKK-gamma, IP1, IP2, NEMO, ZC2HC9"	ENSG00000269335	"Inhibitor of nuclear factor kappa B kinase subunit gamma"	Q9Y6K9	X	154541199-154565046	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"	"DNA damage, Host-virus interaction, Transcription, Transcription regulation"		"Disease mutation, Ectodermal dysplasia, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 28.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000426, CAB010373"	Uncertain		Enhanced	Cytosol				Cytosol		"CAB010373: AB_2124846, HPA000426: AB_1851572"	"unprognostic (7.53e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.37e-3)"	"unprognostic (9.77e-2)"	"unprognostic (3.68e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.18e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.78e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.36e-2)"	6.5	5.8	5.2	10.2	6.1	15.1	5.0	5.4	9.2	5.2	4.5	9.1	5.9	7.5	5.2	6.2	6.3	4.5	7.7	5.1	4.9		3.9	16.3	6.5	10.4	6.9	5.1	5.1	6.1	3.5	2.0	6.8	6.7	5.0	3.9	5.6	5.7	3.9	4.6	11.4	6.6	8.1	3.7	10.8	7.4	4.2	6.2	6.9	5.0	6.9	9.9	4.9	6.2	11.3	13.7	28.8	21.8	13.8	17.9	13.5	15.9	16.4	4.0	13.0	9.1	7.7	11.0	10.7	13.9	11.4	16.5	11.6	9.6	12.8	27.1	12.0	15.0	5.8	9.8	4.9	15.3	8.2	10.5	23.7	21.7	14.0	10.3	36.8	9.1	8.3	16.0	6.5	13.6	5.8	12.8	9.1	15.5	10.6	17.3	3.7	27.3	11.7	6.3	13.6	11.3	10.2	7.1	7.1	13.3	12.5	7.7	7.2	11.5	13.8	10.6	12.4	28.3	25.6	25.2	17.8	24.0	15.8	18.7	15.4	10.5	15.4	28.8	17.9	20.5	12.3	11.3	11.4	13.0	13.7	10.1	9.5	11.3	25.4	13.8	21.8	12.2	13.0	13.5										
CTAG1A	"ESO1, LAGE2A"	ENSG00000268651	"Cancer/testis antigen 1A"	P78358	X	154585143-154586821	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"heart muscle: 3.0;testis: 8.1"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 120.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB013061	Enhanced									"CAB013061: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0		0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.8	28.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0										
CTAG1B	"CT6.1, CTAG, CTAG1, ESO1, LAGE2A, LAGE2B, NY-ESO-1"	ENSG00000184033	"Cancer/testis antigen 1B"	P78358	X	154617609-154619282	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	56	"testis: 12.0"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 128.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB015453	Enhanced									"CAB015453: AB_784921"																		0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	12.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	128.5	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CTAG2	"CAMEL, CT6.2a, CT6.2b, ESO2, LAGE-1, LAGE-1a, LAGE-1b, LAGE1, MGC138724, MGC3803"	ENSG00000126890	"Cancer/testis antigen 2"	O75638	X	154651972-154653579	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 8.5;skeletal muscle: 5.7;testis: 11.9"	"Group enriched"	"Detected in some"	37	"K-562: 28.2;RPMI-8226: 62.9;SK-BR-3: 41.1;U-266/84: 71.2"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA071467, HPA076586"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Vesicles"				"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA071467: , HPA076586: "							"prognostic unfavourable (2.35e-4)"		"unprognostic (3.87e-1)"						"unprognostic (1.00e-1)"		"unprognostic (1.25e-2)"	0.2	1.0	0.4	0.0	0.0	0.2	0.1	0.2	0.5	0.0	0.2			0.0	0.0	0.0	1.0	2.9	0.0	8.5	0.0	0.0	0.1	0.8	0.2	0.0	0.2		0.8	3.6	0.0	0.4	4.4		0.2	0.0		0.1	0.0	5.7	0.2	0.0	0.0	0.0	0.3	0.6	11.9			0.0		0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.9	0.0	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.1	0.0	1.3	0.0	0.1	0.0	0.5	71.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GAB3		ENSG00000160219	"GRB2 associated binding protein 3"	Q8WWW8	X	154675249-154751583	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 17.8;HMC-1: 20.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA010090	Approved									"HPA010090: AB_1849362"	"unprognostic (2.67e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavourable (5.07e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.19e-1)"	10.3	3.5	3.7	11.5	6.6	12.4	5.9	1.3	4.9	4.1	4.2	4.3	0.5	3.5	6.7	5.5	2.7	4.3	6.6	10.3	3.2	2.4	3.5	2.4	8.6	9.4	5.6	0.7	2.3	4.0	4.2	3.2	5.4	4.0	3.0	3.8	4.3	3.4	2.2	2.6	4.6	8.8	3.9	7.4	19.6	4.0	5.3	4.7	7.6	5.3	2.4	8.7	4.4	3.1	1.3	4.3	18.2	4.5	1.8	11.1	3.7	0.5	0.0	0.7	1.0	0.6	1.9	0.4	0.5	0.5	0.1	0.2	0.0	0.6	2.0	0.5	0.0	0.3	0.4	0.3	0.0	2.7	0.8	17.8	1.9	1.8	1.0	5.2	20.2	0.5	0.2	1.3	0.7	4.0	4.3	5.9	0.7	0.2	2.0	4.8	0.1	0.1	2.6	0.1	0.2	1.1	0.0	2.6	0.3	0.3	0.2	0.3	1.1	3.2	3.4	1.1	1.5	0.7	0.4	6.4	5.6	2.2	1.6	6.7	0.6	18.2	4.4	7.6	11.1	4.5	7.5	0.8	2.8	7.6	4.3	1.3	1.0	5.4	9.2	1.8	2.4	2.4	0.8	3.7	3.7	6.6	1.3	4.9	3.2	2.4	5.6	0.7	4.0	4.7
DKC1	"Cbf5, DKC, dyskerin, NAP57, NOLA4, XAP101"	ENSG00000130826	"Dyskerin pseudouridine synthase 1"	O60832	X	154762742-154777689	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Isomerase, Ribonucleoprotein, RNA-binding"	"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 113.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000166, HPA000447, HPA001022, CAB033086"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"			40000	"Nucleoli fibrillar center"	Nucleoplasm	"CAB033086: AB_2091314, HPA000166: AB_1078669, HPA000447: AB_1078667, HPA001022: "	"unprognostic (9.87e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (2.66e-5)"	"unprognostic (2.86e-1)"	"prognostic unfavourable (2.94e-4)"	"prognostic unfavourable (1.39e-5)"	"unprognostic (7.02e-2)"	"prognostic unfavourable (9.13e-4)"	"unprognostic (2.53e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.63e-2)"	"prognostic unfavourable (1.46e-9)"	"unprognostic (5.28e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.04e-1)"	"unprognostic (2.55e-1)"	17.6	18.1	17.2	22.5	17.3	42.3	25.8	19.6	20.7	16.6	20.3	14.8	20.7	17.4	19.7	17.1	33.6	18.5	15.9	16.9	15.4	16.3	15.2	22.5	15.2	26.8	15.6	16.6	23.9	38.7	22.6	24.6	19.1	17.0	17.1	26.2	13.7	20.8	18.7	40.8	25.5	18.5	18.3	20.9	25.8	17.6	33.1	16.7	31.3	26.6	28.7	33.2	16.4	20.8	23.5	18.5	16.7	15.5	20.8	26.8	14.8	36.1	20.2	12.5	17.8	7.8	8.0	18.5	13.8	9.8	20.7	19.6	25.4	18.1	69.3	36.4	11.6	19.5	38.0	22.8	31.2	16.7	21.1	35.3	21.2	22.0	11.0	46.4	21.3	7.6	21.9	22.8	52.1	14.3	31.8	17.4	14.0	21.0	31.2	35.7	20.8	25.3	27.2	28.0	35.8	13.0	20.6	27.5	13.6	12.2	21.4	18.8	10.8	18.7	11.4	14.9	22.4	19.1	45.6	32.2	44.5	113.1	10.2	49.2	16.1	4.8	13.1	16.7	21.4	15.5	26.8	23.5	17.6	22.7	18.5	17.1	23.3	22.2	4.0	20.8	14.9	13.4	13.4	14.8	17.2	17.3	19.6	20.7	15.4	16.3	15.6	16.6	17.0	16.7
MPP1	"DXS552E, PEMP"	ENSG00000130830	"Membrane palmitoylated protein 1"	Q00013	X	154778684-154821007	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 58.4;REH: 36.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 46.4;neutrophil: 45.3"	"Group enriched"	"Detected in all"	7	"dendritic cells: 12.7;granulocytes: 46.4;monocytes: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076675	Enhanced		Supported	"Plasma membrane,Centriolar satellite"			4300000	"Plasma membrane"	"Centriolar satellite"	"HPA076675: "	"unprognostic (2.15e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.83e-3)"	"unprognostic (7.14e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.79e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.70e-3)"	"prognostic favourable (4.60e-6)"	"unprognostic (6.69e-2)"	"unprognostic (2.53e-2)"	"unprognostic (4.68e-2)"	"unprognostic (6.67e-3)"	18.7	18.2	12.7	14.4	19.2	52.9	9.9	25.8	30.9	7.1	18.3	10.0	15.1	32.0	8.9	9.5	6.1	10.0	13.5	14.1	14.3	13.0	23.3	20.4	18.2	11.9	15.9	13.5	7.2	18.9	19.5	6.5	45.6	28.8	9.1	10.1	6.4	17.1	10.9	14.6	6.3	42.7	11.0	15.8	27.4	7.9	4.1	7.4	27.1	8.3	6.4	6.9	10.0	7.1	1.6	12.7	46.4	20.9	2.0	3.8	15.8	11.1	2.3	5.2	5.2	5.4	5.7	16.9	4.2	6.4	7.1	8.7	6.3	1.0	8.7	8.2	4.6	1.3	5.9	1.8	5.6	9.2	10.4	58.4	1.6	6.7	8.1	11.9	33.9	5.5	2.5	7.8	1.9	16.0	25.2	1.4	7.9	0.0	27.0	15.8	0.5	7.7	36.9	1.3	4.2	4.1	0.9	1.3	2.1	3.4	0.3	3.6	0.9	7.0	7.4	6.5	3.5	14.3	11.3	10.2	13.9	3.4	9.1	16.8	3.1	9.0	20.9	46.4	1.2	16.7	1.4	1.6	1.4	1.3	12.7	0.7	3.8	1.9	45.3	2.0	20.3	3.5	0.7	15.8	12.7	19.2	25.8	30.9	14.3	13.0	15.9	13.5	28.8	7.4
SMIM9	CXorf68	ENSG00000203870	"Small integral membrane protein 9"	A6NGZ8	X	154823348-154834662	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	4	"testis: 4.1"	"Cell line enhanced"	"Detected in single"		"Daudi: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060970	Uncertain									"HPA060970: "													"unprognostic (2.63e-5)"					0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.0		0.0	0.0	0.0	0.0	0.9		0.0	0.0		0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.0	4.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0										
F8	"DXS1253E, F8C, FVIII, HEMA"	ENSG00000185010	"Coagulation factor VIII"	P00451	X	154835788-155026940	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"		"Disease mutation, FDA approved drug targets, Hemophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB018777	Enhanced				"Secreted to blood"		6400000			"CAB018777: AB_640320"	"unprognostic (2.09e-1)"	"unprognostic (5.66e-4)"	"unprognostic (4.94e-2)"	"unprognostic (8.32e-5)"	"unprognostic (1.26e-1)"	"unprognostic (5.05e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.27e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.67e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.44e-2)"	48.9	9.4	6.8	3.1	7.2	1.5	32.2	1.5	8.6	11.9	10.3	2.2	6.1	2.3	11.1	8.5	18.4	5.4	4.4	38.0	4.9	4.4	17.1	31.3	24.4	25.6	5.6	1.2	18.8	7.2	6.0	14.0	2.8	5.1	20.5	3.5	8.8	4.0	7.1	30.3	2.0	4.3	12.8	3.3	39.0	3.2	17.2	1.8	1.1	15.8	15.0	3.0	17.5	20.2	2.3	3.0	5.2	3.3	4.0	12.9	2.7	4.7	3.9	0.8	1.7	6.0	9.4	0.2	2.6	1.6	1.8	3.1	0.1	5.7	10.2	7.2	2.6	0.5	0.9	0.9	1.6	4.1	1.5	2.1	2.0	0.0	2.8	1.6	4.9	6.7	0.5	1.6	2.2	1.1	0.8	7.9	8.9	2.3	1.4	1.5	1.2	3.9	1.1	1.3	1.4	1.6	1.1	3.1	2.4	6.2	0.6	3.2	1.4	4.2	1.1	9.3	4.7	14.7	2.7	4.6	3.8	4.9	8.6	10.6	4.9	3.7	3.3	0.5	6.5	2.8	12.9	2.3	3.9	6.8	3.0	1.6	2.0	5.1	5.2	4.0	2.6	0.4	5.2	2.7	6.8	7.2	1.5	8.6	4.9	4.4	5.6	1.2	5.1	1.8
H2AFB1		ENSG00000274183	"H2A histone family member B1"	P0C5Y9	X	154884972-154885558	"Predicted intracellular proteins"	"mRNA processing"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"testis: 6.4"	"Cell line enriched"	"Detected in single"	19	"HDLM-2: 16.8"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"																																							0.0	0.0		0.1		1.4	0.0		0.0	0.0	0.0			0.3	0.0	0.0	0.0	0.0	0.0	0.1			0.0	0.0	0.0	0.1			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.9	0.9	0.6	0.1		0.3	0.0	6.4			0.0		0.0	0.0		0.9	0.0	1.5	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.4	0.1	0.8	0.5	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.6	0.0	0.0	0.0	0.1	0.1	0.7	0.7	0.0	0.0	0.0	0.9	0.0	0.0	1.5	0.0	0.0	0.0	0.4	0.0										
F8A1	"DXS522E, F8A"	ENSG00000277203	"Coagulation factor VIII associated 1"	P23610	X	154886349-154888061	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA046960	Uncertain									"HPA046960: "	"unprognostic (6.72e-2)"	"prognostic favourable (1.67e-6)"	"unprognostic (2.92e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.18e-3)"	"unprognostic (3.31e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.68e-2)"	"unprognostic (6.28e-2)"	"unprognostic (6.16e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.69e-1)"	2.9	1.3	1.8	1.8	1.8	4.9	1.8	1.8	1.8	1.9	2.1	1.8	1.8	2.0	1.8	4.0	1.8	1.7	1.8	3.0	1.8		3.3	5.0	2.4	2.6	1.8	1.8	1.8	3.6	0.0	1.8	1.8	4.6	2.4	2.1	1.8	3.6	3.0	2.5	2.3	1.8	2.0	1.8	2.2	1.4	1.8	1.8	1.8	2.7	1.8	2.9	1.8	1.8	3.5	5.9	9.0	4.4	1.2	5.9	2.0	34.7	16.0	3.2	5.0	11.1	5.3	0.0	9.1	7.8	9.6	12.6	6.3	13.7	3.8	30.3	5.6	3.8	4.5	4.3	8.0	20.3	2.2	3.9	4.9	6.1	3.4	7.1	2.0	10.1	4.0	3.2	1.8	2.0	0.4	14.4	5.6	17.8	11.4	31.3	5.6	18.5	20.9	3.1	3.4	10.8	12.2	15.8	6.6	5.5	6.9	11.7	8.1	14.1	5.8	5.7	12.5	4.1	7.4	14.6	14.2	33.5	2.9	25.5	12.2	0.0	4.4	9.0	4.3	4.3	2.3	2.0	4.7	5.1	4.9	3.5	5.3	5.9	8.4	1.2	1.6	5.9	2.2	2.0										
FUNDC2	"DC44, HCBP6"	ENSG00000165775	"FUN14 domain containing 2"	Q9BWH2	X	155025980-155060303	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA059129	Approved									"HPA059129: "	"unprognostic (2.23e-1)"	"prognostic favourable (9.20e-4)"	"unprognostic (2.03e-1)"	"prognostic unfavourable (7.26e-4)"	"unprognostic (2.07e-2)"	"unprognostic (6.20e-2)"	"prognostic unfavourable (3.78e-5)"	"unprognostic (6.56e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.49e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.67e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.81e-1)"	6.1	6.6	5.2	2.8	6.1	4.8	20.5	9.3	5.3	8.3	6.2	1.9	7.5	3.6	6.6	8.2	6.4	5.7	5.1	22.6	4.9	5.3	8.3	5.6	5.2	5.5	5.7	2.3	19.4	12.7	6.2	10.2	4.4	7.9	10.5	4.6	5.8	10.7	5.5	26.3	2.8	5.0	9.8	4.5	3.4	5.4	8.9	4.2	2.8	8.6	10.9	3.9	7.4	17.4	5.6	6.1	4.6	5.8	3.6	6.2	6.7	6.8	4.2	6.3	4.7	8.6	6.7	5.2	4.0	4.6	5.0	10.3	4.1	2.8	8.9	10.6	5.1	2.9	6.8	5.5	3.4	4.6	9.0	2.8	5.5	2.2	3.9	5.7	3.7	7.5	8.4	4.1	3.5	3.4	3.6	6.4	5.1	3.4	4.1	3.4	4.3	9.6	3.6	4.5	8.7	5.1	2.8	3.5	7.2	3.4	3.5	4.9	3.7	5.5	3.5	3.7	5.3	6.7	6.3	4.0	6.7	9.5	3.6	7.2	2.9	3.1	4.8	4.6	5.9	5.0	5.6	5.6	5.5	5.7	6.1	4.9	6.0	6.2	0.4	3.6	5.8	5.5	5.6	6.7	5.2	6.1	9.3	5.3	4.9	5.3	5.7	2.3	7.9	4.2
CMC4	"MTCP1, MTCP1NB, p8, P8MTCP1"	ENSG00000182712	"C-X9-C motif containing 4"	P56277	X	155061622-155071362	"Disease related genes, Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 36.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA045866	Approved		Supported	Mitochondria				Mitochondria		"HPA045866: AB_10964642"										"unprognostic (4.54e-3)"				"unprognostic (7.31e-2)"				11.5	9.2	13.4	9.2	12.6	6.2	26.7	7.1	8.9	11.0	11.3	6.7	13.2	9.7	9.9	13.6	12.5	8.9	8.3	49.6	10.9	10.0	12.0	21.8	15.0	26.2	13.7	5.7	11.9	34.6	7.1	11.4	6.8	11.6	10.5	6.0	7.6	14.5	12.6	21.2	8.2	11.4	15.2	15.8	8.3	8.5	7.3	7.4	5.4	14.5	10.0	7.7	12.4	8.7	11.3	10.8	11.8	7.5	12.0	9.0	4.6	19.6	5.0	3.0	6.6	8.4	8.1	4.7	3.9	5.6	5.6	9.5	3.7	3.8	13.5	10.3	4.3	6.5	4.0	5.2	4.0	14.3	10.1	2.2	3.4	4.5	8.6	4.2	3.1	7.7	8.5	5.8	7.6	4.7	2.2	5.0	5.8	7.4	5.6	7.9	1.8	14.3	4.3	7.0	8.8	6.3	1.2	6.2	5.1	5.2	5.8	6.8	4.3	2.4	5.5	8.6	5.3	5.5	5.2	20.3	20.4	36.0	8.1	9.7	5.6	1.1	7.5	11.8	9.0	4.2	8.7	11.0	7.1	8.3	10.8	11.3	2.2	5.9	0.8	12.0	1.5	2.1	8.2	4.6	13.4	12.6	7.1	8.9	10.9	10.0	13.7	5.7	11.6	7.4
MTCP1	"P13MTCP1, p8MTCP1"	ENSG00000214827	"Mature T cell proliferation 1"	P56278	X	155061622-155147937	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 14.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032040			Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA032040: "	"unprognostic (2.42e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.29e-3)"	"unprognostic (8.30e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.40e-5)"	"unprognostic (9.30e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.94e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavourable (4.52e-8)"	"unprognostic (1.55e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.75e-2)"	6.4	7.1	4.1	5.3	5.3	7.2	15.8	4.4	4.8	6.0	6.2	3.4	7.7	5.7	6.0	8.2	7.0	6.1	4.4	30.1	4.7	2.9	6.7	12.8	8.5	15.5	4.5	2.7	9.1	20.7	3.9	6.5	3.5	6.4	5.8	6.1	3.9	7.3	7.0	11.4	12.0	6.7	8.7	7.2	6.7	6.2	16.1	3.8	2.5	8.2	5.4	7.2	6.9	4.0	0.2	0.0	0.8	0.7	0.5	2.0	0.1	1.4	4.9	2.4	3.8	1.6	1.3	2.6	3.0	1.5	1.9	4.7	4.2	7.4	2.6	3.0	0.6	4.7	3.1	3.5	2.3	1.8	3.1	1.2	14.0	2.3	1.3	2.8	3.2	2.4	1.6	3.1	3.0	1.7	1.1	4.8	1.3	2.0	3.7	6.0	1.1	0.8	3.9	2.5	6.0	2.4	2.0	1.2	1.8	2.1	1.2	2.1	2.1	1.3	1.8	2.2	3.8	2.1	2.2	10.5	4.5	5.1	4.2	3.4	3.1	0.0	0.6	0.8	1.1	0.0	2.0	0.2	1.2	0.4	0.0	0.1	0.2	1.4	0.0	0.5	0.7	0.0	0.0	0.1	4.1	5.3	4.4	4.8	4.7	2.9	4.5	2.7	6.4	3.8
BRCC3	"BRCC36, C6.1A, CXorf53"	ENSG00000185515	"BRCA1/BRCA2-containing complex subunit 3"	P46736	X	155071420-155123074	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Metalloprotease, Protease"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA048737			Supported	Nucleoplasm				Nucleoplasm		"HPA048737: "	"unprognostic (1.16e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.47e-3)"	"unprognostic (1.33e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.72e-2)"	"unprognostic (3.71e-3)"	"unprognostic (7.14e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.90e-1)"	12.9	14.8	11.3	11.2	16.5	14.0	12.9	20.0	18.6	11.8	19.5	9.1	15.2	16.7	9.4	11.8	20.4	12.1	8.3	10.3	10.3	12.1	18.3	12.3	9.4	12.5	10.4	10.5	10.7	12.2	14.3	11.8	14.2	15.3	12.2	19.5	8.7	15.5	12.6	21.3	10.0	19.2	13.1	8.9	11.1	13.7	3.9	12.9	10.2	13.9	13.7	12.7	11.4	11.6	13.4	16.2	25.0	17.8	21.0	19.0	12.3	31.4	19.5	8.2	6.4	6.2	5.1	13.6	12.9	8.2	7.9	17.5	17.6	13.8	30.3	23.6	8.2	12.2	21.1	11.5	11.5	17.6	16.9	6.1	30.7	14.6	5.5	21.4	9.5	6.3	5.2	12.9	11.0	10.8	9.9	9.0	6.4	13.3	8.2	7.6	7.3	13.9	12.9	14.1	12.6	9.5	14.9	13.5	5.8	8.5	13.6	7.7	9.4	7.3	12.1	7.1	10.9	10.4	19.4	11.5	18.7	39.4	10.3	20.1	8.2	22.6	14.7	25.0	16.2	17.8	19.0	13.4	16.0	14.8	16.2	11.8	12.5	14.0	8.0	21.0	16.9	10.4	18.6	12.3	11.3	16.5	20.0	18.6	10.3	12.1	10.4	10.5	15.3	12.9
VBP1	"PFD3, PFDN3"	ENSG00000155959	"VHL binding protein 1"	P61758	X	155197007-155239817	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB006260, HPA023230"	Approved		Supported	Vesicles,Cytosol				Cytosol	Vesicles	"CAB006260: AB_425740, HPA023230: AB_1858727"	"unprognostic (1.55e-3)"	"unprognostic (1.12e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.85e-3)"	"unprognostic (5.31e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.54e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.80e-1)"	17.3	19.2	37.8	15.5	28.0	24.5	18.4	26.1	32.5	14.9	16.9	20.6	12.5	12.8	14.9	16.3	17.8	13.8	13.3	35.9	35.4	36.8	22.9	17.4	13.0	21.0	40.9	25.6	15.3	11.8	18.3	22.0	16.9	33.9	18.2	19.2	10.1	11.1	15.6	50.5	10.9	14.3	16.4	46.0	13.9	12.5	8.7	22.9	21.0	18.4	25.6	22.0	16.9	12.8	15.0	18.4	37.0	12.6	13.8	21.6	15.7	35.1	12.7	27.7	18.4	11.5	15.9	8.0	17.5	13.6	23.1	36.2	15.1	18.1	45.3	37.5	14.7	13.9	40.1	16.4	30.0	23.8	28.1	19.0	20.1	11.8	13.7	30.6	15.0	11.8	19.6	19.2	24.3	21.2	37.1	27.0	25.9	14.6	28.8	27.4	16.0	27.4	24.8	22.0	26.5	20.0	16.1	30.1	18.3	12.0	14.2	19.3	12.1	23.7	12.3	18.5	22.9	31.3	43.1	30.5	44.2	79.2	16.4	38.0	22.6	8.5	11.6	37.0	14.4	12.6	16.5	15.0	16.9	17.2	18.4	11.8	19.6	20.7	13.6	13.8	10.4	15.1	21.6	15.7	37.8	28.0	26.1	31.9	35.4	36.8	40.9	25.6	33.9	22.9
RAB39B	"MRX72, WSN"	ENSG00000155961	"RAB39B, member RAS oncogene family"	Q96DA2	X	155258241-155264589	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"		"Autism spectrum disorder, Disease mutation, Mental retardation, Parkinson disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 15.7;Karpas-707: 20.8;U-266/70: 20.9;U-266/84: 14.5"	"Cancer enhanced"	"Detected in many"		"glioma: 6.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001114, HPA042505"	Approved									"HPA001114: AB_1079732, HPA042505: "	"prognostic favourable (8.95e-4)"	"unprognostic (1.20e-3)"	"unprognostic (3.52e-2)"	"unprognostic (7.10e-5)"	"unprognostic (1.77e-1)"	"unprognostic (7.47e-4)"	"unprognostic (2.19e-1)"	"unprognostic (6.00e-4)"	"unprognostic (1.78e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.87e-4)"	"unprognostic (5.41e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.21e-2)"	"unprognostic (4.94e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.24e-1)"	0.9	3.8	9.4	4.8	12.1	1.7	1.7	14.2	21.5	1.3	1.7	5.8	1.8	1.5	1.0	11.6	1.1	1.4	1.6	1.1	10.4	11.0	1.8	1.0	1.5	8.5	10.1	9.6	1.2	4.7	7.7	10.8	0.9	11.9	3.9	1.6	1.0	1.2	2.8	0.6	0.6	2.0	0.9	9.5	5.3	2.6	2.0	7.3	4.5	4.6	0.0	9.9	2.4	0.7	4.9	5.4	3.3	0.5	3.5	8.7	3.8	0.0	0.2	3.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.7	0.7	0.0	0.0	0.0	0.1	0.0	6.6	0.3	1.3	0.0	0.0	1.0	0.0	2.8	0.1	0.0	0.2	4.6	0.0	0.0	20.8	0.1	1.1	5.7	0.0	4.0	0.3	0.0	0.0	1.2	0.0	0.0	7.9	6.1	0.0	0.0	3.6	0.2	0.1	0.0	0.4	1.3	0.0	0.6	20.9	14.5	3.6	3.7	0.0	0.0	1.0	0.4	2.5	5.7	0.3	5.9	4.9	7.7	7.4	5.4	3.4	8.1	8.7	3.3	3.5	0.5	1.4	5.6	3.8	9.4	12.1	14.2	15.8	10.4	11.0	10.1	9.6	11.9	7.3
CLIC2	XAP121	ENSG00000155962	"Chloride intracellular channel 2"	O15247	X	155276211-155334657	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 62.3;vagina: 66.1"	"Group enriched"	"Detected in some"	5	"HDLM-2: 36.5;K-562: 19.7;Karpas-707: 18.2;RPMI-8226: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 9.5;myeloid DC: 24.5;non-classical monocyte: 6.5"	"Group enriched"	"Detected in many"	14	"dendritic cells: 24.5;monocytes: 9.5"					"Low region specificity"	"Detected in all"			"HPA047381, HPA060101"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"			290000	"Plasma membrane"	Nucleoplasm	"HPA047381: , HPA060101: "	"unprognostic (3.27e-2)"	"unprognostic (5.21e-3)"	"unprognostic (9.70e-2)"	"unprognostic (7.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-1)"	"prognostic unfavourable (1.74e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.97e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.54e-1)"	26.5	3.7	3.8	7.5	6.1	3.4	24.1	2.6	4.8	15.5	6.8	0.6	3.3	4.0	11.3	10.5	10.4	6.5	9.8	9.4	3.7	3.4	5.4	6.3	31.0	15.6	7.5	1.4	12.5	2.6	2.0	7.8	4.5	6.8	9.1	6.9	3.0	5.4	3.2	10.3	5.2	7.3	10.2	5.2	32.1	4.7	5.6	4.3	6.9	62.3	8.7	12.4	14.0	66.1	0.0	24.5	0.6	9.5	1.1	0.1	1.0	0.2	0.0	0.4	0.3	0.3	2.0	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	36.5	0.2	5.1	0.1	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.0	19.7	18.2	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	31.1	0.1	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.4	0.0	1.7	0.5	0.7	0.3	1.1	1.6	0.0	0.9	1.1	0.6	0.0	1.8	0.1	0.0	9.5	0.1	0.0	0.0	0.1	24.5	0.0	0.0	0.0	0.6	1.1	6.5	2.5	0.0	1.0	3.8	6.1	2.6	4.8	3.7	3.4	7.5	1.4	6.8	4.3
H2AFB2		ENSG00000277858	"H2A histone family member B2"	P0C5Z0	X	155380787-155381134	"Predicted intracellular proteins"	"mRNA processing"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 2.3;pancreas: 2.4;salivary gland: 2.8"	"Cell line enhanced"	"Detected in some"		"A-431: 2.0;CAPAN-2: 3.2;HeLa: 4.2;NB-4: 2.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.3		0.0		0.0	0.0		0.1	0.0	0.3			2.3	0.0	0.0	0.5	0.0	0.0	1.3			0.1	0.0	0.0	0.2			0.2	2.4	0.0		0.1		0.0	0.1		2.8	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.4			0.0		0.0	0.0		0.4	0.6	0.0	0.3	0.0	0.4	1.2	2.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.7	1.1	0.0	0.0	0.2	1.5	0.0	4.2	0.0	0.0	1.7	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.1	2.6	0.0	0.0	0.7	0.0	0.0	1.4	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.2	0.4	0.9	0.0	2.0	1.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.4	1.2										
F8A2		ENSG00000274791	"Coagulation factor VIII associated 2"	P23610	X	155382115-155383230	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"BEWO: 2.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046960	Uncertain									"HPA046960: "					"unprognostic (2.04e-2)"					"unprognostic (5.07e-1)"				"unprognostic (8.70e-2)"				0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
F8A3		ENSG00000277150	"Coagulation factor VIII associated 3"	P23610	X	155456914-155458672	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 6.3;parathyroid gland: 10.5"	"Cell line enhanced"	"Detected in many"		"U-266/70: 23.3;U-266/84: 21.7"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"eosinophil: 6.3"	"Low lineage specificity"	"Detected in many"											HPA046960	Uncertain									"HPA046960: "	"unprognostic (1.83e-1)"	"unprognostic (9.94e-2)"			"unprognostic (3.30e-2)"	"unprognostic (2.08e-1)"		"unprognostic (2.94e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.38e-1)"		"unprognostic (7.03e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.47e-1)"		"unprognostic (1.53e-1)"	"unprognostic (7.96e-2)"	2.3	1.4		1.4		2.1	1.2		2.5	0.9	1.7			1.1	0.0	1.6	0.0	0.6	0.9	0.3			1.8	1.8	0.4	0.8			1.0	0.0	10.5		0.4		0.0	0.3		0.1	0.6	4.2	0.0	1.9	0.0		0.7	1.5	0.0			0.0		0.1	2.9		1.0	1.0	6.3	0.7	0.4	1.8	0.3	0.5	0.0	1.2	0.0	4.9	3.5	0.0	0.2	0.0	0.0	0.0	2.3	0.0	6.5	0.6	8.0	6.3	1.3	0.0	0.0	0.9	3.1	8.3	5.4	0.1	5.6	11.1	4.0	0.0	0.0	5.0	3.9	3.1	0.0	0.0	8.2	0.0	11.5	0.0	2.2	0.4	0.5	0.0	6.0	4.9	3.9	0.0	2.3	4.6	0.0	0.1	0.0	6.9	2.7	11.4	0.1	8.1	13.2	23.3	21.7	0.3	3.3	0.1	0.0	0.0	0.6	6.3	1.8	0.4	1.1	0.8	1.6	1.5	0.9	1.0	0.9	1.0	1.5	0.4	0.7	1.0	0.3	0.3										
H2AFB3	H2AFB	ENSG00000277745	"H2A histone family member B3"	P0C5Z0	X	155459415-155460005	"Predicted intracellular proteins"	"mRNA processing"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 14.6"	"Cell line enriched"	"Detected in some"	5	"HDLM-2: 13.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.2	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.2	0.0		0.0		0.0	0.0		0.0	0.0	0.4	0.0	0.0	0.0		0.2	0.0	14.6			0.0		0.0	0.0		0.4	0.3	0.0	0.3	0.0	0.7	0.0	0.5	2.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.5	0.0	0.0	0.0	0.0	0.0	13.6	0.2	0.0	2.3	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.2	0.0	0.6	0.8	1.2	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0										
TMLHE	"BBOX2, FLJ10727, TMLH, XAP130"	ENSG00000185973	"Trimethyllysine hydroxylase, epsilon"	Q9NVH6	X	155490115-155669944	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carnitine biosynthesis"	"Dioxygenase, Oxidoreductase"	"Autism, Autism spectrum disorder, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034589, HPA040331"	Approved		Supported	Mitochondria				Mitochondria		"HPA034589: AB_10670571, HPA040331: "	"unprognostic (1.98e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.41e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.10e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.27e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.20e-3)"	"unprognostic (6.97e-2)"	"prognostic favourable (3.68e-6)"	"unprognostic (1.69e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.75e-2)"	10.1	15.0	8.5	6.7	10.5	6.7	10.4	17.1	13.5	11.3	10.5	10.0	9.1	10.7	10.9	10.1	9.5	9.5	7.4	22.3	10.3	7.5	15.8	16.9	6.9	14.6	12.5	7.4	12.4	10.7	18.4	17.5	7.6	11.5	7.7	11.6	10.6	16.2	9.6	28.1	7.8	10.0	13.8	13.7	9.2	9.8	3.1	11.2	12.2	10.5	5.3	8.7	10.2	9.1	9.1	10.3	14.7	15.7	4.3	5.6	4.5	15.2	7.5	6.2	18.1	7.7	11.9	0.0	6.2	9.1	7.8	20.4	5.3	8.6	0.0	25.0	10.8	8.3	13.2	6.0	8.9	6.2	9.1	6.8	12.2	6.2	10.8	6.4	4.9	12.6	12.7	8.7	13.2	12.3	9.5	5.6	12.9	5.7	7.7	7.2	1.9	0.1	7.7	9.9	5.8	9.4	5.2	5.9	8.9	5.8	0.3	6.7	6.7	7.3	10.3	6.6	6.3	13.0	7.6	7.0	7.5	5.9	8.0	10.0	6.0	1.9	10.1	11.3	3.9	11.4	2.9	6.2	4.3	3.3	10.3	9.1	5.6	4.9	14.7	4.3	15.7	4.7	4.2	4.5	8.5	10.5	17.1	13.5	10.3	7.5	12.5	7.4	11.5	11.2
SPRY3	HSPRY3	ENSG00000168939	"Sprouty RTK signaling antagonist 3"	O43610	X	155767812-155782459	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.4;EFO-21: 4.1"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB013505	Uncertain		Approved	Nucleoli,Cytosol				Cytosol	Nucleoli	"CAB013505: "	"unprognostic (3.70e-2)"	"unprognostic (4.39e-1)"	"unprognostic (5.24e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.52e-4)"	"unprognostic (1.21e-2)"	"unprognostic (9.60e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.44e-2)"	"unprognostic (3.49e-2)"	1.6	2.1	1.3	0.4	1.8	2.8	1.2	7.5	1.5	1.3	0.8			1.2	1.5	5.8	0.8	1.1	0.8	0.9	1.3	1.5	0.9	0.7	0.9	0.3	1.1		2.8	0.4	1.3	1.1	1.9		0.9	1.4		1.1	1.2	1.2	0.4	1.1	1.2	1.2	1.4	0.7	0.1			1.0		0.5	0.8	0.7	0.0	0.5	0.4	0.5	0.2	0.2	0.0	0.5	0.2	2.3	8.4	1.7	0.8	0.0	2.0	1.3	0.6	1.0	0.2	1.4	0.0	4.1	1.1	0.3	0.9	0.6	0.6	0.2	0.4	1.0	2.1	0.1	0.7	0.4	0.4	2.0	1.1	0.8	0.5	1.3	0.1	0.6	1.6	0.3	0.2	0.3	0.8	0.0	0.5	0.2	2.0	0.9	0.7	0.6	0.6	1.0	0.0	0.5	0.5	0.6	2.1	0.6	0.9	0.3	0.6	0.6	0.1	1.8	2.0	1.0	1.1	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.1	0.5	0.0	0.0										
VAMP7	"SYBL1, TI-VAMP, VAMP-7"	ENSG00000124333	"Vesicle associated membrane protein 7"	P51809	X	155881293-155943769	"Predicted intracellular proteins, Predicted membrane proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036733	Approved		Supported	Vesicles			14000	Vesicles		"HPA036733: AB_10672228"	"unprognostic (7.54e-3)"	"unprognostic (1.35e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.15e-3)"	"unprognostic (2.70e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.95e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.15e-1)"	"prognostic favourable (2.83e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.97e-1)"	11.9	12.7	43.9	9.5	51.2	13.4	51.9	21.2	41.1	38.4	9.3	2.5	2.5	9.6	36.5	6.6	10.4	8.5	9.3	26.9	46.8	12.5	61.4	20.5	10.3	9.8	50.6	44.8	34.5	7.9	12.8	35.0	68.7	58.5	9.4	10.5	2.5	8.3	9.0	12.0	9.3	11.3	12.0	63.0	8.4	8.4	5.6	47.6	2.5	10.4	2.5	11.6	10.2	26.1	6.6	13.5	34.8	13.8	11.2	11.0	10.6	21.9	9.6	6.6	13.7	18.4	17.7	17.8	17.1	15.3	15.5	31.5	10.3	14.4	30.6	31.9	20.5	7.9	14.8	12.0	20.6	12.7	13.0	12.7	14.3	7.3	20.6	26.0	19.9	16.4	12.0	17.3	15.9	17.2	27.1	17.0	17.5	11.0	10.1	14.8	4.7	14.1	7.7	13.0	22.7	20.6	11.1	5.0	14.6	10.1	10.2	15.0	10.0	21.9	18.1	14.3	14.9	20.5	24.2	39.2	49.5	42.9	12.5	31.9	15.9	34.8	12.9	19.7	8.3	13.8	10.5	6.5	9.9	10.2	13.5	6.6	9.2	9.8	11.2	11.2	12.8	7.7	11.0	10.6	43.9	51.2	21.2	41.1	46.8	12.5	50.6	44.8	58.5	47.6
IL9R	CD129	ENSG00000124334	"Interleukin 9 receptor"	Q01113	X	155997581-156010817	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 6.3;urinary bladder: 10.9"	"Cell line enriched"	"Detected in some"	11	"HMC-1: 74.2"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 1.4"	"Group enriched"	"Detected in some"	6	"basal ganglia: 1.7;pons and medulla: 4.7;thalamus: 1.5"	"Cell type enhanced"	"Detected in many"		"eosinophil: 6.3"	"Group enriched"	"Detected in many"	25	"B-cells: 4.1;granulocytes: 6.3;T-cells: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA063240, HPA064557"	Approved				"Intracellular and membrane"					"HPA063240: , HPA064557: "	"unprognostic (1.07e-2)"	"unprognostic (3.27e-3)"	"unprognostic (9.52e-3)"	"unprognostic (4.13e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.26e-4)"	"unprognostic (8.94e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.98e-8)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.07e-1)"	"prognostic favourable (1.90e-7)"	0.3	0.1	0.3	1.1	1.7	0.4	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.7	3.0	0.3	0.5	0.4	0.9	0.3	0.3	0.2	0.3	0.5	1.3	3.2	0.3	0.3	0.3	0.3	0.0	0.3	0.3	4.7	0.4	1.2	0.3	0.4	0.3	0.3	0.4	2.4	0.3	0.3	3.5	0.8	0.3	1.5	0.3	0.4	0.3	2.9	10.9	0.3	4.1	0.0	6.3	0.0	0.1	2.4	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	6.8	0.0	0.0	0.0	0.1	74.2	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.3	2.6	1.3	0.0	0.0	0.1	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.1	0.0	0.0	0.0	6.3	0.0	0.0	0.0	1.8	0.8	1.3	0.0	4.1	0.0	0.0	1.8	0.1	0.0	0.0	2.4	0.3	0.3	1.7	0.4	0.3	0.3	0.2	0.3	0.3	4.7	1.5